<SEC-DOCUMENT>0001104659-21-060332.txt : 20210503
<SEC-HEADER>0001104659-21-060332.hdr.sgml : 20210503
<ACCEPTANCE-DATETIME>20210503172325
ACCESSION NUMBER:		0001104659-21-060332
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		151
CONFORMED PERIOD OF REPORT:	20210617
FILED AS OF DATE:		20210503
DATE AS OF CHANGE:		20210503

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVAVAX INC
		CENTRAL INDEX KEY:			0001000694
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				222816046
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-26770
		FILM NUMBER:		21884778

	BUSINESS ADDRESS:	
		STREET 1:		21 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		240-268-2000

	MAIL ADDRESS:	
		STREET 1:		21 FIRSTFIELD ROAD
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm212692d3_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"></p>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 4pt; text-align: center"><b>Washington, D.C. 20549</b></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>SCHEDULE 14A</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>(Rule 14a-101)</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>INFORMATION REQUIRED IN</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>PROXY STATEMENT</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>SCHEDULE 14A INFORMATION</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;<B>Proxy Statement Pursuant to Section
14(a)</B></p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 4pt; text-align: center"><b>of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></p>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Filed by the Registrant</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%">&#9746;</TD></TR>
</TABLE>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 11.5pt; text-indent: -11.5pt"></p>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Filed by a Party other than the Registrant</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%"> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#9744;</FONT></TD></TR>
</TABLE>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Check the appropriate box:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&#9744;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Preliminary
    Proxy Statement</font></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&#9744;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt">&nbsp;</td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&#9746;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt">&nbsp;</td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Definitive Proxy Statement</font></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&#9744;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt">&nbsp;</td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Definitive Additional Materials</font></td></tr>
<tr>
    <td style="vertical-align: top; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&#9744;</font></td>
    <td style="vertical-align: bottom; font-size: 10pt">&nbsp;</td>
    <td style="vertical-align: bottom; font-size: 10pt"><font style="font-size: 10pt">Soliciting Material Pursuant to &sect;240.14a-12</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in">&nbsp;<b>&nbsp;</b></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>NOVAVAX, INC.</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>(Name of registrant as specified in its
charter)</b></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>(Name of person(s) filing proxy statement,
if other than the registrant)</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate
box):</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">&#9746;</font></td>
    <td colspan="2" style="padding-right: 0.7pt; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif">No fee required.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">&#9744;</font></td>
    <td colspan="2" style="padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td colspan="2" style="padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(1)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Title of each class of securities to which the transaction applies:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(2)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Aggregate number of securities to which the transaction applies:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(3)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Per unit price or other underlying value of the transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(4)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Proposed maximum aggregate value of the transaction:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt; width: 4%">&nbsp;</td>
    <td style="vertical-align: top; width: 3%; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(5)&nbsp;</font></td>
    <td style="vertical-align: top; width: 93%; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Total fee paid:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td colspan="2" style="padding-right: 0.7pt; text-align: justify">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td colspan="2" style="padding-right: 0.7pt; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Fee paid previously with preliminary materials.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td colspan="2" style="padding-right: 0.7pt; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td colspan="2" style="padding-right: 0.7pt; text-align: justify">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(1)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Amount Previously Paid:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(2)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Form, Schedule or Registration Statement No.:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(3)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Filing Party:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">(4)</font></td>
    <td style="vertical-align: top; padding-right: 0.7pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif">Date Filed:</font></td></tr>
<tr>
    <td style="padding-right: 0.7pt">&nbsp;</td>
    <td style="vertical-align: top; padding-right: 0.7pt">&nbsp;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 0.7pt">&nbsp;</td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm212692d3_sch14-aimg001.jpg" ALT="(GRAPHIC)">&nbsp;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt; color: White">2021
proxy statement&nbsp;</font></p>



<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><IMG SRC="tm212692d3_sch14-aimg003.jpg" ALT="(GRAPHIC)"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: center; color: #7C7E81"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt">Creating
Tomorrow&rsquo;s Vaccines Today</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: center; color: #7C7E81">&nbsp;&nbsp;</p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: rgb(48,96,156) 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0"></p>

<div style="float: left; width: 48%">

<p style="margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse; background-color: White">
<tr style="background-color: #486C93">
    <td colspan="2" style="padding: 2pt 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: White"><b>NOVAVAX FYE 2020 AT A GLANCE</b></font></td>
    <td style="padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt; text-align: center; background-color: White"><font style="color: White">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; width: 46%; padding-top: 2pt; padding-right: 5pt; padding-bottom: 2pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: rgb(73,109,147)">$476M</font></td>
    <td style="vertical-align: bottom; width: 50%; border-bottom: #69737B 1pt solid; padding: 2pt 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">revenue</font></td>
    <td style="vertical-align: bottom; width: 4%; padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt">&nbsp;</td></tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-right: 5pt; padding-bottom: 2pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: rgb(73,109,147)">$747M</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">invested in R&amp;D</font></td>
    <td style="padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-right: 5pt; padding-bottom: 2pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: rgb(73,109,147)">450+</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">U.S. patents and pending patent applications</font></td>
    <td style="padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-right: 5pt; padding-bottom: 2pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: rgb(73,109,147)">691</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">employees, of which 83% are engaged in R&amp;D</font></td>
    <td style="padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-right: 5pt; padding-bottom: 2pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: rgb(73,109,147)">438,700</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">total sq.ft. in U.S., Swedish, and Czech facilities</font></td>
    <td style="padding-top: 2pt; border-right: rgb(105,115,123) 1pt solid; padding-bottom: 2pt; vertical-align: bottom">&nbsp;</td></tr>
<tr>
    <td style="text-align: right">&nbsp;</td>
    <td style="vertical-align: bottom; padding-right: 5pt; padding-left: 5pt">&nbsp;</td>
    <td style="border-right: rgb(153,159,164) 1pt solid; vertical-align: bottom">&nbsp;</td></tr>
</table>



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #486C93">
    <td style="padding-top: 2pt; padding-bottom: 2pt; font-size: 10pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: White"><b>DEVELOPMENT
    PIPELINE</b></font></td>
    <td style="padding-top: 2pt; border-right: rgb(153,159,164) 1pt solid; padding-bottom: 2pt; text-align: center; background-color: White"><font style="color: White">&nbsp;</font></td>
    </tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 96%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; color: #2E2E2E"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Coronavirus</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; color: #2E2E2E"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">NVX-CoV2373</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">Variant Strain (Booster and/or
Bivalent)</font></p></td>
    <td style="border-right: rgb(153,159,164) 1pt solid; width: 4%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #2E2E2E">&nbsp;</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 8pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">Seasonal Influenza</font></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 2pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">NanoFlu&trade; vaccine (Older Adults)</font></p></td>
    <td style="padding-top: 1pt; padding-bottom: 2pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #2E2E2E">&nbsp;</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 8pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">Combination Vaccines</font></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                            </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">NanoFlu vaccine/NVX-CoV2373</font>&nbsp;</p></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0">&nbsp;</p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2E2E2E">NanoFlu vaccine/RSV</font></p></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #2E2E2E">&nbsp;</font></p></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 2pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 39.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
                                            </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">NanoFlu vaccine/NVX-CoV2373/RSV</font></p></td>
    <td style="padding-top: 1pt; padding-bottom: 2pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p></td></tr>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-left: 5.4pt; text-indent: 0; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-top: 1pt; border-right: rgb(153,159,164) 1pt solid; font-size: 10pt">&nbsp;</TD></TR>
</table>


<p style="margin: 0"></p>

<p style="margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="margin: 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

</div>


<div style="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:50%">

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 100%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B">&nbsp;</p>
                            <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Novavax,
                                         Inc. (Nasdaq: NVAX), together with our wholly-owned subsidiaries, Novavax AB and Novavax
                                         CZ, is a biotechnology company promoting improved global health through the discovery,
                                         development and commercialization of innovative vaccines to prevent serious infectious
                                         diseases and address urgent, global health needs.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">We
have more than a decade of experience contending with some of the world&rsquo;s most devastating diseases, including COVID-19,
seasonal influenza, RSV, Ebola, MERS, and SARS. Hard-won lessons and significant advances illustrate that our proven technology
has tremendous potential to make a substantial contribution to public health worldwide.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Our
vaccine candidates, including both our coronavirus vaccine candidate, (&ldquo;NVX-CoV2373") and our nanoparticle seasonal quadrivalent
influenza vaccine candidate (&ldquo;NanoFlu<sup>TM</sup>&rdquo; vaccine), are genetically engineered, three-dimensional nanostructures
of recombinant proteins critical to disease pathogenesis.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #69737B"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</font></p>

<p style="margin: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #69737B">We
are also developing proprietary immune-stimulating saponin-based adjuvants at Novavax AB, our wholly-owned Swedish
subsidiary.&nbsp;Matrix-M&trade; adjuvant has been shown to enhance immune responses and has been well tolerated in multiple
clinical trials.&nbsp;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 11pt Arial, Helvetica, Sans-Serif; color: #69737B">&nbsp;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 11pt Arial, Helvetica, Sans-Serif; color: #69737B">&nbsp;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 11pt Arial, Helvetica, Sans-Serif; color: #69737B">&nbsp;</font></p>
<p style="margin: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #69737B">&nbsp;</font></p>
<p style="margin: 0; text-align: justify"><font style="font: 11pt Arial, Helvetica, Sans-Serif; color: #69737B">&nbsp;</font></p></td></tr>
</table></div>
<br clear="ALL"><br>




<!-- Field: Page; Sequence: 3; Value: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->




<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg004.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #7C7E81"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt">Creating
Tomorrow&rsquo;s Vaccines Today</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; color: #7C7E81"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<div style="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:46%">


</div>
<div style="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:52%">



</div>
<br clear="ALL"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>
<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 44%; background-color: #486C93; padding-top: 12pt; padding-bottom: 12pt; font-size: 10pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: White"><b>LETTER
    FROM OUR CEO</b></font></td>
    <td style="width: 56%; padding-top: 12pt; padding-bottom: 12pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 30%; border-right: #69737B 1pt solid; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg005.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 1%; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 69%; padding-right: 0; padding-left: 5.4pt; text-align: justify"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt">DEAR
                                         NOVAVAX STOCKHOLDER:</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">You
        are cordially invited to our Annual Meeting of Stockholders on Thursday, June 17, 2021, beginning at 8:30 a.m. Eastern
        Time. Due to the public health impact of the coronavirus pandemic (&ldquo;COVID-19") and to support the health and well-being
        of our stockholders, this year&rsquo;s Annual Meeting of Stockholders will be held in a virtual meeting format only. You
        can virtually attend the live webcast of the Annual Meeting of Stockholders at <FONT STYLE="color: rgb(0,61,165)">www.virtualshareholdermeeting.com/NVAX2021</FONT>.
        We are pleased to also provide a copy of our 2020 Annual Report to Stockholders with this Proxy Statement.</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Your
        vote is important, and we hope you will be able to attend the Annual Meeting. You may vote over the Internet, by telephone,
        or, if you requested printed proxy materials, by mailing a proxy card or voting instruction form. Please review the instructions
        for each of your voting options described in this Proxy Statement. Also, please let us know if you plan to attend the
        live virtual webcast of our Annual Meeting by marking the appropriate box on the proxy card, if you requested printed
        proxy materials, or, if you vote by telephone or over the Internet, by indicating your plans when prompted.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">We
look forward to seeing you at our 2021 Annual Meeting.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 40%; font-size: 10pt; padding: 10pt 5pt 1pt 10pt; background-color: rgb(239,239,239); border: rgb(0,86,149) 1pt solid"><IMG SRC="tm212692d3_sch14-aimg007.jpg" ALT=""><p style="margin-top: 0; margin-bottom: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&nbsp;</b></font></p>
                                                           <p style="margin-top: 0; margin-bottom: 0; text-align: justify; margin-right: 20pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>At
Novavax, our dedication to our mission necessitates that we focus efforts on a vaccine that can help global health authorities
address, control, and potentially eradicate SARS-CoV-2, the virus responsible for COVID-19. We are seeking to fulfill our mission
with NVX-CoV2373.&nbsp;</B></FONT></P>
                                                           <P STYLE="margin-top: 0; margin-bottom: 0; text-align: justify; margin-right: 20pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<IMG SRC="tm212692d3_sch14-aimg008.jpg" ALT="" STYLE="width: 25px; height: 21px">&nbsp;</p></td>
    <td style="width: 15%; font-size: 10pt; text-align: justify"><p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
                                                                 <p style="margin-top: 0; margin-bottom: 0">&nbsp;</p></td>
    <td style="width: 45%">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Yours truly,</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 6pt; text-align: justify"><IMG SRC="tm212692d3_sch14-aimg006.jpg" ALT="">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: rgb(73,109,147)"><font style="font-size: 10pt"><b>STANLEY
        C. ERCK</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">President and Chief Executive Officer</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">May
        3, 2021</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p></td></tr>
</table>




<!-- Field: Page; Sequence: 4; Value: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->




<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg004.jpg" ALT=""></FONT></P>

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #7C7E81"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt">Creating
Tomorrow&rsquo;s Vaccines Today</FONT></P>



<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 86%; background-color: #486C93; padding: 10pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.5pt; color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt"><b>NOTICE
                                         OF ANNUAL MEETING OF STOCKHOLDERS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 12.5pt; color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt"><b>TO
        BE HELD ON THURSDAY, JUNE 17, 2021</b></font></p></td>
    <td style="width: 14%; padding: 10pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.4pt 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt">TO
THE STOCKHOLDERS OF NOVAVAX, INC.:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>NOTICE
IS HEREBY GIVEN</b>&nbsp;that the 2021 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Novavax, Inc., a Delaware
corporation (the &ldquo;Company,&rdquo; &ldquo;Novavax,&rdquo; &ldquo;we,&rdquo; or &ldquo;us&rdquo;), will be held:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD ROWSPAN="2" STYLE="padding: 2pt; vertical-align: top; width: 4%; font-size: 10pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg009.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 23%; background-color: #486C93; font-size: 10pt">&nbsp;&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>WHEN</b></font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 2%; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD ROWSPAN="2" STYLE="padding: 2pt; vertical-align: top; width: 6%; font-size: 10pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg010.jpg" ALT="">&nbsp;&nbsp;</font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 26%; background-color: #486C93; font-size: 10pt">&nbsp;&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>VIRTUAL
    WEBCAST</b></font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 2%; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD ROWSPAN="2" STYLE="padding: 2pt; vertical-align: top; width: 7%; font-size: 10pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg011.jpg" ALT="">&nbsp;&nbsp;</font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 30%; background-color: #486C93; font-size: 10pt">&nbsp;&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>RECORD
    DATE</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Thursday,
                             June 17, 2021</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8:30
        a.m. Eastern Time</font></p></td>
    <TD STYLE="padding: 2pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt; font-size: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">www.virtualshareholdermeeting.com/NVAX2021</FONT></td>
    <TD STYLE="padding: 2pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stockholders
    of record at the close of business on April 20, 2021 are entitled to notice of and to vote</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>Matters
to Be Voted on at the Annual Meeting</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding-right: 0; padding-left: 5.4pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Proposal</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify; width: 5%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>1</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; width: 95%; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Election
    of three directors as Class II directors to serve on the board of directors, each for a three-year term expiring at the 2024
    Annual Meeting of Stockholders</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>2</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advisory
    vote to approve the compensation of our Named Executive Officers</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>3</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Amendment
    and restatement of the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the &ldquo;2015 Stock Plan&rdquo;)
    to increase the number of shares of the Company&rsquo;s common stock, par value $0.01 (our &ldquo;Common Stock&rdquo;), available
    for issuance thereunder by 1,500,000 shares</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>4</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification
    of certain April 2020 equity awards </font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>5</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification
    of certain June 2020 equity awards </font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>6</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification
    of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending
    December 31, 2021</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding: 3pt 0 3pt 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #486C93"><B>7</B></FONT></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding: 3pt 0; font-size: 10pt; text-align: justify; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transaction
    of such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
board of directors has fixed the close of business on April 20, 2021 (the &ldquo;Record Date&rdquo;) as the record date for determining stockholders
of the Company entitled to notice of and to vote at the Annual Meeting and any adjournments or postponements thereof.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
following Proxy Statement is included with the Company&rsquo;s Annual Report to Stockholders for the fiscal year ended December
31, 2020, which contains financial statements and other information of interest to stockholders.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 40%; text-align: right; vertical-align: middle">&nbsp;</td>
    <td style="width: 18%; text-align: right; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg012.jpg" ALT="">&nbsp;&nbsp;&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 40%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">By
Order of the Board of Directors,</font></p>
                           <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>
                           <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><IMG SRC="tm212692d3_sch14-aimg013.jpg" ALT="">&nbsp;</P>
                           <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><b>JOHN
A. HERRMANN III</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Executive
Vice President, Chief Legal Officer<br>
and Corporate Secretary</font></p></td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gaithersburg,
Maryland</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">May 3<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">,
<FONT STYLE="color: #231F20">2021</FONT></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="2" style="border-top: #486C93 1pt solid; border-right: Black 1pt solid; border-bottom: #486C93 1pt solid; border-left: #486C93 1pt solid; padding: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Whether
    or not you plan to attend the virtual webcast of the annual meeting, please promptly vote</b> over the Internet or by telephone
    as per the instructions on the enclosed proxy or complete, sign and date the enclosed proxy and mail it promptly in the accompanying
    envelope. Postage is not needed if mailed in the United States.</font></td>
    <td style="border-top: #486C93 1pt solid; border-right: #486C93 1pt solid; border-bottom: #486C93 1pt solid; padding: 5.4pt; background-color: #486C93; text-align: center"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 6pt 0pt 4.5pt; text-align: center; color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>IMPORTANT
                                         NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDERS ANNUAL MEETING
                                         TO BE HELD ON JUNE 17, 2021</b></font><font style="font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 4.5pt"></p>

<!-- Field: Rule-Page --><div align="CENTER" style="margin-top: 3pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: White 1pt solid; width: 70%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 4.5pt"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 4.5pt; text-align: center; color: white"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Our
        Notice of Annual Meeting, Proxy Statement, and Annual Report are available free of charge at <B>www.virtualshareholdermeeting.com/NVAX2021</B></FONT></p></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center; width: 30%"></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; width: 50%"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></td></tr>
</table>




<!-- Field: Page; Sequence: 5; Value: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="background-color: rgb(73,109,147); padding: 5.4pt; font-size: 10pt; text-align: center; width: 30%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: White"><b>PROXY
    STATEMENT</b></font></td>
    <td style="padding: 5.4pt; font-size: 10pt; width: 20%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding: 5.4pt; font-size: 10pt; width: 50%">&nbsp;</td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 14pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>Table
of Contents</b>&nbsp;</font></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></p>
<div style="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 10%; border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a001">1</A></b></font></td>
    <td style="width: 90%; border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a001"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Proxy Summary</b></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a002">7</A></b></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a002"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Board of Directors and Corporate Governance</b></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b><A HREF="#a003">7</A></b></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a003"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Proposal 1</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#8213;Election of Directors</font></b></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a004">7</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a004"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nominees for Election as Class II Directors</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a005">9</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a005"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Directors Continuing as Class III Directors</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a006">11</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a006"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Directors Continuing as Class I Directors</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a007"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">12</font></A></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a007"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Information Regarding the Board and Corporate Governance Matters</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a008">13</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a008"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Leadership Structure and Risk Oversight</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a009">15</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a009"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Board Committees</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a010">19</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a010"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nomination Procedures</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a011">21</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a011"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Corporate Governance Guidelines</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a012">21</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a012"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Code of Business Conduct and Ethics</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a013">22</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a013"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stockholder Communications with the Board of Directors</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a014">22</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a014"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain Relationships and Related Transactions</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a015"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">22</font></A></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a015"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Compensation Committee Interlocks and Insider Participation</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a016">23</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a016"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Compensation of Directors</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 8pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a017">26</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 10pt; padding-bottom: 2pt"><A HREF="#a017"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Executive Officers and Compensation</b></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b><A HREF="#a018">26</A></b></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a018"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Proposal 2</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#8213;Advisory Vote on Executive Compensation (Say-on-Pay)</font></b></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a019">27</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a019"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Executive Officers</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a020">30</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a020"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Compensation Discussion and Analysis</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a021">42</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a021"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Compensation Committee Report</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a022">43</A></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a022"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Executive Compensation Tables</font></A></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i><A HREF="#a023">43</A></i></font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt"><A HREF="#a023"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Summary Compensation Table</i></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i><A HREF="#a024">44</A></i></font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt"><A HREF="#a024"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Grants of Plan-Based Awards Table</i></font></A></td></tr>
    <tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt; width: 10%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i><A HREF="#a025">46</A></i></font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt; width: 90%"><A HREF="#a025"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Outstanding Equity Awards at 2020 Fiscal Year End</i></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i><A HREF="#a026">48</A></i></font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt"><A HREF="#a026"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Options
    Exercised and Stock Appreciation Rights Exercised and Stock Vested</i></font></A></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i><A HREF="#a027">48</A></i></font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt"><A HREF="#a027"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Overview of Employment and Change in Control Agreements</i></font></A></td></tr>

</table>

<p style="margin: 0"></p>
</div>
<div style="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">

<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; width: 10%"><A HREF="#a028"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>51</i></font></A></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; padding-left: 12.25pt; width: 90%"><A HREF="#a028"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #69737B"><i>Potential Payments Upon Termination</i></font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a029">53</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a029"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2020 CEO Pay Ratio</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid"><A HREF="#a030"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>54</b></font></A></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid">
<p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0"><A HREF="#a030"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2F5496"><b>Proposal 3</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#8213;Amendment and Restatement of the 2015 Stock Plan</font></A></p>


</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid"><A HREF="#a031"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>64</b></font></A></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><A HREF="#a031"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2F5496"><b>Proposal 4&#8213;</b></font>Ratification of Certain April 2020 Equity Awards</A></p></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid"><A HREF="#a032"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>64</b></font></A></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt; border-bottom: rgb(72,108,147) 1pt solid">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><A HREF="#a032"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #2F5496"><b>Proposal 5&#8213;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ratification of Certain June 2020 Eequity Awards</font></A></p></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 10pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a033">72</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 10pt; padding-bottom: 2pt"><A HREF="#a033"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Audit Matters</b></font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b><A HREF="#a034">72</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a034"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Proposal 6</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&#8213;Ratification of the Appointment of Ernst &amp; Young LLP as the Company&rsquo;s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2021</font></b></a></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a035">72</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a035"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Fees and Services</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a036">73</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a036"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Audit Committee Pre-Approval Policies and Procedures</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a037"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">74</font></A></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a037"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Audit Committee Report</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a038">75</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a038"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Stock Ownership Information</b></font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a039">75</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a039"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Security Ownership of Certain Beneficial Owners and Management</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a040">77</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a040"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Information about the Annual Meeting and Voting</b></font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><A HREF="#a041">82</A></b></font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a041"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Additional Information</b></font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a042">82</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a042"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stockholder Proposals</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a043">83</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a043"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Other Matters</font></A></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><A HREF="#a044">A-1</A></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><A HREF="#a044"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Appendix A&mdash;Novavax, Inc. Amended and Restated 2015 Stock Plan</font>&nbsp;</A></p>

</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><A HREF="#a045">B-1</A></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 2pt; padding-bottom: 2pt">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><A HREF="#a045"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Appendix B&mdash;Stockholder Complaint</font></A></p></td></tr>
</table>
</div>
<br clear="ALL"><br>



<!-- Field: Page; Sequence: 6; Value: 93 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 35%; background-color: #486C93; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: White"><b><a name="a001"></a>PROXY
    SUMMARY</b></font></td>
    <td style="width: 65%; padding-top: 12pt; padding-bottom: 12pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><i>This
summary represents only selected information. You should review the entire proxy statement before voting.</i></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>Novavax,
Inc. 2021 Annual Meeting of Stockholders</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD ROWSPAN="2" STYLE="vertical-align: top; width: 4%; padding-top: 0pt; padding-right: 2pt; padding-bottom: 2pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg009.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></font></td>
    <TD STYLE="vertical-align: bottom; width: 23%; background-color: #486C93; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>&nbsp;&nbsp;WHEN</b></font></td>
    <TD STYLE="vertical-align: bottom; width: 2%; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD ROWSPAN="2" STYLE="vertical-align: top; width: 6%; padding: 2pt; text-align: right"><IMG SRC="tm212692d3_sch14-aimg010.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;</font></td>
    <TD STYLE="padding: 2pt; vertical-align: bottom; width: 26%; background-color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>&nbsp;&nbsp;VIRTUAL
    WEBCAST</b></font></td>
    <TD STYLE="vertical-align: bottom; width: 2%; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD ROWSPAN="2" STYLE="vertical-align: top; width: 7%; padding: 2pt; text-align: right"><IMG SRC="tm212692d3_sch14-aimg011.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;</font></td>
    <TD STYLE="vertical-align: bottom; width: 30%; background-color: #486C93; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>&nbsp;&nbsp;RECORD
    DATE</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Thursday,
                             June 17, 2021</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8:30
        a.m. Eastern Time</font></p></td>
    <TD STYLE="padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(72,108,147)">www.virtualshareholdermeeting.com/NVAX2021</FONT></td>
    <TD STYLE="padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stockholders of record at
    the close of business on April 20, 2021 are entitled to notice of and to vote</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: #496D93"><B>MATTERS
TO BE VOTED ON AT THE ANNUAL MEETING</B></FONT></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding-right: 5pt; padding-left: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Proposal</b></font></td>
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Board
    Recommendation</b></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>See
    Page</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; width: 4%; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>1</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; width: 65%; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Election of three directors as Class II directors to
serve on the board of directors, each for a three-year term expiring at the 2024 Annual Meeting of Stockholders</font></td>
    <TD STYLE="padding: 3pt 5pt; width: 7%; border-bottom: #69737B 1pt solid; text-align: center"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; width: 13%; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #486C93"><b>FOR
    </b></font><br>
    <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">all nominees</font></td>
    <TD STYLE="padding: 3pt 5pt; width: 11%; border-bottom: #69737B 1pt solid; text-align: center">7</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>2</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Advisory vote to approve the compensation of our Named
Executive Officers</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #486C93"><b>FOR
    </b></font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center">26</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>3</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
Amendment and restatement of the Novavax, Inc. 2015 Stock Plan to increase the number of shares of Common Stock available for issuance
thereunder by 1,500,000 shares</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: left; vertical-align: top"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0pt; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>FOR
</B></FONT></p></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">54</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>4</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ratification of certain April 2020 equity awards</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #486C93"><b>FOR
    </b></font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center">64</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>5</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ratification of certain June 2020 equity awards</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #486C93"><b>FOR
    </b></font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center">64</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>6</B></FONT></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ratification of the appointment of Ernst &amp; Young
LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg014.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #486C93"><b>FOR
    </b></font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #69737B 1pt solid; text-align: center">72</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding: 3pt 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: rgb(73,109,147)"><B>7</B></FONT></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding: 3pt 5pt; text-align: left; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Transaction of such other business as may properly come
before the Annual Meeting or any adjournments or postponements thereof</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #486C93 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&nbsp;</font></td>
    <TD STYLE="padding: 3pt 5pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 321pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">1</FONT></B></P>



<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Proxy
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font: 14pt Arial, Helvetica, Sans-Serif"><B>HOW
TO VOTE</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">Have
your Notice of Internet Availability, proxy card, or voting instruction form in hand, with your 16-digit control number available.
Even if you plan to attend the virtual meeting, please vote as soon as possible to ensure your shares are represented.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="font-size: 9pt; vertical-align: bottom">
    <TD ROWSPAN="2" STYLE="padding: 2pt 5pt; font-size: 9pt; width: 12%; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; width: 17%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg015.jpg" ALT=""><font style="font-size: 9pt"></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; width: 17%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg016.jpg" ALT=""><font style="font-size: 9pt"></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; width: 17%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg017.jpg" ALT=""><font style="font-size: 9pt"></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; width: 17%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg018.jpg" ALT=""><font style="font-size: 9pt"></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg019.jpg" ALT=""><font style="font-size: 9pt"></font></td></tr>
  <tr style="font-size: 9pt; vertical-align: bottom">
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Internet</b></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Telephone</b></font></td>
    <TD STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt 5pt; font-size: 9pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Virtual
    Device</b></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Mail</b></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #486C93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>During
    the Meeting</b></font></td></tr>
  <tr style="font-size: 9pt; vertical-align: top">
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid; background-color: #F2F2F2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Registered
    Holders</b></font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt">Visit, 24/7</font></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-size: 9pt">www.proxyvote.com</font></p></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt">Dial toll-free, 24/7</font></p>
    <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt">1-800-690-6903</font></p></td>
    <TD STYLE="border-right: rgb(73,109,147) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid; padding: 2pt 5pt; font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Scan the QR code available on your proxy card</font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Return
    a properly executed proxy card (if received by mail) in the postage-paid envelope provided</font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Attend
    the virtual meeting at <FONT STYLE="color: rgb(72,108,147)">www.virtualshareholder meeting.com/NVAX2021</FONT> and follow
    the instructions provided during the Annual Meeting</FONT></td></tr>
  <tr style="font-size: 9pt; vertical-align: top">
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid; background-color: #F2F2F2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Beneficial
    Owners (holders in street name)</b></font></td>
    <td colspan="2" style="padding: 2pt 5pt; font-size: 9pt; border-top: #69737B 1pt solid; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The
    availability of telephone and Internet voting for beneficial owners will depend on the voting processes of your broker, bank, or
    other nominee, so please follow the voting instructions in the materials you receive</font></td>
    <TD STYLE="border-right: rgb(73,109,147) 1pt solid; border-bottom: #69737B 1pt solid; padding: 2pt 5pt; font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Scan the QR
    code if one is provided by your broker, bank, or other nominee</font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Return
    a properly executed voting instruction form by mail, depending upon the methods your broker, bank, or other nominee makes available</font></td>
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #69737B 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Contact
    your broker, bank, or other nominee to request a legal proxy and voting instructions</font></td></tr>
  <tr style="font-size: 9pt; vertical-align: top">
    <TD STYLE="padding: 2pt 5pt; font-size: 9pt; border-bottom: #486C93 1pt solid; background-color: #F2F2F2"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Deadline</b></font></td>
    <TD COLSPAN="3" STYLE="text-align: center; border-right: rgb(73,109,147) 1pt solid; border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt 5pt; font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11:59
    p.m. Eastern Time on June 16, 2021</font></td>
    <TD COLSPAN="2" STYLE="border-bottom: #486C93 1pt solid; padding: 2pt; white-space: nowrap; text-align: center; font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Before
    the polls close at the Annual Meeting on June 17, 2021</font></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>Board
of Directors</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse; margin-bottom: 3.75pt">
<tr>
    <TD COLSPAN="2" ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: left; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Name
    and Principal Occupation</b></font></td>
    <TD ROWSPAN="2" STYLE="white-space: nowrap; border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; text-align: center; vertical-align: bottom"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Age</B></FONT><B><SUP>(1)</SUP></B></p></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><p style="margin: 0"></p>
                                                                                <p style="margin: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Director Since</B></FONT></p></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    Current </b><br>
    <b>Public </b><br>
    <b>Company Boards</b></font></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Independent</b></font></td>
    <TD COLSPAN="4" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Committee
    Membership</b></font></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Audit</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Compensation</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Nominating
    &amp; Corporate <br>
    Governance</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Research
    &amp; Development</b></font></td></tr>
<tr style="background-color: #F2F2F2">
    <td style="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="9" style="border-bottom: #486C93 1pt solid; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>CLASS
    I DIRECTORS, FOR TERMS EXPIRING AT THE 2023 ANNUAL MEETING</b></font></td></tr>
<tr>
    <td style="text-align: center; width: 7%; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg020.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="vertical-align: top; width: 26%; border-bottom: #69737B 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Stanley
C. Erck</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">President
and Chief <br>
Executive Officer, <br>
Novavax, Inc.</font></p></td>
    <td style="width: 3%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">72</font></td>
    <td style="width: 6%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2009</font></td>
    <td style="width: 8%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="width: 11%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="width: 6%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="width: 12%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="width: 11%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="width: 10%; border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg021.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Rajiv
I. Modi, Ph.D.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Chairman
and Managing <br>
Director, Cadila <br>
Pharmaceuticals, Ltd.</font></p></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">60</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2009</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg022.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="vertical-align: top; border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Gregg
H. Alton, Ph.D.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Former
Interim Chief <br>
Executive Officer and <br>
Chief Patient Officer, <br>
Gilead Sciences</font></p></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">55</font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2020</font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1</font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg024.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <td style="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>2
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>




<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; text-align: right"><FONT STYLE="font: 11pt Arial, Helvetica, Sans-Serif"><B>Proxy
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse; margin-bottom: 3.75pt">
<tr>
    <TD COLSPAN="2" ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; text-align: left; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Name
    and Principal Occupation</b></font></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; white-space: nowrap; text-align: center; vertical-align: bottom"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Age
<SUP>(1)</SUP></B></FONT></p></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><p style="margin: 0"></p>
                                                                                <p style="margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Director
                                         </b><br> <b>Since</b></font></p></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    Current </b><br>
    <b>Public </b><br>
    <b>Company Boards</b></font></td>
    <TD ROWSPAN="2" STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Independent</b></font></td>
    <TD COLSPAN="4" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding: 2pt; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Committee
    Membership</b></font></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Audit</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Compensation</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Nominating
    &amp; Corporate <br>
    Governance</b></font></td>
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-right: 2pt; padding-bottom: 2pt; padding-left: 2pt; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Research
    &amp; Development</b></font></td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid; padding: 2pt; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="9" style="border-bottom: #486C93 1pt solid; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>CLASS
    II DIRECTORS, FOR TERMS EXPIRING AT THE 2021 ANNUAL MEETING</b></font></td></tr>
<tr>
    <TD STYLE="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle; width: 7%"><IMG SRC="tm212692d3_sch14-aimg025.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding: 2pt; width: 26%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Richard
H. Douglas, Ph.D.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Former
Senior Vice <br>
President, Corporate <br>
Development, Genzyme <br>
Corporation</font></p></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 3%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">68</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 6%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2010</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 8%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 11%"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 6%"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 12%"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 11%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 10%"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td></tr>
<tr>
    <TD STYLE="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg026.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Margaret
G. McGlynn, R. Ph.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #2E2E2E">Former President, <br>
Merck Vaccines and <br>
Infectious Disease,<br>
 Merck &amp; Co, Inc.</p></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">61</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2020</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td></tr>
<tr>
    <TD STYLE="text-align: center; padding: 2pt; vertical-align: middle; border-bottom: rgb(105,115,123) 1pt solid"><IMG SRC="tm212692d3_sch14-aimg027.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="vertical-align: top; padding: 2pt; border-bottom: rgb(105,115,123) 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Gary
C. Evans</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Chairman
of the Board and <br>
Chief Executive Officer, <br>
Generation Hemp, Inc.&nbsp;</font></p></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">63</font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1998</font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1</font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><IMG SRC="tm212692d3_sch14-aimg024.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><IMG SRC="tm212692d3_sch14-aimg033.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="padding: 2pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&mdash;</font></td></tr>
    <tr>
    <TD STYLE="text-align: center; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg028.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="vertical-align: top; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>David M. Mott</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Private Investor, Mott<br>
Family Capital</font></p></td>
    <TD STYLE="padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">55</font></td>
    <TD STYLE="padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2020</font></td>
    <TD STYLE="padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">5</font></td>
    <TD STYLE="padding: 2pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <TD STYLE="padding: 2pt; text-align: center">&mdash;<font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg033.jpg" ALT=""></font></td>
    <TD STYLE="padding: 2pt; text-align: center">&mdash;<font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <TD STYLE="padding: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></td></tr>


</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse; margin-bottom: 3.75pt">
<tr style="background-color: #F2F2F2">
    <td style="text-align: center; border-bottom: #486C93 1pt solid; padding: 2pt; vertical-align: middle; border-top: rgb(73,109,147) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td colspan="9" style="border-bottom: #486C93 1pt solid; padding: 2pt; border-top: rgb(73,109,147) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CLASS
    III DIRECTORS, FOR TERMS EXPIRING IN 2022</b></font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle; width: 7%"><IMG SRC="tm212692d3_sch14-aimg029.jpg" ALT=""><font style="font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></font></td>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding: 2pt; width: 26%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Rachel
                                         K. King</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Founder
        and Chief <br>
Executive officer, <br>
GlycoMimetics, Inc.</font></p></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 3%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 6%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2018</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 8%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 11%"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 6%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 12%"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 11%"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center; width: 10%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: #69737B 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg030.jpg" ALT=""><font style="font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></font></td>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Michael
                                         A. McManus, Jr., J.D.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former
        President and <br>
Chief Executive Officer, <br>
Misonix, Inc.&nbsp;</font></p></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1998</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg034.jpg" ALT=""><font style="font-size: 9pt"></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <td style="border-bottom: #69737B 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: #486C93 1pt solid; padding: 2pt; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg031.jpg" ALT=""><font style="font-size: 9pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></font></td>
    <td style="vertical-align: top; border-bottom: #486C93 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>James
                                         F. Young, Ph.D.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former
        Chairman of the <br>
Board and Chief <br>
Executive Officer, <br>
Targeted Microwave <br>
Solutions, Inc.&nbsp;</font></p></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2010;</font></p>
                                                               <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><IMG SRC="tm212692d3_sch14-aimg035.jpg" ALT=""><font style="font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">since
        2011</font></p></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg023.jpg" ALT=""></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""></font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg033.jpg" ALT=""></font></td></tr>
<tr>
    <td style="text-align: center; border-bottom: #486C93 1pt solid; padding: 2pt; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td colspan="3" style="border-bottom: #486C93 1pt solid; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Number
    of meetings in 2020</font></td>
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Board&#8213;14</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center">5</td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center">8</td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center">9</td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1)
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of April 19, 2021</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 6%; padding: 0; text-align: center; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg033.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 15%; padding: 0; text-align: left; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Committee
    Chair</font></td>
    <td style="text-align: left; width: 1%; padding: 0; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 6%; padding: 0; text-align: center; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg032.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 15%; padding: 0; text-align: left; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Committee
    Member</font></td>
    <td style="text-align: left; width: 1%; padding: 0; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 6%; padding: 0; text-align: center; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg035.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 15%; padding: 0; text-align: left; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Chairman
    of the Board</font></td>
    <td style="text-align: left; width: 1%; padding: 0; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 6%; padding: 0; text-align: center; vertical-align: middle"><IMG SRC="tm212692d3_sch14-aimg036.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 28%; padding: 0; text-align: left; vertical-align: middle"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Audit
    Committee Financial Expert</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #496D93"><B>| </B></FONT><B><FONT STYLE="color: #231F20">3</FONT></B></FONT></P>


<!-- Field: Page; Sequence: 9; Options: NewSection -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Proxy
Summary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>BOARD
ATTRIBUTES</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg037.jpg" ALT="" STYLE="height: 39px; width: 30px"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 28%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg038.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg039.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 22%; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg040.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Independence</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Diversity</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Age</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 1pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Tenure</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><IMG SRC="tm212692d3_sch14-aimg041.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><IMG SRC="tm212692d3_sch14-aimg042.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><IMG SRC="tm212692d3_sch14-aimg043.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 10pt"><IMG SRC="tm212692d3_sch14-aimg044.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td></tr>
</table>

<p style="margin: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>BOARD
REFRESHMENT</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">We
have added four new independent directors to our Board since 2018, including three in 2020.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg045.jpg" ALT="">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>BOARD
EXPERTISE</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Audit
    &amp; Accounting</b></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 18%; border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Biotechnology
    </b><br>
    <b>&amp; Medicine</b></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 18%; border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Corporate
    </b><br>
    <b>Governance</b></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 18%; border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Executive
    Leadership</b></font></td>
    <td style="width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 18%; border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Financial
    Services </b><br>
    <b>&amp; Investments</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg046.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg047.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg048.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg049.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg050.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operations</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Public
    Company </b><br>
    <b>Board Experience</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Risk
    Management</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Strategic
    Planning</b></font></td>
    <td style="padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Technology
    </b><br>
    <b>&amp; Innovation</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg051.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg052.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg053.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg054.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg055.jpg" ALT=""><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>4
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>



<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 11pt; color: rgb(105,115,123)">Proxy
Summary</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: rgb(0,61,165) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 11pt; color: rgb(105,115,123)"></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 11pt; color: rgb(105,115,123)">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>ISG
Stewardship Principles</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Our Board and executive leaders are stewards of our stockholders&rsquo;
interests, believing that strong and effective corporate governance is essential to our success. As a cornerstone of our corporate governance
program, we provide transparent disclosure to our stockholders on a consistent basis. Our approach integrates all components of effective
governance, including a strong ethical culture, an ongoing stockholder engagement program, sound financial, regulatory and legal compliance
functions. Novavax supports and follows the Investor Stewardship Group&rsquo;s (&ldquo;ISG&rdquo;) Corporate Governance Framework for
U.S. Listed Companies. Below is an illustration how certain of our governance practices directly support each of the six ISG principles.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>ISG
    Principle</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 3pt 0.1in 2pt 2pt; border-bottom: black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Novavax&rsquo;s
    Practice</B>&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; width: 47%; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Boards
    are accountable to stockholders</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; width: 6%; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; width: 47%; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Separate
    CEO and Board Chairman roles</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="2" STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stockholders
    should be entitled to voting rights in proportion to their economic interest&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">One class
    of voting stock; we believe in a &ldquo;one share, one vote&rdquo; standard</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No
    &ldquo;poison pill&rdquo;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Boards
    should be responsive to stockholders and be proactive in order to understand their perspectives&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Proactive
    year-round engagement with stockholders</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">All Directors
    attended at least 75% of Board and committee meetings in 2020</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">All of the
    then-current Board members attended the 2020 Annual Meeting</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Directors
    are expected to devote sufficient time and effort necessary to fulfill their respective responsibilities</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Boards
    should have a strong, independent leadership structure&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">8 of 10
    directors are independent</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Independent
    Board Chairman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Regular
    executive sessions of independent directors</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Four
    fully independent standing Board committees&mdash;Audit, Compensation, Nominating and Corporate Governance, and Research and Development</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Boards
    should adopt structures and practices that enhance their effectiveness&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">40% of directors
    are gender, racially, or ethnically diverse</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Average
    age of director nominees is 64 years</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Balance
    of new and experienced directors, with three new independent directors added in 2020 and average director tenure of 9.8 years</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Annual
    Board and committee self-evaluations</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD ROWSPAN="4" STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Boards
    should develop management incentive structures that are aligned with the long-term strategy of the company&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Annual Say-on-Pay
    advisory vote</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Active Board
    oversight of risk management</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></TD>
    <TD STYLE="padding-bottom: 2pt; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Clawback
    policy</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-right: 0.1in; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg056.jpg" ALT=""></FONT></TD>
    <TD STYLE="padding-bottom: 2pt; border-bottom: black 1pt solid; padding-top: 3pt; padding-left: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Anti-hedging
    and anti-pledging policy</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #496D93"><B>| </B></FONT><B><FONT STYLE="color: #231F20">5</FONT></B></FONT></P>




<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-size: 11pt; color: rgb(105,115,123)">Proxy
Summary</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: rgb(0,61,165) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 11pt; color: rgb(105,115,123)"></FONT></P>



<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b>Executive
Compensation Highlights</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>STOCKHOLDER
ENGAGEMENT</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; width: 49%; border-top: #003DA5 1pt solid; border-bottom: #486C93 1pt solid; border-left: #003DA5 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 5pt 3.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Stockholder
                                         Engagement Highlights</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt 26pt; text-align: justify; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;We
        received 88% Say-on-Pay approval in 2020, up from 70% in 2019</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt 26pt; text-align: justify; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;We
        continued our Stockholder Outreach program in 2020</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt 26pt; text-align: justify; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;&#8239;&#8239;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Topics
        discussed in connection with our Stockholder Outreach program included matters relating to our business, corporate governance,
        and executive compensation</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt 26pt; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">In
response to stockholder feedback, in April 2020 the Compensation Committee awarded performance-vesting (as compared to time-vesting)
awards to our executive officers</FONT></p></td>
    <td rowspan="2" style="vertical-align: top; width: 4%; border-top: #003DA5 1pt solid; border-right: #69737B 1pt solid; border-bottom: #486C93 1pt solid; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 23%; border-top: #003DA5 1pt solid; border-bottom: #69737B 1pt solid; font-size: 10pt; text-align: center; background-color: rgb(242,242,242)"><IMG SRC="tm212692d3_sch14-aimg057.jpg" ALT="" STYLE="height: 85px; width: 85px"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="width: 24%; border-top: #003DA5 1pt solid; border-right: #003DA5 1pt solid; border-bottom: #69737B 1pt solid; background-color: rgb(242,242,242)"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 8pt 0 0pt; text-align: center; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>STOCKHOLDER
                                         OUTREACH</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">In
        2020, we contacted our top</font><br>
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">stockholders representing <br>
approximately</font><br>
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: #486C93"><b>8.1%</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 8pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">of
        shares outstanding</font></p></td></tr>
<tr>
    <td style="border-bottom: #69737B 1pt solid; font-size: 10pt; text-align: center; background-color: rgb(242,242,242)"><IMG SRC="tm212692d3_sch14-aimg058.jpg" ALT="" STYLE="height: 84px; width: 85px"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: #69737B 1pt solid; border-right: #003DA5 1pt solid; background-color: rgb(242,242,242)"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 8 0 0pt; text-align: center; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>SAY-ON-PAY
                                         VOTE</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 8pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stockholder
        approval</font><br>
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">improved to</font><br>
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt; color: #486C93"><b>88%</b></font><br>
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">in 2020</font></p></td></tr>
</table>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>COMPENSATION
PHILOSOPHY AND OBJECTIVES</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Our
compensation program is designed to attract, retain, and reward a high-performance workforce in an extremely competitive recruitment
and retention market to achieve Novavax&rsquo;s mission, vision, and goals.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 23%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg059.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="width: 2%; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="width: 24%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg060.jpg" ALT=""></td>
    <td style="width: 2%; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="width: 24%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg061.jpg" ALT=""></td>
    <td style="width: 2%; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="width: 23%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg062.jpg" ALT=""></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Attract
    and retain highly qualified employees</font></td>
    <TD STYLE="padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Reward
    executives for meeting the strategic goals and objectives</font></td>
    <TD STYLE="padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Reward
    strong individual performance</font></td>
    <TD STYLE="padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="background-color: #F2F2F2; padding-left: 5.4pt; font-size: 10pt; padding-right: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Align
    executives&rsquo; interests with those of our stockholders</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><b>COMPENSATION
PROGRAM BEST PRACTICES</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</P>

<DIV STYLE="float: left; width: 49%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #F2F2F2">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt; vertical-align: top; width: 2%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #005695 1pt solid; padding-right: 2pt; padding-bottom: 3pt; vertical-align: top; width: 5%; padding-top: 3pt"><IMG SRC="tm212692d3_sch14-aimg063.jpg" ALT=""></TD>
    <TD STYLE="border-bottom: #005695 1pt solid; padding-left: 5pt; padding-bottom: 3pt; vertical-align: bottom; width: 91%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>What
    We Do</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-bottom: 3pt; vertical-align: top; width: 2%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 5pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 5pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg149.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 5pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Link what we pay our Named Executive Officers (&ldquo;NEOs&rdquo;)
    to our short- and long-term performance</FONT></TD>
    <TD STYLE="padding-top: 5pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg149.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Base pay increases on merit</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg149.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Have a Compensation Committee made up of 100% independent
    directors</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg149.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Engage an independent compensation consultant for competitive
    analysis, based on a combination of survey data and peer group data</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 8pt"><IMG SRC="tm212692d3_sch14-aimg149.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Have a clawback policy</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<DIV STYLE="float: right; width: 49%">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #F2F2F2">
    <TD STYLE="padding-left: 5pt; padding-bottom: 3pt; vertical-align: top; width: 2%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #005695 1pt solid; padding-right: 2pt; padding-bottom: 3pt; vertical-align: top; width: 5%; padding-top: 3pt"><IMG SRC="tm212692d3_sch14-aimg064.jpg" ALT=""></TD>
    <TD STYLE="border-bottom: #005695 1pt solid; padding-left: 5pt; padding-bottom: 3pt; vertical-align: bottom; width: 91%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>What
    We Do NOT Do</B></FONT></TD>
    <TD STYLE="padding-right: 5pt; padding-bottom: 3pt; vertical-align: top; width: 2%; padding-top: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 5pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 5pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT="" STYLE="width: 15px; height: 15px"></TD>
    <TD STYLE="padding-top: 5pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No incentivizing excessive risk-taking that would have
    a material adverse effect on our business and operations</FONT></TD>
    <TD STYLE="padding-top: 5pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No excise tax gross ups</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Our equity plan prohibits repricing of underwater stock
    options or stock appreciation rights without stockholder approval</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No guarantee of salary increases or bonuses</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No single-trigger change in control provisions</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="background-color: #F2F2F2">
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 8pt; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 2pt; padding-bottom: 8pt; vertical-align: bottom"><IMG SRC="tm212692d3_sch14-aimg065.jpg" ALT=""></TD>
    <TD STYLE="padding-top: 3pt; padding-left: 5pt; padding-bottom: 8pt; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">No hedging or pledging</FONT></TD>
    <TD STYLE="padding-top: 3pt; padding-right: 5pt; padding-bottom: 8pt; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

</DIV>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"></P>

<DIV STYLE="clear: both">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"></P>

</DIV>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Auditors</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ernst
 &amp; Young LLP has served as our independent auditors since 2014. We are asking our stockholders to ratify the selection of Ernst
 &amp; Young as our independent auditors for the fiscal year ending December 31, 2021. Representatives of Ernst &amp; Young LLP
are expected to be present at the Annual Meeting and will have an opportunity to address the Annual Meeting if they desire to
do so. They will also be available to respond to appropriate questions from stockholders.</font></p>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>6
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>





<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 96%; background-color: #486C93; padding: 5.4pt; font-size: 10pt"><a name="a002"></a><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b>BOARD
    OF DIRECTORS AND CORPORATE GOVERNANCE</b></font></td>
    <td style="width: 4%; font-size: 10pt; padding: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b><a name="a003"></a>Proposal
1</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif">&#8213;Election of Directors</font></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">In
accordance with the Company&rsquo;s charter, the Board of Directors (the &ldquo;Board&rdquo;) may consist of no fewer than three
directors, with the specific number to be authorized by the Board from time to time at its discretion. The Board is presently
authorized to consist of ten members, and currently includes the following ten individuals.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD STYLE="width: 32%; background-color: #F2F2F2; font-size: 10pt; text-align: center; padding-right: 6pt; padding-left: 6pt; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Class
    I Directors</b></font></td>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-top: rgb(72,108,147) 1pt solid; border-right: rgb(72,108,147) 1pt solid; border-left: rgb(72,108,147) 1pt solid; width: 32%; background-color: #F2F2F2; font-size: 10pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Class
    II Directors</b></font></td>
    <TD STYLE="width: 2%; font-size: 10pt; text-align: center; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="width: 32%; background-color: #F2F2F2; font-size: 10pt; text-align: center; padding-right: 6pt; padding-left: 6pt; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #486C93"><b>Class
    III Directors</b></font></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; background-color: #F2F2F2; font-size: 10pt; text-align: center; padding-right: 6pt; padding-left: 6pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Terms
    expiring  at the <BR>
2023 Annual Meeting</b></font></td>
    <TD STYLE="font-size: 10pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="border-right: rgb(72,108,147) 1pt solid; border-bottom: #486C93 1pt solid; border-left: rgb(72,108,147) 1pt solid; background-color: #F2F2F2; font-size: 10pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Terms
    expiring at the <BR>
2021 Annual Meeting</b></font></td>
    <TD STYLE="font-size: 10pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt; text-align: center; padding-right: 6pt; padding-left: 6pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Terms
    expiring  at the<BR>
 2022 Annual Meeting</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 17pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Gregg
                                         H. Alton, Ph.D.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 17pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stanley C. Erck</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 17pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Rajiv I. Modi, Ph.D.</font></p></td>
    <TD STYLE="font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="border-right: rgb(72,108,147) 1pt solid; border-left: rgb(72,108,147) 1pt solid; background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Richard
                                         H. Douglas, Ph.D.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Margaret G. McGlynn, R. Ph.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">David M. Mott</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Gary C. Evans*</font></p></td>
    <TD STYLE="font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Rachel
                                         K. King</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Michael A. McManus, Jr., J.D.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 19pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">James F. Young, Ph.D., <i><br>
Chairman of the
        Board</i></font></p></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt">&nbsp;</td>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</td>
    <TD STYLE="border-bottom: rgb(72,108,147) 1pt solid; border-right: rgb(72,108,147) 1pt solid; border-left: rgb(72,108,147) 1pt solid; background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt">&nbsp;</td>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</td>
    <TD STYLE="background-color: #F2F2F2; padding-right: 6pt; padding-left: 6pt">&nbsp;</td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">*
Mr. Evans will not be standing for election at the Annual Meeting.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Members
of the Board are divided into three classes, designated as Class I, Class II, and Class III, each serving staggered three-year
terms. The term of the Class II directors expires at the 2021 Annual Meeting. The terms of the Class III and Class I directors
will expire at the 2022 and 2023 Annual Meetings of Stockholders, respectively. A director of any class who is elected by the
Board to fill a vacancy resulting from an increase in the number of directors holds office for the remaining term of the class
to which he or she is elected. A director who is elected by the Board to fill a vacancy arising in any other manner holds office
for the remaining term of his or her predecessor. Directors elected by the stockholders at an annual meeting to succeed those
whose terms expire at the meeting are of the same class as the directors they succeed and are elected for a term to expire at
the third Annual Meeting of Stockholders after their election and until their successors are duly elected and qualified.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In
the event of any increase or decrease in the authorized number of directors, the newly created or eliminated directorships must
be apportioned by the Board among the three classes to ensure that no one class has more than one director more than any other
class, unless otherwise determined by a resolution of the Board. However, since existing directors cannot move across classes,
the number of directors continuing in office following the Annual Meeting, as well as the nominees for election at the Annual
Meeting, including their ages and positions as of April 19, 2021, are reflected below followed by biographical information for
each such director and nominee.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="vertical-align: top; width: 5%; border-top: #486C93 1pt solid; border-bottom: #486C93 1pt solid; border-left: #486C93 1pt solid; padding: 5.4pt; font-size: 10pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg066.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <td style="width: 95%; border-top: #486C93 1pt solid; border-right: #486C93 1pt solid; border-bottom: #486C93 1pt solid; padding: 5.4pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>The
    Board recommends that stockholders vote <font style="color: #486C93">FOR </font>the election of the nominees.</b></font></td></tr>
</table>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><a name="a004"></a>&nbsp;</B></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Nominees
for Election as Class II Directors</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">After recommendation by the Nominating and
Corporate Governance Committee, the Board has designated Richard H. Douglas, Ph.D., Margaret G. McGlynn, R. Ph., and David M. Mott
as nominees for election as Class II directors of the Company at the Annual Meeting. If elected, each such nominee will serve until
the expiration of his or her term at the 2024 Annual Meeting of Stockholders and until his or her successor is elected and qualified.
Dr. Douglas, Ms. McGlynn, and Mr. Mott have consented to being named in this Proxy Statement and</P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">to serve if elected. The Board
has no reason to believe that Dr. Douglas, Ms. McGlynn, and Mr. Mott will be unable or unwilling to serve if elected. If any nominee
becomes unavailable to serve as a director, the persons named in the proxy will vote the proxy for a substitute nominee or nominees
as they, in their discretion, shall determine. Gary C. Evans will not be standing for election at the Annual Meeting.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif">Information
on the nominees follows.</font></p>
</div>
<BR CLEAR="ALL">


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #496D93"><B>| </B></FONT><B><FONT STYLE="color: #231F20">7</FONT></B></FONT></P>




<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Board
of Directors and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg067.jpg" ALT=""><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT
        DIRECTOR SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><br>
2010</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 7pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Audit</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Research
        and Development</font></p></td>
    <td colspan="2" style="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 5pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>RICHARD
    H. DOUGLAS, PH.D.</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Genzyme
        Corporation</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former Senior Vice President, Corporate
        Development (1989 to 2011)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Douglas led Genzyme Corporation&rsquo;s
        Corporate Development team, and was involved in numerous acquisitions, licenses, financings, joint ventures, and strategic
        alliances</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Integrated
        Genetics</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Douglas served in science and corporate
        development capacities (1982 until its merger with Genzyme Corporation in 1989, now Sanofi Genzyme)</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></p>
	<FONT STYLE="color: rgb(72,108,147); font: 9pt Arial, Helvetica, Sans-Serif"><b>OTHER
        CURRENT PUBLIC COMPANY BOARDS</b></font>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Aldeyra Therapeutics (Nasdaq: ALDX)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></font></p></td>
    <td style="padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93">
        <font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">University of Michigan Technology Transfer
        National Advisory Board</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 25pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">MaxCyte, Inc. (LSE: MXCT)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 4pt"><B>&nbsp;</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-size: 9pt">Postdoctoral
        fellow, Dr. Leroy Hood&rsquo;s laboratory at the California Institute of Technology</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ph.D. in Biochemistry, University of California,
        Berkeley</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science in Chemistry, University
        of Michigan</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: rgb(72,108,147)"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 9pt Arial, Helvetica, Sans-Serif">Dr.
    Douglas is well-suited to serve on our Board due to his significant business experience and scientific background.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 3.5pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt">&nbsp;</td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg068.jpg" ALT=""><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
        </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT
        DIRECTOR SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><br>
2020</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif">Compensation</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;
Nominating and</font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Corporate</font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;Governance</font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <td colspan="2" style="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 5pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>MARGARET
    G. MCGLYNN, R. PH.</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>International
        AIDS Vaccine Initiative</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer,
        leading extensive partnership efforts to advance the development, global launch and access to a broadly effective HIV
        vaccine (2011 to 2015)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Merck</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Served in leadership roles of increasing
        responsibility for more than two decades (1983 to 2009) including:</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President, U.S. Hospital and Specialty
        Products Division</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President of Merck Vaccines and Infectious
        Diseases</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;<font style="color: #486C93"><b>OTHER
        PUBLIC COMPANY BOARDS</b></font></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Amicus Therapeutics (Nasdaq: FOLD)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vertex Pharmaceuticals (Nasdaq: VRTX)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; background-color: white"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;<font style="color: #486C93"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">HCU Network America, a patient advocacy organization; Ms. McGlynn founded HCU Network America in 2016 which is focused on the rare genetic disease homocystinuria (HCU) and related disorders</font></p></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hilleman Institute for Developing World
        Vaccine Research</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Gavi, The Vaccine Alliance</font></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The Biotechnology Innovation Organization </font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Life Science Cares Philadelphia, a non-profit
        organization</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Honorary Doctorate, the State University
        of New York at Buffalo</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Master&rsquo;s in Business Administration
        and Marketing, The State University of New York at Buffalo</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science in Pharmacy, The State
        University of New York at Buffalo</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms.
McGlynn is well-suited to serve on the Novavax Board due to her extensive experience in the pharmaceutical and vaccine industries.
In addition, her experience in for-profit and non-profit vaccine organizations and deep experience in vaccine commercialization
and understanding of global public health make Ms. McGlynn an ideal board member.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 3.5pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>8
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>



<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #69737B; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt">
                                                                                                          <IMG SRC="tm212692d3_sch14-aimg069.jpg" ALT=""><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT
        DIRECTOR SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><br>
2020</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation<IMG SRC="tm212692d3_sch14-aimg070.jpg" ALT=""></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Research and Development</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <td colspan="2" style="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 5pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>DAVID
    M. MOTT</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Mott
        Family Capital</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Private investor</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>New
Enterprise Associates</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font: 9pt Arial, Helvetica, Sans-Serif">General Partner (2008 to 2020)</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>MedImmune</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer,
        Vice Chairman (2000 to 2008), during which he led the sale of the company to AstraZeneca in June 2007 for $15.6 billion</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;
        </font>&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Served in various senior roles, including
        Chief Operating Officer and Chief Financial Officer (1992 to 2000)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">During
        the course of his career, Mr. Mott has been involved in more than $40 billion in corporate acquisitions, fundraising,
        partnerships and other capital formation ventures. He has supported more than 35 initial public offerings or corporate
        acquisitions, overseen more than a dozen new drugs from development to commercialization, and served on 25 corporate boards.</font></p></td>
    <td style="padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        PUBLIC COMPANY BOARDS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chairman, Adaptimmune Therapeutics (Nasdaq: ADAP)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chairman, Ardelyx (Nasdaq: ARDX)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chairman, Epizyme (Nasdaq: EPZM)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chairman, Imara (Nasdaq GS: IMRA)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chairman, Mersana Therapeutics (Nasdaq GS: MRSN)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Arts, Dartmouth College</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        Mott is well-suited to serve on our Board. His more than three decades of global management, board and investment experience
        across numerous private and public biopharmaceutical companies, as well as his extensive experience building, leading
        and financing biopharmaceutical companies adds significant value to our Board.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 3.5pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>


<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><a name="a005"></a>Directors
Continuing as Class III Directors</b></font></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><IMG SRC="tm212692d3_sch14-aimg071.jpg" ALT=""><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT
        DIRECTOR SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><br>
2018</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Nominating and Corporate Governance</font></p></td>
    <td colspan="2" style="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 5pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>RACHEL
    K. KING</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 8pt; padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>GlycoMimetics,
        Inc.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font: 9pt Arial, Helvetica, Sans-Serif"><b></b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Founder and Chief Executive Officer (2003
        to present)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><b>New Enterprise Associates</b></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font: 9pt Arial, Helvetica, Sans-Serif">Executive in Residence (2001 to 2003)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&nbsp;</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Novartis
        Corporation</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior
        Vice President  (1999 to 2001</font>)</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Genetic
        Therapy, Inc.</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Manager of Laboratory Operations from 1989 to 1993 and Vice President
for Product Planning from 1993 to 1996 including early-stage development, initial public offering and acquisition by Novartis;
Chief Executive Officer of GTI, a wholly owned subsidiary of Novartis from 1996 to 1998.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mrs.
        King worked previously at <b>ALZA Corporation</b> and <b>Bain and Company</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        </td>
    <td style="padding-top: 2pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT PUBLIC COMPANY BOARDS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">GlycoMimetics (Nasdaq: GLYC)</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Committee of the Biotechnology
        Innovation Organization</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">University of Maryland BioPark</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">M.B.A., Harvard Business School</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Arts, Dartmouth College</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mrs.
        King is well-suited to serve on our Board due to her successful growth and development of businesses and products, her
        experience as a chief executive officer of a public company, and her significant experience in governance, legal, finance
        and risk management.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 3.5pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #496D93"><B>| </B></FONT><B><FONT STYLE="color: #231F20">9</FONT></B></FONT></P>




<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="margin: 0">&nbsp;</P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: #888A8C"><B>Board
of Directors and Corporate Governance</B></FONT></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg072.jpg" ALT=""></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><B>INDEPENDENT
<BR>
DIRECTOR SINCE <BR>
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1998</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Audit </font><font style="font-size: 9pt"><img src="tm212692d3_sch14-aimg070.jpg" alt="" style="height: 15; width: 15"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <TD COLSPAN="2" STYLE="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 8pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt">&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>MICHAEL
    A. MCMANUS, JR., J.D.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 8pt; padding-left: 8pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Misonix,
        Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer (1999
        to 2016)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>New
        York Bancorp Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President, Chief Executive Officer and
        Director (1991 to March 1998)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;
        </font>&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer,
        Home Federal Savings Bank, the principal subsidiary of New York Bancorp Inc. (February 1995 to March 1998)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Jamcor
        Pharmaceuticals Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer (1990
        to November 1991)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Office
        of the President of the United States</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Assistant to the President of the United
        States (1982 to 1985)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
McManus held previous positions at <b>Pfizer Inc.</b> and <b>Revlon Group</b></font></p></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        McManus served in the <b>U.S. Army Infantry</b> (1968 to 1970)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 5pt">&nbsp;</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        McManus is the recipient of the <b>Ellis Island Medal of Honor</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT PUBLIC COMPANY BOARDS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The Eastern Company (Nasdaq: EML)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">J.D., Georgetown University Law Center</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Arts in Economics, University
        of Notre Dame</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0in; text-indent: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. McManus&rsquo;s successful growth and development of businesses and products, his experience as a chief executive officer
        of a public company, and his extensive experience in governance, legal, finance and risk management make him a well-qualified
        member of our Board. </font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 8pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>


<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg073.jpg" ALT=""></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><B>DIRECTOR SINCE</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><B></b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2010</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>CHAIRMAN
        OF THE BOARD SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif">2011</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Nominating and Corporate Governance</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Research and Development </font><font style="font-size: 9pt"><img src="tm212692d3_sch14-aimg070.jpg" alt="" style="height: 15; width: 15"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <TD COLSPAN="2" STYLE="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 8pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt">&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>JAMES
    F. YOUNG, PH.D.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 8pt; padding-left: 8pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Targeted
        Microwave Solutions, Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former Chairman of the Board and Chief
        Executive Officer (2016 to 2018)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>MedImmune,
        Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former President, Research and Development
        (2000 to 2008)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Vice President, Research and
        Development (1999 to 2000)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President (1995 to 1999)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Research and Development
        (1989 to 1995)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;</FONT>&#8239;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sagimet Biosciences, a privately-held biopharmaceutical
company</FONT></p></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ph.D. in Microbiology and Immunology, Baylor
        College of Medicine</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science degrees in General
        Science and Biology, Villanova University</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr.
        Young is well-suited to serve on our Board due to his years of experience in the fields of molecular genetics, microbiology,
        immunology, and pharmaceutical development. In addition, Dr. Young brings extensive scientific background and experiences,
        particularly in the areas of vaccine research and development.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 8pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>

<p style="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>10 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 2 -->
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</p>



<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><a name="a006"></a>Directors
Continuing as Class I Directors</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg074.jpg" ALT=""></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
        </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>INDEPENDENT</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><B>DIRECTOR SINCE</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><B></b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2020</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>COMMITTEES</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>&nbsp;</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Audit</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <td colspan="2" style="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 5pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt">&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>&nbsp;GREGG
    ALTON</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 8pt; padding-left: 8pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Gilead
        Sciences</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Served in an array of leadership roles
        across a portfolio of responsibilities for more than 20 years from 1999 to 2019,  including:</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interim Chief Executive Officer</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chief Patent Officer, responsible for
        Gilead&rsquo;s government affairs, public affairs, patient outreach and engagement initiatives, as well as efforts to
        facilitate access to its medicines globally</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Oversight for commercial operations in&nbsp;Europe,&nbsp;Asia,&nbsp;Latin
        America&nbsp;and&nbsp;Africa, as well as government affairs, public affairs and global medical affairs</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General Counsel and Chief Compliance Officer</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Cooley
        Godward, LLP</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Attorney, specializing in corporate finance
        transactions for healthcare and information technology companies (1993 to 1996 and 1998 to 1999)</font></p></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        PUBLIC COMPANY BOARDS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Corcept Therapeutics (Nasdaq: CORT)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Enochian Biosciences <font style="color: #486C93">(Nasdaq:
        ENOB)</font></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Several non-profit organizations, including
        Black Women&rsquo;s Health Imperative, AIDSVu and the Boys and Girls Clubs of Oakland</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">J.D., Stanford University</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science in Legal Studies, University
        of California, Berkeley</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        Alton is well-suited to serve on the Novavax Board. His extensive industry experience and broad global experience across
        multiple business areas, as well as his deep insight in infectious disease will contribute to the Board&rsquo;s understanding
        of our mission and corporate goals.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 8pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg075.jpg" ALT=""></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
                                                                                                          <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
                                         </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>DIRECTOR
SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2009</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(0,86,149)"><b>COMMITTEES</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -14.5pt; margin: 0pt 0 0pt 26.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(0,86,149)"><b>&nbsp;</B></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(0,86,149)"><B>&#9679;&nbsp;&nbsp;&nbsp;
        </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">None</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(0,86,149)"><b>&nbsp;</b></font></p></td>
    <TD COLSPAN="2" STYLE="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 8pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt">&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>STANLEY
    C. ERCK</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 2pt 8pt 1pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Novavax,
        Inc.</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President
        and Chief Executive Officer of Novavax, Inc. (April 2011 to present)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interim
        Chief Financial Officer (November 2017 to March 2018)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive
        Chairman (February 2010 to April 2011)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Iomai
Corporation</b>&nbsp;</font></p>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">President and Chief Executive Officer (2000 to 2008, when it was acquired by Intercell AG)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        Erck previously held leadership positions at <b>Procept</b>, a publicly traded immunology company, <b>Integrated Genetics</b>,
        now Sanofi Genzyme, and <b>Baxter International</b></font></p></td>
    <td style="padding-top: 2pt; padding-bottom: 1pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">MaxCyte, Inc. (LSE: MXCT)</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">MDBio Foundation</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 1pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">M.B.A., University of Chicago</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science in Economics, University
        of Illinois</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 1pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
        Erck is well-suited to serve on our Board due to his leadership experience in the biotechnology industry, having held
        chief executive officer positions for several companies, and his extensive experience of serving on other public company
        boards.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="width: 20%; border-bottom: #486C93 1pt solid; background-color: #F2F2F2; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <TD STYLE="width: 40%; border-bottom: #486C93 1pt solid; padding-left: 8pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td>
    <td style="width: 40%; border-bottom: #486C93 1pt solid; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>11</b></font></font></p>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;&nbsp;</p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; border-top: #486C93 1pt solid; background-color: #F2F2F2; padding-top: 5pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg076.jpg" ALT=""></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>&nbsp;</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #486C93"><b>AGE
        </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><b>DIRECTOR
SINCE </b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif">2009</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(0,86,149)"><b>COMMITTEES</b></font></p>
        <p style="text-indent: -14.5pt; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt">&nbsp;</P>
        <P STYLE="text-indent: -14.5pt; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(0,86,149)"><b>&#9679;&nbsp;&nbsp;&nbsp;
</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">None</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -14.5pt; margin: 0pt 0 0pt 26.5pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font>
</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif"></font></p></td>
    <TD COLSPAN="2" STYLE="border-top: #486C93 1pt solid; background-color: #486C93; padding-left: 8pt; font-size: 10pt; padding-top: 2pt; padding-bottom: 2pt">&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>RAJIV
    I. MODI, PH.D.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 8pt; padding-left: 8pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 1pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Cadila
Pharmaceuticals, Ltd.</b></font></p>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">Chairman and Managing Director (1995 to present)</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 1pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>OTHER
        CURRENT DIRECTORSHIPS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cadila Pharmaceuticals, Ltd.</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Numerous other private companies and foreign
        public companies</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.75pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 1pt 3.5pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EDUCATION</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ph.D. in Biological Science, University
        of Michigan</font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor&rsquo;s degree of Technology in
        Chemical Engineering, University College, London</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.5pt; text-indent: -14.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p></td>
    <td><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 1pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>ELECTION
        TO NOVAVAX BOARD</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr.
        Modi was elected to our Board based on his relationship with the Company&rsquo;s largest stockholder
        in 2009. As of April 19, 2021, Satellite Overseas (Holdings) Limited, a subsidiary of Cadila Pharmaceuticals, Ltd., holds
        less than one percent of the Company&rsquo;s outstanding Common Stock. Dr. Modi serves as a member of the boards of other
        Cadila group companies.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 1pt; color: #486C93"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>KEY
        SKILLS AND QUALIFICATIONS</b></font></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr.
        Modi is well-suited to serve on our Board due to his extensive leadership experience, as well as technical expertise in
        the development and manufacturing of pharmaceutical products. He also brings broad experience in international joint ventures
        and pharmaceutical sales.</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><br>
<br>
<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 9pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p></td></tr>
<tr style="font-size: 10pt; vertical-align: top">
    <td style="border-bottom: #486C93 1pt solid; width: 20%; background-color: #F2F2F2; font-size: 10pt"><font style="font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; width: 40%; padding-left: 8pt; font-size: 10pt; padding-right: 8pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="border-bottom: #486C93 1pt solid; width: 40%; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><a name="a007"></a>Information
Regarding the Board and Corporate Governance Matters</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>


<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
March 18, 2021, the Board determined, upon the recommendation by the Nominating and Corporate Governance Committee, that all of
the members of the Board are &ldquo;independent&rdquo; directors as defined in the Nasdaq listing standards, except Dr. Modi and
Mr. Erck.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Mr.
Erck is currently the President and Chief Executive Officer of the Company. Dr. Modi is not an &ldquo;independent&rdquo; director
due to his interest in Cadila Pharmaceuticals, Ltd. and the joint venture it has with the Company. These relationships are described
in detail in the section titled &ldquo;Certain Relationships and Related Transactions.&rdquo;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">During 2020, the Board met 14 times and acted by
written consent in lieu of a meeting five times and the non-employee directors met four times in executive session during the same period.
As the year progressed and the</P>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">severity of the COVID-19 global pandemic became more clear, the directors convened an additional 17 times
during 2020 during which management provided operational updates. Each of our incumbent directors attended at least 75% of the aggregate
of the total number of meetings of the Board they were eligible to attend, as well as the total number of meetings held by all committees
on which they served.</p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Arial, Helvetica, Sans-Serif"></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Recognizing
that director attendance at the Company&rsquo;s Annual Meeting of Stockholders provides stockholders with an opportunity to communicate
with members of the Board, the Company strongly encourages (but does not require) members of the Board to attend such meetings.
All of the then-current Board members attended the 2020 Annual Meeting of Stockholders.</font></p>
</DIV>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>12 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>




<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><a name="a008"></a>Leadership
Structure and Risk Oversight</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">One of the most critical roles of our Chief Executive
Officer and board members is managing risk. Today&rsquo;s environment consists of ongoing disruption, innovation, and technological change.
Increasing disruption leads to greater risks, which may become greater still because they are often interconnected. The Board separates
the positions of Chairman of the Board and Chief Executive Officer thereby allowing our Chief Executive Officer to focus on our day-to-day
business, while allowing the</P>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Chairman of the Board to lead the Board in its fundamental role of providing advice to and independent oversight
of management. The Board recognizes the commitment that our Chief Executive Officer is required to devote to his position, as well as
the commitment required to serve as our Chairman of the Board, particularly as the Board&rsquo;s oversight responsibilities continue
to grow. Mr. Erck and Dr. Young each are responsible for:</p>
</DIV>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="border-top: rgb(136,138,140) 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</font></p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD COLSPAN="2" STYLE="padding-left: 3.75pt; font-size: 10pt; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: white"><b>PRESIDENT
    AND CHIEF EXECUTIVE OFFICER</b></font></td></tr>
<tr>
    <TD STYLE="border-bottom: #888A8C 1pt solid; width: 16%; font-size: 10pt; text-align: center; padding-top: 6pt; padding-bottom: 6pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg077.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #888A8C 1pt solid; vertical-align: top; width: 84%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&nbsp;</B></FONT></P>
                                                                                  <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>Stanley
C. Erck</b></font></p>
                                                                                  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3.5pt"><font style="font: 9pt Arial, Helvetica, Sans-Serif"><b>&nbsp;</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font: 9pt Arial, Helvetica, Sans-Serif">general
charge and supervision of the business of the Company</font></p>


        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.5in; text-indent: -0.25in"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">managing
        the risks the company faces in the ordinary course of operating the business including reputation risk, culture risk,
        cybersecurity risk and extended enterprise risk</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"></FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 2pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 5pt">&nbsp;</FONT></p></td></tr>
</table>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD COLSPAN="2" STYLE="padding-left: 3.75pt; font-size: 10pt; padding-top: 3pt; padding-bottom: 3pt; text-align: center"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: white"><b>CHAIRMAN
    OF THE BOARD</b></font></td></tr>
<tr>
    <TD STYLE="border-bottom: #888A8C 1pt solid; width: 16%; font-size: 10pt; text-align: center; padding-top: 6pt; padding-bottom: 6pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg078.jpg" ALT=""></font></td>
    <TD STYLE="border-bottom: #888A8C 1pt solid; vertical-align: top; width: 84%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&nbsp;</B></FONT></P>
                                                                                  <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>James
F. Young, Ph.D.</b></font></p>
                                                                                  <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font: 9pt Arial, Helvetica, Sans-Serif"><b>&nbsp;</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font: 9pt Arial, Helvetica, Sans-Serif">presiding
at all meetings of the Board</font></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font: 9pt Arial, Helvetica, Sans-Serif">advising
Board committee chairs in fulfilling their roles</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font: 9pt Arial, Helvetica, Sans-Serif">serving
as a liaison between the Board and senior management team</font></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">mentoring and advising the senior scientific
        team</font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">providing an extensive network of contacts</font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><font style="font: 10pt Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font: 9pt Arial, Helvetica, Sans-Serif">reporting regularly to the Board</FONT></P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></p></td></tr>
</table>
</DIV>
<BR>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 5pt">&nbsp;</FONT></P>

<P STYLE="border-top: rgb(136,138,140) 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Our Chief Executive Officer and Chairman
work closely together to execute our strategic plan. Our Chairman leads our Board, serves as a liaison between the Board and senior
management team, mentors and advises the senior scientific team, provides an extensive network of contacts, and reports regularly
to the Board. We believe the combination of Mr. Erck as the President and Chief Executive Officer and Dr. Young as the Chairman
of the Board is an effective leadership structure. The additional avenues of communication between the Board and management associated
with having Dr. Young serve as Chairman provides the basis for the proper functioning of the Board and its oversight of management.</p>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Our Chief Executive Officer and senior management
team are primarily responsible for managing the risks Novavax faces in the ordinary course of operating the business. The Board actively
oversees potential risks and risk management activities by receiving operational and strategic presentations from management, which include
discussions of key risks to the business. In addition, the Board delegates risk oversight to each of its key committees within their areas
of responsibility.</p>

</DIV>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>13</b></font></font></p>




<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">For
example:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 8%; text-align: center; font-size: 10pt; border-top: rgb(72,108,147) 1pt solid; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><IMG SRC="tm212692d3_sch14-aimg079.jpg" ALT=""></TD>
    <TD STYLE="width: 1%; text-align: center; font-size: 10pt; border-top: rgb(72,108,147) 1pt solid; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 91%; font: 9pt Arial, Helvetica, Sans-Serif; border-top: rgb(72,108,147) 1pt solid; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reviews
                                         and discusses with management the system of disclosure controls and internal controls
                                         over financial reporting and discusses the key risks facing the Company and the processes
                                         or actions being taken to mitigate those risks&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reviews
        specific risk areas, such as cybersecurity risk, on a regular basis with input from management&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reviews
        and discusses with the Senior Vice President, Information Technology the current cybersecurity risks and our cybersecurity
        risk management program and activities&nbsp;</FONT></P></TD></TR>
<TR>
    <TD STYLE="text-align: center; font-size: 10pt; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;<IMG SRC="tm212692d3_sch14-aimg080.jpg" ALT=""></FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in; font: 9pt Arial, Helvetica, Sans-Serif; border-bottom: rgb(72,108,147) 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oversees
    incentive compensation programs and strategies, as well as key employee retention issues</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: center; font-size: 10pt; padding-top: 2pt; padding-bottom: 3pt"><IMG SRC="tm212692d3_sch14-aimg081.jpg" ALT=""></TD>
    <TD STYLE="text-align: center; font-size: 10pt; padding-top: 2pt; padding-bottom: 3pt"></TD>
    <TD STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-top: 2pt; padding-bottom: 3pt"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Periodically
                                         reviews the current Directors&rsquo; skill sets and the Company&rsquo;s anticipated future
                                         needs.&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oversees
        the Company&rsquo;s corporate governance structure.&nbsp;</FONT></P></TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="border-bottom: rgb(72,108,147) 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="text-align: center; font-size: 10pt; padding-top: 2pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg082.jpg" ALT=""></FONT></TD>
    <TD STYLE="text-align: center; font-size: 10pt; padding-top: 2pt; padding-bottom: 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 9pt Arial, Helvetica, Sans-Serif; padding-top: 2pt; padding-bottom: 3pt"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Periodically
                                         reviews and assesses our research and development programs&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oversees
        strategies and investments specific to research and development programs</FONT></P></TD></TR>
<TR>
    <TD COLSPAN="3" STYLE="border-bottom: rgb(72,108,147) 1pt solid; text-align: center; font-size: 10pt"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Board
committees are chaired by independent directors and at each Board meeting the committee chairs deliver reports to the full Board on the
activities and decisions made by the committees at recent meetings. In addition, there is significant cross-over of members of the various
committees allowing information to flow freely outside of a full board meeting.</FONT></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 12pt; text-align: justify"></p>


<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>14 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><b><a name="a009"></a>Board
Committees</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Our
Board currently maintains four standing committees: Audit Committee, Compensation Committee, Nominating and Corporate Governance
Committee and Research and Development Committee. In addition to the descriptions below, please refer to the &ldquo;Compensation
Committee Report&rdquo; and &ldquo;the Audit Committee Report&rdquo; included in this Proxy Statement. The members of the committees
are shown below.</FONT></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>

<BR CLEAR="ALL">


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD COLSPAN="2" STYLE="padding-top: 1pt; font-size: 10pt; text-align: right; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD COLSPAN="4" STYLE="padding-top: 1pt; border-bottom: #486C93 1pt solid; vertical-align: bottom; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font: 10pt Arial, Helvetica, Sans-Serif"><b>Committee Memberships</b></font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; vertical-align: bottom; width: 25%; border-bottom: #486C93 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Director</b></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: bottom; width: 15%; border-bottom: #486C93 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Independent</b></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: bottom; width: 15%; border-bottom: #486C93 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Audit</b></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: bottom; width: 15%; border-bottom: rgb(0,61,165) 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Compensation</b></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: bottom; width: 15%; border-bottom: rgb(0,61,165) 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Nominating
    and </b><br>
    <b>Corporate<br>
 Governance</b></font></td>
    <TD STYLE="padding-top: 1pt; text-align: center; width: 15%; border-bottom: #486C93 1pt solid; vertical-align: bottom; padding-bottom: 1pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Research
and </b></font><br>
<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Development</b></font></p></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregg
    H. Alton</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;<img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><IMG SRC="tm212692d3_sch14-aimg084.jpg" ALT=""></b></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard
    H. Douglas, Ph.D.</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="" STYLE="width: 20px; height: 19px"></font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="" STYLE="width: 20px; height: 19px">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stanley
    C. Erck</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; vertical-align: top; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary
    C. Evans</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><IMG SRC="tm212692d3_sch14-aimg084.jpg" ALT=""></b></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg086.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel
    K. King</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT=""></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Margaret
    G. McGlynn, R. Ph.</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg086.jpg" ALT="" STYLE="width: 20px; height: 20px"></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT=""></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael
    A. McManus, Jr., J.D.</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg084.jpg" ALT="" STYLE="width: 40px; height: 18px"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>&nbsp;</b></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rajiv
    I. Modi, Ph.D.</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding-top: 2.5pt; vertical-align: top; font-size: 10pt; text-align: center; padding-bottom: 2.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">David
    M. Mott</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg086.jpg" ALT="" STYLE="width: 20px; height: 20px"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="">&nbsp;</font></td></tr>
<tr>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; padding-left: 5.4pt; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James
    F. Young, Ph.D. <IMG SRC="tm212692d3_sch14-aimg087.jpg" ALT=""></font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><img src="tm212692d3_sch14-aimg083.jpg" alt=""></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="">&nbsp;</font></td>
    <TD STYLE="padding-top: 1pt; vertical-align: top; border-bottom: Black 1pt solid; font-size: 10pt; text-align: center; padding-bottom: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><IMG SRC="tm212692d3_sch14-aimg086.jpg" ALT="" STYLE="width: 20px; height: 20px">&nbsp;</font></td></tr>
</table>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 5%; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;<IMG SRC="tm212692d3_sch14-aimg086.jpg" ALT=""></font></td>
    <td style="width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Committee Chair</font></td>
    <td style="vertical-align: top; width: 2%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 5%; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><IMG SRC="tm212692d3_sch14-aimg085.jpg" ALT="">&nbsp;</font></td>
    <td style="width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Committee Member</font></td>
    <td style="vertical-align: top; width: 2%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 5%; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><IMG SRC="tm212692d3_sch14-aimg087.jpg" ALT="">&nbsp;</font></td>
    <td style="width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Chairman of the Board</font></td>
    <td style="vertical-align: top; width: 2%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</font></td>
    <td style="width: 5%; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;<IMG SRC="tm212692d3_sch14-aimg088.jpg" ALT=""></font></td>
    <td style="width: 29%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Audit Committee Financial Expert</font></td></tr>
</table>


<p style="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>15</b></font></font></p>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD STYLE="border-top: white 1pt solid; padding-top: 1pt; padding-bottom: 2pt; padding-left: 5.4pt; font-size: 10pt; width: 47%; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>&nbsp;Audit
    Committee</b></font></td>
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 2.5pt 2pt 5pt; font-size: 10pt; text-align: right; width: 53%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white">Meetings
    in 2020:&nbsp;&nbsp;5</FONT></td></tr>
</table>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; width: 13%; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg089.jpg" ALT=""></FONT></td>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 35%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><B>MEMBERS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 9pt">Michael
        A. McManus, Jr., J.D. <IMG SRC="tm212692d3_sch14-aimg070.jpg" ALT="" STYLE="height: 15px; width: 17px"></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 9pt">Gregg
        H. Alton</FONT></p>
        </td>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 52%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&nbsp;</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 9pt">Richard
        H. Douglas, Ph.D.</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;</FONT><FONT STYLE="font-size: 9pt">Gary
        C. Evans</FONT></p></td></tr>
<tr>
    <td colspan="3" style="border-bottom: #486C93 1pt solid; padding: 2pt 6.5pt 2pt 5pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">During 2020, the Audit Committee met five times and did not act by written consent in lieu of a meeting.</font></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.05in; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>PRINCIPAL
        RESPONSIBILITIES</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 3.5pt; text-align: justify">The Audit Committee is
responsible for:</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;the appointment, compensation, retention, and oversight of the work
of any independent registered public accounting firm engaged for the purpose of preparing or issuing an audit report or performing other
audit, review or attestation services; the Audit Committee meets with our independent registered public accounting firm to discuss the
scope and results of its examination and reviews the financial statements and reports contained in the Company&rsquo;s periodic and other
financial filings</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">&#8239;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">The Audit Committee&rsquo;s
role is to also:</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;review
the adequacy and efficacy of all accounting, auditing, and financial control systems, as well as disclosure controls and procedures</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;monitor
the adequacy of our accounting and financial reporting processes and practices</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;consider
any issues raised by its members, the independent registered public accounting firm, and employees</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-align: justify; text-indent: -11.5pt"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif">&#8239;&#8239;&#8239;oversee
the Company&rsquo;s compliance with applicable federal and state laws and regulations, and the implementation and operation of the Company&rsquo;s
corporate compliance program</font></p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"> <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93"><b>&#9679;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif">&#8239;annually review the Company&rsquo;s corporate compliance program with the Company&rsquo;s Chief Legal Officer and Chief Compliance Officer, and monitor the program&rsquo;s progress and results during the year</font></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">The Audit Committee is authorized
        to investigate any matter brought to its attention, retain the services of independent advisors (including legal counsel, auditors,
       </p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 5pt; text-align: justify">&nbsp;</p></td>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">and other experts), and
receive and respond to concerns and complaints relating to accounting, internal accounting controls, and auditing matters.</P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 8pt; text-align: justify">The Audit Committee meets regularly
        with both the Company&rsquo;s management team and its independent auditor. At times, the Audit Committee meets in executive session
        without management or the independent auditor present.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>CHARTER</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;The
Audit Committee acts pursuant to a written charter as adopted by the Board. A current copy of the charter is available on the
Company&rsquo;s website at <font style="color: #486C93">www.novavax.com</font>.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;The Audit Committee reviews and evaluates its charter annually to ensure its adequacy and accuracy, and is charged with
        performing an annual self-evaluation with the goal of continuing improvement.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&#8239;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>AUDIT
        COMMITTEE REPORT</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;The
        Audit Committee Report is on page 74 of this Proxy Statement.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>QUALIFICATIONS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;Each
Audit Committee member is an &ldquo;independent director,&rdquo; as defined by the listing standards of the Nasdaq.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;The Board has determined that each of Mr. McManus, Mr. Alton, and Mr. Evans qualifies as an &ldquo;audit committee financial
        expert&rdquo; as defined by the rules and regulations of the Securities and Exchange Commission, and is financially sophisticated
        as required by the listing standards of the Nasdaq.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>16 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>



<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD COLSPAN="2" STYLE="border-top: white 1pt solid; padding-top: 1pt; padding-bottom: 2pt; font-size: 10pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>Compensation
    Committee</b></font></td>
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 2.5pt 2pt 5pt; font-size: 10pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white">Meetings
    in 2020:&nbsp;&nbsp;8</FONT></td></tr>
<tr style="background-color: #F2F2F2">
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; width: 13%; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg090.jpg" ALT=""></FONT></td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 35%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><B>MEMBERS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">David M. Mott <IMG SRC="tm212692d3_sch14-aimg070.jpg" ALT="" STYLE="height: 15; width: 17"></FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">Richard H. Douglas, Ph.D.</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">Rachel K. King</FONT></p>
        </td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 52%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-size: 9pt">Margaret G. McGlynn, R. Ph.</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">Michael A. McManus, Jr., J.D.</FONT></p>
        </td></tr>
<tr>
    <td colspan="3" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: black">During 2020, the Compensation Committee met eight times and acted by written consent in lieu of a meeting four times.</font></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>PRINCIPAL
        RESPONSIBILITIES</B>&nbsp;</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Compensation Committee is responsible for:</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;assisting the Board with its responsibilities
relating to the compensation of the Company&rsquo;s officers and directors and the development, administration and oversight of
the Company&rsquo;s compensation and benefits plans</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;reviews and recommends salaries and other compensatory benefits for
employees, executive officers, and directors</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Compensation Committee&rsquo;s
authority and responsibilities include, but are not limited to:</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;review and recommend to the Board the goals and objectives relevant to our Chief Executive Officer and other executive officers;
        annually evaluate the performance of the Chief Executive Officer and other executive officers; approve or recommend to the Board the compensation levels and annual awards for the Chief Executive Officer and other executive officers</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;oversee our overall compensation philosophy, policies, and programs</p>

        <P STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="font-style: normal; font-weight: normal; color: #486C93">&#9679;&#8239;</FONT><FONT STYLE="font-style: normal; font-weight: normal">&#8239;&#8239;make&nbsp;recommendations&nbsp;to&nbsp;the&nbsp;Board&nbsp;about&nbsp;the&nbsp;compensation of directors</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;approve and administer our equity-based plans and awards and management incentive compensation plans </p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;review
        and approve employment agreements, severance arrangements, retirement arrangements, change in control provisions, and any supplemental
        benefits or perquisites for executive officers and senior management</p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has the authority
        to engage independent compensation consultants or advisors, as it may deem appropriate in its sole discretion, and to approve related
        fees and retention terms.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Compensation Committee routinely
holds meetings, some of which management attends, as well as executive sessions without management, where compensation is discussed.
The chair of the Compensation Committee is responsible for leadership of the Compensation Committee and sets meeting agendas.</p></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">The Compensation Committee may
        request that any executive officer or employee, outside counsel, or consultant attend Compensation Committee meetings or confer
        with any members of, or consultants to, the Compensation Committee. The Compensation Committee is supported in its efforts by our
        Legal and Human Resources teams, to which the Compensation Committee delegates authority for certain administrative functions.
        The Chief Executive Officer gives performance assessments and compensation recommendations for each executive officer (other than
        himself). The Chairman gives performance assessments and compensation recommendations for the Chief Executive Officer. The Compensation
        Committee considers the Chief Executive Officer&rsquo;s and the Chairman&rsquo;s recommendations and the information provided by
        the Human Resources team in its deliberations regarding executive compensation. The compensation of the executive officers is based
        on these deliberations. The Chief Executive Officer and the Executive Vice
        President, Chief Human Resources Officer generally attend Compensation Committee meetings but are not present for executive sessions
        or any discussion of their own compensation.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>CHARTER</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;The
        Compensation Committee acts pursuant to a written charter as adopted by the Board; a current copy of the charter is available on the Company&rsquo;s
        website at <font style="color: #486C93">www.novavax.com</font><font style="color: #231F20"></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;The Compensation Committee reviews and evaluates its charter annually to ensure its adequacy and accuracy, and is charged with performing an annual self-evaluation with the goal of continuing improvement</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>COMPENSATION
        COMMITTEE REPORT</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;The Compensation Committee Report is on page 42 of this Proxy Statement</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>QUALIFICATIONS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>&#8239;Each Compensation Committee member is a &ldquo;non-employee director,&rdquo; as defined by Rule 16b-3 of the Securities
        and Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;) and an &ldquo;independent director,&rdquo; as defined by
        the listing standards of the Nasdaq, including the heightened standards that apply to compensation committee members</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>17</b></font></font></p>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<!-- Field: Split-Segment; Name: 3 -->
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>




<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 2.5pt 2pt 5.4pt; font-size: 10pt; width: 80%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>Nominating
    and Corporate Governance Committee</b></font></td>
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 2.5pt 2pt 5pt; font-size: 10pt; text-align: right; width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white">Meetings
    in 2020:&nbsp;&nbsp;9</FONT></td></tr>
</table>


<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt 2pt 2px; font-size: 10pt; width: 13%; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg091.jpg" ALT=""></FONT></td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 35%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93"><B>MEMBERS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">Gary Evans <IMG SRC="tm212692d3_sch14-aimg070.jpg" ALT="" STYLE="height: 15; width: 17"></FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">Rachel K. King</FONT></p>
        </td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 52%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-size: 9pt">Margaret G. McGlynn, R. Ph.</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">James F. Young, Ph.D.</FONT></p>
        </td></tr>
<tr>
    <td colspan="3" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">During 2020, the Nominating and Corporate Governance Committee met nine times and did not act by written consent in lieu of a meeting.</font></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>PRINCIPAL
        RESPONSIBILITIES</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The primary function of the Nominating
and Corporate Governance Committee is to:</p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;review and make recommendations to the Board regarding the Board&rsquo;s size, structure, and composition</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;establish criteria for Board membership</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 7pt">&#8239;</FONT>identify
        and evaluate candidates qualified to become members of the Board, including candidates proposed by stockholders</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;select, or recommend for selection, director nominees to be presented for approval at the Annual Meeting of Stockholders
        and to fill vacancies on the Board</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;oversee the Company&rsquo;s corporate governance guidelines</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;evaluate Company policies relating to the recruitment of Board members</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT><FONT STYLE="font-size: 9pt">&#8239;</FONT><FONT STYLE="font-size: 8pt">&#8239;</FONT>develop
        and recommend to the Board corporate governance policies&nbsp;and&nbsp;practices</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 5pt">&#8239;</FONT>&#8239;oversee&nbsp;management&rsquo;s&nbsp;plans&nbsp;for&nbsp;succession&nbsp;to&nbsp;senior&nbsp;management positions</P>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in">&nbsp;</P>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">The Nominating and Corporate Governance
        Committee&rsquo;s goal is to contribute to the effective representation of the </p>

        </td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">Company&rsquo;s stockholders and to play a leadership
        role in shaping the Company&rsquo;s corporate governance.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">In reviewing and evaluating director
        candidates, including candidates submitted by stockholders, the Nominating and Corporate Governance Committee does not differentiate
        between candidates based on the proposing constituency, but rather applies the same criteria to each candidate.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>CHARTER</B></FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;The
Nominating and Corporate Governance Committee acts pursuant to a written charter as adopted by the Board; a current copy of the charter
is available on the Company&rsquo;s website at <FONT STYLE="color: #486C93">www.novavax.com</FONT><FONT STYLE="color: #231F20">.</FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><FONT STYLE="color: #486C93"><B>&#9679;</B></FONT><FONT STYLE="font-size: 9pt">&#8239;&#8239;</FONT>The
        Nominating and Corporate&nbsp;Governance&nbsp;Committee reviews and evaluates its charter annually to ensure its adequacy and
        accuracy, and is charged with performing an annual self-evaluation with the goal of continuing improvement</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>QUALIFICATIONS</B></FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><font style="color: #486C93">&#9679;</font>Each Nominating and Corporate Governance Committee member is an &ldquo;independent director,&rdquo; as defined by the listing
        standards of the Nasdaq.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p></td></tr>
</table>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>18 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #486C93">
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 5.4pt 2pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>Research
    and Development Committee</b></font></td>
    <TD STYLE="border-top: white 1pt solid; padding: 1pt 2.5pt 2pt 5pt; font-size: 10pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white">Meetings in 2020:&nbsp;&nbsp;&mdash;</font></td></tr>
</table>


<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; width: 13%; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg092.jpg" ALT=""></FONT></td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 35%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 3pt; color: #486C93"><FONT STYLE="font-size: 9pt"><B>MEMBERS</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">James F. Young, Ph.D. </FONT><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg070.jpg" ALT="" STYLE="height: 15; width: 17"></FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
        </FONT><FONT STYLE="font-size: 9pt">David M. Mott</FONT></p>
        </td>
    <td style="border-bottom: #888A8C 1pt solid; padding: 2pt 5.4pt; width: 52%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; text-indent: -11.5pt"><FONT STYLE="font-size: 9pt; color: #486C93">&#9679;&nbsp;&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-size: 9pt">Richard H. Douglas, Ph.D.</FONT></p>
        </td></tr>
<tr>
    <td colspan="3" style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt; font-size: 10pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: black">The Research and Development Committee was formed in December 2020 and did not meet or act by written consent in lieu of a meeting in 2020.</font></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 25.5pt; padding: 2pt 5.4pt; text-align: justify; border-bottom: rgb(0,61,165) 1pt solid">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>PRINCIPAL
        RESPONSIBILITIES</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt; text-align: justify">The
primary function of the Research and Development Committee is to: </p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&#8239;&#8239;<FONT STYLE="font-size: 7pt">&#8239;</FONT>review
        and assess the Company&rsquo;s research and development programs, with the Committee Chair playing a day-to-day role providing
        input on key aspects of such research and development programs</FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;evaluate the Company&rsquo;s progress in achieving research and development goals and objectives, and make recommendations
        to the Board on modifications to the Company&rsquo;s research and development goals and objectives</p>



        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 7pt">&#8239;</FONT>review
        and assess the Company&rsquo;s intellectual property portfolio and strategy</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><font style="color: #486C93">&#9679;</font>&#8239;&#8239;&#8239;review the Company&rsquo;s regulatory efforts and strategy</p>

        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 7pt">&#8239;</FONT>oversee
        management&rsquo;s exercise of its responsibility to assess and manage risks associated with the Company&rsquo;s research and
        development programs and regulatory matters</p>



        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 0.4in; text-align: justify; text-indent: -0.18in"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;&#8239;select,
retain, and supervise any advisors as the Committee deems necessary, in its discretion, to fulfill its mandates under its Charter,
and compensate, at the expense of the Company, such advisors</p></td>
    <td style="border-bottom: #486C93 1pt solid; padding: 2pt 5.4pt">

            <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">The Research and Development Committee&rsquo;s
        goal is to contribute to the Company&rsquo;s development of a robust intellectual property portfolio, and to play a leadership
        role in shaping the Company&rsquo;s research and development programs and strategies.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify">&nbsp;</p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>CHARTER</B></FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;The
Research and Development Committee acts pursuant to a written charter as adopted by the Board; a current copy of the charter is available
on the Company&rsquo;s website at <FONT STYLE="color: #486C93">www.novavax.com</FONT><FONT STYLE="color: #231F20">.</FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;&#8239;<FONT STYLE="font-size: 7pt">&#8239;</FONT>The
        Research and Development Committee reviews and evaluates its charter annually to ensure its adequacy and accuracy, and is charged
        with performing an annual self-evaluation with the goal of continuing improvement</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 8pt; text-align: justify; color: #486C93"><FONT STYLE="font-size: 9pt"><B>QUALIFICATIONS</B></FONT>&nbsp;</p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt"><FONT STYLE="color: #486C93">&#9679;</FONT>&#8239;Each
Research and Development Committee member is an &ldquo;independent director,&rdquo; as defined by the listing standards of the Nasdaq.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 30.5pt; text-align: justify; text-indent: -11.5pt">&nbsp;</p></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>
<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b><a name="a010"></a>Nomination Procedures</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Stockholders who wish to nominate qualified
candidates to serve as directors may do so in accordance with the procedures set forth in the Company&rsquo;s Amended and Restated
By-Laws (&ldquo;By-Laws&rdquo;), which procedures did not change during the last fiscal year. As stated in the By-Laws, a stockholder
must notify the Company in writing, by notice delivered to the attention of the Secretary of the Company at the address of the
Company&rsquo;s principal executive offices, of a proposed nominee.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In order to ensure meaningful consideration
of such candidates, notice must be received not less than 60 days nor more than 90 days prior to the anniversary date of the applicable
year&rsquo;s Annual Meeting of Stockholders. However, in the event the date of the applicable year&rsquo;s Annual Meeting of Stockholders
is more than 30 days before or after the anniversary date of the prior year&rsquo;s Annual Meeting of Stockholders, notice by the
stockholder to be timely it must be received not later than the close of business on the 10th day following the day on which such
notice of the date of the meeting was</P>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">mailed or public disclosure of the date of such meeting was made, whichever occurs first.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The notice must include the following information
for each proposed nominee:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">name, age, business and residence address;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">his or her principal occupation or employment;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">the class and number of shares of capital stock and other securities of the Company, if any, which
are beneficially owned by such nominee and whether and the extent to which any hedging or other transaction or series of transactions
has been entered into by or on behalf of, or any other agreement, arrangement or understanding has been made, the effect or intent
of which is to increase or decrease the voting power or economic interest of, such person with respect to the Company&rsquo;s securities; and</td></tr></table>

</DIV>
<BR CLEAR="ALL">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>19</b></font></font></p>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>


<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">any other information concerning the nominee that must be disclosed as to nominees in proxy solicitations,
or is otherwise required, in each case pursuant to applicable law.</td></tr></table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The notice must also include with respect to
the stockholder giving the notice and each Stockholder Associated Person:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">the name and address, as they appear on the Company&rsquo;s books, of such stockholder;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">a description of all direct and indirect compensation and other material monetary arrangements,
agreements or understandings during the past three years, and any other material relationship, if any, between or concerning such
stockholder and each Stockholder Associated Person, on the one hand, and each proposed nominee, and his or her respective affiliates
and associates, on the other hand;</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">the class and number of shares of capital stock and other securities of the Company that are owned
by such person; and</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">any derivative positions held of record or beneficially by such person and whether and the extent
to which any hedging or other transaction or series of transactions has been entered into by or on behalf of, or any other agreement,
arrangement or understanding has been made, the effect or intent of which is to increase or decrease the voting power or economic
interest of, such person, with respect to the Company&rsquo;s securities.</td></tr></table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">For purposes of this Proxy Statement, a &ldquo;Stockholder
Associated Person&rdquo; of any stockholder means:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 27pt">(i)</td><td style="text-align: justify">any &ldquo;affiliate&rdquo; or &ldquo;associate&rdquo; (as those terms are defined in Rule 12b-2
under the Exchange Act) of the stockholder who owns beneficially or of record any capital stock or other securities of the Company
or, through one or more derivative positions, has an economic interest (whether positive or negative) in the price of securities
of the Company, and</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 27pt">(ii)</td><td style="text-align: justify">any person acting in concert with such stockholder or any affiliate or associate of such stockholder
with respect to the capital stock or other securities of the Company.</td></tr></table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition, any nominee proposed by a stockholder
shall complete a questionnaire, in a form provided by the Company. The completed questionnaire shall be submitted within ten days
after the Company provides the questionnaire. The Company may require any proposed nominee to furnish other information as may
reasonably be required to determine the eligibility of the nominee to</P>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">serve as a director. Nominations received through this process
will be forwarded to the Nominating and Corporate Governance Committee for review.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Nominating and Corporate Governance Committee
strives to maintain a board of directors with a diverse set of skills and qualifications to ensure the board of directors is adequately
serving the needs of the Company&rsquo;s stockholders. Before evaluating director candidates, the Nominating and Corporate Governance
Committee reviews the skills and qualifications of the directors currently serving on the Board and identifies any areas of weakness
or skills of particular importance. On the basis of that review, the Nominating and Corporate Governance Committee will evaluate
director candidates with those identified skills. While the Nominating and Corporate Governance Committee does not have a formal
policy on Board diversity, the committee takes into account a broad range of diversity considerations when assessing director candidates,
including individual backgrounds and skill sets, professional experiences, underrepresented classes, and other factors that contribute
to the Board having an appropriate range of expertise, talents, diversity, experiences, and viewpoints. The Nominating and Corporate
Governance Committee considers the following skills and experiences necessary to the Board: industry knowledge, clinical development
expertise, commercialization expertise, manufacturing expertise, financial expertise and capital raising experience, and scientific
or medical education and experience, particularly in vaccine-related fields.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">While there are no set minimum requirements,
a candidate should:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">be intelligent, thoughtful, and analytical</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">have excelled in both academic and professional settings</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">possess superior business-related knowledge, skills, and experience</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">demonstrate achievement in his or her chosen field</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">reflect the highest integrity, ethics, and character</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">be free of actual or potential conflicts of interest</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">have the ability to devote sufficient time to the business and affairs of the Company</td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="color: #486C93">&#9679;</font></td><td style="text-align: justify">demonstrate the capacity and desire to represent the best interests of our stockholders as a whole</td></tr></table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In addition to the above criteria (which may
be modified from time to time), the Nominating and Corporate Governance Committee may consider such other factors as it deems in
the best interests of the Company and its stockholders and that may enhance the effectiveness and responsiveness of the Board and
its committees. Finally, the Nominating and Corporate Governance</P>

</DIV>
<BR CLEAR="ALL">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt"><b>20 <font style="font-family: Arial, Helvetica, Sans-Serif; color: #486C93">|
</font></b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ir.novavax.com</font></b></p>

<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; border-bottom: #486C93 1pt solid; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><b>Board
of Directors and Corporate Governance</b></font></p>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Committee must consider a candidate&rsquo;s independence to make
certain the Board includes at least a majority of &ldquo;independent&rdquo; directors to satisfy all applicable independence requirements,
as well as a candidate&rsquo;s financial sophistication and special competencies.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Nominating and Corporate Governance Committee
identifies potential candidates through referrals and recommendations, including by incumbent directors, management, and stockholders,
as well as through business and other organizational networks. To date, the Nominating and Corporate Governance Committee has not
retained or paid any third party to identify or evaluate, or assist in identifying or evaluating, potential director nominees,
although it reserves the right to engage executive search firms and other third parties to assist in finding suitable candidates.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Current members of the Board with the requisite
skills and experience are considered for re-nomination, balancing the value of the member&rsquo;s continuity of service with that
of obtaining a new perspective, and considering each individual&rsquo;s contributions, performance and level of participation,
the current composition of the Board, and the Company&rsquo;s needs. The Nominating and Corporate Governance Committee also must
consider the age and length of service of incumbent directors.</p>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Board adopted a policy in 2005 not to re-nominate
a director for re-election if such director has served ten years as a director or has reached 75 years of age, unless circumstances
exist which cause the Nominating and Corporate Governance Committee to believe that despite such factors, such a nomination was
in the best interest of the Company and its stockholders.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">In
accordance with this policy, although Dr. Douglas will have served on our Board for more than ten years, the Nominating and Corporate
Governance Committee determined to nominate him for reelection to the Board at the Annual Meeting due to his extensive knowledge of our
corporate history, operations and strategy, and the Company&rsquo;s urgent objective in developing its NVAX-CoV2373 vaccine against the
SARS-CoV-2 virus. If any existing members do not wish to continue in service or if it is decided not to re-nominate a director, new candidates
are identified in accordance with those skills, experience, and characteristics deemed necessary for new nominees, and are evaluated
based on the qualifications set forth above. In every case, the Nominating and Corporate Governance Committee meets (in person or telephonically)
to discuss each candidate and may require personal interviews before final approval. Once a slate of nominees is selected, the Nominating
and Corporate Governance Committee presents it to the full Board.</font></p>

</DIV>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><a name="a011"></a>Corporate Governance Guidelines</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Board has adopted corporate governance
guidelines that are available on the Company&rsquo;s website at <font style="color: #486C93">www.novavax.com</font><font style="color: #231F20">.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 12pt">&nbsp;</FONT></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><a name="a012"></a>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Board has adopted a Code of Business
Conduct and Ethics (&ldquo;Code of Ethics&rdquo;) that applies to each employee, officer, and director, including but not
limited to, the Chief Executive Officer and Chief Financial Officer. The Code of Ethics is reviewed at least annually by the
Nominating and Corporate Governance Committee. A current copy of the Code Ethics, is available on the Company&rsquo;s</P>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">website
at <font style="color: #486C93">www.novavax.com</font><font style="color: #231F20">.</font>&nbsp;The Company intends to
disclose on its website any future amendments to and waivers of the Code of Ethics that apply to its Chief Executive Officer,
Principal Financial Officer and Principal Accounting Officer, and persons performing similar functions.</p>

</DIV>
<BR CLEAR="ALL">

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><font style="font-size: 9pt"><b>NOVAVAX, INC.
</b><font style="font-family: Arial, Helvetica, Sans-Serif">2021 PROXY STATEMENT <font style="color: #486C93">|</font> <b>21</b></font></font></p>

<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Board
of Directors and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><A NAME="a013"></A>Stockholder Communications with the Board of Directors</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Board welcomes communications from stockholders
and has adopted a procedure for receiving and addressing such communications. Stockholders may send written communications to the
entire Board or individual directors, addressing them to:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #F2F2F2; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 2%; border-top: #496D93 1pt solid; border-left: #496D93 1pt solid; text-align: right">&nbsp;</td>
    <td style="width: 6%; border-top: #496D93 1pt solid; text-align: right">&nbsp;</td>
    <td style="width: 7%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 34%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 7%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 5%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 7%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 29%; border-top: #496D93 1pt solid">&nbsp;</td>
    <td style="width: 3%; border-top: #496D93 1pt solid; border-right: #496D93 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="border-left: #496D93 1pt solid; text-align: right">&nbsp;</td>
    <td style="text-align: center"><IMG SRC="tm212692d3_sch14-aimg093.jpg" ALT=""></td>
    <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>MAIL</b></font></td>
    <td>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Novavax, Inc.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Attention: Corporate Secretary</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">21 Firstfield Road</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Gaithersburg, Maryland 20878</p></td>
    <td>&nbsp;</td>
    <td style="text-align: center"><IMG SRC="tm212692d3_sch14-aimg094.jpg" ALT=""></td>
    <td><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>EMAIL</b></font></td>
    <td>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93">ir@novavax.com</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0">Mark &ldquo;Attention: Corporate Secretary&rdquo; in the &ldquo;Subject&rdquo;
        field</p></td>
    <td style="border-right: #496D93 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #496D93 1pt solid; border-left: #496D93 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid; text-align: right">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-bottom: #496D93 1pt solid">&nbsp;</td>
    <td style="border-right: #496D93 1pt solid; border-bottom: #496D93 1pt solid">&nbsp;</td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">All such communications will be forwarded to
the full Board or to any individual director or directors to whom the communication is directed unless the communication is clearly
of a marketing nature or is unduly hostile, threatening, illegal, or similarly inappropriate, in which case the Company has the
authority to discard the communication or take appropriate legal action.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><A NAME="a014"></A>Certain Relationships and Related Transactions</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&rsquo;s Code of Ethics provides
that the Audit Committee is responsible for approving all transactions or business relationships involving Novavax and any director
or executive officer, including any transactions between Novavax and either the director or officer personally, members of their
immediate families, or entities in which they have an interest. In evaluating related party transactions, the Audit Committee members
apply the same standards of good faith and fiduciary duty they apply to their general responsibilities as a committee of the Board
and as individual directors. The Audit Committee will approve a related party transaction when, in its good faith judgment, the
transaction is in the best interest of the Company.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Modi, a director of Novavax, is also the managing director of Cadila
Pharmaceuticals, Ltd. (&ldquo;Cadila&rdquo;). Novavax and Cadila have formed a
joint venture called CPL Biologicals Private Limited, of which Novavax owns 20% and Cadila owns the remaining 80%. As of April 19,
2021, a subsidiary of Cadila owns 125,000 shares of Novavax&rsquo;s outstanding Common Stock.</p>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In June 2020, in advance of David M. Mott joining
the Company&rsquo;s Board of Directors, the Company agreed to sell&nbsp;32,916&nbsp;shares of Common Stock to him in a sale exempt
from the registration requirements of the&nbsp;Securities Act of 1933, as amended, pursuant Section 4(a)(2) thereunder, at a purchase
price of $45.57&nbsp;per share, reflecting the closing price of the Company&rsquo;s Common Stock on the trading date prior to the
date of the parties&rsquo; agreement regarding the sale, for total gross proceeds of $1.5 million. Mr. Mott joined the Company&rsquo;s
Board of Directors later in the same month.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>




<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">There are no family relationships among any
of the directors or executive officers (or any board member nominee) of Novavax. No director, executive officer, nominee, or any
associate of any of the foregoing has any interest, direct or indirect, in any proposal to be considered and acted upon at the
Annual Meeting (other than the election of directors)</p>
</div>
<BR CLEAR="ALL"><BR>

<p style="font: 5pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><A NAME="a015"></A>Compensation Committee Interlocks and Insider Participation</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">During 2020, Dr. Douglas, Ms. King, Mr. McManus,
Mr. Mott and Dr. Young served as members of the Compensation Committee. None of the members of the Compensation Committee were
at any time during 2020 an employee or executive officer of Novavax.</p>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">No executive officer of the Company currently serves, or during
2020 served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers
serving as a member of the Company&rsquo;s Board or Compensation Committee.</p>

</div>
<BR CLEAR="ALL"><BR>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>22
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 28; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Board
of Directors and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0"><b><A NAME="a016"></A>Compensation of Directors</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Compensation paid to our non-employee directors
is comprised of two components: (i) cash compensation and (ii) equity awards.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><font style="font-size: 14pt"><b>CASH COMPENSATION</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our non-employee director cash compensation
arrangement for 2020 was as follows:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 76%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Non-Employee
    Director Service</b></font></td>
    <td style="width: 24%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-size: 9pt"><b>2020
        Cash Retainer</b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-size: 9pt"><b>($)</b></font></p></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Board
    member</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">40,000</font></td></tr>
<tr style="background-color: #F2F2F2">
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Supplemental
    cash retainers:</b></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b><i>Chairperson:</i></b></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Board</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Audit
    Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation
    Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Nominating
    and Corporate Governance Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Research
    and Development Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b><i>Member:</i></b></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Audit
    Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,500</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Nominating
    and Corporate Governance Committee</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,000</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 30.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Research
    and Development Committee<br>&nbsp;&nbsp;&nbsp;*<i>beginning 2021</i></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 1pt 0; text-align: center; vertical-align: top"><P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 1pt; margin-bottom: 1pt"><FONT STYLE="font-size: 9pt">5,000*</FONT></p></td></tr>
<tr style="background-color: #F2F2F2">
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Board
    and Committee meetings:</b></font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-right: 57pt; padding-bottom: 1pt; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; padding: 6pt 2.15pt 1pt 5.4pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Directors
    do not receive compensation for attending meetings. Directors are reimbursed for reasonable costs and expenses incurred in
    connection with attending any Board or committee meetings or any other Company related business activities.</font></td></tr>
</table>
<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 14pt; color: #496D93"><b>NON-EMPLOYEE DIRECTOR
DEFERRED FEE POLICY</b></font><font style="font-size: 14pt">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company&rsquo;s Director Deferred Fee
Policy for its non-employee directors permits an eligible director to defer receipt of all or part of the director&rsquo;s cash
retainer. To defer fees payable during any calendar year, a director must make an election by the end of the preceding
calendar year. A director can elect to have 100% of deferred amounts credited to a &ldquo;cash account&rdquo; or a &ldquo;Company common stock
account,&rdquo; or, alternatively, a director may elect to have deferred amounts credited 50% to each account. Cash accounts are
credited with interest quarterly at the IRS Applicable Federal Rate for short-term debt instruments for the last month of
such calendar quarter. Company Common Stock accounts are credited as if amounts were invested in notional stock units based
upon the market price of Common Stock and are credited with additional notional units if dividends are paid on Common Stock.
Payment of deferred amounts</P>
</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">is to be made in cash upon the occurrence of certain events, including the director&rsquo;s separation
from service, death of the director, or a change in control of the Company. The director may also elect to receive payment of
the deferred amounts in a specified year that is not more than ten years from the year in which the director&rsquo;s fees were
earned. A director may elect to receive payment in either a lump sum or in up to ten annual installments.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Dr. Douglas has elected to defer fees earned
in the fiscal year ending December 31, 2020. The following table shows how he currently has his deferred fees credited.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Name</b></font></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Annual
    Retainer</b></font></td></tr>
<tr>
    <TD ROWSPAN="2" STYLE="width: 32%; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Richard
    H. Douglas, Ph.D.</font></td>
    <TD STYLE="vertical-align: top; width: 50%; border-bottom: #69737B 1pt solid; padding: 1pt -6.5pt 1pt 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    account</font></td>
    <TD STYLE="vertical-align: top; width: 18%; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; padding-right: 15pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0%</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding: 1pt -6.5pt 1pt 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company
    Common Stock account</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; padding-right: 15pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">100%</font></td></tr>
</table>

</div>
<BR CLEAR="ALL"><BR>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">23</FONT></B></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Board
of Directors and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><font style="font-size: 14pt"><b>EQUITY AWARDS</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><i>Annual
Equity Awards</i></b></font></p>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On June 25, 2020, the Compensation Committee
granted options to purchase 6,900 shares of Common Stock to each of Dr. Douglas, Ms. King, and Messrs. Evans and McManus, and options
to purchase 4,400 shares of Common Stock to Mr. Mott. In recognition of his service as our Chairman of the Board, Dr. Young was
granted an option to purchase 15,180 shares of Common Stock. All of the aforementioned options have an exercise price of $83.54
per share and will vest in full one year from the date of grant subject to continued service on the Company&rsquo;s Board of Directors
through the vesting date.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On June 25, 2020, the Compensation Committee granted time-vesting restricted
stock units (&ldquo;RSUs&rdquo;) representing a right to receive 3,450 shares of Common Stock to each of Dr. Douglas, Mr. Evans, Ms. King
and Mr. McManus. In recognition of his service as our Chairman of the Board, Dr. Young received RSUs representing a right to receive 7,590
shares of Common Stock. All of the aforementioned RSUs will vest in full one year from the date of grant subject to continued service
on the Company&rsquo;s Board through the vesting date.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left"><b><i>Equity Awards upon Appointment to the
Board or a Committee</i></b></p>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On June 13, 2020, the Board granted
an option to purchase 8,000 shares of Common Stock, effective as of June 16, 2020, to Mr. Mott in connection with
his appointment to the Board. The option has an exercise price of $52.15 per share and will vest in full on June 16, 2021
subject to continued service on the Company&rsquo;s Board through the vesting date.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">On October 31, 2020, the Board granted an option
to purchase 7,700 shares of Common Stock to Mr. Alton in connection with his appointment to the Board. The option has an exercise
price of $80.71 per share and will vest</P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">in full one year from the date of grant, subject to continued service on the Company&rsquo;s Board
through the vesting date.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">On December 5, 2020, the Board granted an option to purchase 7,700
shares of Common Stock, effective as of December 7, 2020, to Ms. McGlynn in connection with her appointment to the Board. The option has
an exercise price of $123.12 per share and will vest in full on December 7, 2021 subject to continued service on the Company&rsquo;s Board through
the vesting date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">On December 5, 2020, the Board granted time-vesting RSUs representing
the contingent right to receive 20,000 shares of Common Stock to Dr. Young, in connection with the appointment of Dr. Young as Chair of
the newly established standing Research and Development Committee of the Board. The Board, upon recommendation of the Compensation Committee,
with Dr. Young recused from both meetings, determined the size of the award based on Dr. Young&rsquo;s substantial time commitment and
impact providing Board oversight of the Company&rsquo;s research and development efforts, including process development, manufacturing
scale-up, technology transfer and other activities related to the Company&rsquo;s regulatory efforts and strategy. Fifty percent (50%)
of the RSUs subject to this grant vested on January 1, 2021, and the remaining fifty percent (50%) of the RSUs subject to this grant will
vest on July 1, 2021, in each case subject to continued service on the Company&rsquo;s Board through the vesting date. Dr. Young&rsquo;s prior
experience has provided substantial value to the Board and management team, as Dr. Young provides oversight of efforts to resolve innumerable
obstacles developing its COVID-19 vaccine at an accelerated pace. The December 2020 award made to Dr. Young reflected a unique situation
related to accelerated activity and demands connected to developing the Company&rsquo;s COVID-19 vaccine. The Board plans to evaluate
new director compensation limits later in 2021, when it will be evaluating corporate governance provisions more generally.</p>

</div>
<BR CLEAR="ALL"><BR>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>24
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Board
of Directors and Corporate Governance</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><font style="font-size: 14pt"><b>DIRECTOR COMPENSATION
TABLE</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Company does not pay employee directors
additional compensation for service on the Board. The following table sets forth information concerning the compensation paid by
the Company to each individual who served as a non-employee director at any time during fiscal year 2020:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr>
    <td style="text-align: left; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Name</b></font></td>
    <td style="text-align: center; width: 15%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt"><b>Fees
        Earned or <BR>
Paid in Cash<sup>(1)</sup></b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt"><b>($)</b></font></p></td>
    <td style="text-align: center; width: 15%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt"><b>Option
        Awards<sup>(2)</sup></b></font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt"><b>($)</b></font></p></td>
    <td style="vertical-align: bottom; width: 15%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Stock
Awards</B><SUP>(3)</SUP></FONT><BR>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>($)</B></FONT></td>
    <td style="text-align: center; width: 15%; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt"><b>Total<br>
<font style="font-family: Arial, Helvetica, Sans-Serif">($)</font></b>&nbsp;</font></p></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Gregg
    H. Alton<sup>(4)</sup></font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,151</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">557,362</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">564,513</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Richard
    H. Douglas, Ph.D.<sup>(5)</sup></font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,500</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">515,767</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">288,213</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">861,480</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Gary
    C. Evans</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60,000</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">515,767</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">288,213</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">863,980</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Rachel
    K. King</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">52,500</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">515,767</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">288,213</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">856,480</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Margaret
    G. McGlynn, R. Ph.<sup>(6)</sup></font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,528</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">851,389</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">854,917</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Michael
    A. McManus, Jr., J.D.</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,272</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">515,767</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">288,213</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">876,252</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Rajiv
    I. Modi, Ph.D.<sup>(7)</sup></font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">David
    M. Mott<sup>(8)</sup></font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">26,294</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">701,038</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">727,332</font></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">James
    F. Young, Ph.D.</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,952</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,134,687</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: top; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,159,069</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; vertical-align: bottom; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,387,708</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><font style="font-size: 9pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</font></td>
    <td style="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 9pt">Represents
        fees earned in 2020, pro-rated as applicable for a partial year of service.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 5pt"><font style="font-size: 9pt">Represents options granted
    in 2020 in respect of 2020 service on the Board. The grant date fair value was calculated in accordance with Financial Accounting
    Standards Board Accounting Standards Codification (&ldquo;FASB ASC&rdquo;) Topic 718. Assumptions used in the calculation
    of this amount are included in Note 13 to the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020
    filed with the SEC on March 1, 2021. As of December 31, 2020, the aggregate number of stock options held by each non-employee
    director is as follows:</font></td></tr>
</table>

<p style="margin: 0"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="margin: 0"><font style="font-size: 9pt"></font></p>

<table cellspacing="0" cellpadding="0" style="width: 65%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 10%">
<tr>
    <td style="vertical-align: top; width: 20%; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Alton</font></td>
    <td style="vertical-align: bottom; width: 10%; text-align: right; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,770</font></td>
    <td style="vertical-align: top; width: 5%; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; width: 20%; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. McManus</font></td>
    <td style="vertical-align: bottom; width: 10%; text-align: right; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,900</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Douglas</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">45,900</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Modi</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Evans</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,990</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Mott</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,400</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms. King</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,900</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 5.4pt; vertical-align: bottom; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Young</font></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 5.4pt; vertical-align: bottom; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">103,930</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms. McGlynn</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,770</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding: 1pt 5.4pt; vertical-align: top"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding: 1pt 5.4pt; vertical-align: bottom; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td></tr>
</table>
<p style="margin: 0"><font style="font-size: 9pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 5%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 95%"><font style="font-size: 9pt">Represents restricted stock
    units granted in 2020 in respect of 2020 service on the Board. The grant date fair value was calculated in accordance with
    FASB ASC Topic 718. Assumptions used in the calculation of this amount are included in Note 13 to the Company&rsquo;s Annual
    Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 1, 2021. As of December 31, 2020, the
    aggregate number of restricted stock units held by each non-employee director is as follows:</font></td></tr>
</table>

<p style="margin: 0"><font style="font-size: 9pt">&nbsp;</font></p>

<p style="margin: 0"><font style="font-size: 9pt"></font></p>

<table cellspacing="0" cellpadding="0" style="width: 65%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; margin-left: 10%">
<tr>
    <td style="vertical-align: top; width: 20%; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Alton</font></td>
    <td style="vertical-align: bottom; width: 10%; text-align: right; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</font></td>
    <td style="vertical-align: top; width: 5%; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; width: 20%; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. McManus</font></td>
    <td style="vertical-align: top; width: 10%; text-align: right; padding: 1pt 5.4pt; border-top: rgb(0,61,165) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,450</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Douglas</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,450</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Modi</font></td>
    <td style="vertical-align: top; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Evans</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,450</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr. Mott</font></td>
    <td style="vertical-align: top; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms. King</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(105,115,123) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,450</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 5.4pt; vertical-align: bottom; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dr. Young</font></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 5.4pt; vertical-align: bottom; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,590</font></td></tr>
<tr>
    <td style="vertical-align: top; padding: 1pt 5.4pt; border-bottom: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms. McGlynn</font></td>
    <td style="vertical-align: bottom; text-align: right; padding: 1pt 5.4pt; border-bottom: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</font></td>
    <td style="vertical-align: top; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding: 1pt 5.4pt; vertical-align: top"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding: 1pt 5.4pt; vertical-align: bottom; text-align: right"><font style="font-size: 9pt">&nbsp;</font></td></tr>
</table>
<p style="margin: 0"><font style="font-size: 9pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 5%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 5pt 0 0"><font style="font-size: 9pt">(4)</font></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; width: 95%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 5pt 0 0; text-align: justify"><font style="font-size: 9pt">Mr.
        Alton was appointed to the Board on October 31, 2020.</font></p></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 5pt"><font style="font-size: 9pt">(5)</font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 5pt"><font style="font-size: 9pt">Dr. Douglas&rsquo; fees
    in respect of 2020 were deferred in accordance with the Non-Employee Director Deferred Fee Policy, described above.&nbsp;</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6)</font></td>
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ms.
    McGlynn was appointed to the Board on December 5, 2020.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7)</font></td>
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Due
    to his relationship with Cadila and CPL Biologicals Private Limited, Dr. Modi did not receive compensation for his services
    as a director in 2020.</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8)</font></td>
    <td style="padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mr.
    Mott was appointed to the Board on June 14, 2020.</font></td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">25</FONT></B></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 76%; background-color: #496D93; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b><A NAME="a017"></A>EXECUTIVE
    OFFICERS AND COMPENSATION</b></font></td>
    <td style="width: 24%; padding-top: 12pt; padding-bottom: 12pt; font-size: 10pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: #496D93"><b><A NAME="a018"></A>Proposal
2</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt">&mdash;Advisory Vote on Executive Compensation
(Say-on-Pay)</font></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">We
are asking stockholders to approve, on an advisory, non-binding basis, the compensation of our Named Executive Officers as disclosed
in this Proxy Statement, as required pursuant to section 14A of the Exchange Act (15 U.S.C. 78n-1). The Company provides its stockholders
with the opportunity to cast an annual advisory vote to approve the compensation of its Named Executive Officers and this Proposal 2, commonly referred to as a &ldquo;say-on-pay&rdquo; proposal, gives our stockholders the opportunity to express their views
on our executive compensation programs.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">As
described in detail in the Compensation Discussion and Analysis section and the related tables and narrative disclosure in this
Proxy Statement, our executive compensation programs are designed to:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="width: 21%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 4pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg095.jpg" ALT=""></font></td>
    <td style="width: 4%; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 22pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td>
    <TD STYLE="width: 27%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 4pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg096.jpg" ALT=""></font></td>
    <td style="width: 4%; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 22pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td>
    <TD STYLE="width: 19%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 4pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg097.jpg" ALT=""></font></td>
    <td style="width: 3%; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 4pt"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></td>
    <TD STYLE="width: 22%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-right: 17.3pt; padding-bottom: 1pt; padding-left: 4pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg098.jpg" ALT=""></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 2pt 3.75pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Attract
    and retain highly qualified employees</font></td>
    <TD STYLE="padding: 2pt 17pt 2pt 4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt 4.5pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Reward
    executives for meeting the strategic goals and objectives</font></td>
    <TD STYLE="padding: 2pt 17pt 2pt 4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Reward
    strong individual performance</font></td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;</font></td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Align
    executives&rsquo; interests with those of our stockholders</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">Please
read the Compensation Discussion and Analysis section for additional details about our executive compensation objectives, philosophy,
and programs, along with the compensation paid to our Named Executive Officers with respect to the fiscal year ended December
31, 2020 and the rationale for such compensation.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">The
Board is asking stockholders to cast a non-binding, advisory vote &ldquo;FOR&rdquo; the compensation paid to our Named Executive
Officers in 2020, as disclosed pursuant to the compensation disclosure rules of the Securities and Exchange Commission, including
the Compensation Discussion and Analysis, compensation tables, and related narrative discussion included in this Proxy Statement.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">We
recommend that you vote &ldquo;FOR&rdquo; the following resolution at the Annual Meeting:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 13.5pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>RESOLVED</b>,
that the compensation of the Company&rsquo;s Named Executive Officers as disclosed in the Company&rsquo;s Proxy Statement for
the 2021 Annual Meeting of Stockholders pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis,
compensation tables, and narrative discussion, is hereby approved.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 13.5pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">Although
the say-on-pay vote we are asking you to cast is non-binding, the Board and the Compensation Committee, who are responsible
for designing and administering our executive compensation programs, value the opinions of our stockholders on this Proposal
 2 and will consider the outcome of the vote on Proposal 2 when making future compensation decisions for our Named
Executive Officers. The Board has determined to provide stockholders with an annual opportunity to approve the compensation
of the Named Executive Officers.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="vertical-align: top; width: 7%; border-top: #496D93 1pt solid; border-bottom: #496D93 1pt solid; border-left: #496D93 1pt solid; padding: 3pt 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg099.jpg" ALT=""></td>
    <td style="width: 93%; border-top: #496D93 1pt solid; border-right: #496D93 1pt solid; border-bottom: #496D93 1pt solid; padding-top: 3pt; padding-right: 10.5pt; padding-bottom: 3pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>The
    Board recommends that stockholders vote</b></font><b> <font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93">FOR
    </font></b><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">the compensation paid to our Named
    Executive Officers in 2020.</font></b></td></tr>
</table>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>26
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>


<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><font style="font-family: Arial, Helvetica, Sans-Serif"><b><A NAME="a019"></A>Executive
Officers</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Our executive officers hold office until
the first meeting of the Board following the Annual Meeting of Stockholders and until their successors are duly chosen and qualified,
or until they resign or are removed from office in accordance with our By-Laws. The following information outlines our executive
officers, their ages and positions as of April 19, 2021, followed by biographical information for each executive officer.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg100.jpg" ALT=""></font></td>
    <td style="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg101.jpg" ALT=""></td>
    <td style="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg102.jpg" ALT=""></td>
    <td style="vertical-align: bottom; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg103.jpg" ALT=""></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</font></td></tr>
<tr>
    <td style="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>STANLEY
    C. ERCK</b></font></td>
    <td style="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>GREGORY
    M. GLENN, M.D.</b></font></td>
    <td style="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>JOHN
    J.TRIZZINO</b></font></td>
    <td style="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: white"><b>JOHN
    A. HERRMANN III</b></font></td></tr>
<tr>
    <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Age
    72</font></td>
    <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Age
    67</font></td>
    <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Age
    61</font></td>
    <td style="vertical-align: bottom; padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Age
    55</font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">President
    and <br>
Chief Executive <br>
Officer and <br>
Director</font></td>
    <td style="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">President,
Research and <br>
Development</font></td>
    <td style="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Executive
    Vice President,<BR>
Chief Commercial Officer,<br> Chief Business Officer and<BR>
Interim Chief Financial
    Officer</font></td>
    <td style="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Executive
    Vice President,<BR>
Chief Legal Officer and <br>
Corporate Secretary</font></td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
<tr>
    <td style="vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt"></td>
    <td style="width: 40%; padding-left: 5pt; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="width: 40%; padding-left: 5pt; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td></tr>
<tr>
    <TD ROWSPAN="2" STYLE="border-top: rgb(0,86,149) 1pt solid; vertical-align: top; background-color: #F2F2F2; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 2pt 3pt"><IMG SRC="tm212692d3_sch14-aimg104.jpg" ALT="">&nbsp;</p>



	<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>President</b></font></p>
	<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>and
 Chief Executive </b></font></p>
	<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Officer
 and Director</b></font></p>

	</td>
    <td colspan="2" style="background-color: #496D93; padding-top: 2pt; padding-bottom: 2pt; padding-left: 5pt; font-size: 11pt; border-top: rgb(0,86,149) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>Stanley
    C. Erck</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 3.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>CAREER
        HIGHLIGHTS</b></font></p>

        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Novavax,
        Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer of
        Novavax, Inc. (April 2011 to present)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interim Chief Financial Officer (November
        2017 to March 2018)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Chairman (February 2010 to April
        2011)</font></p>

	        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Iomai
Corporation </b></font></p>

        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President and Chief Executive Officer (2000 to 2008, when it was acquired
by Intercell AG)</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif">Mr.
        Erck previously held leadership positions at <b>Procept</b>, a publicly traded immunology company, <b>Integrated Genetics</b>,
        now Sanofi Genzyme, and <b>Baxter International</b></font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.05in">&nbsp;</p></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0; color: #496D93"><b>EDUCATION</b></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.75pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">M.B.A., University of Chicago</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.75pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science in Economics, University
        of Illinois</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt; color: #496D93"></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p></td></tr>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</table>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">27</FONT></B></P>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
<tr>
    <td style="vertical-align: top; width: 20%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td></tr>
<tr>
    <TD ROWSPAN="2" STYLE="border-top: rgb(0,86,149) 1pt solid; vertical-align: top; background-color: #F2F2F2; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 5pt; margin-right: 5pt; margin-bottom: 5pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg105.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif"><b>&nbsp;</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>President,</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Research and</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Development</b></font></p></td>
    <td colspan="2" style="vertical-align: bottom; background-color: #496D93; padding-top: 4pt; padding-bottom: 2pt; padding-left: 0.125in; font-size: 11pt; border-top: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>Gregory
    M. Glenn, M.D.</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 3.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Novavax,
        Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President, Research and Development (March
        2016 to present)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Research and Development
        (January 2014 to March 2016)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Chief Medical Officer
        (January 2011 to January 2014)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President and Chief Scientific
        Officer (June 2010 to January 2011)</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Iomai
        Corporation</b>, which was acquired by Intercell AG in 2008</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chief Scientific and Founder</font></p></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Johns
        Hopkins University&rsquo;s School of Public Health</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Associate in International Health</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Walter
        Reed Army Institute of Research</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Clinical and Basic Research Scientist</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 4.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>EDUCATION</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Graduate of the Medical Research Fellowship,
        Walter Reed Army Institute of Research</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">M.D., Oral Roberts University School of
        Medicine</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Arts in Biology and Chemistry, Whitman
        College</font></p></td></tr>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</table>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
<tr>
    <td style="vertical-align: top; width: 20%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td></tr>
<tr>
    <td rowspan="2" style="vertical-align: top; border-bottom: rgb(0,86,149) 1pt solid; background-color: #F2F2F2; padding-right: 5.4pt; padding-left: 5.4pt; border-top: rgb(0,86,149) 1pt solid"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 5pt; margin-right: 5pt; margin-bottom: 5pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg106.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif"><b>&nbsp;</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Executive
Vice</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>President, Chief</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Commercial <br>
Officer, Chief <br>
Business Officer</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>and Interim Chief <br>
Financial Officer</b></font></p></td>
    <td colspan="2" style="vertical-align: bottom; background-color: #496D93; padding-top: 4pt; padding-bottom: 2pt; padding-left: 0.125in; font-size: 11pt; border-top: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>John
    J. Trizzino</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #496D93 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 3.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Novavax,
        Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Vice President, Chief Commercial
        Officer and Chief Business Officer (November 2020 to present) and Interim Chief Financial Officer (as of April 2021)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Chief Business Officer
        and Chief Financial Officer and Treasurer (March 2018 to November 2020)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Commercial Operations
        (March 2014 to March 2018)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Business Development
        (August 2010 to September 2011)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, International and
        Government Alliances (July 2009 to September 2011)</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>ImmunoVaccine,
        Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Chief Executive Officer (September 2011
        to September 2013)</font></p></td>
    <td style="border-bottom: #496D93 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Medimmune,
        LLC</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vice President, Vaccine Franchise</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 4.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>ID
        Biomedical</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, Business Development</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Henry
        Schein, Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vice President, Business Development in
        the Medical Group</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vice President, General Manager, GIV Division</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 4.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>CURRENT
        DIRECTORSHIPS</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The Maryland Tech Council</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 4.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>EDUCATION</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">M.B.A., New York University</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Science, Long Island University, CW Post</font></p></td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>28
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
<tr>
    <td style="vertical-align: top; width: 20%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 40%; font-size: 11pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</font></td></tr>
<tr>
    <TD ROWSPAN="2" STYLE="border-top: rgb(0,86,149) 1pt solid; vertical-align: top; background-color: rgb(242,242,242); padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 5pt; margin-right: 5pt; margin-bottom: 5pt; text-align: left"><IMG SRC="tm212692d3_sch14-aimg107.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif"><b>&nbsp;</b></font></p>
                                                                                                                                                                                                   <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Executive
        Vice <br>
President, Chief <br>
Legal Officer and <br>
Corporate Secretary</b></font></p></td>
    <td colspan="2" style="vertical-align: bottom; background-color: #496D93; padding-top: 4pt; padding-bottom: 2pt; padding-left: 0.125in; font-size: 11pt; border-top: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: white"><b>John
    A. Herrmann III</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 3.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>CAREER
        HIGHLIGHTS</b></font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Novavax,
        Inc.</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Vice President, Chief Legal Officer
        and Corporate Secretary (June 2020 to present)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Vice President, General Counsel
        and Corporate Secretary (June 2014 to June 2020)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vice President, General Counsel and Corporate
        Secretary (March 2012 to June 2014)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive
Director, Legal Affairs and Corporate Secretary (April 2010 to March 2012)</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-size: 9pt">&nbsp;</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-size: 9pt"><b>Ore Pharmaceuticals</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt"><font style="font-size: 10pt; color: #496D93">&#9679;</font><font style="font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-size: 9pt">General
Counsel</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 25.5pt; text-indent: -13.5pt">&nbsp;</p></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 2pt 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Gene
        Logic</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deputy General Counsel (prior to Gene Logic
        becoming Ore Pharmaceuticals)</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Celera
        Genomics</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Counsel</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 0.05in"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>Baxter
        Healthcare</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 7pt 25.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Senior Corporate Counsel, Renal Division</font></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 4.5pt; color: #496D93"><font style="font-family: Arial, Helvetica, Sans-Serif"><b>EDUCATION</b></font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 2pt 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">J.D., University of Illinois</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bachelor of Arts. in Political Science and History,
        Brown University</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 27.5pt; text-indent: -13.5pt">&nbsp;</p></td></tr>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">29</FONT></B></P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0 2.15pt 0 0"><b><A NAME="a020"></A>Compensation Discussion
and Analysis</b></p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 10pt 0; color: #496D93"><b><A NAME="b001"></A>CD&amp;A CONTENTS</b></p>

<div style="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 11%; border-bottom: #496D93 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b001"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>30</b></font></a></td>
    <td style="width: 89%; border-bottom: #496D93 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b001"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Compensation Discussion and Analysis</b></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b002"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b002"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Overview</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b003"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b003"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive Compensation Philosophy</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b004"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b004"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Objectives of the Executive Compensation Program</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b005"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>32</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b005"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Attract and Retain Highly Qualified Executives</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b006"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>32</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b006"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Reward Executives for Meeting Strategic Goals and Objectives of the Company</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b007"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>33</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b007"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Align Executives&rsquo; Interests with Those of Our Stockholders</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b008"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b008"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Oversight and Operation of the Executive Compensation Program</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b009"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b009"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Process for Setting Executive Compensation</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b010"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>34</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b010"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Survey Data</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b011"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>34</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b011"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Peer Data</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b012"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>34</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b012"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Internal Equity</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b013"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>35</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b013"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Independent Compensation Analysis</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b014"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b014"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">What the Compensation Program Is Designed to Reward</font></a></td></tr>
</table>

</div>
<div style="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt; width: 11%"><a href="#b015"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>35</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt; width: 89%"><a href="#b015"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Company Performance</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b016"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>35</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12.5pt"><a href="#b016"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Individual Performance</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b017"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b017"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2020 Performance and Outcomes</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b018"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b018"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Elements of Compensation</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b019"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>37</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b019"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Base Salary</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b020"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>37</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b020"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Incentive Cash Bonus Program</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b021"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>38</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b021"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Equity Awards</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b022"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>38</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b022"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Stock Options</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b023"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>39</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b023"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Restricted Stock Units</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 1pt; padding-bottom: 1pt"><a href="#b024"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>40</i></font></a></td>
    <td style="padding-top: 1pt; padding-bottom: 1pt; padding-left: 12pt"><a href="#b024"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #69737B"><i>Clawback Policy</i></font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b025"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">40</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b025"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Perquisites and Other Personal Benefits</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b026"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">40</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b026"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Employment Agreements and Severance Benefits</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b027"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">40</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b027"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax and Accounting Implications</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b028"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b028"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prohibition on Hedging and Pledging Our Company Stock</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b029"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b029"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation Risk Assessment</font></a></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b030"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41</font></a></td>
    <td style="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt"><a href="#b030"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stockholder Outreach</font></a></td></tr>
</table>
</div>
<br clear="ALL">


<p style="margin: 0; font: 9pt Arial, Helvetica, Sans-Serif; color: Red"><b>&nbsp;</b></p>
<!-- Field: Rule-Page --><div align="LEFT"><div style="font-size: 1pt; border-top: rgb(0,86,149) 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->


<p style="margin: 0; font: 9pt Arial, Helvetica, Sans-Serif; color: Red"><b>&nbsp;</b></p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b002"></A>OVERVIEW</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Compensation Discussion and Analysis (the
 &ldquo;CD&amp;A&rdquo;) discusses the compensation of our five executive officers for 2020 (each a &ldquo;Named Executive Officer&rdquo;
or an &ldquo;NEO&rdquo;):</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg108.jpg" ALT=""></td>
    <TD STYLE="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg109.jpg" ALT=""></td>
    <TD STYLE="width: 20%; text-align: center">&nbsp;<IMG SRC="tm212692d3_sch14-aimg110.jpg" ALT=""></TD>
    <TD STYLE="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg111.jpg" ALT=""></td>
    <TD STYLE="vertical-align: bottom; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg112.jpg" ALT=""></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></td>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><B>STANLEY
    C. ERCK</B></FONT></td>
    <TD STYLE="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><B>GREGORY F. COVINO<SUP>(1)</SUP></B></FONT></td>
    <TD STYLE="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: white"><B>DR. GREGORY M. GLENN</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><B>JOHN
J. TRIZZINO</B></FONT></td>
    <TD STYLE="vertical-align: bottom; background-color: #496D93; padding-top: 1pt; padding-bottom: 2pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><B>JOHN
A. HERRMANN III</B></FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">President
    and Chief<BR>
Executive Officer</FONT></td>
    <TD STYLE="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Former Executive Vice<BR>
President, Chief<BR>
Financial Officer and<BR>
Treasurer</FONT></td>
    <TD STYLE="text-align: center"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif">President, Research and<BR>
Development</FONT></TD>
    <TD STYLE="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive
    Vice<br>
    President, Chief <br>
    Commercial Officer,<br>
    Chief Business<BR>
Officer and Interim<BR>
Chief Financial<BR>
Officer</FONT></td>
    <TD STYLE="padding-top: 2pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Executive
    Vice <br>
    President, Chief Legal<BR>
Officer and Corporate<BR>
Secretary</FONT></td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 8pt"><SUP>(1)</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 8pt">Effective April 12, 2021,
Mr. Covino stepped down from his position as our Executive Vice President, Chief Financial Officer and Treasurer and will remain
with the Company as an executive advisor. As of this same date, Mr. Trizzino was appointed interim Chief Financial Officer of
the Company.</FONT></TD>
</TR></TABLE>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="width: 100%; border: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 0 8pt">The CD&amp;A reviews:</p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 39.5pt; text-indent: -0.25in">&nbsp;</p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 4pt 39.5pt; text-indent: -0.25in"><font style="font-size: 10pt; color: #496D93">&#9679;</font><font style="font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-size: 10pt">the Company&rsquo;s executive compensation philosophy</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 4pt 39.5pt; text-indent: -0.25in"><font style="font-size: 10pt; color: #496D93">&#9679;</font><font style="font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-size: 10pt">the objectives and operation of the compensation program</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 4pt 39.5pt; text-indent: -0.25in"><font style="font-size: 10pt; color: #496D93">&#9679;</font><font style="font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-size: 10pt">how
compensation was set for 2020</font></p>
        <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 39.5pt; text-indent: -0.25in"><font style="font-size: 10pt; color: #496D93">&#9679;</font><font style="font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-size: 10pt">the various elements of compensation paid to the executive officers for services during 2020.</font></p>
        <p style="font: 4pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 39.5pt; text-indent: -0.25in">&nbsp;</p></td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>30
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b003"></A>EXECUTIVE COMPENSATION PROGRAM</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our executive compensation program is designed
to attract, retain, and reward highly qualified executives in an extremely competitive recruitment and retention market to achieve
the Company&rsquo;s mission, vision, and goals. We maintain a compensation philosophy that rewards Company performance  as
it relates to key performance goals.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">The
Compensation Committee believes the components of our executive compensation program provide the tools needed to deliver performance-vesting
compensation to retain and reward high-performing executives, align with general industry practices, and benefit our stockholders.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I>2020 Performance Highlights</I></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: rgb(0,61,165) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">2020 was an extraordinary year beset by profound challenges and uncertainty.
 We  confronted challenges retaining remaining employees, including senior team members,
following, in 2019, disappointing Phase 3 clinical trial results for ResVax for prevention of RSV disease in infants via maternal immunization
and the sale of manufacturing assets and capabilities to Catalent Biologics&rsquo; Paragon Gene Therapy unit (including the transfer of
leases to two Novavax product development and manufacturing facilities and over 100 Novavax employees). Following the emergence of the
COVID-19 pandemic, the Board determined to focus Novavax on developing a COVID-19 vaccine and to seek to retain the team necessary to
advance these efforts. Despite the impediments created by the COVID-19 pandemic and the company-specific challenges we faced entering
2020, we produced remarkable operational results in 2020, resulting in significant value creation for our stockholders. The Compensation
Committee believes that the 2020 compensation of all our employees, including our Named Executive Officers, is appropriate not only due
to the achievement of critical milestones under exceedingly difficult conditions, but also because it serves to continue to encourage
their extraordinary efforts towards the achievement of our key priorities and anticipated milestones in 2021 and beyond. Over the past
year, we leveraged our years of vaccine expertise to help global health authorities address, control and eradicate the SARS-CoV-2 virus.
These efforts are reflected by the following highlights:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="5" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; background-color: rgb(239,239,239)">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%; border-top: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid; border-left: rgb(0,86,149) 1pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in; text-align: justify"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
                           We                            responded to the COVID-19 pandemic at an unprecedented pace, engineering a recombinant protein
                           subunit-based                            vaccine, NVX-CoV2373, within one month of the SARS-CoV-2 sequence being published in
                           early 2020.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        We         successfully secured over $2 billion of funding from partners including the Coalition for Epidemic Preparedness
        (CEPI),         the Bill and Melinda Gates Foundation, and the U.S. government through both Operation Warp Speed and the
        Department of         Defense.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        We         advanced NVX-CoV2373 through various clinical trials including into three efficacy trials globally, as well as
        scaled our         manufacturing capabilities.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
         <IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""> Over         the course of 2020, our
        employee base grew at a rapid pace. We began 2020 with approximately 150 employees and         ended the         year with
        almost 700 employees globally.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        We         acquired Novavax CZ (formerly, Praha Vaccines, a.s.) in the Czech Republic, including a 150,000-square foot state
        of the         art vaccine and biologics manufacturing facility and other support buildings, along with the existing
        employees and all         related and required infrastructure.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        Throughout         2020 and continuing into 2021, we built a global supply chain comprised of manufacturing sites and
        partners across over         10 countries. Through these efforts, our projected manufacturing capacity is over 2 billion
        annualized doses.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD STYLE="width: 2%; font-size: 10pt; border-top: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 49%; border-top: rgb(0,86,149) 1pt solid; border-right: rgb(0,86,149) 1pt solid; border-bottom: rgb(0,86,149) 1pt solid; text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
                           We                            secured licensing agreements in 2020 and early 2021 with the Serum Institute of India (Serum),
                           SK bioscience,                            and Takeda Pharmaceutical Company Limited (Takeda) for supply of NVX-CoV2373 in
                           India, South Korea                            and Japan, respectively.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in; text-align: justify"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        We         successfully demonstrated remarkable results in terms of NVX-CoV2373&rsquo;s safety and efficacy. In our U.K. Phase
        3 clinical         trial initiated in September 2020, we demonstrated 96% efficacy against the original strain of COVID-19 and
        86% efficacy against         the B.1.1.7 variant strain. In volunteers 65 years of age and older, 10 cases of COVID-19 were
        observed, with 90% of those         cases occurring in the placebo group.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        We         gathered critical data from our Phase 2b clinical trial initiated in South Africa in August 2020, when the B.1.351
        variant         was widely circulating. In this trial, we demonstrated efficacy of 55% in the portion of the study population
        that was HIV-negative,         as well as efficacy of 49% in the overall trial population.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        There         were no severe cases of disease in the vaccine arms of our U.K. Phase 3 or South Africa Phase 2b
        trials.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.27in"><IMG SRC="tm212692d3_sch14-aimg113.jpg" ALT=""><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">
        In         late 2020, we initiated our PREVENT-19 pivotal Phase 3 trial in the U.S. and Mexico, and in early 2021, we
        completed enrollment         in a diverse study population of 30,000 participants underscoring our commitment to serving
        diverse populations.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">31</FONT></B></P>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I>2020 Pay Decisions</I></B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: rgb(0,61,165) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><B><I></I></B></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">In
early 2020, Novavax faced substantial challenges. When the COVID-19 pandemic hit, we decided to pivot to developing a COVID-19 vaccine,
despite our very limited resources and the high level of risk inherent in the undertaking.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">During
2020, we maintained an executive compensation program designed to provide incentives that were necessary to retain key employees to avoid
disruption to the Company&rsquo;s important work around COVID-19, as described above. In April 2020, in acknowledgment of the extraordinary
work of our employees to implement a new vaccine program against SARS-CoV-2, our Compensation Committee approved a grant of performance-vesting
equity awards to our employees, including a grant of stock options to our Named Executive Officers. Our Compensation Committee will continue
to monitor our executive compensation program and consider further changes as our business continues to evolve in the future, including
a focus on including financial metrics in our annual incentive plan as we expand our commercial operations.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</font></p>




<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We conducted our most recent advisory vote on executive compensation at our 2020 Annual Meeting of Stockholders.
Our Board and our Compensation Committee value the opinions of our stockholders. Close attention was given to the outcome of this
vote even though it is non-binding. Approximately 88% of the votes cast on the advisory vote on executive compensation were in
favor of our Named Executive Officer compensation as disclosed in our 2020 proxy statement.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">We continued our stockholder outreach in late 2020 to discuss topics related to our business, corporate
governance, and executive compensation. Stockholder feedback is important, and the information we glean from these engagements
is highly valued. Certain of our stockholders had previously expressed a preference for performance-vesting long-term compensation
(as compared to time-vesting). Accordingly, as further discussed below in this CD&amp;A, consistent with 2019, in April 2020 the
Compensation Committee awarded performance-vesting awards to our executive officers.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b004"></A>OBJECTIVES OF THE EXECUTIVE COMPENSATION PROGRAM</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Compensation Committee believes the
compensation for our executive officers should be designed to attract, motivate, incentivize and retain highly qualified executive
officers responsible for the success of Novavax and should be determined within a framework that rewards performance and aligns
the interests of the executive officers with the interests of the Company&rsquo;s stockholders.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Within this overall philosophy, the Compensation
Committee&rsquo;s objectives are to:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="text-align: center; vertical-align: bottom">
    <TD STYLE="width: 21%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg114.jpg" ALT=""></td>
    <TD STYLE="width: 4%; padding-bottom: 1pt">&nbsp;</td>
    <TD STYLE="width: 27%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg115.jpg" ALT=""></td>
    <TD STYLE="width: 4%; padding-bottom: 1pt">&nbsp;</td>
    <TD STYLE="width: 19%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg116.jpg" ALT=""></td>
    <TD STYLE="width: 3%; padding-bottom: 1pt">&nbsp;</td>
    <TD STYLE="width: 22%; border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-bottom: 1pt"><IMG SRC="tm212692d3_sch14-aimg117.jpg" ALT=""></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 2pt 3.75pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Attract and retain highly qualified executives</font></td>
    <TD STYLE="padding: 2pt 17pt 2pt 4pt; text-align: center">&nbsp;</td>
    <TD STYLE="padding: 2pt 4.5pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Reward
    executives for meeting strategic goals and objectives</font></td>
    <TD STYLE="padding: 2pt 17pt 2pt 4pt; text-align: center">&nbsp;</td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Reward strong individual performance</font></td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; text-align: center">&nbsp;</td>
    <TD STYLE="padding: 2pt 3pt 2pt 4pt; background-color: #F2F2F2; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Align executives&rsquo; interests with those of our stockholders</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>
<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b005"></A>Attract and Retain Highly
Qualified Executives</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Our executive compensation program is designed to attract, motivate,
and retain, from a limited pool of resources, individuals who are highly experienced with proven records of success, and to provide total
compensation that is competitive with Company peers within the biotechnology and pharmaceutical industries.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b006"></A>Reward Executives for Meeting
Strategic Goals and Objectives of the Company</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Compensation Committee believes a significant
portion of an executive officer&rsquo;s total compensation should reflect overall Company performance. The executive compensation program
rewards the Company&rsquo;s executive officers for achieving specified corporate performance goals, as well as goals that fall within
their individual functional areas. Incentives are based on meeting criteria in each of these categories and reflect the executive officer&rsquo;s
overall contribution to the Company. As described above, because of the unprecedented and dedicated activity of the Company&rsquo;s employees
related solely to the development of NVX-CoV2373, the Company&rsquo;s vaccine candidate against</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>32
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> SARS-CoV2, on a global scale, the strategic
goals for purposes of our executive compensation plans centered around this main Company objective.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b007"></A>Align Executives&rsquo;
Interests with Those of Our Stockholders</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Compensation Committee believes that
Novavax&rsquo;s long-term success depends upon aligning executives&rsquo; and stockholders&rsquo; interests. To support this objective,
Novavax provides executive officers with the opportunity to receive equity grants in various forms. The Compensation Committee
granted equity awards to our Named Executive Officers in April 2020 in the form of performance-vesting stock options and in December
2020 in the form of time-vesting stock options and RSUs.&nbsp;<font style="background-color: white">We consider grants of stock
options to align the interests of our executives with our stockholders&rsquo; interest because value is created in such grants
when the value of Common Stock appreciates after the grant. We also view RSUs granted to our executive officers as important incentives,
designed to encourage retention and stock ownership.</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In April 2020, our NEOs (other than Mr. Covino, who was not then employed
by the Company) received performance-vesting stock options that became eligible to vest upon the initiation of a Phase 2 clinical trial
of the Company&rsquo;s vaccine candidate against SARS-CoV-2 and will vest 50% on August 24, 2021 and 50% on August 24, 2022, the first
and second anniversaries of such initiation, subject to the executive officer&rsquo;s continued service through the vesting date.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">In December 2020, our NEOs (other than Mr.
Covino, who was not eligible for an annual grant and who received equity awards in connection with his appointment) received the
following equity awards:</p>




<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 27.35pt"><font style="font-size: 10pt">(i)</font></td><td style="text-align: justify"><font style="font-size: 10pt">time-vesting RSU grants that will vest in equal annual installments
on the first, second, and third anniversary of the grant date, subject to continued service through the vesting date; </font></td></tr></table>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 27pt"><font style="font-size: 10pt">(ii)</font></td><td style="text-align: justify"><font style="font-size: 10pt">time-vesting stock options that vest as to 25% on the first anniversary
of the grant date, and as to the remaining 75% in equal monthly installments over the following three years, subject to continued
service through the vesting date, as further discussed in the section entitled &ldquo;Elements of Compensation&mdash;Equity Awards&rdquo;
below.</font></td></tr></table>

<p style="margin: 0">&nbsp;</p>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-size: 10pt">For a discussion
of all equity grants made to our NEOs during 2020, see &ldquo;Equity Awards&rdquo; below.</font></p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b008"></A>OVERSIGHT AND OPERATION OF THE EXECUTIVE COMPENSATION
PROGRAM</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Compensation Committee is appointed by the Board
to assist in the development, review and approval of the compensation of the Company&rsquo;s directors, officers, and employees, as well
as the development and administration of the Company&rsquo;s compensation plans. For details on the Compensation Committee&rsquo;s oversight
of the executive compensation program, see the section titled &ldquo;Information Regarding the Board and Corporate Governance Matters&mdash;Compensation Committee&rdquo; beginning on page 12  of this Proxy Statement.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Chief Executive Officer (the &rdquo;CEO&rdquo;)
evaluates and provides to the Compensation Committee performance assessments and compensation recommendations for each executive
officer other than himself. The Chairman of the Board evaluates the CEO&rsquo;s performance and makes compensation recommendations
for the CEO to the Compensation Committee. The Compensation Committee considers the CEO&rsquo;s and the Chairman&rsquo;s recommendations,
information provided by the Human Resources team, and advice provided by its compensation consultant in its deliberations regarding
executive compensation and recommends to the Board the compensation of the executive officers based on such deliberations. The
Board determines executive compensation based on the recommendation of the Compensation Committee. In 2020, the CEO and the Executive
Vice President, Chief Human Resources Officer generally attended Compensation Committee meetings, but were not present for executive
sessions or any discussion of their own compensation.</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b009"></A>PROCESS FOR SETTING EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Generally, compensation packages for each executive
officer are analyzed and discussed separately at the first Compensation Committee meeting each year. Prior to that meeting, an independent
compensation consultant performs a comprehensive competitive analysis on the compensation package for each executive officer. In September
2016, the Compensation Committee retained Radford, a part of the Total Rewards practice at Aon plc (&ldquo;Radford&rdquo;), to conduct
annual analyses of each executive&rsquo;s compensation and provide ongoing compensation support. In the fourth quarter</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">33</FONT></B></P>
<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> of 2020, Radford
completed a thorough competitive analysis for 2021 executive compensation, and this analysis was used by the Compensation Committee to
inform decisions made regarding the type and amount of equity granted to executive officers in December 2020.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b010"></A>Survey Data</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">When determining overall compensation for 2020,
the Compensation Committee reviewed analysis based on a combination of compensation survey data and peer group data provided by Radford,
with survey data provided through the Radford Global Life Sciences Survey (the &ldquo;Survey&rdquo;). The Survey provides total compensation
and practices data for more than 900 life sciences companies and more than 600,000 individuals. Global market data is available for 50
countries and positions at the executive, management, professional, sales, and support levels, as well as overall compensation practices.
Target industries include biotechnology, pharmaceutical, diagnostic and clinical research organizations. In 2018, Radford used a customized
selection of Survey data comprised of public biopharmaceutical companies with 100-1,000 employees and a market capitalization of $200M-$1.5
billion to better align the Survey data with Novavax&rsquo;s compensation programs.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Radford benchmarks each executive officer&rsquo;s
current compensation against the 50th percentile of the Survey and available peer group data. The Compensation Committee believes
this is a common reference point among biotechnology companies similar in size to Novavax. The Company remains competitive by
targeting the 50th percentile of the Survey data.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>




<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><a name="b011"></a>Peer Data</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
Compensation Committee also considered peer group data in making its executive compensation decisions in 2020. In doing so, the
Compensation Committee used comparative compensation information from a relevant peer group of companies (the &ldquo;Peer Group&rdquo;).
The Compensation Committee selected the companies in the Peer Group with the assistance of Radford based on factors including,
but not limited to, the following:</font></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 11pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg118.jpg" ALT=""></TD>
    <TD STYLE="width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg119.jpg" ALT=""></TD>
    <TD STYLE="width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg120.jpg" ALT=""></TD>
    <TD STYLE="width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg121.jpg" ALT=""></TD>
    <TD STYLE="width: 20%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg122.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Peer Group utilized
in 2020 consists of the following 17 companies, all with a market cap up to approximately 3x of Novavax&rsquo;s market capitalization
as of September 17, 2020:</font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #F2F2F2; border-collapse: collapse">
<tr>
    <td style="vertical-align: top; width: 2%; border-top: #003DA5 1pt solid; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="width: 31%; border-top: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="width: 1%; border-top: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="width: 32%; border-top: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="width: 1%; border-top: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="width: 31%; border-top: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="vertical-align: top; width: 2%; border-top: #003DA5 1pt solid; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt"><font style="font-size: 4pt">&nbsp;</font></td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp; </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acceleron Pharma</font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp; </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Emergent BioSolutions</font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp; </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Moderna</font></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp; </font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Alnylam Pharmaceuticals</font></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Exelixis</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Nektar Therapeutics</FONT></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">BioMarin Pharmaceutical</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FibroGen</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Neurocrine Biosciences</FONT></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">bluebird bio</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Immunomedics</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sarepta Therapeutics</FONT></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">ChemoCentryx</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Inovio Pharmaceuticals</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">United Therapeutics</FONT></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dynavax Technologies</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt; text-indent: -13.5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #496D93">&nbsp;&nbsp;&nbsp;
</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ionis Pharmaceuticals</FONT></td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="padding-top: 2pt; padding-bottom: 2pt; padding-left: 21.5pt">&nbsp;</td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #003DA5 1pt solid; border-left: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 3.5pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt"><font style="font-size: 4pt">&nbsp;</font></td>
    <td style="vertical-align: top; border-right: #003DA5 1pt solid; border-bottom: #003DA5 1pt solid; padding-top: 2pt; padding-bottom: 2pt; padding-left: 1pt"><font style="font-size: 4pt">&nbsp;</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b012"></A>Internal Equity</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><font style="font-size: 10pt">The Compensation Committee
considers internal equity when determining executive compensation to ensure the Company is fair in its compensation practices across
roles similar in scope and level of responsibility.</font></p>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>34
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; border-bottom: rgb(0,86,149) 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C">&nbsp;</P>


<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b013"></A>Independent Compensation
Analysis</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">As required by rules adopted by the SEC
under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the Compensation Committee engaged Radford after
assessing Radford&rsquo;s independence. Based upon this assessment, it was determined the engagement of Radford did not raise
any conflicts of interest or similar concerns. The Compensation Committee assesses Radford&rsquo;s independence and potential
conflicts of interest on a regular basis, no less than annually.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Radford was authorized by the Compensation Committee
to work with certain executive officers of the Company, as well as other employees in the Company&rsquo;s Human Resources, Legal,
and Finance departments in connection with Radford&rsquo;s work on behalf of the Compensation Committee.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0; color: #496D93"><b><A NAME="b014"></A>WHAT THE COMPENSATION PROGRAM IS DESIGNED TO REWARD</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b015"></A>Company Performance</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The executive compensation program is designed
to reward both individual and Company performance. Because of the key roles the executive officers play in the success of the
Company, a significant portion of the achievement of corporate goals is reflective of the executive officers&rsquo; individual performance.
Accordingly, a significant portion of an executive officer&rsquo;s total compensation package is based on the Company&rsquo;s performance
and the achievement of certain corporate goals. During 2020, in recognition of the unprecedented and dedicated activity of the
Company&rsquo;s employees related solely to the development of NVX-CoV2373, the Company&rsquo;s vaccine candidate against SARS-CoV2, on a
global scale, the Board determined that traditional corporate objectives would not be set and instead set a single corporate objective
to develop NVX-CoV2373 (&ldquo;2020 Objective&rdquo;). This 2020 Objective is described below under &ldquo;2020 Performance and Outcomes.&rdquo;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i><A NAME="b016"></A>Individual Performance</i></b></p>

<!-- Field: Rule-Page --><div align="LEFT" style="margin-top: 3pt"><div style="font-size: 1pt; border-top: rgb(0,86,149) 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0"><b><i></i></b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">Typically, the CEO recommends individual performance
goals and objectives for executive officers other than himself at the beginning of the year, and, in the first quarter of the following
year, reviews each executive officer&rsquo;s achievement of specific performance goals and objectives. Because of his key role in the
overall success of the Company, the CEO&rsquo;s performance goals and objectives typically are the same as the Company&rsquo;s performance
goals. As described above, for 2020, all our NEOs&rsquo; incentive compensation was based entirely on achievement of the 2020 Objective
and the discretion of the Compensation Committee.</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">35</FONT></B></P>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><B>Executive Officers and Compensation</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b017"></A>2020
PERFORMANCE AND OUTCOMES</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">During the first quarter of 2021,
the Compensation Committee reviewed the Company&rsquo;s performance related to the 2020 Objective. The following table summarizes
its conclusions regarding this objective:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>2020 Objective</b></font></td>
    <td colspan="2" style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Weight</b></font></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Achievement</b></font></td>
    <td style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Percent</b></font></td>
    <td style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 4.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Explanation</b></font></td></tr>

<tr>
    <td style="width: 19%; border-right: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Development
    of NVX-<br>
CoV2373</font></td>
    <td style="white-space: nowrap; width: 8%; padding-right: -3.5pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">100%</font><br><p style="margin: 0pt 0"></p> </td>
    <td style="border-right: rgb(191,191,191) 1pt solid; padding-left: 0in; text-align: left; width: 9%"><IMG SRC="tm212692d3_sch14-aimg123.jpg" ALT="">&nbsp;</td>
    <td style="width: 12%; border-right: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Exceeded
    <br>
objective</font></td>
    <td style="width: 9%; border-right: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">150%</font></td>
    <TD STYLE="width: 43%; padding-right: 5.4pt; padding-left: 5.4pt; padding-top: 8pt"><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 16pt; text-indent: -16pt"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;</b></font>&nbsp;&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Over $2B in funding secured</font></p>
                                                                      <p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 16pt; text-indent: -16pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT="">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Acquired
Novavax CZ</font></p>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;&nbsp;&nbsp;Established
global supply chain of 2B potential doses of NVX-CoV2373 at full production capacity</font></p>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Over
50,000 participants enrolled in COVID-19 clinical trials</font></p>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;&nbsp;&nbsp;Onboarded
approximately 525 employees globally, representing a 311% growth rate</font></p>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;&nbsp;&nbsp;Successful
UK Phase 3 NVX-CoV2373 results that met primary endpoint and key secondary endpoints</font></p>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-indent: -0.5in"><IMG SRC="tm212692d3_sch14-aimg124.jpg" ALT=""><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><b>&nbsp;&nbsp;</b></font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;&nbsp;&nbsp;&nbsp;Successful
South African Phase 2b NVX-CoV2373 results that met primary endpoint</font></p></td></tr>

<tr>
    <td style="border-top: #003DA5 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 22%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Total</b></font></td>
    <td style="border-top: #003DA5 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: -3.5pt; padding-left: 5.4pt; text-align: center; width: 7%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>100%</b></font></td>
    <td style="vertical-align: top; border-top: #003DA5 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 13%">&nbsp;</td>
    <td style="vertical-align: top; border-top: #003DA5 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 13%">&nbsp;</td>
    <td style="border-top: #003DA5 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; width: 10%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>150%</b></font></td>
    <td style="vertical-align: top; border-top: #003DA5 1pt solid; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; width: 35%">&nbsp;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td>
    <td style="border-bottom: #BFBFBF 1pt solid; padding-right: -3.5pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td>
    <td style="vertical-align: top; border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td>
    <td style="vertical-align: top; border-right: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 4pt">&nbsp;</FONT></td></tr>
   </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b018"></A>ELEMENTS
OF COMPENSATION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">The Compensation Committee believes the
most effective executive compensation program is one that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"> <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #005695">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">provides a competitive base salary</FONT></TD></TR> </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 4pt"> <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #005695">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">rewards
the achievement of established annual and long-term goals and objectives</FONT></TD></TR> </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"> <TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt; color: #005695">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">provides an incentive for retention</FONT></TD></TR> </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">For this reason, the executive compensation
program is comprised of three primary elements:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 33%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg125.jpg" ALT=""></TD>
    <TD STYLE="width: 34%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg126.jpg" ALT=""></TD>
    <TD STYLE="width: 33%; text-align: center"><IMG SRC="tm212692d3_sch14-aimg127.jpg" ALT=""></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Compensation
Committee believes these three elements are the most effective combination to motivate and retain executive officers.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Compensation
Committee has not adopted any formal guidelines for allocating total compensation between equity compensation and cash compensation,
but generally seeks to provide an overall executive compensation package designed to attract, motivate, and retain highly qualified
executive officers, to reward them for performance over time, and to align the interests of the executive officers with the interests
of our stockholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>36
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b019"></A>Base
Salary</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><B><I></I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Compensation
Committee&rsquo;s philosophy is to maintain base salaries at a competitive level sufficient to recruit and retain individuals possessing
the skills and capabilities necessary to achieve the Company&rsquo;s goals over the long term.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">The base salaries for the NEOs as of
December 31, 2020 were:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <td style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Executive</b></font></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom">
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><b>Base Salary</b></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><b>($)</b></p></td>
    <td colspan="3" style="border-bottom: #003DA5 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Percentage Increase in Base Salary </b></font><br>
<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>from December 31, 2019</b></font></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; width: 42%; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Stanley C. Erck</font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center; width: 28%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">662,000</font></td>
    <TD STYLE="vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 17%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">3.0%</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: left; width: 1%">&nbsp;</td>
    <TD STYLE="vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 12%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory F. Covino<sup>(1)</sup></font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">440,000</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&mdash;&nbsp;&nbsp;&nbsp;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory M. Glenn, M.D.</font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">487,000</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">&nbsp;&nbsp;3.0%</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: left">&nbsp;</td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John J. Trizzino<sup>(2)</sup></font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">430,000</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">9.3%</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: super; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><font style="font-size: 9.5pt"><sup>(2)</sup></font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John A. Herrmann III<sup>(3)</sup></font></td>
    <td style="vertical-align: bottom; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">415,000</font></td>
    <td style="border-bottom: #003DA5 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">8.8%</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; vertical-align: super; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><font style="font-size: 9.5pt"><sup>(3)</sup></font></td>
    <td style="border-bottom: #003DA5 1pt solid; vertical-align: top; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Mr. Covino
                                         was hired as the Company&rsquo;s Executive Vice President, Chief Financial Officer and
                                         Treasurer in November 2020. His base salary was determined after reviewing the Survey.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">In
                                         June 2020, the Board approved Mr. Trizzino&rsquo;s promotion to Executive Vice President,
                                         Chief Business Officer and Chief Financial Officer. Mr. Trizzino&rsquo;s additional responsibilities
                                         in his new role, along with the growth of the Company and the related increase in the
                                         complexity of the chief financial officer and chief business officer position, his individual
                                         performance, and a review of the Survey data, were factors used by the Compensation Committee
                                         in its decision to increase his base salary on July 1, 2020. On November 7, 2020, upon
                                         Mr. Covino&rsquo;s acceptance of his offer letter and employment agreement, the Company
                                         determined that Executive Vice President John J. Trizzino would transition from his role
                                         of Chief Financial Officer and take on the newly created role of Chief Commercial Officer,
                                         in addition to continuing his role as Chief Business Officer, effective November 16,
                                         2020.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">In
                                         June 2020, the Board approved Mr. Herrmann&rsquo;s promotion to Executive Vice President,
                                         Chief Legal Officer and Corporate Secretary. Mr. Herrmann&rsquo;s additional responsibilities
                                         for his new role, including overseeing the Company&rsquo;s global program management
                                         and business development departments beginning in June 2020, along with the growth of
                                         the Company and the complexity of his new position, his individual performance, and a
                                         review of the Survey data, were factors used by the Compensation Committee in its decision
                                         to increase his base salary on July 1, 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b020"></A>Incentive
Cash Bonus Program</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The incentive cash bonus
program is designed to motivate and reward executive officers for the achievement of specific corporate and, for our executive
officers other than our CEO, individual objectives. As described below, for purposes of 2020 bonuses, individual objectives were
not taken into account. The purpose of the incentive cash bonus program is to align company, departmental, and individual goals
throughout the Company and to provide an incentive that further ties compensation to individual contribution and teamwork.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">As described above, for
2020, in recognition of the unprecedented and dedicated activity of the Company&rsquo;s employees related solely to the development
of NVX-CoV2373, the Company&rsquo;s vaccine candidate against SARS-CoV2, on a global scale, the Board determined that traditional
corporate objectives would not be set and instead set a single corporate objective, the 2020 Objective, to develop this vaccine,
as described above. In reviewing the Company&rsquo;s achievement against the 2020 Objective during the first quarter of 2021, the
Compensation Committee determined that the 2020 Objective was achieved at a level of 150% of target, based on the achievements
described above under &ldquo;2020 Performance and Outcomes&rdquo;.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">A target bonus
for each named executive officer is set at a percentage of the executive officer&rsquo;s base salary, with such percentages being
based on market data, although the ultimate amount of any bonus payout is at the discretion of the Compensation Committee. The
Compensation Committee believes the higher the individual&rsquo;s position within Novavax, the more closely his or her bonus award
should be tied to the Company&rsquo;s success.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">The 2020 NEO bonus targets, which remained
unchanged from 2019, and actual incentive cash bonus awards received, based on the achievement of the 2020 Objective, as described
above, were as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <td style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Executive</b></font></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Bonus Target as Percentage <br>
of Base Salary</b></font></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom">
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Incentive Cash Bonus Award Received</b></p>
        <p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><b>($)</b></p></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; width: 35%; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Stanley C. Erck</font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center; width: 25%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">60.0%</font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 23%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">591,463</font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center; width: 17%">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory F. Covino<sup>(1)</sup></font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">40.0%</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">33,000</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory M. Glenn, M.D.</font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">50.0%</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">362,582</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John J. Trizzino</font></td>
    <td style="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">40.0%</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">249,535</font></td>
    <td style="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
<tr>
    <td style="vertical-align: top; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John A. Herrmann III</font></td>
    <td style="vertical-align: bottom; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">40.0%</font></td>
    <td style="border-bottom: #003DA5 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">241,705</font></td>
    <td style="border-bottom: #003DA5 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: center">&nbsp;</td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-size: 9pt">Mr. Covino
                                         was hired as the Company&rsquo;s Executive Vice President, Chief Financial Officer and
                                         Treasurer in November 2020. For 2020, Mr. Covino&rsquo;s annual bonus was pro-rated for
                                         the portion of the year he was employed by the Company.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">37</FONT></B></P>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b021"></A>Equity
Awards</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">Equity awards are a fundamental
incentive element in the Company&rsquo;s executive compensation program because they emphasize long-term performance, as measured
by creation of stockholder value, and foster a commonality of interest between stockholders and key executives. In addition, they
are crucial to a competitive compensation program for executive officers because they act as a powerful retention tool. Most importantly,
given the significant and high potential outcome the Company faces around its development of NVX-CoV2373, its vaccine candidate
for the SARS-CoV-2 virus responsible for the COVID-19 pandemic, as well as the ongoing efforts to attain licensure for its NanoFlu
vaccine, the Compensation Committee believes that equity awards create appropriate incentives for rewarding our executives for
increases in stock performance as a result of our efforts towards improved global health and align the executives&rsquo; interests
with those of our stockholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In the case of stock options,
the executive officers are further motivated by the potential appreciation in stock price above the exercise price of the stock
options. To encourage continued employment, equity grants to executive officers, other than retention- and performance-vesting
grants, typically require the executive to remain an employee of the Company for three or four years before the award is fully
vested. In addition, the Compensation Committee may grant equity awards that vest as the Company achieves certain performance milestones.
The Compensation Committee believes it is important to tie the long-term benefit potentially realizable by the executive to a long-term
commitment with Novavax.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">Annual equity grants are
awarded to executive officers at the discretion of the Board upon a recommendation by the Compensation Committee or at the discretion
of the Compensation Committee pursuant to the authority delegated by the Board. In making its recommendations or determinations,
the Compensation Committee considers Company performance, competitive data, and the individual&rsquo;s scope of responsibility
and continuing performance. With guidance from Radford based on its analysis of competitive data, annual equity awards were awarded
to all eligible employees including the NEOs, in December 2020.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The following table contains
information about the grant, vesting, and forfeiture of outstanding performance-vesting awards as of December 31, 2020:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
 <tr>
    <TD STYLE="vertical-align: top; border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</td>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #003DA5 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Number of Shares</b></font>&nbsp;</td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; width: 83%; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-vested at December 31, 2016</font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 10%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,000</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left; width: 7%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vested</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,250</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-vested at December 31, 2017</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,750</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vested</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-vested at December 31, 2018</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">48,750</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">38,758</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vested</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,009</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)</FONT></td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-vested at December 31, 2019</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,499</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Granted</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">830,000</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Vested</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(40,243</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: top; border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Forfeited</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(16,256</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">)&nbsp;</FONT></td></tr>
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-vested at December 31, 2020</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">830,000</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; vertical-align: bottom; padding-top: 1pt; padding-bottom: 1pt; text-align: left"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b022"></A>Stock
Options</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In April 2020, in acknowledgment
of the extraordinary work of our employees to implement a new vaccine program against SARS-CoV-2, our Compensation Committee approved
a grant of performance-vesting stock options to our employees, including to our NEOs (other than Mr. Covino, who was not then employed
by the Company). The stock options vest subject to the satisfaction of a performance-based vesting requirement, followed by time-based
vesting. The performance metric required the Company to initiate a COVID-19 Phase 2 clinical trial within twelve (12) months of
the grant date, which occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>38
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">on August 24, 2020. As
a result of the attainment of the performance objective, fifty percent (50%) of the shares underlying the stock option will vest
on August 24, 2021, the first anniversary of the initiation date, and the remaining fifty percent (50%) of the shares underlying
the stock option will vest on August 24, 2022, the second anniversary of the initiation date, in each case subject to continued
service with the Company through such vesting date. The following table contains the performance-vesting stock options granted
to each NEO:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
 <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>Executive</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: #003DA5 1pt solid; padding-right: 3pt; padding-left: 3pt; text-align: center; text-indent: 1pt; vertical-align: bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif"><B>Performance-Vesting Stock Options</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 60%"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">Stanley C. Erck</FONT></TD>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 23%"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">400,000</FONT></TD>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 17%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory
F. Covino<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 9pt Arial, Helvetica, Sans-Serif">&#8213;</FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">Gregory M. Glenn, M.D.</FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">165,000</FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">John J. Trizzino</FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">140,000</FONT></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">John A. Herrmann III</FONT></TD>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right"><FONT STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif">125,000</FONT></TD>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</TD></TR>
 </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Mr. Covino
                                         was hired as the Company&rsquo;s Executive Vice President, Chief Financial Officer and
                                         Treasurer in November 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In November 2020, the
Board granted 8,200 time-vesting stock options to Mr. Covino pursuant to his appointment as the Company&rsquo;s Executive Vice
President, Chief Financial Officer, and Treasurer. The stock options will vest as to 25% of the shares underlying the option on
the first anniversary of the grant date and as to the remaining 75% in equal monthly installments over a three-year period subject
to continued service with the Company through such vesting date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In December 2020, the
Compensation Committee awarded to each Named Executive Officer, other than Mr. Covino, an option to purchase Common Stock. The
stock options vest as to 25% of the shares underlying the option on the first anniversary of the grant date and as to the remaining
75% in equal monthly installments over a three-year period, subject to continued service with the Company through the applicable
vesting date. The following table contains the time-vesting stock options granted to each NEO:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Executive</b></font></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 1pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Time-Vesting Stock Options</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 60%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Stanley C. Erck</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 23%; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">41,700</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 17%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory F. Covino<sup>(1)</sup></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory M. Glenn, M.D.</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">18,700</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John J. Trizzino</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">9,500</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John A. Herrmann III</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">12,700</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-size: 9pt">Mr. Covino
                                         was hired as the Company&rsquo;s Executive Vice President, Chief Financial Officer and
                                         Treasurer in November 2020, and was therefore not eligible for an annual equity grant.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b023"></A>Restricted
Stock Units</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In June 2020, the Compensation
Committee awarded Mr. Trizzino 2,500 time-vesting RSUs in connection with his promotion to Executive Vice President, Chief Business
Officer and Chief Financial Officer and his assumption of additional responsibilities for his new role; and awarded Mr. Herrmann
2,500 time-vesting RSUs in connection with his promotion to Executive Vice President, Chief Legal Officer and Corporate Secretary
and his assumption of additional responsibilities for his new role. The RSUs vest in three equal annual installments on the first
three anniversaries of the date of grant, in each case subject to continued service with the Company through the applicable vesting
date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In November 2020, the
Board awarded Mr. Covino 7,300 time-vesting RSUs in connection with his appointment as the Company&rsquo;s Executive Vice President,
Chief Financial Officer, and Treasurer. The RSUs vest in three equal annual installments on the first three anniversaries of the
date of grant, in each case subject to continued service with the Company through the applicable vesting date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">In December 2020, the
Compensation Committee recommended to the Board to include the executive officers in our annual grant process in order to further
promote the retention of key leadership talent to support the Company&rsquo;s 2020 Objective. In December 2020, the Board awarded
the executive officers time-vesting RSUs that vest in three equal</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">39</FONT></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"></P>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">annual installments on the first three anniversaries
of the date of grant, subject to continued service with the Company through the applicable vesting date. The following table contains
the RSUs granted to each NEO:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Executive</b></font></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; text-indent: 1pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Time-Vesting RSUs</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt; width: 83%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Stanley C. Erck</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 10%; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">20,900</font></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; width: 7%">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory F. Covino <sup>(1)</sup></font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#8213;</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">Gregory M. Glenn, M.D.</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">9,300</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John J. Trizzino</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">4,800</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; padding-left: 5.4pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">John A. Herrmann III</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">6,300</font></td>
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: right">&nbsp;</td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-size: 9pt">Mr. Covino
                                         was hired as the Company&rsquo;s Executive Vice President, Chief Financial Officer and
                                         Treasurer in November 2020, and was therefore not eligible for an annual equity grant.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I><A NAME="b024"></A>Clawback
Policy</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">On April 26, 2017, the
Board adopted a policy providing that, if the Company is required to prepare an accounting restatement due to material non-compliance
with financial reporting requirements under applicable securities laws, with respect to any cash bonus or other cash compensation
paid or awarded, or equity-based bonus or other equity-based incentive compensation that was exercised, vested or settled, within
six months preceding such restatement, and that was granted or earned or became vested based wholly or in part upon the attainment
of any financial reporting measure, if the recipient of such cash or equity-based bonus or other cash or equity-based incentive
compensation engaged in fraud, intentional misconduct, or gross negligence that caused or partially caused the need for the restatement,
the Board generally may seek reimbursement of any amount paid under an award in excess of what would have been paid had such material
noncompliance not occurred.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b025"></A>PERQUISITES
AND OTHER PERSONAL BENEFITS</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Company does not have
any executive perquisite programs. From time to time, on a limited or exception basis, it may decide to provide other benefits
that are related to a business purpose or are customary among peer public companies that may otherwise be considered perquisites.
All of the NEOs are eligible to participate in the Company&rsquo;s benefit plans offered to all employees, including health, dental
and vision insurance, a prescription drug plan, flexible spending accounts, short- and long-term disability, life insurance, and
a 401(k) plan. The NEOs are also eligible to participate in the Company&rsquo;s Amended and Restated 2013 Employee Stock Purchase
Plan (the &ldquo;ESPP&rdquo;).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b026"></A>EMPLOYMENT
AGREEMENTS AND SEVERANCE BENEFITS</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">As of December 31, 2020,
the Company had employment agreements in place with all of the NEOs. The employment agreements provide for certain payments if
the NEO is terminated by the Company without cause or leaves for good reason. The terms of these agreements are described in greater
detail in the section titled &ldquo;Overview of Employment and Change in Control Agreements.&rdquo; All of the NEOs are &ldquo;at
will&rdquo; employees.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Company has established
a Change in Control Severance Benefit Plan, which provides for severance payments to participating employees if the participant&rsquo;s
employment is terminated in connection with a change in control. This plan is described in greater detail in the section titled
 &ldquo;Overview of Employment and Change in Control Agreements.&rdquo; The Compensation Committee believes it is important to provide
such employees with an incentive to remain with the Company amid the uncertainty that often accompanies efforts to consummate a
corporate sale or similar transaction that may enhance stockholder value. All of the NEOs participate in the Change in Control
Severance Benefit Plan.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b027"></A>TAX
AND ACCOUNTING IMPLICATIONS</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">Section 162(m) limits
to $1 million the amount a company may deduct for compensation paid to certain current and former executive officers, subject to
certain limited exceptions. The Compensation Committee believes its primary responsibility is to provide a compensation program
that attracts, retains and rewards the executives necessary for our success. Accordingly, the Compensation Committee has authorized,
and will continue to authorize, compensation arrangements that are not deductible in whole or in part. The Compensation Committee
may consider the accounting implications of significant equity-related compensation decisions.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>40
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b028"></A>PROHIBITION
ON HEDGING AND PLEDGING OUR COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">Our insider trading policy
prohibits all directors, officers and other employees from engaging in hedging of Common Stock or similar transactions that transfer
to another, in whole or in part, any of the economic consequences of ownership of Common Stock, such as put and call options and
short and long sales, convertible debentures or preferred stock and debt securities (debentures, bonds and notes). Further, our
insider trading policy provides that no director, executive officer or vice president may engage in any transaction involving pledging
of Common Stock.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b029"></A>COMPENSATION
RISK ASSESSMENT</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The Compensation Committee
regularly reviews the Company&rsquo;s compensation and benefits programs, policies and practices, including its executive compensation
program and its incentive-based compensation programs for its executive officers, to determine whether such programs, policies
and practices create risks that are reasonably likely to have a material adverse effect on the Company. Our compensation and governance-related
policies are enhanced by our clawback policy, described in the section titled &ldquo;Elements of Compensation &mdash; Clawback
Policy&rdquo; on page 40 of this Proxy Statement, as well as a policy prohibiting hedging and pledging of our securities by our
directors and officers, including our NEOs. Based on its assessment, the Compensation Committee does not believe that our compensation
programs, policies and practices, in conjunction with our existing processes and controls, create risks that are reasonably likely
to have a material adverse effect on our business and operations.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="b030"></A>STOCKHOLDER
OUTREACH</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
 <tr>
    <td rowspan="5" style="vertical-align: top; width: 51%; padding-right: 5.4pt; font-size: 10pt; text-align: justify"><p style="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif"><font style="font-family: Arial, Helvetica, Sans-Serif">Active
                                            stockholder outreach and interaction is paramount to Novavax&rsquo;s investor relations strategy.
                                            Consistent with that, Novavax attended <b>nine </b>investor conferences in 2020, the majority
                                            of which included presentations and opportunities to meet with institutional investors in
                                            virtual one-on-one settings. Novavax further conducted one non-deal roadshow in the U.S..
                                            Novavax holds an annual stockholder day in the second quarter. In total, Novavax conducted
                                            <b>over 200 </b>individual calls or meetings with buy-side investors and had <b>over 20 </b>interactions
                                            with sell-side analysts in 2020. The Company believes these interactions are central to communicating
                                            Novavax&rsquo;s investment opportunity, corporate strategy, milestones and goals, and to
                                            obtaining feedback directly from the investment community.</font></p></td>
    <td style="vertical-align: top; width: 3%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <TD STYLE="width: 46%; padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center; background-color: rgb(0,86,149)"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: White"><b>STOCKHOLDER
    OUTREACH FORUMS</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="border-bottom: #003DA5 1pt solid; background-color: #F2F2F2; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 4pt 26.5pt; text-indent: -0.25in"><font style="color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>Nine
</b>investor conferences, with presentations and one-on-one meetings with institutional investors&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 4pt 26.5pt; text-indent: -0.25in"><font style="color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>One </b>non-deal roadshow in the U.S.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 4pt 26.5pt; text-indent: -0.25in"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 4pt 26.5pt; text-indent: -0.25in"><FONT STYLE="color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><B>Eight
        </B>events hosted by sell-side analysts, including panels, forums, and group calls&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 26.5pt; text-indent: -0.25in"><font style="color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font>Our
Annual Stockholder Day&nbsp;</p></td></tr>
<tr style="vertical-align: top">
    <td rowspan="3" style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt">&nbsp;&nbsp;</td></tr>
<tr style="">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; font-size: 10pt; text-align: center; background-color: rgb(0,86,149)"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: White"><b>IN
    TOTAL, IN 2020, WE CONDUCTED:</b></font></td></tr>
<tr style="vertical-align: top; ">
    <TD STYLE="border-bottom: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; background-color: rgb(242,242,242)">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 26.5pt; text-indent: -0.25in"><font style="color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><b>Over
200</b> individual calls and/or meetings with buy-side investors&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0pt 26.5pt; text-indent: -0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #005695">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>Over
20 </b>interactions with sell-side analysts</font>&nbsp;&nbsp;&nbsp;</p></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">41</FONT></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; text-indent: 0"></P>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 98%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #F2F2F2; border-collapse: collapse">
 <tr style="vertical-align: top">
    <TD STYLE="width: 100%; border: #003DA5 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 12pt 15pt 0 17pt"><b><a name="a021"></a>Compensation Committee Report</b></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 15pt 0 17pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 15pt 0 17pt; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">The Compensation Committee of
the Company has reviewed and discussed the Compensation Discussion and Analysis required by Item 402(b) of Regulation S-K with
management and based on such review and discussions, the Compensation Committee recommended to the Board of Directors that the
Compensation Discussion and Analysis be included in this Proxy Statement.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 15pt 0 17pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify"><b>COMPENSATION COMMITTEE</b></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">David M. Mott, Chair</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">Richard H. Douglas, Ph.D.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">Rachel K. King</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">Margaret G. McGlynn, R. Ph.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 5in; text-align: justify">Michael A. McManus, Jr., J.D.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 15pt 0 17pt">&nbsp;</p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 22pt 12pt 17pt; text-align: justify"><i>This Compensation Committee Report shall not be deemed incorporated by reference by any general statement
incorporating by reference this Proxy Statement into any filing under the Securities Act of 1933 or under the Securities Exchange
Act of 1934 except to the extent that Novavax specifically incorporates this information by reference and shall not otherwise be
deemed filed under the Securities Act of 1933 and the Securities Exchange Act of 1934 and shall not be deemed soliciting material.</i></p>

<p style="margin: 0pt 0">&nbsp;</p></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>42
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0">&nbsp;</P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 18pt"><B><A NAME="a022"></A>Executive
Compensation Tables</B></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="a023"></A>SUMMARY
COMPENSATION TABLE</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">The following table sets forth information
concerning the compensation of our NEOs for the fiscal years ended December 31, 2020, 2019, and 2018.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 5.4pt; text-align: left; vertical-align: bottom; width: 26%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Name
    and </B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Principal Position</B></FONT></FONT></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; text-align: center; vertical-align: bottom; width: 6%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Year</B></FONT></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Salary<SUP>(1)</SUP></B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></p></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Stock
        Awards<SUP>(2)</SUP></B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></p></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Option
        Awards<SUP>(3)</SUP></B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></p></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Non-Equity
        Incentive Plan Compensation<SUP>(4)</SUP></B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></p></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>All
        Other Compensation<SUP>(5)</SUP></B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-size: 8pt"><B>($)</B></FONT></p></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; width: 10%; padding-right: 10pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 8pt"><B>Total</B></FONT></p>
        <p style="margin-top: 0pt; text-align: center; vertical-align: bottom; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>($)</B></FONT><FONT STYLE="font-size: 8pt">&nbsp;</FONT></p></td></tr>
<tr style="vertical-align: top">
    <TD ROWSPAN="3" STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>Stanley
        C. Erck</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 1pt 8pt"><FONT STYLE="font-size: 8pt">President and CEO</FONT></p></td>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2020</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">657,181</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,710,730</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,115,244</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">591,463</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,400</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,086,018</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">642,720</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">431,631</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">986,660</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">366,351</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,200</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,438,562</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2018</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">638,040</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,509,358</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,000</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,158,398</FONT></td></tr>
<tr style="vertical-align: top">
    <TD ROWSPAN="3" STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>Gregory
        F. Covino<SUP>(6)</SUP></B></FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 1pt 8pt"><FONT STYLE="font-size: 8pt">Former EVP, Chief
        Financial Officer and Treasurer</FONT></p></td>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2020</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">55,000</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">661,745</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">659,967</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">33,000</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,032</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,417,774</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2018</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td></tr>
<tr style="vertical-align: top">
    <TD ROWSPAN="3" STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0"><FONT STYLE="font-size: 8pt"><B>Gregory M. Glenn, M.D.</B></FONT></p>
        <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 1pt 8pt"><FONT STYLE="font-size: 8pt">President,
        Research and Development</FONT></p></td>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2020</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">483,443</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,206,210</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">22,859,741</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">362,582</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,400</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">24,923,376</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">470,453</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">348,306</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">819,421</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">225,818</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,200</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,875,198</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2018</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">460,125</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,131,189</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">79,142</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,000</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,681,456</FONT></td></tr>
<tr style="vertical-align: top">
    <TD ROWSPAN="3" STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0"><FONT STYLE="font-size: 8pt"><B>John J. Trizzino</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 1pt 8pt"><FONT STYLE="font-size: 8pt">EVP, Chief Commercial
        Officer, Chief Business Officer and Interim Chief Financial Officer</FONT></p></td>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2020</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">415,892</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">831,410</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,819,717</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,535</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,400</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,327,954</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">390,701</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">330,831</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">584,103</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">150,421</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,546</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,465,602</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2018</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">378,078</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">890,700</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">53,498</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,500</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,329,776</FONT></td></tr>
<tr style="vertical-align: top">
    <td rowspan="3" style="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0; text-align: justify"><FONT STYLE="font-size: 8pt"><B>John
        A. Herrmann III</B></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 1pt 0 1pt 8pt"><FONT STYLE="font-size: 8pt">EVP, Chief Legal
        Officer and Corporate Secretary</FONT></p></td>
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2020</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">402,842</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,025,960</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,924,907</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">241,705</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,400</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,606,814</FONT></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding-top: 1pt; padding-bottom: 1pt; text-align: center; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">378,591</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">329,470</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">488,397</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">145,758</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,200</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,353,416</FONT></td></tr>
<tr style="vertical-align: top">
    <td style="border-bottom: rgb(0,61,165) 1pt solid; padding-top: 1pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2018</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">362,695</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">712,560</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,321</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,000</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding: 1pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,137,576</FONT></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Includes
                                         amounts earned, but deferred at the election of the NEO, such as salary deferrals under
                                         the Company&rsquo;s 401(k) plan.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">The
                                         amount reported in this column represents the grant date fair value of time-vesting RSUs
                                         granted to our NEOs in 2019 and 2020 and performance-vesting RSUs granted to our NEOs
                                         in 2019. The grant date fair value was calculated in accordance with FASB ASC Topic 718.
                                         Assumptions used in the calculation of this amount are included in Note 13 to the Company&rsquo;s
                                         Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on
                                         March 1, 2021. The grant date fair values of the performance-vesting RSUs granted in
                                         2019 as reported in the table above are based on the probable outcome of the performance
                                         conditions associated with the RSUs on the grant date, which is the same value as if
                                         all applicable performance milestones associated with the RSUs were achieved at maximum
                                         levels.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">The
                                         amount reported in this column represents the grant date fair value of time-vesting stock
                                         options and SARs granted to our NEOs in 2018 and 2019 and time-vesting and performance-vesting
                                         stock options granted to our NEOs in 2020. The grant date fair value was calculated in
                                         accordance with FASB ASC Topic 718 assuming all contingent awards were granted on a non-contingent
                                         basis. Assumptions used in the calculation of this amount are included in Note 13 to
                                         the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2020 filed
                                         with the SEC on March 1, 2021. The grant date fair values of the performance-based stock
                                         options granted in 2020 as reported in the table above are based on the probable outcome
                                         of the performance condition associated with the stock options on the measurement date
                                         under FASB ASC Topic 718, which assumes the performance condition is satisfied in full.
                                         The amount included for awards granted in 2020 also includes the incremental fair value,
                                         determined under ASC Topic 718, associated with the contingency with respect to the contingent-based
                                         awards granted in 2019 having been satisfied.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(4)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">Represents
                                         annual performance bonuses awarded in 2020, 2019, and 2018 under the Company&rsquo;s
                                         incentive cash bonus program. For a description of the incentive cash bonus program,
                                         see page 37 in the CD&amp;A.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(5)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 9pt">For
                                         2020, All Other Compensation consisted of (i) employer matching contributions to the
                                         Company&rsquo;s 401(k) plan for Messrs. Erck, Covino, Trizzino, and Herrmann, and Dr.
                                         Glenn; and (ii) for Mr. Covino this amount includes a commuting allowance of $3,500 per
                                         month, grossed up to $8,032 in total, to cover Mr. Covino&rsquo;s tax liability for such
                                         commuting allowance.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(6)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Mr.
                                         Covino was appointed as Executive Vice President, Chief Financial Officer and Treasurer
                                         effective November 16, 2020. Effective April 12, 2021, Mr. Covino stepped down from his
                                         position as our Executive Vice President, Chief Financial Officer and Treasurer and will
                                         remain with the company as an executive adviser.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">43</FONT></B></P>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="a024"></A>GRANTS
OF PLAN-BASED AWARDS TABLE</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify">The following table sets forth
information with respect to option awards and other plan-based awards granted to our NEOs during the fiscal year ended December
31, 2020:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD COLSPAN="6" STYLE="white-space: nowrap; padding-right: 2.4pt; text-align: center; border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Estimated
    Future</B><br>
    <B>Payouts Under</B><br>
    <B>Non-Equity Incentive</B><br>
    <B>Plan Awards<SUP>(1)</SUP></B></FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="white-space: nowrap; padding-right: 2.4pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Estimated</B><br>
    <B>Future</B><br>
    <B>Payouts</B><br>
    <B>Under</B><br>
    <B>Equity</B><br>
    <B>Incentive</B><br>
    <B>Plan Awards</B></FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>All
    Other</B><br>
    <B>Stock</B><br>
    <B>Awards:</B><br>
    <B>Number of</B><br>
    <B>Shares of</B><br>
    <B>Stock or</B></FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="white-space: nowrap; padding-right: 2.4pt; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>All
    Other</B><br>
    <B>Option</B><br>
    <B>Awards:</B><br>
    <B>Number of</B><br>
    <B>Securities</B><br>
    <B>Underlying</B></FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exercise
    or</B><br>
    <B>Base Price</B><br>
    <B>of Option</B></FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="white-space: nowrap; padding-bottom: 1pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Grant</B><br>
    <B>Date Fair</B><br>
    <B>Value of</B><br>
    <B>Stock and</B><br>
    <B>Option</B></FONT></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: #003DA5 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Name</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Target</B><br>
    <B>($)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Maximum</B><br>
    <B>($)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Grant</B><br>
    <B>Date</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Target</B><br>
    <B>(#)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Units</B><br>
    <B>(#)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Options</B><br>
    <B>(#)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Awards<SUP>(2)</SUP></B><br>
    <B>($/Sh)</B></FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: #003DA5 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Awards<SUP>(3)</SUP></B><br>
    <B>($)</B></FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Stanley C. Erck</B></FONT></td>
    <td style="width: 1%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 7%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">393,827</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 7%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">591,463</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 8%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 8%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 7%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 8%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 8%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 1%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="width: 11%; text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">41,700<SUP>(4)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,808,977</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,900<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,710,730</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">400,000<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">31,664,800</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,000<SUP>(4)</SUP></FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,641,467</FONT></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Gregory F. Covino</B></FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">22,000</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">33,000</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/16/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,300<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">661,745</FONT></td></tr>
<tr>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/16/2020</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,200<SUP>(4)</SUP></FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">90.65</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">659,967</FONT></td></tr>
<tr>
    <td style="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Gregory M. Glenn, M.D.</B></FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">241,425</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">362,582</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,700<SUP>(4)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,156,544</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,300<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,206,210</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">165,000<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,061,730</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,000<SUP>(4)</SUP></FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,641,467</FONT></td></tr>
<tr>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>John J. Trizzino</B></FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">165,750</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,535</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,500<SUP>(4)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,095,570</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,800<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">622,560</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6/25/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,500<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">208,850</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">140,000<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,082,680</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100,000<SUP>(4)</SUP></FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(105,115,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,641,467</FONT></td></tr>
<tr>
    <td style="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td style="vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td>
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>John A. Herrmann III</B></FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">160,576</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">241,705</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,700<SUP>(4)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,464,605</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,300<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">817,110</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6/25/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,500<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">208,850</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">125,000<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; border-bottom: rgb(105,113,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,895,250</FONT></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td style="border-bottom: rgb(0,61,165) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99,000<SUP>(4)</SUP></FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,113,123) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,565,052</FONT></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">The
                                         target cash bonus amount for fiscal 2020 was based on achievement of 100% of the 2020
                                         Objectives and the individual&rsquo;s earned base salary for 2020 and represented 60%
                                         of Mr. Erck&rsquo;s base salary, 40% of Mr. Covino&rsquo;s base salary, pro-rated for
                                         the portion of the year Mr. Covino was employed by the Company, 50% of Dr. Glenn&rsquo;s
                                         base salary, 40% of Mr. Trizzino&rsquo;s base salary, and 40% of Mr. Herrmann&rsquo;s
                                         base salary. The maximum cash bonus amount for fiscal 2020 was capped at achievement
                                         of 150% of the 2020 Objective.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Stock
                                         options granted have an exercise price or base value, as applicable, equal to the closing
                                         price of a share of Common Stock as reported on Nasdaq on the date of grant (or, if no
                                         closing price is reported on that date, the closing price on the immediately preceding
                                         date on which a closing price was reported).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">The
                                         grant date fair value was calculated in accordance with FASB ASC Topic 718, assuming
                                         all contingent awards were granted on a non-contingent basis. Assumptions used in the
                                         calculation of this amount are included in Note 13 to the Company&rsquo;s Annual Report
                                         on Form 10-K for the year ended December 31, 2020 filed with the SEC on March 1, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(4)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Represents
                                         time-vesting stock options granted to our NEOs under the 2015 Stock Plan. All stock option
                                         awards in this column are options to purchase shares of Common Stock, have a ten-year
                                         term and are subject to service-based vesting, as described below. The grant date fair
                                         value also includes the incremental fair value, determined under ASC Topic 718, associated
                                         with the contingency with respect to the contingent-based stock options granted in 2019
                                         having been satisfied.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(5)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Represents
                                         time-vesting RSUs granted to our NEOs under the 2015 Stock Plan. All time-vesting RSUs
                                         are subject to service-based vesting, as described below.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(6)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Represents
                                         performance-vesting options granted to our NEOs under the 2015 Stock Plan. The performance
                                         criteria applicable to performance-vesting options are described below.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>44
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I>Narrative
Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-size: 13pt"><B><I></I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">During 2020, each of the
NEOs was party to an employment agreement that provides for a base salary and other benefits. The NEOs were eligible to participate
in the 2015 Stock Plan and the ESPP, and our benefit plans and programs during 2020. Each of the NEO&rsquo;s annual cash bonus
opportunity was established and determined pursuant to the 2020 Objective, as more fully described in the CD&amp;A above. As described
above, in 2020, each NEO was granted stock options and RSUs that are eligible to vest based on continued service, and each NEO
other than Mr. Covino was granted a stock option that became eligible to vest based on the achievement of a specified performance
criterion, the Company&rsquo;s initiation of a COVID-19 Phase 2 clinical trial within twelve (12) months of the grant date, which
occurred when the Company initiated its Phase 2 clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020, and once this metric
was met, vests based on continued service.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">The severance arrangements
with the NEOs and the effect of a change in control on their outstanding equity awards are described below under &ldquo;Overview
of Employment and Change in Control Agreements.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">45</FONT></B></P>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<!-- Field: Split-Segment; Name: 5 -->
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-size: 14pt"><B><A NAME="a025"></A>OUTSTANDING
EQUITY AWARDS AT 2020 FISCAL YEAR END</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify">The following table sets forth
certain information with respect to the value of all outstanding equity awards held by the NEOs as of December 31, 2020:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
 <tr style="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="padding-right: 13pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD COLSPAN="13" STYLE="text-align: center; border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Option
    Awards<SUP>(1)</SUP></B></FONT></td>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Stock
    Awards<SUP>(2)</SUP></B></FONT></td>
    <TD STYLE="padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr style="vertical-align: bottom">
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Name</B></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Grant&nbsp;Date</B></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.4pt 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Number
                                         of<BR>
 Securities<BR>
 Underlying<BR>
 Unexercised<BR>
 Options</B></FONT><FONT STYLE="font-size: 8pt">&nbsp;</FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.4pt 0pt 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exercisable</B></FONT><FONT STYLE="font-size: 8pt"><br>
        <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>(#)</B></FONT></FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 2.4pt 0pt 0; text-align: center"></p></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 2.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Number
    of<BR>
 Securities<BR>
 Underlying<BR>
 Unexercised<BR>
 Options</B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Unexercisable</B></FONT><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>(#)</B></FONT></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid; padding-right: 2.4pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Option<BR>

    Exercise<BR>
 Price</B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>($)<SUP>(3)</SUP></B></FONT></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Option<BR>

    Expiration</B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Date</B></FONT></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Number
    of<BR>
 Shares or<BR>
 Units of<BR>
 Stock That<BR>
 Have Not<BR>
 Vested</B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>(#)</B></FONT></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Market<BR>

    Value of<BR>
 Shares or<BR>
 Units of<BR>
 Stock That<BR>
 Have Not<BR>
 Vested</B></FONT><FONT STYLE="font-size: 8pt"><br>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>($)<SUP>(4)</SUP></B></FONT></FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-bottom: 1pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom; width: 16%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Stanley
    C. Erck</B></FONT></td>
    <TD STYLE="vertical-align: bottom; width: 1%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/1/2012</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,181</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; width: 11%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/1/2022</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 3%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; width: 9%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; width: 1%; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/2/2013</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/2/2023</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2014</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2024</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2015</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">178.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2025</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/15/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/15/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; white-space: nowrap; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,499</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,330</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2017</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,869</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,630</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2027<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2018</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,249</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,250</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2028<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,092</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,897</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,249</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,751</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(8)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,249</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,751</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">400,000</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2030<SUP>(7)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: top; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">41,700</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2030<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,900</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,710,730</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Gregory
    F. Covino</B></FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/16/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,200</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">90.65</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/16/2030<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/16/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,300</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">661,745</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Gregory
    M. Glenn, M.D.&nbsp;</B></FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2014</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,749</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">0</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2024</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2015</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">0</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">178.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2025</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/15/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,499</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">0</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/15/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">550</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">0</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2017</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,084</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,257</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2027<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2018</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,644</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,880</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2028<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20,656</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">45,444</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(9)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,249</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,751</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">165,000</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2030<SUP>(7)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,700</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2030<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,300</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,206,210</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>John
    J. Trizzino</B></FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/10/2014</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">117.20</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/10/2024</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2015</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">178.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2025</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">394</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,214</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2017</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,668</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,009</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2027<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2018</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,082</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,507</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2028<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,075</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,096</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,149</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,651</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(8)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,249</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,751</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">140,000</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2030<SUP>(7)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6/25/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,500</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">208,850</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,500</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2030<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,800</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">622,560</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>John
    A. Herrmann III&nbsp;</B></FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2014</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,499</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/6/2024</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2015</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,999</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">178.80</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3/5/2025</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">394</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2016</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,214</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11/14/2026<SUP>(6)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2017</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,668</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,009</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27.60</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/15/2027<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2018</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,664</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,007</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46.00</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/13/2028<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&mdash;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,946</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,279</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2019</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,187</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,063</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5.95</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9/26/2029<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">125,000</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19.08</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4/17/2030<SUP>(7)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6/25/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,500</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">208,850</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,700</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">129.70</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2030<SUP>(5)</SUP></FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; white-space: nowrap; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(105,115,123) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
<tr>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12/14/2020</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#8213;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,300</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; white-space: nowrap; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; padding-left: 0; padding-right: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">817,110</FONT></td>
    <TD STYLE="border-bottom: rgb(0,61,165) 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&nbsp;</FONT></td></tr>
 </table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">All
                                         stock options and SARs included in this table were awarded under the Amended and Restated
                                         2005 Stock Incentive Plan (the &ldquo;2005 Stock Plan&rdquo;) or 2015 Stock Plan and,
                                         except as noted, vest in four equal annual installments on the first four anniversaries
                                         of the date of grant, subject to continued service with the Company through the applicable
                                         vesting date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-size: 9pt; color: #231F20"><B>46
</B></FONT><B><FONT STYLE="font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">All
                                         RSUs included in this table were awarded under the 2015 Stock Plan and, except as noted,
                                         vest in three equal annual installments on the first three anniversaries of the date
                                         of grant, subject to continued service with the Company through the applicable vesting
                                         date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">The
                                         exercise price of stock options and base value of SARs is equal to the closing price
                                         of a share of Common Stock on the date of grant (or, if no closing price is reported
                                         on that date, the closing price on the immediately preceding date on which a closing
                                         price was reported).</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(4)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-size: 9pt">Amounts
                                         in this column have been calculated by multiplying the number of RSUs subject to the
                                         applicable award by $111.51, which was the closing price of the Common Stock on December
                                         31, 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(5)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Twenty-five
                                         percent of the shares subject to this stock option vest one year following the date of
                                         grant, and the remaining seventy-five percent will vest in equal monthly installments
                                         over the following three years, subject to continued service with the Company through
                                         the applicable vesting date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(6)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Represents
                                         performance- and time-vesting stock options and assumes achievement of performance at
                                         threshold levels. These stock options are eligible to vest according to the satisfaction
                                         of both a time-vesting requirement, pursuant to which 25% of the shares subject to this
                                         option vest one year following the date of grant, and the remaining 75% will vest in
                                         equal monthly installments over the following three years subject to continued employment
                                         through the vesting date; and a performance-vesting requirement, pursuant to which 33.33%,
                                         33.33%, and 33.34% of the shares will vest if, at any time during the four-year period
                                         from the grant date, the volume-weighted average stock price of the Common Stock meets
                                         or exceeds three separate pre-determined dollar targets, respectively, for twenty (20)
                                         consecutive trading days. The Company&rsquo;s Common Stock did not meet one pre-determined
                                         dollar target for twenty (20) consecutive trading days and therefore 33.34% of the shares
                                         were cancelled on October 31, 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(7)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Represents
                                         performance- and time-vesting stock options that vest subject to the satisfaction of
                                         a performance-based vesting requirement, followed by time-based vesting. The performance
                                         metric required that the Company initiate a COVID-19 Phase 2 clinical trial within twelve
                                         (12) months of the grant date, which occurred when the Company initiated its Phase 2
                                         clinical trial of NVX-CoV2373 in the U.S. on August 24, 2020. As a result of the attainment
                                         of the performance objective, these options will vest as to 50% of the underlying shares
                                         on August 24, 2021 and as to 50% of the underlying shares on August 24, 2022, subject
                                         to continued service with the Company through such applicable vesting date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-size: 9pt">(8)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-size: 9pt">Twenty-five
                                         percent of the shares underlying this stock appreciation grant under the 2015 Stock Plan
                                         will vest on the first anniversary of the grant date, and the remaining 75% will vest
                                         in equal monthly installments over the following three years, subject to continued service
                                         with the Company through the vesting date.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-size: 9pt; color: #496D93"><B>|</B></FONT><B> <FONT STYLE="font-size: 9pt; color: #231F20">47</FONT></B></P>

<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B><FONT STYLE="color: #231F20"></FONT></B></P>



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8D"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8D"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8D"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><A NAME="a026"></A><B>OPTIONS
EXERCISED AND STOCK APPRECIATION RIGHTS EXERCISED AND STOCK VESTED</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table sets forth certain information concerning the exercise of stock options and/or SARs held by the NEOs and the holding
of RSUs that vested during the fiscal year ended December 31, 2020.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="border-bottom: #486C93 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Option/SAR
    Awards</B></FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="4" STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Stock
    Awards</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; text-align: left; vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Executive</B></FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of Shares</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Acquired on Exercise (#)</B></FONT></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Value</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Realized</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>on</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Exercise</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)<SUP>(1)</SUP></B></FONT></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of Shares</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Acquired on Vesting (#)<SUP>(2)</SUP></B></FONT></FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Value</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Realized</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>on</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Vesting</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)<SUP>(3)</SUP></B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 38%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Stanley
    C. Erck</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 13%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">102,317</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 1%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 1%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; width: 13%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">8,039,414</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 1%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 13%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">12,618</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 1%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; width: 1%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">819,842</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory
    F. Covino</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory
    M. Glenn, M.D.</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">97,760</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">9,142,404</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">39,348</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">4,391,538</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">John
    J. Trizzino</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">72,388</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">7,278,978</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">35,906</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: #888A8C 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">4,030,180</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: rgb(72,108,147) 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">John
    A. Herrmann III</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">83,953</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: rgb(72,108,147) 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">7,069,224</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">35,322</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-right: 0; border-bottom: rgb(72,108,147) 1pt solid; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 0; border-bottom: rgb(72,108,147) 1pt solid; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">3,965,781</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">This
                                         amount represents the difference between the market price of a share of Common Stock
                                         at the time of exercise and the exercise price of the stock option or SAR.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Amounts
                                         in this column represent RSUs that vested during 2020.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The
                                         dollar amount in this column is determined by multiplying the number of shares of Common
                                         Stock underlying RSUs that vested during 2020 by the closing price of a share of Common
                                         Stock on the date the RSUs vested.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><A NAME="a027"></A><B>OVERVIEW
OF EMPLOYMENT AND CHANGE IN CONTROL AGREEMENTS</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Employment
Agreements</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">On
December 31, 2020, the Company had employment agreements in place with each of our NEOs. Each employment agreement provides for
a base salary subject to review each year, an incentive bonus, and equity awards. Salary information and the target amount of
the incentive bonus are described in greater detail on pages 37 through 38 in the CD&amp;A. The amount of any incentive bonus
and the form of payment (cash, equity, or some combination of the two) are at the discretion of the Board.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
employment agreements with Messrs. Erck, Trizzino and Herrmann and Dr. Glenn also provide that additional equity may be awarded
to the NEO based upon his performance and subject to the Board&rsquo;s approval. The employment agreements with all of our NEOs
further provide for the reimbursement of reasonable expenses incurred in connection with the performance of duties and for the
NEO to participate in the Company&rsquo;s Severance Plan (discussed below). Each NEO must devote his full business time to the
performance of services to the Company.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
employment agreements require each NEO to maintain the confidentiality of the Company&rsquo;s proprietary information and provide
that all work product discovered or developed by the NEO in the course of the NEO&rsquo;s employment belongs to the Company. In
addition, in the employment agreements, the NEOs have agreed not to compete with the Company, directly or indirectly, within the
United States or interfere with or solicit the Company&rsquo;s contractual relationships, in each case during the term of his
employment and for the duration of the severance period provided for the NEO following the termination of his employment.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
an NEO is terminated without &ldquo;cause&rdquo; or leaves the Company for &ldquo;good reason&rdquo; (as such terms are defined
in each employment agreement), the NEO may receive a lump sum separation payment. The amount of these payments is more specifically
described in the section &ldquo;Potential Payments Upon Termination&rdquo; beginning on page 51. To be entitled to such a payment,
the NEO must execute and deliver to the Company a waiver and separation agreement, releasing the Company from any claims.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>48
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Amended
and Restated Change in Control Severance Benefit Plan</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
August 2005, the Board adopted a Change in Control Severance Benefit Plan, which was amended in July 2006, December 2008, and
June 2011 (the &ldquo;Severance Plan&rdquo;). The purpose of the Severance Plan is to provide severance pay and benefits to a
select group of employees in the event their employment with the Company is terminated following a change in control event, to
provide such employees with an incentive to remain with the Company, and help the Company consummate a strategic corporate sale
or transaction that maximizes stockholder value. Participants in the Severance Plan are recommended by the CEO and approved by
the Board. Selected participants with existing severance agreements are deemed to elect coverage under the Severance Plan and
are not eligible for any severance benefits under other agreements unless expressly provided otherwise by the Board. Each of our
NEOs participates in the Severance Plan.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Severance Plan provides for the payment of benefits upon certain triggering events. A triggering event occurs if a participant&rsquo;s
employment is terminated due to an &ldquo;Involuntary Termination without Cause&rdquo; for a reason other than death or disability
or as a result of a &ldquo;Constructive Termination&rdquo; either (i) within a certain period (not to exceed 24 months) after
the effective date of a &ldquo;Change in Control&rdquo; or (ii) before the Change in Control but after the first day on which
the Board and/or senior management of the Company has entered into formal negotiations with a potential acquirer that results
in the consummation of the Change in Control.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
specific periods of time following the effective date of a Change in Control during which payment of benefits under the Severance
Plan may be triggered by termination, and the severance payment and benefits provided pursuant to the Severance Plan, are as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="5" STYLE="border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Severance<SUP>(1)(2)</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 52%; padding-left: 10pt; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Executive</B></FONT></TD>
    <TD STYLE="width: 1%; padding-left: 6pt; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; padding-right: 1.3pt; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Protected
    Period</B></FONT></TD>
    <TD STYLE="width: 1%; padding-right: 1.3pt; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Payment</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; border-bottom: #486C93 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Continuation
                                         of</B>&nbsp;</FONT></P>
        <P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Benefits
        Period</B></FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Stanley
    C. Erck</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">24
    months</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">24
    months salary</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 2.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">18
    months</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Gregory
    F. Covino</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months salary</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 2.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Gregory
    M. Glenn, M.D.</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months salary</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 2.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    J. Trizzino</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months salary</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 2.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    A. Herrmann III</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 1.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months salary</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 2.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12
    months</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">If
                                         a triggering event occurs, the participant is entitled to a lump sum severance payment;
                                         a bonus equal to 100% of the target annual performance bonus for the year in which the
                                         termination date occurred multiplied by the length in years of the participant&rsquo;s
                                         severance benefit period; and Company-paid continuation of medical, dental, and vision
                                         benefits for the same number of months as the severance period, with the exception of
                                         Mr. Erck, whose benefits continue for 18 months.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The
                                         NEOs are also entitled to certain payments and benefits upon termination of employment
                                         that are provided on a non-discriminatory basis to salaried employees generally upon
                                         termination of employment. These include accrued salary and accrued but unused vacation
                                         pay, and availability for distribution of plan balances under the Company&rsquo;s 401(k)
                                         plan.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>49</B></FONT></P>


<!-- Field: Page; Sequence: 55 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
used in the Severance Plan, the below terms have the following meanings:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR>
    <TD STYLE="vertical-align: top; width: 25%; border-bottom: #496D93 1pt solid; padding-right: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Term</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 75%; border-bottom: #496D93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Definition</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>Involuntary
    Termination without Cause Cause</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
                                       termination of an eligible employee&rsquo;s employment which is initiated by the Company
                                       for a reason other than Cause:</FONT></P>
        <P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">conviction
of, a guilty plea with respect to, or a plea of nolo contendere to a charge that the eligible employee has committed a felony under the
laws of the United States or of any state or a crime involving moral turpitude, including, but not limited to, fraud, theft, embezzlement,
or any crime that results in or is intended to result in personal enrichment at the expense of the Company</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">material
        breach of any agreement entered into between the eligible employee and the Company that impairs the Company&rsquo;s interest
        therein</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">willful
misconduct, significant failure to perform the eligible employee&rsquo;s duties, or gross neglect by the eligible employee of the eligible
employee&rsquo;s duties</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">engagement
        in any activity that constitutes a material conflict of interest with the Company</FONT></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; padding-right: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; padding-right: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>Constructive
    Termination</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">A
                                       termination initiated by an eligible employee because any of the following events or conditions
                                       has occurred:</FONT></P>
        <P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">a
change in the eligible employee&rsquo;s position or responsibilities (including reporting responsibilities) which represents an adverse
change from the eligible employee&rsquo;s position or responsibilities as in effect immediately preceding the effective date of a Change
in Control or at any time thereafter; the assignment to the eligible employee of any duties or responsibilities which are inconsistent
with the eligible employee&rsquo;s position or responsibilities as in effect immediately preceding the effective date of a Change in
Control or at any time thereafter; except in connection with the termination of the eligible employee&rsquo;s employment for Cause or
the termination of an eligible employee&rsquo;s employment because of an eligible employee&rsquo;s disability or death, or except resulting
from a voluntary termination by the employee other than as a result of a Constructive Termination</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 5pt; color: rgb(73,109,147)">&#8239;</FONT><FONT STYLE="font-size: 3pt">&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">a
        material reduction in the eligible employee&rsquo;s pay or any material failure to pay the eligible employee any compensation
        or benefits to which the eligible employee is entitled within five (5) days of the date due</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the
        Company&rsquo;s requiring the eligible employee to relocate his principal worksite to any place outside a fifty (50) mile
        radius of the eligible employee&rsquo;s current worksite, except for reasonably required travel on the business of the
        Company or its affiliates which is not materially greater than such travel requirements prior to the Change in Control</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the
        failure by the Company to continue in effect (without reduction in benefit level and/or reward opportunities) any material
        compensation or employee benefit plan in which the eligible employee was participating immediately preceding the effective
        date of a Change in Control or at any time thereafter, unless such plan is replaced with a plan that provides substantially
        equivalent compensation or benefits to the eligible employee</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">any
        material breach by the Company of any provision of the Severance Plan</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the
failure of the Company to obtain an agreement, from any successors and assigns to assume and agree to perform the obligations created
under the Severance Plan as a result of a Change in Control</FONT></P></TD></TR>
<TR>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; padding-right: 10pt; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>50
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>

<!-- Field: Page; Sequence: 56 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font-size: 11pt; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #888A8C"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font-size: 11pt; margin-top: 0pt; margin-bottom: 0pt; text-align: right"></P>

<P STYLE="font-size: 11pt; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 25%; border-bottom: #496D93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Term</B></FONT></TD>
    <TD STYLE="width: 75%; border-bottom: #496D93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Definition</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><B>Change
    in Control</B></FONT></TD>
    <TD STYLE="vertical-align: bottom"><P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">A
sale, lease, license, or other disposition of all or substantially all of the assets of the Company</FONT></P>
                                       <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">A
consolidation or merger of the Company with or into any other corporation or other entity or person, or any other corporate reorganization,
in which the stockholders of the Company immediately prior to such consolidation, merger, or reorganization, own less than 50% of the
outstanding voting power of the surviving entity and its parent following the consolidation, merger, or reorganization</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&#8239;Any
        transaction or series of related transactions involving a person or entity, or a group of affiliated persons or entities
        (but excluding any employee benefit plan or related trust sponsored or maintained by the Company or an affiliate) in which
        such persons or entities that were not stockholders of the Company immediately prior to their acquisition of the Company
        securities as part of such transaction become the owners, directly or indirectly, of securities of the Company representing
        more than 50% of the combined voting power of the Company&rsquo;s then outstanding securities other than by virtue of
        a merger, consolidation, or similar transaction and other than as part of a private financing transaction by the Company</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&nbsp;</FONT></P>
        <P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 2pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: -0.25in; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">A
change in the Incumbent Board, which occurs if the existing members of the Board on the date the Severance Plan was initially adopted
by the Board (the &ldquo;Incumbent Board&rdquo;) cease to constitute at least a majority of the members of the Board, provided, however,
that any new Board member shall be considered a member of the Incumbent Board for this purpose if the appointment or election (or nomination
for such election) of the new Board member is approved or recommended by a majority vote of the members of the Incumbent Board who are
then still in office</FONT></P></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><A NAME="a028"></A><B>POTENTIAL
PAYMENTS UPON TERMINATION</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table summarizes the payment that would be payable to our NEOs as of December 31, 2020, in the event of the various
termination scenarios, including termination other than for cause, termination for cause, and termination in connection with a
change in control:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: #496D93 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Triggering Event</B></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: #496D93 1pt solid; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Executive</B></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Benefit</B></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Other Than</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>for Cause<SUP>(1)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>For Cause<SUP>(2)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>in Connection</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>with a Change</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>in Control<SUP>(3)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Stanley C.
    Erck</FONT></TD>
    <TD STYLE="width: 1%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 33%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Severance
    Payment</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">993,000</FONT></TD>
    <TD STYLE="width: 3%; border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">1,324,000</FONT></TD>
    <TD STYLE="width: 3%; border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Bonus</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">595,800</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(4)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Equity
    Awards</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">56,657,427</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(5)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Health
    Insurance</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">33,396</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(6)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">33,396</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(6)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">1,026,396</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">58,610,623</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory F. Covino</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Severance
    Payment</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">440,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">440,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Bonus</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">176,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(4)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Equity
    Awards</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">171,052</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(5)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Health
    Insurance</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">27,474</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(6)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">440,000</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">814,526</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory M. Glenn, M.D.</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Severance
    Payment</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">487,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">487,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Bonus</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">243,500</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(4)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Equity
    Awards</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">31,051,145</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(5)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Health
    Insurance</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">27,474</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><SUP>(6)</SUP></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">487,000</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">31,809,119</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>51</B></FONT></p>

<!-- Field: Page; Sequence: 57 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="vertical-align: bottom; border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Triggering
    Event</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Executive</B></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Benefit</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Other Than</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>for Cause<SUP>(1)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>For Cause<SUP>(2)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Termination</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>in Connection</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>with a Change</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>in Control<SUP>(3)</SUP></B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 28%; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    J. Trizzino</FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 33%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Severance
    Payment</FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">430,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 12%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 2%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">430,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Bonus</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">172,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(4)</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    Awards</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">22,447,563</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(5)</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Health
    Insurance</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">27,474</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(6)</SUP></FONT></TD></TR>
<TR STYLE="background-color: #E6E7E8">
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">430,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">23,077,037</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    A. Herrmann III</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Severance
    Payment</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">415,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">381,368</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Bonus</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">166,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(4)</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    Awards</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">19,367,985</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(5)</SUP></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Health
    Insurance</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">27,474</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(6)</SUP></FONT></TD></TR>
<TR STYLE="background-color: #E6E7E8">
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">415,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">19,942,827</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">On
                                         December 31, 2020, the Company had employment agreements with Dr. Glenn and Messrs. Erck,
                                         Covino, Herrmann, and Trizzino, which provided for a lump sum cash severance payment
                                         equal to 18 months&rsquo; base salary for Mr. Erck and 12 months&rsquo; base salary for
                                         Dr. Glenn and Messrs. Covino, Herrmann and Trizzino if the executive is terminated without
                                         &ldquo;cause&rdquo; or leaves for &ldquo;good reason.&rdquo; All vested and exercisable
                                         stock options held by Dr. Glenn and Messrs. Covino, Herrmann and Trizzino must be exercised
                                         within three months following the termination date. All vested and exercisable stock
                                         appreciation rights held by Dr. Glenn and Messrs. Erck and Trizzino must be exercised
                                         within three months following the termination date. Mr. Erck is entitled to (i) continuation
                                         of medical, dental, and vision benefits for 18 months following the date of termination
                                         and (ii) the accelerated vesting of 50% of the unvested portion of each stock option
                                         or restricted stock grant made by the Company. Mr. Erck may exercise all outstanding
                                         vested stock options held at termination (including any accelerated options or grants)
                                         during the 12-month period following the date of termination.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">In
                                         the event an NEO is terminated for cause, the Company has no further obligation to the
                                         executive other than the obligation to pay any unpaid base salary and unused vacation
                                         accrued through the termination date. Cause means (i) the executive&rsquo;s willful failure
                                         (or, with respect to Mr. Covino&rsquo;s agreement, the executive&rsquo;s failure) or
                                         refusal to perform in all material respects the services required to be performed by
                                         him; (ii) the executive&rsquo;s willful failure (or, with respect to Mr. Covino&rsquo;s
                                         agreement, the executive&rsquo;s failure) or refusal to carry out any proper and material
                                         direction by the President and Chief Executive Officer or Board (or, with respect to
                                         Mr. Erck&rsquo;s agreement, the Board, and with respect to Mr. Herrmann&rsquo;s agreement,
                                         the CMO, the CEO or the Board) with respect to the services to be rendered by him or
                                         the manner of rendering such services; (iii) the executive&rsquo;s willful misconduct
                                         or gross negligence in the performance of his duties (or, with respect to Mr. Covino&rsquo;s,
                                         Mr. Herrmann&rsquo;s and Mr. Trizzino&rsquo;s agreements, the executive&rsquo;s misconduct
                                         in the performance of his duties); (iv) the executive&rsquo;s commission of an act of
                                         fraud, embezzlement, or theft or felony involving moral turpitude; (v) the executive&rsquo;s
                                         use of confidential information, other than for the benefit of the Company in the course
                                         of rendering services to the Company; or (vi) a breach of the executive&rsquo;s non-competition
                                         obligations.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 8.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Under
                                         the Severance Plan, all current unvested stock options become vested and exercisable
                                         in full only upon a termination of employment following a Change in Control (a double
                                         trigger acceleration). The Severance Plan provides that all vested and exercisable stock
                                         options may be exercised within one year from the participant&rsquo;s termination date,
                                         provided, however, that no exercise may occur later than the expiration date of the option
                                         as set forth in the applicable stock option agreement.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bonus
                                         equals 100% of the NEO&rsquo;s target annual bonus award, expressed as a monthly payment,
                                         multiplied by the participant&rsquo;s severance benefit period, expressed monthly.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Represents
                                         the value of all unvested stock options outstanding at the closing price on December
                                         31, 2020, minus any applicable exercise price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reflects
                                         the premiums for health, dental, and vision coverage under the Company&rsquo;s group
                                         health insurance program. Amounts are based on the premiums in effect at December 31,
                                         2020.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>52
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>


<!-- Field: Page; Sequence: 58 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"></P>


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Termination
as a Result of Death or Disability</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
the event an NEO is terminated as a result of death or disability, all outstanding equity awards granted to the executive on or
after March 2016 will vest as to 50% of the unvested portion of each grant as of the termination date. Otherwise, the Company
has no further obligation to the executive other than the obligation to pay any unpaid base salary and unused vacation accrued
through the termination date. If the executive dies while in the employ of the Company (or within three months after the date
on which the executive ceases to be an employee), vested and exercisable options may be exercised by the executive&rsquo;s estate
for one year following the executive&rsquo;s death. If the executive becomes disabled while in the employ of the Company, vested
and exercisable options may be exercised by the executive for a period of one year after the executive ceases to be an employee
due to a disability.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><A NAME="a029"></A><B>2020
CEO Pay Ratio</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K,
the following information describes the relationship of the annual total compensation of our employees and the annual total compensation
of Stanley C. Erck, our President and Chief Executive Officer (our &ldquo;CEO&rdquo;).</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">For
2020:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>2020
    Annual Total Compensation</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>($)</B></FONT></FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Pay
    Ratio Estimate</B></FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 57%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Mr.
    Erck, our Chief Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 1%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">48,086,018</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 10%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 2%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 15%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">The
    median of all employees, other than Mr. Erck</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">400,755</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; vertical-align: top; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt">120:1</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">To
identify its median employee and determine the annual total compensation of that median employee and the CEO:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Company determined that, as of December 31, 2020, its employee population consisted of
                                         approximately 691 individuals, with approximately 390 employees based in the United States,
                                         232 employees located in the Czech Republic, and 69 employees located in Sweden. All
                                         employees are included, whether employed as full-time, part-time, temporary, or seasonal
                                         employees, and compensation was annualized for any full-time employee that was not employed
                                         for all of fiscal year 2020.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">We
                                         identified our median employee by reviewing compensation data reflected in payroll records
                                         consisting of base salary and annual cash incentive payments, which was consistently
                                         applied to all employees included in the calculation. Base salary and annual cash incentive
                                         payments were used because they represent the Company&rsquo;s principal broad-based compensation
                                         elements.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">No
                                         cost-of-living adjustments were made in identifying the median employee. For compensation
                                         of employees located in Sweden and the Czech Republic, the exchange rate used was the
                                         same as for financial statement translation purposes at December 31, 2020.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 3pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">After
                                         identifying the median employee, all of the elements of such employee&rsquo;s compensation
                                         for 2020 in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K,
                                         were totaled, resulting in annual total compensation of $400,755. With respect to the
                                         annual total compensation of the CEO, the Company used the amount reported in the &ldquo;Total&rdquo;
                                         column of the Summary Compensation Table included in this Proxy Statement.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
CEO Pay Ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules, based on our internal
records and the methodology described above. The SEC rules for identifying the median compensated employee allow companies to
adopt a variety of methodologies, to apply certain exclusions and to make reasonable estimates and assumptions that reflect their
employee populations and compensation practices. Accordingly, the pay ratio reported by other companies may not be comparable
to the CEO Pay Ratio reported above, as other companies have different employee populations and compensation practices and may
use different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>53</B></FONT></p>

<!-- Field: Page; Sequence: 59 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><A NAME="a030"></A><FONT STYLE="color: #496D93"><B>Proposal
3</B></FONT><B><FONT STYLE="color: #231F20">&mdash;Amendment and Restatement of the 2015 Stock Plan</FONT></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">At
the Annual Meeting, stockholders will be asked to approve the adoption of the Amended and Restated 2015 Stock Incentive Plan adopted
by our Board on March 18, 2021 (the &ldquo;Amended 2015 Stock Plan&rdquo;). The 2015 Stock Plan was originally adopted by our
Board on March 5, 2015 and approved by Novavax stockholders on June 18, 2015, with an amendment thereto approved by our stockholders
on June 9, 2016, and an amendment and restatement thereof approved by our stockholders on each of June 15, 2017, June 14, 2018,
June 28, 2019, and June 25, 2020. Currently, 10,900,000 shares are authorized for issuance under the 2015 Stock Plan.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
discussed further below, stockholders are being asked to approve the Amended 2015 Stock Plan to enable us to increase the number
of shares of Common Stock available for issuance pursuant to awards under the plan by 1,500,000 shares.</FONT></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top; background-color: rgb(242,242,242)">
    <TD STYLE="width: 100%; border: rgb(72,108,147) 1pt solid; padding: 5.4pt 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>If
    stockholders do not approve this proposal, the Amended 2015 Stock Plan will not become effective and our 2015 Stock Plan will
    remain in effect in accordance with its terms.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Equity
grants are an essential element of our compensation program. Stockholder approval of the Amended 2015 Stock Plan will allow us
to continue to attract and retain high quality and high performing directors, executives, and other employees with equity incentives.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: top; background-color: rgb(242,242,242)">
    <TD STYLE="width: 100%; border: rgb(72,108,147) 1pt solid; padding: 5.4pt 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><B>The
    Company is currently in a critical stage for its ultimate long-term success. We are working to advance NVX-CoV2373, our vaccine
    candidate designed to protect against the SARS-CoV-2 virus responsible for the COVID-19 pandemic. It is essential that the
    Company continue to be able to attract and retain best-in-class talent, and our ability to grant equity awards is key to our
    successful retention efforts.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Board approved the Amended 2015 Stock Plan and the additional shares of Common Stock authorized for issuance under it based upon
its review and consideration of:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the
                                         Company&rsquo;s historic rates of equity award issuances</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the
                                         dilutive impact to stockholders</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">equity
                                         plan guidelines established by certain institutional investors and proxy advisory firms</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">advice
                                         provided by Radford, the Compensation Committee&rsquo;s independent consultant</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Board believes that it is in the best interest of the Company&rsquo;s stockholders for the Company&rsquo;s employees (including
its officers), directors, and consultants to have an ownership interest in the Company and that granting equity awards to such
persons motivates them to contribute to the Company&rsquo;s success. <B>During 2020, we grew our employee headcount by 523 employees,
representing a 311% growth rate. </B>Given the emphasis placed on equity awards in the Company&rsquo;s compensation philosophy
and, the Company&rsquo;s unprecedented growth during 2020, more equity awards were granted under the 2015 Stock Plan (prior to
its amendment) in 2020 than previously anticipated.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
a result, the remaining shares of Common Stock available for issuance under the 2015 Stock Plan are not sufficient to continue
implementing the Company&rsquo;s stock incentive program over the next two years, taking into account our historical burn rate
(discussed below) and certain other factors, including the Company&rsquo;s anticipated need to attract new employees with appropriate
levels of experience and talent. Accordingly, on March 18, 2021, our Board approved the Amended 2015 Stock Plan, subject to stockholder
approval, to increase the number of shares of Common Stock reserved for issuance under the Amended 2015 Stock Plan by 1,500,000
shares and to increase the number of shares of Common Stock that may be issued under the Amended 2015 Stock Plan upon the exercise
of incentive stock options by 1,500,000 shares. The Amended 2015 Stock Plan is being submitted to the Company&rsquo;s stockholders
for approval.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>54
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>

<!-- Field: Page; Sequence: 60 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Board believes the Amended 2015 Stock Plan continues to promote the interests of our stockholders and continues to be consistent
with principles of good corporate governance including:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Independent
                                         Committee. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Amended 2015 Stock Plan will continue to be administered by the Compensation Committee
                                         and its authorized delegates. The Compensation Committee is composed entirely of independent
                                         directors who meet the Nasdaq Global Select Market (&ldquo;Nasdaq&rdquo;) standards for
                                         independence and &ldquo;non-employee directors&rdquo; under Rule 16b-3(b)(3) of the Exchange
                                         Act.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Stockholder
                                         Approval is Required for Additional Shares. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Amended 2015 Stock Plan does not contain an annual &ldquo;evergreen&rdquo; provision.
                                         The Amended 2015 Stock Plan authorizes a fixed number of shares and, as a result, stockholder
                                         approval is required to issue any additional shares under awards under the Amended 2015
                                         Stock Plan. This gives our stockholders the opportunity to provide direct input on our
                                         equity compensation programs.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>No
                                         Discounted Stock Options or SARs. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">All
                                         stock options and SARs under the Amended 2015 Stock Plan must have an exercise price
                                         or base value that is not less than the closing price of a share of Common Stock on the
                                         date of grant (or, if no closing price is reported on that date, the closing price on
                                         the immediately preceding date on which a closing price was reported).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Performance
                                         Awards. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Under
                                         the Amended 2015 Stock Plan, the Compensation Committee may grant performance-based awards
                                         designed to reward individual and Company performance.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>No
                                         Repricing. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Other
                                         than in connection with a corporate transaction affecting the Company, the Amended 2015
                                         Stock Plan prohibits any repricing of stock options or SARs without obtaining stockholder
                                         approval in accordance with Nasdaq requirements.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>No
                                         Liberal Share Recycling. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Shares
                                         retained or withheld by or delivered to the Company to satisfy the purchase or exercise
                                         price of (or withholding taxes applicable to) an award and the total number of shares
                                         subject to a SAR any portion of which is settled in shares reduce the number of shares
                                         available for issuance under the Amended 2015 Stock Plan. In addition, the number of
                                         shares available for delivery under the Amended 2015 Stock Plan will not be increased
                                         by any shares that have been delivered under the Amended 2015 Stock Plan that are subsequently
                                         repurchased using proceeds directly attributable to stock option exercises.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Minimum
                                         Vesting Provisions. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Amended 2015 Stock Plan requires a minimum vesting</FONT></TD>
</TR></TABLE>

</DIV>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">
<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify"><TD STYLE="width: 0.35in; text-align: left"></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">period
                                         of at least one year for all awards granted under the plan, subject to a carve-out for
                                         awards not exceeding five percent of the total shares of Common Stock reserved for issuance
                                         under the Amended 2015 Stock Plan.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Accelerated
                                         Vesting on a Change in Control. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Amended 2015 Stock Plan provides that, upon the consummation of a corporate transaction
                                         (as described below), the plan administrator may not accelerate the time-based vesting
                                         of an award unless such award is not assumed or substituted by the acquiring or succeeding
                                         company in such transaction. Further, the Amended 2015 Stock Plan requires that, on the
                                         consummation of a corporate transaction, the performance-based vesting of any award be
                                         determined based on the greater of (a) assumed achievement of the applicable performance
                                         goals at 100% of target with the result prorated based on the period of the Participant&rsquo;s
                                         actual employment or service relationship with the Company prior to the corporate transaction
                                         during the applicable full performance period, or (b)</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt; color: #231F20">&nbsp;&nbsp;
                                         </FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">actual
                                         achievement of the applicable performance goals through the date of the corporate transaction.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Clawback
                                         Policy. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Awards
                                         under the Amended 2015 Stock Plan are subject to recoupment in accordance with any applicable
                                         Company clawback or recoupment policy that may be adopted by the Board or as otherwise
                                         required by law or applicable listing standards. The Company&rsquo;s current clawback
                                         policy, as adopted by the Board, provides that, if the Company is required to prepare
                                         an accounting restatement due to material non-compliance with financial reporting requirements
                                         under applicable securities laws, with respect to any cash bonus or other cash compensation
                                         paid or awarded, or equity-based bonus or other equity-based incentive compensation that
                                         was exercised, vested or settled, within six months preceding such restatement, and that
                                         was granted or earned or became vested based wholly or in part upon the attainment of
                                         any financial reporting measure, if the recipient of such cash or equity-based bonus
                                         or other cash or equity-based incentive compensation engaged in fraud, intentional misconduct,
                                         or gross negligence that caused or partially caused the need for the restatement, the
                                         Board generally may seek reimbursement of any amount paid under an award in excess of
                                         what would have been paid had such error not been made.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.35in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg128.jpg" ALT="" STYLE="width: 20px; height: 18px"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Payment
                                         of Dividends. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
                                         Amended 2015 Stock Plan expressly prohibits the payment of dividends or dividend equivalents
                                         on unvested awards.</FONT></TD>
</TR></TABLE>

</DIV>
<BR CLEAR="ALL">

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>55</B></FONT></p>

<!-- Field: Page; Sequence: 61 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>EXISTING
EQUITY PLAN INFORMATION</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Since
its adoption in 2015, we have granted equity awards exclusively under our 2015 Stock Plan. In 2020, the Company granted stock
options covering a total of 3,363,766 shares and 511,846 RSUs. Our 2020 burn rate was determined to be 7.3%. The following table
provides information regarding the three-year average burn rate for the preceding three fiscal years as follows:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Stock</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>SARs</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Granted</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Full</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Value</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Awards</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Granted</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Performance-</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Vesting Stock</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Full Value</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Awards</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Granted</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: right; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Burn
    Rate<SUP>(1)</SUP>&nbsp;&nbsp;&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 40%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2020</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">862,166</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; width: 2%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">511,846</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; width: 2%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; width: 10%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,827,650</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; width: 2%; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; width: 13%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">4,201,662</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; width: 7%; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">7.3%</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2019</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,620,721</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,184,932</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">66,677</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,872,330</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">11.9%</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2018</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(2)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">830,616</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">830,616</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">4.5%</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Three-year
    average</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,104,501</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">565,593</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">964,776</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,634,869</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">7.9%</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Our
                                         weighted average common shares outstanding in each of the last three years was: 2020,
                                         57,554,000; 2019, 24,100,000; and 2018, 18,488,000.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reflects
                                         awards as adjusted for the 1-for-20 Reverse Stock Split.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
2020 and through April 19, 2021, the Company granted stock options covering a total of 3,399,174 shares and 930,369 RSUs. As of
April 19, 2021, our 2015 Stock Plan had 2,364,405 shares of Common Stock available for future grant as equity awards. If the Amended
2015 Stock Plan is approved, the total number of shares of Common Stock that will be available for future awards under the Amended
2015 Stock Plan will be 3,864,405, which is the sum of 1,500,000 shares, plus the number of shares currently available under the
2015 Stock Plan. If the stockholders do not approve the Amended 2015 Stock Plan, the Amended 2015 Stock Plan will not become effective,
and additional awards will only be granted from the shares currently available under the 2015 Stock Plan.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>POTENTIAL
DILUTION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
of April 19, 2021, 74,080,008 shares of Common Stock were outstanding. The following table provides information regarding the
number of shares subject to each type of outstanding award under the 2015 Stock Plan and the 2005 Stock Plan, the number of shares
of our Common Stock available for future awards under the 2015 Stock Plan, the number of additional shares that would be available
for future awards under the Amended 2015 Stock Plan, if approved by stockholders, and the dilutive impact of each to our stockholders
as of April 19, 2021.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding Shares</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; vertical-align: bottom; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>As
    a</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Percentage</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>of Stock</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>on a Fully</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Diluted Basis</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt; width: 72%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Outstanding
    stock options and SARs (with performance-based stock options measured at maximum)</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; width: 1%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right; width: 10%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">5,170,324</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right; width: 5%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right; width: 2%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right; width: 7%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">6.4%</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right; width: 3%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Outstanding
    RSUs (with performance-based RSUs measured at maximum)</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,105,949</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1.4%</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total
    shares subject to outstanding awards under the 2015 Stock Plan and the 2005 Stock Plan</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">6,276,273</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">7.8%</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total
    shares available for future awards under the 2015 Stock Plan</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,364,405</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2.9%</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Proposed
    additional shares available for future awards under the Amended 2015 Stock Plan</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,500,000</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1.8%</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total
    potential dilution</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">10,140,678</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12.0%</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
indicated by the numbers in the table above, as of April 19, 2021, the potential dilution under our 2015 Stock Plan and 2005 Stock
Plan was 10.7%. If the Amended 2015 Stock Plan is approved by our stockholders, our potential dilution will be 12.0%.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>56
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>


<!-- Field: Page; Sequence: 62 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>SUPPLEMENTAL
EQUITY COMPENSATION PLAN INFORMATION</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table provides supplemental information on the Company&rsquo;s equity compensation plans as of April 19, 2021 in addition
to the required information presented under &ldquo;Equity Compensation Plan Information&rdquo; included elsewhere in this Proxy
Statement. Under the plans included in the table below, the Company&rsquo;s Common Stock may be issued upon the exercise of options.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Plan
    Category</B></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities to be</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Issued Upon</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Exercise of</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options,</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Warrants, and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Rights (a)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Weighted-</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Average Exercise</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Price of</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options,</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Warrants, and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Rights (b)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Weighted-</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Average</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Remaining</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Term of</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options,</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Warrants, and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Rights (c)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Restricted</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Stock Awards</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding (d)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Remaining</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Available for</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Future Issuance</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Under Equity</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Compensation</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Plans (Excluding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Reflected in</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Column (a)) (e)</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; border-bottom: rgb(136,138,140) 1pt solid; width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    compensation plans approved by security holders<SUP>(1)</SUP></FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; width: 1%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-left: 0; padding-right: 0; text-align: center; width: 9%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">5,170,324</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-right: 0; text-align: center; width: 1%; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-left: 0; padding-right: 0; text-align: center; width: 9%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">39.22</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-right: 0; text-align: center; width: 1%; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-left: 0; padding-right: 0; text-align: center; width: 9%; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">8.3</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-right: 0; text-align: center; width: 1%; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-left: 0; padding-right: 0; text-align: center; width: 9%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,105,949</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-right: 0; text-align: center; width: 1%; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(136,138,140) 1pt solid; padding-left: 0; padding-right: 0; text-align: center; width: 9%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,577,302</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    compensation plans not approved by security holders</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    </TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">5,170,324</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">39.22</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">8.3</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">1,105,949</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-right: 0; text-align: center; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,577,302</FONT></TD>
    </TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         our 2015 Stock Plan, 2005 Stock Plan and ESPP. The 2005 Stock Plan terminated pursuant
                                         to its terms on February 23, 2015 and no further awards will be made pursuant to that
                                         plan. The weighted-average exercise price in column (b) excludes RSUs, which do not have
                                         an exercise price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>REASONS
FOR SEEKING STOCKHOLDER APPROVAL</B></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Our
Board believes the ability to grant equity compensation to all employees has been, and will continue to be, essential to the Company&rsquo;s
ability to attract and retain the highest quality and highest performing employees and directors. Our Board also believes equity
compensation motivates our employees, including our executive officers, and our directors to contribute to the achievement of
our corporate objectives and encourages the alignment of their interests with the interests of our stockholders. After a review
of its routine historical practice and an estimation of the Company&rsquo;s future growth, the Company believes the availability
of 1,500,000 additional shares of Common Stock under the Amended 2015 Stock Plan would provide a sufficient number of shares to
enable the Company to continue to make awards at historical average annual rates for the next year. The Compensation Committee
determined that reserving shares sufficient for approximately one year of new awards at historical grant rates is in line with
the practice of our peer public companies.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>SUMMARY
OF THE AMENDED 2015 STOCK PLAN</B></FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following summary describes the material terms of the Amended 2015 Stock Plan. This summary of the Amended 2015 Stock Plan is
not a complete description of all provisions of the Amended 2015 Stock Plan and is qualified in its entirety by reference to the
Amended 2015 Stock Plan, which is filed as Appendix A to this Proxy Statement.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Purpose;
Term</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
purpose of the Amended 2015 Stock Plan is to secure for the Company and its stockholders the benefits arising from capital stock
ownership by employees, officers, and directors of, as well as consultants and advisors to, the Company, its parents and its subsidiaries.
Unless sooner terminated in accordance with its terms, the Amended 2015 Stock Plan will terminate upon the close of business on
March 4, 2025.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Administration</I></B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Amended 2015 Stock Plan is administered by the Compensation Committee and its authorized delegates. Subject to the terms of the
Amended 2015 Stock Plan, the Compensation Committee has the authority to determine the individuals to whom, and the time or times
at which, awards are made, the number of shares of Common Stock</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>57</B></FONT></p>


<!-- Field: Page; Sequence: 63 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">subject
to each award, and the terms of all awards and all award agreements; to construe the plan and the award agreements under the plan;
to prescribe the forms, rules and procedures relating to the plan; to determine the form of settlement of awards (whether in cash,
shares of Common Stock, or other property); and to make all other determinations and take all other actions that are, in the Compensation
Committee&rsquo;s judgment, necessary or desirable for the administration of the Amended 2015 Stock Plan. Notwithstanding the
foregoing, except in connection with a change in control of the Company or the death or disability of a participant after the
time an award has been granted, the Compensation Committee may not accelerate the time or times at which an award vests or becomes
exercisable. The Compensation Committee&rsquo;s construction and interpretation of the terms and provisions of the Amended 2015
Stock Plan and any award agreement are final and conclusive.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Shares
Reserved</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"></P>


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Subject
to adjustment as described below, the number of shares of Common Stock that are reserved for issuance under the Amended 2015 Stock
Plan is 12,400,000 shares. Shares of Common Stock underlying any award made under the Amended 2015 Stock Plan to the extent the
award expires, terminates or is forfeited, in whole or in part, without the issuance of shares become available for issuance again
under the Amended 2015 Stock Plan. Shares of Common Stock that are retained or withheld by or delivered to the Company to satisfy
any purchase or exercise price or tax withholding obligation, and the total number of shares of Common Stock subject to a SAR,
any portion of which is settled in shares of Common Stock, are treated as issued under the Amended 2015 Stock Plan. The shares
available for issuance under the Amended 2015 Stock Plan are not increased by any shares that have been delivered under the Amended
2015 Stock Plan that are subsequently repurchased using the proceeds directly attributable to stock option exercises. The closing
price of share of Common Stock as reported on Nasdaq on April 19, 2021 was $221.50 per share.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Maximum
Number of Shares Available under Incentive Stock Options</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
maximum aggregate number of shares that may be issued under the Amended 2015 Stock Plan upon the exercise of incentive stock options
is 12,400,000.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Individual
Limits</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
maximum number of shares of Common Stock subject to stock options and the maximum number of shares of Common Stock subject to
SARs that may be granted to any person in any calendar year is, in each case, 500,000 shares. The maximum number of shares subject
to other awards that may be granted to any person in any calendar year is 250,000 shares.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Non-Employee
Director Limits</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">A
participant in the Amended 2015 Stock Plan who is a non-employee member of our Board may not receive shares of Common Stock underlying
awards under the Amended 2015 Stock Plan in any calendar year in excess of 100,000 shares. This limit does not apply to any award
or shares of Common Stock granted pursuant to a director&rsquo;s election to receive shares of Common Stock in lieu of cash fees.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Eligible
Participants</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Compensation Committee may select recipients of awards from among key employees, officers, or directors of, or consultants or
advisors to the Company and its parents and subsidiaries who are expected to contribute to the Company&rsquo;s future growth and
success. Eligibility for stock options intended to be &ldquo;incentive stock options&rdquo; within the meaning of Section 422
of the Code is limited to employees of the Company or its parents and subsidiaries, in accordance with Section 422 of the Code.
As of April 19, 2021, 891 employees, 4 consultants, and 8 directors are eligible to participate in the Amended 2015 Stock Plan.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Awards</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Amended 2015 Stock Plan provides for grants of stock options, restricted stock, unrestricted stock, SARs, stock units, RSUs, and
performance awards. Dividend equivalents may also be provided in connection with awards under the Amended 2015 Stock Plan.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>58
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>


<!-- Field: Page; Sequence: 64 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Restricted
                                         and Unrestricted Stock. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">A
                                         restricted stock award is an award of stock subject to forfeiture restrictions, while
                                         an unrestricted stock award is not subject to restrictions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #496D93"><B><I>Stock
                                         Options and SARs. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">The
                                         Amended 2015 Stock Plan provides for the grant of incentive stock options, non-statutory
                                         stock options and SARs. Stock options entitle the holder to acquire shares of Common
                                         Stock upon payment of the exercise price. A SAR is a right entitling the holder upon
                                         exercise to receive an amount (payable in cash or in shares of Common Stock of equivalent
                                         value) equal to the excess of the closing price of the shares of Common Stock subject
                                         to the SAR on the exercise date over the base value from which appreciation under the
                                         SAR is to be measured. The exercise price of a stock option, and the base value against
                                         which a SAR is to be measured, may not be less than the closing price (or, in the case
                                         of an incentive stock option granted to a ten percent stockholder, 110% of the closing
                                         price) of a share of Common Stock on the date of grant (or, if no closing price is reported
                                         on that date, the closing price on the immediately preceding date on which a closing
                                         price was reported). The Amended 2015 Plan will be administered based on closing prices
                                         on the dates of grants (or, on the immediately preceding date on which a closing price
                                         was reported, as described above), which may differ substantially from market prices
                                         shortly following the grants. The Compensation Committee will determine when stock options
                                         or SARs become exercisable and the terms on which such awards remain exercisable. Stock
                                         options and SARs will generally have a maximum term of ten years (or, in the case of
                                         an incentive stock option granted to a ten percent stockholder, five years); however,
                                         in general, if (i) a participant holds an outstanding but unexercised stock option or
                                         SAR on the date that is ten years from the date of grant (or, in the case of a stock
                                         option or SAR with a maximum term of less than ten years, the last day of such maximum
                                         term) and has not exercised such stock option or SAR as of the regular closing time of
                                         the exchange on which shares of Common Stock are traded on the last day of the applicable
                                         term of the stock option or SAR, (ii) on such date shares of Common Stock is publicly
                                         traded, and (iii) at such time the value of a share of Common Stock (measured based on
                                         the closing price of a share of Common Stock) is greater than the exercise price or base
                                         value applicable to such stock option or SAR, such stock option or SAR to the extent
                                         then vested and exercisable will be automatically exercised on the last day of the applicable
                                         term and the number of shares of Common Stock otherwise to be delivered upon exercise
                                         of the stock option or SAR will be reduced by, in the case of a stock option, a number
                                         of shares having a value equal to the aggregate exercise price of the stock option being
                                         exercised and, in the case of a stock option or SAR, a number of shares having a value
                                         equal to the amount necessary to satisfy any applicable tax withholding obligation (but
                                         not in excess of the maximum withholding amount consistent with the award being subject
                                         to equity accounting treatment under the Accounting Rules).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 3pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Stock
                                         Units. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">A
                                         stock unit award is denominated in shares of Common Stock and entitles the recipient
                                         to receive stock or cash measured by the value of the shares in the future. The delivery
                                         of Common Stock or cash under a stock unit may be subject to the satisfaction of performance
                                         or other vesting conditions.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 3pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 23pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93">&#9679;</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #496D93"><B><I>Performance
                                         Awards. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">A
                                         performance award is an award of a stock option, SAR, restricted stock, or RSU the vesting,
                                         settlement or exercisability of &Iuml;&Iuml;which is subject to specified performance
                                         criteria.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Vesting</I></B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Compensation Committee will determine the time or times at which awards will vest or become exercisable, provided that no award
may vest prior to the first anniversary of the grant date, subject to the Compensation Committee&rsquo;s discretion to accelerate
the vesting of an award upon a change in control of the Company or the death or disability of a participant. However, a number
of shares of Common Stock not exceeding five percent of the number of shares of Common Stock that may be delivered in satisfaction
of awards under the Amended 2015 Stock Plan may be delivered in satisfaction of awards that are not subject to the minimum one-year
vesting period.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Termination
of Employment or Service</I></B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Compensation Committee determines the effect of the termination of employment or service on an award. Unless otherwise provided
by the Compensation Committee, upon a termination of employment or service, all unvested stock options and SARs will terminate,
all other unvested awards will be forfeited, and vested stock options and SARs then held by the participant will remain exercisable
for a period of three months, or 12 months in the case of death or disability, following such termination of employment or, in
each case, until the applicable expiration date, if earlier. All stock options and SARs held by a participant, whether vested
or unvested, immediately prior to the participant&rsquo;s termination of employment or service will terminate if such termination
is for cause.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>59</B></FONT></p>

<!-- Field: Page; Sequence: 65 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Non-transferability
of Awards</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
general, awards under the Amended 2015 Stock Plan may not be transferred except by will or the laws of descent and distribution,
unless, in the case of awards other than incentive stock options, expressly permitted in the agreement evidencing the award. Awards
other than incentive stock options may be transferred pursuant to a domestic relations order (within the meaning of Rule 16a-12
of the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Recovery
of Compensation</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Compensation Committee may cancel, rescind, withhold or otherwise limit or restrict any award at any time under the Amended 2015
Stock Plan if the participant is not in compliance with the provisions of the Amended 2015 Stock Plan or the award or if the participant
breaches any agreement with the Company with respect to non-competition, non-solicitation, or confidentiality. The Compensation
Committee also may recover any award or payments or gain with respect to any award under the Amended 2015 Stock Plan in accordance
with any applicable Company clawback or recoupment policy, as such policy may be in effect from time to time, or as otherwise
required by applicable law or applicable stock exchange listing standards. On April 26, 2017, the Board adopted a policy providing
that, if the Company is required to prepare an accounting restatement due to material non-compliance with financial reporting
requirements under applicable securities laws, with respect to any cash bonus or other cash compensation paid or awarded, or equity-based
bonus or other equity-based incentive compensation that was exercised, vested or settled, within six months preceding such restatement,
and that was granted or earned or became vested based wholly or in part upon the attainment of any financial reporting measure,
if the recipient of such cash or equity-based bonus or other cash or equity-based incentive compensation engaged in fraud, intentional
misconduct, or gross negligence that caused or partially caused the need for the restatement, the Board generally may seek reimbursement
of any amount paid under an award in excess of what would have been paid had such error not been made.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Adjustment
Provisions</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
the outstanding shares of Common Stock are exchanged for a different number or kind of shares or other securities of the Company
or increased or decreased as a result of any recapitalization, reclassification, stock dividend, stock split or reverse stock
split, or additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed
with respect to such shares of Common Stock or other securities, an appropriate and proportionate adjustment will be made to (a)
the maximum number and kind of shares reserved for issuance under the Amended 2015 Stock Plan, (b) the maximum number of shares
that can be issued upon exercise of incentive stock options under the Amended 2015 Stock Plan, (c) the limitations on the number
of shares of Common Stock that may be delivered through awards granted to any person in any calendar year and the limitations
on awards granted to our non-employee directors, (d) the number and kind of shares or other securities subject to any then outstanding
awards under the Amended 2015 Stock Plan, and (e) the exercise or purchase prices (or base values) relating to awards and any
other provision of awards affected by such change, without (in the case of stock options or SARs) changing the aggregate exercise
price (or base values) for such awards. For example, on May 10, 2019, the Company effected the 1-for-20 Reverse Stock Split, which
resulted in appropriate and proportionate adjustments.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Change
in Control</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
the event of a corporate transaction (as defined in the Amended 2015 Stock Plan) in which awards are not assumed or substituted
by the acquiring or succeeding corporation (or an affiliate thereof), the Compensation Committee will provide for the accelerated
vesting or delivery of shares under awards and may provide for (a) the cash-out of outstanding awards or (b) the termination of
awards that are not exercised prior to the consummation of the transaction. In the event of a corporate transaction in which awards
are assumed or substituted by the acquiring or succeeding corporation (or an affiliate thereof), the Compensation Committee will
provide that such awards will continue in existence with appropriate adjustments or modifications. The performance-based vesting
of any award is determined based on the greater of (a) assumed achievement of the applicable performance goals at 100% of target
with the result prorated based on the period of the Participant&rsquo;s actual employment or service relationship with the Company
prior to the corporate transaction during the applicable full performance period, or (b) actual achievement of the applicable
performance goals through the date of the corporate transaction. Except as the Compensation Committee may otherwise provide in
any case, all awards will terminate automatically or, in the case of restricted stock, will be forfeited automatically upon the
consummation of a covered transaction other than awards that are assumed by the acquiring or succeeding corporation. In general,
a corporate transaction under the Amended 2015 Stock Plan means a consolidation, merger, combination or reorganization of the
Company, the sale, lease or other</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>60
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>


<!-- Field: Page; Sequence: 66 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">disposition
of all or substantially all of the assets of the Company, a transaction or series of related transactions involving a person or
entity, or a group of affiliated persons or entities in which such persons or entities become the owners, directly or indirectly,
of securities of the Company representing more than 50% of the combined voting power of the Company&rsquo;s then outstanding securities
other than by virtue of a merger, consolidation or similar transaction, or a dissolution or liquidation of the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Prohibition
on Repricing</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Except
in connection with certain corporate transactions involving the Company, the Company may not, without obtaining stockholder approval,
amend the terms of outstanding stock options or SARs to reduce the exercise price or base value of such awards, cancel outstanding
stock options or SARs in exchange for stock options or SARs with an exercise price or base value that is less than the exercise
price or base value applicable to the original award, or cancel outstanding stock options or SARs that have an exercise price
or base value greater than the closing price of a share of Common Stock on the date of such cancellation in exchange for cash
or other consideration.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Plan
Amendments and Termination</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Board may at any time, and from time to time, modify or amend the Amended 2015 Stock Plan in any respect, except that any such
modification or amendment will be subject to stockholder approval to the extent required by applicable tax or securities laws
or stock exchange listing requirements, and no such modification or amendment may adversely affect the rights under an award previously
granted to a participant without such participant&rsquo;s consent. The Compensation Committee may amend outstanding award agreements
only with the consent of the affected participant, except that the Administrator, without the consent of the affected participant,
may amend or modify the terms and provisions of the Amended 2015 Stock Plan and of any outstanding incentive stock options granted
under the Amended 2015 Stock Plan to the extent necessary to qualify any or all such stock options as incentive stock options
or to the extent necessary to ensure the qualification of the Amended 2015 Stock Plan under Rule 16b-3 (if then applicable) or
compliance with, or exemption from, Section 409A of the Code. The Board may at any time suspend or terminate the Amended 2015
Stock Plan except that any such suspension or termination may not adversely affect the rights under an award previously granted
to a participant while the Amended 2015 Stock Plan is in effect without the consent of the affected participant.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>FEDERAL
INCOME TAX CONSEQUENCES</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following is a summary of some of the material federal income tax consequences associated with the grant and exercise of awards
under the Amended 2015 Stock Plan under current federal tax laws and certain other tax considerations associated with awards under
the Amended 2015 Stock Plan. The summary does not address tax rates or non-U.S., state, or local tax consequences, nor does it
address employment tax or other federal tax consequences except as noted.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Restricted
Stock</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">A
participant who is awarded or purchases shares subject to a substantial risk of forfeiture generally does not have income until
the risk of forfeiture lapses. When the risk of forfeiture lapses, the participant has ordinary income equal to the excess of
the value of the shares at that time over the purchase price, if any, and a corresponding deduction is generally available to
the Company. However, a participant may make an election under Section 83(b) of the Code to be taxed on restricted stock when
it is acquired rather than later, when the substantial risk of forfeiture lapses. An 83(b) election must be made not later than
thirty (30) days after the transfer of the shares to the participant and must satisfy certain other requirements. A participant
who makes an effective 83(b) election will realize ordinary income equal to the value of the shares as of the time of acquisition
less any price paid for the shares. A corresponding deduction will generally be available to the Company. If a participant makes
an effective 83(b) election, no additional income results by reason of the lapsing of the restrictions.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">For
purposes of determining capital gain or loss on a sale of shares awarded under the Amended 2015 Stock Plan, the holding period
in the shares begins when the participant realizes taxable income with respect to the transfer. The participant&rsquo;s tax basis
in the shares equals the amount paid for the shares plus any income realized with respect to the transfer. However, if a participant
makes an effective 83(b) election and later forfeits the shares, the tax loss realized as a result of the forfeiture is limited
to the excess of what the participant paid for the shares (if anything) over the amount realized (if any) in connection with the
forfeiture.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>61</B></FONT></p>

<!-- Field: Page; Sequence: 67 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->




<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Incentive
Stock Options</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
general, a participant realizes no taxable income upon the grant or exercise of an incentive stock option. However, the exercise
of an incentive stock option may result in an alternative minimum tax liability to the participant. With some exceptions, a disposition
of shares purchased under an incentive stock option within two years from the date of grant or within one year after exercise
produces ordinary income to the participant (and generally a deduction to the Company) equal to the value of the shares at the
time of exercise less the exercise price. Any additional gain recognized on the disposition is treated as a capital gain, for
which the Company is not entitled to a deduction. If the participant does not dispose of the shares until after the expiration
of these one- and two-year holding periods, any gain or loss recognized upon a subsequent sale is treated as a long-term capital
gain or loss, for which the Company is not entitled to a deduction.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Non-statutory
Stock Options</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">In
general, a participant has no taxable income upon the grant of a non-statutory stock option but realizes income in connection
with exercise of the option in an amount equal to the excess (at time of exercise) of the value of the shares acquired upon exercise
over the exercise price. A corresponding deduction is generally available to the Company. Upon a subsequent sale or exchange of
the shares, any recognized gain or loss is treated as a capital gain or loss for which the Company is not entitled to a deduction.
An incentive stock option that is exercised more than three months after termination of employment (other than termination by
reason of death) is generally treated as a non-statutory stock option. Incentive stock options are also treated as non-statutory
stock options to the extent they first become exercisable by an individual in any calendar year for shares having a value (determined
as of the date of grant) in excess of $100,000.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>SARs</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
grant of a SAR does not itself result in taxable income, nor does taxable income result merely because a SAR becomes exercisable.
In general, a participant who exercises a SAR for shares of stock or receives payment in cancellation of a SAR will have ordinary
income equal to the amount of any cash and the value of any stock received. A corresponding deduction is generally available to
the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Restricted
Stock Units</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
grant of an RSU does not itself result in taxable income. Instead, the participant is taxed upon delivery of the underlying shares
(and a corresponding deduction is generally available to the Company). If the shares delivered are restricted for tax purposes,
the participant will be subject to the rules described above for restricted stock.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Section
162(m)</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Section
162(m) limits to $1 million the amount a company may deduct for compensation paid to certain current and former executive officers,
subject to limited exceptions.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 13pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B><I>Certain
Change in Control Payments</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Under
Section 280G of the Code, the vesting or accelerated exercisability of stock options or the vesting and payment of other awards
in connection with a change in control of a corporation may be required to be valued and taken into account in determining whether
participants have received compensatory payments contingent on the change in control in excess of certain limits. If these limits
are exceeded, a substantial portion of amounts payable to the participant, including income recognized by reason of the grant,
vesting or exercise of awards, may be subject to an additional 20% federal tax and may be non-deductible to the Company.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>NEW
PLAN BENEFITS</B></FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">No
awards under the Amended 2015 Stock Plan have been granted to date. Because future awards under the Amended 2015 Stock Plan will
be granted in the discretion of the Compensation Committee, the type, number, recipients, and other terms of such awards cannot
be determined at this time.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>62
<FONT STYLE="color: #005695">| </FONT>ir.novavax.com</B></FONT></p>

<!-- Field: Page; Sequence: 68 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: rgb(72,108,147) 1pt solid; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table sets forth the awards that were granted to our Named Executive Officers, our executive officers as a group, our
non-employee directors as a group, and our other employees (who are not executive officers) as a group under the 2015 Stock Plan
during 2020. The number of performance-based stock options and RSUs listed in the table below is based on the performance condition
being satisfied in full.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Name
    and Position</B></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Time-Vesting</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Stock Options</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Performance-</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Vesting Stock</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options (Assuming</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>all Performance</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Conditions Achieved)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Time-Vesting&nbsp;&nbsp;&nbsp;</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>RSUs</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid; vertical-align: bottom"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Performance-</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Vesting RSUs</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 48%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Stanley
    C. Erck, <I>President and CEO</I></FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">41,700</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">400,000</FONT></TD>
    <TD STYLE="width: 4%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">20,900</FONT></TD>
    <TD STYLE="width: 4%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Gregory
    F. Covino, <I>Former EVP,</I></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><I>Chief
    Financial Officer and Treasurer</I></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">8,200</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">7,300</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Gregory
    M. Glenn, M.D., <I>President,</I></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><I>Research
    and Development</I></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">18,700</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">165,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">9,300</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    J. Trizzino, EVP, <I>Chief Commercial Officer,</I></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><I>Chief
    Business Officer and Interim</I></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><I>Chief
    Financial Officer</I></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">9,500</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">140,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">7,300</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">John
    A. Herrmann III, EVP, <I>Chief Legal</I></FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20"><I>Officer
    and Corporate Secretary</I></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">12,700</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">125,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">8,800</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Executive
    Group</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">90,800</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">830,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">53,600</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Non-Executive
    Director Group</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">70,580</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">41,390</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Non-Executive
    Officer&nbsp;&nbsp;Employee Group</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,372,386</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">742,906</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>EQUITY
COMPENSATION PLAN INFORMATION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table provides information about the Common Stock authorized for issuance under our equity compensation plans as of
December 31, 2020. See also the information regarding stock options in Note 13 to the Company&rsquo;s consolidated financial statements
for the year ended December 31, 2020, included in the Company&rsquo;s Annual Report on Form 10-K filed with the SEC on March 1,
2021.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 11pt">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 10pt; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Plan
    Category</B></FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities to</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>be Issued Upon</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Exercise of</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options,</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Warrants, and</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Rights (a)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Weighted-Average</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Exercise Price</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>of Outstanding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Options, Warrants,</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>and Rights (b)</B></FONT></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Number
    of</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Remaining</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Available for</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Future Issuance</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Under Equity</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Compensation</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Plans (Excluding</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Securities in</B></FONT><BR>
    <FONT STYLE="font-size: 9pt; color: #231F20"><B>Column (a)) (c)</B></FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 61%; border-bottom: #888A8C 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    compensation plans approved by security holders</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">6,679,629</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">$39.96</FONT></TD>
    <TD STYLE="width: 4%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 7%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,729,512</FONT></TD>
    <TD STYLE="width: 2%; border-bottom: #888A8C 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Equity
    compensation plans not approved by security holders</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #486C93 1pt solid; padding-left: 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">Total</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">6,679,629</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">$39.96</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9.5pt; color: #231F20">2,729,512</FONT></TD>
    <TD STYLE="border-bottom: #486C93 1pt solid; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consists
                                         of the 2015 Stock Plan, 2005 Stock Plan, and ESPP. The 2005 Stock Plan terminated pursuant
                                         to its terms on February 23, 2015 and no further awards will be made pursuant to that
                                         plan. The weighted-average exercise price in column (b) excludes RSUs, which are not
                                         subject to an exercise price.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 11pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>REQUIRED
VOTE</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #496D93"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Approval
of the Amended 2015 Stock Plan requires the affirmative vote of the holders of a majority of the shares of Common Stock present
in person or represented by proxy and voting on the matter. Abstentions and broker non-votes will not be counted as shares voting
on this matter and accordingly will have no effect on the approval of this Proposal 3.</FONT></P>

<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="vertical-align: top; width: 5%; border-top: #005695 1pt solid; border-bottom: #005695 1pt solid; border-left: #005695 1pt solid; padding: 5.4pt; font-size: 10pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><img src="tm212692d3_sch14-aimg129.jpg" alt=""></FONT></td>
    <td style="width: 95%; border-top: #005695 1pt solid; border-right: #005695 1pt solid; border-bottom: #005695 1pt solid; padding: 5.4pt; font-size: 10pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>For
    Proposal 3, the Board recommends that stockholders vote </B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93">FOR
    </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">the adoption of the Amended 2015 Stock
    Plan to increase the number of shares available for issuance thereunder by 1,500,000 shares.</FONT></B></td></tr>
</table>
<P STYLE="font: 9.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; color: #231F20"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>
<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"></P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: Red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <FONT STYLE="color: #005695">|</FONT> <B>63</B></FONT></p>

<!-- Field: Page; Sequence: 69 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->




<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: rgb(73,109,147)"><B><A NAME="a031"></A>PROPOSALS
4 AND 5</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><A NAME="a032"></A>&mdash;RATIFICATION OF CERTAIN APRIL
2020 EQUITY AWARDS AND RATIFICATION OF CERTAIN JUNE 2020 EQUITY AWARDS</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
Novavax Board of Directors seeks stockholder approval of resolutions ratifying two sets of equity awards made in April 2020 and
June 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Prior
to voting on Proposals 4 and 5 and to provide stockholders full transparency of any challenges to the ratification of Proposals
4 and 5, below is a summary of a derivative action filed by Thomas Golubinski, a Novavax stockholder. Mr. Golubinski has brought
a purported derivative action in the Delaware Court of Chancery challenging the grants approved by the Board of Directors described
below<SUP>1</SUP>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Through
the derivative action, Mr. Golubinski seeks to rescind or collect damages on behalf of the Company with respect to (1) certain
equity awards granted in April 2020 and (2) certain equity awards granted in June 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">A
copy of Mr. Golubinski&rsquo;s complaint is attached as Appendix B to this Proxy Statement (the &ldquo;Complaint&rdquo;). Stockholders
should read the Complaint in its entirety to understand fully Mr. Golubinski&rsquo;s allegations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: rgb(73,109,147)"><B>SUMMARY
OF DERIVATIVE ACTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Mr.
Golubinski provided a brokerage statement indicating that, as of September 30, 2020, he owned 392 shares of Common Stock. As of
the Record Date, there were 74,080,008 shares of Common Stock outstanding. If Mr. Golubinski continued to hold 392 shares as of
the Record Date, his position represented ownership of approximately 0.0005% of the Company&rsquo;s outstanding shares. The ratification
proposals detailed below provide stockholders holding over 99.99% of the outstanding Common Stock as of the Record Date the opportunity
to ratify the challenged equity awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">If
a majority of (1) the votes present in person virtually or represented by proxy at the Annual Meeting and voting on a ratification
proposal, and (2) the disinterested votes, meaning the votes cast by stockholders who did not receive the relevant equity awards,
present in person virtually or represented by proxy at the Annual Meeting and voting on a ratification proposal, vote in favor
of either of the resolutions ratifying the equity awards granted in April 2020 or in June 2020, the Company intends to seek dismissal
of some or all of Mr. Golubinski&rsquo;s Complaint on the grounds that one set or both sets of the equity awards have been ratified
by the Company&rsquo;s stockholders and Mr. Golubinski&rsquo;s Complaint fails as a matter of law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
portions of the discussion below that summarize Mr. Golubinski&rsquo;s allegations are qualified in their entirety by reference
to the Complaint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: rgb(73,109,147)"><B>APRIL
2020 AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">As
discussed in the Compensation Discussion and Analysis section of this Proxy Statement under the sub-sections titled &ldquo;2020
Performance Highlights&rdquo; and &ldquo;2020 Pay Decisions&rdquo; beginning on page 31 of this Proxy Statement, Novavax faced
substantial challenges in early 2020. When the COVID-19 pandemic hit, Novavax decided to launch a COVID-19 vaccine development
program-despite its limited resources at the time-in an effort to turn the Company&rsquo;s prospects around.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
March 11, 2020, Novavax announced (1) it had been awarded initial funding of $4 million from the Coalition for Epidemic Preparedness
Innovations (&ldquo;CEPI&rdquo;) to facilitate the development of a vaccine for a new strain of the coronavirus (&ldquo;COVID-19&rdquo;)
in preparation for potential future clinical trials; and (2) a subsequent CEPI award may be available to cover the Company&rsquo;s
program expenditures through Phase 1 clinical trial results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">A
                                         derivative action is a lawsuit brought by a stockholder of a corporation on the corporation&rsquo;s
                                         behalf to enforce or defend a legal right or claim of the corporation. Mr. Golubinski&rsquo;s
                                         derivative action is styled Thomas Golubinski v. Richard H. Douglas, et al., C.A. No.
                                         2021-0172-JRS (Del. Ch.).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>64</B>&nbsp;<B>|
ir.novavax.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 70 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">At
meetings held on April 17 and April 18, 2020, the Compensation Committee approved equity-based awards covering 2,827,650 shares
to employees, including certain members of senior management, in the U.S. and Sweden in recognition of the extraordinary work
of Novavax employees to implement a new vaccine program against SARS-CoV-2 and to incentivize the additional work necessary to
make the program successful. We refer to those grants as the &ldquo;April 2020 Awards.&rdquo; The Board ratified the Compensation
Committee&rsquo;s decision by unanimous written consent dated April 20, 2020. We refer to the April 2020 Awards made to certain
members of senior management (which are detailed below) as the &ldquo;Challenged April 2020 Awards,&rdquo; as those are the awards
challenged in the Complaint. The Challenged April 2020 Awards were performance-vesting options to purchase shares of Common Stock.
The remaining April 2020 Awards were (1) performance-vesting options to purchase shares of Common Stock granted to (a) certain
other members of senior management and (b) employees in Sweden, none of whom is an executive officer; and (2) performance-vesting
restricted stock units granted to employees in the United States who did not receive options. Each April 2020 Award vests as to
50% of the shares underlying the award on the first anniversary of the initiation of a Phase 2 clinical trial of the Company&rsquo;s
vaccine candidate against SARS-CoV-2 (which occurred when Novavax initiated its Phase 2 clinical trial of NVX-CoV2373 in the United
States on August 24, 2020), and as to the remaining 50% of the shares underlying the award on the second anniversary of the initiation
of such trial, in each case generally subject to the individual&rsquo;s continued employment with the Company through the applicable
vesting date. The per-share exercise price of the April 2020 Awards granted in the form of stock options is $19.08, which, as
required by the 2015 Stock Plan, is equal to the last reported sale price of our Common Stock as of the date of the grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
following tables set forth the recipients and amounts of the April 2020 Awards, including the Challenged April 2020 Awards:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Challenged
    April 2020 Awards</I></B></FONT></TD>
    <TD STYLE="width: 40%; text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 40%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Performance-Vesting</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name
    and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Options</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stanley C. Erck</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>President, Chief Executive Officer and Director</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">400,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John J. Trizzino</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>SVP, Chief Business Officer and Chief Financial
    Officer</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">140,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory M. Glenn, M.D.</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>President, Research and Development</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">165,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>SVP, General Counsel and Corporate Secretary</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Brian Rosen</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>SVP, Commercial Strategy</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">115,000</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Remaining
April 2020 Awards (Options)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="vertical-align: top; padding-left: 5.4pt; width: 59%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; width: 41%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of Performance-</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 5.4pt; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name
    and Position on Date of Award</B></FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Vesting
    Options</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; padding-left: 5.4pt; border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Employee
    Group [n=60]</FONT></TD>
    <TD STYLE="vertical-align: top; text-align: center; border-bottom: rgb(0,61,165) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1,556,600</FONT></TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 59%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Remaining April 2020 Awards
    (RSUs)</I></B></FONT></TD>
    <TD STYLE="text-align: center; width: 41%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Number of Performance-</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Name and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Vesting Restricted Stock Units</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Employee Group [n=104]</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">326,050</FONT></TD></TR>
<TR>
    <TD STYLE="width: 59%; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 41%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 1pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
values below for each April 2020 Award category were calculated in accordance with Financial Accounting Standards Board Accounting
Standards Codification Topic 718, Stock Compensation (&ldquo;FASB ASC Topic 718&rdquo;) using a measurement date of June 25, 2020,
because the April 2020 Awards were conditioned upon Novavax stockholders</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <B>| 65</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<!-- Field: Split-Segment; Name: 6 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">approving
an amendment and restatement of the 2015 Stock Plan, which occurred on June 25, 2020 (as discussed further below):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 75%; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>FASB
    ASC Topic 718 Value</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Award
    Category</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>($)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Challenged
    April 2020 Awards</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stanley C. Erck</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31,664,800</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John J. Trizzino</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">11,082,680</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory M. Glenn, M.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">13,061,730</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-size: 3pt">&nbsp;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;9,895,250</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Brian Rosen</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;9,103,630</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    April 2020 Awards (Options)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid">&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">123,149,948&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    April 2020 Awards (RSUs)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">27,238,217</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
FASB ASC Topic 718 values for the option awards were calculated using the Black-Scholes option pricing model. Assumptions used
in the calculation of this amount are included in Note 10 to Novavax&rsquo;s Quarterly Report on Form 10-Q for the quarterly period
ended June 30, 2020 filed with the SEC on August 10, 2020. For accounting purposes, the April 2020 Awards had a measurement date
of June 25, 2020, because the awards were conditioned on stockholders approving an increase in shares available under the equity
plan. That approval was obtained at the 2020 Annual Stockholder Meeting on June 25, 2020. Applying the same methodology, but using
a measurement date of April 17, 2020, which is the date the Compensation Committee approved the April 2020 Awards, yields substantially
lower calculated values, as illustrated by the following table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 75%; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Unaudited
    Value</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Calculation if Measured
    as</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>of April 17, 2020</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Award Category</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>($)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Challenged
    April 2020 Awards</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stanley C. Erck</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,550,600</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John J. Trizzino</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,292,710</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory M. Glenn, M.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,702,123</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,047,063</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Brian Rosen</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1,883,298</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    April 2020 Awards (Options)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">25,462,920&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    April 2020 Awards (RSUs)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,221,034</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
figures in the table above are illustrative only. These figures differ from the FASB ASC Topic 718 Values in the prior table primarily
due to the 378% increase in the market price of Novavax common stock from April 17, 2020 (when it closed at $19.08 per share)
to June 25, 2020 (when it closed at $83.54 per share).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
May 11, 2020, 23 days after the Compensation Committee&rsquo;s April 18 meeting approving the grant of the April 2020 Awards and
21 days after the Board ratified the Compensation Committee&rsquo;s decision, Novavax entered into a $384 million restated funding
agreement with CEPI. That afternoon, Novavax issued a press release announcing the restated funding agreement with CEPI. We encourage
stockholders to read the Current Report on Form 8-K Novavax filed with the SEC on May 15, 2020, which contains a summary of the
restated funding agreement, as well as the redacted version of the restated funding agreement filed as Exhibit 10.1 to the Novavax
Quarterly Report on Form 10-Q filed with the SEC on August 10, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
May 12, 2020, the market price of a share of Common Stock closed at $39.82, an increase of $15.32 from the closing price of $24.50
on May 11, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>The
Complaint and Dispute</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Mr.
Golubinski&rsquo;s Complaint alleges the Challenged April 2020 Awards were unlawful because Novavax had not publicly disclosed
 &ldquo;its total request for funding or the timeline of its continued negotiations&rdquo; with CEPI and because &ldquo;it is likely</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>66</B>&nbsp;<B>|
ir.novavax.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">that
the Board knew that CEPI intended to make further investments, and it had an idea of the amount and timeline of the second CEPI
investment when it&rdquo; made the Challenged April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">In
addition, the Complaint alleges the directors breached their fiduciary duties and committed waste when granting the Challenged
April 2020 Awards. The Complaint further alleges that the Challenged April 2020 Awards were &ldquo;spring-loaded,&rdquo; meaning
they were granted prior to the release of material information reasonably expected to result in an increase in the market price
of Novavax shares, and that the recipients of those awards breached their fiduciary duties in accepting the awards and were unjustly
enriched by the awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
individuals named as defendants in the Complaint dispute those allegations. Among other things, they note that in its Annual Report
on Form 10-K filed on March 11, 2020, Novavax disclosed: &ldquo;In March 2020, the Company was awarded initial funding of $4 million
from CEPI to facilitate its development of a vaccine for a new strain of the coronavirus (&lsquo;COVID-19&rsquo;) in preparation
for potential future clinical trials. A subsequent CEPI award may be available to cover the Company&rsquo;s program expenditures
through Phase 1 clinical trial results.&rdquo; In a press release issued the same day, the Company disclosed: &ldquo;Novavax recently
announced that [CEPI] awarded an initial funding of $4 million to support its effort to develop a COVID-19 vaccine. CEPI and Novavax
are having ongoing discussions on additional funding from CEPI to address Novavax&rsquo;s costs through Phase 1.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
March 11, 2020, during the Company&rsquo;s quarterly earnings call, Novavax Chief Financial Officer John Trizzino stated: &ldquo;We
do expect additional funding from CEPI to support activities through Phase I clinical trials.&rdquo; On April 8, 2020, Novavax
issued a press release again disclosing: &ldquo;[I]n March [CEPI] awarded an initial funding of $4 million to support Novavax&rsquo;s
efforts, with additional funding discussions ongoing.&rdquo; The individuals named as defendants acknowledge that, at the time
of the Challenged April 2020 Awards, Novavax management was optimistic that a restated funding agreement would be reached with
CEPI, and Novavax was seeking to obtain a restated funding commitment that was as large as possible and as quickly as possible.
The individuals named as defendants contend that, at the time of the Challenged April 2020 Awards, discussions with CEPI were
ongoing; however, an agreement on aggregate funding had not been finalized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">As
previously disclosed in the Company&rsquo;s Schedule 14A filed on May 13, 2020, the April 2020 Awards were conditioned upon Novavax
stockholders approving an amendment and restatement of the 2015 Stock Plan to (1) increase the individual award and director limits
under the plan; and (2) increase the number of shares of Common Stock available for issuance under the 2015 Stock Plan. At the
2020 Annual Meeting of Stockholders, held on June 25, 2020 (the &ldquo;2020 Annual Meeting&rdquo;), Novavax stockholders approved
the amendment and restatement of the 2015 Stock Plan, satisfying the stockholder approval condition applicable to the Challenged
April 2020 Awards. The results of the stockholder vote were disclosed in the Company&rsquo;s Current Report on Form 8-K filed
on June 26, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt; color: rgb(73,109,147)"><B>JUNE
2020 AWARDS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">At
a meeting on April 17, 2020, the Compensation Committee resolved that future director awards would occur on an annual cycle on
the date of each annual stockholder meeting, starting at the 2020 Annual Meeting to take place on June 25, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
June 25, 2020, following the 2020 Annual Meeting, the Compensation Committee granted options to purchase shares of Common Stock
and time-vesting restricted stock units to the non-employee directors then in office, other than to Dr. Modi (who has not received
compensation for Board service since he joined the Board). In addition, on June 25, 2020, the Compensation Committee also granted
time-vesting restricted stock units to two executive officers and seven non-executive employees, as well as a time-vesting option
to purchase shares of Common Stock to a non-executive employee. We refer to these awards collectively as the &ldquo;June 2020
Awards&rdquo; and to the awards made to our non-employee directors and our executive officers as the &ldquo;Challenged June 2020
Awards.&rdquo; The options and time-vesting restricted stock units granted to the non-employee directors on June 25, 2020 vest
as to 100% of the underlying shares on the first anniversary of the grant date, generally subject to the non-employee director&rsquo;s
continued service on the Board through such date (and expected to be accelerated if the next annual meeting occurs within a few
weeks prior to that first anniversary if the director&rsquo;s final term ends at that next annual meeting). The time-vesting restricted
stock units granted to our executive officers and employees on June 25, 2020 vest as to one-third of the underlying shares on each
of the first three anniversaries of the grant date, generally subject to the individual&rsquo;s continued employment through the
applicable vesting date. Each option granted to a non-executive employee vests as to one-fourth of the underlying shares on the
first anniversary of the grant date and as to the remaining three-fourths of the underlying shares in equal monthly installments
for 36 months thereafter, generally subject to the individual&rsquo;s continued employment through the applicable vesting date.
The per-share exercise price of each option granted in the June 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <B>| 67</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<!-- Field: Page; Sequence: 73 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Awards
is $83.54, which, as required by the 2015 Stock Plan, which is equal to the last reported sale price of Common Stock on the date
of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
Challenged June 2020 Awards granted to non-employee directors were annual awards for director service. The Challenged June 2020
Awards granted to our executives reflected the promotion of each of Messrs. Trizzino and Herrmann to Executive Vice President.
The following table sets forth the recipients and amounts of the June 2020 Awards, including the Challenged June 2020 Awards:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Challenged
June 2020 Awards (Options)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of Time-</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Vesting Options</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Director Group</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard H. Douglas, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary C. Evans</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel K. King</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Gray 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">David M. Mott</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">4,400</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James Young, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">15,180&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Challenged
June 2020 Awards (RSUs)</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of Time-</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Vesting Restricted</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Stock Units</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John J. Trizzino</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>SVP, Chief Business Officer and Chief Financial
    Officer</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,500</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>SVP, General Counsel and Corporate Secretary</I></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,500</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Director Group</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard H. Douglas, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary C. Evans</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel K. King</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James Young, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">7,590</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
Challenged June 2020 Awards were promptly disclosed in Form 4s filed on June 26, 2020 and June 29, 2020, consistent with Novavax&rsquo;s
past practice .</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Remaining June 2020
    Awards (Options)</I></B></FONT></TD>
    <TD STYLE="width: 34%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name
    and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Time-Vesting
    Options</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Employee Group [n=1]</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">20,000</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>Remaining June 2020 Awards
    (RSUs)</I></B></FONT></TD>
    <TD STYLE="text-align: center; width: 40%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 20%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Number
    of</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Time-Vesting Restricted</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name and Position on Date of Award</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Stock Units</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(73,109,147) 1pt solid; padding-left: 0.125in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Non-Executive Employee Group [n=7]</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">22,300</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>68</B>&nbsp;<B>|
ir.novavax.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 74 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt; color: Gray"><B>Executive
Officers and Compensation</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(73,109,147) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
values below for each June 2020 Award category were calculated in accordance with FASB ASC Topic 718 using a measurement date
of June 25, 2020:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>FASB
    ASC Topic 718 Value</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Award Category</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>($)</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Challenged
    June 2020 Awards (Options)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard H. Douglas, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">515,767</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary C. Evans</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">515,767</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel K. King</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">515,767</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">515,767</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">David M. Mott</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">328,895</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James Young, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1,134,687</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Challenged
    June 2020 Awards (RSUs)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John J. Trizzino</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">208,850</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">208,850</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Non-Executive
    Director Group</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard H. Douglas, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">288,213</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary C. Evans</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">288,213</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel K. King</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">288,213</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael A. McManus, Jr., J.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">288,213</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James Young, Ph.D.</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">634,069</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    June 2020 Awards (Options)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1,472,886</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.125in; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Remaining
    June 2020 Awards (RSUs)</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(73,109,147) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1,862,942</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
FASB ASC Topic 718 values for the option awards were calculated using the Black-Scholes option pricing model. Assumptions used
in the calculation of this amount are included in Note 10 to Novavax&rsquo;s Quarterly Report on Form 10-Q for the quarterly period
ended June 30, 2020 filed with the SEC on August 10, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
July 6, 2020, Novavax entered into an arrangement with the U.S. federal government contemplating $1.6 billion in funding to support
certain activities related to the development of NVX-CoV2373, including the manufacture and delivery to the U.S. government of
100 million doses of NVX-CoV2373. (The arrangement subsequently has been amended to contemplate up to $1.75 billion in funding.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">On
July 7, 2020, Novavax issued a press release announcing the contemplated $1.6 billion funding arrangement and Novavax filed a
Form 8-K with the SEC on July 10, 2020 containing a summary of the arrangement. Redacted versions of the base agreement and project
agreement, as well as the first modification thereto, were subsequently filed by Novavax as Exhibits 10.1, 10.2, and 10.3, respectively,
to the Novavax Quarterly Report on Form 10-Q filed with the SEC on November 10, 2020. (Additional modifications were filed by
Novavax as Exhibits 10.41, 10.42, 10.43, 10.44 and 10.45 to the Novavax Annual Report on Form 10-K filed with the SEC on March
1, 2021.)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
market price of Common Stock closed at $107.56 on July 7, 2020, an increase of $25.12 from the closing price of $79.44 on July
6, 2020. The stock price subsequently declined to $85.31 on September 8, 2020, closed at $80.71 on October 30, 2020, and closed
at $78.74 on November 10, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT <B>| 69</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 75 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 13pt"><B><I>The
Complaint and Dispute</I></B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Mr.
Golubinski&rsquo;s Complaint alleges the Challenged June 2020 Awards were improper because Novavax did not publicly disclose its
 &ldquo;ongoing effort to obtain funding from BARDA.&rdquo; According to the Complaint, the directors breached their fiduciary
duties and committed waste when granting the Challenged June 2020 Awards. The Complaint further alleges the Challenged June 2020
Awards were &ldquo;spring-loaded&rdquo; and the recipients of those awards were unjustly enriched.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
individuals named as defendants in the Complaint dispute those allegations. They acknowledge that, as of June 25, 2020,
Novavax was in discussions with the U.S. government program that was then called &ldquo;Operation Warp Speed&rdquo; regarding
a Statement of Work for potential funding in the near-term. They also acknowledge that Novavax understood it had been
selected as a candidate for Operation Warp Speed funding, and management was optimistic that the aggregate amount of such
funding would exceed $1 billion. They note that considerable media and analyst attention was given to the Company&rsquo;s
efforts to obtain U.S. government funding prior to the June 2020 Awards and the Company had disclosed efforts to obtain such
funding. At a highly publicized meeting at the White House on March 2, 2020, for example, Mr. Erck told then-President Trump:
 &ldquo;Frankly, we need money. We&rsquo;re a biotech company, and not one of the larger pharma companies, so we need money to
get scale.&rdquo; On June 4, 2020, after Novavax announced a $60 million contract with the U.S. Department of Defense to
support the manufacturing of NVX-CoV2373, an equity analyst from Cantor Fitzgerald published a report noting that Cantor
Fitzgerald &ldquo;anticipated additional funding from government organizations&rdquo; for Novavax, &ldquo;although [Novavax]
was not part of the &lsquo;unofficial&rsquo; list of 5 &lsquo;finalists&rsquo; for Operation Warp Speed.&rdquo; On June 8,
2020, also referencing Novavax&rsquo;s $60 million contract with the Department of Defense, an equity analyst from B. Riley
FBR published a report noting that &ldquo;this development further strengthens our conviction in a sizeable funding to be
secured from U.S. BARDA.&rdquo; They also note that (1) the date for the annual director equity awards had been set on April
17, 2020, while the first press reports regarding Operation Warp Speed appeared on April 29, 2020, and Operation Warp Speed
was officially announced on May 15, 2020, (2) the Company&rsquo;s Annual Report on Form 10-K filed on March 11, 2020, stated:
 &ldquo;We anticipate seeking &hellip; additional funds through a combination of public or private equity or debt
financings, as well as potential collaborations, strategic alliances and marketing, distribution or licensing arrangements
and non-dilutive funding from governmental and non-governmental funding entities, as well as other sources,&rdquo; and (3)
the Company&rsquo;s Quarterly Report on Form 10-Q filed on May 11, 2020, stated: &ldquo;We are seeking significant funding to
support the development and manufacture of NVX-CoV2373. Various government entities and private foundations are offering
incentives, grants and contracts to encourage additional investment by commercial organizations into preventative and
therapeutic agents against COVID-19&hellip;.&rdquo;The individuals named as defendants in the Complaint contend that, at the
time of the June 2020 Awards, discussions with Operation Warp Speed were ongoing, and an agreement on aggregate funding had
not been finalized.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><B>STOCK
VOLATILITY</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Company&rsquo;s Common Stock has experienced substantial volatility since the beginning of the COVID-19 pandemic. Below is a
stock price chart during 2020:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt; color: Red"><IMG SRC="tm212692d3_sch14-aimg130.jpg" ALT=""></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Volatility
has continued during 2021, with a closing price low of $112.98 per share on January 4, 2021, and a closing price high of $319.93 per
share on February 8, 2021. On April 30, 2021, the closing price of Common Stock was $236.93 per
share.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>70
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 76 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Executive
Officers and Compensation</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">All
of the equity grants included in both the Challenged April 2020 Awards and the Challenged June 2020 Awards require that a minimum
of at least one year pass before any portion of an award vests (subject to potential accelerated vesting of a non-employee director&rsquo;s
award if such director&rsquo;s final term ends at the 2021 Annual Stockholders Meeting, which will occur eight days prior to the
anniversary of the 2020 Annual Stockholders Meeting).</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><B>PURPOSE
OF RESOLUTION</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Board of Directors, not including those directors recusing themselves as specified below (the &ldquo;Recused Directors&rdquo;),
is seeking stockholder ratification of each of the April 2020 Awards and the June 2020 Awards because it does not believe further
prosecution of the action is in the best interests of the Company, and seeks stockholder input regarding that determination. The
individuals named as defendants dispute the allegations that the April 2020 Awards and the June 2020 Awards were spring-loaded,
and they deny that they breached their fiduciary duties in granting or accepting them. The individuals named as defendants also
dispute the allegations that the April 2020 Awards and the June 2020 Awards constituted corporate waste or unjustly enriched the
recipients. The Board, not including the Recused Directors, believes that the litigation could take years to resolve, and that
continued uncertainty associated with the litigation will reduce the incentive value of the April 2020 Awards and the June 2020
Awards. The Board, not including the Recused Directors, also believes that the legal fees, distraction and disruption associated
with continued litigation will have a negative impact on the Company at a time when the Company&rsquo;s financial resources and
management time and attention would be best spent completing clinical development, scaling up manufacturing, and seeking regulatory
approvals for NVX-CoV2373, as well as pursuing the Company&rsquo;s other efforts to maximize value for its stockholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If
a majority of (1) the votes present in person virtually or represented by proxy at the Annual Meeting and voting on a ratification
proposal, and (2) the disinterested votes, meaning the votes cast by stockholders who did not receive the relevant equity awards,
present in person virtually or represented by proxy at the Annual Meeting and voting on a ratification proposal, vote in favor
of the resolution ratifying the April 2020 Awards or the resolution ratifying the June 2020 Awards, the Company intends to seek
dismissal of part or all of Mr. Golubinski&rsquo;s Complaint on the grounds that the Challenged April 2020 Awards and/or the Challenged
June 2020 Awards have been ratified by the Company&rsquo;s stockholders and that the Complaint therefore fails as a matter of
law.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
director and executive defendants reserve the right to, and Novavax currently expects they will, continue to dispute the allegations
in the Complaint regardless of the outcome of the vote on either proposal. The Board, not including the Recused Directors, is
seeking ratification of all April 2020 Awards and June 2020 Awards, rather than only the Challenged April 2020 Awards and the
Challenged June 2020 Awards, to minimize the risk that a subsequent suit will seek to challenge the grants to rank-and-file employees
based on similar theories.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Approval
of the ratification of each of the April 2020 Awards and the June 2020 Awards requires the affirmative vote of a majority of the
votes cast and a majority of the disinterested votes cast on the proposal.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 14pt"><B>BOARD
RECOMMENDATION REGARDING PROPOSAL 4 AND PROPOSAL 5</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #F2F2F2"><TD STYLE="vertical-align: top; width: 7%; border-top: #005695 1pt solid; border-bottom: #005695 1pt solid; border-left: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg131.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 93%; border-top: #005695 1pt solid; border-right: #005695 1pt solid; border-bottom: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 3pt; padding-right: 10.5pt; padding-bottom: 3pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><B>The
Board recommends you vote </B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B>FOR</B></FONT>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><B>ratification of the April 2020 Awards.</B></FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Directors
Alton, McGlynn, and Mott recused themselves from the Board vote making this recommendation because they were not on the Board
of Directors at the time of the April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #F2F2F2"><TD STYLE="vertical-align: top; width: 7%; border-top: #005695 1pt solid; border-bottom: #005695 1pt solid; border-left: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg131.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 93%; border-top: #005695 1pt solid; border-right: #005695 1pt solid; border-bottom: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 3pt; padding-right: 10.5pt; padding-bottom: 3pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><B>The
Board recommends you vote </B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93">FOR</FONT></B><B>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">ratification of the June 2020 Awards.</FONT></B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Directors
Alton and McGlynn recused themselves from the Board vote making this recommendation because neither was on the Board at the time
of the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">71</FONT></B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>


<!-- Field: Page; Sequence: 77 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->






<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 26%; background-color: #005695; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b><a name="a033"></a>AUDIT
    MATTERS</b></font></td>
    <td style="width: 74%; padding-top: 12pt; padding-bottom: 12pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: white; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: #496D93"><B>Proposal
6</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt; color: #231F20"><A NAME="a034"></A>&mdash;Ratification of
the Appointment of Ernst &amp; Young LLP as the Company&rsquo;s Independent Registered Public Accounting Firm for the Fiscal Year
Ending December 31, 2021</FONT></B></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
Audit Committee, comprised solely of independent directors, has appointed the firm Ernst &amp; Young LLP as the Company&rsquo;s
independent registered public accounting firm for the fiscal year ending December 31, 2021. The Board recommends the stockholders
of the Company ratify this appointment. Although ratification is not required by the Company&rsquo;s By-Laws or otherwise, the
Company believes it is advisable to give stockholders an opportunity to ratify this selection.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
affirmative vote of the majority of the shares present in person virtually or represented by proxy at the Annual Meeting and voting
on this proposal shall constitute ratification of the appointment of Ernst &amp; Young LLP. If the appointment of Ernst &amp;
Young LLP as the Company&rsquo;s independent auditor is ratified, the Audit Committee may, in its discretion, change the appointment
at any time during the year should it determine such a change would be in the best interest of the Company and its stockholders.
If the stockholders, however, do not ratify the appointment, the Audit Committee will reconsider whether to retain Ernst &amp;
Young LLP, but may proceed with the retention of Ernst &amp; Young LLP if it deems it to be in the best interest of the Company
and its stockholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Representatives
of Ernst &amp; Young LLP are expected to be present at the Annual Meeting and will have an opportunity to address the Annual Meeting
if they desire to do so. They will also be available to respond to appropriate questions from stockholders.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<TR STYLE="background-color: #F2F2F2"><TD STYLE="vertical-align: top; width: 7%; border-top: #005695 1pt solid; border-bottom: #005695 1pt solid; border-left: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 5pt; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg131.jpg" ALT="">&nbsp;</TD>
    <TD STYLE="width: 93%; border-top: #005695 1pt solid; border-right: #005695 1pt solid; border-bottom: #005695 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; padding-top: 3pt; padding-right: 10.5pt; padding-bottom: 3pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>The
    Board recommends you vote </B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93">FOR</FONT></B><B>
    <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">the ratification of the appointment
    of Ernst &amp; Young LLP as the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December
    31, 2021.</FONT></B></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><B><A NAME="a035"></A>Fees
and Services</B></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table shows the fees billed by Ernst &amp; Young LLP for professional services rendered as the Company&rsquo;s independent
registered public accounting firm during the 2020 and 2019 fiscal years.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Fiscal
    Year Ending December 31,</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 70%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 15%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>2020</B></FONT></TD>
    <TD STYLE="width: 15%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>2019</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>E&amp;Y
    Fee Category</B></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>($)</B></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>($)</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Audit
    fees</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 23pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">2,447,357</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 30pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">735,908</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Audit-related
    fees</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 23pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">171,396</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 30pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Tax
    fees</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 23pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">1,100,435</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 30pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">79,247</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">All
    other fees</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 23pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-right: 30pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Total
    fees</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-right: 23pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">3,719,188</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-right: 30pt; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">815,155</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B><I>Audit
fees. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">Consists of fees for professional
services rendered in connection with the audit of the Company&rsquo;s annual consolidated financial statements for 2020 and 2019
and the reviews of the consolidated financial statements included in the Company&rsquo;s quarterly reports on Forms 10-Q. These
amounts included fees billed for annual financial statement and internal control audits, quarterly reviews, consultations on accounting
matters, and registration statement filings and consents.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>72
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B>&nbsp;</P>


<!-- Field: Page; Sequence: 78 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Audit
Matters</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B><I>Audit-related
fees. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">Consists of fees for assurance and
related services that were reasonably related to the performance of the independent registered public accounting firm&rsquo;s
audit or review of the Company&rsquo;s financial statements.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B><I>Tax
fees. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">Consists of fees for professional
services rendered for tax compliance, tax advice, and tax planning for the Company. Tax fees related to tax compliance, including
the preparation, review and filing of tax returns, was $252,735 and $59,247, for the years ended December 31, 2020 and 2019, respectively.
These amounts represent those billed for tax return preparation for the Company and its subsidiaries.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B><I>All
other fees. </I></B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">Consists of fees for products
and services provided other than those described above.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><B><A NAME="a036"></A>Audit
Committee Pre-Approval Policies and Procedures</B></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:49%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">As
contemplated by applicable law and as provided by the Audit Committee&rsquo;s charter, the Audit Committee is responsible for
the appointment, compensation, retention, and oversight of the work of the Company&rsquo;s independent registered public accounting
firm. In connection with such responsibilities, the Audit Committee is required, and it is the Audit Committee&rsquo;s policy,
to pre-approve the audit and permissible non-audit services (both the type and amount) performed by the Company&rsquo;s independent
registered public accounting firm in order to ensure that the provision of such services does not impair the firm&rsquo;s independence,
in appearance or fact.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Under
the policy, unless a type of service to be provided by the independent registered public accounting firm has received general
pre-approval, it will require separate pre-approval by the Audit Committee. If fees for a proposed service of a type that has
been pre-approved exceed the pre-approved amount, the Audit Committee and the independent registered public accounting firm must
confer, and the Audit Committee must grant its approval before further work may be performed. For audit services (including the
annual financial statement audit, quarterly statement reviews, and other procedures required to be performed by the independent
registered public accounting firm to be able to form an opinion on the Company&rsquo;s consolidated financial statements), the
independent registered public accounting firm must provide to the Audit Committee in advance an engagement letter, outlining the
scope of audit services proposed to be performed with respect to the audit for that fiscal year and associated fees. If, in advance
of its meeting, the Audit Committee agrees to the engagement</FONT></P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">letter,
the engagement will be formally accepted by the Audit Committee at its next regularly scheduled meeting.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">All
permissible non-audit services not specifically approved in advance must be separately pre-approved by the Audit Committee, as
noted above, with the exception of certain services of limited financial expense for which the Audit Committee has authorized
the Audit Committee Chair to hire at their discretion. Generally, requests or applications to provide services must be in writing
and include a description of the proposed services, the anticipated costs and fees, and the business reasons for engaging the
independent registered public accounting firm to perform the services. The request must also include a statement as to whether
the request or application is consistent with SEC rules on registered public accounting firm independence.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">To
ensure prompt handling of unexpected matters, the Audit Committee has delegated authority to pre-approve audit and permissible
non-audit services between regularly scheduled meetings of the Audit Committee to its Chair, who is responsible for reporting
any pre-approval decisions to the Audit Committee at its next scheduled meeting. Except as noted above, the Audit Committee has
not and will not delegate to management of the Company the Audit Committee&rsquo;s responsibilities to pre-approve services performed
by the independent registered public accounting firm. The Audit Committee pre-approved all audit services provided to the Company
by each independent registered public accounting firm engaged during the fiscal years ended December 31, 2020 and 2019.</FONT></P>

</div>
<BR CLEAR="ALL"><BR>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">73</FONT></B></P>


<!-- Field: Page; Sequence: 79 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Audit
Matters</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>



<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; background-color: #F2F2F2; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 100%; border-top: rgb(0,61,165) 1pt solid; border-right: rgb(0,61,165) 1pt solid; border-left: rgb(0,61,165) 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p>
	<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt"><b><A NAME="a037"></A>Audit Committee Report</b></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 10pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">The Audit Committee operates
        under a written charter adopted by the Board of Directors and monitors the Company&rsquo;s financial reporting process on behalf
        of the Board of Directors. This report reviews the actions taken by the Audit Committee with regard to the Company&rsquo;s financial
        reporting process during 2020 and particularly with regard to the Company&rsquo;s audited consolidated statements of financial
        condition as of December 31, 2020, and the related statements of operations, comprehensive loss, changes in stockholders&rsquo;
        deficit, and cash flows for each of the years in the three-year period ended December 31, 2020.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">The Audit Committee believes it has taken the actions necessary or appropriate to fulfill its oversight responsibilities under the Audit Committee&rsquo;s
        charter. In fulfilling its oversight responsibilities, the Audit Committee has reviewed and discussed the Company&rsquo;s audited
        financial statements with management and with Ernst &amp; Young LLP, the Company&rsquo;s independent registered public accounting
        firm, the matters required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB)
        and SEC, which includes, among other items, matters related to the conduct of the audit of the Company&rsquo;s financial statements.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">The Audit Committee meets with
        the independent registered public accounting firm, with and without management present, to discuss the results of its examinations,
        its evaluations of the Company&rsquo;s internal controls, the overall quality of the Company&rsquo;s financial reporting, and their
        judgments as to the Company&rsquo;s accounting principles and such other matters as are required to be discussed with the Audit
        Committee in accordance with PCAOB standards. The Audit Committee has also received the written disclosures and the letter from
        Ernst &amp; Young LLP required by the PCAOB independence and ethics rule, Rule 3526, &ldquo;Communication with Audit Committees
        Concerning Independence,&rdquo; relating to the firm&rsquo;s independence from the Company and its related entities, discussed
        with Ernst &amp; Young LLP its independence from the Company and considered the compatibility of the firm&rsquo;s provision of
        non-audit services with maintaining its independence. Management and the Company&rsquo;s internal and independent auditors also
        made presentations to the Audit Committee throughout the year on specific topics of interest, that include but are not limited
        to:</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        information technology systems, controls and security </FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        critical accounting policies </FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </FONT>&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">the impact of new accounting guidance</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT>&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        compliance with internal controls required under Section 404 of the Sarbanes-Oxley Act </FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        compliance with Company&rsquo;s Code of Business Conduct and Ethics</FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
        </FONT>&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">risk management initiatives and controls </FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27.35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;
        significant legal matters </FONT></p>

        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: rgb(72,108,147)">&#9679;</FONT>&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;
        insider and related party transactions </FONT></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 62pt; text-align: justify; text-indent: -27pt">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">Additionally, the Audit Committee
        discussed with the Company&rsquo;s internal and independent auditors the overall scope and plan for their respective audits.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">Based on the review and discussions
        referred to above, the Audit Committee recommended to the Company&rsquo;s Board of Directors that the Company&rsquo;s audited financial
        statements be included in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 31, 2020 for filing
        with the SEC.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 251pt; text-align: justify"></p>
       </td></tr>
</table>


<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; background-color: #F2F2F2">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 50%; border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 48%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="width: 2%; border-right: Navy 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>AUDIT COMMITTEE</b></font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael A. McManus, Jr., J.D., Chair</font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregg H. Alton</font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard H. Douglas, Ph.D.</font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary C. Evans</font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="border-left: rgb(0,61,165) 1pt solid">&nbsp;</td>
    <td colspan="2" style="border-right: rgb(0,61,165) 1pt solid">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td colspan="2" style="border-bottom: rgb(0,61,165) 1pt solid; border-left: rgb(0,61,165) 1pt solid"> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 17pt; text-align: justify"><i>This Audit Committee Report shall not be deemed incorporated by reference by any general statement incorporating
by reference this Proxy Statement into any filing under the Securities Act of 1933 or under the Securities Exchange Act of 1934
except to the extent that Novavax specifically incorporates this information by reference and shall not otherwise be deemed filed
under the Securities Act of 1933 and the Securities Exchange Act of 1934 and shall not be deemed soliciting material.</i></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 15pt 0pt 17pt; text-align: justify">&nbsp;</p></td>
	<td style="border-right: Navy 1pt solid; border-bottom: rgb(0,61,165) 1pt solid">&nbsp;</td>
	</tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>74
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font-size: 10pt; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 50%; background-color: #005695; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b><a name="a038"></a>STOCK OWNERSHIP INFORMATION</b></font></td>
    <TD STYLE="width: 50%; padding-top: 12pt; padding-bottom: 12pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</td></tr>
</table>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: white; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: white; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><A NAME="a039"></A><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><B>Security
Ownership of Certain Beneficial Owners and Management</B></FONT></P>

<P STYLE="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">The
following table sets forth certain information as of April 19, 2021, unless otherwise indicated, with respect to the beneficial
ownership of our Common Stock by (i) each director of the Company, (ii) each of the Named Executive Officers of the Company, as
identified in the &ldquo;Summary Compensation Table&rdquo; of this Proxy Statement, and (iii) all directors and executive officers
of the Company as a group.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; color: #231F20; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 64%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 18%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Shares
    of Common</B></FONT></TD>
    <TD STYLE="width: 18%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Stock
    Beneficially</B></FONT></TD>
    <TD STYLE="padding-right: 8.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>Percentage
    of Class</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(35,31,32)"><B>Beneficial
    Owner<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(35,31,32)"><B>Owned<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-right: 21.3pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: rgb(35,31,32)"><B>Outstanding<SUP>(3)</SUP></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>5%
    or Greater Stockholders</B></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">The
    Vanguard Group</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(4)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">5,598,760</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">7.6%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">BlackRock,
    Inc.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(5)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">5,137,631</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">6.9%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">RA
    Capital Management, L.P.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(6)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">3,788,564</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">5.1%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20"><B>Directors
    and Named Executive Officers</B></FONT></TD>
    <TD STYLE="text-align: center; padding-right: 0; border-bottom: #888A8C 1pt solid; padding-left: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; padding-left: 0; padding-right: 0; border-bottom: #888A8C 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregg
    H. Alton</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Richard
    H. Douglas, Ph.D.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(7)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">68,500</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20">*</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gary
    C. Evans</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(8)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">72,474</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif; color: #231F20">*</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Rachel
    K. King</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(9)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">32,500</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Margaret
    G. McGlynn, R. Ph.</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Michael
    A. McManus, Jr.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(10)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">48,951</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Rajiv
    I. Modi, Ph.D.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(11)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">125,000</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">David
    M. Mott</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(12)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">72,961</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">James
    F. Young, Ph.D.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(13)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">158,750</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Stanley
    C. Erck</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(14)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">549,194</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory
    F. Covino</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">&mdash;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">Gregory
    M. Glenn, M.D.</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(15)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">204,206</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">John
    A. Herrmann III</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(16)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">128,329</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">John
    J. Trizzino</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(17)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">128,557</FONT></TD>
    <TD STYLE="border-bottom: #888A8C 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #E6E7E8">
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">All
    directors and executive officers as a group (14 persons)</FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><SUP>(18)</SUP></FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">1,589,422</FONT></TD>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding-left: 0; padding-right: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">2.1%</FONT></TD></TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">*</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less
                                         than 1%.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Each
                                         beneficial owner named in the table above (except as otherwise indicated in the footnotes
                                         below) has an address in c/o Novavax, Inc., 21 Firstfield Road, Gaithersburg, Maryland
                                         20878.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Beneficial
                                         ownership is determined in accordance with the rules and regulations of the SEC and includes
                                         voting or investment power with respect to shares of the Common Stock. Unless otherwise
                                         indicated, each beneficial owner named in the table has sole voting and investment power
                                         over the shares beneficially owned. With respect to each person or group, percentages
                                         are calculated based on the number of shares of Common Stock beneficially owned, including
                                         shares that may be acquired by such person or group within 60 days of April 19, 2021
                                         upon the exercise of stock options, RSUs, SARs, warrants, or other purchase rights.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3)</FONT></TD><TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Percentages
                                         have been calculated based on 74,080,008 shares of the Common Stock outstanding as of
                                         April 19, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
                                         reported by the Vanguard Group (&ldquo;Vanguard&rdquo;) on Schedule 13G as filed on February
                                         10, 2021. Vanguard is a parent holding company or control person in accordance with Rule
                                         13d-1(b)(1)(ii)(G). Beneficial ownership (and other information in this footnote) is
                                         as of December 31, 2020. Vanguard beneficially owns 5,598,760 shares of Common Stock,
                                         for which it has no sole voting power and sole dispositive power with respect to 5,467,285
                                         shares of Common Stock. The principal office address of Vanguard is 100 Vanguard Blvd.,
                                         Malvern, PA 19355.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">75</FONT></B></P>


<!-- Field: Page; Sequence: 81 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Stock
Ownership Information</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
                                         reported by BlackRock, Inc. (&ldquo;BlackRock&rdquo;) on Schedule 13G/A as filed on February
                                         5, 2021. BlackRock is a parent holding company or control person in accordance with Rule
                                         13d-1(b)(1)(ii)(G). Beneficial ownership (and other information in this footnote) is
                                         as of December 31, 2020. BlackRock beneficially owns 5,137,631 shares of Common Stock,
                                         for which it has sole voting power with respect to 5,008,280 shares of Common Stock and
                                         sole dispositive power with respect to 5,137,631 shares of Common Stock. The principal
                                         office address of BlackRock is 55 East 52nd Street, New York, NY 10055.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
                                         reported by RA Capital Management, L.P. (&ldquo;RA Capital&rdquo;) on Schedule 13G/A
                                         as filed on February 16, 2021. RA Capital is a parent holding company or control person
                                         in accordance with Rule 13d-1(b)(1)(ii)(G). Beneficial ownership (and other information
                                         in this footnote) is as of December 31, 2020. RA Capital beneficially owns 3,788,564
                                         shares of Common Stock, for which it has no sole voting power or sole dispositive power.
                                         The principal office address of RA Capital is 200 Berkeley Street, 18<SUP>th</SUP> Floor,
                                         Boston, MA 02116.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         40,000 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         55,750 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Includes 625 shares of Common owned by Mr. Evans as a result
                                         of shares held in trusts for the benefit of Mr. Evans&rsquo;s children.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         26,000 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Includes 2,200 shares of Common Stock indirectly owned by
                                         Mrs. King as a result of shares held in trusts for the benefit of Mrs. King&rsquo;s children</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         43,000 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11)</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consists
                                         of 125,000 shares owned by Satellite Overseas (Holdings) Limited, a wholly-owned subsidiary
                                         of Cadila Pharmaceuticals Ltd. Dr. Modi is a managing director of Cadila Pharmaceuticals
                                         Ltd.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12)</FONT></TD><TD STYLE="padding-right: 5pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         8,000 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(13)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         99,750 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Also includes 1,500 shares of Common Stock owned by Dr. Young&rsquo;s
                                         spouse. Dr. Young disclaims beneficial ownership of these securities, and this report
                                         shall not be deemed an admission that Dr. Young is the beneficial owner of the securities
                                         for purposes of Section 16 or for any other purpose.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         487,033 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Also includes 41,666 shares of Common Stock that would be
                                         acquired if Mr. Erck&rsquo;s SARs that are exercisable or scheduled to vest within 60
                                         days of April 19, 2021 were exercised at $221.50, the closing price of Novavax&rsquo;s
                                         Common Stock on April 19, 2021, and settled in shares of Common Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         173,854 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Also includes 27,541 shares of Common Stock that would be
                                         acquired if Dr. Glenn&rsquo;s SARs that are exercisable or scheduled to vest within 60
                                         days of April 19, 2021 were exercised at $221.50, the closing price of Novavax&rsquo;s
                                         Common Stock on April 19, 2021, and settled in shares of Common Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(16)</FONT></TD><TD STYLE="padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         128,054 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(17)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                         120,604 shares of Common Stock issuable upon the exercise of options exercisable within
                                         60 days of April 19, 2021. Also includes 7,666 shares of Common Stock that would be acquired
                                         if Mr. Trizzino&rsquo;s SARs that are exercisable or scheduled to vest within 60 days
                                         of April 19, 2021 were exercised at $221.50, the closing price of Novavax&rsquo;s Common
                                         Stock on April 19, 2021, and settled in shares of Common Stock</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #231F20"><TR STYLE="vertical-align: top">
<TD STYLE="width: 10pt"></TD><TD STYLE="width: 36pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(18)</FONT></TD><TD STYLE="text-align: justify; padding-right: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Includes
                                                                                                                                             1,182,045 shares of Common Stock issuable upon the exercise of options exercisable within 60 days of April 19, 2021. Also includes
                                                                                                                                             76,873 shares of Common Stock that would be acquired if Messrs. Erck&rsquo;s and Trizzino&rsquo;s and Dr. Glenn&rsquo;s SARs that
                                                                                                                                             are exercisable or scheduled to vest within 60 days of April 19, 2021 were exercised at $221.50, the closing price of
                                                                                                                                             Novavax&rsquo;s Common Stock on April 19, 2021, and settled in shares of Common Stock.</FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Arial, Helvetica, Sans-Serif; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>76
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 82 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>
<!-- Field: Split-Segment; Name: 7 -->
<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 100%; background-color: #005695; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt"><a name="a040"></a><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b>INFORMATION
    ABOUT THE ANNUAL MEETING AND VOTING</b></font></td>
    </tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Proxy Statement (&ldquo;Proxy Statement&rdquo;)
is being furnished to stockholders in connection with the solicitation of proxies by the Board for use at the 2021 Annual Meeting
of Stockholders (the &ldquo;Annual Meeting&rdquo;) to be held:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td rowspan="2" style="vertical-align: top; width: 5%; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg132.jpg" ALT="" STYLE="height: 31px; width: 30px"><font style="font-size: 9pt"></font></td>
    <td style="vertical-align: bottom; width: 25%; background-color: #005695; padding-bottom: 3pt; padding-left: 0.125in; padding-top: 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>WHEN</b></font></td>
    <td style="vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td rowspan="2" style="vertical-align: top; width: 5%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg133.jpg" ALT="" STYLE="height: 53px; width: 30px"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="vertical-align: bottom; width: 26%; background-color: #005695; padding-bottom: 3pt; padding-left: 0.125in; padding-top: 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>VIRTUAL
    WEBCAST</b></font></td>
    <td style="vertical-align: bottom; width: 2%; padding-right: 5.4pt; padding-bottom: 2pt; padding-left: 5.4pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td rowspan="2" style="vertical-align: top; width: 5%; padding-right: 5.4pt; padding-bottom: 2pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg134.jpg" ALT="" STYLE="height: 31px; width: 30px"><font style="font-size: 9pt"></font></td>
    <td style="vertical-align: bottom; width: 30%; background-color: #005695; padding-bottom: 3pt; padding-left: 0.125in; padding-top: 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: white"><b>RECORD
    DATE</b></font></td></tr>
<tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 3pt; padding-top: 3pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt">Thursday,
                                         June 17, 2021</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt">8:30 a.m. Eastern Time</font></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 9pt"></font></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding-top: 3pt; padding-right: -6.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><u>www.virtualshareholdermeeting.com/NVAX2021</u></font></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><font style="font-size: 9pt">&nbsp;</font></td>
    <td style="padding-top: 3pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Stockholders
    of record at the close of business on April 20, 2021 are entitled to notice of and to vote</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:49%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This Proxy Statement, the form of proxy, and the Company&rsquo;s Annual Report on Form 10-K for the fiscal
year ended December 31, 2020 (the &ldquo;Annual Report&rdquo;) are being mailed or made available to our stockholders on or about
May 6, 2021.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><font style="font-size: 13pt"><b><i>Why
am I receiving these materials?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Company has made these proxy materials
available to you on the Internet or, upon your request, has delivered print versions of these proxy materials to you by mail, in
order to provide you with information regarding the matters on which you may vote at the Annual Meeting. You are invited to attend
the live virtual webcast of the Annual Meeting and are requested to vote on the proposals described in this Proxy Statement.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><font style="font-size: 13pt"><b><i>Can
I access the materials on the Internet instead of receiving paper copies?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Yes, stockholders may access the Proxy
Statement and the Annual Report via the Internet and vote online at <FONT STYLE="color: rgb(72,108,147)">www.proxyvote.com</FONT>.
On or about May 6, 2021, a Notice of Internet Availability of Proxy Materials (the &ldquo;Notice&rdquo;) will be mailed to
stockholders of record as of the close of business on the Record Date. We are furnishing our proxy materials to our stockholders on
the Internet in lieu of mailing a printed copy of our proxy materials. You will not receive a printed copy of our proxy materials
unless you request one. If you would like to receive a printed or electronic copy of the proxy materials, free of charge, you should
follow the instructions for requesting such materials in the Notice. The Notice instructs you as to how you may access and review on
the Internet all of the important information contained in these proxy materials or request a printed copy of those materials. The
Notice also instructs you as to how you may vote your proxy.</p>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:49%">

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD STYLE="width: 100%; border: #003DA5 1pt solid; padding: 6pt 5pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
Company encourages stockholders to take advantage of the availability of the proxy materials on the Internet to help reduce the
environmental impact of printing and mailing annual meeting materials<font style="background-color: white">.</font></font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><font style="font-size: 13pt"><b><i>What
is &ldquo;householding&rdquo; and how does it affect me?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Company has adopted the process called &ldquo;householding&rdquo; for mailing annual meeting materials
to stockholders who share the same address. These stockholders will have received a notice from their bank, broker, or other holder
of record, indicating they will receive only one copy of this Proxy Statement and Annual Report.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">If you own your shares through a bank, broker,
or other holder of record and wish to either stop or begin householding, you may do so, or you may request a separate copy of this
Proxy Statement and Annual Report, either by contacting your bank, broker, or other holder of record at the telephone number or
address provided in the above referenced notice, or contacting Novavax:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>







<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <TD STYLE="vertical-align: top; width: 12%; padding: 6pt 5.4pt 5pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg135.jpg" ALT="" STYLE="width: 30px">&nbsp;</td>
    <TD STYLE="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>TELEPHONE</b></font></td>
    <TD STYLE="width: 60%; padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(240) 268-2000</font></td></tr>
<tr style="vertical-align: top; background-color: #F2F2F2">
    <TD STYLE="padding: 4pt 5.4pt 5pt; text-align: center"><IMG SRC="tm212692d3_sch14-aimg136.jpg" ALT="" STYLE="height: 23px; width: 30px"></td>
    <TD STYLE="padding: 4pt 5.4pt 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>MAIL</b></font></td>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; padding-bottom: 5pt">
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Novavax, Inc.</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Attention: Corporate Secretary</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">21 Firstfield Road</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Gaithersburg, Maryland 20878</p>
        <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></p></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">If you request to begin or stop householding,
you should provide your name, the name of your broker, bank, or other record holder, and your account information.</P>

</div>
<BR CLEAR="ALL"><BR>



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><B>|</B></FONT><B>
<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">77</FONT></B></P>

<!-- Field: Page; Sequence: 83 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Information
about the Annual Meeting and Voting</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>&nbsp;</B></FONT></P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:49%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>What
is the purpose of the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, stockholders will
vote on the following matters:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="border-bottom: #005695 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Proposal</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; width: 4%; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>1</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; width: 96%; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To elect three directors as Class II directors to serve
on the Board, each for a three-year term expiring at the 2024 Annual Meeting of Stockholders</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>2</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To approve, on an advisory basis, the compensation paid
to our Named Executive Officers</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>3</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">Amendment
    and restatement of the Novavax, Inc. 2015 Stock Plan to increase the number of shares of our Common Stock available for issuance
    thereunder by 1,500,000 shares</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>4</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To ratify certain April 2020 equity awards</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>5</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To ratify certain June 2020 equity awards</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>6</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To ratify the appointment of Ernst &amp; Young LLP as
the Company&rsquo;s independent registered public accounting firm for the fiscal year ending December 31, 2021</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: #005695 1pt solid; padding-bottom: 1pt; padding-left: 5.4pt; text-align: justify; padding-top: 2pt"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695"><B>7</B></FONT><B><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #005695">&nbsp;&nbsp;&nbsp;
    </FONT></B></TD>
    <TD STYLE="border-bottom: #005695 1pt solid; padding-bottom: 1pt; text-align: justify; vertical-align: top; padding-top: 2pt"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">To transact such other business as may properly come
before the Annual Meeting or any adjournments or postponements thereof</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In addition, management will report on the Company&rsquo;s performance during fiscal year 2020 and respond
to questions from stockholders.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>Who
is entitled to vote?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The
only class of stock of the Company entitled to vote at the Annual Meeting is its Common Stock. Only the record holders of shares of
Common Stock at the close of business on the Record Date may vote at the Annual Meeting. On the Record Date, there were 74,080,008
shares of Common Stock outstanding and entitled to be voted. Each share entitles the holder to one vote on each of the matters to be
voted upon at the Annual Meeting.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>What
is the quorum requirement for the Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The presence in person virtually or by proxy
of the holders of a majority of the shares of Common Stock issued and outstanding on the Record Date and entitled to vote is required
to constitute a quorum at the Annual Meeting. If a quorum is not present, the stockholders entitled to vote who are present in
person virtually or</P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">represented by proxy at the Annual Meeting have the power to adjourn the Annual Meeting until a quorum is present,
without notice other than an announcement at the Annual Meeting, so long as such adjournment is less than 30 days and a new record
date is not fixed. At any adjourned meeting at which a quorum is present, any business may be transacted that might have been transacted
at the Annual Meeting as originally scheduled. Abstentions and broker non-votes will count in determining whether a quorum is present
at the Annual Meeting. A broker non-vote occurs when a broker, bank or other nominee who holds shares represented by a proxy has
not received voting instructions with respect to a particular item and does not have discretionary authority to vote such shares
on the item.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>







<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>Why
is the Company holding a virtual Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Due to the public health impact of the coronavirus outbreak (&ldquo;COVID-19") and to support the
health and well-being of our stockholders, this year&rsquo;s Annual Meeting will be held in a virtual meeting format only. We have
designed our virtual format to enhance, rather than constrain, stockholder access, participation, and communication. For example,
the virtual format allows stockholders to communicate with us in advance of, and during, the Annual Meeting so they can ask questions
of our Board of Directors or management. Similar to our in-person meetings,  we may answer questions as they come in during the
live Q&amp;A session of the Annual Meeting, as well as address questions in advance, to the extent relevant to the business of
the Annual Meeting as time permits.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>How
can I attend the virtual Annual Meeting?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Annual Meeting will be held entirely
online. To attend the live webcast of the Annual Meeting, you must demonstrate that you were a Novavax stockholder as of the close
of business on April 20, 2021 or hold a valid proxy for the Annual Meeting from such a stockholder.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; word-spacing: -2pt">To
                                            participate in the Annual Meeting live via the Internet you must register at <FONT STYLE="color: #005695">www.virtualshareholdermeeting.com/NVAX2021
                                            </FONT>by <B>11:59 p.m. &nbsp;Eastern &nbsp;Time &nbsp;on &nbsp;June &nbsp;16, &nbsp;2021</B>.</FONT></TD></TR></TABLE>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.3in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; word-spacing: -2pt">On
                                            the day of the Annual Meeting, if you have properly registered, you may enter the Annual
                                            Meeting by logging in using the password you received via email in your registration confirmation
                                            at <FONT STYLE="color: #005695">www.virtualshareholdermeeting.com/NVAX2021</FONT>.</FONT></TD></TR></TABLE>

</div>
<BR CLEAR="ALL"><BR>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20"><B>78
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #496D93">|</FONT></B><B> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #231F20">ir.novavax.com</FONT></B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: Red; text-indent: 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Information
about the Annual Meeting and Voting</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #888A8C; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #005695"><B>Even if you plan to attend the live virtual webcast of the Annual Meeting, we strongly encourage you to
vote in advance by Internet, telephone, or mail so your vote will be counted.</B></FONT>
Please note that no members of management or the Board will be in attendance at the physical location. A replay of the meeting,
as well as any questions pertinent to meeting matters and management&rsquo;s answers (including any questions that could not be
answered during the meeting due to time constraints), will be made publicly available on our investor relations website promptly
after the Annual Meeting.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>How
do I vote?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You may vote using any of the following
methods:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="padding: 2pt 5pt"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg137.jpg" ALT="" STYLE="height: 26px; width: 30px">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg138.jpg" ALT="" STYLE="height: 49px; width: 30px">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg139.jpg" ALT="" STYLE="height: 26px; width: 30px">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg140.jpg" ALT="" STYLE="height: 23px; width: 30px">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 9pt"><IMG SRC="tm212692d3_sch14-aimg141.jpg" ALT="" STYLE="height: 52px; width: 30px">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; width: 12%"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; vertical-align: bottom; width: 17%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Internet</B></FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; vertical-align: bottom; width: 17%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Telephone</B></FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: rgb(0,86,149) 1pt solid; vertical-align: bottom; width: 17%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Virtual
    Device</B></FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; vertical-align: bottom; width: 17%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Mail</B></FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; vertical-align: bottom; width: 20%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>During
    the Meeting</B></FONT></TD>
    </TR>
  <TR>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top; background-color: #F2F2F2"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Registered
    Holders</B></FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Visit, 24/7</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #005695"><FONT STYLE="font-size: 9pt">www.proxyvote.com</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #005695"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top"><P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">Dial toll-free, 24/7</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">1-800-690-6903</FONT></P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">&nbsp;</FONT></P></TD>
    <TD STYLE="padding: 2pt 5pt; border-right: rgb(0,86,149) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Scan
    the QR code available on your proxy card</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Return
    a properly executed proxy card (if received by mail) in the postage-paid envelope provided</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Attend
    the virtual meeting at <FONT STYLE="color: #005695">www.virtualshareholdermeeting.com/NVAX2021</FONT> and follow the instructions
    provided during the Annual Meeting</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; background-color: #F2F2F2"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Beneficial
    Owners (holders in street name)</B></FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The
    availability of telephone and Internet voting for beneficial owners will depend on the voting processes of your broker, bank, or
    other nominee, so please follow the voting instructions in the materials you receive</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-right: rgb(0,86,149) 1pt solid; border-bottom: rgb(105,115,123) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Scan
    the QR code if one is provided by your broker, bank, or other nominee</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Return
    a properly executed voting instruction form by mail, depending upon the methods your broker, bank, or other nominee makes available</FONT></TD>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #69737B 1pt solid; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Contact
    your broker, bank, or other nominee to request a legal proxy and voting instructions</FONT></TD></TR>
  <TR>
    <TD STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; vertical-align: top; background-color: #F2F2F2"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Deadline</B></FONT></TD>
    <TD COLSPAN="3" STYLE="padding: 2pt 5pt; border-right: rgb(0,86,149) 1pt solid; border-bottom: #005695 1pt solid; text-align: center; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11:59
    p.m. Eastern Time on June 16, 2021</FONT></TD>
    <TD COLSPAN="2" STYLE="padding: 2pt 5pt; border-bottom: #005695 1pt solid; text-align: center; vertical-align: top"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Before
    the polls close at the Annual Meeting on June 17, 2021</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:49%">
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #005695"><B>Telephone or the
Internet</B>. </FONT>The telephone and Internet voting procedures established by the Company for stockholders are designed to authenticate
your identity, to allow you to give your voting instructions and to confirm that these instructions have been properly recorded. The
availability of telephone and Internet voting for beneficial owners will depend on the voting processes of your broker, bank, or other
nominee. Therefore, we recommend you follow the voting instructions in the materials you receive.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>





<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="color: #005695"><B>At the live
virtual webcast of the Annual Meeting</B>. </FONT>All stockholders may vote at the Annual Meeting. If you are a registered
holder, you must register using the virtual 16-digit control number included on your Notice of Internet Availability of Proxy Materials
or your proxy card (if you received a printed copy of the proxy materials). If you hold your shares beneficially through a bank, broker
or other record holder, you must provide a legal proxy from your bank, broker or other record holder during registration and you will
be assigned a virtual 16-digit control number in order to vote your shares during the Annual Meeting. If you are unable to obtain a legal
proxy to vote your shares, you will still be able to attend the Annual Meeting (but will not be able to vote your shares) so long as you
demonstrate proof of stock ownership such as a copy of your proxy card, voter instruction card,</P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:49%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Notice of Internet Availability, or brokerage
statement showing proof of your ownership of Common Stock as of April 20, 2021. Instructions on how to connect and participate
via the Internet, including how to demonstrate proof of stock ownership, are posted at <FONT STYLE="color: rgb(72,108,147)">www.virtualshareholdermeeting.com/NVAX2021</FONT><FONT STYLE="color: #005695">.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #005695 1pt solid"><FONT STYLE="font-size: 13pt"><B><I>What
is the difference between a stockholder of record and a beneficial owner of shares held in street name?</I></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>Stockholder of Record.
</B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If your shares are registered directly in your name with the
Company&rsquo;s transfer agent, Computershare, Inc., you are considered the stockholder of record with respect to those shares,
and the proxy materials were sent directly to you by the Company.&nbsp;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>&#9679;</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; color: #005695"><B>Beneficial Owner of
Shares Held in Street Name. </B></FONT><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">If your shares are held in an account at a brokerage firm, bank, broker-dealer, or other similar organization,
then you are the &ldquo;beneficial owner&rdquo; of shares held in &ldquo;street name.&rdquo; As a beneficial owner, you have the
right to instruct your broker, bank, or other nominee how to vote your shares.</FONT></TD></TR></TABLE>

</div>
<BR CLEAR="ALL"><BR>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 8pt 0 0pt; text-indent: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">79</FONT></B></P>

<!-- Field: Page; Sequence: 85 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: normal 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Information
about the Annual Meeting and Voting</B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #496D93">&nbsp;</p>

<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>How
does discretionary voting authority apply?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">All properly executed proxies will be voted
in accordance with the instructions of the stockholder. If you are a stockholder of record and you sign and return a proxy card
without giving specific instructions, then the persons named as proxy holders, Stanley C. Erck and John A. Herrmann III, will vote
your shares in the manner recommended by the Board on all matters presented in this Proxy Statement and as the proxy holders may
determine in their discretion with respect to any other matters properly presented for a vote at the Annual Meeting, including
any floor proposals.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Broker non-votes occur when a beneficial
owner of shares held in street name does not give instructions to the broker, bank or other nominee holding the shares as to how
to vote on matters deemed &ldquo;non-routine.&rdquo; Generally, if shares are held in street name, the beneficial owner of the
shares is entitled to give voting instructions to the broker, bank or other nominee holding the shares. If the beneficial owner
does not provide voting instructions, the broker, bank or other nominee can still vote the shares with respect to matters that
are considered to be &ldquo;routine,&rdquo; but not with respect to &ldquo;non-routine&rdquo; matters. Under the rules and interpretations
of the Nasdaq and the New York Stock Exchange, which generally govern this issue regardless of the exchange on which the company
is listed, &ldquo;non-routine&rdquo; matters are matters that may substantially affect the rights or privileges of stockholders,
such as mergers, stockholder proposals, equity compensation matters, and the election of directors, even if they are not contested.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Although the determination of whether a
broker, bank or other nominee will have discretionary voting power for a particular matter is typically determined only after proxy
materials are filed with the SEC, we expect that your broker, bank or other nominee will be permitted to vote your shares only
with respect to the ratification of the appointment of Ernst &amp; Young LLP as the Company&rsquo;s independent auditor for the
year ending December 31, 2021 (Proposal 6), even if they do not receive instructions from you in a timely manner, so long as they
hold your shares in their name and have requested your instructions. Furthermore, we do not expect your broker,</P>
</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">bank or other nominee
to have authority, discretionary or otherwise, to vote your shares for the election of directors, the approval, on an advisory
basis, of the compensation paid to our Named Executive Officers, the amendment of the Novavax, Inc. 2015 Stock Plan, or the ratification
of the April 2020 equity grants and June 2020 equity grants (Proposals 1, 2, 3, 4 and 5), unless they receive proper instructions
to do so from you in a timely manner.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In order to minimize the number of broker
non-votes, the Company encourages you to vote or to provide voting instructions with respect to each proposal to the organization
that holds your shares by carefully following the instructions provided in the proxy card or voting instruction form.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>What
are the Board&rsquo;s recommendations?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <TD COLSPAN="2" STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Proposal</b></font></td>
    <TD COLSPAN="2" STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: bottom"><b>Board Recommendation</b></td>
    </tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify; width: 4%"><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93"><b>1</b></font><b><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify; width: 76%"><font style="font-size: 9pt">Election
    of directors</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: right; width: 8%"><img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; width: 12%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b>FOR<br>

    </b></font>all nominees</td>
    </tr>
<tr style="vertical-align: top">
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>2</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;
</font></b></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The
    approval, on an advisory basis, of the compensation paid to our Named Executive Officers</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; text-align: right"><img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b>FOR</b></font></td>
    </tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>3</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-size: 9pt">Amendment
    and restatement of the Novavax, Inc. 2015 Stock Plan to increase the number of shares of Common Stock available for issuance thereunder
    by 1,500,000 shares</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: right">&nbsp;<img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b>FOR
    </b></font></td>
    </tr>
<tr>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>4</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification
    of certain April 2020 equity awards</font></td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: right"><img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: #69737B 1pt solid; padding: 2pt 5pt; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b>FOR
    </b></font></td>
    </tr>
<tr>
    <TD STYLE="border-bottom: Black 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93"><b>5</b></font><b><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification
    of certain June 2020 equity awards</font></td>
    <TD STYLE="border-bottom: Black 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: right"><img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: Black 1pt solid; padding: 2pt 5pt; vertical-align: top"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><b>FOR
    </b></font></td>
    </tr>
<tr>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93"><b>6</b></font><b><font style="font: 16pt Arial, Helvetica, Sans-Serif; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: justify"><font style="font-size: 9pt">Ratification
    of Ernst &amp; Young LLP as independent auditors for 2021</font></td>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: top; text-align: right"><img src="tm212692d3_sch14-aimg142.jpg" alt="">&nbsp;</td>
    <TD STYLE="border-bottom: #496D93 1pt solid; padding: 2pt 5pt; vertical-align: top"><font style="font: 9pt Arial, Helvetica, Sans-Serif; color: #496D93"><b>FOR
    </b></font></td></tr>
</table>

</div>
<BR CLEAR="ALL"><BR>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>80
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>


<!-- Field: Page; Sequence: 86 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Information
about the Annual Meeting and Voting</B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>What
is the voting requirement to approve each of the proposals?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr>
    <td colspan="2" style="vertical-align: bottom; border-bottom: #496D93 1pt solid; padding-right: 5pt; padding-left: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Proposal</b></font></td>
    <td style="vertical-align: bottom; border-bottom: #496D93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Vote
    Required</b></font></td>
    <td style="vertical-align: top; border-bottom: #496D93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Broker
    Non-<br>
Votes Allowed</b></font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: #496D93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Abstentions</b></font></td>
    <TD STYLE="vertical-align: bottom; border-bottom: #496D93 1pt solid; padding-right: 5pt; padding-left: 5pt; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>You
    May Vote</b></font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify; width: 4%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>1</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify; width: 31%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Election of directors</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center; width: 20%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Plurality
    of votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center; width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center; width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center; width: 15%"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FOR
    or WITHHOLD</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>2</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">The approval, on an advisory basis, of the compensation
paid to our Named Executive Officers</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Majority
    of votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FOR,
    <br>
AGAINST, <br>
ABSTAIN</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>3</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-size: 9pt">Amendment
    and restatement of the Novavax, Inc. 2015 Stock Plan to increase the number of shares of Common Stock available for issuance thereunder
    by 1,500,000 shares</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Majority
    of votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FOR,
    <br>
AGAINST, <br>
ABSTAIN</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>4</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification of April 2020 equity awards</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Majority
    of votes cast and a majority of the disinterested votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FOR,
    <br>
AGAINST, <br>
ABSTAIN</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>5</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification of June 2020 equity awards</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Majority
    of votes cast and a majority of the disinterested votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #69737B 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FOR,
    <br>
AGAINST, <br>
ABSTAIN</font></td></tr>
<tr style="vertical-align: top">
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93"><b>6</b></font><b><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #496D93">&nbsp;&nbsp;&nbsp;
    </font></b></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Ratification of Ernst &amp; Young LLP as independent auditors
for 2021</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Majority
    of votes cast</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Yes</font></td>
    <TD STYLE="padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; text-align: center"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">No
    effect</font></td>
    <TD STYLE="text-align: center; padding: 3pt 5pt 2pt; border-bottom: #496D93 1pt solid; vertical-align: top"><FONT STYLE="font-size: 9pt">FOR,
    <BR>
    AGAINST, <BR>
    ABSTAIN</FONT><FONT STYLE="font-size: 9pt"></FONT></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>Can
I change my vote after I have voted?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Stockholders may revoke proxies at any time
before they are exercised at the Annual Meeting by:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif">(a)</font></td><td style="text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">signing and submitting a later-dated proxy
to the Secretary of the Company</font></td></tr></table>



<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif">(b)</font></td><td style="text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">delivering written notice of revocation
to the Secretary of the Company</font></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif">(c)</font></td><td style="text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">voting electronically at the Annual Meeting</font></td></tr></table>
<p style="margin-top: 0; margin-bottom: 0">&nbsp;</p>





<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In light of disruptions caused by COVID-19,
if you intend to revoke your proxy by such written notice, we advise that you also send a copy via email to <font style="color: #496D93">ir@novavax.com
</font>with &ldquo;Attention: Corporate Secretary&rdquo; in the subject line. Attendance at the live virtual webcast of the Annual
Meeting will not itself be deemed to revoke a proxy unless the stockholder gives affirmative notice at the Annual Meeting that
the stockholder intends to revoke the stockholder&rsquo;s proxy and vote at the live virtual webcast of the Annual Meeting.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>Where
can I find the voting results of the Annual Meeting?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Preliminary voting results will be announced
at the Annual Meeting. The Company will publish the final voting results in a Current Report on Form 8-K, which</P>
</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">the Company is
required to file with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) within four business days following the Annual
Meeting.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; border-bottom: #496D93 1pt solid"><font style="font-size: 13pt"><b><i>Who
bears the cost of solicitation of proxies?</i></b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Company will bear the cost of soliciting
proxies. This cost also includes support for the hosting of the live virtual webcast of the Annual Meeting. In addition to
solicitations by mail, the Company&rsquo;s directors, officers, and regular employees may, without additional remuneration, solicit
proxies in person, by telephone, or by electronic transmission and/or facsimile transmission. The Company may also utilize the
assistance of third parties in connection with our proxy solicitation efforts and will compensate such third parties for their
efforts. The Company has retained MacKenzie Partners, Inc. to assist in the solicitation of proxies. The cost for these services,
together with reimbursement of expenses are not expected to exceed $25,000 in the aggregate. The
Company will also request brokerage houses, custodians, nominees and fiduciaries or other similar organizations to forward copies of
the proxy materials to those persons for whom they hold shares and request instructions for voting the proxies. The Company will
reimburse such brokerage houses, custodians, nominees and fiduciaries or other similar organizations for their reasonable expenses
in connection with this distribution.</P>
</div>
<BR CLEAR="ALL"><BR>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">81</FONT></B></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<table cellspacing="0" cellpadding="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 40%; background-color: #496D93; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b><A NAME="a041"></A>ADDITIONAL
    INFORMATION</b></font></td>
    <td style="width: 60%; padding-top: 12pt; padding-bottom: 12pt">&nbsp;</td></tr>
</table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><font style="font-size: 18pt"><b><A NAME="a042"></A>Stockholder
Proposals</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93"><font style="font-size: 14pt"><b>STOCKHOLDER
PROPOSALS FOR INCLUSION IN THE COMPANY&rsquo;S PROXY STATEMENT</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Stockholders who wish to present proposals for inclusion in the Company&rsquo;s proxy materials for the
Company&rsquo;s 2021 Annual Meeting of Stockholders should follow the procedures prescribed in Rule 14a-8 under the Exchange Act
and the Company&rsquo;s By-Laws. Those procedures require that the Company receive a stockholder proposal in writing at the Company&rsquo;s
principal executive offices no later than January 3, 2022. If the date of next year&rsquo;s</P>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Annual Meeting of Stockholders is changed by more than 30 days from the anniversary date of this
year&rsquo;s Annual Meeting (June 17, 2021), then the deadline is the close of business on the 10<sup>th</sup>&nbsp;day following
the date on which such notice of the date of the meeting was mailed or public disclosure of the date of such meeting was made,
whichever occurs first.</p>

</div>
<BR CLEAR="ALL"><BR>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93"><font style="font-size: 14pt"><b>OTHER STOCKHOLDER
PROPOSALS</b></font></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93">&nbsp;</p>
<DIV STYLE="POSITION:RELATIVE;FLOAT:LEFT;WIDTH:48%">
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Under the Company&rsquo;s By-Laws, stockholders
who wish to include a proposal in the Company&rsquo;s 2021 Annual Meeting of Stockholders (but do not wish to include such proposal in
the Company&rsquo;s proxy materials) must give the Company timely written notice. To be timely, the Company&rsquo;s By-<font style="color: #231F20">Laws</font>&nbsp;provide
that such notice must be received by the Company at its principal executive offices not less than 60 days nor more than 90 days prior
to the anniversary date of this year&rsquo;s Annual Meeting on June 17, 2021 However, in the event the date of the meeting is more than
30 days before or after the anniversary date of the prior year&rsquo;s Annual Meeting of Stockholders, notice by the stockholder to be
timely must be so received not later than the close of business on the 10<sup>th</sup>&nbsp;day following the date on which such notice
of the date of the meeting was mailed or public disclosure of the date of such meeting was made, whichever occurs first.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #496D93">&nbsp;</p>





<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In addition to being timely, any such notice
must include the following information regarding each matter the stockholder proposes to bring before the Annual Meeting:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><b>&#9679;</b></font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">a brief description of the business desired
to be brought before the Annual Meeting and the reasons for conducting such business at the Annual Meeting</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.25in; padding-bottom: 5pt"></td><TD STYLE="width: 0.25in; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><b>&#9679;</b></font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">the name and address, as they appear on
the Company&rsquo;s books, of the stockholder proposing such business</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.25in; padding-bottom: 5pt"></td><TD STYLE="width: 0.25in; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><b>&#9679;</b></font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">the number of shares of capital stock and
other securities of the Company which are beneficially owned by the stockholder and each Stockholder Associated Person</font></td></tr></table>

</div>
<DIV STYLE="POSITION:RELATIVE;FLOAT:RIGHT;WIDTH:48%">


<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<TD STYLE="width: 0.25in; padding-bottom: 5pt"></td><TD STYLE="width: 0.25in; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><b>&#9679;</b></font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">any derivative positions held of record
or beneficially by the stockholder and any Stockholder Associated Person and whether and the extent to which any hedging or other
transactions or series of transactions has been entered into by or on behalf of, or any other agreement, arrangement, or understanding
has been made, the effect or intent of which is to increase or decrease the voting power or economic interest of, such stockholder
or any Stockholder Associated Person with respect to the Company&rsquo;s securities</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.25in"><font style="font-family: Arial, Helvetica, Sans-Serif; color: #496D93"><b>&#9679;</b></font></td><td style="text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif">any material interest of the stockholder
or any Stockholder Associated Person in such proposal</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For purposes of this Proxy Statement, a
 &ldquo;Stockholder Associated Person&rdquo; of any stockholder means:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 27.35pt"><font style="font-family: Arial, Helvetica, Sans-Serif">(i)</font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">any &ldquo;affiliate&rdquo; or &ldquo;associate&rdquo;
(as those terms are defined in Rule 12b-2 under the Exchange Act) of the stockholder who owns beneficially or of record any capital
stock or other securities of the Company or, through one or more derivative positions, has an economic interest (whether positive
or negative) in the price of securities of the Company, and</font></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<TD STYLE="width: 18pt; padding-bottom: 5pt"></td><TD STYLE="width: 27pt; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">(ii)</font></td><TD STYLE="text-align: justify; padding-bottom: 5pt"><font style="font-family: Arial, Helvetica, Sans-Serif">any person acting in concert with such
stockholder or any affiliate or associate of such stockholder with respect to the capital stock or other securities of the Company.</font></td></tr></table>
</div>
<BR CLEAR="ALL"><BR>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>82
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>

<!-- Field: Page; Sequence: 88 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Additional
Information</B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Please note that if the stockholder proposes
to nominate a director for election to the Company&rsquo;s Board, the procedures described under the caption &ldquo;Nomination
Procedures&rdquo; herein relating to director nominations must be followed.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 18pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><b><A NAME="a043"></A>Other Matters</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Board knows of no other matters which
will be presented for consideration at the Annual Meeting. If any other business should come before the Annual Meeting, however,
it is the intention of the persons named in the enclosed proxy to vote, or otherwise act, in accordance with their best judgment
on such matters.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">* * *</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
<tr style="background-color: #F2F2F2">
    <td style="width: 100%; border: #496D93 1pt solid; padding: 6pt 10.5pt 6pt 8pt; text-align: justify"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The Board of Directors hopes stockholders will attend the live virtual webcast of the Annual Meeting. Whether or not you plan to attend, you are urged to complete, sign, date, and return the enclosed proxy in the accompanying envelope, or vote over the Internet or telephone as described therein. Your prompt response will greatly facilitate arrangements for the Annual Meeting, and your cooperation is appreciated. Stockholders who attend the virtual webcast of the Annual Meeting may vote their stock personally even if they have sent in their proxies.</font></td></tr>
</table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 265.5pt"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; font: 10pt Arial, Helvetica, Sans-Serif; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 50%">&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>By Order of the Board of Directors,</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>&nbsp;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <TD><IMG SRC="tm212692d3_sch14-aimg143.jpg" ALT=""></td></tr>
<tr style="vertical-align: top; text-align: left">
    <TD>&nbsp;</td>
    <TD><font style="color: #496D93"><b>JOHN A. HERRMANN III</b></font></td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>Executive Vice President, Chief Legal Officer</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&nbsp;</td>
    <td>and Corporate Secretary</td></tr>
</table>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 265.5pt">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Gaithersburg, Maryland</p>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">May 3<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: #231F20">,
2021</FONT>&nbsp;</p>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">83</FONT></B></P>


<!-- Field: Page; Sequence: 89 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<p style="margin: 0"><img src="tm212692d3_sch14-aimg144.jpg" alt="image">&nbsp;&nbsp;&nbsp;</p>

<p style="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 100%; background-color: #496D93; padding-top: 12pt; padding-bottom: 12pt; padding-left: 12.5pt"><font style="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: white"><b><A NAME="a044"></A>APPENDIX A&mdash;NOVAVAX, INC.
2015 STOCK INCENTIVE PLAN AMENDED AND RESTATED MARCH 18, 2021</b></font></td>
    </tr>
</table>
<P STYLE="margin: 0">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><B>1.</B></td><td style="text-align: justify"><B><U>Purpose</U>.</B></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the
Plan is to secure for the Company and its stockholders the benefits arising from capital stock ownership by employees, officers
and directors of, and consultants or advisors to, the Company. Capitalized terms and operational rules related to such terms not
otherwise defined in the Plan are defined on Exhibit A, which is incorporated herein by reference.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><B>2.</B></td><td style="text-align: justify"><B><U>Type of Stock Awards and Administration</U>.</B></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(a)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Types
of Stock Awards</u><font style="font-style: normal">. The Plan provides for the grant of Options (including Incentive Stock Options
and Non-Statutory Options), Restricted Stock, Unrestricted Stock, Stock Appreciation Rights (or SARs), Stock Units, Restricted
Stock Units (or RSUs) and Performance Awards.</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(b)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Administration</u>.</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>The
Plan will be administered by the Administrator, whose construction and interpretation of the terms and provisions of the Plan
and any Award Agreement shall be final and conclusive. The Administrator may in its sole discretion grant Stock Awards with respect
to shares of Common Stock and direct the Company to issue shares of Common Stock upon the grant, vesting or exercise of such Stock
Awards as provided in the Plan.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Subject to the express provisions of the Plan, the Administrator shall have authority:</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
determine the individuals to whom, and the time or times at which, Stock Awards are made, the number of shares subject to each Stock
Award and the terms of all Stock Awards and Award Agreements, which need not be identical;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
construe the Plan and Award Agreements;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
prescribe forms, rules and procedures relating to the Plan;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
determine the form of settlement of Stock Awards (whether in cash, shares of Common Stock or other property); and</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(5)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;To
make all other determinations and take all other actions that are, in the judgment of the Administrator, necessary or desirable for the
administration of the Plan.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font>The Administrator may correct any defect, supply any omission or reconcile any inconsistency in the Plan or in any Award
Agreement (or any inconsistency between the Plan and any Award Agreement) in the manner and to the extent it shall deem expedient
to carry the Plan into effect and it shall be the sole and final judge of such expediency. No director or individual acting pursuant
to authority delegated by the Administrator shall be liable for any action or determination under the Plan made in good faith.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><B>3.</B></td><td style="text-align: justify"><B><U>Participant Eligibility</U>.</B></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(a)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>General</u><font style="font-style: normal">.
The Administrator may select Participants from among key employees, officers or directors of, or consultants or advisors to, the
Company who are expected to contribute to the Company&rsquo;s future growth and success; <u>provided</u>, <u>however</u>, that
the class of persons to whom Incentive Stock Options may be granted shall be limited to employees of the Company, and <u>provided</u>,
further, that persons to whom Non-Statutory Options or SARs may be</font></p>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>NOVAVAX,
INC. </B>2021 PROXY STATEMENT</FONT> <FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93"><B>|
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">A-1</FONT></B></P>

<!-- Field: Page; Sequence: 90 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #888A8C; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix A</B></FONT></P>
<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: #496D93 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><font style="font-style: normal">
granted shall be limited to persons employed by or providing services to the Company and its &ldquo;qualifying
subsidiaries.&rdquo; For these purposes, a &ldquo;qualifying subsidiary&rdquo; means a subsidiary in which the Company owns a
 &ldquo;controlling interest&rdquo; as described in Treasury Regulations &sect;1.409A-1(b)(5)(iii)(E)(1).</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>





<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(b)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Grant of Stock Awards to Directors and Officers</u><font style="font-style: normal">. In the discretion of the
Administrator, the selection of a director or officer (as defined for purposes of Rule 16b-3) as a Participant, and the terms of
any Stock Award granted to such Participant, including the grant date, the purchase or exercise price, the number of shares underlying
the Stock Award and other terms and conditions, shall be determined either (i) by the Board, of which all members shall be &ldquo;non-employee
directors&rdquo; (as hereinafter defined) or (ii) by the Compensation Committee, consisting of two or more directors having full
authority to act in the matter, each of whom shall be a &ldquo;non-employee director&rdquo; (with any action of the Compensation
Committee subject to approval or ratification by the Board, if required). For the purposes of the Plan, a director shall be deemed
to be a &ldquo;non-employee director&rdquo; only if such director qualifies as a &ldquo;non-employee director&rdquo; within the
meaning of Rule 16b-3.</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><B>4.</B></td><td style="text-align: justify"><B><U>Stock Subject to Plan</U>.</B></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(a)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Number
of Shares</u><font style="font-style: normal">. Subject to adjustment as provided in Section&nbsp;10 below, the maximum number
of shares of Common Stock that may be delivered in satisfaction of Stock Awards under the Plan shall be 12,400,000 shares. Subject
to adjustment as provided in Section&nbsp;10 below, the maximum aggregate number of shares that may be issued upon the exercise
of Incentive Stock Options shall in no event exceed 12,400,000 shares.</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(b)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Reversion of Shares to the Share Reserve</u><font style="font-style: normal">. Shares of Common Stock underlying
any Stock Award to the extent the Stock Award, for any reason, expires, terminates or is forfeited, in whole or in part, without
the issuance of shares, shall revert to and again become available for issuance under the Plan. Shares of Common Stock that are
retained or withheld by or delivered to the Company to satisfy any purchase or exercise price or tax withholding obligation, and
the total number of shares of Common Stock subject to a SAR any portion of which is settled in shares of Common Stock, will be
treated as issued under the Plan. The shares of Common Stock available for issuance pursuant to Section&nbsp;4(a) will not be increased
by any shares that have been delivered under the Plan that are subsequently repurchased using the proceeds directly attributable
to stock option exercises.</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(c)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Individual Limits</u>. <font style="font-style: normal">The following additional limits will apply to Stock Awards
of the specified type granted to any person in any calendar year:</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">(i)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>Options:
500,000 shares of Common Stock.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">(ii)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font>SARs: 500,000 shares of Common Stock.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">(iii)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</font>Stock Awards other than Options or SARs: 250,000 shares of Common Stock.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In applying the foregoing
limits, (A) all Stock Awards of the specified type granted to the same person in the same calendar year will be aggregated and
made subject to one limit; (B) the limits applicable to Options and SARs refer to the number of shares of Common Stock subject
to those Stock Awards; and (C) the share limit under clause (iii) refers to the maximum number of shares of Common Stock that may
be delivered, or the value of which could be paid in cash or other property, under a Stock Award or Stock Awards of the type specified
in clause (iii) assuming a maximum payout.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(d)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Non-employee
Director Limits</u>. <font style="font-style: normal">Notwithstanding any other provision of the Plan to the contrary, including
subsection (c) above, a Participant who is a non-employee director, in any calendar year, may not receive shares of Common Stock
underlying Stock Awards in excess of 100,000 shares. The foregoing limit shall not apply to any Stock Award or shares of Common
Stock granted pursuant to a director&rsquo;s election to receive shares of Common Stock in lieu of cash fees.</font></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellpadding="0" cellspacing="0" width="100%" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in"><B>5.</B></td><td style="text-align: justify"><B><U>Provisions Applicable to Options
                                         and Stock Appreciation Rights</U>.</B></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">(a)<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></FONT><U>Forms
of Award Agreements</U><FONT STYLE="font-style: normal">. As a condition to the grant of an Option or SAR under the Plan, each
recipient of an Option or SAR shall execute an Award Agreement in such form not inconsistent with the Plan  as may be approved
by the Administrator. Such Award Agreements may differ among Participants and among Stock Awards.</FONT></p>

<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</p>





<p style="font: italic 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-style: normal">(b)<font style="font-family: Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font></font><u>Exercise Price and Base Value</u>. <font style="font-style: normal">Subject to Section&nbsp;3(b), the exercise
price, or base value from which appreciation is to be measured, per share of Common Stock subject to a Stock Option or SAR, as
applicable, shall</FONT></P>



<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20"><B>A-2
</B></FONT><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #496D93">| </FONT></B><B><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #231F20">ir.novavax.com</FONT></B></P>


<!-- Field: Page; Sequence: 91 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="margin: 0; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">be
determined by the Administrator; <U>provided</U>, <U>however</U>, that the exercise price of an Option or base value of a SAR
shall not be less than 100% of the Fair Market Value of a share of Common Stock at the time of grant of such Option or SAR, or
less than 110% of such Fair Market Value in the case of an Incentive Stock Option granted to a Participant described in Section
6(b). Except in connection with a corporate transaction involving the Company (which term shall include, without limitation, any
stock dividend, stock split, extraordinary cash dividend, recapitalization, reorganization, merger, consolidation, split-up, spin-off,
combination, or exchange of shares) or as otherwise contemplated by Section 10 or Section 11 of the Plan, the Company may not,
without obtaining stockholder approval in accordance with the applicable requirements of the NASDAQ Global Select Market, (A)
amend the terms of outstanding Stock Options or SARs to reduce the exercise price or base value of such Stock Options or SARs,
(B) cancel outstanding Stock Options or SARs in exchange for Stock Options or SARs with an exercise price or base value that is
less than the exercise price or base value of the original Stock Options or SARs, or (C) cancel outstanding Stock Options or SARs
that have an exercise price or base value greater than the Fair Market Value of a share of Common Stock on the date of such cancellation
in exchange for cash or other consideration.&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;<I><U>Payment of Exercise Price</U>.</I> Payment of the exercise price of Options granted under the Plan shall be
made by delivery of cash or a check to the order of the Company in an amount equal to the exercise price of such Options or through
a broker-assisted exercise program acceptable to the Administrator, or, to the extent legally permissible and acceptable to the
Administrator, (i) by delivery to the Company of shares of Common Stock of the Company already owned by the Participant having
a Fair Market Value equal in amount to the exercise price of the Options being exercised, (ii) through the withholding of shares
of Common Stock otherwise to be delivered upon exercise of the Option having a Fair Market Value equal to the aggregate exercise
price of the Option being exercised, or (iii) by any other means approved by the Administrator. The fair market value of any non-cash
consideration which may be delivered upon exercise of an Option shall be determined by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;<I><U>Maximum Term</U>.</I> Except as otherwise provided in Section 6 regarding Incentive Stock Options, Options and
SARs will have a maximum term of 10 years from the date of grant, subject to earlier termination as provided in the Plan or the
applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;<I><U>Exercise of Options and SARs</U>.</I> Unless the Administrator expressly provides otherwise, no Option or SAR
will be deemed to have been exercised until the Administrator receives a notice of exercise (in form acceptable to the Administrator),
which may be an electronic notice, signed (including electronic signature in form acceptable to the Administrator) by the appropriate
person and, in the case of an Option, accompanied by any payment required under the Option. An Option or SAR exercised by any
person other than the Participant will not be deemed to have been exercised until the Administrator has received such evidence
as it may require that the person exercising the Stock Award has the right to do so. Notwithstanding the foregoing, unless otherwise
provided by the Administrator in an Award Agreement, if (i) a Participant holds an outstanding but unexercised Option or SAR on
the date that is ten (10) years from the date of grant (or, in the case of an Option or SAR with a maximum term of less than ten
(10) years, the last day of such maximum term) and has not exercised such Option or SAR as of the regular closing time of the
exchange on which the Common Stock is traded on the last day of the applicable term of the Option or SAR, (ii) on such date the
Common Stock is publicly traded, and (iii) at such time the Fair Market Value of a share of Common Stock is greater than the exercise
price or base value applicable to such Option or SAR, such Option or SAR, to the extent then vested and exercisable, shall be
automatically exercised on the last day of the applicable term, and the number of shares of Common Stock otherwise to be delivered
upon exercise of the Option or SAR shall be reduced by, in the case of an Option, a number of shares having a Fair Market Value
equal to the aggregate exercise price of the Option being exercised and, in the case of an Option or SAR, a number of shares having
a Fair Market Value equal to the amount necessary to satisfy any applicable tax withholding obligation (but not in excess of the
maximum withholding amount consistent with the award being subject to equity accounting treatment under the Accounting Rules).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(f)
 &nbsp;&nbsp;<I><U>Vesting and Effect of Termination of Employment or Other Service Relationship</U></I>. Subject to Section 8(b)
below, the Administrator will determine the time or times at which an Option or SAR will vest or become exercisable and the terms
on which an Option or SAR will remain exercisable. Unless the Administrator expressly provides otherwise, however, the following
rules will apply when a Participant&rsquo;s employment or other service relationship with the Company ceases:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;Immediately upon the cessation of the Participant&rsquo;s employment or other service relationship and except as provided
in (ii) and (iii) below, each Option or SAR that is then held by the Participant or by the Participant&rsquo;s permitted transferees,
if any, will cease to be exercisable and will terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-3</B></FONT></P>




<!-- Field: Page; Sequence: 92; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;Subject to (iii) and (iv) below, all Options and SARs held by the Participant or the Participant&rsquo;s permitted
transferees, if any, immediately prior to the cessation of the Participant&rsquo;s employment or other service relationship with
the Company, to the extent then exercisable, will remain exercisable for the lesser of (i) a period of three months or (ii) the
period ending on the latest date on which such Option or SAR could have been exercised without regard to this Section 5(f)(ii),
and will thereupon immediately terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iii)
 &nbsp;&nbsp;All Options and SARs held by a Participant or the Participant&rsquo;s permitted transferees, if any, immediately prior
to (A) the cessation of the Participant&rsquo;s employment or other service relationship due to his or her death or disability
(within the meaning of Section 22(e)(3) of the Code or any successor provision thereto) or (B) the Participant&rsquo;s death within
three months following the Participant&rsquo;s termination of employment, to the extent then exercisable, will remain exercisable
for the lesser of (i) a period of twelve (12) months or (ii) the period ending on the latest date on which such Option or SAR
could have been exercised without regard to this Section 5(f)(iii), and will thereupon immediately terminate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iv)
 &nbsp;&nbsp;All Options and SARs (whether or not exercisable) held by a Participant or the Participant&rsquo;s permitted transferees,
if any, immediately prior to the cessation of the Participant&rsquo;s employment or other service relationship with the Company
will immediately terminate upon such cessation of employment or other service relationship if the termination is for Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>6.&nbsp;&nbsp;&nbsp;<U>Special
Provisions for Incentive Stock Options</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options
granted under the Plan which are intended to be Incentive Stock Options shall be subject to the following additional terms and
conditions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I><U>Express Designation</U>.</I> All Incentive Stock Options granted under the Plan shall, at the time of grant,
be specifically designated as such in the Award Agreement evidencing the grant of Incentive Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)&#8239;&#8239;&#8239;&#8239;<U>10%
Stockholder</U>. If any employee to whom an Incentive Stock Option is to be granted under the Plan is, at the time of the grant of such
Option, the owner of stock possessing more than 10% of the total combined voting power of all classes of stock of the Company (after
taking into account the attribution of stock ownership rules of Section 424(d) of the Code), then the following special provisions shall
be applicable to the Incentive Stock Option granted to such employee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;the exercise price per share of the Common Stock subject to such Incentive Stock Option shall not be less than 110%
of the Fair Market Value of one share of Common Stock at the time of grant; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;the Option may not be exercisable after the expiration of five years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(c)&#8239;&#8239;&#8239;&#8239;<I><U>Dollar Limitation</U>.</I> For so long as the Code shall so provide, Options granted to any employee under the
Plan (and any other incentive stock option plans of the Company) which are intended to be Incentive Stock Options shall not be
Incentive Stock Options to the extent that such Options, in the aggregate, become exercisable for the first time in any one calendar
year for shares of Common Stock with an aggregate Fair Market Value (determined as of the respective date or dates of grant) of
more than $100,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(d)&#8239;&#8239;&#8239;&#8239;<I><U>Continuous Employment</U>.</I> Except as provided in Section 5(f) above, no Incentive Stock Option may be exercised
unless, at the time of such exercise, the Participant is, and has been continuously since the date of grant of the Option, employed
by the Company. For all purposes of the Plan and any Incentive Stock Option granted hereunder, &ldquo;employment&rdquo; shall
be defined in accordance with the provisions of Section 1.421-1(h) of the Income Tax Regulations (or any successor regulations).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Provisions
of Other Stock Awards</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;&#8239;<I><U>Restricted Stock Awards</U>.</I> As a condition to the grant of an award of Restricted Stock under the Plan,
each recipient of Restricted Stock shall execute an Award Agreement. The terms and conditions of such Restricted Stock Award Agreements
may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical;
<U>provided</U>, <U>however</U>, that each Restricted Stock Award Agreement shall include</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>A-4
| ir.novavax.com</B></FONT></P>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(through
incorporation of the provisions hereof by reference in the Award Agreement or otherwise) the substance of each of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;<I><U>Purchase Price</U>.</I> At the time of the grant of an award of Restricted Stock, the Administrator will determine
the price to be paid by the Participant for each share subject to the award, if any.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(ii)
 &nbsp;&nbsp;<I><U>Consideration</U>.</I> At the time of the grant of an award of Restricted Stock, the Administrator will determine
the consideration permissible for the payment of the purchase price of the Restricted Stock. The purchase price of the shares
of Common Stock acquired pursuant to an award of Restricted Stock shall be paid in one of the following ways: (i) in cash at the
time of purchase; (ii) by services rendered or to be rendered to the Company; or (iii) in any other form of legal consideration
that may be acceptable to the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iii)
 &nbsp;&nbsp;<I><U>Vesting</U>.</I> At the time of grant of an award of Restricted Stock, the Administrator will determine the
conditions under which shares of Restricted Stock will vest or no longer be subject to a substantial risk of forfeiture or repurchase
option in favor of the Company, which conditions will be set forth in the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iv)
 &nbsp;&nbsp;<I><U>Termination of Participant&rsquo;s Service</U>.</I> Except as otherwise provided in the applicable Award Agreement,
shares of Restricted Stock that have not vested will be forfeited upon the termination of the Participant&rsquo;s employment or
other service relationship with the Company for any reason.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)&nbsp;&nbsp;
<I><U>Restricted Stock Units</U>.</I> As a condition to the grant of RSUs under the Plan, each recipient of an RSU shall execute
an RSU Award Agreement in such form not inconsistent with the Plan as may be approved by the Administrator. The terms and conditions
of RSU Award Agreements may change from time to time, and the terms and conditions of separate RSU Award Agreements need not be
identical; <U>provided</U>, <U>however</U>, that each RSU Award Agreement shall include (through incorporation of the provisions
hereof by reference in the Award Agreement or otherwise) the substance of each of the following provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(i)&nbsp;&nbsp;<I><U>Consideration</U>.
</I>At the time of grant of an award of RSUs, the Administrator will determine the consideration, if any, to be paid by the Participant
upon delivery of each share of Common Stock subject to the award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(ii)&nbsp;&nbsp;<I><U>Vesting</U>.
</I>At the time of the grant of an award of RSUs, the Administrator may impose such restrictions or conditions to the vesting
of the shares subject to the award as it deems appropriate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iii)&nbsp;&nbsp;<I><U>Payment</U>.
</I>RSUs may be settled by the delivery of shares of Common Stock, their cash equivalent, or a combination of the two, as the
Administrator deems appropriate. Settlement of RSUs shall occur no later than two and one-half (2<SUP>1</SUP>/<SUB>2</SUB>) months
following the year in which such RSUs vest, unless the applicable Award Agreement expressly provides that the award of RSUs is
intended to comply with the rules applicable to non-qualified deferred compensation under Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(iv)&nbsp;&nbsp;<I><U>Termination
of Participant&rsquo;s Service</U>.</I> Except as otherwise provided in the applicable Award Agreement, RSUs (and any related
dividend equivalents) that have not vested will be forfeited upon the termination of the Participant&rsquo;s employment or other
service relationship with the Company for any reason and RSUs, whether vested or unvested, will be forfeited immediately upon
the termination of the Participant&rsquo;s employment or other service relationship with the Company if the termination is for
Cause.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional
Terms Applicable to all Stock Awards</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;<I><U>Award Provisions</U>.</I> The Administrator will determine the terms of all Stock Awards, subject to the limitations
provided in the Plan. By accepting (or, under such rules as the Administrator may prescribe, being deemed to have accepted) a
Stock Award, the Participant will be deemed to have agreed to the terms of the Stock Award and the Plan. Notwithstanding any provision
of this Plan to the contrary, awards of an acquired company that are converted, replaced or adjusted in connection with the acquisition
may contain terms and conditions that are inconsistent with the terms and conditions specified herein, as determined by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;<I><U>Vesting</U>.</I> Notwithstanding anything provided in Section 5(f), Section 7(a)(iii), Section 7(b)(ii) or Section
11 hereof, no Stock Award shall vest prior to the first anniversary of the grant date. Notwithstanding the foregoing, a number
of shares of Common Stock not exceeding 5% of the number of shares of Common Stock that may be delivered in satisfaction of Stock
Awards may be delivered in satisfaction of Stock Awards that are not subject to the minimum vesting period specified in the preceding
sentence. Nothing in this Section 8(b) shall preclude the Administrator from taking action, in its sole discretion, to accelerate
the vesting of any Stock Award in connection with</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-5</B>&nbsp;</FONT></P>




<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">or
following the cessation of a Participant&rsquo;s employment or other service relationship due to his or her death or disability
(within the meaning of Section 22(e)(3) of the Code or any successor provision thereto), or accelerating the vesting of Stock
Awards pursuant to Section 11 below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;<I><U>Nontransferability of Stock Awards</U>.</I> Except as provided in this Section 8(c), Stock Awards shall not
be assignable or transferable by the person to whom they are granted, either voluntarily or by operation of law, other than by
will or the laws of descent and distribution, and, in the case of Options and SARs, during the life of the Participant, shall
be exercisable only by the Participant. Awards, other than Incentive Stock Options, may be transferred pursuant to a domestic
relations order (within the meaning of Rule 16a-12 promulgated under the Exchange Act) or as otherwise expressly permitted by
the Administrator in the applicable Award Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;<I><U>Investment Representations</U>.</I> The Company may require any person to whom a Stock Award is granted, as
a condition of receiving or exercising such Stock Award, as applicable, to give written assurances in substance and form satisfactory
to the Company to the effect that such person is acquiring the Common Stock subject to the Stock Award for his or her own account
for investment and not with any present intention of selling or otherwise distributing the same, and to such other effects as
the Company deems necessary or appropriate in order to comply with federal and applicable state securities laws, or with covenants
or representations made by the Company in connection with any public offering of its Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;<I><U>Compliance with Securities Laws</U>.</I> Each Stock Award shall be subject to the requirement that if, at any
time, counsel to the Company shall determine that the listing, registration or qualification of the shares subject to such Stock
Award upon any securities exchange or under any state or federal law, or the consent or approval of any governmental or regulatory
body, or that the disclosure of non-public information or the satisfaction of any other condition is necessary as a condition
of, or in connection with, the issuance or purchase of shares thereunder, such Stock Award may not be issued or exercised, as
applicable in whole or in part, unless such listing, registration, qualification, consent or approval, or satisfaction of such
condition shall have been effected or obtained on conditions acceptable to the Administrator. Nothing herein shall be deemed to
require the Company to apply for or to obtain such listing, registration or qualification, or to satisfy such condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(f)
 &nbsp;&nbsp;<I><U>Additional Restrictions</U>.</I> The Administrator may cancel, rescind, withhold or otherwise limit or restrict
any Stock Award at any time if the Participant is not in compliance with all applicable provisions of the applicable Award Agreement
and the Plan, or if the Participant breaches any agreement with the Company with respect to non-competition, non-solicitation
or confidentiality. Without limiting the generality of the foregoing, the Administrator may recover Stock Awards made under the
Plan and payments under or gain in respect of any Stock Award in accordance with any applicable Company clawback or recoupment
policy, as such policy may be amended and in effect from time to time, or as otherwise required by applicable law or applicable
stock exchange listing standards, including, without limitation, Section 10D of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(g)
 &nbsp;&nbsp;<I><U>Dividend Equivalents, Etc</U>.</I> The Administrator may provide for the payment of amounts (on terms and subject
to conditions established by the Administrator) in lieu of cash dividends or other cash distributions with respect to Common Stock
subject to a Stock Award whether or not the holder of such Stock Award is otherwise entitled to share in the actual dividend or
distribution in respect of such Stock Award. Any entitlement to dividend equivalents or similar entitlements will be established
and administered either consistent with an exemption from, or in compliance with, the requirements of Section 409A. Dividends
or dividend equivalent amounts payable in respect of Stock Awards that are subject to restrictions may be subject to such limits
or restrictions as the Administrator may impose. Notwithstanding the foregoing, no dividends or dividend equivalents may be paid
to a Participant in connection with a Stock Award prior to the date on which such Stock Award vests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(h)&nbsp;&nbsp;<I>[Reserved.]</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(i)
 &nbsp;&nbsp;<I><U>Coordination with Other Plans</U>.</I> Stock Awards under the Plan may be granted in tandem with, or in satisfaction
of or substitution for, other Stock Awards under the Plan or awards made under other compensatory plans or programs of the Company.
For example, but without limiting the generality of the foregoing, awards under other compensatory plans or programs of the Company
may be settled in Common Stock (including, without limitation, Unrestricted Stock) if the Administrator so determines, in which
case the shares delivered will be treated as awarded under the Plan (and will reduce the number of shares thereafter available
under the Plan in accordance with the rules set forth in Section 4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>A-6
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(j)
 &nbsp;&nbsp;<I><U>Section 409A</U>.</I> Each Award Agreement will contain such terms as the Administrator determines, and will
be construed and administered, such that the Stock Award either qualifies for an exemption from the requirements of Section 409A
or satisfies such requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>9.&nbsp;&nbsp;&nbsp;<U>Rights
as a Stockholder</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nothing
in the Plan will be construed as giving any person the rights as a stockholder with respect to any shares of Common Stock underlying
a Stock Award (including, without limitation, any rights to receive dividends or non-cash distributions with respect to such shares)
except as to shares of Common Stock actually issued under the Plan. Except as otherwise provided in an Award Agreement, no adjustment
shall be made for dividends or other rights for which the record date is prior to the date such shares of Common Stock are issued.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>10.&nbsp;&nbsp;<U>Adjustment
Provisions for Recapitalizations and Related Transactions</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)&nbsp;&nbsp;If
(i) the outstanding shares of Common Stock are (A) exchanged for a different number or kind of shares or other securities of the
Company or (B) increased or decreased as a result of any recapitalization, reclassification, stock dividend, stock split or reverse
stock split or (ii) additional shares or new or different shares or other securities of the Company or other non-cash assets are
distributed with respect to such shares of Common Stock or other securities, an appropriate and proportionate adjustment shall
be made to (1) the maximum number and kind of shares reserved for issuance under the Plan, (2) the maximum number of shares that
can be issued upon exercise of Incentive Stock Options under the Plan, (3) the limitations on Stock Awards pursuant to Section
4(c) and (d), (4) the number and kind of shares or other securities subject to any then outstanding Stock Awards under the Plan,
and (5) the exercise or purchase prices (or base values) relating to Stock Awards and any other provision of Stock Awards affected
by such change, without (in the case of Options or SARs) changing the aggregate exercise price or base values for such Stock Awards.
Any adjustment made pursuant to this Section 10 shall be made by the Administrator having due regard, where applicable, for the
qualification of Incentive Stock Options under Section 422 and the requirements of Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;Any adjustments under this Section 10 will be made by the Administrator, whose determination as to what adjustments,
if any, will be made and the extent thereof will be final, binding and conclusive. No fractional shares will be issued under the
Plan on account of any such adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>11.&nbsp;&nbsp;<U>Merger,
Consolidation, Asset Sale, Liquidation, etc</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;<I><U>General</U>.</I> In the event of (i) a consolidation, merger, combination or reorganization of the Company in
which outstanding shares of Common Stock are exchanged for securities, cash or other property of any other corporation or business
entity, (ii) the sale, lease or other disposition of all or substantially all of the assets of the Company, (iii) a transaction
or series of related transactions involving a person or entity, or a group of affiliated persons or entities (but excluding any
employee benefit plan or related trust sponsored or maintained by the Company or an affiliate) in which such persons or entities
become the owners, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined
voting power of the Company&rsquo;s then outstanding securities (a &ldquo;<B><I>Securities Acquisition</I></B>&rdquo;) other than
by virtue of a merger, consolidation or similar transaction, or (iv) a dissolution or liquidation of the Company (hereinafter,
each of the events described in (i) through (iv) above shall be a &ldquo;<B><I>Corporate Transaction</I></B>&rdquo;), if Stock
Awards are not assumed, or equivalent stock awards are not substituted, by the acquiring or succeeding corporation (or an affiliate
thereof), the Administrator will provide that all or any outstanding Stock Awards shall become vested and exercisable (or that
any reacquisition or repurchase rights held by the Company shall lapse) at or immediately prior to such event, and will (1) upon
written notice to the Participants, provide that all Stock Awards that are outstanding, whether vested or unvested and whether
exercisable or unexercisable, including Stock Awards that are &ldquo;out-of-the-money&rdquo; or &ldquo;underwater,&rdquo; will
terminate immediately prior to the consummation of a Corporate Transaction, unless exercised (to the extent then vested and exercisable)
by the Participant within a specified period following the date of such notice, if applicable, or (2) in the event of a consolidation,
merger, combination, reorganization or Securities Acquisition under the terms of which holders of the Common Stock of the Company
will receive upon consummation thereof a payment for each share surrendered in the transaction (the &ldquo;<B><I>Sale Price</I></B>&rdquo;),
make or provide for a cash payment to the Participant equal to the difference between (A) the Sale Price times the number of shares
of Common Stock subject to such outstanding Stock Awards (to the extent then vested or exercisable at prices not in excess of
the Sale Price), and (B) the aggregate exercise price of all such outstanding Stock Awards (to the extent then vested or exercisable
at prices not in excess of the Sale Price) in exchange for the termination of such Stock Awards. In the event of a Corporate Transaction,
if such Stock Awards are assumed, or equivalent stock awards are substituted, by the acquiring or succeeding corporation (or an
affiliate thereof), the Administrator shall provide that such Stock Awards shall continue in existence with appropriate adjustments
or modifications, provided that any such</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-7</B></FONT></P>




<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">options
substituted for Incentive Stock Options shall meet the requirements of Section 424(a) of the Code. Notwithstanding anything to
the contrary in this Section 11(a), the vesting of any performance-based Stock Awards will be determined based on the greater
of (i) assumed achievement of the applicable performance goals at 100% of the performance target, as provided in the Award Agreement
with the result prorated based on the period of the Participant&rsquo;s actual employment or other service relationship with the
Company prior to the Corporate Transaction during the applicable full performance period, or (ii) actual achievement of the applicable
performance goals, as provided in the Award Agreement, through the date of the consummation of the Corporate Transaction. Except
as the Administrator may otherwise determine in any case, each Stock Award will automatically terminate (and in the case of outstanding
shares of Restricted Stock will be forfeited automatically) upon consummation of the Corporate Transaction, other than Stock Awards
assumed pursuant to clause (1) of this Section 11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)&nbsp;&nbsp;<I><U>Substitute
Options</U>.</I> The Company may grant Stock Awards under the Plan in substitution for Stock Awards held by employees of another
corporation who become employees of the Company, or a subsidiary of the Company, as the result of a merger, consolidation, combination
or reorganization of the employing corporation with the Company or a subsidiary of the Company, or as the result of the acquisition
by the Company, or one of its subsidiaries, of property or stock of the employing corporation. The Company may direct that substitute
Stock Awards be granted on such terms and conditions as the Administrator considers appropriate in the circumstances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>12.&nbsp;&nbsp;<U>No
Employment Rights</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nothing
contained in the Plan or in any Award Agreement shall confer upon any Participant any right with respect to the continuation of
his or her employment or other service relationship with the Company or interfere in any way with the right of the Company at
any time to terminate such employment or to increase or decrease the compensation of the Participant. The loss of existing or
potential profit in a Stock Award will not constitute an element of damages in the event of a termination of a Participant&rsquo;s
employment or other service relationship with the Company for any reason, even if the termination is in violation of an obligation
of the Company to the Participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>13.&nbsp;&nbsp;<U>Other
Employee Benefits</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Except
as to plans which by their terms include such amounts as compensation or as otherwise specifically determined by the Administrator,
the amount of any compensation deemed to be received by an employee as a result of the issuance of a Stock Award, the lapse of
any restrictions thereon, or the exercise of an Option or SAR, or the sale of shares received upon such exercise will not constitute
compensation for purposes of determining any other employee benefits of such employee, including, without limitation, benefits
under any bonus, pension, profit sharing, life insurance or salary continuation plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>14.&nbsp;&nbsp;<U>Amendment
of the Plan and Stock Awards</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;The Board may at any time, and from time to time, modify or amend the Plan in any respect, except that any such modification
or amendment (i) shall be subject to stockholder approval if the approval of the stockholders of the Company is required under
Section 422 or any successor provision with respect to Incentive Stock Options, Rule 16b-3 (if then applicable), or any other
applicable tax or securities law or stock exchange listing requirements, and (ii) shall not adversely affect the rights under
any Stock Award previously granted to a Participant without the Participant&rsquo;s consent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;With the consent of the affected Participant, the Administrator may amend outstanding Stock Award Agreements in a
manner not inconsistent with the Plan, <U>provided</U>, <U>however</U>, that, without the consent of the affected Participant,
the Administrator shall have the right to amend or modify (i) the terms and provisions of the Plan and of any outstanding Incentive
Stock Options granted under the Plan to the extent necessary to qualify any or all such Options for such favorable federal income
tax treatment (including deferral of taxation upon exercise) as may be afforded incentive stock options under Section 422, (ii)
the terms and provisions of the Plan and of any outstanding Stock Award to the extent necessary to ensure (A) the qualification
of the Plan under Rule 16b-3 (if then applicable) or (B) compliance with, or exemption from, Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>15.&nbsp;&nbsp;<U>Withholding</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;The delivery, vesting and retention of Common Stock, cash or other property under a Stock Award are conditioned upon
full satisfaction by the Participant of all tax withholding requirements with respect thereto. The Administrator will prescribe
such rules for the withholding of taxes as it deems appropriate. The Company shall have the right to deduct from payments of any
kind otherwise due to a Participant any federal, state or local taxes of any</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>A-8
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">kind
required by law to be withheld with respect to any shares of Common Stock issued, or cash or other property delivered, in settlement
of a Stock Award, upon the exercise of Options or SARs, and upon the lapse of any restrictions with respect to a Stock Award.
Subject to the prior approval of the Administrator, which may be withheld in its sole discretion, a Participant may elect (i)
to cause the Company to hold back shares of Common Stock from a Stock Award or (ii) to deliver to the Company shares of Common
Stock already owned by the Participant in satisfaction of tax withholding obligations but, in each case, not in excess of the
maximum withholding amount consistent with the award being subject to equity accounting treatment under the Accounting Rules.
The shares of Common Stock so delivered or held back shall have a Fair Market Value equal to such withholding obligation. The
Fair Market Value of the shares used to satisfy such withholding obligation shall be determined by the Company as of the date
that the amount of tax to be withheld is to be determined. A Participant who has made an election pursuant to this Section 15(a)
may only satisfy his or her withholding obligation with shares of Common Stock which are not subject to any repurchase, forfeiture,
unfulfilled vesting or other similar requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;Notwithstanding the foregoing, in the case of a Reporting Person, no election to use shares for the payment of withholding
taxes shall be effective unless made in compliance with any applicable requirements of Rule 16b-3 (unless it is intended that
the transaction not qualify for exemption under Rule 16b-3).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>16.&nbsp;&nbsp;<U>Effective
Date and Duration of the Plan</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;<I><U>Effective Date</U>.</I> The Plan is effective as of the Amendment Date, subject to its approval by the Company&rsquo;s
stockholders at the Company&rsquo;s annual meeting in 2021. If such stockholder approval is not obtained within twelve months
after the Amendment Date, Options and SARs granted under the Plan shall not vest and shall terminate and neither Options nor SARs
shall be granted thereafter under the Plan. Amendments to the Plan not requiring stockholder approval shall become effective when
adopted by the Board; amendments requiring stockholder approval (as provided in Section 14) shall become effective when adopted
by the Board, but no Options or SARs granted after the date of such amendment shall become exercisable (to the extent that such
amendment to the Plan was required to enable the Company to grant such Options or SARs) and no other Stock Award shall become
vested, unless and until such amendment shall have been approved by the Company&rsquo;s stockholders. If such stockholder approval
is not obtained within twelve months of the Board&rsquo;s adoption of such amendment, any Options or SARs granted on or after
the date of such amendment shall terminate to the extent that such amendment was required to enable the Company to grant such
Options or SARs. Subject to this limitation, Stock Awards may be granted under the Plan at any time after the Amendment Date and
before the termination of the Plan as provided in Section 16(b) below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)&nbsp;&nbsp;<I><U>Termination</U>.
</I>The Board may suspend or terminate the Plan at any time, except that such suspension or termination of the Plan shall not
adversely affect a Participant&rsquo;s rights under a Stock Award previously granted to the Participant while the Plan is in effect
without the consent of the Participant. Unless sooner terminated in accordance with this Section or Section 11, the Plan shall
terminate upon the close of business on the day immediately preceding the (10<SUP>th</SUP>) tenth anniversary of the Amendment
Date. Stock Awards outstanding on such date shall remain in force and effect in accordance with their terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>17.&nbsp;&nbsp;<U>Provision
for Foreign Participants; Sub Plans</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;The Administrator may, without amending the Plan, modify Stock Awards granted to Participants who are foreign nationals
or employed outside the United States to recognize differences in laws, rules, regulations or customs of such foreign jurisdictions
with respect to tax, securities, currency, employee benefit or other matters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;The Board may from time to time establish one or more sub-plans under the Plan for purposes of satisfying applicable
blue sky, securities or tax laws of various jurisdictions. The Board will establish such sub-plans by adopting supplements to
the Plan setting forth (i) such limitations on the Board&rsquo;s discretion under the Plan as it deems necessary or desirable
and (ii) such additional terms and conditions not otherwise inconsistent with the Plan as it deems necessary or desirable. All
supplements so established will be deemed to be part of the Plan, but each supplement will apply only to Participants within the
affected jurisdiction (as determined by the Administrator).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>18.&nbsp;&nbsp;<U>Miscellaneous</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;<I><U>Waiver of Jury Trial</U>.</I> By accepting a Stock Award under the Plan, each Participant waives any right to
a trial by jury in any action, proceeding or counterclaim concerning any rights under the Plan and any Stock Award, or under any
amendment, waiver, consent, instrument, document or other agreement delivered or which in the future may be delivered in connection
therewith, and agrees that any such action, proceedings or counterclaim will be tried before a court and not before a jury. By
accepting a Stock Award under the Plan, each Participant certifies that no</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-9</B></FONT></P>




<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">officer,
representative, or attorney of the Company has represented, expressly or otherwise, that the Company would not, in the event of
any action, proceeding or counterclaim, seek to enforce the foregoing waivers. Notwithstanding anything to the contrary in the
Plan, nothing herein is to be construed as limiting the ability of the Company and a Participant to agree to submit disputes arising
under the terms of the Plan or any Stock Award made hereunder to binding arbitration or as limiting the ability of the Company
to require any eligible individual to agree to submit such disputes to binding arbitration as a condition of receiving a Stock
Award hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;<I><U>Limitation of Liability</U>.</I> Notwithstanding anything to the contrary in the Plan, neither the Company nor
the Administrator, nor any person acting on behalf of the Company or the Administrator, will be liable to any Participant or to
the estate or beneficiary of any Participant or to any other holder of a Stock Award by reason of any acceleration of income,
or any additional tax (including any interest and penalties), by reason of the failure of a Stock Award to satisfy the requirements
of Section 422 or Section 409A or by reason of Section 4999 of the Code, or otherwise asserted with respect to the Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>19.&nbsp;&nbsp;<U>Governing
Law</U>.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;<I><U>Certain Requirements of Corporate Law</U>.</I> Stock Awards will be granted and administered consistent with
the requirements of applicable Delaware law relating to the issuance of stock and the consideration to be received therefor, and
with the applicable requirements of the stock exchanges or other trading systems on which the Common Stock is listed or entered
for trading, in each case as determined by the Administrator.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;<I><U>Other Matters</U>.</I> Except as otherwise provided by the express terms of an Award Agreement, under a sub-plan
described in Section 17(b) or as provided in Section 19(a) above, the provisions of the Plan and of Stock Awards under the Plan
and all claims or disputes arising out of or based upon the Plan or any Stock Award under the Plan or relating to the subject
matter hereof or thereof will be governed by and construed in accordance with the domestic substantive laws of the State of Maryland
without giving effect to any choice or conflict of laws provision or rule that would cause the application of the domestic substantive
laws of any other jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;<I><U>Jurisdiction</U>.</I> By accepting a Stock Award, each Participant will be deemed (a) to have submitted irrevocably
and unconditionally to the jurisdiction of the federal and state courts located within the geographic boundaries of the United
States District Court for the District of Maryland for the purpose of any suit, action or other proceeding arising out of or based
upon the Plan or any Stock Award; (b) to agree not to commence any suit, action or other proceeding arising out of or based upon
the Plan or a Stock Award, except in the federal and state courts located within the geographic boundaries of the United States
District Court for the District of Maryland; and (c) to have waived and agreed not to assert, by way of motion as a defense or
otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named
courts that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an
inconvenient forum, that the venue of the suit, action or proceeding is improper or that the Plan or a Stock Award or the subject
matter thereof may not be enforced in or by such court.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>A-10
| ir.novavax.com&nbsp;</B></FONT></P>




<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 18pt"><B>Exhibit
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Accounting
Rules</I></B>&rdquo;: Financial Accounting Standards Board Accounting Standards Codification Topic 718, or any successor provision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Administrator</I></B>&rdquo;:
The Compensation Committee, except that the Compensation Committee may delegate (i) to one or more of its members (or one or more
other members of the Board (including the full Board)) such of its duties, powers and responsibilities as it may determine; (ii)
to one or more officers of the Company the power to grant Stock Awards to the extent permitted by Section 157(c) of the Delaware
General Corporation Law; and (iii) to such employees or other persons as it determines such ministerial tasks as it deems appropriate.
In the event of any delegation described in the preceding sentence, the term &ldquo;Administrator&rdquo; will include the person
or persons so delegated to the extent of such delegation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Adoption
Date</I></B>&rdquo;: March 5, 2015</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Amendment
Date</I></B>&rdquo;: March 18, 2021</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Award
Agreement</I></B>&rdquo;: An agreement evidencing the grant of a Stock Award under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Board</I></B>&rdquo;:
The Board of Directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Cause</I></B>&rdquo;:
In the case of any Participant who is party to an employment or severance-benefit agreement that contains a definition of &ldquo;Cause,&rdquo;
the definition set forth in such agreement will apply with respect to such Participant under the Plan for so long as such agreement
is in effect. In the case of any other Participant, &ldquo;Cause&rdquo; will mean willful misconduct in connection with the Participant&rsquo;s
employment or service on behalf of the Company, or the willful failure of the Participant to perform his or her responsibilities
in the best interests of the Company (including, without limitation, breach, whether willful or not, by the Participant of any
provision of any employment or services agreement, nondisclosure, non-competition, non-solicitation or other similar agreement
between the Participant and the Company), as determined by the Board, which determination is conclusive. The Participant shall
be considered to have been discharged &ldquo;for cause&rdquo; if the Administrator determines, within 30 days after the termination
of the Participant&rsquo;s employment or other service relationship with the Company for any other purported reason, that discharge
for cause was warranted (and the Company may rescind the delivery of shares pursuant to any Stock Award in those circumstances).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Code</I></B>&rdquo;:
Internal Revenue Code of 1986, as amended or replaced from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Compensation
Committee</I></B>&rdquo;: The Compensation Committee of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Common
Stock</I></B>&rdquo;: The Company&rsquo;s common stock, $.01 par value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Company</I></B>&rdquo;:
Novavax, Inc. and the parent and all present and future subsidiaries of Novavax, Inc. as defined in Sections 424(e) and 424(f)
of the Code; <B><U>provided</U></B>, <B><U>however</U></B>, that status as a &ldquo;parent&rdquo; or &ldquo;subsidiary&rdquo;
corporation depends on satisfaction of the criteria in Sections 424(e) and (f) of the Code as of the date on which such determination
is being made and does not necessarily continue to exist merely because it existed as of the date of grant of an Option or other
Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Corporate
Transaction</I></B>&rdquo;: The meaning set forth in Section 11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Exchange
Act</I></B>&rdquo;: The Securities Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Fair
Market Value</I></B>&rdquo;: As of any date, the value of the Common Stock determined as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(1)
 &nbsp;&nbsp;If the Common Stock is listed on any established stock exchange, including but not limited to the NASDAQ Global Select
Market, the Fair Market Value of a share of Common Stock shall be the closing sales price for such stock (or the closing bid,
if no sales were reported) as quoted on such exchange (or in the case of multiple exchanges, the exchange with the greatest volume
of trading in the Common Stock) on the day of determination, as reported in <I>The Wall Street Journal</I> or such other source
as the Administrator deems reliable. If the day of determination is not a market trading day, then the trading day immediately
preceding the day of determination shall be used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-11</B></FONT></P>








<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(2)
 &nbsp;&nbsp;In the absence of such markets for the Common Stock, the Fair Market Value shall be determined in good faith by the
Administrator consistent with the requirements of Section 409A.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Incentive
Stock Options</I></B>&rdquo;: An Option intended to be an &ldquo;incentive stock option&rdquo; within the meaning of Section 422.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Non-Statutory
Options</I></B>&rdquo;: An Option that is not intended to be an Incentive Stock Option.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Option</I></B>&rdquo;:
An option entitling the holder to acquire shares of Common Stock upon payment of the exercise price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Participant</I></B>&rdquo;:
An individual who is granted or receives a Stock Award under the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Performance
Award</I></B>&rdquo;: A Stock Award subject to Performance Criteria.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Performance
Criteria</I></B>&rdquo;: Specified criteria, other than the mere continuation of employment or the mere passage of time, the satisfaction
of which is a condition for the grant, exercisability, vesting or full enjoyment of a Stock Award. A Performance Criterion may
include any measure or measures of performance relating to any or any combination of the following (measured either absolutely
or by reference to an index or indices and determined either on a consolidated basis or, as the context permits, on a divisional,
subsidiary, line of business, project or geographical basis or in combinations thereof): sales; revenues; assets; expenses; earnings
before or after deduction for all or any portion of interest, taxes, depreciation, amortization or equity expense, whether or
not on a continuing operations or an aggregate or per share basis; return on equity, investment, capital, capital employed or
assets; one or more operating ratios; operating income or profit, including on an after-tax basis; net income; borrowing levels,
leverage ratios or credit rating; market share; capital expenditures; cash flow; stock price; stockholder return; sales of particular
products or services; customer acquisition or retention; acquisitions and divestitures (in whole or in part); joint ventures,
strategic alliances, licenses or collaborations; spin-offs, split-ups and the like; reorganizations; recapitalizations, restructurings,
financings (issuance of debt or equity) or refinancings; manufacturing or process development; or achievement of clinical trial
or research objectives, regulatory or other filings or approvals or other product development milestones. A Performance Criterion
and any targets with respect thereto determined by the Administrator need not be based upon an increase, a positive or improved
result or avoidance of loss and may be based on objective or subjective individual goals. The Administrator may provide that a
Stock Award will be adjusted to reflect events (for example, the impact of charges for restructurings, discontinued operations,
mergers, acquisitions, extraordinary or other unplanned items, and other unusual or non-recurring items, and the cumulative effects
of tax or accounting changes) occurring during the performance period that affect the applicable Performance Criterion or Criteria.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Plan</I></B>&rdquo;:
The Novavax, Inc. 2015 Stock Incentive Plan, as amended and restated on the Amendment Date, and as further amended from time to
time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Reporting
Person</I></B>&rdquo;: Individuals who are required to file reports under Section 16(a) of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Restricted
Stock</I></B>&rdquo;: Common Stock subject to forfeiture or restrictions requiring that it be redelivered or offered for sale
to the Company if specified conditions are not satisfied.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Restricted
Stock Unit</I></B>&rdquo; or &ldquo;<B><I>RSU</I></B>&rdquo;: A Stock Unit that is, or as to which the delivery of Common Stock
or cash in lieu of Common Stock is, subject to the satisfaction of specified performance or other vesting conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Rule
16b-3</I></B>&rdquo;: Rule 16b-3 promulgated under the Exchange Act, or any successor rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Sale
Price</I></B>&rdquo;: The meaning set forth in Section 11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Section
422</I></B>&rdquo;: Section 422 of the Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Securities
Acquisition</I></B>&rdquo;: The meaning set forth in Section 11(a).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Stock
Appreciation Right</I></B>&rdquo; or &ldquo;<B><I>SAR</I></B>&rdquo;: A right entitling the holder upon exercise to receive an
amount (payable in cash or in shares of Common Stock of equivalent value) equal to the excess of the Fair Market Value of the
shares of Common Stock subject to the right over the base value from which appreciation under the SAR is to be measured.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>A-12
| ir.novavax.com</B></FONT></P>








<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
A</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Stock
Awards</I></B>&rdquo;: Any or a combination of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(a)
 &nbsp;&nbsp;Options (including Incentive Stock Options and Non-Statutory Options),</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(b)
 &nbsp;&nbsp;Stock Appreciation Rights,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(c)
 &nbsp;&nbsp;Restricted Stock,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(d)
 &nbsp;&nbsp;Unrestricted Stock,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(e)
 &nbsp;&nbsp;Stock Units,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(f)
 &nbsp;&nbsp;Restricted Stock Units, and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(g)
 &nbsp;&nbsp;Performance Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Stock
Unit</I></B>&rdquo;: An unfunded and unsecured promise, denominated in shares of Common Stock, to deliver Common Stock or cash
measured by the value of Common Stock in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&ldquo;<B><I>Unrestricted
Stock</I></B>&rdquo;: Common Stock not subject to any restrictions under the terms of the Stock Award.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>A-13</B></FONT></P>








<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 70%; background-color: rgb(81,112,148)">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 100%; padding: 4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt"><B>&nbsp;<FONT STYLE="color: White"><A NAME="a045"></A>APPENDIX
                                         B&mdash;STOCKHOLDER COMPLAINT</FONT></B></FONT></P></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 12pt"><B>IN
THE COURT OF CHANCERY OF THE STATE OF DELAWARE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding: 5.4pt 5.4pt 5.4pt 0; border-bottom: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">THOMAS
GOLUBINSKI, derivatively on behalf of Nominal Defendant NOVAVAX, INC.,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 2.75in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Plaintiff,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-vs-</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RICHARD
        H. DOUGLAS, STANLEY C. ERCK,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">GARY
        C. EVANS, GREGORY M. GLENN, JOHN A.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">HERRMANN
        III, RACHEL K. KING, MICHAEL A.</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">McMANUS,
        JR., RAJIV I. MODI, DAVID M. MOTT,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">BRIAN
        ROSEN, JOHN J. TRIZZINO, and</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">JAMES
        F. YOUNG,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 2.75in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Defendants,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">-and-</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">NOVAVAX,
        INC.,</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left; margin-left: 2.75in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Nominal
        Defendant.</FONT></P></TD>
    <TD STYLE="width: 50%; padding: 5.4pt; text-align: left; vertical-align: middle"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">C.A.
        No. 2021-0172-JRS</FONT></P>
                                                                                     <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">REVISED
        PUBLIC VERSION FILED</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">APRIL
        20, 2021</FONT></P></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>VERIFIED
STOCKHOLDER DERIVATIVE COMPLAINT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Plaintiff
Thomas Golubinski (&ldquo;<B>Plaintiff</B>&rdquo;), by and through his undersigned counsel, submits this verified stockholder
derivative complaint on behalf of nominal defendant Novavax, Inc. (&ldquo;<B>Novavax</B>&rdquo; or the &ldquo;<B>Company</B>&rdquo;)
against the defendants named herein for breach of fiduciary duty, corporate waste, and unjust enrichment. The allegations in this
complaint are based on Plaintiff&rsquo;s personal knowledge as to himself, and upon information and belief, including the investigation
of counsel, the review of publicly available information, and the review of books and records produced by the Company in response
to Plaintiff&rsquo;s demand under 8 <I>Del. C.</I> &sect; 220 (&ldquo;<B>Section 220</B>&rdquo;) as to all other matters. All
such books and records are expressly incorporated into this complaint. For the avoidance of doubt, this incorporation by reference
does not change the pleading standard applicable to any motion to dismiss that may be filed in this case.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>NATURE
OF THE ACTION</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">1.&nbsp;&nbsp;Plaintiff
brings this stockholder derivative action on behalf of Novavax against the Company&rsquo;s directors and certain of its executive
officers to remedy directors&rsquo; wrongfully granting themselves and certain executive officers spring-loaded stock options
and restricted stock units to personally benefit from the timing and pricing of the grants. This misconduct has damaged the Company
and gives rise to claims for breach of fiduciary duty, waste of corporate assets, and unjust enrichment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2.&nbsp;&nbsp;Novavax
describes itself as a late-stage biotechnology company that promotes global health through the discovery, development, and commercialization
of innovative vaccines to prevent serious infectious diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3.&nbsp;&nbsp;Although
Novavax has not succeeded in bringing a vaccine to market in its 33-year history, on February 26, 2020, the Company announced
that it had made progress in its efforts to develop a vaccine to protect against COVID-19.<SUP>1</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">4.&nbsp;&nbsp;In
connection with these efforts, Novavax announced in March 2020 that it had received $4 million in funding from the Coalition for
Epidemic Preparedness Innovations (&ldquo;<B>CEPI</B>&rdquo;), an international nonprofit that gives money to vaccine developers.
The Company also disclosed that it was engaged in ongoing discussions with CEPI regarding additional funding to address the costs
of shepherding the COVID-19 vaccine trial through Phase 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>1</SUP>&nbsp;&nbsp;See
https://ir.novavax.com/news-releases/news-release-details/novavax-advances-development-novel-covid-19-vaccine.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-1</B></FONT></P>




<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">5.&nbsp;&nbsp;On
April 17 and 18, 2020, the Compensation Committee of the Company&rsquo;s board of directors (the &ldquo;<B>Board</B>&rdquo;) granted
certain named executive officers (&ldquo;<B>NEOs</B>&rdquo;) stock options, collectively representing 830,000 shares of the Company&rsquo;s
common stock (the &ldquo;<B>April 2020 Awards</B>&rdquo;). Another 2,612,850 options were granted to other Company employees at
the same meeting. The stock options had an exercise price of $19.08, which reflected the Company&rsquo;s closing price on April
17, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6.&nbsp;&nbsp;Just
over three weeks later, after the close of the market on May 11, 2020, Novavax announced that CEPI would grant up to $384 million
for the Phase 1 and Phase 2 trials of the Company&rsquo;s COVID-19 vaccine candidate, NVX-CoV2373.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">7.&nbsp;&nbsp;Unsurprisingly,
the price of Novavax&rsquo; stock surged nearly 60%, and kept rising over the next few days in response to the announcement. On
May 18, 2020, the Company&rsquo;s stock closed at $56.96, a <B>109% increase</B> from the closing price of $19.08 on April 17,
2020. This meteoric rise in the stock price resulted in $31,440,400 in aggregate gains for the NEOs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">8.&nbsp;&nbsp;Although
Novavax had described the March 2020 $4 million CEPI grant as a &ldquo;partial payment,&rdquo; the Company had not disclosed to
the market its total request for funding or the timeline of its continued negotiations with CEPI at the time it issued the April
2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">9.&nbsp;&nbsp;Moreover,
as of April 16, 2020, the Company was regularly lobbying multiple funding partners, including the Biomedical Advanced Research
and Development Authority (&ldquo;<B>BARDA</B>&rdquo;), a government office involved in Operation Warp Speed (&ldquo;<B>OWS</B>&rdquo;),
the U.S. government&rsquo;s $10 billion effort to develop and deliver a COVID-19 vaccine. The OWS program coordinates the development,
manufacturing, and distribution of COVID-19 countermeasures, between components of the Department of Health and Human Services,
including the Centers for Disease Control and Prevention, the FDA, the National Institutes of Health, the Department of Defense,
and BARDA. The Company&rsquo;s ongoing effort to obtain funding from BARDA was not disclosed to the public.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">10.&nbsp;&nbsp;In
a report distributed to the Board on June 25, 2020, senior management informed the Board, including recipients of the June 2020
Awards (defined below), that the Company should expect approximately $1 billion in funding from Operation Warp Speed within a
week. NOVA0000230-238.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">11.&nbsp;&nbsp;That
same day, the Board granted six non-employee directors and two NEOs options and restricted stock units (&ldquo;<B>RSUs</B>&rdquo;)
collectively representing 73,570 shares of common stock (the &ldquo;<B>June 2020 Awards</B>&rdquo;). Each stock option had an
exercise price of $83.54 per share, the closing price of the Company&rsquo;s stock that day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">12.&nbsp;&nbsp;Less
than two weeks later, on July 7, 2020, the Company issued a press release announcing that it had been selected to participate
in OWS. As part of the Company&rsquo;s participation in OWS, BARDA awarded Novavax $1.6 billion to complete late-stage clinical
development of its COVID-19 vaccine (the &ldquo;<B>OWS Grant</B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">13.&nbsp;&nbsp;Novavax&rsquo;
stock price again unsurprisingly soared, reaching a high of $111.77 that day and continuing to rise over the next few weeks. By
July 22, the stock price had reached $146.45, a 75% increase over the closing price on June 25 and a <B>668% increase</B> over
the closing price on April 17. The directors and officers made aggregate gains of $4,628,288 from the June 2020 Awards alone&mdash;on
top of the $31,440,400 that the NEOs made from the April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">14.&nbsp;&nbsp;By
granting and receiving both the April 2020 Awards and the June 2020 Awards without making appropriate disclosures to the market,
defendants violated their fiduciary duties to Novavax and its stockholders. The options and RSUs were &ldquo;spring-loaded,&rdquo;
<I>i.e</I>., granted just prior to the Company&rsquo;s release of material information reasonably expected to drive the market
price of the shares higher.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">15.&nbsp;&nbsp;The
Company&rsquo;s management exploited its relationships with regulators and influential players in the vaccine community to both
secure funding and position itself to receive even more funding for COVID-19 research prior to granting spring-loaded awards to
Company insiders who were in possession of material non-public information.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">16.&nbsp;&nbsp;Through
this derivative action, Plaintiff seeks rescission of the April 2020 Awards and the June 2020 Awards, or alternatively, to recover
for Novavax the damages caused by the misconduct alleged herein and to compel the recipients of the spring-loaded awards to disgorge
to Novavax the improper benefits they received.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-2
| ir.novavax.com</B></FONT></P>








<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>PARTIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>Plaintiff</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">17.&nbsp;&nbsp;Plaintiff
is a stockholder of Novavax, was a stockholder of Novavax at the time of the wrongdoing alleged herein and has been a stockholder
of Novavax continuously since July 1, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>Nominal
Defendant</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">18.&nbsp;&nbsp;Nominal
Defendant Novavax is a Delaware corporation based in Gaithersburg, Maryland. According to its website, it is a late-stage biotechnology
company focusing on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>Director
Defendants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">19.&nbsp;&nbsp;Defendant
Richard H. Douglas (&ldquo;<B>Douglas</B>&rdquo;) has been a director of Novavax since 2010 and is a member of the Audit Committee,
the Compensation Committee, and the Research &amp; Development Committee. According to the Company&rsquo;s Form Def 14A filed
on May 13, 2020 for the period ending June 25, 2020 (the &ldquo;<B>Proxy</B>&rdquo;), he received total compensation of $119,296
for fiscal year 2019. Douglas received 6,900 options and 3,450 RSUs in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">20.&nbsp;&nbsp;Defendant
Stanley C. Erck (&ldquo;<B>Erck</B>&rdquo;) has been the President and CEO of Novavax since April 19, 2011. Erck served as Interim
CFO of Novavax from November 10, 2017 to March 14, 2018 and as Principal Accounting Officer until March 14, 2018. He has been
a member of the Board since 2009. According to the Proxy, Erck&rsquo;s total compensation for fiscal year 2019 was $2,438,562.
Erck received 400,000 options from the April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">21.&nbsp;&nbsp;Defendant
Gary C. Evans (&ldquo;<B>Evans</B>&rdquo;) has been a member of the Board since 1998 and is a member of the Audit Committee and
Chair of the Nominating &amp; Corporate Governance Committee (the &ldquo;<B>Governance Committee</B>&rdquo;). According to the
Proxy, he received total compensation of $121,796 for fiscal year 2019. Evans received 6,900 options and 3,450 RSUs in the June
2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">22.&nbsp;&nbsp;Defendant
Rachel K. King (&ldquo;<B>King</B>&rdquo;) has been a member of the Board since 2018 and is a member of the Compensation Committee
and the Governance Committee. According to the Proxy, she received total compensation of $114,296 for fiscal year 2019. King received
6,900 options and 3,450 RSUs in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">23.&nbsp;&nbsp;Defendant
Michael A. McManus, Jr. (&ldquo;<B>McManus</B>&rdquo;) has been a member of the Board since 1998 and is Chair of the Audit Committee
and a member of Compensation Committee. According to the Proxy, he received total compensation of $134,296 for fiscal year 2019.
McManus received 6,900 options and 3,450 RSUs in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">24.&nbsp;&nbsp;Defendant
Rajiv I. Modi (&ldquo;<B>Modi</B>&rdquo;) has been a member of the Board since 2009.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">25.&nbsp;&nbsp;Defendant
David Mott (&ldquo;<B>Mott</B>&rdquo;) has been a member of the Board since June 16, 2020. Mott currently serves as Chair of the
Compensation Committee. Mott received 4,000 options in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">26.&nbsp;&nbsp;Defendant
James F. Young (&ldquo;<B>Young</B>&rdquo;) has been a member of the Board since April 2010 and was named Chairman of the Board
in April 2011. Young is a member of the Governance Committee and Chair of the Research &amp; Development Committee. Young was
Chair of the Compensation Committee during the issuance of both the April 2020 Awards and the June 2020 Awards. According to the
Proxy, he received total compensation of $223,741 for fiscal year 2019. Young received 15,180 options and 7,590 RSUs in the June
2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-3</B></FONT></P>








<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>Officer
Defendants</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">27.&nbsp;&nbsp;Defendant
Gregory M. Glenn (&ldquo;<B>Glenn</B>&rdquo;) has been the President of Research &amp; Development at Novavax since March 2016.
Glenn served as Senior Vice President of Research and Development at Novavax from January 13, 2014 to March 2016. Glenn served
as the Chief Medical Officer and Senior Vice President at Novavax from January 2011 to January 2014. Glenn served as the Chief
Scientific Officer of Novavax beginning in July 2010. According to the Proxy, he received total compensation of $1,875,198 for
fiscal year 2019. He received 165,000 options in the April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">28.&nbsp;&nbsp;Defendant
John A. Herrmann III (&ldquo;<B>Herrmann</B>&rdquo;) has served as Executive Vice President and Chief Legal Officer at Novavax
since June 2020. He was Senior Vice President of Novavax from June 2014 until June 2020 and acted as the Company&rsquo;s General
Counsel from March 8, 2012 until June 2020. Herrmann was Corporate Secretary of Novavax beginning in April 2010 and served as
Vice President of Novavax from March 8, 2012 to June 2014. Herrmann served as an Executive Director of Legal Affairs at Novavax
from April 2010 to March 2012. According to the Proxy, he received total compensation of $1,353,416 for fiscal year 2019. Herrmann
received 125,000 options in the April 2020 Awards and 2,500 RSUs in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">29.&nbsp;&nbsp;Defendant
Brian Rosen (&ldquo;<B>Rosen</B>&rdquo;) has been the Senior Vice President, Commercial Strategy at Novavax since June 2018. Rosen
was previously the Vice President, Government Affairs and Public Policy at Novavax from February 2015 through May 2018. Rosen
received 100,000 options in the April 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">30.&nbsp;&nbsp;Defendant
John Joseph Trizzino (&ldquo;<B>Trizzino</B>&rdquo;) has been Chief Business Officer and Treasurer of Novavax since March 14,
2018 and served as the Company&rsquo;s CFO from March 14, 2018 until November 2020. Trizzino was also a Senior Vice President
at Novavax until June 2020, when he was promoted to Executive Vice President. He has also served as the Chief Commercial Officer
at Novavax since November 2020. In this capacity, Trizzino is responsible for all pre-commercial and commercial launch strategy
and execution as well as public relations. According to the Proxy, he received total compensation of $1,465,602 for fiscal year
2019. Trizzino received 140,000 options in the April 2020 Awards and 2,500 RSUs in the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">31.&nbsp;&nbsp;Together,
defendants Douglas, Erck, Evans, Glenn, Herrmann, King, McManus, Modi, Mott, Rosen, Trizzino, and Young are the &ldquo;<B>Individual
Defendants</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>SUBSTANTIVE
ALLEGATIONS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>Background</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">32.&nbsp;&nbsp;Novavax
presents itself as a late-stage biotechnology company focusing on the discovery, development, and commercialization of vaccines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">33.&nbsp;&nbsp;Prior
to the onset of the COVID-19 pandemic, the Company&rsquo;s lead vaccine candidates included ResVax, an aluminum-adjuvanted vaccine
candidate aimed at treating respiratory syncytial virus (&ldquo;<B>RSV</B>&rdquo;), which causes lower respiratory tract infections
during infancy and early childhood. The vaccine, which is currently in Phase 3 clinical trials despite its failure to meet the
trial&rsquo;s primary efficacy endpoint, seeks to protect infants via maternal immunization.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">34.&nbsp;&nbsp;The
Company also is developing two additional RSV vaccines, one meant for older adults (60 years and older) that is in Phase 2 clinical
trials, and another for healthy children between six months to five years of age that has not yet progressed beyond Phase 1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">35.&nbsp;&nbsp;In
addition, Novavax is working on a vaccine for seasonal influenza in older adults (NanoFlu), a combination respiratory vaccine
to protect against influenza and RSV, as well as a vaccine to protect against Ebola. These therapies are in various stages of
clinical testing. The Company also has vaccine candidates for MERS and SARS in preclinical stages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">36.&nbsp;&nbsp;The
Company&rsquo;s proprietary adjuvant,<SUP>2</SUP> Matrix-M, is used in several of its vaccine candidates to enable a vaccine to
enhance the amplitude of the immune response and qualitatively change the way the immune system</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>2</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">An
                                         adjuvant is a pharmacological or immunological agent that improves the immune response
                                         of a vaccine. Adjuvants may be added to a vaccine to boost the immune response to produce
                                         more antibodies and longer-lasting immunity, thus minimizing the dose of antigen needed.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-4
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">attacks
microorganisms. It also allows immunization with much lower doses of antigen, which results in the need for fewer necessary vaccine
doses, as well as increased supply and manufacturing capacity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">37.&nbsp;&nbsp;Despite
its ongoing trials and its proprietary technology, the Company has never brought a vaccine to market in its 33-year history. Indeed,
its failures are well documented despite decades of public and private funding.<SUP>3</SUP> For example, its proposed vaccines
for SARS, MERS, and Ebola never progressed beyond early safety studies. In 2016, the Company laid off one-third of its staff after
its late-stage clinical trial to treat RSV in older people failed. Nevertheless, the Company was able to attract the attention
of the Bill &amp; Melinda Gates Foundation (the &ldquo;<B>Gates Foundation</B>&rdquo;), which decided to fund a second clinical
trial of the RSV vaccine with an $89 million grant. That study tested whether giving the vaccine to pregnant women would pass
the immunity to their newborns, who can become very sick from the virus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">38.&nbsp;&nbsp;That
trial, however, failed to meet its primary efficacy endpoint and the Company again found itself in such a dire financial crisis
that it needed a reverse 20 to 1 stock split to lift its share price to avoid being delisted from NASDAQ. To stave off closing,
Novavax sold its manufacturing facilities to Catalent for approximately $18 million. The sale included 100 workers, or about one-third
of the Company&rsquo;s work force at the time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">39.&nbsp;&nbsp;On
February 6, 2020, shares of Novavax traded at less than $7 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">40.&nbsp;&nbsp;As
stated above, Novavax&rsquo; pipeline was unpromising, and the Company experienced several setbacks throughout its history&mdash;despite
the backing of highly influential sponsors such as the Gates Foundation. The Company&rsquo;s relationship with the Gates Foundation,
however, had its benefits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">41.&nbsp;&nbsp;In
late February 2020, Dr. Richard Hatchett, head of CEPI, received a phone call from executives at the Gates Foundation.<SUP>4</SUP>
The Gates Foundation&rsquo;s representatives reportedly touted Novavax&rsquo; technology, which uses moth cells in an attempt
to build important molecules at a much faster rate than typical vaccines.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">42.&nbsp;&nbsp;This
outreach by the Gates Foundation soon set into motion a series of events resulting in the Company receiving numerous rounds of
government financing in support of COVID-19 vaccine research.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">43.&nbsp;&nbsp;Armed
with the non-public knowledge that powerful groups were advocating for Novavax to receive immense amounts of money despite its
long history of failure, Company directors began to award themselves and executives stock options and RSUs. They did so knowing
that the Company&rsquo;s stock price would skyrocket in response to the news, when it was eventually disclosed to the public.
<B><I>The Company&rsquo;s Incomplete Disclosures</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">44.&nbsp;&nbsp;On
February 26, 2020, the Company reported it &ldquo;produced and is currently assessing multiple nanoparticle vaccine candidates
in animal models prior to identifying an optimal candidate for human testing, which is expected to begin by the end of spring
2020&rdquo; to develop a COVID-19 vaccine. Purportedly, the COVID-19 vaccine candidate was an outgrowth of &ldquo;its proprietary
recombinant protein nanoparticle technology platform to generate antigens derived from the coronavirus spike (S) protein. Novavax
expected to utilize its proprietary Matrix-M<SUP>TM</SUP> adjuvant with its COVID-19 vaccine candidate to enhance immune responses.&rdquo;<SUP>5</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">45.&nbsp;&nbsp;Defendant
Erck stated that the Company&rsquo;s &ldquo;previous experience working with other coronaviruses, including both MERS and SARS,
allowed us to mobilize quickly against COVID-19 and successfully complete the critical preliminary steps to engineer viable vaccine
candidates.... Now that the protein has been expressed stably in our baculovirus system, we aim to identify the optimal candidate
and scale up production of sufficient vaccine for preliminary clinical trials. We are now well-positioned to advance the COVID-19
vaccine candidate to Phase I clinical testing in May or June.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">46.&nbsp;&nbsp;The
Gates Foundation&rsquo;s outreach to CEPI yielded an immediate dividend. On March 10, 2020, the Company announced it received
$4 million from CEPI &ldquo;to accelerate vaccine development to prepare for Phase 1.&rdquo; The press</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>3</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">See
                                         Katie Thomas and Megan Twohey, <I>How a Struggling Company Won $1.6 Billion to Make a
                                         Coronavirus Vaccine</I>, N.Y. Times, (July 16, 2020),</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>4</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">In
                                         addition to funding several of the Company&rsquo;s failed vaccine trials, the Gates Foundation
                                         also helped found CEPI and is one of its largest benefactors.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>5</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://ir.novavax.com/news-releases/news-release-details/novavax-advances-development-novel-covid-19-vaccine</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://www.nytimes.com/2020/07/16/health/coronavirus-vaccine-novavax.htmlsearchResultPosition=16.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-5</B></FONT></P>




<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">release
stated in general terms that CEPI and the Company &ldquo;are having ongoing discussions on additional funding from CEPI to address
Novavax&rsquo; costs through Phase 1.&rdquo; The Company further disclosed it had entered into an agreement with &ldquo;Emergent
BioSolutions, Inc. [&ldquo;<B>Emergent</B>&rdquo;] to provide contract development and manufacturing services, supplying Novavax
with vaccine product for preclinical testing and for use in its Phase 1 clinical trial.&rdquo; Dr. Hatchett also was quoted in
the press release as stating that &ldquo;CEPI has moved quickly and urgently to coordinate with global health authorities and
vaccine-development partners. CEPI is pleased to be partnering with Novavax to rapidly develop a potential vaccine candidate against
the global threat posed by COVID-19.&rdquo;<SUP>6</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">47.&nbsp;&nbsp;The
Company reiterated on March 11, 2020 in its Fourth Quarter and Full Year 2019 Financial Results that it received $4 million in
CEPI funding and was discussing additional funding from CEPI.<SUP>7</SUP> Erck stated that &ldquo;CEPI stepped out and provided
money virtually immediately for a portion of what the total ask was and with the expectation that they would have time to then
evaluate the rest of the grant. So it&rsquo;s a partial payment.&rdquo;<SUP>8</SUP> Erck, however, never disclosed the Company&rsquo;s
total request or timeline of the negotiations between CEPI and the Company. He merely disclosed a relatively nominal grant from
CEPI despite the Company&rsquo;s record of failures and made general forward-looking statements about the possibility of additional
funding sometime in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">48.&nbsp;&nbsp;On
March 19-20, 2020, the Board convened a meeting. In discussing the contents of the Company&rsquo;s upcoming 2020 Proxy Statement,
the Board recommended that the Proxy ask stockholders to approve the Company&rsquo;s Amended and Restated 2015 Stock Incentive
Plan (the &ldquo;<B>2015 Plan</B>&rdquo;) to increase the number of shares of common stock available for issuance under the plan
from 3,800,000 to more than 10,000,000. NOVA0000343-346. Accordingly, the Board was positioning itself to maximize the amount
of stock that could be issued under the 2015 Plan to themselves and others.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">49.&nbsp;&nbsp;On
April 8, 2020, the Company issued a press release identifying its COVID-19 vaccine candidate, NVX-CoV2373, as &ldquo;a stable,
prefusion protein made using Novavax&rsquo; proprietary nanoparticle technology, and [that it] will initiate a first-in-human
trial in mid-May. Novavax&rsquo; proprietary Matrix-M<SUP>TM</SUP> adjuvant will be incorporated with NVX-CoV2373 in order to
enhance immune responses and stimulate high levels of neutralizing antibodies.&rdquo; According to the Company, it was awarded
$4 million in funding from CEPI &ldquo;with additional funding discussions ongoing.&rdquo;<SUP>9</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">50.&nbsp;&nbsp;At
the same time, the Company began to apply pressure on government officials (including former Novavax employees working in the
federal government) to secure financing. This is evidenced by a whistleblower action filed by Dr. Rick Bright, who was the director
of BARDA until his removal in April 2020, which he alleges was politically motivated. In 2006, Dr. Bright worked in the private
sector as Vice President of Research and Development and Global Influenza Programs at Novavax overseeing the development of new
vaccines.<SUP>10</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">51.&nbsp;&nbsp;Dr.
Bright&rsquo;s complaint alleges that on April 10, 2020, Erck called Dr. Bright&rsquo;s office requesting to speak directly with
Dr. Bright about Novavax&rsquo; proposal for a COVID-19 vaccine. Since Novavax had already submitted a white paper about the vaccine
in response to a Broad Agency Announcement (&ldquo;<B>BAA</B>&rdquo;) issued by BARDA, federal law prohibited Dr. Bright from
speaking with Erck about the proposal. Dr. Bright&rsquo;s assistant thus informed Erck that BARDA could not discuss the proposal
at that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">52.&nbsp;&nbsp;Undeterred,
three days later, on April 13, 2020, Novavax&rsquo; Senior Vice President of Commercial Strategy, defendant Rosen, circumvented
Dr. Bright&rsquo;s office entirely and sent an email directly to Dr. Bright&rsquo;s supervisor, Dr. Kadlec, who served as the
Assistant Secretary for Preparedness and Response.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">53.&nbsp;&nbsp;In
his email, Rosen touted Novavax&rsquo; history of working with coronaviruses, provided information about &ldquo;recent milestones&rdquo;
in the Company&rsquo;s development of its COVID-19 vaccine candidate, and lauded the vaccine candidate as &ldquo;one of the earliest
and most promising.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>6</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://ir.novavax.com/news-releases/news-release-details/novavax-awarded-funding-cepi-covid-19-vaccine-development</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>7</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://ir.novavax.com/news-releases/news-release-details/novavax-reports-fourth-quarter-and-full-year-2019-financial</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>8</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transcript,
                                         Novavax, Fourth Quarter 2019 Financial Results (March 11, 2020).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>9</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://ir.novavax.com/node/14586/pdf.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>10</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">On
                                         November 9, 2020, Dr. Bright was named a member of President-elect Joe Biden&rsquo;s
                                         coronavirus advisory board. See https://www.cnn.com/2020/11/09/politics/biden-coronavirus-advisers-experts-rick-bright/index.html.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-6
| ir.novavax.com</B></FONT></P>








<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">54.&nbsp;&nbsp;The
whistleblower complaint further details that Dr. Kadlec responded to Rosen&rsquo;s email that he was &ldquo;looking forward to&rdquo;
speaking with him. <I>See</I> email from R. Kadlec to B. Rosen (Apr. 13, 2020), attached to the Whistleblower complaint as Exhibit
51.<SUP>11</SUP> The whistleblower complaint states that &ldquo;Dr. Bright, who received notice of his removal just four days
later, does not know whether Dr. Kadlec ultimately spoke to Novavax about its proposal but assumes that he did so. This of course
warrants further inquiry.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">55.&nbsp;&nbsp;On
April 16, 2020, the Board convened a meeting where it received an update on NVX-CoV2373, the Company&rsquo;s COVID-19 vaccine
candidate. In addition to members of the Board, Messrs. Glenn, Hermann, and Rosen, among other executives, were present. The discussion
addressed the need for financing to initiate large scale manufacturing and focused on leasing a facility in the Czech Republic
to scale up production. The Board then resolved to execute a non-binding term sheet for the facility subject to finalizing arrangements.
NOVA0000348. Given this discussion, it is reasonably conceivable that the Board soon expected to receive good news regarding additional
funding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">56.&nbsp;&nbsp;The
meeting then addressed &ldquo;funding activities&rdquo; led by Rosen. As of this date the Company only had received $4 million
from CEPI. As set forth above, it had already begun to violate myriad rules concerning contacting the government to exert pressure
on a former executive and his superior to secure funds. Indeed, the minutes reflect that Rosen reported on ongoing discussions
with CEPI, the Gates Foundation, the U.S. government, and a potential arrangement with Takeda Pharmaceutical Company Limited (&ldquo;<B>Takeda</B>&rdquo;).
NOVA0000027. None of this information (apart from the modest $4 million grant from CEPI) was public. <I>Id. See also</I> additional
Board report dated April 16, 2020, NOVA0000011-15 at NOVA0000012 (&ldquo;Agenda: ... 4. Funding.).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">57.&nbsp;&nbsp;The
Board also discussed management&rsquo;s recommendation not to propose an option exchange at the upcoming shareholder meeting but
rather to make an &ldquo;extraordinary grant to the Novavax employees that would be discussed&rdquo; at the next Compensation
Committee meeting. NOVA0000348. Simply stated, there was no longer any consideration concerning swapping out underwater options
but instead the plan was to grant new options that would be far more lucrative for their recipients.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">58.&nbsp;&nbsp;The
Board was presented with an additional report at the meeting, which was produced to Plaintiff with extensive redactions. Most
of the redactions address what could fairly be deemed proprietary scientific information. However, the report does discuss proposed
phased trials and leasing the facility in Prague. NOVA0000362-375.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">59.&nbsp;&nbsp;Accordingly,
as of April 16, 2020, the Company was in ongoing discussions and lobbying multiple funding partners including BARDA. None of this
information was released to the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>The
April 2020 Spring-Loaded Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">60.&nbsp;&nbsp;On
April 17, 2020, the Compensation Committee (at that time, Douglas, King, McManus, and Young) convened a meeting. Also present
at the meeting, among others, were Erck, Herrmann, and Trizzino.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">61.&nbsp;&nbsp;The
meeting approved a supplementary equity grant to the Company&rsquo;s executives and employees because of their work on developing
a possible COVID-19 vaccine. It was further resolved at the meeting that the equity grants would vest pursuant to the following
performance requirements: &ldquo;50% of such equity grants shall vest on the first anniversary of the initiation of a Phase 2
clinical trial&rdquo; of the Company&rsquo;s COVID-19 vaccine candidate and &ldquo;50% of such equity awards shall vest upon the
second anniversary of the initiation of such trial (the &ldquo;Performance Vesting Rule&rdquo;). Accordingly, the options would
vest regardless of the vaccine ever being approved or even demonstrating efficacy justifying Phase 3 trials. NOVA0000002-5.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>11</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Although
                                         this exhibit is cited in Dr. Bright&rsquo;s pleading, it is not readily available on
                                         the internet, while other exhibits are easily accessible. There is no explanation as
                                         to why some exhibits are in the public domain and others are not.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-7</B></FONT></P>




<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">62.&nbsp;&nbsp;The
chart below lists the options granted at the April 17, 2020 Compensation Committee meeting:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(81,112,148) 1pt solid; padding: 0 5.4pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Executive</B></FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: rgb(81,112,148) 1pt solid; padding: 0 5.4pt; text-align: center; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Option
    Shares</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 50%; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory
    Glenn</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 29%; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">165,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 21%; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    Trizzino</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">140,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Sven
    Andreasson</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Timothy
    Hahn</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    Herrmann</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Russell
    Wilson</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Jill
    Hoyt</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">115,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Jody
    Lichaa</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">115,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Brian
    Rosen</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">115,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Christopher
    Dunne</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gale
    Smith</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Brian
    Webb</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Kathleen
    Callahan</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">80,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Iksung
    Cho</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">80,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Biegie
    Lee</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">80,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Vivek
    Shinde</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: right; text-indent: 0; padding: 0 5.4pt; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">80,000</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 5.4pt; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">63.&nbsp;&nbsp;The
Compensation Committee convened again the following day, April 18 2020. According to the minutes, the Committee decided that Erck&rsquo;s
2019 equity grant did &ldquo;not sufficiently represent the value the Committee wanted.&rdquo; Accordingly, it was resolved that
Erck would be awarded &ldquo;400,000 incentive stock options...to purchase that specified number of shares of the Company&rsquo;s
Common Stock&rdquo; subject to the vesting rules established on April 17, 2020. The meeting, occurred over a 50-minute period.
NOVA0000190-192. The supplemental grants were approved by unanimous written consent of the Board dated April 20, 2020. NOVA0000092-93.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">64.&nbsp;&nbsp;The
following table lists the options granted to each NEO at the April 17 and 18, 2020 meetings of the Compensation Committee:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(81,112,148) 1pt solid; padding: 0 0 0 4pt; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Name</B></FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: rgb(81,112,148) 1pt solid; padding: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Position</B></FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(81,112,148) 1pt solid; padding: 0; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>Options</B></FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; width: 35%; text-align: justify; text-indent: 0; padding: 0 0 0 4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stanley
    C. Erck</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; width: 2%; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; padding: 0 0 0 40pt; vertical-align: bottom; width: 31%; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">President
    and CEO</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; width: 2%; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 30%; text-align: center; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">400,000</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 0 0 4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory
    M. Glenn, M.D.</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; padding: 0 0 0 40pt; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">President,
    R&amp;D</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">165,000</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 0 0 4pt; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    J. Trizzino</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; padding: 0 0 0 40pt; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">EVP,
    CBO and CFO</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; border-bottom: Gray 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">140,000</FONT></TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: bottom; text-align: justify; text-indent: 0; padding: 0 0 0 4pt; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    A. Herrmann III</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: rgb(81,112,148) 1pt solid; padding: 0 0 0 40pt; vertical-align: bottom; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">EVP,
    Chief Legal Officer</FONT></TD>
    <TD STYLE="text-align: justify; text-indent: 0; padding: 0; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; padding: 0; border-bottom: rgb(81,112,148) 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">125,000</FONT></TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">65.&nbsp;&nbsp;On
May 11, 2020, the Company suddenly announced, in the wake of the option awards, that it received an additional $384 million in
funding from CEPI for COVID-19 vaccine development and manufacturing. The press release quoted Dr. Hatchett, the head of CEPI,
as describing the grant as an &ldquo;expansion of our partnership with Novavax [that] represents CEPI&rsquo;s single biggest investment
to date.&rdquo;<SUP>12</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">66.&nbsp;&nbsp;The
press release stated CEPI will invest up to $384 million of additional funding, &ldquo;on top of $4 million it invested in March,
to advance clinical development of NVX-CoV2373, Novavax&rsquo; coronavirus vaccine candidate against SARS-CoV-2.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">67.&nbsp;&nbsp;The
Company&rsquo;s stock immediately soared 30% ahead of the market close. This, of course, would have been anticipated by anyone
who knew the gravity of the news prior to its disclosure. Then, after the closing bell, the stock surged another 54%. Novavax&rsquo;
stock price kept rising over the next few days in response to the announcement. On May 18, 2020, the stock price closed at $56.96,
a 109% increase over the closing price of $19.08 on April 17, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>12</SUP>&nbsp;&nbsp;https://ir.novavax.com/node/14611/pdf.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-8
| ir.novavax.com</B></FONT></P>










<!-- Field: Page; Sequence: 110; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Since
the exercise price of the April 2020 Awards was equal to the closing price on the grant date, the NEOs recorded $31,440,399 in
aggregate gains as of May 18, 2020 reflected in the chart below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: red"><IMG SRC="tm212692d3_sch14-aimg145.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0; color: red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">68.&nbsp;&nbsp;The
generous grants on the eve of receiving extraordinary funding support the reasonable inference that the Company was in negotiations
with CEPI&mdash;before the grants were awarded&mdash;to receive an amount of funding that far exceeded the initial, modest $4
million that the Gates Foundation had secured on behalf of the Company though it had it never brought a product to market. A July
16, 2020 article in <I>The New York Times</I> reported that CEPI &ldquo;took note in March when, weeks after it awarded Novavax
its initial $4 million contract, [] the company announced that its flu vaccine had succeeded in a late-stage clinical trial&mdash;its
first major success, and an important validation of its underlying vaccine technology.&rdquo;<SUP>13</SUP> Therefore, it is likely
that the Board knew that CEPI intended to make further investments, and it had an idea of the amount and the timeline of the second
CEPI investment when it awarded the NEOs and other employees stock options on April 17 and 18, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">69.&nbsp;&nbsp;That
the directors awarded themselves and the NEOs spring loaded grants knowing that spectacular news was on the immediate horizon
is further evidenced by Erck&rsquo;s and Rosen&rsquo;s inappropriate outreaches in April 2020 to Dr. Bright, a former employee,
followed by the end run to his superior, Dr. Kadlic, who returned Rosen&rsquo;s email.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">70.&nbsp;&nbsp;Stockholders
only became aware of the spring-loaded grants after the fact when the Company filed the Proxy. While the Proxy requested that
stockholders approve the amendment to the 2015 Plan, it did not seek approval of the grants. The grants, instead, had been approved
by written consent of the Board.<SUP>14</SUP></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">71.&nbsp;&nbsp;On
May 16, 2020, the Board convened a meeting and granted 15,000 unrestricted shares of common stock pursuant to the 2015 Plan and
25,000 shares of performance-based RSUs subject to certain vesting rates to Cheryl Keech. Ms. Keech was deemed a &ldquo;consultant&rdquo;
to the Company though she is reported to be the Chief Medical Officer and Senior Vice President of ILiAD Biotechnologies, LLC.
Ms. Keech had attended the March 19-20, 2020 Board meeting and was involved in the Company&rsquo;s trials. NOVA0000201-204.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">72.&nbsp;&nbsp;On
June 3, 2020, <I>Bloomberg</I> reported that the federal government was working with seven pharmaceutical companies as part of
its OWS program.<SUP>15</SUP> According to <I>Bloomberg&rsquo;s</I> sources, these companies included Johnson &amp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>13</SUP></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><I>See
</I>Katie Thomas &amp; Megan Twohey, <I>How a Struggling Company Won $1.6 Billion to Make a Coronavirus Vaccine</I>, N.Y. TIMES,
July 16, 2020, https://www.nytimes.com/2020/07/16/health/coronavirus-vaccine-novavax.htmlauth=link-dismiss-google1tap.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>14</SUP></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">https://www.sec.gov/Archives/edgar/data/1000694/000110465920060342/tm
2019396d1_def14a.htm#equitycompensationplaninfo.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>15</SUP></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Riley
Griffin &amp; Jennifer Jacobs, <I>White House Works With Seven Drugmakers in &lsquo;Warp Speed&rsquo; Push,</I> BLOOMBERG, June
3, 2020, https://www.bloomberg.com/news/articles/2020-06-03/white-house-working-with-seven-drugmakers-in-warp-speed-push.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-9</B></FONT></P>








<!-- Field: Page; Sequence: 111; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Johnson,
Merck &amp; Co., Pfizer Inc., Moderna Inc., and the University of Oxford in collaboration with AstraZeneca Plc&mdash; as well
as two additional firms that had not yet been disclosed at that time. While Novavax did not make any disclosures to the market
at that time, within weeks, the Board began discussions regarding imminent funding from OWS of more than $1 billion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><I>The
June 2020 Spring-Loaded Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">73.&nbsp;&nbsp;On
June 25, 2020, the Board convened a meeting. The Agenda for the meeting indicates there would be several presentations concerning
the progress of the COVID vaccine candidate. NOVA0000129. Additionally, there was to be a discussion concerning a financial update.
NOVA0000274-297. The Agenda for the meeting also states that the Compensation Committee would offer a presentation concerning
equity grants. NOVA0000129.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">74.&nbsp;&nbsp;Importantly,
the equity grants were awarded on the same day the Board discussed imminent funding from OWS of more than $1 billion. At the same
June 25, 2020 meeting when the awards were made, the Board received a report entitled &ldquo;Funding and Policy&rdquo; presented
by Rosen. NOVA0000376-380. Rosen&rsquo;s report lays out his &ldquo;Congressional / Administration Strategy&rdquo; to secure funding
including &ldquo;Outreach and Results[:] House and Senate appropriators, vaccine leaders, Maryland delegation.&rdquo; The report
indicates &ldquo;very positive receptivity, letters to BARDA, [and] Hearing on vaccine production.&rdquo; NOVA0000377. Rosen&rsquo;s
report further notes that defendant Trizzino is the co-chair of the Biotechnology Industry Organization (BIO) and &ldquo;BIO provides
multiple high profile speaking opportunities and legislative interactions&rdquo; including &ldquo;OWS Leadership Interaction.&rdquo;
NOVA0000378.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">75.&nbsp;&nbsp;Rosen
apparently presented the Board with an additional report stating that negotiations were underway with parties at Operation Warp
Speed and an &ldquo;<B>[a]greement was expected in [approximately] 1 week[.]&rdquo; The expected budget for the funding from OWS
was &ldquo;Budget: [approximately] 1.2B&mdash;includes cost of Phase 2b ZA trial.&rdquo; It also states that &ldquo;Brian W and
Tim meeting with OWS CMC PDT.</B>&rdquo; NOVA0000232. (Emphasis added).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">76.&nbsp;&nbsp;There
was an additional funding report delivered to the Board on June 25, 2020 that stated the &ldquo;[t]otal OWS Budget estimated at
$1.190B (Budget $ 1.074B and Advance Payment Request $116M = $1.190B.&rdquo; NOVA0000317.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">77.&nbsp;&nbsp;Knowing
full well that the Company was about to receive over $1 billion, the Board granted six non-employee directors and two NEOs options
and RSUs covering 73,570 shares. All the stock options had an exercise price of $83.54 per share, the closing price of the Company&rsquo;s
common stock that day and were disclosed in Form 4s filed on June 26, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">78.&nbsp;&nbsp;The
Board had not granted a single award to any director in the month of June since 2015, and it had been only six months since the
directors received awards in December 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">79.&nbsp;&nbsp;The
following table shows the options and RSUs granted to each director and officer in the June 2020 Awards:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 30%; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 34%; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; text-align: center; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Options/</B></FONT></TD>
    <TD STYLE="width: 16%; text-align: center; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Grant</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: rgb(81,112,148) 1pt solid; text-align: left; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(81,112,148) 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Position</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(81,112,148) 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>RSUs</B></FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(81,112,148) 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Type</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">David
    M. Mott</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">4,400</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael
    A. McManus, Jr.</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Michael
    A. McManus, Jr.</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel
    K. King</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Rachel
    K. King</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary
    C. Evans</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gary
    C. Evans</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard
    H. Douglas</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">6,900</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Richard
    H. Douglas</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">3,450</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James
    Young</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">15,180&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Options</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">James
    Young</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">7,590</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    J. Trizzino</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">EVP,
    CBO and CFO</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: Gray 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,500</FONT></TD>
    <TD STYLE="border-bottom: Gray 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0; border-bottom: rgb(81,112,148) 1pt solid; padding-right: 5pt; padding-left: 5pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">John
    A. Herrmann III</FONT></TD>
    <TD STYLE="border-bottom: rgb(81,112,148) 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 50pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">EVP,
    Chief Legal Officer</FONT></TD>
    <TD STYLE="text-align: center; border-bottom: rgb(81,112,148) 1pt solid; padding-right: 5pt; padding-left: 5pt; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">2,500</FONT></TD>
    <TD STYLE="border-bottom: rgb(81,112,148) 1pt solid; text-align: left; text-indent: 0; padding-right: 5pt; padding-left: 35pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">RSUs</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-10
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">80.&nbsp;&nbsp;On
July 7, 2020, the Company issued a press release, announcing that it has been selected to participate in Operation Warp Speed.
As part of the OWS program, BARDA awarded Novavax $1.6 billion to complete late-stage clinical development, including a pivotal
Phase 3 clinical trial; establish large-scale manufacturing; and deliver 100 million doses of NVX-CoV2373 as early as late 2020.
BARDA had already granted hundreds of millions of dollars to drug makers, including Moderna Inc. and Johnson &amp; Johnson, prior
to the announcement of the grants to Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">81.&nbsp;&nbsp;The
Company announced that it received $1.6 billion from BARDA on July 7, 2020. Given media reports in early June 2020 detailing discussions
between OWS and other pharmaceutical companies that received grants, it is reasonably conceivable that, at least as early as June
3, 2020, Novavax was participating in negotiations with BARDA and was expecting to receive funding. Nevertheless, Board minutes
evidence that Novavax was aware of the impending OWS funding prior to the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">82.&nbsp;&nbsp;The
market&rsquo;s reaction to a $1.6 billion award was predictably positive. Novavax&rsquo; stock price soared to $104.56 on extremely
high volume that day and continued to rise over the next few weeks in response to the $1.6 billion OWS grant. By July 22, the
stock price had reached $146.45, a 75% increase over the $83.54 closing price on June 25. The directors and officers made gains
of $4,628,288 in aggregate just from the June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">83.&nbsp;&nbsp;The
price movements of the Company&rsquo;s common stock during this period are below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: red"><IMG SRC="tm212692d3_sch14-aimg146.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center; color: red"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">84.&nbsp;&nbsp;On
Wednesday, February 24, 2021, the Company&rsquo;s stock closed at $239.94 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-11</B></FONT></P>








<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>THE
INDIVIDUAL DEFENDANTS&rsquo; BREACHES OF FIDUCIARY DUTIES</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">85.&nbsp;&nbsp;At
all relevant times, the Individual Defendants were required to act in accordance with their fiduciary duties of loyalty, good
faith, and disclosure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">86.&nbsp;&nbsp;Defendants
Douglas, King, McManus, Mott, and Young, as the members of the Compensation Committee at the time some or all of the options and
RSUs were granted, authorized and approved the spring-loaded stock option grants described herein.<SUP>16</SUP> These defendants
breached their fiduciary duties by authorizing and approving the April 2020 Awards and June 2020 Awards while in possession of
material non-public information regarding the imminent additional $384 million in funding from CEPI and the $1.6 billion OWS Grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">87.&nbsp;&nbsp;Each
of the Individual Defendants, excluding Modi, breached their fiduciary duty of loyalty by accepting and entering into option agreements
for the spring-loaded options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">88.&nbsp;&nbsp;Each
of the Individual Defendants breached their fiduciary duties of loyalty, good faith, and candor by failing to ensure that Novavax
properly disclosed the efforts it was making to secure additional funding, the substance or timing of its negotiations with various
funding partners, or the amount of funding it expected to receive; or alternatively, by not refraining from taking advantage of
this material non-public information to obtain options and RSUs at bargain prices.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">89.&nbsp;&nbsp;The
foregoing misconduct was unjustifiable and constituted a breach of these Individual Directors&rsquo; fiduciary duties as officers
and directors of Novavax. The foregoing misconduct was not, and could not have been, a proper exercise of business judgment. Rather,
it was intended to, and did, unduly benefit the Individual Defendants at the expense of Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">90.&nbsp;&nbsp;As
a direct and proximate result of the Individual Defendants&rsquo; breaches of fiduciary duties, Novavax has sustained damages,
including, but not limited to, the value of the spring-loaded stock options granted to the Individual Defendants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>DEMAND
FUTILITY</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">91.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation set forth above, as though fully set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">92.&nbsp;&nbsp;Plaintiff
brings this action derivatively and in the right and for the benefit of Novavax to redress the Individual Defendants&rsquo; breaches
of fiduciary duties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">93.&nbsp;&nbsp;Plaintiff
is a stockholder of Novavax, was a stockholder of Novavax at the time of the wrongdoing alleged herein, and has been a stockholder
of Novavax continuously since that time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">94.&nbsp;&nbsp;Plaintiff
will adequately and fairly represent the interests of Novavax in enforcing and prosecuting its rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">95.&nbsp;&nbsp;As
a result of the facts set forth herein, Plaintiff has not made any demand on the Board to institute this action against the Board.
Such a demand would be a futile and useless act because the Board is incapable of making an independent and disinterested decision
to institute and prosecute this action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">96.&nbsp;&nbsp;At
the time Plaintiff commenced this derivative action, the Board consisted of ten directors: (i) defendant Douglas, (ii) defendant
Erck, (iii) defendant Evans, (iv) defendant King, (v) defendant McManus, (vi) defendant Modi, (vii) defendant Mott, (viii) defendant
Young, and two non-party directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">97.&nbsp;&nbsp;Plaintiff
did not make a demand on the Board prior to bringing this stockholder derivative suit because, for the reasons described above,
there is reason to doubt that at least half of the Board is disinterested with respect to the claims herein because they face
a substantial likelihood of personal liability; or that they could have made an</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 20%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><SUP>16</SUP></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">In
                                         April 2020, the Compensation Committee consisted of defendants Douglas, King, McManus,
                                         and Young. Defendant Mott was added to the Compensation Committee on June 16, 2020, less
                                         than two weeks before receiving grants via the June 2020 Awards.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-12
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">independent
and disinterested decision to bring the claims herein. Indeed, one of the directors, Erck, participated in the April 2020 Awards
and six of the directors participated in the June 2020 Awards. Seven directors have enjoyed this immense financial benefit as
a result of the actions identified in this Complaint.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">98.&nbsp;&nbsp;Accordingly,
pre-suit demand is excused as futile. In particular:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>i.&nbsp;&nbsp;Douglas
</B>granted and approved the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. Douglas also included himself in the improper June 2020 Awards while in possession of material non-public
information regarding the imminent OWS Grant, and was therefore unjustly enriched in light of his acquisition of 6,900 options
and 3,450 RSUs at an artificially low price. The foregoing is a breach of the duty of loyalty and so egregious on its face that
it cannot be the product of business judgment. As such, he has a substantial likelihood of liability in this action and is incapable
of assessing whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>ii.&nbsp;&nbsp;Erck
</B>participated in the improper April 2020 Awards when he received 400,000 options. Furthermore, he was in possession of material
non-public information related to the impending $384 million CEPI funding announced on May 11, 2020. Erck also granted and approved
the improper June 2020 Awards while in possession of material non-public information regarding the imminent OWS grant. The foregoing
is breach of the duty of loyalty and so egregious on its face that it cannot be the product of business judgment. As such, he
has a substantial likelihood of personal liability in this action. Additionally, the Proxy states that the Company does not consider
defendant Erck to be independent. Defendant Erck also has served with Douglas on the board of directors of MaxCyte, Inc. for approximately
three years. As such, he is incapable of assessing whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>iii.&nbsp;&nbsp;Evans
</B>granted and approved the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. Evans also granted and approved the improper June 2020 Awards while in possession of material non-public
information regarding the imminent OWS Grant, and was therefore unjustly enriched in light of his acquisition of 6,900 options
with an exercise price of $83.54 and 3,450 RSUs at an artificially low price. The foregoing is a breach of the duty of loyalty
and so egregious on its face that it cannot be the product of business judgment. As such, he has a substantial likelihood of liability
in this action and is incapable of assessing whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>iv.&nbsp;&nbsp;King
</B>granted and approved the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. King also included herself in the improper June 2020 Awards while in possession of material non-public
information regarding the imminent OWS Grant, and was therefore unjustly enriched in light of her acquisition of 6,900 options
and 3,450 RSUs at an artificially low price. The foregoing is a breach of the duty of loyalty and so egregious on its face that
it cannot be the product of business judgment. As such, she has a substantial likelihood of liability in this action and is incapable
of assessing whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>v.&nbsp;&nbsp;McManus
</B>granted and approved the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. McManus also included himself in the improper June 2020 Awards while in possession of material non-public
information regarding the imminent OWS Grant, and was therefore unjustly enriched in light of his acquisition of 6,900 options
and 3,450 RSUs at an artificially low price. The foregoing is a breach of the duty of loyalty and so egregious on its face that
it cannot be the product of business judgment. As such, he has a substantial likelihood of liability in this action and is incapable
of assessing whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>vi.&nbsp;&nbsp;Modi
</B>approved and granted the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. Modi also granted and approved the improper June 2020 Awards while in possession of material non-public
information regarding the imminent OWS Grant. The foregoing is a breach of the duty of loyalty and so egregious on its face that
it cannot be the product of business judgment. As such, he has a substantial likelihood of liability in this action. Additionally,
the Company&rsquo;s Proxy states the Company does not consider Modi to be independent. Accordingly, he is incapable of assessing
whether to pursue the claims herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-13</B></FONT></P>








<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>vii.&nbsp;&nbsp;Mott
</B>granted and approved the improper June 2020 Awards while in possession of material non-public information regarding the imminent
OWS Grant, and was therefore unjustly enriched in light of his acquisition of 4,400 options at an artificially low price. The
foregoing is a breach of the duty of loyalty and so egregious on its face that it cannot be the product of business judgment.
As such, he has a substantial likelihood of liability in this action and is incapable of assessing whether to pursue the claims
herein with disinterested independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>viii.&nbsp;&nbsp;Young
</B>granted and approved the improper April 2020 Awards while in possession of material non-public information regarding the imminent
$384 million CEPI grant. Young also granted and approved the June 2020 Awards while in possession of material non-public information
regarding the imminent OWS Grant, and was therefore unjustly enriched in light of his 15,180 options and 7,590 RSUs of the Company&rsquo;s
securities at an artificially low price. In addition, Young purchased 1,500 shares at $48.83 on June 3, 2020. The foregoing is
a breach of the duty of loyalty and so egregious on its face that it cannot be the product of business judgment. As such, he has
a substantial likelihood of liability in this action and is incapable of assessing whether to pursue the claims herein with disinterested
independence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">99.&nbsp;&nbsp;&nbsp;&nbsp;Five
of the directors (Douglas, King, McManus, Mott, and Young) are currently members of the Compensation Committee. Young was chair
of the Compensation Committee when the April 2020 Awards were granted. Mott is currently Chair and was part of the Compensation
Committee when the June 2020 Awards were granted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">100.&nbsp;&nbsp;Four
out of five of the current Compensation Committee directors (Douglas, King, McManus, and Mott) are incapable of independently
and disinterestedly considering a demand to vigorously prosecute this action because they granted spring-loaded stock option awards
to Novavax&rsquo; directors and certain officers, including themselves, which was a self-interested transaction subject to the
entire fairness standard; was not the product of a valid exercise of business judgment; was a waste of Novavax&rsquo; assets;
and for which they each face a substantial likelihood of liability.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">101.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, and Young either knew or recklessly disregard the material non-public information regarding
the imminent $384 million CEPI grant when granting and approving the spring-loaded April 2020 Awards to Erck, Glenn, Herrmann,
Rosen, and Trizzino.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">102.&nbsp;&nbsp;Defendant
directors Douglas, Evans, King, McManus, Mott, and Young are interested due to the receipt of the spring-loaded June 2020 Awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">103.&nbsp;&nbsp;Defendant
directors Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young either knew or recklessly disregarded how the material non-public
information of the imminent $1.6 billion from the OWS grant would affect the share price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">104.&nbsp;&nbsp;Accordingly,
there is reasonable doubt that at least half the Board can disinterestedly consider a demand to prosecute this action.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>CLAIMS
FOR RELIEF</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>COUNT
I</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>AGAINST
DEFENDANTS DOUGLAS, ERCK, EVANS, KING, McMANUS,</B><BR>
<B>MODI, AND YOUNG FOR BREACH OF FIDUCIARY DUTY FOR</B><BR>
<B><U>GRANTING THE SPRING-LOADED APRIL 2020 AWARDS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">105.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation set forth above, as though fully set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">106.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, and Young, by virtue of their positions as directors of the Company, owe fiduciary
duties of loyalty and good faith and, in furtherance of those duties, were required to act in the best interests of Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">107.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, and Young authorized and granted the spring-loaded April 2020 Awards to Erck, Glenn,
Herrmann, Rosen, and Trizzino as described herein. These defendants authorized and approved the April 2020 Awards at issue at
a time when they possessed material non-public information soon to be released by Novavax that would positively affect Novavax&rsquo;
share price. NOVA0000002-5, 7-9, 92. These actions were not a good faith exercise of business judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-14
| ir.novavax.com</B></FONT></P>






<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">108.&nbsp;&nbsp;As
a direct and proximate result of the failure of defendants Douglas, Erck, Evans, King, McManus, Modi, and Young to perform their
fiduciary obligations, Novavax has sustained and will continue to sustain significant damages. As a result of the misconduct alleged
herein, these defendants are liable to Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>COUNT
II</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>AGAINST
DEFENDANTS DOUGLAS, ERCK, EVANS, KING, McMANUS,</B><BR>
<B>MODI, MOTT, AND YOUNG FOR BREACH OF FIDUCIARY DUTY</B><BR>
<B><U>FOR GRANTING THE SPRING-LOADED JUNE 2020 AWARDS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">109.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation set forth above, as though fully set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">110.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young, by virtue of their positions as directors of the Company, owe fiduciary
duties of loyalty and good faith and, in furtherance of those duties, were required to act in the best interests of Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">111.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young authorized and granted the spring-loaded June 2020 Awards to Douglas,
Evans, Herrmann, King, McManus, Mott, Trizzino, and Young. These grants were made when Douglas, Erck, Evans, King, McManus, Modi,
Mott, and Young possessed material non-public information soon to be released by Novavax that would positively affect the share
price. NOVA0000155-158. These actions were not a good faith exercise of prudent business judgment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">112.&nbsp;&nbsp;As
a direct and proximate result of the failure of defendants Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young to perform
their fiduciary obligations, Novavax has sustained and will continue to sustain significant damages. As a result of the misconduct
alleged herein, these defendants are liable to Novavax.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>COUNT
III</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>AGAINST
DEFENDANTS DOUGLAS, ERCK, EVANS, KING, McMANUS, MODI,</B><BR>
<B>MOTT, AND YOUNG, FOR WASTE OF CORPORATE ASSETS</B><BR>
<B><U>FOR GRANTING THE SPRING-LOADED AWARDS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">113.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation as set forth above, as though full set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">114.&nbsp;&nbsp;Defendants
Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young, as directors of the Company, had a duty to ensure that their compensation
decisions did not create an unwarranted risk of non-compliance with the law and the Company&rsquo;s governing documents. By granting
spring-loaded awards, defendants Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young, have wasted the Company&rsquo;s valuable
corporate assets solely for the financial gain of Glenn, Herrmann, Rosen, Trizzino, Douglas, Erck, Evans, King, McManus, Mott,
and Young.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">115.&nbsp;&nbsp;As
a result of the waste of corporate assets, defendants Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young are liable to
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>COUNT
IV</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>AGAINST
THE INDIVIDUAL DEFENDANTS, EXCLUDING MODI, FOR</B><BR>
<B>BREACH OF FIDUCIARY DUTY FOR ACCEPTING THE</B><BR>
<B><U>SPRING-LOADED AWARDS</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">116.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation set forth above, as though fully set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">117.
As directors and/or officers of Novavax, the Individual Defendants owe Novavax the fiduciary duty of loyalty and are required
to act in the best interests of the Company and its stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-15</B></FONT></P>








<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">118.&nbsp;&nbsp;All
of the Individual Defendants, excluding Modi, breached their fiduciary duties by accepting the spring-loaded awards and entering
into option agreements for such options knowing the options were spring-loaded at the time of grant. As of April 16, 2020 the
Company was in ongoing discussions and lobbying multiple funding partners including Operation Warp Speed participant BARDA, which
had been initially funded with approximately $10 billion to combat COVID-19 by the federal government as demonstrated by the allegations
in the Whistleblower complaint. With this material non-public information, the Board granted the April 2020 Awards to Erck, Glenn,
Herrmann, Rosen, and Trizzino. The additional funding report delivered to the Board on June 25, 2020 reiterated that the &ldquo;total
OWS Budget [was] estimated at $1.190 (Budget $1.074B and Advance Payment Request $116M = $1.190B.&rdquo; NOVA0000317. All of the
Individual Defendants knew full well that the Company was about to receive over $1 billion when the Board granted the June 2020
Awards. Each of the Individual Defendants knew this information was material and would result in an increase in Novavax&rsquo;
stock price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">119.&nbsp;&nbsp;As
a direct and proximate result of the Individual Defendants&rsquo; (excluding Modi) breaches of fiduciary duty, Novavax has been
harmed and sustained damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>COUNT
V</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>AGAINST
THE INDIVIDUAL DEFENDANTS, EXCLUDING MODI,</B><BR>
<B><U>FOR UNJUST ENRICHMENT</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">120.&nbsp;&nbsp;Plaintiff
repeats and realleges each and every allegation set forth above, as though fully set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">121.&nbsp;&nbsp;Each
of the Individual Defendants, excluding Modi, received improper spring-loaded awards as alleged herein, thus damaging the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">122.&nbsp;&nbsp;It
would be unconscionable and against the principles of justice, equity and good conscience for the Individual Defendants, excluding
Modi, to retain the spring-loaded awards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B><U>PRAYER
FOR RELIEF</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>WHEREFORE</B>,
Plaintiff demands judgment as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">A.&nbsp;&nbsp;Finding
that any demand upon the Board concerning the wrongdoing complained of herein would be futile;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">B.&nbsp;&nbsp;Finding
that defendants Douglas, Erck, Evans, King, McManus, Modi, and Young breached their fiduciary duties to Novavax and its stockholders
regarding the granting and approval of the April 2020 Awards;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">C.&nbsp;&nbsp;Finding
that defendants Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young breached their fiduciary duties to Novavax and its
stockholders regarding the granting and approval of the June 2020 Awards;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">D.&nbsp;&nbsp;Finding
that defendants Douglas, Erck, Evans, King, McManus, Modi, Mott, and Young wasted corporate assets;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">E.&nbsp;&nbsp;Finding
that the Individual Defendants, excluding Modi, breached their fiduciary duties for accepting the spring-loaded Awards;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">F.&nbsp;&nbsp;Finding
that the Individual Defendants, excluding Modi, were unjustly enriched;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">G.&nbsp;&nbsp;Entering
an Order awarding the Company the amount of damages it sustained as a result of the Individual Defendants&rsquo; breaches of fiduciary
duties and waste of corporate assets and any other damages that the Company may sustain in connection with the facts alleged herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">H.&nbsp;&nbsp;Entering
an Order rescinding the spring-loaded awards, or compelling the Individual Defendants, excluding Modi, to disgorge their ill-gotten
gains;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">I.&nbsp;&nbsp;Granting
other appropriate equitable relief to remedy the misconduct alleged herein;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>B-16
| ir.novavax.com</B></FONT></P>




<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0; color: #8C8E8C"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><B>Appendix
B</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: rgb(81,116,148) 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">J.&nbsp;&nbsp;Awarding
to Plaintiffs the costs and disbursements of this action, including reasonable attorneys&rsquo; fees, accountants&rsquo; and experts&rsquo;
fees, costs and expenses; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">K.&nbsp;&nbsp;Granting
such other and further relief as the Court deems just and proper.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 49%; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>ASHBY
    &amp; GEDDES, P.A.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>Of
    Counsel:</I></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>/s/
    F. Troupe Mickler IV</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Stephen
    E. Jenkins (#2152)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>LEVI
    &amp; KORSINSKY, LLP</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">F.
    Troupe Mickler IV (#5361)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Gregory
    M. Nespole</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">500
    Delaware Avenue, 8th Floor</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Daniel
    Tepper</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Wilmington,
    DE 19801</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Correy
    A. Kamin</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(302)
    654-1888</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Ryan
    Messina</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">55
    Broadway, 10th Floor</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">New
    York, NY 10006</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>Counsel
    to Plaintiff</I></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">(212)
    363-7500</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Dated:
    February 26, 2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Public
    Version Filed: March 3, 2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Revised
    Public Version Filed: April 20, 2021</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><B>NOVAVAX,
INC.</B> 2021 PROXY STATEMENT <FONT STYLE="color: #517094">|</FONT> <B>B-17</B></FONT></P>




<!-- Field: Page; Sequence: 119; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P></DIV>
    <!-- Field: /Page -->



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg147.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0"><FONT STYLE="font: 10pt Arial, Helvetica, Sans-Serif"><IMG SRC="tm212692d3_sch14-aimg148.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #517094">21
Firstfield Road, Gaithersburg, MD 20878</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt; color: #517094"><B>240-268-2000
| www.novavax.com</B><BR>
<B>Nasdaq: NVAX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #517094"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font: 16pt Arial, Helvetica, Sans-Serif; color: #517094"><B></B></FONT></P>

<!-- Field: Page; Sequence: 120 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: rgb(81,112,148)"><B>&nbsp;</B></FONT></P>

<div  align="center"><p align="right" style="margin: 0in 0in 0pt; text-align: right;"></p></div><div><div align="center"><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><IMG SRC="tm212692d3_sch14-aimg151.jpg" ALT="GRAPHIC" STYLE="width: 773px; height: 1000px"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
D52180-P56450
For Withhold
For Against Abstain
For Against Abstain
! ! !
! ! !
! !
! !
! ! ! ! !
! ! !
! ! !
NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG, MD 20878
  1b.  Margaret G. McGlynn, R. Ph.
  1a.  Richard H. Douglas, Ph.D.
  1c.  David M. Mott
The Board of Directors recommends you vote FOR
proposals 2, 3, 4, 5, and 6.
2.  The approval, on an advisory basis, of the compensation
paid to our Named Executive Officers.
3.  Amendment and restatement of the Amended and
Restated Novavax, Inc. 2015 Stock Plan to increase the
number of shares of Common Stock available for issuance
thereunder by 1,500,000 shares.
4.  Ratification of certain April 2020 equity awards.
5.  Ratification of certain June 2020 equity awards.
NOTE: To consider such other business as may properly come
before the meeting or any adjournment or postponement
thereof.
6.  Ratification of the appointment of Ernst &amp; Young LLP as
our independent registered public accounting firm for
the fiscal year ending December 31, 2021.
The Board of Directors recommends you vote FOR the
following:
1.  Election of Class II directors to serve on the Board of
Directors, each for a three-year term expiring at the 2024
Annual Meeting of Stockholders.
  Nominees:
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate
or partnership name by authorized officer.
NOVAVAX, INC.
VOTE BY INTERNET
Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information
up until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your
records and to create an electronic voting instruction form.
During The Meeting - Go to www.virtualshareholdermeeting.com/NVAX2021
You may attend the meeting via the Internet and vote during the meeting. Have the information
that is printed in the box marked by the arrow available and follow the instructions.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m.
Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand
when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we
have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,
Edgewood, NY 11717.
SCAN TO
VIEW MATERIALS &amp; VOTE w</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img width="850" height="1100"src="tm212692d3_sch14-aimg150.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">D52181-P56450
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Notice and Proxy Statement, Form 10-K and Annual Report are available at www.proxyvote.com.
NOVAVAX, INC.
Annual Meeting of Stockholders
June 17, 2021 8:30 AM Eastern Time
This proxy is solicited by the Board of Directors
The stockholder(s) hereby appoint(s) Stanley Erck and John Herrmann, or either of them, as proxies and attorneys-in-fact, each
with the power to act without the other and to appoint his substitute, and hereby authorize(s) them to vote, as designated on the
reverse side of this proxy card and in their discretion on such other business as may properly come before such meeting, all of the
shares of Common Stock of NOVAVAX, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders
to be held at 8:30 AM, Eastern Time on June 17, 2021, and any adjournment or postponement thereof and otherwise to represent
the stockholder(s) at such meeting with all powers possessed by the stockholder(s) if personally present at the meeting.
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made but
the card is signed, this proxy will be voted in accordance with the Board of Directors' recommendations, and the
discretion of the proxies with respect to such other business as may properly come before the meeting and any
adjournment or postponement thereof.
Continued and to be signed on reverse side</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:avoid;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; color: rgb(81,112,148)"><B>&nbsp;</B></FONT></P>








</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm212692d3_sch14-aimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg001.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@"K )8 P$1  (1 0,1 ?_$ -8  0 !! (# 0
M       *!@<("04+ 0($ P$!  $% 0$               <#! 4&" $"$  !
M! (! @,!" \%!P,"!P   0(#! 4&!Q$($A,)(3'1(A05EE<805%AD9)3E;75
M-G:VUC=W,B/4519Q@4+25)07,R09L5)RLD-%)E8X$0$  @ $ @0(" L&!0,$
M P$  0(1 P0%(08Q05$289$BLA.4!Q=Q@3)2,W/45:&QT4)BDM,4-!4(P7*"
M(U06HM)#4S7"LR3PX9-T8T3D)__:  P# 0 "$0,1 #\ G\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZN'S7S__ # ]AOTJYCY@;I^ACWW?<T_Z>O\ ^2G_ #//]Y<O?]^?U+_\I_\
M,#V&_2KF/F!NGZ&'N^YI_P!/7_\ )3_F/]Y<O?\ ?G]2_P#RG_S ]AOTJYCY
M@;I^AA[ON:?]/7_\E/\ F/\ >7+W_?G]2_\ RLHNW/NYX*[K:NV7.$MIN;-!
MI-O%T=B?;P.9P:T[.8KV;5!C&Y>G4=926&J]56/Q(WIT7IU0PF\;!NFQ6RZ[
MGEQ2<V)FN%HMC$<)Z)G#I97;=XV_=ZWMH+]^,N8BW"8PF>,=,0R7,,R8
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M/*G_  UQGX<$,2.-L4;(V=?#&QK&]5ZKX6HC4ZK]E>B'14SC.*$(C",'N'H
M D@>@7^KW<[^T_''YCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
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M]S/+S9_2ZJ_!2.'PXR@SF/>)WG<9SJ3_ /$R_)RX\'7;X;3Q^#!A ;,P(
M20/0+_5[N=_:?CC\QYXA_P!JGTVB^KS/.JD[V>?0:OZRGFRD,D2I%
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M[5/IM%]7F>=5)WL\^@U?UE/-E(9(E2*
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M_''YCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
M                         ?-<N5<=3M9"]8BJ4J-:>Y<M3O2.&M5K1.FL
M6)I'=&LBAB8KG*OL1$/:UM>T5K&-IG"(\+R9BL3:>$0@B]X7/U_N:[CN3N7+
M$\S\+D\W-@]'JRO\3<=HFN228S7((FHC6,6[!$ZY*J(GCFLN53J#E[:J[+L^
M1H(B/25KWKSVWMQMXNB/!" =[W&VZ[IFZS'_ "YMW:>"E>%?'T_&QI,RQ8
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M)MT7O'_IK/9\J>O#H:<FL:QK6,:C&-1$:UJ(C6HGN(B)[B$AM)\$=#V#T
M  "2!Z!?ZO=SO[3\<?F//$/^U3Z;1?5YGG52=[//H-7]93S92&2)4B@
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MG,5LZD84U&77,^/Y-OPQC\:9>2M7.IV.N5:?+R;VI\4<:_@G\#; :(VX
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MYCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
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MZ;CG;AG3Y>;F3;X(ZH^*,(="[?H\O;]%E:+*^1ETB/AGKGXYQGXUX#'KP
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M^KW<[^T_''YCSQ#_ +5/IM%]7F>=5)WL\^@U?UE/-E(9(E2*
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MMHB(B?\ E/D7V(G1/UPS/VCJ_;__ !^G^HR_,ASKK?X[/^NOYTK?%VM@
M5'IVG[3R%M> T71\#DMHV_:<C#BL!K^(KNLY#)79W(B-C8G1L4$+>KYII%;%
M!$U7O<UJ*I1U&HR-)D7U6IO6FGI&-K3PB(_^NB.F9Z%7(R,W4YU=/D5F^?><
M(B.F9_)VST1'2XK*8VYALKE<+D8VPY'"Y/(8?)0LD9,R'(XJY-0O0MFC58YF
MPVJ[VH]JJUW3JB]%*E+US*5S*?(M6)CX)C&/P/C,I;+S+9=OEUM,3\,3A/X7
MPGT^0   D@>@7^KW<[^T_''YCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
M                                             60Y [:.WOE7(6LQ
MR/PMQIN>9O-A9<S6>T_"7LS;97B;!7;9RTE3Y1F;7@8C&(Z5? U$1.B(9/2;
MSNVAI&7H]3G9>7'1%;VB(^",</P++4;;M^KM-]3D969>>F;5B9\>&+'/8/2\
M[#MB\3K';MJ>-D?UZRZ_?V37W>W_ .UN*S56%O3[C4,OE<[<T9/R=9F3'Z45
MM^.)8S,Y5Y?S?E:7+B?!C7\4PL=GO15[),OYKL;C.3=7>_KY?R'R'D)(857W
M/##F:N51S4^TJF3RO:/S+E\+VR;Q^EEQ_9@L,SD?8;_)KFT_NWG^W%8_/^@U
MP?;\:ZSSCRS@7*J^!N3H:IL43.O]E/"N/Q,KD1/MOZJ9+*]J.YU^FTV1;X)M
M7^V5AF>S_;I^BS\^OP]VW]D+([#Z!VQQN>NH]R^,LL]OEMV?CF:N_P"XCWXC
M8Y43V^ZJ-_W&3R?:GE3_ !&BF/[N9^6JQS?9[?\ Z.K_ %J?DLOQV%^EIR]V
MG]RU+E[=]\XXV_6<;I>UX&E'K4>Q5,TS*Y]M&O%.^GE:#:K:S:<4J/5)U<BN
M3HBIU,7S3SOH-]V:=OTV5G9>=.96T][NS&%<>&,3CCCAU+_E[E/5[/N?[[GY
MN5F9<9=JQW8M$XSAV\.C'K;TB,6^@     %5$155>B)[55?<1/MJ! "[@MCA
MV_G[G/:J[VR5]@Y>Y#R=>1BHK9()=HR,<,C53V.;)'$BHJ>ZBG56TY,Z?:M+
MD3TTT^7'_##GG<\WT^Y:C.CHMGWG_BF/[%HS(+(   ) OH'X)\NX=RFSJU?*
MJ8#CS76O\/P?,MW=ARDC/%]M&56+T^Z11[4\W#3Z/)[;9EO%%82+[/<O_-U6
M;X*5\Z4E0AQ)P  Z^CE[^;W+?]4^1/WPS)U?M_\ X_3_ %&7YD.===_'9_UU
M_.E;TNUL   %X^"> >6.Y/?:?''#^JVMDSTZQ2Y.\]'UM=U7&R2(Q^:VK-+&
M^MB<=$B]6HOBGG<G@B8]RHACMTW70;-I9UFX9D4RNJ.FUI[*QUS^".N5[M^W
M:S=-1&FT5._F=<_FUCMM/5'X9ZH2\^QST^>+NS774R,2U]WYES=%L&V\F7J;
M8YHV2(U\V U"I)XW8#6H9$Z>%%^,6U3QSN7X+&0#S-S9KN8L[N3CE;=6?(RX
MG_BO/YUOP1T1X9DV'EW2;)E=ZO\ F:VT>5>8_!6/S:^#IGIE#8Y$_F/R3_4;
M?/WLRYT1I/X/)^IIYL(5U7\7G?77\Z5(%=0   "2!Z!?ZO=SO[3\<?F//$/^
MU3Z;1?5YGG52=[//H-7]93S92&2)4B@
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MR%IYR]JS-1/_ %<Z</@K$5_'BW;$;-Y  '7T<O?S>Y;_ *I\B?OAF3J_;_\
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MC\QYXA_VJ?3:+ZO,\ZJ3O9Y]!J_K*>;*0R1*D4
M                                     (SGK>=TE?9-GU7M4U+(MGQ^
MG6*>]\IR59FOADV2>L]-0UB=8U5JR8FC8??G8J_!DGA141S29O9KLDY.3F;[
MGQA?,B:96/S?S[?'/DQ\$HOY[W:,S,IM&3.-:3%\SX?S:_%\J?B:"25$>
M!Z/\Q6^&&-TT[U;%7A8GB?-8E<D<$+&I[7/FF<UK4^RJB,.OA#SCU=*=]V8\
M.KP+VN\*\73PMARN TG&6-A1(_+>[9LZU^>V!9DZ(YTL>5R4L:JOMZ,1/L'+
M_,6X?S7>]3KH^COFSW?[M?)K^"(= ;+HOY=M61H_SJ9<8_WIXV_#,LGC"LH
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MS92&2)4B@
M      #!_OO[S=3[..(;FQS25,MR=M,5S$<6:8^1%ER^=\KH_,9*)JK)!K.O
M)(V>Y*J(C^C86KXY$Z;+ROR[G\P[A&3&-=%3"<V_97LC]*W1$?'T0P6_[WD[
M+HISIPMJKXQEU[;=L_HUZ9GXNF4)_9-DV#<MBS^X;9E;.=VG:LQD-@V+-7'J
M^UE,QE+#[5ZW*JJOA1\LBHQJ?!C8C6I[$0Z1R<G*T^333Y%8KD9=8K6(Z(B(
MPB$&9N;F9^;;/SK3;.O:;6F>N9Z9<,5'P   &?GIG]NTG<7W9:)CLA16WI'&
M4T'*.]N>Q75)*FOVXG:YA["^Q%7-[)Y#5;UZK#%*ON(IJO.>[QM&PYMZ3AJ<
M_P#RJ=N-H\J?\-<?CF&Q<J[;.Y;QEQ:,=/D_YE^SA\F/CM^")373F].(   1
M8M:]&;N1Y<Y/W[:N1,_J?#>E9WD3<\S2?-.FX;E?PV4VC)W:=JKA,7+#B:#[
M-.9KVI:NH]J.^%'U]A-^=[1-GT&BRLC24S-1J:Y-(G\RD3%8B8QGC/'LCXT4
M9?)&YZS69N=J;TR,BV;>8_.M,3:9CA'".';/Q-O';SZ5/:3P%+0S<VH3<L[Q
M2\J5NV<HNKY]E>W'[5L8C6$@BUG%)XO:W_V\LK%1.DAH&[<\[]NL3EQF>@TT
M_F97DXQX;?*GQX>!N.V\I[/MTQF=STVHC\[,\KQ1\F/%CX6R&***"*.&&..&
M&&-D4443&QQ111M1D<<<;$1C(V,1$1$1$1$Z(:A,S,XSTMFZ.$=#]#P   #K
MU.1/YC\D_P!1M\_>S+G6>D_@\GZFGFPYSU?\7G?6W\Z5(E=0   "2!Z!?ZO=
MSO[3\<?F//$/^U3Z;1?5YGG52=[//H-7]93S92&2)4B@
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MN>%K>";?)K\<]3<.4-DG<M;^^Y\?_"R+8^"UXXQ7PQ7IM\4)>Y *8P
M      .O4Y$_F/R3_4;?/WLRYUGI/X/)^IIYL.<]7_%YWUM_.E2)74    D@
M>@7^KW<[^T_''YCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
M         &D+UV__ /,_%_\ 6K%_NMLI)7LO_P#-9W_ZT^=5HO/_ /XK*_\
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M,\ZJ3O9Y]!J_K*>;*0R1*D4
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M5CA'7,S5R]R]D;)D8SA?77CR[_\ IKV5CQS/&>K#8D:BV,
M Z]3D3^8_)/]1M\_>S+G6>D_@\GZFGFPYSU?\7G?6W\Z5(E=0   "2!Z!?ZO
M=SO[3\<?F//$/^U3Z;1?5YGG52=[//H-7]93S92&2)4B@
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MBT5(IIJ1PB/PS,]=IZYGC*%-7J]3KM1;5ZNTWS[SQG\41'56.J(4&72W
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MBT%=!HXX1QM;KO;KM/XHCJC@@K==TU.[ZRVLU,\>BM>JE>JL?CF>N6/YE6.
M   !D[VH=IO*'=]R77T#CRJM#$8]U:UO>_7:LDNOZ-A)GKUL6W(K&7LW=C8Y
M*-!KDDL/3Q.\,37O3"[[OVBY?T4ZK5SCF3C%*1/E7GP=E8_.MU?"RNS[/J]Z
MU7[OIHPRXP[]YCA2/[;3U1U_ F>=M?;3Q;VK<9XSC+BW#I3HP>&WGL];2.78
M=PSSXVLM[!L60:QK[=VPJ=&,]D5>/I'$UK$Z'.F\[SKM\UMM;KK8VGA6L?)I
M7JK6.J(\<SQE-VV;9I-ITL:325PI'3/7:>NUIZYG_P"T<&0!BF0
M           Z]3D3^8_)/]1M\_>S+G6>D_@\GZFGFPYSU?\ %YWUM_.E2)74
M    D@>@7^KW<[^T_''YCSQ#_M4^FT7U>9YU4G>SSZ#5_64\V4ADB5(H
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M=:]G3Y%L^-5-*3J:UFL7PCO169QF(MTQ$SQPQP)=.U.?:JF\S:U@Y=SHXB?
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M/\:>=S+^;3]6/R/KTF9\Z_ZUORGRKF?\\S_Y>S'^-'<R_FT_5C\AZ3,^=?\
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MC+VH5K7:]+W8K$^GMT1$?F>!OOL_M:VOU/>FT_Y->F9G\Z>V4G\A1*@
M     =>IR)_,?DG^HV^?O9ESK/2?P>3]33S8<YZO^+SOK;^=*D2NH   !) ]
M O\ 5[N=_:?CC\QYXA_VJ?3:+ZO,\ZJ3O9Y]!J_K*>;*0R1*D4
M                                   (\'KI]P;ZV-XS[8\%>5KLS(G)
M_(44,B?"Q>,L2T-,Q-E&_":RUEF6+CF.]CDJQ.Z>XI+?LQVG&^=O6;'R8]'E
M_#/&\Q\$81\<HXY^W&:Y>5M67/RI])?X(X5CXYQGXD<4E]&8
M      -Z7H-?SVYY_I-KW[X-(R]J7_B])]?;S&_>S[^/U/U-?.E*'(22J
M       '7J<B?S'Y)_J-OG[V9<ZSTG\'D_4T\V'.>K_B\[ZV_G2I$KJ    2
M0/0+_5[N=_:?CC\QYXA_VJ?3:+ZO,\ZJ3O9Y]!J_K*>;*0R1*D4
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M52=[//H-7]93S92&2)4B@
M    #'+N\Y+7A_MAYUY'8_R[6M<:[/-C7HY&N;F+]"3$X9S57W7IE;\*HGV5
M]AE]@T?\PWK2Z.?DWSJX_!$XS^")8[=]5^Y;7J-5UTRK3'PX81^&80+H6O;%
M&DCE?+X&K*]R]7/E5.LKW*OM5SY%55^ZIU).$SPZ'/D=''I?J>/0
M          ;TO0:_GMSS_2;7OWP:1E[4O_%Z3Z^WF-^]GW\?J?J:^=*4.0DE
M4          .O4Y$_F/R3_4;?/WLRYUGI/X/)^IIYL.<]7_%YWUM_.E2)74
M   D@>@7^KW<[^T_''YCSQ#_ +5/IM%]7F>=5)WL\^@U?UE/-E(9(E2*
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M<]^_L!^]-M]3O]G/J8][?T>[Y\_:/\3#W$^WS[MW#UNO[<]^_L!^]-M]3O\
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M,M_E'4/TH/<G_4-_HMV]?G[0>_'^GK[PVGU&?LQ]0;NL^@RW^4=0_2@]R?\
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MUW_2]R7[0.3]'O.7SYDZO)S-1GZ><GT^?Z?&M:7B_=GTF9W8QF,8X8^%Q_\
MU3<[<@<YZS9<SD/4:7/RM/D:B,[T&1Z&*VM>DT[T>CR^],Q$X3QP\#:$=6.3
M@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
@                                       #_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm212692d3_sch14-aimg003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg003.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P#Z P$1  (1 0,1 ?_$ +4  0 # 0 # 0$
M      H " D'! 4& PL!  ,! 0$! 0$            &!P@%! (# 1    8!
M P0 ! ,#"@<      0(#! 4&!P 1""$2$PDQ02(4,A4646$W0E(C,R75%U=W
M&&(D-64FE[<1  $"! ,$!0H#! D% 0    $" P 1! 4A,09!46$2<8&1(A.A
M,D)2<H(C%!4'T6(SL<&2LM)#4Y.S)%1T->%C<S0E%O_:  P# 0 "$0,1 #\
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M/6/YE;=V V1:-/6-JRT?)@JK7(N*WGU1^5.S?GMB]FEF._$T00 "J_QXJ?\
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M35S@[S%;9DK4VXXTY91AVN6X*8<2*E?(#5"*0O#5^O(**?>;@V29$%4QMNA
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M#L&VEXIEZG92Q)!<A*8RBV&2<6R&1*7"W2\4Y=(@PDHA5W\RUF%K1 MU0.W
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:_>9_I_F\D63ZDC^RJ/T?$_27_!E^I^6/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm212692d3_sch14-aimg004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg004.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P#Z P$1  (1 0,1 ?_$ +,  0 # 0 " P
M      H " D'! 4!!@L!  ,! 0$! 0$            &!P@%! (# 1    8!
M P0! @,%!@<!     0(#! 4&!P 1""$2$PDQ(A1!%191,B,W&&%28]475T(S
M-#6V=Y>W$0 ! @0#! 4)! <( P$    ! @, $00%(3$&05&!$F%QD2(3H=$R
M0G(C%!4'L5)B@I(S<Y,T5!;!\<)#4[,D=/"R1#7_V@ , P$  A$#$0 _ .CW
M;E+R=;7>[MFW(O-S=LVN=L;MFZ&3+8DBW;H6&120013))@1)%%(@%*4  "E
M #6FZ:QV55,TI5)3%1;3_EI^Z.B('47>[)J' FI? "U>NK>>F-!O5_[!;_3\
M[HXPSUDRV76AYA6CX&(G;W9'\\K2[X0YT:^HC(3#A=1E"645Q9." <J97)D%
M1^#:5-:Z4I'[6:VULH;JJ>:BE"0GG1ZV S*<QME,0Q:5U'4LW#X2X.K<8>D
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M;=>Q7@/"8_X'X@=T%@1U8>*D4DG9GS9 HNK'6+4JBID66<'*4JZXM[6L65(
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M^PP:KDT+,M'"2)W*D+)&*BH+ZNR_>U< 78Z:Z15"_0=,P_I9KU0WZC-71&:
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M/?&>]5X"<U6=LJ#UUQFRB@T96^J/7;A2.BP3;M&=@C7+IPH(2PB":#=(QS;
M/T@.FQ_56G%,.)36,%1;4!B<RDRV0N,Z=OJ7D*52N\H6DG+*8GMAK-FK4!<J
M]-U.U1#&>K=CBWL+.PLDB5PPDXN10.V>LG2)NATET%!*/P(?(" @ ZSFR\[3
MNI?844O(4"DC,$8@B+BZTV^VIEY(4TH$$'(@YB# <J?2]F"C3LM9.,:C;)^/
M7*[AXRHTG*M8K(-6;G.*A8MJ[DU&T3;6+4# 1!3S(/1*&QTSB'>:T6/ZBT%2
MTEF]39J@)%8!*%=) Q23MP(Z1$LNVB*QAPNVHAVG./(2 M/0"<% ;,0>N*$0
MN/.?> %'$?5Z=RJQ64[@QEV=5C+]'Q*[GKW*E0@RN89RH;N$14(!N[??<=-#
MM7I2Z@+J'*%\RS44$^61A?:IM1VXE+"*MKV0J7DF(^%>/G/#D',,GDWB[D?D
MN3 /&QE[ZQM)V;(BA@*<4I2Z+LXV-2W/]8E,GT^=PU_1=M+VILI:?HV4;0@I
MF>")DQ_#;M0W)84XU5.KV%?-(<52 C6[A+Z:YR M4#E+EDXA%25]ZTF('#<$
M\3FVCF59JD<,G5]G$R!'O&C)PF50L<S\J2IRAYEC$ 4S(6I/J$V\PJAL04.<
M24ZH<ID<PA.8)^\9$;!MAPL6BEM/)J[N4GE,PV,1/85G(R^Z,#M.R$2  % "
ME  *     ;  !T   .@  :DT4B*\<K\$QG)+C[DW#\@1('5HKKDU<>JE*(Q5
MNC-I*KR:9S!_"%M,M4N\P=?$8X? CKK6.YKL]U9N")\J%CF&])P4.()XQS;O
M0(N=N=HE9K3@=RABD]L#W+Z_.<2(J)FXR93!0 4;+F;,XP45@ W8J4BA)@/.
MT6,3<N_TG+L(AK0']5Z:./QC$L\2?-G$8_IR_C_Y79\//&ROI_X/9)Q'=<BY
MOSMCV9HEF91J-%QS"69!JG)$:R8)R%LLR*;9TY! CE-)NP1,([F)YPZ!\SS7
M^I:.OIV;;;'4NL$\[A3.4Q@E.0RQ4>$.VC+#543[M?<&RVZ!R("L\<5*SZ@.
M,=W]N;'DSDS'-3P+@'$5]O$#;WGZDRA9*PU:GCR1,$Z(,'3%55W[4RBLI+%!
MXY)VB4$6J8;_ ,00US-!+LU%6.72ZU#33K8Y6TJSFH8KR.0P'23NCH:Q3=*J
ME1;[<RXXVLS6I,I2&2<]IQ/4(S_]:?K?R@;/I[_R<PW*U:B8ZA%G\'7;]&Q3
MIA=+A+@K'L$U8HSA^@^C:\R%9TH"I!3%P* ;#UV:=9:OHOE7PEFJ$KJ7E24I
M!,T(&)QPD5&0PV3A=TOIFJ^8?$75@IIVTS"5@$*4<!AC,)$SURA#W]./'G_8
M?#/_ ,OI'^1ZDWS>Z_S51^\7YXH_RNV?R['[M/FCQ7W&;CG(,GD>YP/A[[9^
MU<,G'@QK3FRPH.D3H+ DX;PR:Z"@IG'M.0Q3E'J @(;Z^DWF[(4%"JJ)@@_K
M%[.,?PVJV*!2:=B1$O03YH))F;UF\KZ3E/(5/HV#K_?Z'$V63;TZWPS6.<Q\
M]572@NH5;R*R:*H.F\>X(@X*8H"5=(WR&PZO%NUG8JFA9J*JI::JE('.@DS2
MH8'9E/$=!B/UVEKNQ5N,T[#CE.%GE4)2*<QMS P/2(2SZYIO.R_&JLTOD3CZ
MX47(6,5/T0DYM[=%->VU6.;HFJ\Z@X1>/ <+-XPY63G<2F!5KW#OW[ZCFK6[
M8+RNHM#K;M(]W^[ZJCZ2<AMQ'08I^FG+@;8ABY-K;J6N[WO62/1/9@>J,@/:
M/Z_<S6+DJYRQ@#%-DO\ 7LJPS>9M[>J-V:HP%[B02C)-P]2<O6QBDLC C=R!
MPW S@JWQ^+_HG5=N9LXH+J^AIUA4D%4^\@X@##U3,=4H3-6:=KG;G\9;F5.-
MO)FKEV+&!G/[PD>N<9_5;UQ<T[5::S6Y3 .1JS&STY#PDE:)IK')QE;B7KQ%
MJ^F'JWYJJHFSB6)SJ@4I1_< H!UTUOZOTXPPMY%4RM:$DA(G-1 F ,,R876=
M,WQYY#2Z=Q"%* *C*203B3CL$,SIM0@,/XRKU*J<2Y/7L=T]E"PL1&-R*2#M
ME7HLJ*#=JW R1'$G(?;;["8OD74ZCU$=9XJ'W:^L74OJ'C/.$DG*:CM.X>01
M;6&6Z.F2PR#X;:  !G(#[3]L$0Y#\:/8)R,S/D',UHXPY7+*76;57C(U5G&>
M*"KC, 85:O)'/,G!)O$1"21#CN("IY#CU,.KW:+SI2T6YJW,UK'(VG$S/>4<
M5*RVGR2B.7*UZCN=<Y7.TCO,M6 PP2,$C/8/[82)Q5X.X<PO@+'%!N6+L;W&
M[1\$B_NUCL=*K5@DI&VS&\C.%_,96.>N3LF#MP+5N4#]A4$2; '74@OFI;A<
M;H]5T[SS=.520E*U) 2,$X C$C$]),4RTV"AHK>U3OLM+?"9J4I*22HXG$@X
M#(= BPG]./'G_8?#/_R^D?Y'KE?-[M_-5'[Q?GCH_*[9_+L?NT^:,=O:[Z^9
M&\1N-LG<7\/L7%EA'+JGW2CXW@(.#/*U^1\DA#V0L4Q)%,G#J#D4E$%U1W5%
MNZ)\E3  ?]"ZK12N/45ZJ"&%CG0MQ2E24,"F9F0%#$;)CIA,U=IQ3Z&JJTL#
MQ4GE4A  FDXA4A(3!S.X]$8QDX(\ZBL%8<G&W,Q(ER^;23B+!DT)&+R;1!=J
MTD7#()D&JKUJV=*)IK&*)TR*&* @ CJB_P!3Z8YO$^,I_$ (!F9R.) ,IR)
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&^WY.F/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm212692d3_sch14-aimg005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg005.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ +8    & P$! 0
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M@MQPXO&L#A20/=I<+B2$A32U( 1+LW$B=/(/<6V>UA 3A09(IKJE74M':?G
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M#S2C0K!<$LD-27.%L3MF$K4)9^9 SN[BK E$?^R9):![U+[:5RW)F\?Y,/\
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>%98?MO\ M4K\?CBIZ=,TY0T(0T(0T(0T(0T(7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm212692d3_sch14-aimg006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg006.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *0"6 P$1  (1 0,1 ?_$ (@  0 #  ,! 0
M       ("0H$!@<% P$! 0$!                  $" Q    <!  (" @$"
M PD!     0(#! 4&!P@ "1$2$Q0A(Q4B%K9!,B47=SAX&3D*$0$  @("  ,&
M!P           0(1(3$206%Q\%&AL2(R@9'1X5(#$__:  P# 0 "$0,1 #\
MW\> \!X#P'@/ > \!X#P'@/ \"Z7ZAP;C[([)N71VE5[+\UJZ("\FYUR(.)%
M^J!OTH&N1#8JTM9;')J%$K9@Q17<K" B!/J4QBEB)M.(Y9[N?/<EW[[1.C(B
M#]9G*-.I7&U$N+!/6>I.L$+(1K9(!J^,68A*?!T^49-FEGDHP_RU8-7,L\:K
ME(=Z9HB)R^7&.72:5K'U3MJ.\CD>!"#NGOS">!,S8W75WDE8+G<GZM<QW%:6
M1M)ZAL=S_ *J,!4(159(J,>S*)5927=F1BX=G\KNEB%^I3FJUFTXA2IPIA_;
M7MGV.G>Q/V*2%[Y\Y]S"V)6/BGB7-[?8:5$O7,6_,HAL&Q2T(^BY^YE6.W!-
MB1T*2,LB)E2I(QQDD75:MUI]->?&6HKR.9X#P'@/ I:]H_LPN7/TU3^*>(*H
MWW7V5=#-2M,LSADDA+P.)5=Z<$GN\;>'W_6@*57VOY%VR3L2%='3_*H MB&!
M2PW2L3':VJPEGZ\.4MCY+PG_ "GT+U/JW7&W7*>=7K3-)TF<<R$,PL\N@@#V
ML9;".B@>J9[$G3^K5J)A,H?[K"5+\@(IQFTQ,ZC$)?:'H] R2FSVB:C=:MG=
M#JS%22L=QND[&UNMPC%+_?<R4Q+.6C%J03"!2_8X"<X@4H"80 21&=1RJ.:^
MV6_=*/#1_K,XKUOKRKJ_MMT>E]#D4^8^3_VFQQ2.M 7[1H=:ZZ2U;*@/Y/[#
M7W"9_C^FL;Y ?+AOIC[YQ\T9>THS_P#0+"XHII.9[;DK;<[+=J-3\TY>Y)YU
MC+[28IU/28'?V39^@>@YDLI#4:M1;=<TK)-H=DV$X))$3_K?8K2Q_GG&->?[
M+\,4:ZNQQ_,&>[2M9G-J:T*JH:O,4QDK'5*3T).%9EMKVN,5OZK6&<3@+&;D
M$ ^$Q#^ #^ C$XSKAZ?X13/[#MG[QP>]R%RH?7?K3Y<Y36I,:8;/UI%W];5(
M2U,577^:WU?CHVW0-:NR1VBB"C%H44U .44SD,)@,8W6*SK$S949ZDN;<_\
M=; W'N'V2[F3O*9S+9;SFN,84_*VIF+8]7(-4K9C<[%BE358PH7+4XS]>7:I
M/A<E;11T"G,N<Y_QV6[S-)Q737%2J/3,WJ\-2,]J=;HU-KK,C"!JE1A(ZNUV
M&9)B(E:QD-$MFD>R0 QA'ZIIE 3"(C_(B/D<7:? KW[W[ZKO'$'1Z/3*5*;U
MUWOLD[J7+W+]0<I)6K3[4@D!GL]/OS@9M1\GI2*@/+#8GWXVC%HF8"B=8Q2>
M&JUFWHIRXGXD6[GU[2-]ZPF673J@S9J5NF_23-1#*=-L]&G6,BZX\XNH[\B3
MJE<:XG=6!FUNM!B@^U2PQYFYS'CD7?YK+<VZQB->WCY_)J-:-&K!JV8L6S=D
MR9-T6C-FT13;-6C5LF5%NV;-T2D10;H(D A"$ "E*     >1R<CP'@/ XC]^
MQBV3N2DWK2.CF#=5V^?OW*+-DS:H$%1=R[=.#IH-VZ*91,<YS 4I0^1'X\#/
MUV![MGJ>I97R7ZUL@/UKT)T4_FZOFNP?W-%OS#4WL(JDWMMQ=6Z.!ZXT2!S%
MN=9U-J18$BV:B!6ZKW\Q_P /AN*>-M1">W!'KES?BU._:=-STEMW8/0#TEEZ
M:ZFNY"+W;2K(N<CQ:!KZ/Q^M1LK@'G].&K[ J39LW22_)^50A3%):TVUX);]
M"[OG7,&&ZMT-K4JI"YMC=&L.@7&000%T[)#5U@J]6;1[0IBB[DY Z96[5'Y+
M^5PJ0GR'S\^$B,SA33S=QGH/LJDJ'W?[0(IQ)5&8-'Z%R=Z\7SY5YB.#TUZ0
M']*O.W5[Z-X[8=_GHE9!\Z_NJ3B+@C'*@W1^Y3?BODU,]=57WLF+*,9M8Z.9
MM8^/8MT6C)BR;I-6;-JW(5)!LU;($30;MT4B@4A"% I2@   !Y&'*\!X%(>Q
M]E=+=G] :7Q1ZS9&"H\)BTPXH_8'?=MA4K)5,/N"C5!POD. U!U_P[4]W9,U
MQ%^L[^L+7S'+^8RB_P!2@;ZQ6.UOPAZMC_I4X*SZ41OFKYM(]B[FNJ#Z?WSL
MB??= Z'-RIR)?L.FS>['>TZK,C+)_*32)BV:")/@@ 8"@/@F]O#4/H[_ -F>
MKCT^4:986J7QGGT9V4);'.*XG3X(-)MLI+'8,%K.7*L_9)S;HGZ8)F/(.D$6
M_P"NA]2*F,4J8B(O?C;]^RO<WZ^N#ZKG5BZ"V-6+F-3A:_9ZCFE8KLI:-94J
MMCC6\LSLTWGS),DY6(9!DZ(*IY$C505!%),BBI3$"X(_KM;B'>^X_93@_$W$
M;[M>?>_YPJM@K-;?XK5FBQX.9U^T7Z+3E*!68@LNV2<Q/]W:+ [>KN4"C'1Z
M*ZRI/E(2#,)6LVMUCEER];,PW]K_ $UM#!STBR<ZMHE0C)[N;H.!FI&"V&[8
MD]=-CQG#G D>6,8N<8Y*J<@="/O-U S:QVEXH=-N5--?]D++K;-(C7I^L^;;
MQ2J54\XJ-;H-#KT54Z93X9A7JQ6X1HFRB86%BVY&K"/8MD@ J:*""8!_M,8?
MDQA$PB(QPYW+M'@/ X[MVU8-7+Y\Y;LF+)NL[>/':R;9JT:MTS+.'+EPL8B*
M#=!(@F.<P@4I0$1$ #P*JKY[6\WM-PG<9X,SBU^P3=(1PK%S;7%'T<PY_P U
ME?H<"?\ .'IR9^,MJJ2"OU_*SC7$S,B'R4C,3?QX:Z3S;4(3]>Y3::SA-EZF
M]T>^JZQ0H1[&(9_ZYN5$9VDX)?=*L;LC+.,<?E4<%UCJO0K%9%D&K-*4790H
M*E.Y-& V34,4U&,XI^?MPEOZQ.(KCF*EF[.ZEK%:@.Q.@*S$0),RJ"#-KF7'
M'/,0L+S-N2\7AH]NUB82)J;(R+BS/6J28S=A_*J<3$23,8EK9U''MM;]X8>%
M=.<\9YUGSYL/->KM7CO.]JH4_0+26.<"TDFS"<:&0))1;H ,#>4B78)NFQQ
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9_#)X#P'@/ > \!X#P'@/ > \!X#P'@?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm212692d3_sch14-aimg007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg007.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *P R P$1  (1 0,1 ?_$ +P   $%  ,
M      D%!@<("@ "! $  @(# 0$             !@<#!0($"  !$   !@ #
M!00#"0P+       ! @,$!08 $0<2$Q06""$Q%0DR%QA!(F(C,S0U5CAATR14
M9"75-I8W=QF!D4-TM%6U)K97V!$  0(# P@##@0& P       0(# !$$,1(%
M(4%1<3(3% 9A@0>AL=$B8G*2LC-3-'05%I%"4C7AXB-#@]0D9#;_V@ , P$
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H9>;GZ)Q1<E[G[B:N[J]=7+VL]D[,\EGZLW3&L+L^#\G\/"*AVQ__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm212692d3_sch14-aimg008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg008.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %0 9 P$1  (1 0,1 ?_$ (4   ,! 0
M      <("08* 0 " P$                " P$$!0 0  $$ @ $ P,-
M      $" P0%!@< $1,($A46(3'249'14A24594F%U<8"1$  0,"! ,)
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EA.@CF%+"?$>#+_%E3A;>-Y^WHN@W](_+B'S5/T\*\5I4X+__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm212692d3_sch14-aimg009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg009.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +0 M P$1  (1 0,1 ?_$ +L   (" @,
M      D*  @&!P$"!0$  @(# 0$             !@< !0$#! @"$   !@$"
M @8""P\%       ! @,$!08'$0@ $B$3%!47"3$605&!(B/55I9'5QAAH<'1
M0F(T-29VMB<WEQEGM]<X>!$  0($ @0(" P' 0       0(# !$$!2$2,4%1
M!M$BLA-3D],487$R0G*2-0?P@9%2(T-C<S1T%1:QP?%B,R1U%__:  P# 0 "
M$0,1 #\ <&IWF4[1[_F",P;4+[+35\F;2^IT4DWI]E3A7TW'=L[41"<<1Z3
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AUJMK/V,LLO@ ,=2$4_=G/I'N>YUOZL;'/M9YI_">C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>tm212692d3_sch14-aimg010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg010.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ -  > P$1  (1 0,1 ?_$ )T   ,  @,
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M P$/B?ZC;C+!<;35-FF9*J'RW$D(&G4PH,2H1W'DA,DWQ]YH;E3F7HF2&O:
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MJ3D58AS7=NI\M4TY#K4E"U:_)2!FL\\60<E:ICA.L2(Y0,FF5Z9$HA@! #
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(69>U_35'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>tm212692d3_sch14-aimg011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg011.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *  H P$1  (1 0,1 ?_$ *<   (# 0$
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MU*7IK5<(23>$ *,$Q\I1%T>&RDG<0RK;IGWT.5;NU%J7BB\#*HZHOW$@WPX
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M1C!'ZO-M&+5/_!,FOH#^!1Y#R&*>PC^@2!QD\*CNV3'\VISGE/3KJM\G\@.
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HUAMU0-QB 5%3@5 )B3<.6U939J8JV+VJB65MI(O$"0 E!$28#+;_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>tm212692d3_sch14-aimg012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg012.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ *T    %!0$!
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MTZ?>$:$]-WC[M%BF*2QD-C+M(C=I808BD(]MZ2REM"W6EO)<"4K5ZJZ:M_\
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MTV\[W)_B+A3TV_F&QZ^G36?G80$I."X?7M=:BUJ2G,=CIL;F6N2I+DIQ+JV
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M?C%^TR?U_K414/W:/0A$<P5M/']:7."^'E(.Z3QGA(Z@I(*<=KTJ24J (*5
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MW"&6X\&&VZ\/G5L-D@:E,(89!(JS-6>[JGY_ G_'C\R/)Z;797RO5*\=N([
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43U6F$\AH((:""&@@AH((:""__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>tm212692d3_sch14-aimg013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg013.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@#Z P$1  (1 0,1 ?_$ )8  0 " P #  ,
M       ("08'"@($!0$#"P$! 0$! 0                $" P00   & @(!
M @,$" 0' 0    $" P0%!@<(  D1$A,A% HQ02(W43(S%35E-CAC5!878<1F
MAQA8&5D1  (" 00! P,$ P         !$0(A,4$2 U%A<1/PH3*!D2(CT4)2
M_]H # ,!  (1 Q$ /P#OXX X X X X!AF0LC4#$M-G\B91NE7QY0ZJP6E+)<
M;G.1M;K<)'MRB95U)3$LX:L6J8 '@/4<!,80*4!$0#@'+%V1=S&U>6]5-@LJ
M=7>-IRI:KX@JT@]R7V,96CU:/ 61D>1:5\\)I]4K2R1F<@3[M[(IIIV19F#%
ML8X"W)[OM+<JU.M:5E*VO@M/Z(L3Y@Q5UCZ]K9YN=[N^4LM-K#GBQ/\ (UBF
MK398QOEV9<6RO0SB6L#Q])'(A6W;1<R9C^E-=PH!0 .'Z&>R.7\="X'D,'@H
MHFD0RBIR)ID 3'44,4A"%#[3&,80*4 _2/ -?267L30RQFTQE#'<4X(82'0D
MKK6F*Q#@'D2&2=2:1RF  ^P0\\%AF05ZY5"W)K*U2U5NSI-P(*ZE>G(R:30!
M4!%,5CQKIR5,% #\/J$//W<$,DX!\&S6JL4J%?66Y6.!J5<C$A6DI^S3$? P
ML>B'VJOI65<-6+1(/'ZRBA0X!4CD+Z@#I^QED!+&MFWCQ2O8?G_W8_>UA.S7
M*J0SOW01 LM<ZK R]6;) J/@RA79TTP^)Q*4!'@VNN[4PRVFH7"J9 JU?N]&
ML<);Z=:XEE.UJT5N3:3,#/0TB@1RPDXF48*KLWS)V@<#$43.8I@'[>#!D? (
MS;';C:U:D+8E;[$97@,9.,YY)B,28K;S"4FY7MM\FSID91+1&*8OU6S<AUT@
M7>+@DS;"LF"JI/<)Y%2;T*ZNRGN=HVCV4<?:K85PI==RMWLI@P=U;7#%[TC-
MY#0L@83,I:\3R4=.*0!Y5N0ZK-J#154[8AG2XMVH%6.-5IR4O%2W7&5@M]LQ
MU1K/?Z,MC&\V&IP$S;\=.)Z-M"]&L<C&-G<Q5%K'# $3.*P+]4[8SIL (KBG
MZR? 0X,,SG@#@#@#@#@#@&+VZ\4O'\.O8K[;ZO2*^U PN9VW3\36X=N!2B8P
MKR<R[9,D@*4/(^HX> X!5UEGO<ZCL+OWD1<MZ,+/9IDI[2T/1)"8R6^%4#&(
M*:?^W\19&QQ*8@@8?<\%^\0X-KKN]B*4G]47T_Q[M5JCF3*$NFF!1!_$8$RD
MYCU?/GR"*ZL W.;T^/CY('+!KX>SP;"I/U*/35<EVK5QMU'T1R[()B)9'QYD
MNI$2,!?4*;EV[J:K!L</L_&J4OG[^2"/J[%L6;87W<T\V++&?[%[08(RJZF0
M$8N*I>4:?-3SP2D*<Y4JZWEAG?<(4P"8HMP,7[P#@PZM:HE%P0< < < < I0
M[!>S+9;#F>(+2C0_27(NT6U%MI\;<5+E:6$I3-9L6UZ<>.&#">NF1%DVC.:^
M55:G,Y:MWC0B'X"&7%4WL\>^ANM:M<K.$1%L&DV.*@UAMO/J(-Y\=YKL-><)
M66GZ^V*R-,9Z1XCE$S$41;U'#9EV+W-UJCSD3(#V5:O3*G(/AJK\%!%Y;=:A
M?<K4[B^W'#N_U>P?UJ=;V.KILM!7[*.-;%D%C0J9.4:#R'CS&\NRM3##V+FL
M]$PBZT+/EA_<DIDS)&&BV+,/2JH J 2KR;ZZ.O\ .Q<TWR[W_P"7&+."P[I-
MI-H[2$VC2.@9+83.DYFVX5V&:(HM6* 5'#L7'P*:K)H0" DH?T_@ / !P8CK
M6K;/07ZU^WO-0?,;'=UMTQZBL!0<533?7ZD8KC$TCD,FX:MK;,NW-G$/2/X%
MCD%0!^/CSR#E5:5,;4^FXUTNZA'NP^Z?8]L1)&-[KU2Z;23<5&/U@#TE.K$P
M42W(B!"CX $E"?\ $1X'R-822-DTSZ:?IZJ:J;B4UIE\D/"*F64>9.R_EBTK
M.E3>1$[P@6]@V=>?/V'3$!Y98?;=[EF6KVBFH&EC6Q--5M?,<X0);BL"6A>E
M1!VS^?)%BX-')RTH\</9)\DR,Z4%,JBHE*)Q$ \\AAV=M7)53M?W-V^VYHG-
M'^I/#S7=7;N,,JPR!D [P6VKVMX"L+%Q+9+R$V<(1\Y*Q3D1 S!JY31!<H)"
MLJL!FO'N;5,<KX1K:D=!=HV:G8_+W<=N!EC=O(*JI),N":?8IC%>JU%764%=
M>!@JA7%(B1GHQ#SZ/=],7[G@?6F?SY&SX*^Q+%%!;9"]<VB^-L7R>/L9:5:P
MM(=O799C$UMUB.BG;R3A>.71092D])0,E,'(^5$J:KE5554I3";R(AR&':S<
MSDT_TX:<Y4T1T%Q5KUFF4AW61(F=R+;IJ K$PZGJAC]*]WF;M$9CNGRSM-!1
MY7JE&R"2"9RI))"K[GH*!? C6+VY6E%F$[.0U8@YFRV*38PE?KT5(SD[,R;E
M)G&Q$-$M%G\G)R#M<Q$6K%@R;G554.(%(F03"( '(9.%K87=&$V R7D;O%S-
M5W%LUEU=L\IK1TX:[3B*B8[&[+/7R[,^?I2O% SM_7HN?:#(IB4HB<K%!$BO
MN,RE/?0]"K"^/=Y?L7Z]-/6K-:OTBQ;<[7+&R-V+[;G/D;8')%C1(ZF**C9S
M$E&.'ZJ=8#?N**KC0Z*4@FV!(BCI($  6[5N 0Y7LFX7XHO%X,#@#@#@#@%.
M&^/>#IKH_;E<)-W5NV6VO<KI1D)J[KS#K7C(AYQVF11C&VEVQ37B*>=<J@"9
M)8RTB0@@<&ABB \&ZTM;/^OD@.T2^HU[%CA)'D\2=06O\P8JC.,!@GE+:-Y"
MJJ"*:CSYE)PG7)H$3?B(8:^H00^*8_?<&OZZ^K-L4OZ:S4FQRS:Y[NYXVP[
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M8>F5:W,):4O$@WDD#).6#M] QAFHJ)'(L#55<$Q!02" WUI<I>B4D^>O[07
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MNBF83"0I  0 9:M?=-^YT08<S7B/87'L#E?!V1Z=E;&]G;_,0=RHTZPL,$]
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M8EW+6(AVS1B@O)2KU9PN8I %190QC>1'@:Y>IG' ' ' ' ' ' ' ' ' ' '
M' ' ' -,8@_:Y!_)C^MI+\H/VO\ W!_ZV_S/!6;GX(. . . . . . . . .
M. . . :"VN_M;V3_ (5^068_X]_ _P N['_&?Y5_F/\ !]7!5JO<U%UL_P!@
MFG_Y%_V^XT_MG_(C^FV7Y:?R#_F/<X>HM^3)M<$' ' ' ' ' ' ' ' ' ' '
) ' ' ' ' /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>tm212692d3_sch14-aimg014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg014.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &0 9 P$1  (1 0,1 ?_$ (\  0$  P$
M      @)!08'"@$! 0 # 0              !08$!P@#$   !@$"! (&"P
M       ! @,$!08'  @1$A,)(10Q(K,5.!EQP=$CD^-4=95V5Q$  0(% 00)
M!0$!         0(# !$A! 4&,4%1$F&QT4(34Q0U%G&!4G*2D8/_V@ , P$
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<]P6]BIH'4_LCWZ]D,8+W1K]NV/4MK3$;/C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>tm212692d3_sch14-aimg015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg015.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P H P$1  (1 0,1 ?_$ *4   (# 0$
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?9W*S%AG9_J N:R^\.U&O_/>Z-W._D>S=+0=K$W__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>tm212692d3_sch14-aimg016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg016.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *  9 P$1  (1 0,1 ?_$ )T   (# 0
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BN PJTF-1O]),X?A:[XXV^742^XLMVJ_C^45KZ+7^[OC_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>tm212692d3_sch14-aimg017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg017.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P H P$1  (1 0,1 ?_$ *   0 " P$
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M;*4NG43%2AB SC*W3#SKGZFZ"BN!W?*7866Y-/=@ZA@8&B#=A<?Q7"P_5O\
M:+O/Z=N5@/>_]JG)KN_KY-T6);OR0<NJ_P#MN?"_T?4)+*\C974I#+8//>%@
M9Q?"P]8^+\.'=^Z]I_4].^W5::D('4,@V-7(ZYVIS<YKIQB5,C';U\K[WZV9
M_P #G1?[.UIP\E:KW23>5RO/_,&2YBIO-:1B_)FFXN'G,Y\0X\++_EXUM>>Y
J53R67WD&\),X(3A41],]1<VTWDSOP%3\TF=W'1';,HDF71+6;["<;?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>tm212692d3_sch14-aimg018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg018.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 'P H P$1  (1 0,1 ?_$ )0  0$! 0
M      @)  <! 0$! 0$!              4&  <!!!    8"  ,$"04!
M     0(#! 4&!P@ $PD1%!49,1(CE=765Y=9(2*T-W@7$0 ! @0# @L%"0$
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M)4X YE$9 _:,CP&>$+YIVC=(.FRNHNB)IJ"42,@J$S[<QPB6"0KE7K*NJ_\
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()SD(D[!C_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>tm212692d3_sch14-aimg019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg019.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +  9 P$1  (1 0,1 ?_$ *0   ,! 0$
M      @)"@ &!P$! 0$! 0$             !@4'  0#$   !0($ P0&!0T
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(J/X_YGV(_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>tm212692d3_sch14-aimg020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg020.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1P!& P$1  (1 0,1 ?_$ )\   (" @,!
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M/AU>=OW0@( +0*Y<!T0=W9;S7T;B 2RF8XIN?X3<BFS/&:TX^GA+JL;RV]M
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MV,C)'8$!Y^.XX E^4E14-0- >H%SOFZF.D=C<^KS+'@#Z9\U8V&SVL=775W
M6DUH'M/P))4AOQQ^(?X@O&JYJ(_#/D9XS>0W/"X\1EG)/\V\2YQEBGT! ;7C
M^-4F46;\12UC5*DH<<U]".@K<9]SN#KOFR,97(M+6_4!&%I'81BEJ6$\P03]
1$_GM^O?^&OPZJE/7/227_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>tm212692d3_sch14-aimg021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg021.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@!& P$1  (1 0,1 ?_$ *    (" @,! 0
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#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>tm212692d3_sch14-aimg022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg022.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10!& P$1  (1 0,1 ?_$ *    (#  (# 0
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M,JS1"$8V7V9UQ)S"896!NZ[YB&*;EMOON/KKU.8&XN.'BE=TG@TIX4XCP_\
MSN?CK\A$XAO7<[Y4\0+S,2+**@:9<K5*9.J\F]>$*1-0]>G8NTPZ,=WS"F8$
MW3)8!Z@<  !TB0U<$-==&6X-7WT_J&SM9J;'1<GEUC!SF/Y5NT<QF=\8IOGE
M*3:/DTE&+J^5APJ^G*&FX15(8[TJKZ,()_Y5FX=-$TKEGRHA*.0BBG:NFKYJ
MV?,7+=XR>((NFCMJLFX:NFKA,JJ#ELX1,=)=!=(X&(<HB4Q1 0$0'1*-78T*
M%1*]7:OXYJ<U<[0Y4;0T&U]PO[=$SEZ[744(W8QD8S3_ )7TK*OEDV[5 GWK
M+JD('4=  DH,ZX2 %.54K0Z',3TLGFS-2"1;J5LY<4NEJK$=0N%ZZY3,8&;$
M@[MGU^>M  9B7$O/GNV;"FV3_D2G<]H1H*)Z>GQKL3F.?I4%_*LG?YFOR^VB
MUW:R>)>$G*<7!0<B_KUJO"3M5$J\FS5=M7L<5VFHY0,Z1.T3.)! H@!]]1F[
MOQ#]2!J<34HL;%KRC<9#R_A6/R5PO(Y!M4@Z$9UP+:11>2@R:.[IUL!%CN4N
M0J&4:I$W QMP .FF.7N&UM27F2)4XNJ4VO:^XS $P3^6<B&8)1=XO_%!8<B5
M^;R%VEV4=[3E&-G:9DB2*I#"(^U 4#BL82+%-L ^@[ZC]UWM;ZD:Z E?SG#I
M4@M>SI&)Y@F:,\6BJ>B/QP9.7J]N?_[Q@K7;,BS.U3(=)_'-0CO<G<D(#8#D
M%(1WW$=NNBVO>3?-60P!O]QI6?L_6T^3YSGHF#16DW\('G=G?Q-O4=XM>4\U
M\KAVV@C'TB2FUQ7DVCB12? 1L+9V@T9F;.%WC1+8QU>1.FWT&?[1W):7K R-
M\#B>3EJO-^[;N;!77#)8V@9N:!6O]5HIXORC66B55G/CI8I%)O8H;<RR>%IZ
M6<E3;VFO]3BWQC,2"X$DF #VH==4'2'%N9=,DL77B %Z5"OISRHM>XGV^[S)
MVN'<[G(O;[?'ESY[\>''KOOMMHM&H:YM$,J9Z95UP45Z5@9G%6Z6;&ZMI?*]
MF0<'I[9RD(B1PG2JV522*&WV/'[8X]4RZZND=31'_23P%6%EQXXCL591D69^
MV\88[NCYJH/42.&M=D5T#]>@@54@#HL[RUJ\$KQ635F)ZU\LC-+24G_(UU,S
MLD1Y_9,C34Q+)E2*4RKM^D\57-L101$14 .NVJVW^3!WAZ>GJJP]GF,5P"40
M@<*<'X78"H!I5&S2<,VF7D['.FH,GCE/M@W5XME3B1?O$ Y>V&VY0'KJHM[E
M)A=Y?ZGLK1_;UTV6W;$\DM"=*T'XNHU<2AX:O1]*CV,;&ID.)1(V50/R0*F(
M!NU*F([(AOZ]-5JZ2\?(B@E>0J1W$$ 8I5*EEOPGCV:"631HL4W<V%JO$+G:
M$9M6W-Z4"@^< BU32,LF! #D;[@+]0#3U(Z[:,=.73TRKR6#+9I+BNG/C2./
MR<>,\)CJ(I]ZJBA6<_1[13GC*2:O !(Z[B?KX%9"9-P">Y#(=L W'J/I]-3?
MLJYN63!I+0AX(>=03]P[:VOK4N#7:4XJ#@E:^O%N5>Y4\4L1R>0&*,@[N^,8
M_P#M<<]*5PW>EEF:K>29NB" %51<(*&(<-MA =:8M'.=;,<[ZBT5F29FB1S$
M0 I4/K,!9Y_&V2O&=6??LYJ@3U;IJ=B,Y/\ +RF#;/*Q<A'OTWPFY#,FQU\E
M"BL \@>L!/OS'7J7'4G]:1Z5/O'11)Y4[9=%]P<Y'RAD:U'54 >X9BVLKNJ0
M2 FZB*;2!K3=,@>G$-P]1T"/F /"NR#3#J)52GAZ!*L3)3!29QY?8E!+O?+4
MJTQQ3;AP,=["/6P)FWV$2B93;25QBU1^4TG81 2$X%37SA,YX)]IYA0%&!LD
MQ*UNDB>7D ('LP-[2534:@5,!5!1-5$!$1 0V'52]Q7.A<^53NSM'ME:Y0<!
MSH@,#(.X>\.SN\TQ598GEV55@H!1&P!(,I.9!-)FNX4:-%6IFI7!1.<";&$I
M@^NJL9*RXNRV4*W'/$5=&TF>WLV/:\IQ1:>+BSR)B<*6>O8UR?D6(MB\P"14
MIN-+)H-6Q54#J) X)*)"X,<>WQZ!_D/Z:2BV^U?<+HCSY?&I%-<73H@CWA1\
M*M+S1RVOC^,KQZC;R1\;-NVVQF19'W4FS6%P0T@R5;I\$T4Q)PV. &Y!OMMI
MXO-OMHXR2R,X<J:;"]N@\:G/!)R4TK+R4H=\R)3:54Y"\JW&M6W(F-GRRC)6
M0))1B:EVKKYPB]7DB$1,  IP#B40V*/[:=.UH[6*X30W$].=-7=_W,UN27DC
M23QY9?RK:'CBG1F.Z+5J-#&,I&U:&:1#(3G*<XMVQ1*03'(0A3#U^@!K0D">
M2U @2LW3.U2N=B%-5G-IE@/)>BRJ7VER'BVY51^F0! JKRC3,)9H5=40^T3H
MM)^13*.VX@H/T*&E_P /KI+C7CQN,DOABF$,D)?:C:F"I# )>V[C;I88]XF(
M!QZE<MS?N/KKOXJ)*[_$$_-\*Z'D]+6R P+D63HQA;3\94['(,ERAN=N=G%O
MW *%(9)<IA*8@#]P"&O'>ZQ"= -2#MB&.2[:)CI7#'F<L^M85,3M7^4\N/[E
M>;/)V&SM9QU8I]P@Q8J S?/>XBX;K&;%0!/@LN.X"4NV_IJE.YY2PE$))JZ+
M+:=4K<7:?[::'@:A59M)NI]A%-)*;D'[19%)\@1,&1VX B21,5,5!*9J9,IM
MQ*(?KJGGRO\ N#H!+N0Y5:T.V,M-M9*XN0D9@ *IH'?+22=VC.U14@I!64>0
MEI%M8T8Y-)4B::2@MB)$,V*)OXW &]0+HUH)W3)I<I/6GO1 Z$/+FKIZ<JT9
M1,;&$JD0K,,W!HH(Y)U'1LC'H"H5%,HAR+W@,MQ[O+T-ZCI[W03BW?J:Y W!
M5QJ+1FW%PT:VKJ3AA0J>;$.G)844"K12K.9&QTQ2.7;- (<AT[+%*%$@% P;
ME  ^@Z9-EGN&3M(844<^=.]S!;OB?J<!AT(IYGBNC9$L$XN"V*KN)_\ IL;\
MHX<@(++/-S\SJ;D)]PA^P:V!LKG.VFV<X([R@HK''<[6-[AO&L(<P3N0A$(P
M3+#V5WKXH YQP$U HF6XY8D-P#?MM&U6BF2J@CMN "YDDBA]!WTZ _*:8E]M
M>NPFI_7;1FC%KH>"]:R"]N\"F8=@6IN4Q4L[%5J4P@8Z#&S?*LS"4.)#( 7U
MZB,00>%<#&.^5W"KTF(5A.QKZ)D4"N&,DR=1[M VPD5:O43MW"9BB E,!TE!
M#J&BRMUL+<R0:]5O=.M7A\1 <T@C!<1E63Z]^,47X^Y=\SE!KKEA5G<*[N-0
M>IM5039.92[M4 (FX22$#H%8)[%2 0*7??;5.=V;7,KS$W)>/7K5Y=L=PON1
M&^[?\R8HU$J48(M<)#X^LMA[)'I5&#LC=X*(("S1!JX(J4RYR&$%>:?(!W W
M35-Q6,L%XYTX1A"9U<K]P_\ 2V]MG =6D@XA#AU]= ]2<*!F?)$I,56T,8YL
MC8',F\*JJBNY.Y,]564YN#NT5NWW2@(%] Z_KJ1;;;022Y%/%*9KV;>;>+_&
M&!N6*'!*=,>W#!1<%#6>P-IQPJS+%IE8M@1!,ZBI@*D44%' $WV'H&WZZ<M[
MB8;8Z%U:3QX4T;/'=3W -X!I#N"#ERJ01D>GD*<J-+D(-S),G4JB\<ID4.F(
M)1;EJ^C]S D;AP[(";_JVV'2':&T6][< 7#2?F&3DRKU]U;HW:;)[HW!OR\0
MN=.[B&*,=%LF#=$K=!JW(@FB3CQ2(3T(7B %V+^P;:TK;Q,@@;#&HC:$"XUE
M"^G=<WDD[BKGN)5$7U50L4Y3MGDE:)8BI1AL1T&-HA5CG $#7;(<DRLLNW14
M$>V9TPK\5$IF !YE,^X#N([ NB#QKQ9N\*_&:F$E2I^M9_KC%W)+4A@\KV2H
M2.1.Y?V'$\FX3>R;EDV3 QW<O1)-(LLU2* &50!VD4>2I0T!CA7<L:OB+F(R
M=B8Z>A)%K*0LNP;2<9)L5B.&;Z/>($<-GC99,1(J@N@<#%$/4!T9N."8TC*7
M Z@?E-+^_)0A&-?%3+4P+>,)+.JV+8K\4S Y%@G(QZZ)#&WY")3B(].G74>W
M^WA= =3 7<5J3]O7ERV?0Q[@T)@M98_'GR(8HTR_8QL"T<NQL$JU2AE%>Z84
MRBR<M52)\CB ;N7 CT+JB-_9!"1Y;&M*YBM(=G7+_N";DNDCTX \":+SQ7PE
M#8^G'LLHHS<)3ZRCA-+@;B)'"BK@-@[9.FRO[^FO!MT@80[$ ]:L.:.VG&AS
M&X=,*9@TQM5A,E)+12)5F*A)5 J228$,5 -RF$#!ON8W3U#7LNGF8!OX<1CC
M3;):P6K"Z)C0>E%?XCTZ6DI1WD"2:$18(N)%A'$.00V*@=VRW+R$P!Q#C]=3
MKLS:7,<)1H'J/6L_?N5W Y76@\P I@H3AF*,C*&2&N,::,T9DI-V*3<M:_2J
MHR'>1MUREA,C"0# @B!@*NX 5'"W^+5FDJN?[$QU;S!@!5.-D$C1)D'57+/"
MMEC\%RU/96<C?*\Y))Y)EKFF00:OLN(V*-NZ;M=+B(FKA)V';1X)<0'XE$J?
M'?1E&I>%&3#K1+B "&P]0'H(#Z"&BUVA'EX&X>."D[8L<U>2R#B!T:5G7V+H
M$I%;;CR9=%6>/G^-62JJ*,S49E[][N" R:S-90RS'D0QVX&&/C13AB,JRG>;
M_GMDSS E9FN-(&PXWA:#=)=F-?LC)U!R?;10,U3(]8/F_(X&3<E-L)CEW#IU
MU'.Y()#:.>P..'(_"GOMNYB;>Z)"P8\3C2L[7CB_TL(BR1P/%P4;.7J[ALB*
MA>ZBON1/B1(2 )RE]=@'6:=Q,S+MX>UP!=Q6M&LF8-J8^ A[E& /7IC3+_$[
MR-M""D0]MF,K1--X=@@B1VWBY=1(QB-3M^8BW(BF/0P#^FE&O\J)!B#CX>AI
M6PO9S+H+2B\SZ>VFI4+/[C)DK&P\?5744QER@G(-I4KUBHV:**%15=#W .J5
M!$G^1MP !'7LV>;[FY;&475G3_O%Q(VT?ADTTZ%_DBG8JK54A'3=6;N+^'8A
M2\?U!()6X6E=9DB4_L(I$Y"MH\!*'?D7ID&+<NYU%@VZZ0V6R^WA:\X#2,PG
M"LB;]+]W=2!3J+W<5R)YU[/'V.;3)VE++N8C1ZMZ38N8^F4V*<"_K.)8*1*0
M'[&+>'(G\Y<9E(A22LQP("A2@V;%(V*/=>7'@*;6-TM Y"B T6CUS0H5S0H4
MH;\A@?C;%-X'D<+ N2Q2 .6+BHGRF4-_XQE2,#IQQR@?CL$N8HB7;B(!I.;R
M_)=Y_P"AQ54]U"/]9OE)YRX(BTFN],/&Y/',HI7+9D%U5SHK?'-;UCZI1]H0
M 4U^R"+^JY-DV[LI!Y<A.V1Y#MN!=4?W6WLUSRKKYDJ_[;6/;ZA(]A]_.KJ[
M9=W0VW:9F63[7@'OD8[VQ,D]XHB?#\\&6B@E6FN/EHL$A#WUR?2+>5,B*9-C
M*13>.=-R"'^D"O#;C]0]=11T7;>ANN?<-"<((?\ L5+;:7>_-=]O!8+UGG3I
M_P 9:G*C+!R=B>+Y#LN8'<>,(\^6C,$TBLQS8E=]R3WNTX^R#*6U1(#\0'V4
M<5R(;B3;TU*.RQV +L",WKKM<#<!K6>H0N<WPU'QII[Q/[D.M"6BR;::<1;%
MSGIXS-8[_2*=;XV?^NGPRW_"7M?E/CXW^Q?/_,?\H^T]NA\=_;O[C_YK[;M<
K>QW_ /:_]GIJ]@FD:4T($3)."=*S^_5K/F+YJE5S7BOKHGM=KE<T*%?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>tm212692d3_sch14-aimg023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg023.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $@ 4 P$1  (1 0,1 ?_$ )(   (# 0
M      @)! 8'"@$  @(#                !08 ! $"!Q    0"!P,("P$
M         0(#! 4& !$2$P<7"!0T-6$D%18W&#@)(5%B(S-38U1D9389$0 !
M 04&! 8# 0         ! @ 1,0,$(4%1$@4&82(R,X%"$Q05%G$T-7+_V@ ,
M P$  A$#$0 _ ._BL!KJ&NH:AY!]0\M(T97WF1Z^6.E.3$</\.5$(]J*Q#:;
M+*$%;H])&D^'/U!8DG"+0](%%'+M1R:YA+$2B9\\](@*29P,Z;0VLK7*DU56
M]&D22]:H9B+<@.%ZE>4<2&5=S;A3I$@4],Y6I30Y(CE!LS$?FQ(O/ , G^=&
ML7N?9@9ZXQ]YKK7G3ECF),.PW>PV^KMKI&QF5<\[MVMDVOF5W5[RC3]NV]]@
M]K[6G^%R>CZGII?'JAV[L7<S[F ?6]9^&]Q[B?\ *Y_5R9U._P QZW6X/Y77
MM4,78QJ@\I3'Z<9\@$5C6,&G7&Y_,$28EGB+Q6(PU&:7Y7CY@PF&)*'<*0.;
MX [6M)KI7:4:AA#$J*J0;JQI\K1-]Z7+I9J4T^KTP2#D !RAP)2/,A5X+RA5
ML#;7K%ZKL_45U$LJG:9/)/,21F+R 3<H&#K%)XPW_P MC1K.V)L[N=?>K,74
MQ8@SJ_-,V%T!F%N(*LRN2 #*?W\,7"[AJ:+*RA+C "@5BR*5<"@<R0E%;PW#
M345,-K:"Y%)*&68I-^* ;[;9BO,;( L1VQHL^JGG<.L<U3,.:6#=@LB[! N%
ML7,^RG+VZ P@:ZO#?-G8;QR1_$1V9_V$&W[]M]E]:JA_;7]>7^STK['<Z##A
MCP8-KW\Q?Z_4GO=OJ$>.'%BSAW#V&Y[FUX=P_P" 3</P_E>Q50$OK,8F,?'C
..BQA/2(0NAX-,IJV6_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>tm212692d3_sch14-aimg024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg024.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &@ R P$1  (1 0,1 ?_$ *    (" @,
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5[DKR\GY?8VB"O_J7LU_#_&NT1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>tm212692d3_sch14-aimg025.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg025.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10!& P$1  (1 0,1 ?_$ *    (" @,
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M$P;:,.6KV#@ACM$P;6(J,>V+*.U7_3KJJ:]2]'?1*(CJ+G^U9U=?2_H76O\
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MKH_:'1SN[M%[==$.IT?V6Z?VOZKFOM76]^D%OTN?^3'X8*Y]X'?Z%?[/U/\
MH4_M3_;G[&+N_M[]C^4V>F/T_P"H]W_O?N==/_*^G=KMZY"_'GZKF&G@GCZ)
&*7.@@O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>tm212692d3_sch14-aimg026.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg026.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@!& P$1  (1 0,1 ?_$ *    (" @(#
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0R^I<U\:9MUCJVN=555__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>tm212692d3_sch14-aimg027.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg027.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@!& P$1  (1 0,1 ?_$ *$   (" @(#
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ML5\ML8R'*,%_=*R ?'[2&>'/=&3V+&5&?\9LA(OR&]W8-53AR_:O7EE6IB0
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MD.E-;R:F"AZ\M#(':!#)FR45[RR1HG"<JY>AG*D-  =UTSML:MC/WY/H9L7
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CK>-G5+C^7A.[CDC?BC<C5X?RG7LEJ;^U)"G%Z0MKG6+%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>tm212692d3_sch14-aimg028.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg028.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@!& P$1  (1 0,1 ?_$ )X   (" @,!
M      @)!PH%!@ #! L!   & P$                " P4&!P$$" D0  $$
M 0(% P0" @$%      (! P0%!A$' "$2$P@Q% E!(B,543)A<4*AP5)C)!$
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>tm212692d3_sch14-aimg029.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg029.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 1@!& P$1  (1 0,1 ?_$ )X   (#  ,! 0$
M      @)!@<*  ,% @0+ 0 " @,! 0             &!P % @,$ 0@0  $$
M 0,# P,"!04       ,! @0%!A$2!P A"#$3%$$B"2,543(S) IAP4,E%A$
M 0($ P0'!@8" P       0(# !$$!2$Q$D%1$P;P87&!D2(RH;'!T105X?%"
M8B,'<A92,T/_V@ , P$  A$#$0 _ -_'4B1#\YSW$N-L>DY3FES'I:>,0,=I
M2M*>5.GRG;(=74U\49I]M;SR_8"+&&4Y7=FM71>H 3E$BD4MN>N51_+IQ!X!
MP:0BK%F7M;!R/F"VB/3]*5^P2ROQ3 AR!NU1DQ;*<SMO$%WVIH>JFJ?U8GM
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M^<(6-EB,GO<KU.A+@ST=OT=KINT_F773K=R6#2UJ*,F9 GNVC,0%\WH#B5O
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BSS_R[H3=\^]_7'[]Q?K-FOT]>B7DE_C#%^KJ*>.=2)'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>tm212692d3_sch14-aimg030.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg030.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10!& P$1  (1 0,1 ?_$ *,   (" P$! 0
M      <)" H !@L% @0!   ' 0$!               " P4&!P@!! D0  $$
M 0(% @4# P,%      $" P0%!A$' "$2$P@Q"4$B%!4742,683(8<8$ED3,T
M&0H1  $"! ,%!08% P4       $" P 1(00Q$@5!41,&!V%QL2(4\(&1,D(5
MH='A4B/!8C/Q<T06"/_:  P# 0 "$0,1 #\ O\<"!&I9MG6)[<X_*RC,[J+1
MTL5QF/\ 42.XX]+FRE=N'65D&.AZ=:VT]WY(\6,V[(?7\J$*/ QH,8X2 )F
M@;[?/<QER=51V/'_  $I+C%SE%9#R/=FYA^J9+&+/N+QK!&WVSR%BJQFIY=<
M9E6J1TJ0A.95909"%NJRH%3$*-S]^/%';J9,B9UD.X^]&10I"4K8RO</)Y*%
MN](#CC5) 548G$83KS;;B)1^@XC.I<TV^F^9;94F8P4D>,2K0>2[W7;_ -(A
MX(5E)F4J(I(_2(B-DOG!L))?6QAOB_CZ6FEK0B<TF'&G%*U$*5]=%EPIO6KU
M*NO7X\1Q_J*P2%-L. '^]'Y18K71VY:'GN&EJ_VW()6TWF/MA-N(%2C-MT_'
MZTFOM,5NF7/9YA)D.J2VVJ;A^8(RB(J'U+/6EA^*\0.2QH-';2^<K:]HXT9[
M\R:?"(IKG3N[TL%33H40)RR+J??#.JW>W+<%A0K#>"LJ+K )K;#D+?+;=B<]
MB<:-(#9BR<_Q*4Y,O,&:=0XDN36GK"M;4K]UR.GB8-N(>3F;,Q3\8KUYMRW7
MPW@4KB3\.9$L(D:? E1IT&;'9EPYL-]J3$EQ9#:78\F-(94ME^.^TL*0M!*5
M)(()'!H)'Z>! C5,XS3']N\4N\SRB6J'1T$-4N6MII4B4^M2T,1(%?%1^[-L
M[*8ZW'C,(^=Y]U"$\U#@ 3CA(%3 7V]P"\RB\B;S;S0T_P V6'7L!P.0\F73
M;.T4U 2U$B,@?2SMP["+H;:VZ2XA:C%C%$=![IP03E3AMA!]Q+29DC,<(#_F
MSO1.VZP5^KI7RBTLHRST-J_>+*PO10&I)25M'_?B-\RW2;:V)!$Y;3$CY,8<
MOKX!"5% 5*8K6*V,B&G*LM=LYK?W25,6^MYY2EN-MZJ2E064E)UT'_4<9AYH
MU-=^HVXRY0KZ29XQN'DO2&]*0+II17<+3(I4!39W_&#G3[:N5S#4M=<EB#(0
M"AU2%I0K5.H2DGU/,<1U%F^E/RK$Q%BLWK;BLKN1*A3M@$[S[="SI[%J(PY$
MEMI6Y&F(24F,XA"^E]*AKTH0HZDZ'ASL'KJT7FX<TRQ,Y>^":KI5EJ%N6RZ0
M9&664R=F(VQ.CVD_-S(6;N7XQ[PS%SVNJ2QC-I9E"V9$;_D%NPD%U3;3Z#%C
M-(6@MJ!2K0\:%Y&UNUNPFWXK7&(^4*,Q(;HQEU3Y-=T]Q5UE>")_,4@ UVD8
MBL.GF0%^+]NQ>4G?/CO?V*&,KQOK<>8V7N[66$,9AC#:NM<3;FSGR BVKDD,
MU3C@EQTI8+[:;+)S=\46$\,!(,TB)8]UKM=_N-]GM]WO=:>UVNGK[G<UZ.WT
M<]==-.?!8/$;<@83NIOQ68M)3W\*V*B5.;7T11UC6^Z&1-2#@\*6UU /-8?1
M-/6H2=0)<N(LC5">.C=M,<%5 ")%O-]S3EKH#J2=#S(X+Y6@5"D>2[MU/*2
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M>O/ER_J-..7'^,RA< 9A%0'W#]7/([<QUZXT8KK:PD#O=]26A]T?:^F Z?\
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/992]THG7PE"T9P($?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>tm212692d3_sch14-aimg031.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg031.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 10!& P$1  (1 0,1 ?_$ *    (#  (" P
M      @)!PH+  8!!0(#! $   <! 0$               (#!08'" 0!"1
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M_-;HVR&PN=K;+ KKLC'@/A4Y;55F&L[<S+-:1AB\DH/<92()]2@['<!.M(Z
MI=:KJ7$IEBVVY@8Z8N4-4(3FG&D[5VYQ3.C8&H3CEE7<X63SY-)+L+EXJ6OK
MX$A@*Q"41L7-%=!]MQL@!I=$4.A155]>(:VZNFR_C6R&W>Y"H[<,S1]ZV^QL
MV'</F%PP%P4J%X*.RFR?&-X7X[)K@\E<Y<GN7-S93X=97B4EN.,*NDR8U8YV
M$)QL]8\L%4NE.K37B_\ H;H7;9(V;G<,D_(;D=>![<!64_V%^T>HS+)LEK)
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MXQB#D;,?=_(+1K<ZXRUL%2!/W;8R&KS5I'VE557%PMJ6+5(VB(OM#(ATZ\N
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9]S]/W'5T\2AVK[JJ#CWT</!:]KG H5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>tm212692d3_sch14-aimg032.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg032.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ #P / P$1  (1 0,1 ?_$ %\   ,!
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E=B-K&P_T7+(NS['KU79F(+=!$PW+ YQJ+!$I2I,-CY3FFO;_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>tm212692d3_sch14-aimg033.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg033.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &  9 P$1  (1 0,1 ?_$ (D   ,! 0
M      @)"@,' 0 # 0$!               %!@<#! @0   & 0,$  0'
M      $" P0%!@<1" D $A,4(=(5%I'14I)3DU01  $"!0,# @,'!0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>tm212692d3_sch14-aimg034.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg034.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &  R P$1  (1 0,1 ?_$ )H  0$! 0$
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M\=7490X.USNR)K/E"E3(F"0F.$3NS>.GV5B[2-%<U]PYF0N9R4F(A#2)%R*
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,\'LJ_K#L[>/W1__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>tm212692d3_sch14-aimg035.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg035.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %  4 P$1  (1 0,1 ?_$ 'T  0$! 0
M      H)! L!  (#                  $#  ($$    @<' @0#"0
M   $!@$" P4'%P@2$Q05%A@) !D1(20F(I(C-&0E985'*0H:$0 !! (# 0$
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&:W=G/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>tm212692d3_sch14-aimg036.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg036.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %0 4 P$1  (1 0,1 ?_$ 'L   ,!
M      8'" D!  ,!                   ! @,0   #!@0& @(#
M  $#!@(3! 4'"!06%Q@ $1(5"1DB(R$E,R0*$0 ! @4# P4            1
M  $A,4%A E$2(O"!D<'A,D(#_]H # ,!  (1 Q$ /P!LV/5B\#Y]LU!H6\)+
MU65MV2Y(5.?YK.$W>8IY_4VHY:OG;:BC$M,D7%Q"?6P,-'%@/9G[!+/(#&63
M ;X'T6^>.;Y/M^+*F1KU_EP9@#)LTD54S*25#E V:M)*^4)84L.0B"0-CQC,
M*6K!!D?UHMA&_C^+@%E.W])565NJEB/L2R<YKAZQ]UO/1/!7-XS.NT' OM+L
M3K3AM1_O<8;FZ^UTYX*FRKD+B?=)6B]TDV3D7XAX$?+/1^EL/1=4W$0Y<CG%
MNDNGQEC$,H6)S*C86I\;$1,&75DJI$(>,K@VH\Z *@0/ UDUVR^!OJKR:.7%
M"R2K-4BJ5.)=1A!^3^F2I7E3O-"G5LCJ30]OT%"*-8K10+J6-2*].#GYY)1\
M!3V+G#J9,I1LIF#%R!(F@TT##383JAF#D"'3+0C1:\WWF:6;ODWNKW*=YW3Z
M")OL.6]D'><!H/W[+C_)'ZIQW3I??>_ZOSPH&P69;:1Q$NZ"J#2&MC,U\+VF
MU5+.S9.4LKFMJ U,H"CH=01I+E0"I]Y(2:Y6*CI7. D_6$I[!C(L9GT"/]OD
M'!!5E/*#FH?V2VE\@N"T4CF4S5>UL"Q\W<G;DAJ8M\0(U/"[G/DO"6PZ.AX*
MYH):U:SF-T+)Q9@3+ / 9*<O!!,$V!@WUU@/"KSL5U_N4Z]4J=>R/='UX;05
AO9UD#9+TX7&[D-7'6GGS?X?N.+^#GG\^"!4<=M0/5?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>tm212692d3_sch14-aimg037.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg037.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ -  H P$1  (1 0,1 ?_$ )L   $% 0
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M)CJW<97=N)S/;EG6S?.3[>L@F/<-/20KL3. 5EES3<K",B&<1QV[ Z0IEDG
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ABE_S<V<Z(76@,/\ LPS]=%RHT#4JX8L%$$%$$%$$?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>tm212692d3_sch14-aimg038.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg038.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )@ H P$1  (1 0,1 ?_$ (0   (# 0$
M      @) P8'!0H!  (" P$               4& P0  0('$   !P ! P0"
M P$!       ! @,$!08'"  1$B$3% DB%3$R%U$6$0 " 0,# P0" @(#
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)=.2Z\^TZ:__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>tm212692d3_sch14-aimg039.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg039.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@ H P$1  (1 0,1 ?_$ *8   ,! 0$
M      @)"@ &!P$  P$! 0              !08'  ,$$   !@$" P,(!0T
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<QJ.A5\SR3Y<CEIXM,=6.E3T/*&>68ST<>B/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>tm212692d3_sch14-aimg040.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg040.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ +0 9 P$1  (1 0,1 ?_$ )D  0$! 0
M      D'" H! 0$! 0                8'! 40   & @ % 00%#0
M  $" P0%!@<( !$2$PD4(2(5&#&4%E8743)2TB,ST]15E:8G9Q$  0($! ,#
M" D%         0(#$2$$!0 Q$@9!42)Q0A-A@:&24Q05%I&QP=$R4G*B8^%B
M<R0E_]H # ,!  (1 Q$ /P!U3Y\WJ\BN8,DX\URR)6=;\/XYL<E79.42FVK6
M_/6K-X[9)2CP&8.;:^6D :&,"4<1HP;=14U7!C^T:R+7MG:-O9J[NRNLN#R
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%OVX__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>tm212692d3_sch14-aimg041.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg041.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ? "6 P$1  (1 0,1 ?_$ ,,   $$ 04!
M       '" D*!0$" P0&"P$!   ' 0                $" P4&!P@$$
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M/SUD2*L2/4'9U Y,/[!UCU[R-RW>@T@,+]\;BW\)JWP5ZM.;M=M2*R^JS=(
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M]Z=/\M$121RE>34LJ4WAH]J [](&$!,JH(=*213&'V  S-:7&@4":"JA*O\
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M0R9^E9O!HD*K.."])@.7O4#$;@.VP]^/O#56)M75V!22&@IO40H     &P
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M\' JBWRJXY6KBKF^W8?LQ%UVD8X&3I4^HF)4;51I!54\!,H*=I#N$T"^&>$
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M\PI_<1Z4?^,_)W^P>GP^E*1;RN5.[?S!HD<=[@GTIP4!$HM@3S-R;$IE^_1
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E/>S_ "^^._"_>^*OFGY]Y%XK_>'P/CNZ_*=6F*G^)79GT9K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>tm212692d3_sch14-aimg042.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg042.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ <0"6 P$1  (1 0,1 ?_$ +,   $$ P$! 0
M       '" D*! 4& 0," 0$  P$  P$              0,$ @4&!P@0   &
M 0,"! ('! 8&"P    $" P0%!@< $0@A$C$3% E!%5$B%M:8&5EA,D(C<8%2
M<S07D:&QP6(W<I*RPC,D-3:V=Q@1  (! @0"" 0$!04        ! A$#(3$$
M!4$246%Q@3)2$P:1H2(4L<%"8O#1LL('X7-T%37_V@ , P$  A$#$0 _ +_&
M@#0!H#3SM@@ZQ&.)FQ2T?"Q;0HG</Y)TDT;)@ ";M\Q8Q0,H8"CVD+N8P]
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MK;M0U;UT96)OCXH?%8KO7>3%U2W56]P,?::78X2UUN61*XC9VO2;.7BGJ1@
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M_P#YW8N\/_=S'Q_NG'A^W7$_ ^PZCXD5V,^?\^<X_P#W#DO_ .8S&OTWM?\
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M0*)\2^'^&3^9R5Y<(WZP-#I>LQ7Q9AQM+P3]ACJM'F0)5,\,T.F< 3,()H"
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MB =3#W&'Q,8P^)C&'J8P_2/771!VV/;W+8WM<?:8DB;KTX*-):)<[&8S\&\
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H +2Z2R[A;_(?*V_PZ']TG_V0U06'WT : - &@#0!H T : - &@/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>tm212692d3_sch14-aimg043.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg043.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ;P"6 P$1  (1 0,1 ?_$ +$   (" @,! 0
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M-RVVEE&XL9+NE[EXG7OA?6'OMB]C?==SMZ)5S</NO^WVOP'(ZY\>U#0!H T
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M, [@8I@W 0'X@(#KMN6!R8X$Y0432W[EEC 1%$@"=98XCL!$42 914YA] *
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MXNS=AS;C"*TTBW5)RQ;IEA0UZVYM4?$I#,^)'%7$6%U2>U[.0KNU'+.5#'0
M0!V68GMV4<X6,/<)2BX(4WIT#7D>H=<ZSU2OZ_<W9P_"GIC_ (QHCTFSZ5TO
MI_\ \=BW"7XFM4O\G5D5LKY_SGFY99SE/*]VN9A.HLVCY*;<-X!DL(]Y!85R
M.%E!,RIJ  E[&X;"'KKY*C&."1]!RD\VRY;Q7R";*G'#"5_54%5U9,;U9U(*
M"83&4E&T8BPE3F,/43&DFBHC]^M22I)KM-R+K%,W[K$D- &@#0%>+SES"I[!
MQQKVY_81C<BS@%Z]@K*KUB.W_P">"9?V#K8LK!LHO<!#'P]/QU<LR@Y_NC^_
MI]^G(CQ+6'ASAFL;PW92")"@XL.2[_*/3@78YU$'S2'0*<WJ;VVT80 ^P-:U
M[W^!M6?8-3U46AH"E5S_ .9T#G_R-\V<(YTYG<R>+^".%^/Z16\,5/A+$9(E
M;0[S-,0;>RWCD-F9MB^K3LI*8SQ*X?MDW2$BLR8 @8I"*@H<_?.)?&-(II)M
M\QP-]YU77CGXS^*9<;9UK7/;F7RL@ZMA#B1DVLU]O7HOD1D^SHK(,\PS58*]
M?C"U3&]6$)JV++&$$561R."HJ..PHKTUD^$5]#%?\MI=LM7OQXV:1S?DRVY;
MR/$<M^2]5L-UN5EE[5(OWM;N#6->)Q\C,N'#E"!3D4ES,FR?MH-T3@5-,A?E
M Q<IJPR'_:@P#0%7+S20#:+Y34V;03(5:T8=B5GAB_UE5X6RS\:DHI]HE;'(
M4/N+K:LUT>)K7O<NX41]G3^?^C5KXE0?A\?Y!J&"WKXK)1:2X.X?(L8YORH]
MRB$A..X@@SN<Z*12CN/R$*KL'V &M6[[V;5KV(8?JLL#0!H T!7M\YD$H61X
MXVCVQ%%1+(E=.J #L50H5J433$?0!.0IQ#XCVCJ^R\&BB]P$&]/OWU>L\"C$
M.GW_ +M.0Q+2?ABMK2:XHR]7*L!G](RG;&;E#IW),YY&-GXY00#KVK?6J@ _
M$2#K6O+U^!LV7Z*#<=5%H: K4<B>$/D&XV<]^8?+#@1A?!W).C>0;"]?QWD^
MEY1R>UQ).8:R/7H-6M)WM!^]B9%"YTJ5:*@Z>1R E=J*]Q-@[2*&DM4HN*4L
M*,QO#O\ EVK)4</<&4%.>W(7!6>N(^#KUC4ELX\J59.%:S&7[O-W[)*]+6N\
M#+OX-DZ6FPB0.B1$[EDT*8Q2=XD*J'<JW@J,D-X#_'AR;X$89S3'\F+]>AG,
M@YDO$I7L-25NI]NQ_6H5*RRCQIEB#=5477TUVS&WD"/)]-9P(E6;)@"*(]Q=
M#&<E)X(?KJ# - 54O,;;F]AY>-H!!4%/T'BVK0SH"F*8J;Z:>RUD43'81[3@
MT?H"8/O#6U95(=[-:\ZRP%4=/O\ O_FU:^)5B'3[_P";4/,8EO[Q:PRL-P=P
ML98@D-,-[5/%*([B*,G<)U1 _J.P*H$*8/N'6K==9LVK7L0P;598&@#0!H!3
M/F0QLM<.*C6Z,FYEGF*+Y V1PH0HF%O 315ZQ,*B(=2ID5E&QS#Z;$U;9=)4
M?$JNJL>XJP_#U_#6TLS6.?[P_OZ_=J.1'@-E\0?(%IBOD#*8KL+\&E9SE'M(
MR-464%-JWR% ?4KUXI]P$H*3D<Y<LB#T[EQ1+OUU5=3<:\BZU*DJ/)EI[6L;
M)@]]R/3<8QT)+W>7"#B[!<:E0HU^JT?.6@VB\S;2MU5@\69MG!(Y&6GGZ#4K
MEQ[;8BRQ .H7N =!2II"S<T>.M2.\)*W23<?E4S?(F>4@:/>K.E66N,)Y&JY
M!MEI5KM<E"5K']2LRWY>[GWHH1!7::J97!C(J]@FC/O*\R./<)<I"D2MSD6<
MA'L;8\+-JTN[_H:5<T6F+Y$N$'7<@EKPTJR6:OT5JK*N(Y@^<.RLTSG @B0X
M%"C,;AN>?&:P%I)X>W6AZG?X6)M4(=/%F42BRI5CG$ZU5+]:4E*>1>FT&WSJ
MI6T3-2I&D;('W%%8Y"F, :6B8FA!C-SM]?Q_4K)>+7((Q5;J<))6";D%S$(F
MUC8MJJ[=*!WF(4ZHII"!";[G.(%#J(:)5P68;HJLHX9KRE*9MR[D;+<N4Z+N
M_6J3GD6AQ$1CXI10&\'%AN([!'0S=!$0_P!XHZW8JD4N1I2=77M-8?9U_F_I
MUD^)!P9-=;9!J0RKIP<C9HD0!,=9TX.5!LD0H=3'574*4 ^(CIQ!>BX\X]+B
MC!>(\<>T**U.Q]5H5ZF( 42R;:);#*B(!Z&-)'5$?O'6C)UDWVFZE1)&X]02
M&@(32'DI\>$3(R,1*<Z.(T=*Q$@^B96-?<A\3M7T;*1CI9C(QSYJO:R+M'S!
MZW.BLD<I3IJ$,4P ("&ITRY,RTRY,_)_^G/CB_\ GIP]_P#L=B/_ ,6Z:9<F
M-,N3-?97YY^,K+N-+WC">YX\.315[JTS6'1E.1V(A*W&59*MF[TN]N  48.C
MD6((CT.F ZE*2:=&0X2:I1E-*7S?@:"EYB!5SYA:45@I:1A5).(R159&+D3Q
M;M5D+^-?M))5J\8O01]U)1,QBG(<! =;B=<33_U7:^V7D;UQO&T#(.-K%F^2
MS_Q_Q9@:K6=G1)3-F3\BM(B@KY D&@2#6@P#B(;3<I9+<$:8'2[5DV5%HV$%
M5A(40WPE-1P>9,;%R3HDZ]I[]ZH%IQ//UXRTS!23:9AX/(.-<DXZL;6RTNZU
MA\K]76[[CVWQ9OI96,4<M=TU2]BJ"Z1DU"$.42ZRC)26!A*,K;TRJF6DO'IS
MQK_*&ELJ/=Y%C$Y\J48FC8(I51-L2]1S),B076MI&$H+BN0 &0:DW.T7[C '
MLF((:URVXNJ]ILVYZUVDF.8%,L>1>->6Z%3J8[O5NMU85@ZI$,YV%K2T7:7;
MIM^F;H$U/NV;!B7'\^1M."8!57'\OV1165$B1ZRU9D*;AXJJA<*YB=%S=8A2
MXU7 +? N29VWT9>_1]Z82$_(7>X76)BOU;46\%>K'>[+-/U73PLK'KA)F(X8
M*@F394RUOP/9E?&)&2=N)/GS-+*1T1+Y5=5,DG3FTO:H2MY.P;:<&L<>&LKF
MQDCDZ%C2#LYEZ_'QD7%%2]DJ3HSG_I $:C/,H\!ELAEP@WC\NC4PP_C['>/D
M+3&8]CD<JLD,?OF#T;!C3)\-88"?H4K:$V'TL@S?!8H0S<XB1B5;N5.&K!C$
ME%")$.JJ<B:29#****& A$R$ 3'.<YA I2%*&XB/0 T,2M#Y1N?$?E]PZXZX
M9F2OL;PLD0^1[='+=S*\3<8N!V]9AG*8]KRKPSU,%'*Y1%)ZZ(4I.Y)+N/LV
MK=/5+,U[EROICD)=$!W'T]/Y?CJW^I0'V>GQ_D.I?$$X/';@E;/?*K'\2Z9?
M55*@.T\FW4YTQ4;!&UETBK#1S@0V  F;&+9$ ]1(!Q^ ZKN2TQJLRRW'5)<B
MY'K4-L- &@$K\R[AP.XSY:Q]BK_T&<9,M9;RI#SV39&+DZMQBQ8J%1:6Z#K$
MG*LK-EB/A8N\9(M%KM!4XN 0<E>RJJ3E0ZR($[SS67-F:<FJU:1@L?F?QJ%Y
M%6_$-OX'<=L?XGK5TS5BAGR3M>)N/D?0WV7..5!A\F9JJ,O!K5]*<JT-5JI*
M*F:S3D3,Y)S'NDDRD B9U9K+FR?72M63EPSA/QI\A*FM>,.\<N*%UK+>5=0;
MI^VXXX^BEF<LS1;.EF3R+GZ%%2S-46CU%9,54"%606(HF)B'*88U2YLQ<IK-
ML41Y<O&SA:F'AN26*L!XEAZD+=A5<H0%=QE38V-@W)#_ $];N",='PJ+9JR>
M>X#%\8B92E5!!0P[G,.K[4Z^EYE%US]R;IQQ8F7*W&OCSRXXJT3B_<,FI\2Y
M["F9;IF3%-_A,7.KMBRPADVOPU?OE9R'1Z4M$S+2>23@&R\5,-BJF*'>W5V(
M;4S@Y/4B;&XT54ZLV9/LL88]Q/QPXSX6F[3=<9<7<826/H?)%VC$Z_8LD3]H
MM\M>[G:BUA-=T6IUI2?F#I1,:*AU&[-,/<'O,.LH1<8XYLJOW%=GJ6",1@YR
M;K$U%62LS$G7K%!O4I*%G85ZM'2T4_;B!D7;%ZW,19!4@^NP[&*(E, @(AK-
M]I56CJ/,XT>9N5A&,?5>4%4>V)-L5-J3*-%:-@EU4R!VE6L]/,=LV=.?3O<1
MZB?=L(_3B8=QIE9XQ+HWN$ANF/><_$G)S=!6KYYQ\1=8A3#&6.:2J$L@8P!N
MDO'6@(EP50@CL.P&+OZ".J7":S1:IP>3-ON\X868-OK'N7L8-&G:)_J7%]JJ
M2(E#U$JAY4"F_ 1U%'R,M27$B9ECR><.\5MG)4\F(9&G$ 4!*NXR:*VITJL4
M!["*2J0MZZT(<X;"=1X';Z[#K-6YOL,'<@N(BKEMY.,T<E6<A2:NW/B'$S[O
M;O:_#21W-KM3,1$/8M=F0(W]I@L4?XC%D5-$X?*JHL&KH6XQQS93.ZY8+!"T
MP*4@ 0I"D*4H%*4H !2E#8        -6HJ.WX?#[OVZC^H..OR@5,ZAC&*0B
M:1#**K**& B:229 $ZBRJA@*0H )C&$ #J.I!;D\9O$Y?C3@XDS;XXK7+&5Q
M8V>XI*D(+NOQ96YAK5.%0-S$/$LW!E710$/\:X4*(?(4=:ER6J78C;MQTQQS
M8R#598&@#0"T.<7C:K/,ZWQMW#)\ABZ<?X1R'QER,LWH=2R 6X8'RA-U^Q6:
M @0M8 ./KVSEJ\12+LC'W7#'WU0,@MN3LFIE&6GS-:+^(NA*Y(OEB+F&SGQ?
M.KYON-!P_+TBE6N-H.8^0N)H3#62<B2D_;FTZ;)$8XJ<,<[*"EV1FC=W(.E%
M55P.F5*"=>%.))C@KPP#A31+O2T\LV;);>Z71.W-8MXS=P%"QZW0KT/7DZUC
M"FR%CN+RI0#O\H^N=-QE7*)W[A0R!&Z/8@08MU)C66M0-RKTU5+3$LIVN6*,
M>0\W#R*(+LI*,?H';NVCE(=MTU4CB&X"!BCU 0$ '188HAJN#R*A7.O@_:N(
MEY5>QB#^<PA:I%4*);C%.X4A5EA.L2E6I<I>U"78I@)6C@_:200)W!_%*H0-
MN$U/O1J7(.+JO:0-^7[.G_+^W6? KQ. V_VZ<R<0Z?O_ ':E#$Z*)(JALJD1
M0/@"A"G /P, _'3D1B=1CDB)(N%(T2-G!E"M7*C Z;5R= 0*L5HY.D5!P9 W
M0X)F,)!]=M,R:,^A0(4  "@ !\"AL'X &P:A\2,3GI]G]&I7\AB'3_9J%0G$
MX,8A"F.80(0I1,8QA I2@'43&,([  !J?ZD8CV/%YX^GL[*0')O.$"HTK\8H
MC+8BH\PU.DXFY NRC*_S[%P4IDXIGT4B6ZA=UU-G)P["I >B[<IZ8YFQ:A]Z
M18MUKEX: - &@#0!H T : Q.\T6GY+JDW1K[78NU5.Q,E&$S!3#8KED];*!Z
M&*.QTETC@!TE4S$514*!R&*8 $)3:=5F0TFJ/(K.\Q_%+DG#CJ5O6 FTOE'%
MG<N]7K"(&?9%I+4-U3I?2IE!2X0K4F_:NW#ZY,A?XJ1P 51V(74UIEF:\[36
M,<4*)_JG42,!TU45#HKHJ$.DLW63'M41714 JJ*R9@V,0P 8HAL(:NX%0?C\
M?Y#H@?%R"@MW )&'W114!/;H(G$A@)L/P$#:CD!M7+VU8[LG&>K)4V[QS2K,
M4L $Q=1XB]P%B:6 [+'SF.R:=QC9)@$_B.5HL^0_U;@RR99MPZ$RP+#[8DJA
M75XLNG33198"F_QV_;TU:^)1X!^/^O\ ;J5_('NU>K6:\6&.J5*KTU;K3+K%
M;Q=>KL<YE9=\J<=@]IHU(<Y4BC_64/VI$#J8P!UU&6+R)2;P2Q+!W"/Q+MJJ
M\A\J\IV\=.6%HHA)5S$""R4E78-VF8JK5]=WB8G:V*4;' #$8I"9@B< %0RX
MAVEUYW:X1-B%I+&68]<A")$(FF0J::92D33(4"$(0@ 4I"%* %*4I0V  Z &
MJ2X[: - &@#0!H T : - &@#0"RN5.$_'#F*>DV&8\@X5QSE9 IBO+!%96HF
M/LAME1[A*:;8NI9$LKL<=Q"19KF$ V 0U9"5Q+TIT*Y*VWC2HFC*?C]Q9#J.
MG>'>>'%2Z1Y1$[:'O.5J+4Y[81$00_-(JP2\,Y.0.G>=-L!O78-71N/C%E+M
MK[LEYD+[)@:[UA95)>RX0G"$WV<U3D5@V>05 -]A3*G?6[KJ ;@!DRC^.L]2
MPS\F8.-.7FC VU"GEG2B2"E(!T(E*L)LI8E0VZ@ "LNK=TTP /@(F]/32J_A
M$4-P4_C'=+:JD5?)'&JFM3F #O;ER8PPR*B4?4XLHFVS4BH  /H"6_34.5.#
M\B=->7F3[Q#X]N*":[60SSSYP)((D,0[BK8ORICR-17+MW'07M<_/K/2AO\
M*(H,4C"'H8-8.Y+[L661MPXR0\+BS3^&5&C'U>XK26&I=9H@D6Q2&/[E6KU:
M710["@M99Z/EIF;6!10 'M75!(#C\I2^FJ).;]U2^*BO:2[UB9!H T : - &
#@/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>tm212692d3_sch14-aimg044.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg044.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ <P"6 P$1  (1 0,1 ?_$ ,(   $%  ,! 0$
M       &!P@)"@,$!0(+ 0$!  $% 0$               (! P0%!P8($
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E/M]GO?K/+[>L:3/YN]7FY;.Y30ZMJ2.B(Z(CHB.B(Z(CHB__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>tm212692d3_sch14-aimg045.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg045.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ @ )8 P$1  (1 0,1 ?_$ -   0 !! ,! 0$
M       (!@<)"@$"!00#"P$!  (" P$               $% P0"!@<($
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M)0$ 63< 58IA*("':#KTQMV(OF$ -V2"7MB<P%(0"B<QSB/U2D( "8YQ'Z
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M9O")CZOWIS 8A^RH4I:0#4[%KZ\;*-,\'/GC:(X7<1>5_(SD;K>>XW[!N_S
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M1_:9[RCS;R]\RWLO]U/Q4N O\Q->_=N]_P +8\D<T_*/[3/>3S;R]\RWLO\
M=3\5+@+_ #$U[]V[W_"V/)'-/RC^TSWD\V\O?,M[+_=3\5+@+_,37OW;O?\
M"V/)'-/RC^TSWD\V\O?,M[+_ '4_%2X"_P Q->_=N]_PMCR/S3\H_M,]Y/-O
M+WS+>R_W4_%2X"_S$U[]V[W_  MCR/S3\H_M,]Y/-O+WS+>R_P!U/Q4N O\
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M1#BCQSO&W$VJ$C8VQ&E<HT6Z[7JLC=K$H9G!)O.S]86+(P*.W!0Z"=!N<H"
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M#/F>>&2WF?;RBDK'%I'2#0_ZKWJ*5DT39HS6-[00>@BH7OYB61,(OYZ-T_\
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M3 =0HB&:1YZ8P#O(0'"W>YW6.$[2X"#9^UEK7;CL6X.4'/Q9*2TSM#308PN
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M:G]0_P#HC@;4.Q;T7 ]117AIQH.J<RAQT]3"B8XB8W9)%(D('4?#T(0H ']
M9\S<S #F&\ V>(?]J]\T DZ+:D_ ;]BEIE$K=,(OYZ-T_P#S2Z?_ +C:O^/R
M.?5]M_ZT7X3/W0OG&?\ WY/Q'?O%4WF=8ESU, " '.!1Z=HI3F*0_3Z.V0!
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M;J[ 7^26E[E6*?<Y.)<V"L5J?D7"BBK-JL4A!./=B3KFR=!TQUV+W(\3 L-
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M#&;A\ML6O:7,#HGL<2QC'$T[MX-"!6CNL59ZQJFG:P'0!_<,CN YA#7%LC7
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M@* E/X>A>N6.JZG;7+M/#[EUO;22GORR3NRS-!WC6N=NQ((KM6CIUA/ +W)
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M3")A$PB81,(F$3")A%A%^>Q_AIU7_??%_P#)UNSTG_&/]YG_ )8_OL71.?\
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B:229 *4H    = SP4DN)<XU<3BO8@ T4& "_?(4IA%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>tm212692d3_sch14-aimg046.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg046.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ -$   $$ P$! 0
M       '" D* 04& @0# 0 !!0$! 0               P0%!@<"" $0  $#
M P(#! 8$" D'#0    $" P0%!@< $2$2"#%!$PGP42(4%19A<8$CH;$R0E(D
M%QF1T>%BPC,E=AC!\5-$E"98<H*R0S2T9865-F8W5Q$  0(#! 8%!P<)!P4
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MK8OZX6W?>YCKDAYTM5J16HRDJ?=*BDHY>[LU<J?\0.99$ 9K)C  (.8V$!N
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M\]DRJ()@VVZ^T6=$5(SJ"4NC0A0H^=+_ /6>+>!.\J_^P;_ZA;7\&M%_#O\
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'C0A&A"__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>tm212692d3_sch14-aimg047.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg047.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ +X   (" P$! 0$
M       *" D!!@<"!0,$ 0 " 04!                !P8! P0%" (0  $#
M P(#!04& P8$!P    $" P0%!@< $2$2"#%!$Q0)46$B,A7P<8&A(Q:1T>&Q
MP4)2%QAR)"49HC-38S4V=Q$  0($ P0&!P8$! 0'     0 "$0,$!2$Q!D%1
M81+P<8&1H1.QP2(R0F(5T5)R(Q0'PC,D%N'QHK*20X,E@M)C<Y-$%__:  P#
M 0 "$0,1 #\ ?XT(1H0C0A&A"CYDWJ8Q;C%;\"=5E5^X&@1^W[>#<^6TX.Q,
MV0%B) W)X\Z^<?Y=7&2G/Q&2\EP"A%>/6]DJLK=9M&DT:T(*N9+;K[9K55*-
MSLI;KP;A-.$$?*V=7FR />7DO.Q1[K.:,N7 I:ZKD6ZWDN<%-1JF[3HX3N20
M(\ 1D)[=AMKV&, R$%Y)<3CDNZ])E=KM2OZ\4U&MU>H)1C2X74)GU2=+"'0Y
M'V< D/N!+B=_F'$:J0WG9A\8]*H8\CH?=*5SA9PS9;M5FR*#F'*5'?8JM5#*
MH%^W*P&DIJ,G8):^I%D)2 -ARG;733K9;)LL,FTTAS>49L;NVX+G]MQN$IY=
M+GS@8G)[L,3Q4F\=>IKUNXV>CF%FVJW?!CJ!-*R)3J?=<9] .ZFW)DAAFJHY
MQPYDO@CNUIZO1>FJP'FIFRW':PEO<,O!;6FU5?:5P GE[1L> [QS/>K0<&>N
MK3I#T.D=1N)I%(0LMM/7KC*0NJPF^ 2J3.M6J.MU!"">*C'D.\H[$'4'N?[8
MS&@S+1/#A]R9@>QPP/:%*J#7\LD-N4DM^9AB.UIQ'85=[AK/V'>H&VV[KP_?
M]OWO22E)E)I4Q/U*EN*"?^6K%(?\*ITN0@G8I?:1N>S?MTM[C:KC:9WD7"4^
M5,V1&!X@Y'L*GE%7T=PE>=1S&S)? XCK&8[5V+6O68C0A&A"-"$:$()VT(6A
M9+R=8>'[*KF0\DW+3+3M"WHJY53K%5?2RR@ *\*-&;XO3)\I8Y&6&DJ==6=D
MI)UE4=%57"I;24;'3*AQP ]/ #:3@%CU=53T,AU35.#)+1$D],2=@VJ"N6.H
M*?F[ %J9HZ>+N>E8BN$RHETR($1<"[*7)1),0QJP"M<NC-1W_P!*4R AQ!6A
M2E<BAK+J[;4VJN?05[.6I9##,8XQ!VB&U6*2NI[C2-K*-W-(=&!RA#>,P>"K
MT[RK<E:R5K4I14M:U;\RUJ5S*6LGM)).K,,%D Q7O[??]VO2JL;_ &_'^NJ;
M J*5O2!_]_O3_P#,;B[O_<C]WX:I\;#\X](03^6[\)2G,SA/J9V/_P M51[.
M(J4D'O[..NIV^ZT' \H]"YT)@3^(^DK^?[?EO^>VO601%!_'@/Y?ST1"\XDK
M=<=9)R!B*ZX-\8PO"NV-=E.=0N/6*!,7$6\E!W,:HQ1S0ZK!= V6Q(;<;4GA
MMK$JZ.DKY#J:MEMFTYV.QAQ!S!XB"R*:JJ**<*BD>Z7-&UI\",B$S+T(^K?;
M.9I=%Q/U&?2+#RG,4S H-Z,%-/L>^YB@E+,9\.J+5KW#)4>#*U^5?4?TE).R
M-)G5&@YUM:ZOM'-,H1BYF;V#^)HWYC:FI8-82:]PI+CRRZLX!V37]^1X9;E=
ML"-OMM_;V:7"G"SH0C0A&A"YUE?*EC85Q_<V3<CUR-;UH6G3G*C5)\A22M7+
M\,>#!8YDKF5.H2%)9CLHW4XZH >W650T55<:IE%2,+ZB88 #TG<!F3L"QJNK
MD4-.ZJJ7!LE@B3ZAO).0VI,;K7ZVLB]9>0%5>LJF6WC"@2GACW'#<I2H=-CA
M2T-UVX$MD,5.Z9S8"G'% HC)/AM; $GHG3>FJ33M+Y<N#ZUP'F3(9G<W<T;M
MN923OU]J+W4<SHLI&QY&;L\7;W8=BZ5Z</62UTT9+E6+D5WSW3[F!UJAW[39
M?,_"MFK34"# O1F.>9*& '0Q40D KC$.?,T#K UEIOZY0^?3B%TD-)9#-[=L
MOKVMXX;5E:7OQM-7Y=0?Z"<0';FF&#__ #<,=BMHSEBES%%V)CP7Q4;+N)@5
MBRJXVM+\>=2I*4.IA>9;YFWI$-+J0"D_JM%*QN%:1 =FUP(F-P(VCH4Y"=K<
M6D1':OOXVZ9,JY)0Q/CTINV* _RK16KE#L0/MJVV<A4U*3.DI([%%*$'VZHZ
M8QN&:] $]2F!;'0C8\)#:[KNNX:](X%UFFB/1(/,0"4IY$RI2T@C@>=)VU9,
M]VQ>N0;5W^Q>GG%F.ILVI6O1),:?4*5)HLR5)J<Z6X_3IA2J0R4NN^&DN%(^
M)*01MKSYKX@QR,>U!8TQ&PB"@K=7HT]$MPH?-,MJ^+.EO.OO^:MR^:L-GY#B
MWEN*8JPJC+@\594$D;:FDC]P]2R2.>9+F-W.8/5!16;HJPS(EK'L=O#SMZXJ
M .9_0GNRFL2ZG@/,<2Y2VA;C-IY*IJ*3.>(X(CQ;FHX<A*<5N?B?C-(]XU*K
M=^YTEY#+K3E@^_*,>]IQ[BH]7: FM:76Z?S'[KQ ]CAZPJ6LPX+R]@"Y#:>8
MK!KUBU9Q;B(3M2C%=&K"$%(+]#KD?Q*7562.(\-PJ /%(TQK?<[?=9)GV^:R
M:S:!F,O>&8[5!ZRWUMMF^572W,?';D<LG# ]BY1[?O ^[BK^6L^&:PB,.S[5
MA24K2 KB-T[=J2%)Y2%)4#S)4D@%)!W![-M4@<ATP5"!#'=ZDQ9Z67J43ZA.
MH/3#U#7"Y,F2RU2L19&K$@%Z6MM :AV%=,UX[O35(1RTZ8L\SNW@N$JY%:4>
MN=',8U][M3 &#VILL;,??:-WWALS3-TGJ=SW-M=R=%QPEO.W8&.._P"Z=N28
MGTI4QT:$+!( ))  !)).P '$DGN &C-"4+]5;K4D]1V7)>)[)JJUX6Q)5Y%/
M:,5TB%>]]0E+C5:XW^4\LJFT9X*BT\'=.Z7'@-U#9^Z%TX+/0"OJFPN%0T'B
MQAR;P)S/8$G-77LW.K_12#_1R7?\;Q@7=0V=I541X>WL]G=[._O'YZG)BH?T
MZ=?K7WK5M.Y;]N6A619E!GW/=5U5!FC4&W:6P9$ZJSY9Y4QFF_E0@(W+CBB&
MVFTE2R -]6I]1)I9#ZJH<&4[!S.<<@!M]0 Q*N2I4VHFMD2&E\YY@&@8D[OM
MCE!.L]&/3S?N*^F_&6-NHFLT3)%WV4Z:A1O'AMU!FR82T)^DVM&JDDN+K;EM
MM+4PF64I"D[(2"A"#KF[4MQH+E>)M;;)9E4[SC\QVOA\/,<8)[6*BK*"V2Z6
MO>)DYHZ^4;&QVPWJ;0    V X =P&VW =@X:CZW*SH0C0A&A"QMH0N=Y1Q+C
MC--GU*P\HVA1;SM:J-*;D4RLQ$2 RLC9$N!)V$JG3F2 4/L+;=01P5K+HJZL
MMT\5-%,=+GC:#X'81P."QJNCI:Z2:>K8U\D[#ZMQXA*A^H'Z:5U])\B7DK&Z
MZI>N 9DH!V6^DRKDQL])<V8@7,II.\^@EQ7(Q40D<A(2^$DA2GGI36<F^@4=
M:6RKJ!U-F;RW<[>W;L2BU)I:;:'&KI(OM\>MS([';V[G=A55_LV]WXCM&VW
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MW8Y4DMA.Y5R\.S3<D4^G;>VGLMR,M]:PM,=G,,,>!"7L^;?*YTVY4/.RD<#
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M$#?VGVZW<5JH=.G3M4@:3>;ZNDS(&.''EEAKJ7P_?<6,?D09&*,XT.H.)/\
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M\,[*\HTI78X-V;^W-@=459O=2/Z>482X_$\YD<&#;O/!0'6]W$FG%JD'\^;
MOX,W?^+T)8L#AR]FW#AMP&WP@=P_GITQVI5B(7I+;[ZVV(C#DF9)>;C0XS:2
MMR1,DNH8BL-IVW4MY]Q*$CM.^B( B[!H$2> $3X>"I ^Z/>)PAM.[JBG!O\
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>tm212692d3_sch14-aimg048.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg048.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ -4   (" @,! 0
M       *" D&!P$"!00# 0 !!0$! 0               P0%!@<" 0@0  $#
M P(#! 8%! P)#0    $" P0%!@< $2$2"#%!$PGP46$B%!61H3(C%H&Q)!=Q
MP?%"4C,E=;4V&!G1PD-5)G97ESGA<H*RTC2TU5;6)S<I$0 ! @0"!P,%# @$
M!04    ! @, $00%(3'P05%A<1(&@9$3H;$B,G+!T4)28K(C,Q05%@?ADJ+"
MTE,D-O&"5!?B@Z/#)4.3-$0F_]H # ,!  (1 Q$ /P!_C1!!H@@T00$@ DG8
M#B2>P#UG1!$:LE]56*\=.2*<BH.7=<#&Z%4>VE,RD,.C_)SZJI8I\,@\"GF<
M<3WHTHEI:MPCA2P-YB%%X];65*ZMUFV(=$LN"KG2VMJ/\ZJQ;5OL7)<](AMN
M@=[; V/?I4-)&)QA,N*U1'VM9=RG<*UJK.0[OF!9W+2:Y-AQT[]H1'@.166T
MGU!(&E A(P TG'/,3KB0?1K4JE-RQ6?C*C/F?Z!UM?Z7,DR=UIE4X)4?'=7N
ML \#VC7#@$AQ$=(]:%99N2\E4&Z+C=H61K_HCK=T7 I"Z/>ERTQ25)K4SE(^
M"J;&_+R@<1ML-O9KZ?1143K"/%9:5]&G-"3J&T1@#E75-U"RVZXDAQ62E#X1
MWQ(C'?F+=:V,GF%T//\ >%<BL?9I-^F'?5,6@]K9;N"/)F-HV'#PWT$=O[$3
M5](].5H/BTK:5'6B:#^S(=XB1INIKY2GT*A:D[%^F/+CY8L_P7YZM59D0Z3U
M'8EC2(:BTS(O7%3[J9+*>;9R7-LVNR5B1LD[D19R3PX(.X&J5<_RR007+14'
MF^([Y@M/NI[8M5!U\H$(N;.'QF_=2?</9%X^"NIC!W4G;YN+#>0J'=[#"&U5
M.EL/*AW'0W%I0?!KENSDQZO35I4OEYG&@VI0(0I6LTN=FN5G=\&XM*;.HYI5
M[*A@>^>V+Y072@N;?BT3B5C6/A#BDXCNC>^HR'\&B"#1!!H@@T00:((Q:\KT
MMFP*!-N:[*HQ2:3"3[[SQ*G9#R@?"B0XZ=WI<R0H;(;0"HGV D>@$F0CPD#.
M*G<U=5-YY.=E4:WG)5GV25+:$*(^IJLUIC<@+K4YE04TTZ./PS)" -@M2SIR
MAH)SQ5"*E\V RB*X 2-D@ >H#;VGZ=*^;3W(XCGT]/RZ,>W3W8(-'FT]R")=
M=%G_ -L5G_4&N_\ BZ;I)S(;9B.T>M"GMQ?UDN;_ %FN+^FIWM/I].OJ=CZA
MOV$_-$?/+_UZ_;5YS'C^GIZ?\JL(Z::?I/3\WIZ<"#333]&465>]Y8VN>FWK
MCZZ:Y9=VTAU+M.N&W*@_3:G'*5!1:4ZPH)DQ7-MG&'0XRXG@I)':A4TU/6,&
MFJT)<IU9I4)C]!WC$0LQ4/TKH?IEJ;>&2@9']/ X0R;T(>;W1\CRZ)B3JD?I
M-IWW-=8I=N938;;IEGW=+=(:BP[G8W$6TZ]*<(0EY)33Y"R!]PH\IQ[J?H!R
MB2JOLG,Y2C%3>:T#:G6M(_6&^-/Z?ZR15%-'=9(J3@ES)*MQ^*?(=QPB]Q*@
MH!22%)4 I*DD$*!&X((X$$:S&+]'.B"#1!!H@C&;PNZ@V);E5NJY9J(%(I$9
M4B0ZK8N.J^RS%BM;A3\N4Z0VT@<5+4![=>@$F0S@)D)F*4LS9DN3,MS+JU66
MN'0X+CK=MVZAPF-2HBCL'W@/=D5:4A(+SQ[/L)V0 -.T("!OT]Z&ZE<QW1J#
M7<]>FF,<QP2!VGM( ]I)V 'K)/8.\Z-VFSW((DCC7I7RMD9J/454YJT* ^$K
M;JURI>8?D,J2%I=@T="?CY"%I/NJ6&D'^%I,NI3O.ACL()X1,2V.A;'%.;0N
MZ;@N6YI02DN(COLT*!S[>\$L14/RE(WX<7MR/5I(O*R$=AL:XW]8F!L68VJ+
MM7M&VA3JH_!>IKT]RHU.8^["D*:6^PH2YCS02XIE))2D'<<-)E:E9F.@E(Q&
M<0MO#RB>AF[ESWV\:5NU)U1DR)DBH6G?-TP9 E2G5/OO-,U"H56 V5O+*N4,
M\NY/#5OI^O>IJ?E'CI6A(E)2$D2&60!\L5I_H^PODJ\(I6HSFE2AB>)(\D0"
MS/Y$BFHTRI]/V9GG92$NNQ[2RG3VU,O%(*FXT>[;>9;=:<<^RDO0%I!VYE<2
M1:K=^9QY@BZTPY=:FCCQY58=RHKM=T )%=N?,_BN#]X>Z(I,SGTVYOZ;+@3;
MN:,?5BSWY#JVJ565I34;5K_AG8KH-S02[2JAN/\ )A:7D_OD#CK2+9>+9>&O
M%MSR7)#$9*3[23B..6^*+7VNOM;GA5K903D<TG@H8'S[MNC]2<,(ZJ2E:5(6
ME*D*!2I*@""#W$'M&C*/..4,"^5AYD\^CU.W^F+J$N-Z;1:D[&HV(LBUN4IV
M12)JR&8-A734I"RMVG2E<K5*F.G=E>T=U7(ILHRGK?HY*T+O5I0 L3+K:=8U
MK2-NM0UYC6(T;I/J=25IM5R5-)P;6=1U(4?FGL,,GZQ^--@T00:((J$ZM,T.
M9#O%RSZ)+*K-LV6XQNPO=BMW$US,S:@LI/*]'IRN9B/VC<+6/M#3II,DS(Q,
M(+5S&0R$1(TKIIIKCB/0I-)JE>J<"BT2!)JE7JDEN'3Z=#;+LF7)=.R&VT#L
M '%2CLE"022 "=>3 $SEIIV08G 9Q;%@?I2MS';,*Y+U9AW-?)0A]"'6TR*+
M;;J@%>#36'$EN7.9WV5*6">;^+"0 2V6X58)RA=* !CG$P-)1W!H@@T00:((
M-$$89?\ CNQLJ6K5+'R-:M$O.TZTRIBI4*OP6IT&0DI4E+B4N#GC2F>8EMYI
M2'FE>\A23QTXI:NIH7TU-(M3;Z3@I)D1^C:,C"-13L5318J4)6RH8@B8TWYP
MJQYAOE@U[IC14,NX;^:7;@A<GGK5+?+M0N;%ID+V;547DH+E8LTN*"$3C]]$
M)"9&Z2'5;?TGUJW>2+?<9-W.7HG)+O#8O=D=6,Q&3=2=*N6L&MH>9=!/$9J;
M]]._,:]L5#]NQ!W!X@CB-CV'U:O\4R."-^]0((4E2%*0M"DD*0M"TD+0XA0!
M2H$%)&X._'1!III[\-U>4_UIR.I#$\C%^0:K\9F3$$&##G392]YMZ6.L_!T*
MZW"3O(J4)2!"J*@-R\EMU7%\ZP3KGIP6>N%;2)E;J@D@#)"\U)X'-.Z8U1L?
M2-\-THS35)G6L@ [5)R"N.H[\=<6TZHD6^- =2V2EXSQ56JA!?\ !K]<VMRW
MU)4 ZU.J3;B7IJ!V[T^"AUT$=BTI]>NVT\RI:HY6KE$4E@;#M*CWJ4=U*)XE
M2E'BI2CQ)[R=/----<-X"0D$GL W/?V>P<3HTTTU01;7TEX):L&W&;\N6$@W
MK=$-#L5I]L%VW*#(2'&(37,#X,^H-D.R5#W@DI:X<J@6SJ^8\HR$+H1+$YQ,
MC2,=QK2\,S8DQ[.13+ZR78UGU%Q*%H@W+=%'HTI:'$>(VM+%0EL.*2MOB#MQ
M''3RGM]?5IYZ9EUQ.U*21Y!#9ZLI:<\K[B$$[2!YXQ#^U/TU?[>\0_[P;7_\
MR]NG'W)>/]*_^HKWH1^]+;_/:_63[\']J?IJ_P!O>(O]X-K_ +'^<O7H^Y+Q
M_I7_ -17O0?>EM_GM?KI]^-DV=D*Q,APG:C8=XVU>5/84E#\VV:U3ZU%:6HN
M)2EQ^GOOMH4I32@ 3QY3ZM,JBEJ:17)4MK;7L4"#Y8=,OLU">9A:5IV@@^:,
MQTA"L&B"/CJ-.@5>GSJ558<6HTRIPY-/J-/FL-R8<Z#,97'EPY<9Y*VI$:2P
MXI"T*!2I*B"-CKI"E(4%H)"TD$$9@C$$;Q'BDI6DI4 4D2(.1$)L>97T5+Z1
M<PM5&T(KQPKE!^H52PG.5Q:+7JC*A(K5A27U;[BFAX/T]2E%3D)7*25,K.OH
M3H[J/[_H.2H(^\F  OY0U+[<E?*XQBG5%B-GK.=D?T+I)1\DZT=F:=W Q7!Z
M?5JX168D3TH9^J_3'G_'>8J:X^JGT&K(I]XT]I92*Q8U:6W!NBGN).Z5J1"5
M\2SN#RR([:AQ&^HF^VI%ZM3UN5ZZDS0=BTXI/?@=Q,2=GN*K5<6ZT3Y$F2AM
M2<%#W1O$/4?BNWOPI^./FD7\*?A[\5_.^<?!?A[Y;\W^:>)V?"_+?ON;^!QU
M\R>"[XWV?E/C<W++7S3E+C/"-[\5OPO&F/"Y>:>Z4Y]T5@=7W67T<V]F<=//
M4$[?M%JMKTBCUYB][=ARIUOT.7=D=;B85033'9<UN0U3VF75J7!?;"'4@$'F
M&K1:^D+U<[8+I;PVI"E*3RE4E'EUB<@1/#/,1 5_4UKH*\V^L*TK !Y@)I'-
MJ,L<MTL8PRA8+QUE^G&O=-6?L>96ISC:WFZ.JL0F:\RD<?"?:AJ<D1UI0>/Q
M46,>''43645PMR_#N##C2OE)('8<CV$Q)4U715R>>B=0XG<03W9CM$>[AWIH
MOQ67J#3<AV?4:7;U%6Y7ZE+?0U*H]332UMJATYBH17'HDCXN>XUSHY@HM)5P
MVTR6X.0E)QAVE!YL<A%NP  V' #@ .P#36%H-$$+/>9'08-Y=>]OVG7%RW:)
M5*)9#$J,Q+=CE*'*+4%+4PM"ON5K*!NI(W.VMAZ0=73]+K?:D'$J5(D?*$9Q
MU$TFHZ@:IW9EE0$P"=FF4601?*0Z-W8T9U5NWWS.QV5K_P#D2NGWEM)4HC??
MO.JBKKOJ $CF:S_EIBP#I*S2]5S'Y:HU3GGRO>D['N'<A7I;U O5JMV[;S]1
MIKDJ_:W+81*;?82E3L9TAIY.SAX*X:?6SK2^5=P:IW5->&M4CZ &'&&U9TM:
M&:5;K:7.9(F/3,4P=.-^=0F%954R_B=V;+LZSJTU#N6EJG(E07(50J$JG);-
M$?E*#KBV$/;.AA?@K/B<-:#>*:SW$)M]?(5#B9I,I&8 .<N&$\1%,M3]SH"J
MLI?2ID*DI,]4Y# [IXRAG;I6ZRL7]45MQYENSFJ7=;$="ZW:TMUP2Z?)(:+C
M++\B+!;GI;\= YF4J!)]AUCE[Z>K;([ROB;)."AD1WF7;&G6N[TMT9#C)'/K
M&SS3XQ,#4!$K!H@B(?7/TZP.IWIIR)C@Q&GKHCTMVZ<?3%->(_3[XMUEZ=13
M&(*5)^:<KD%WCL692MP=3W35W79;PS6@GP>;E6-J%8*GP];B!$/?K:FZVMVE
M/ULN9!V*&([\CN,(U%#S:EM2&5QY++CC$F.Z"EV/)86IJ0PZD\4N,NH*3ZB-
M?3&!Q3BDY<-/?C!<09' C33OCJ4A0*5 $*!!!' @C8@CV^K\FO8)::::HOM3
MU>517DO.TA-3=-Z,77'Z5GI8DK^/;I4HR:W&?4OGYQXV-8;L9)[TMD[<-99]
MP-_[B\\OZ8H^TRU3&$O_ '#.-"^^5_@?EG]/S>!.>,L_F>2*M^MV]GLA=7O4
M9=+CQ>:=RI<E%@**RL)I=JR$6S3F@3V!N-21P'#?<ZN_35,*3I^C9&!\!*CQ
M5Z1\\5._5!J;U4NSP\4@<$^B/-$:*54ZI0:E'K-!JE2H-8B.)=BU:B5"72:G
M&<2>9*V9]/>CRFU)4!V*]6IEQ"'4%MU*5MG,* ([CA$6A:VEA;9*7!K!(/>(
M;+\F_(.;<I8!OF\,OY(N;(<-O(;EK60Y=,EFHSZ53+=HL U1M-54PBHS42)]
M1"?TAQTH\'W2-SOA/YA4EMH;JW36]E#2O!YE\N )43+#(2 U2SW1K_1=375=
MM6_6NJ<'B\J>;$@) GCF<3KBWK5!BXP:((6WZ^S_ /HW9O\ -=C\!MNK^0ZE
MZQW=NM=Z6_M%WVE?.$9Y?!_^E9X#YL,;1I3$:!!+[J6@J)&V*MP#]RC?;8'U
MZR50)69;8T).('"->Y:MJGY,QO>%A"JMP3=%'=I8EA7*6"XXTX%\RF7DC;P_
MX*OV-.J%]5'5MU7+/D5.4)5#'CL*9RYA*%_Z+Y7O6S:B[CI./LU8_H%"N25,
M5.IM/N.ML_,X:WI2VD5!HVRX%+3'E*"@E0&ZSMK4E]:=-5'(NLIG5NH D2D8
M</2W1GZ.E+ZQSHIJAM#*B9B9Q&/R=\171@S,W1!U2X9MZL771XUPW)5Z%,5-
MLR?+?CNTA^LN1784EVH0(KFZI$/<I2G;8 []VIM5SM_4=DJ7FVU%IM)P6!G+
M B1.HQ$M6VOL%V8;<<3SN*'J[)ZY@2RAN.@RG'[?HDN4X5O2*13'WW5\5+>?
MB,*<6K;]\MQ>Y]IUA#@ <4D9!1\\:RV2I"2<R!YH]G7$=P:((1DZ\\;,8FZP
M\_V;!BB'2OQW,NBBQTIY6VJ5>L>/=,=MD=[33M4<;![-TD=@U]+]+5AK^GJ6
MH49N>%RGBCT?<C!NHJ44=ZJ&4B2.?F'!8YO=E$2/3?\ +Z'4_$-&\Z/>+XZ8
MLBXZ<<68RNH+#%^Q&B1X:'D8SSS;51+:>T+<#D4K[CRI]6HMRG'WTS5@"?V1
MY!V_6,*'NQ((?/W2Y3'+[2VO_INI/N1@N4)#DO)^3);O\;+R-?<IWB5?>R;K
MJSSGO*W4KWUGB>)_9TZH0!0L 9!EOY@AO5F=6Z=9=7\XQ@VG4-X<%\FZ!'A=
M#-E/,(Y%U.],B5&6=@/$E+N21%4L[<3]S$0./J]6OG_\P5J5U.Z%9)0V!PY0
M?=C9^BDA-@;(S*UD\>8Q:;JDQ:X-$$+<=?7_ !'+,(WW^5V/L/7_ "'4]]^/
MJ.M>Z6_M%WVE?.$9Y?/[E9X#YL3HZO.B+.'4+>M)NFQ\ZU2QZ"W2T-(H-.;J
M,<1U*8@A(6]$KM/0^2IE2M^3]]MJLV#J2VVFG4Q54J77.;UB1M.J1E$[=[-6
MW%Y+C%06VP/5$\]LP1$23Y474X=MNJ*YQMV[2:]Q&^_$_BS??;OU/?CFS2_^
M"B?9_#$,.E+G_K%^7^*/NI/EU9XQ-5Z5?UU]6E3I="MR?$J52=JLJJJC2(<2
M2Q(E1 S*NWPW5RF6E-I "CNH  [@:X=ZMM=<TJF8H IQ8($I8$Y'!.J.V>F[
MA2N)?<K5!M)F9SD=V*M8PB(W7UU&6SF3J8QW<6%Z@NO3K(A0:/3IK\-^.F=7
MX==F5",41IC2>=IQ,I.Q]Y/MWU.=+6=^WV9]JXCD0Z9D3R3(#$CA$/U#<FZV
M[LKH#S.-X##X4S(8_P"$2;M;IB\Q/J'@1JU?N1G,;TB="@IIWRZ1& -.CH0N
M ?@:/6H*VEA@(W)2%*WX]^H9V]=)6E1:I&?&4"9SGGKQ4#.)9JV]27%(75/>
M$DC"0&6K $=L7[V!0JG;%C6=;=9JBZW5Z!:]"HU4K+B%-KJM0IM,C0YE16VM
MQY2%3)#*G""M1'-VGMUF%4XAZI<>;3RH4M1 V F8'9%Y90IIE#:CS*2D G:0
M,XR[2$*PGUYR<!N'USW/);5NJJXVQO,>3RA(2XQ3IU/[0??*VHJ3N=O5K?\
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M7/9%)6H;\@7<5)R#-;"N&W,4VNHCOV!T@IR52AKXR%G]4MC]Z%4HG3K<^*M
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M54J (^"$I\H$XA]==WW=?=356+XNNY;SJJUJ6:C=5=JEP2PM2@I1;=JDJ5X
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&$$&B"/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>tm212692d3_sch14-aimg049.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg049.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ? !] P$1  (1 0,1 ?_$ -0   (#  ,! 0$
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MV%7,QB##AS+,SNV;@661;W:>LF=:8EFA^I;,4\3-4&#,X*F(:BZQOL!MW#O
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MPG44.81,=50XU$ZBAQ$QA'B(U'7HW+++1&&;=.67-'!C 4!$:\/04!,81[@
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M&B"%<>8GD+;/-64..\BSKMQ>S50KZW"VBU3GYV!> JQ=BX68-)%NN@DX*U*
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MJ4=935TU12O%JI24N@X@B4/C#S+[86RH*1+09]D>\U&CN@T01P( 8!*8 $!
M0$!"H" \! 0'@("&B",&F[;':.)MSV>L>-$?#QUNY-N;V.D!0(4L++//;D2!
M"!P*F5E)$*4/Y)?K]/V"L-?9*6K49K4RF?TD]T]8CS_>:84=UJ*8>REU4N0X
MCMBO/;MV_5JWBLRRR]$6RBKV<N-A]^8[.NIX>)W@8FNALWZ@BF+>X<,9I0?
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M!M"W8"YL2LW@FY>86P2]T+FKW 8>^@Z23=&SQ\FAG[-"IOZZE)=(Z$CLAK%
ML<&FKUU87]4 M]JC#(//.P.M.6%C/<3#,SJN; D5[$O-5(HF,2UKI7(Z@GRP
M%#U4(RXT12,<> "^ /RJ'[9W0-5;UI</==3OH^DGVASIQ^K#-Q[0>)3-7) [
MS9W%?15B#S*[8S/]NW]]^?6RQEN673'L,>W[<^++[L_)5EO1C[KL:X8VY8)U
M4>GXZ-7*MX9R4/\ .,GZ)3H+D'@=%0P>G4>KI6:ZE<HZD38=04JY#I&T9QM
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/5L3H-$$&B"#1!!H@C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>tm212692d3_sch14-aimg050.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg050.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ ,P   (" P # 0
M       )" H%!@<! @,$ 0 !! ,!                 P4&!P$"! @0  $$
M 0," P0%!0D+#0    (! P0%!@ 1!Q(((3$302(4"?!A,A4649&Q(Q>!H<'1
M\4+"0QAQ4F*"DC,D-+0F&7*R4X-D)74V1G:V)W<1  $# @(' P<("0(& P
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MW-[<V8=?L++@8'CQ&)4T-1].Z4W\TW-,GI<)Q7'>-N2<EQSDK()(Q*3",7L
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M'/:2/+G3Y4(:O,JV/:&S%8E.N1VV(]HLEOTVTZ&^G9$3Q1&'HRYCNNF[:5@
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M;PUI^+9A\7\=XA^*I3FH-U-5*:N"V^"M?A_A>0>!NQ[>U8/#>TGM]X_N1O\
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MU_WWXT_5^IY^C^;7GC_(W?Y=^/5/A>/J_P"5[E/X/.KL_ Q_C7X-AXO@Z_\
MF>]]K"NY2R[C>$L=[B^%.0^',F$ A9IC\F#"GD"&=-?,=,S'[QA>DB%ZHN8[
M+_N[*0@H^1+IBRC,ILHS&+,(??C?4C>-3F]XJ$[YE8QYE8R64ONR-I7<=8(X
M@T*HB9U@^3\99KE?'6:U[E5EV$WMAC>0P'$5/1L:U\F3=95?!R',!!>8-/=<
M8<$D5477IZUNH;VVCO+8\T$C0YIX'Y#@50-Q;RVD[[:<4FC<6D<1ZCLX+5?S
M_P /\NW[^ETAIIIK3(/EV]^]SV<YT_195]X7G ^<6#!YC1Q.J3-Q.V+TXPYU
MC<52V<>9901L(@[?&1P11_6MAO#^KNEH^H;42P4;FD0]@G4\?0=_M.P\"5*.
MFNH7Y+/X4]79?(?: ^:?I#UC:,=BN&8;F>*<AXO29K@^05>4XGD<!FSI+ZEE
MMS:ZQA/CN#K#S:KL0KN)@2"XV:*!B)(J)Y_N+>>TF=;W+',G8:%I%""KFAFB
MN(FS0.#XG"H(Q!"V;2*51H0C0A&A"-"$:$)>7?OW]8+V>X3(K*Z17Y-SCDE<
M[^!\%%U'D@>LA-!E66BR7778] ->L )1=G."C32;=9A*^E^EKKJ"Y#W LRQA
M]M^_ZK=[CY!K.P&.]0=0V^2P<HH^^</99_N=N \^H*F[F&7Y/R!E>19SFMU,
MR/+LLMYE[D5Y8.>I*L;.<ZKK[I?S6F6]T;::%$!ED1 4011->A;>WAM(&6ML
MT,MXV@- U #3$[<52D\TUS,ZXG<7S/-7$[3\FP;A@M<^GZ?I^;2R2TTTW)MO
MRA>U-[G#GUKE_)JY7>->"9<6X$I#75$ON27 ];&*EOK%6WVZ %^\I")U()@P
M)?YS4#Z_SP9;E7X?"?ZRZ!'$1_./[WNC]Y3'HS*#?9A\=*/Z:W-1N+]@_=][
MMHK<NJ%5PHT(2)?F^]B4ODFE=[H^):5R9GF(5(1N4L=K&/4F9=AE:V7H9+#C
MM"KDJ_Q*-NCHBA'(KDV1.I@4*SN@>IVV<GX)?NI:R.^[<=3'G6TG8UVS<[M4
M"ZRZ?-W'^*6;:W+![8'SFCYW[31Y1V*L*!B8BX"H0DB$)(NZ$A)UHJ+^35T8
MUXZ%536N.F]>WU?N?T?T+HX+/#3<IE]H_?1S?V>7AG@MBWD?']E)^)R3BW))
M$D\9L7'%17Y].ZVIOXS>D(_ZS&3H=79'FG$U'<^Z9RWJ&/\ JFEEV![,K:<P
MX'Z3>!Q&PA/>39_?Y*_[@\]L35T9U'L^B>([P59N[;?FB=J_<-'KZU_+F>)^
M0)(@$C!N2)46G,Y:I[[='DSA-X[>L=6R HO-/GOXLBOAJF<XZ*SO*"7B,SV@
M^?&"</K-]YOD(XJT\LZJRG,@&\XAN#\QY \AU'T\$Q1A]B4RU)C/-2([X"ZR
M^PX#S+S1HA XTZVI X!BNZ*BJBIJ)$$&AP*D8((J-2^NL+*-"%SSD;EKC'B&
MC?R3D_/<4P2ECM&Z4[)KN#5(Z(>8Q&)+PR9[R^QM@''"7R%===I8WE_)X-E%
M)+(=C03Y::N]<US>6MG&9;N1D<8VN('Z^Y(L[L_G8U+$6TPKM*IG;2R=1V&[
MR_EU<4>F@(I*V<G$,5EH,RWD;>+4B>+,<?/T7/#5FY#^6\A<VXSYW*S7X33B
M>#W# =C:GB% LWZYC#3!D[:O.'B.& _9:<2=Q-!P*KQ95E>3YUDESF6:Y!;Y
M5EF13';&\R*]FO6%K9S'54R=DRGB4ND?L@V/2VT&P@(BB)JV8((+6!MO;,;'
M P4:UHH ->F_:JWFFEN)73SN+YG&I)Q).O0+ ;>S]S]_;]!:52=-FFF*ZYP5
MP?R!W&<HXSQ)QI6'/R/(Y(_$3#;<*LQJD:,5M<GO7P14BU-2Q[Q*JH3SBBT"
M*9BFF_-,SM<HLGW]X:1,& VN=L:WB2.X5)79EUA<YG=LL[45D<<3L:-KCP%.
M_4KP7;?P!A7;)P]B/#^",?\ =F.0^NSMG6FVY^2Y',V?O<EM%#?KG6TY2/95
M)&FD!H5Z '7FO-\TN<YS"3,+H_>/. V-:/=:. 'EUZRKWRW+X,KLV65N/8:,
M3M<[:X\2?D7=--J[T:$+P0B0J)(A"2*)"2(HD*ILJ*B^"HJ:$*MA\R7Y5]G3
M6&1=P7;#CSME237I-WR'Q#2QE<G4\ATSDV64X%!912E5KIJ3LRJ:'K852<CB
M0=387#T=UNQ[693G3Z2"C8Y3J.YLAV'8';=3MZK+J?I-S'.S+*FU835\8UC&
MI<P;M[>\;E7\1=T5/%%%2 Q)%$P<!" VS D0@<;-%$A5$4539?'5J[.[U*N=
MFFY>W\?](=9T]"SIYPO0P!P>EP!,5V]TQ0A7P/V*BIX: 2-6FM8H#KTUKLW'
M?<5S[Q&@!QES1R7A49M45*^ERVV&I5!4%0%J)3\FL]-5\Q1I$7VZ;;S)\JS#
M&]MH9';RT5V;10^==]MF>8V7]K/*P;@XTV;-2DS6_-'[\*QI60Y[GSA7I1#M
M<2PJ>\""I)X/%0@X74GFI*2K^73,_HGI>0U^% ['O'^Y.C.K.H&8?$5[6M._
M@M3R?YBO>_ET=Z+:=Q^=PX[_ %>HWC8TF*ET&FZM"_054"2C:[JFW7OMX;Z7
MAZ1Z:@-66D9(^ES.^T2$C+U+GTP+7W,@!^C1OH *B/D&19%EUD=SEN0WV56[
MAJ1VF2W%C>SR)3)=TE6DF4\/FO@*HB)]6I!###;L\.W8R-FYH#1Y $SR2RSN
MYYWN>^NMQ).OC58;V?N?T=;[--R2V:;EY_C_ *2:SIYUG3SKKO!_!'*7<9G]
M9QKQ'C,K(\BG$V<V2HFS1XS6$70]>9/:J*QZFJC(N^Y+ZCQ; T)FJ#IOS/,[
M')[0WE^\,B P'SG&A]EHVD^;6:!=MAEUWF=P+6S:72'6=C1CBX[!Z=05QSLD
M[)./.S/CS[EI?0R/DC(V8TCD7D5^*C4Z]G-BAC550'U.U>*U;JJD6*B[FN[K
MO4X7N^>^I.I+OJ*[\66K+-A/AQ[&C>=[CM/<,%=.1Y';9);>''[5R[WW[7'<
M-S1L'><5-C4<3XC0A&A"-"$:$)3W>=\J'B#N2D6F?<;OP^'>8IBN2IEK7P/4
MPO,9J[DIY=C\7TUCSGSVZ[&%T2/-7&WU74ZZ=ZZS#)PVUO*W&7C  GVV#ZCM
MWU78;B%$<\Z1L\T)N+:D-Z=H'LN/UAO^L,=]56D[@>T#N'[8[.1#Y;XYMZVE
M;?)B%G5*T[>X':@GV'HN1PFB8B$X!;^C,&,^&^Q BZN/*>H,HSI@=83-,E,6
M.]EX[6G7VMJ%5^99+F65.(O(B(]CQBP_O;.^A4:!(31#$A(2\4(50A5/J5-T
M7[.GKMUIKUXZ:8+S]/I_E:PC33RH_D_@_HZ%C33R(_E_,N_Z5_-H0C^3][;\
M^R?GT+*_1!B3;.?%JZN%,M+6:Z+4*KK(DBPL9CQE[C42##;>E2#(O!$ %76'
M/;&TR2$-8,22: =I."RT.>X-8"7DX 8D]PQ3;^U;Y/O/G-#]=DG,XRN"N.7"
M:?.)9QVG^2[V(J"7IUV/&IL8X#[9;>O8JCH;[I'+;4"SS\P,KRX&#+:75WO'
M\MO:[YW8W#BICE/1F87I$M]6WM=Q]\C@/F]^/!6:N NW+A_MFPEC ^'\1AXW
M4]0/VD\E^,R#)+ &T;*UR2\>19MM/--]E-4;;15%L 'W=4SFF;YAG-R;K,)"
M^38-36C<UNH#0U5I9?EMGE<'P]DP,9M.UQWN.LG0+N.FU=R-"$:$(T(1H0C0
MA&A"Q%_]P_<UE^*/NC\/?"N?>_W_ /!?<WP7AZOWE]X_Z#\+_?>K[GY=*1>+
MXC? YO&KARUK7A3&O8M)/#Y#XM/#IC6E*<:X*OAW??\ !;6RLTLEZ<Z60]\>
M7:T,LY0R^I>M9(5Y!QP2HYYIU(2I[435JY!_[%Y1X=?AMGQ-*>?[Q5WG/^#\
M[O$_N*X^!6OF]A)NS*H[+'GWW..^0NZZO97K^'B9GPYP[;MBO4O1UV-1SI1R
MC;Z?#_51+S7S\-6';R=2  7<5@3M+)91YC"[TJ$SLR(U-M)> ; Z.,^<2@^9
M<<D5G&P.*D7-LXD->QQ_BZ@AN+XEMNRWR_.%-QV_K%_ATX!][3&*(?\ =<?_
M *0N$LM=DDE/^FW_ /0K*T]1PPX\"Y#R#RG#C?UHT'#N(64O_JBL^=*IC?\
MY2>:_5NNDDF8@?=0P%WUIG@>: K>-EB3][),!PC:3YY0I;\00OE=1+2&/+>2
M=XE^UUM>LY-PGCW$,90NKWOBV<$S_-\F6*B?:Z'$51\O'3!F#NMG1GX!F7M[
M'O<[N\1C&^9/-BWI,/'QCKUPXM8UO?R/<ZGJ5DGLR_X>'W<']D/]C_WKZ0_%
M_=WI_M+W])/5^\OQ5_OSM_TF_P"IZM4_U#_EG/\ ^?\ B.397^7W<OL>M6;D
?G^-\O_AO Y]M/?[^;V^U,%U%5(D:$(T(1H0C0A?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>tm212692d3_sch14-aimg051.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg051.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ ,,   (" @,! 0
M       )" H&!P$"!0,$ 0 !!0$! 0               P0%!@<! @@0   &
M 0," P4#" <&!P    $" P0%!@< $0@A$C$3%/!!(A4),B,646%Q@9&QP>&A
M\5(D%Q@9T4)B,S2TLL)#=28W=Q$  0($ P4$!@<&! ,)     0(# !$$!2$Q
M0?!181(&<8$B$Y&AL<$R%.%"4F)R(Q6"DJ(S%@?1LI,DPB47TD-C<Z/#TS14
M_]H # ,!  (1 Q$ /P"_QH@@T00:((X,8I2B8P@4I0$QC&$ *4H!N(B(]
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M'SZ#A%9AJA+NRE3;N$"$3C555#"H % J8B(@&XZLW2M+0U5S":XH" A1 49
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M>^4I0^369Q=8-$$45N<6-V^)N7?("D,6X-8IKD.4G89N!1*1&(MR:%I9)$Z
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M9$MRY"CC2A5)<T>J2*](=\F"2K=8SC<OIN\!WW#W Z3>EMWAIIM#ILJ6P@^
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MI61-YQ82!Q)D(1J'VZ9A=0Z9-H25'L G% G(-WE,F7Z\9'FS'-+WVVV"WO\
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MQ2?3,=\5RO;]^M=C,XV#B?)UHPODRC98I:X(V:@V)A88PIS""#T&I^U[%/
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M[>.&[)@W4>2#YRW91[-$@G6>/GBY&S-JB0OQ'5<N52D* =1$VVN%24@J60$
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M%>*UVRT7RRS-RNUAE[7;;$]4D)RQ3SU60E9-XH.XJ.'"PB($)N)4TR 5)(@
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M?F>B,^O7]$\Y\_E^9U\B<_X?!Z82A=8GA$LX74QSD#EG&H=ROD-+CB##DVB
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M^@3_ ,HO^#_S;RR>I^7^7_B7OY7WGS#\5?\ SC?MW\S?[K?6/]0_U9S?\_\
MF.32?\ONY?!V:QIUE_IOE_Y-Y'/+3X^_F\?;#!]56+#!H@@T00:((-$$?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>tm212692d3_sch14-aimg052.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg052.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ? !] P$1  (1 0,1 ?_$ -4   $% 0$! 0$
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MC.<:%PYLD1^FLPY6N$QAF,BW>Z*>M44YIVQ;A7M C>/.U2( U[   TH$I&(
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M@,D17  *%"@ !Q&@!3B(\1_"(Z5Y<NJ-([HGGY<L8(-&KEH@B6VS?_U$N_\
M^-I[_6&>M%94^T(R,BO9,9-I/^M9C_?,O_Q)WKU0C^6GV4^*//"_/5[1\9CX
MM;1K!H@A86#D*^L575'WQC6[9VQ[NBU"*,YZWGRC%WRD,!A;.RDJWD6"O8HW
M<$504*-#%$-<]724M<P::L;2[3JRI4)CG&@Z")&%J:JJ*-T5%*M3;PSI,NO2
M-1PC3'L0\7.W<OO(7$NY08>QLFO5&\;;M_-N2.L>^GAZ)(,Y%-4_2M*YG:E
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MKRY>"$X]2#@Y>Y9>/@("/<2LS*N2-(]@U)SK+K'_ ,E-),H"910P@0A $PB
M!K!( F<G+],9 ),A%M&!]K%M8T09W%=B32Y;\,0JW663*O$VZH8O^CPR"I>5
M5RE6AG9R\XF^P! [>9;A5@,$PLE$L3YT2VTE&\&B"#1!!H@@T00B\@8YL7*U
MJ2ECY'M2$O.TII$R$C!3[%)\R7*)3%*J0J@=1J[1YA%)=(Q%DC>L0Q3  ZZ*
M6KJ:%]-32+4V^DS"DF1_5J.!SPC44S%6R6*E"5LJ&((F.6O+&4_Q#?#'N#:Z
M,AEK$02EVX#5< >6;.CF?7)BQ1TL":",LM05IBTCJJ FC("'5;")4W-0$JIK
MQX2XT:O4J"X;+=TEY)&"79:-"]60YM$5)Q)PJY:IUE%-=OSC*6^?2G7FR',8
MJ1U/8AL=*8Y#IJ)**HJI*)K(KH*&27061.55%=!5,2G1614(!B'*("4P (=F
MC X$ IC(,C,8$1L+\+3>@MNBPVI:-]297.:,2(,(BZUEA*1Q=EN*$%O;M[%+
M4!5<NR("WD! /5>)\XC]\4->?N-N'19+COZ9,K<^24^JKZ2.C*G499HNCA2^
M=[4.Z?/WYF05ZPS*Z<AU\\6C:A42J&"W*Y*/C+%<U),5@2GINEN6^("'43?R
M2:A57I"UJ/L]D114!#L.4OITHV I>.2-5F2=<4DA7SB)A[3&,-3&,/$QC"/$
M3&'B(^<==?+ERS1SP"- $1\WH"H_@  XB(Z.7+EG@BW/:A@I#'ELH7K<3(OO
MS=#,BP%7*!E;>A' %5;1B &#[AX[3Y5'1@]:H@GP HUY75[1EF$+H3(3SF)@
M:2C>&^G,M8JMF1&(N3)F/K?EBFY#1<Y>=N1,B!P'E$HLG\DW<@8#<*<M:ZZF
MZ"N>1O&675HTA"B.L".=RJI6E;#KC:5Z"H ]1,+EH[:/VZ+QBZ;O6CA,BS=T
MT73<-UT52%425171,=)5-1,P&*8HB @("'#7,I*DG94"%#3"X((F,083-SW_
M &'970"\KVM&TA<E$[;WGN2&@>\$ W()D/:KUIU2@<*5+4*\-+,TM34S[.VM
MR679252YY PFZ^PS_.6A$_2('CCU(&Y+=NI@65MB?A;CC#G%,DE RC&88&4*
M!3&(5Y'KN&YCE*8!$ -4 $-:.LNL+W;R5(7H4"#U&-D.(<3MMJ"D:09CK$$]
M<ENVM'GEKGGH6W(M(Y$U)*>E&,1'IG4'E3(=Y(+MVY#J&X% 35$>S0TRZ^O=
MLI4MS0D$GJ$"W&VD[;J@E&DD =9CR[8O^P[V!4;,O:T;N!N BN-L7)#3P(@'
M( BJ,4]=@F "H7MIVAZ=;O4M33?[AMQN?I)*?&!&K;[#W\E:%RT$'Q1[TM$Q
MD]%R,)-Q[25AY=BZC92,?H)NF,A'O43MG;-VV6*9)=LY04,0Y# (&*(@.DVU
MK:6'&R4N)(((R@C(1&ZT)<24+ *")$'(0<H,8RO$?V8*[0LS@6UVKDV&<D"^
MFL<.S]14L&X0.12;L1TX/S<ZT$9P4[0QC"95@H2OK$/KT-P?Q$+_ &Z3Y_ZB
MS(.>L,RP/6R'0K41%)\3V3N>NFR/N+LRC5I1T9M7-%>7EY_*NI;$;B4^RS<1
M(;7]Q^/,I)N%B6V623MC(+-,WW<C8MPK(LYH%4Z@112),*;Y 35Y%6P"' 1T
MQ\1VA-ZL[M%(;[9VFSH6G$=>*3J,.UCN2[5<VJH'^%/96-*#@>K*.;1&YOVM
M&^RO;G?FWL?V?[6]I=4O<_9O=N^=^Z]>3NW=?O.>M.7CKS/L+V]W([R<I9YY
M)=<7UM)V=N8V)3GFEIBJ+>1OFVFV)FPNW;<#:M\N0@+?A[C+?MID,_;6Q)74
MDL<K%S',GC>434+%((KG6(B[)R*@'3"@UF%HX-NMVM8NE"IN164A"CLDA.4@
MY,N$C+)$:N7%%MMMP[OJPN80"5 3 VLQ&7)C/'+"*M/&N <[M1D=LFY*Q[U6
M/ZY;1N%ZDPN1O4 ,""C,Q&4ZFH7FY1%6/ *TJ;C73376NZVM6S<:=QL>E*:?
MVA,>&'*CN-NN(G1/MK.B>(YP<?!"_P 1;6<@M,NV^VR':IVMKPBAY][()KM9
M&%E#QIB&CXTCE!00,9T],0QDSE(?I$,---BW!LS2<8[PA6T)Y(MCUS0M'Q21
M7!HY^5H(@[,R=%:B4:&!P*"@(B4:A0>I2G$-;(D%@J\V8C!R&*#5W.V2+N'<
M.QW;,3K9:5NN7=6>:X6Z,G-+181C1(!M)\9A(!& :4!3I]10 *K4=6<.^G&:
M15B/W'8&ULF0G,^>)B>&@9(A:^[$O5";L)U162G:D3*0\TR,A/)KRQ9WL6;7
MLVP#&%OE.72<JW-<SBV4YMP1T_)8B[TBEF%,J110G2""%+D*'*!2\ * <-0W
MB-5,JYJ[-L[.PG:V<!MR\OWIQ(;.'Q1 /SGM*E/+LS\GP1#?/BN+8W=<\>[N
MFG/BM2WYDMAK7,B25M/I"$2"0%C ;R"X/AD07!$P$(4OK5[:B_VP5R[)LV(_
M?0L%>S@O/GPPE*<-=:JE3<IW8 TNR=G:Q1FS:9Y(=#8 B![DRS(V$A+-\$.9
M:7+8R:RJ980S[VVFH*D*P3!'NC4\0*73*9(I@3H'T!Q\4*_@TZ*HI-T"1MX>
M5*7TCG,YPO9 -IU5//L)4=G1.>;0)9H_IX@:90N+#;J_FTLXV^(*389.!DLB
M6.++GD8#W0&5;+%7!RWZI7/,4$3B).8 $HCHX6,FJ@4I2+MANYC&4E;<CF.3
M/&;U_,:WX)MV.WHG,;,_#FAJMO"F+)3=LB\VEH*(X?:6(W;W<>V$B1-I&G N
M!,[TBT8+=@JH],P,A4_(8!( !] =EU%<W8MF^D=O+OD;1FO9V=..$XYK>:5=
MSVK4!V,-R5LR"=K:T88R\$7&Z@42F(3^(+MT9[E]KN0[-2:)*WA;T<M?6/78
MD 5VEW6PV7>MFR)P(90"3;(%V*A0$ ,#@!'[(:D?"MW59KTS4DGLZCL.#2A6
M!/U3)71#'Q%;4W2U.L ?QDC:0="DXCKQ'3&(,HB)0$Q#)G[#IG 2G2. T.F<
MHT$IDS )1 >RFO29E/#)RY<T41 8I3D,0P")3E$I@](&"@A^$:_NZ!ARY?K@
MS2Y<OEC2/\XLC^QA&X_::_O\# -KPO\ K_SD)8SHT$5X)^7G YL=E%4!K43
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M/:6IPB4CA+9P,P<<(PNL=N-2LNK?:ITR"4AL':F,29Y,<G/"2=33K",4[NS
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MBBQ? ;IN'!:^KP$-3^V4#UTX>13TS@0XA9GC*4U$Z1F$16NK&J"[%RH1M-K
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ME#CQ"H\=/E*^S<[2JI<9;0\V[(%,]&LPVO-N4EP2R'5J;6WB#+3J'ZXGEL-
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M6X4,X<&( G>2<@O0#.I25>'4<.51XG64,- "@!YMN%?4W.L<KJM6T^XJ9U:
M-  P T1>U'2,4%*BCIA)EM,A\YUDXG7#E:XXZ8-$$&B"*7/$@\+]CG\TIF_
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AA%E4/=^X'=VZ[/\ V]F7NP]6FZ.V#1!!H@@T00:((__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>tm212692d3_sch14-aimg053.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg053.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ ,,   (" @,! 0
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M8#JM^)CJNW>P9[*@_'<3<7&'1)%V77IVDJF*ZF;K*9053N)"DG@=G2-1XSA
M5-.]25"Z5\2>;44D<1Z#K' QB/M[?1]6NC3339&G3339%E_IR]?U5Z/KSD6K
M>A5"M8$O>HLO7-3(Z'*F616G>[C_ )WMZ+NJN-DR@I4X@;+):%'!3O6T0J9F
M_*J,P4XJ*:2;HTGU3J"T_,4>])V$RU&+1EG,2K,\67YJM[A]8;4'YP&[YPVZ
M]8AP&TKMMB_+:HMXV97:7<UK7% 8JE$KU&EM3J;4H$D>9J1&DLD0$G:)"NQ
M:*)(A(J(@7V'J9Y5/4)4A]!(4DB1!&PPYFG6GVTO,J"FE"8(Q!'",BUJC9&/
MU2T[5KCB/5JV;?J[H[H+M4HU.J#B(O%40Y<9TDW5/EUM0^^T)-K6D<"1X1K4
MTTLS6E)/$ Q^^FT>D49E(](I=.I4=.",4V#&@LHG!.#45IH.Q$]WNUBMQQPS
M<45'B2?&,DI2@22 !PCT=81E!H@@T017)U_>H%9/2!9LF@T.33KFSS<E-/\
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MPD2"4B0 X =$+AUUU]Q3SZE+>49E1,R3H(\7?W_K_P 7^+6R<:Y[=-_IC<F
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>tm212692d3_sch14-aimg054.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg054.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?0!] P$1  (1 0,1 ?_$ ,L   (" @,! 0
M       )" H&!P$"!00# 0 #  ,! 0$             !@<#! 4( 0(0  $#
M P," P,(!@0+"0    $" P0%!@< $0@A$C$3"?!!%%&!D;$B,A468:'!\2,7
M0E(S&'%BLL+R0R0T)449T>&2E+4F=R@X$0 ! @0"!@8&!@<&! <    ! @,
M$00%(0;P,4%181)Q@9&AL1/!(C)"8A314B,D%0?ADJ*RPC,6\7*"TH,EDU0U
M)N)#HS1$=!?_V@ , P$  A$#$0 _ +_&B"#1!!H@@T01!#DIZCG%WC&Y-HET
MWH+OOZ(E0_EY8"&;BN)E_M46VJP\T^U2+>"E@!7QDAIQ(.X0=,]FRC>KT XP
MWY=*?_,7ZJ>K:KJ!Z8X%SS+:;42V\YSU ]Q'K*Z]B>LB$GYA]<3D!=3TN'AF
MP;,Q51U+(B56X$N7W=OE=!W.H>$"VHZU;;]HC/\ ;OMW';5'M_Y:6I@!5Q=<
M?<VA/J)]*N\0C5N?+@Z2*%M#2-A5ZZO0GN,+UO3G)S"R Z\NYN1N4E,OE??3
MZ%<+EJTL!9ZI;I]M-TJ.A*0=@=B0/?[]-=/EC+U* &:-B8VJ3S'M5/\ MA<?
MS!>Z@DN5+LCL2>4=B91/#T>KYOFY^5%YM7/>]Y7*TC!-[2$-7%=5?KK:) K%
MN=KZ$56H2TI?2%'98'<-SUZZ6/S!I:5FR-J8:;0KYI'LH2G8K<!#!DNHJ'KL
MX'7%K'RZO:43[R=YA7-,S?FRVZA)D6_F3*U%>9G3DM*IV0[LCI;2F;([4I9%
M6,?9._0=NP^G3LNV6QY 2[3L*3(:VT;NB%1%PKV5$M/O)()U+5OZ8E%CKU.N
M<&-G6?@\WU:\8378%4W)%-IMY,/-H();5.FQVJTWW@;=R)(4!X;'7$K,EY:K
M 9TR6U':V2CNU=T=6FS7?J4X/EQ.Y8"N_7WPT+!GKK4V2]$I/(W$KM&2M3;3
MMZXNDO56 TGM[5/SK0K+J:HVDJZJ,:7(*1X(/N2KG^63B07+.^%? Y@>I8P[
M0.F&J@S\@D(N3)3\2,1UI./83#N\-Y]P[R!MM-UX>R#;M\TD!'Q8I,P?B5*=
M6 1&K-&D!BK4B2#T[)#+9)!VW'74VN%KN%J>\BX-+:<V3&!Z#J(Z##W17"BN
M+7G43B7$<#B.D:QUB-P:T(W(-$$&B"#1!!H@@T01@N2<EV)B"RZWD+)-STNT
M+/MV*955K=7D!B.TGP:CL('<],G2G-D,1V4K>><(2A*E';6S1T=37U":2C0I
MRH69 #3 #:3@-L8*FJIZ-A535+"&4C$G37N&LQ5MYJ>K?E/.<FKV%@616,28
MC4Y(A.UZ.ZJ#DB^(FZF2[+G,+*[1H\M )$2*KXI:%;//#?RQ;<N9"HK8E-5=
M E^OU\IQ;0> ]XC><-PVQ*+YG&KKR:>W<S-'JGJ6KK]T<!CO.R$\G=2W'%%2
MW'G%//.N*4XZ\XL]SCKSJRIQUUS?=2E$J4?$ZH&R6P>']D)?'?IX0>WS^'^5
MUT::=<&FG7!T^3I^SQV_\/31AU:>B##JT]$-P]%[_P#5E[?_  '>_P#ZQ;>_
MTG2%^8O_ $-K_P"TCP5#CD?_ *LYO^65^\F%*/\ ^]3=Q_S"H?1\:_M\O]$'
M3X)<HZ!X0G&4SNF?'^V/R^OV_:1]&OOCI^B#QT_1![>WT'Z=&FG?!IIWQFV.
MLDY Q%=<"^<87A7;&NRG+"H]:M^:Y#><;!!5$J# [HM4@/)V2Y'DMNM+3N"G
M6M64=)7L&FK6TNTYV*$^L;0=6(D8STU54T3PJ*1:FW1M![CO&K Q9GX(^KA;
M&9I-&Q/R.-(L/*DQQBG4"]8_93[%OV8YLTS%D)=7Y5IW+*=&R6%J,.2M6S2T
M*V:,9S1D)^VI576CF=H1BI&M:!O^)/'6-N^*GE_.#-<4T=RDW6' *U(6?X5'
M=J.S=#M=3B'B#1!!H@@T01@V2\DV9B"Q+GR3D*MQ;=L^T*7(J];JLH_99CL
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M:B]XRC>K,HEUHNTP.#C8*D]>U/6!TQ5+9F6U71(#3@0_M0N25=6P]1B> (4
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+00:((-$$&B"/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>tm212692d3_sch14-aimg055.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg055.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ ?@!] P$1  (1 0,1 ?_$ ,    (" @,! 0
M       )" H&!P($!0,! 0 !! ,!                 P0&!P$"!0@0  $$
M 0,"! 0"!0D&!@,   $" P0%!@ 1!Q(((3$3%$%1(@GP%6$R(R06@:&QP4)2
M,Q<8<9'1\6*RHL)3<[,9-"5W$0 ! P(#! 8'! @% @<    !  (#$00A,07P
M01(&46%Q@:$3D;'!(C)"%%)B<A71X8*2(R06!_&BLC-#TK-C<X-$)287_]H
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M0[KLZYNG84%3++CK*&Y.1\69'*W<<G8Z9 1(HK&0$I0N^Q=]U,>1Y%YHM/[
M.>'HWECF"/F'3A<&C;QA#96C<[<X?==F.@U&Y4=S!HS]%OS#B;5^,9Z1O!ZV
MY=E"H7:D:X6VVWZYF]@O<E+[7>YG!<Y?G.1L(R.6Q@G)D;J7[=_$,@ELL_F3
M[2" MW&;3T9S9^ :6/):M1WFK1VZWHLML!6Y8../\31E^T*M]"[O+NJ'2M4C
MF)I;O/ _\)W_ +)Q5W[W,;VWO/<,>T]#W/NO5;]M[;T_5]QZ_5Z7H>E]77OT
M]/COMKS90UX:>\KUJ*5W)4/>[FB[SDZMQ)AXJ@893-*>;2K=LW-YTRY"R!X>
MHU7ML(^8W.G,((;7I*2D-310RTKMMMUI-2'[8.-6^2>5JIBPCA_'\7;&3W:%
MI"F9 AO(35P'0?I4B98E)6GXMMJTG([A;UE;L%7)U?EIHEUI/N&YFIN!.)<P
MY,N%-K3CE4[-BPE$=<^0AUAOV[04MM*EA+W5L5)\ ?'71TK3I-4OH[./-[J5
MZ$SO[MEC:/NI,F"J@!VL]L5ASI./<QW31&,PR2_DN/X;AURTN93XQ61W)$6-
M)9A3FW'(SLV(W%>3Z;RDE: ?( :E.N:PW3&_DNBDQPLP>\8%Y(%149@&H7%T
MW3GWKOS+50'3DU8TY-&0H#D2*=2::Y*Q[$X$:,MR'35[(2S%9 ])AM/CTMM)
M2"$CZ3L/T:A-))G5Q<XJ25:P4R"\3,L"P3E&B<I\RQZGRRCF,[>UM(R)D5:%
ME*TK2A?T[A24J!^8!TI;W-Q9R^9;O<R4;QFM)88IXS',T.C.8(2C[&LR#[>'
M<!BR*"?:2^VSE>TAT[E1)=ZJK#<BM9\"DIX<5EI$.'$:5U29) 2XI742/'<:
MG;7Q\V:6\R!HUBW:2",WM )<3O.X*+%CM OF<!_^,E=2FYCC@T#(4.)[5//E
M_O;[>>%+:JHLRSRH8M[6-&L&H#<I*7V:N8EXQ;-T.I2GVCZF%)2H$DGX:C%A
MR[JVHQF6VB<8VDBO6,QVKN7NKV%@\1W4C6O(K0G&G3V*0V!Y]B/)F,5V98/>
M0LAQRU2X85I7N%V,\IEQ3+Z$+*4$J9>24J\/,:Y5S;3V<[K>Y:63-S!S3V&:
M*XC$T+@Z-V1&2S#2"52\_N;]M<?N.[6LQ9KH")'('&$>7R/@$A* 92IU'$<>
MO:-M>Q<]'(J%#S!;'Z[Z63YI&I9R9K)T?6XR\TM)B(Y.BA/NG]EU#7HJH[S1
MI8U/2GAHK<1 O9V@8C]H5';14MD+#B$K3OLM(4-QL1N-]B/,$;^/XV]%9*CM
MMMOU?JT)<0MM7ZJTJ0KX'90(/C_L/X^(#3$(.(VVV]-GK_6=/_\ IQ_S(_-E
M_P"8W\+?Z=?>]2?<_P 8^[_@WWO5OO[O^$/W_JWZNKZO/5+?T\W_ /0OH^'^
M3\SSZ;N"G'Z.+W5:WYV_^B_J^+^:X/)KOX_AKV\.*\GEJ\7DG*/(-VM14)V6
MW09).^T:',<@14)/Q0B/%2!^C5?M%&@=2FA-23UK7NMMMMO!832NQ+&&X.!9
M1EBVT^YR+(S7M.%/UB!0QT-)2D^?0J9+=/R)&FTQQHEHQ@2IT:12B5+]UF9(
M5@G"6-K8=D4>7\HS*7)&T+=;0:L8I;3!ZSK:3Z:/=1T>)*1O\=3?DAC3=7,M
M:21PAS>WB 48YF>?*@AI6*27A=V<)/L3+<498JL'QYN#'0EF'C%48\9H!*5!
MFICE#8Z4^)7T@;[;DG?4.F)?<.+CB7GQ*DD>$;0-S1ZDAG+ZU/<OS;W1R^79
M^0+5PJ_E36!<5U.17>+R+ZKIA538CS4VCFUD^1ZDJU>8!$=\DCS.P LZ!QT;
M3;(Z<&TN0WCD+0[A)J#@X$9 ',*$2L;JE]="\+ZVY<&,!+:@4QJT@D8TR.Y:
M8[/^]KF?ANZS[#*+B/*.5,0A.(-34&XOIDC%75V4SW#+]O\ D-Y-F*"4)9*7
ME)Z2WOYDC70U_ES3M0BBN7W$<%PXXFC1Q"@QIQ- Z<,US])UJ_M7R6[8'21-
M. J26XY5H2>]24YC[U,MYCQRNQWD3LQR%^GKLBI\@C+D9)E-<4652ZX[$#<Q
MG#8;K:BI:O +V/R.N18<O0Z?*9K/46!Y81\+3@<\.,KIW6L3W<8BN+)QC#@<
MW#$8CY5%SMCYFNK#N[R12^W]S+JO*:"+CDB@N9T^W&#5C=[)G,R3,L:*>ZM,
M=2!'ZUI8!ZO/?Z3VM:TV%O+[ +H,D8\N!  XSPTI0.';O7.TN_E=K3Q]/Q<;
M VAJ>$5K6I![-RR6^PN?VMX] Y:X>[G1D&2(SN'$;XF8@5CX1&R7*_;V=>F*
M<@M%MB(Q)6@K$($?K?3\&\5PS6YC8WUEP1&(GS23\K<#7A&=.E+2PNTB'ZRS
MN@^3S /+P/Q.Q%.(GIR"LK5DAV96U\M]KT'Y4&)(>8)W++K[#;KC1.R=_36H
MCR'EJHG@->6C$ E6"#4 KMN-H=;6TZA+C;B%-N-K2%(6A8*5H6D[A25).Q!\
M"-:Y8C-95"CNCXV1P_W(<X\:1V_2@8GR5D\2H1L$@4<Z<NVI.A(\FQ66#03_
M -(UZBT.\_,-'MKP_$^%M?Q 4/B"O/NKVHLM4N+5OP,E=3L.(\"M#ZZBYZEA
M59W+D=B.=\:.2%^VJ.[SB;+(D;U5=/MLBX<YIC6 ]+?8-"SQ>,OY%SQ\QOKA
M/M6CFB*\ ]YVGRM)_#-#3P<>Y==EP3R_):UP;>1NI^*.6OBT=_I3>[!U<B?.
MD.'=Q^9*?</S<>?<<6?B?%2CKSH%>)S74UG;;;]*$YWM%CH8X#PM2  J2N]D
MND%)W<7?6*-ST^1Z&T@@^(VTTE^,IPSX0I*Z36RAMWT<'6?.7 V25&-*E)S3
M'X\BYPT1#^T5=*2W$(/2VMTCV3KNW04G?X[:D'+>I,TW4V23 ?3N(#NS/UT7
M)UJR=?6#XHL)P/=[?\*KK]DW<;6\Z\6PH<]QJOS[#$G'LKQQQ0$^O56/2:R!
M)D,AQ_H%A&K2ZD]9)WWV'EK/,6DOTV]+FBMK)[S7;C7$C=B*XHT>_9>VHQI,
MP\+F[Q3#'MI50H[R)."<3]X^*9DJ13X/*R'AF6_;WZ4F&[:VC^;2PIR2^RVX
MMZ2XS%3XD>2/T:D6@B[ON77VWO2M;<@!N= &#+H&*Y.J.M[7663N+6.,.+LB
M?>RKW+?7VP:F@/"F49A B0UV>1<I<B^\O6FQ[JUKV,A<D5_K2=@IUA"9*E-@
M^(ZSKF<Y22_F#('D\+((_=W \..'3@G?+88;%TK:<3YGDG>?>WK"^[?F').8
M.9^/.UO@_(9PMX.3TN4\F66-2G6Y-'58_;07K*HL'F5!38FTMD'B@MN(*0"2
M/(K:'816&G3:WJ+ 8S&YL8=D7$&A'8X4JD]5N9+J\CTRQ>1,'!SRWY0TBK3V
M@Y+YYGV1<]X)R/D7(';!R;1XW+S3&8V.Y&YF$J\]]U,V3ML].A.T$1GH?=E=
M ZEJ42-_#?QUM;\QZ9=6C+76H7/$;^)O!2F5*'B]BUGT>_ANG76F2L:][0T\
M=>FM?=&:VCVZ?;GX7XIH*B9G^*XWR%R4Q/GV]EEMM7Q["2NSFV;]DEZ/-?B1
MIA]LMX!!5XCI'RTSU?FS4;^5S;9[XK,@ -!(% *8BM,4ZL= L;5@=(QDEUB2
M\@$U)KX;DQ7437=1H0J8OW8ZZ+7=^?,8BM^F+"NX_LY/E]<R5AE4V\YX ?K)
MCI_E&O0_(CW/Y7M^+<Z0#L#RJ3YP8UG,$W#O:P]Y:$N?4O48VVV]JSRKE.(X
MQSF$-_2E9YQ5+6-_I]2!CW,C+1Z?B>BQ7X_+]&FKP/K8G;Q%+XNA_0G+"?I)
M!N,D?@V7]*?K<150;BW@JWZX-K8PE[^?5$F/QU;^7B%-^.O,(R7H YKSM90G
M%]FUFB?P301TGZJ>VR&K='AN%IM'IHW ^:)H.FDHH]+L/NJ4^DUNCS\#X@Z$
M)/'>7P=-[><OA=XG"5DK';:MN*>#G>-(=":J_KK65 I7I B/OF$RY$K%/J'I
MQU+4M9.X5XZGO+VHMU2 Z!J(XHB"6.WM(J=V.)IOR45U>S=8S?G%D>&0$<;=
MS@2!7H%!U*:BH' 7<S@7'O)^=0J,QLEQN);4(N;1JJE-ULMZ2XVVGW+L5]3?
MK*7X$;=6^H\':IH]U+9VI?Q,>0[A%14479I97\++B0-+7-J*]!6@N[3FK&>V
MGA.NP+@9S'49-G%@_4XM'J[>M?:KY E5:K:7(Z3);ZG:]Y>Q<VW4/ [^74T+
M39M7U$W.I\?DQBKB0<<#0#+?T)AJUY'I]F(K+@\YYHT5'57OITK<G:)VF8SV
MZXJ)\A]W(^1\D;1.R[+ISCK\JPF+2XVDQ_7D3/:,^R+:%(;7TJ* 2-]<_7M<
MFU>XH &6;,&,&X=>535.M*TJ+3HL^*X=BYV\GQ4S-1]=9&A"-"$:$*E']S[*
M&<K[Z^>Y,=;;C5);8[B25-D*'K8WBU3"F-K( V<9L/40H? IUZ-Y*A,'+%J#
MFYKG?O.)'L5'<V2^=K]P1DTM;Z&BOBH$_C\?[SJ4[;>*CNVWBMDU-6\YP]R!
M>]!]K#Y-X?I0[N>DRK+%.<;!37RZA&J@K_9IE(]HU&&.OO&"8TZ@^ 5\4[8P
M_0R/^42QCTME]@5C3GO'5XMS+R)5*;])IS(I5O#3ML#"O FUCJ2/B-I1&_Q(
M.O,3#5H7H!XHY:BUNM4Q+L-S-MMW-N/Y+VSCQC974MJ5L% )16V[;:3YK!$=
M9 ^&Y^>D)QD4K&=R9!INE4:$)?OW+HD:7VM98W)@Y?/1^9X\I+6&JA)L$.(M
M&EMNR3-(;->TH=4C;ZO2"NGQU*.4'.;K4?"8Q@[XZTR.5-YW=:X?,0!TIX(>
M<6_!GGZNE+.Y)JX<_MT[0C,QGN)ONC@S'0'>$W,;15,C\VO5!NS%V0Z9^YW/
M1]/I%'D=3&T>YNM7]'V;&_4'_>XJUH,N'=[5'9VAVF6H+;IQ\EN,7#08G.J@
M-R72U,?-N)$MX=W65[;N2R_5;Y <Q-4Z6$L,$)Q@URNE,AHGJD^KX>C^K]6I
M792/-K<4EL"> 4\OCPQ^:N[LWJ.W<5+B#W+T#CR?PXX5]VF\;Z[E<5H=OR6J
MV3)0/81MDR^GW*1Z2=@]T?1U@?+PUY^D%)' TK4Y*WQD.Q>OK191H0C0A8OF
M^7TO'^&Y5G.1R6X=!A^/7&2W$EQ:6TLUU+ ?L9:NI9">LLQR$CXJ( \3I:W@
MDNKAEM"*RR/#0.MQH$E/,RWA?/*:1L:7'L J50"Y S6QY*SW-^1;A2E6F>9=
MD.7S>O<J2[?VDJR2R=_']W:>0V/T)UZHM+9EE:16<?P11M:/V13UA>>+F=UU
M<273_CD>7'O)/Z%B7X_'^\Z<)#;;Q4[H/%-G$^V=E/+'LE>WO^\K FO<=*BH
M4.(<8\D8E[G]7Z6%9'F_I;_JE0\]QJ,.OF.YR985Q9I[\/O/DC=_H952%MHX
M<JONZ>ZZ^9^ZUCV5]+E8L[[,&7#R'%.0XK/[M;PEXU;NI2=D6%>7)=8XZK;8
M&1#<<;3\_1VUYXA<:%JNR08U4!=+[;;9)-9QQMG5AQKG&/9K7!;BZ::%3(J%
M=/YA52!Z%I 5\/WF(M73\G D_#6KF\0+=MO:L@T-4^''K^JRJCJLCHY2)M3=
M08]A DMD$.1Y" M(4 3T.MDE*T^:%@@^(TS((-#FG(-<0O9UA"PSD'"*CD;$
M+S#KQL+K[N!*A.DIZRTI^.ZRV^E(4@E3*W.H $'P\QI>VN)+2=EQ%\;7 ^@Y
M)*:)D\3HG_"X457+EG@JX[<^9)_&>99CRJCC*#42G,(M<8PS-<R:,1BP3$@1
M51Z"1.-=U)2\HH4YX;>7U;ZNFQU&/6-/%Y;QP?7%PXPY[&8TJ?BI7<JTN[%V
MF7IM)))A9AE6<+7NWY85ZU(O[=':M/YDSESF'DF?E<C&N/[ZV.%UN3T=U2R+
M;U'9]6IUZ':O1Y$0"(6G/K:<W/A^G7)YMUING6PT^S#!-*QO&6N:ZF1P(J#C
MUI_R[IC[N?ZZZ<\QQN/ ' BN8Q!/13<K&:4A"4H2-@E(2 /   ;#P_V:J56"
MN6A"ZTV7'KX<N?+=2S$A1GY<IY9"4-1XS2GGG5$D );;022?@-9 +B&MQ)*P
M2&@DY!<HLEF9&CS(SB78\IAJ2PZD@I<9?;2ZTXDC<%*T*!&@@M):<P@$$5&1
M2+?O4]U\3$..J[M:Q*Q2O+.3&HUUR*8KR2Y1\>PI:7H=5*""5-2LOM8Z0$$I
M5[.,X2"EQ.]F?VYT)UQ>'6YQ_+P^ZROS2$8D?@!KVD="@7/&KB"U&E0G^-+B
M^FYG0?Q'P!58;\?U[?\ A&KIZU577MM@N2&I$AQJ-#8<E3)+S4:'%925O2ID
MEQ+$6,RA(*ENR'W0A('B5';02&BKL&C$GJWGU^A9 )]UHJXG#K.[UJXY_HI3
M_P#6;_I1]LU_%O\ E+^8^IZ ]3_-;K_C?U-O/U?XM_=NOS]+X;>&O/?]1_\
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9IZ.GZ>GI\MO#;5<*<KEH0C0A&A"-"%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>tm212692d3_sch14-aimg056.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg056.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $0 4 P$1  (1 0,1 ?_$ (<   ,! 0
M      <("0 * 0$  P$!               %  $&! <0   % @0$!04
M      $" P0%!@< $Q4($1(4%B(C%Q@)(70WMQD1  $" P4$"04
M  $"!0 1 R$Q01(&,D(3!'&!(E)BLA05%F&",S0U_]H # ,!  (1 Q$ /P#O
MP0=M7)ERMG+=P9JL9LY*@LFJ9NX(!3&07!,QA16*4P")3<#  A],601>")Q0
M(-QNB4/R4;]7E@XQC8.Q@K5%N9N<FTBXAI"HZF_H2/GE 9,I7HTBJBM5DP=3
MDB&@AQ >+E0 3(7GW.CM+I=5ET<^PRT+238%E-I$^Z-\_:+39DM3Z@+<@-_(
M=ITJR  M*0;)R[QW1UW" ;_-_<;[&>TO<#=#W(]V>MFE>H=0=N]Q:3D>F^J:
MAU6;E>=UV;D:WYG)D^+"7RYG^2\?TE#V?A\&?#3FRS_)*4NJ4\GU@_XRY^P\
M'U-7W//Q99U9<TMB<^N=V:VZ !N/I3<I\5U[JUW!6/E)"O+"WM?S1IV+JQ65
MGHNF:RGU';M@VJHA%CKD>Q\L[,M"R)1+U*0&9+\>/B59Z[/K=MIM+DD4G7E@
M,I3))4A(D<N%H$EIPVA![G1=-)\]4<N0)J-]<F85,A*C,C-T'9..R8:SXT-C
M]40\H]WF[H>NJ._URE'-0TPQJ<HKR5&1\Z3G5J*416 0;5?-LU (BB  6*CQ
M*@0"G,<"!ZRU+1J(&GF62&JCV5%-RR-T>!)QWE6FR4+Z88:U-9>W::G&K:D*
MO2#B?$1ANBR^+5X\ZC;PNF[#\"5K]Y1'[ I7"K)_3I]"_(J.!S_25TI\Z88O
(!4=\;$B1_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>tm212692d3_sch14-aimg057.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg057.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 9 !D P$1  (1 0,1 ?_$ +4   $#!0$!
M      D !P@! @,$!@H% 0 # 0$! 0$!             @,$ 0<%!@@0  $#
M P(#! 4)!@,) 0    $" P01!08 !R$2"#%1$Q1!82(5"?!QD:&Q,D(C%L%B
M@C,D%X%#D]%RDC0EM28V=Q@1  (! @,%! 8(! <        ! A$#\"$Q06$2
M! 51H1,&<9&Q\2(R@<'10E(C) ?A8H(4<I*R,W,T%?_:  P# 0 "$0,1 #\
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M/3'U,--M[0;K6B7D2FO%>P;(5N8]F48\2I"K!=Q&G2>2G%<;S+0'XM?A^J=
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M^QK3NFSM7=<CROI(Z/[=<+C)FVFT8SNQU QGLANV.VORD!JW6=;BF$JF\RN
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6[WU: %['[WU: +O8Y/Q?>]7=H __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>tm212692d3_sch14-aimg058.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg058.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 8P!D P$1  (1 0,1 ?_$ +L   $#!0$!
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M[\0LN]G[J3V\WQ)IH75$+**."6%*OCD0"^X!$0.*#<@T]JM4P CAN'5 .LF
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MZR!=N2;3E;@=OH7#V"<(7+/63E7*R,JQ9-GDO&W'>D?'QMFBNBV2EE9=,YS
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MI@99/EQ\3YS!V1)]2B7Z>Z3R^#HAE&RZ1 YE%4E$DR_645**9"A[ICF -5!
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M9C<DUJ/24^VO=5T#2^AC$M&+I?M+>.8V[T'LARJ% Y#%.0P5*8H@8HAZP$.
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#A?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>tm212692d3_sch14-aimg059.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg059.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ '@ > P$1  (1 0,1 ?_$ (H  0$! 0
M      H'" 0! 0$! 0$               <$!0(&$   !P ! P,# 0D!
M   ! @,$!08'"  1$B$3"3$4%B-!@;$B,Q47=S@9$0 ! P($!0(#" ,
M   ! @,$$04 (1(&,4%Q@1-182)2%I&QP3)"%'0V(S,5_]H # ,!  (1 Q$
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DHJ,CITUSXX;P-K?2Q2DM_3?CH2-7S#,Y:]>NAS&K53*N/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>60
<FILENAME>tm212692d3_sch14-aimg060.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg060.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ '@ > P$1  (1 0,1 ?_$ (,  0$! 0
M      H'" 8! 0$! 0$               <$!0,&$   !P !! $# P4
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M\]D5:])":>T4!(SJ201]AC,'(S2L5U&X0TYA?'UIQQK+* &/F*BSNLM>PG[
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&JF7 8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>61
<FILENAME>tm212692d3_sch14-aimg061.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg061.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ '@ > P$1  (1 0,1 ?_$ '\  0$! 0
M      H'!@@! 0$! 0$               <$!0,&$   !@(! P,$ P
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@Z.BN]--H';/XR0#%^.?'N=^FE>)VZNKJIX=75ZZ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>62
<FILENAME>tm212692d3_sch14-aimg062.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg062.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ '@ > P$1  (1 0,1 ?_$ (<  0 # 0
M      H&!P@# 0 # 0$!               $!0<#!@$0   & 0,#! $$ P
M      $" P0%!@<1$@@ (1,Q%!4)(C(C,Q87&!D1  (! P,"!0(%!0$
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DCPXUWI75M4=K_P 7*J8OXY\="16G4;G;G\G.AW'/E3:NO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>63
<FILENAME>tm212692d3_sch14-aimg063.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg063.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P C P$1  (1 0,1 ?_$ *$   ,! 0
M      <("@D& 0$! 0$! 0             %!P8$" $0   % @0#!@0$!04
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7\#Y7PW\VUT.O93\OR_K_ +N#*(4__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>64
<FILENAME>tm212692d3_sch14-aimg064.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg064.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ (P C P$1  (1 0,1 ?_$ (\   ,! 0$
M      <)"@@"!@$  @,!                  $" P0%$   !0$%!@4# @<
M       ! @,$!081$A,'"  A%!46%S$B,B,803,)46%"4F)3)"4F$0 ! P("
M!P<%           ! !$"\ ,A,4%A@:'!$C*1T?$B0A,$4;'A8H+_V@ , P$
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>65
<FILENAME>tm212692d3_sch14-aimg065.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg065.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ #P / P$1  (1 0,1 ?_$ &D   ,!
M       #! H! 0 #                   ! @00  $% 0 " P$!
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5$*[^IQEU?X3:$5EJH(. [\<]3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>66
<FILENAME>tm212692d3_sch14-aimg066.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg066.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ &0 9 P$1  (1 0,1 ?_$ (P   (# 0
M      @)!08'"@$  P #                ! 4& P<($  !! $# @,##0$
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+OXX[ M:!C>D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>67
<FILENAME>tm212692d3_sch14-aimg067.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg067.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E0"6 P$1  (1 0,1 ?_$ +     %!0$!
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M5#>:(4A;-R3N2K<">FG#;E^9%13E_9)^)IS_ %6OE77FW#*JR[CZU\A69O\
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M"-QEKQ^:A >@;'K#$M:KQ?XQ<E+45QK<&D>#Y4@F/;PNJ'2S'!(2LC>0>IU
M7#RVI[ KA:QDMRY!.KS,EL:,?G/S[:U 3#2Z0XZ"'!"4"(D-@+44N-PT@@*/
MQ$=ZZCIKED5"2*NYD\.2?312@@-:35-4<O2<GSZ_R8V%65J;;TNJ0J1^;YP
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M.N<>VL.M93BY(25KCY5BSLJ(6QT4^II7= IEIH>Q8!TG4."^_P"K\;&(G/\
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MD:5C&.I;,;K=3@,498<5Y"[TW;M_8;:[P:;:;=O[.U-+)VO@]S]I_?H0B8Y
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M5'==[U7;HVN.G5_BD3Q)D-[)HEPS:'<)>/V^;'EY&[!BNW)Q-D?<#EQ4(+=
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;\_</\]"$.GO/W#_/0A5%*'J>WN'O'[="%__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>68
<FILENAME>tm212692d3_sch14-aimg068.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg068.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E0"6 P$1  (1 0,1 ?_$ +H   $#!0$! 0
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MN-N-K2%MN-N))0XVX@A25 D*!!'36Y*E<=C]W\QH0KT*E[4@E2E4  J22:
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M:P;;NDM*,!Q!58[B?-N'/:!GP2GN.GY6$9?;;_;EK,"V347J$M"E)"D,NC>
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MX\GHNF$XU<6E^5F78;0MMRA&[;;V&W/A/Q"CJ2.HUU/!^Q'_ *;?\(7+,_\
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MTXW<K)#GV2=D-TM3GR/$,VNYW&URY(46U$4=9/P]NO?IKIX6L&VW (C9(?\
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M>W^EZ-&'[M-/9EXD1;!;.%VD(_PK-^:9WR>(Y5Q9A5KE^+:GQB0FV<Q7A7U
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GA>*NGO/X#^NA"KI[S^ _KH0JZ>\_@/ZZ$*XI0]3V]P]X^W0A?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>69
<FILENAME>tm212692d3_sch14-aimg069.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg069.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E0"6 P$1  (1 0,1 ?_$ +D    %!0$!
M       '" D* 0,$!08+ @$  00# 0$               ,$!08! @<("1
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M_.?@LK*/HLWG%+XSD. W]QR.V4EV*XXHA6W:2DBKOM1I@>KR/U/_ /($[?\
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M8Y&492N!%<AVI7=G?_I/&8ML;7#:@*VMI890IAUM%" E*G5;!0'W:C;HM#:
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M(:$(:$+"E(2XI#9-%K:>2CU'J$^[6'LU1./9[UEDWDS,KQ*AO>7&$VRQ\O\
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MQD]:[S-R[BG(%<;Y3<7_ )N^6]J%^Y<=YK(Z;UY?AJ'HK3=QD)&U5TMCD.X
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4]Y_ ?ST(512AZGT]P]X^W0A?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>70
<FILENAME>tm212692d3_sch14-aimg070.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg070.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  *  H# 2(  A$! Q$!_\0
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F6&JSPRO4Q=5REB?K.(]NI+VCIU8PE>56:G[14ZE/"JCAJ?\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>71
<FILENAME>tm212692d3_sch14-aimg071.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg071.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E0"6 P$1  (1 0,1 ?_$ +T    & P$! 0
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M&/I7B*>Q!D_B#TT8VZXY?\?Q!-?B/.YMD$^[!2AUW%>57F<V17K[CIEM]8-
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M,N#RD^9-;#IVA(,5TH*6TTJ%$GOI3;]';24E)PY-51-L&IV &JN/B4@OI?\
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MFCWE%)*3_FJL=]#?45ZVRMR\D"K>)(5MM5O]1.!Q!Y556KECF*7-OE]R>]7
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MN*R,X&B^U);6%,K0E:%H4%H6 I"T*JE25)54*2H'J#T(TEXF.6#"95]P3.>
M MYMK!^2[7AKJ/,4'W>)[QE./YG"9W?F+;O'MTE0![*1RGL#I_5X-7%.@DPD
M<1AZ$K_ [:;E-YCS520IW)N6;]:8<@$*\RQX!$@85;FDF@(;:F6F6K;U 6XK
MWZCW#Z4!3<F+B>U+VMRB35>WJGJ?O'[]<6WC=4XJ&YYRJM*<"7DTJI+J=H*>
MR=HZE5:$5.FKV3R8P374:XJ='$'1EW%5._K#YMDR^<;FUC4)W(X]FLUOA?HC
M+;3SS4UY,F,_);WE" D+2%*JJM!VU\P?U$NW7/4+JDFD;![^2VOHRV;%L3 .
M,CG<>Q5]>1;G'P7'$S<\N!3>+JN1<F;?&\E+5N"PA]N'*#B$N!\%>SPDC<.]
M-"%A8@O#Z"J)Q+I<:B@X+OZ3<C1R9R-;6+<PZA$=Q#JUO!)04H4%D)\LJ\7@
MZ5U-W-A;;N'$T5_92^90.QR5B!R?:L.PB9D<L/N*LEDFSD6YH*+L]RV0U/&,
MTD4077U-[4;E 5/70ITWM=I?WTS;EC7M::BI.&?<KYVFVM7EXK5II3AV8JOY
MRQ]2[U$WK)Q)Q#$<>QC#EY"]84V;)(-Z.1-H;GB$+B^+>J3!^34!Y@HO=L]E
M>FMQVSIS;&VK0V.$>D_:L>W'=9H[YS6%X%1R4E7IN]3%YDQ&[7E4NQR)SC4*
M8XY9&+LALF:V7_+1\^TV0M&ZAZ4]VAO>MG@@)\H,&8S."/-IOI#95>7$D<@I
M?&<B8=P*7?V 7&X..2YJT$?&6H1 \E*:>TTIU[:J]@MI6;F&.(+'-.&-%3S;
M@67QU5+33DH2/4KS/R/?&KK8<:R;&L/FLPY5SCS+DQ=%.%AEOS0T@Q8<K_<$
M. #I2OMUHT/3%G?'_4-B=^]J'%.[UO=Y'8N=;ND;1G"BCVX"]97JQP+E& Y_
M<Z.0,8C7B-!ON.08-S5=BPM\!3T<OP8<+R5,H4I-7*T(K[=$%KTAM-FX/CB@
M#NPG[5G%GOF\2W8$DLICXBGZE<CXDSV/E^+V&Y%N-%-\Q]B;*MKOG)N%M=<C
MQRZE]))9#P6X>Q4-78G%I_IXL&989*SO;KS7M,E2ZG%5^/JR7^;A_**+K%6X
M[#6VQ#=2W_J'SF&"ESKM3M0$$'_#66=5PUGPS)!1ML?AM4C'H6Y*Q;DR[)Q2
MX2FD&:AV,$REH*43%.I;:+@25*VT)[==#0@+&$NY*+.1YQYU4W?!^-3,?9DI
M,AE*K)/2IE3'F#S&E%;R"P5)!"0%#O31KTC<.CD:QIH:^U!O5!TP'N5AOC!Z
M;-P2Q29B][LJ&TI!ZU2E/@&XGVFE=;ZWY0>P+('8./>4H22%+"@1U;I3VT"N
M_P!U=>]J\SQ3?V&DV'U.SVT)#4;D/B:#=E^( 2+Y@%_D6EYT("15P63+(Z%*
M))VMI';78/@(7330.'.GO7K]-J%?\+XE*<"/.NKN47U]:*?%>ON7WZZJ=402
M%*6)8J:Z9NLBN7?(2EH4E"DJ"TA20-Q![';XOWC7-EB".:KS_>BB+F6W^'CN
M-W:^RG4QHT*V2I06KH$*1'<6@^T  I&JSJ)P@M*NX$_J1'MT#[F5L;.=?0,5
M4-]6O.&,V&?RIR7<ID>X7^?-N LX?(<!0X_*\@(_+79YP/?7R3U'.9]_<'4!
MH/BM\V&%K-H:>T_!52^6;UE?-7(/GW>Z+5 N,E4M3*%T1'7O\UMJ@!I51V@?
M9HAVVV'E>:*T4:=YUX_-52P?37XWAX_GH2XD/_ HE2O9X'.O8>W57O\ X&5!
MQI[D3;*[S"&TQ5B(6&&_9G&%!AQ*WB?EW4J<2ZEM1*FR .R@:'WZS2W-S]07
M6[=1KCZ_0BW<8#+$QF-*')-_R7BC WKC(N+^ 8\Z\^@LAEV$H%+NTI\\#S$@
M*4HUKK1-OW"]AAH]C1Z_M0\.C'7,GF@2T/[J3^VX1";NJUP(5KC%;\.,AMB,
M\D-I:46@V.A'@I3OI#<WS2!LFD4KS^*N&].&VCTL;(13C3AW)\>)V^2JWWJQ
MNR"RAS&W8K?A44%R1 VH:VA*CXC]GLUH?1,4=UNNFOB\MV7<$%=4[/+!8_4L
M:_\ O&C,<4S7*^+;(]?UNWF!$G2&&%L;'6%@K;HE.VE :$)U,ZHFGV_680'4
MK6M?@K_8K2W=MP,Q<'Z17+EW)0>.L8M&,2OGL4P;%(XEA#<DOP73(W-41O4?
M- !-"1H!LNH;YUR&O8P-]/VJ>[;]O!JUYU=M/L3^N.;>ZI3$N;$0Q+DE"%_*
MI*6&8ZZ!=*D@(  _9K6]IG?/;ZSFLJZFV]T>X-=$'%F)]JA8^K;BMLG9/%CN
M[%*E0')(6KK_ .V2PVD@T_ZM#O43&FZS-*?!%.QD.ML%7*Q.Z9;Z>>6+#D]C
MF2/TAJ[-3KCM64MMI0^E02JA2**0=#ETSRX33$T46<5N#WJZKZ=\NMF<X-B&
M6M+3Y62VF*XZ1U"GPAMI1]M22V=/;!-IG;6@J\(.ZHQB]"L$<6+6K ,8*DT_
MV03[/RAQP)-/<1KZ8C-8VG]D>X+'C\Q[T?&D)!2H$5#:DT'N*R:C]NNUXD2S
MQ"F.;N!)S>Q/S#/*=B?5T#BVI6,0+TVV.H)2'L?"B/>*ZZ&17G%>CTZK0YP?
MQKM2$>7C4>,M*2D@.Q7Y$9\51X3\9E7\=>.#7D@C!>C' Y)8G6QUV]!T!I[J
M]?\ #41KC')I9@*J/+&T>, 53/?7/>96.^G#.ID-]UA_RH;27&3M6F.[*:;=
M;!ZU0XTHI/V'01_4&XNH]E<Z"1S)/$:CN1ATLT.O YXJT-]=5^>IZQ.4I=QN
M+N,R)4CRV+C=I3:5N>!YMP)4RSV%4L^7TZ^W7SGT_!]=']5N/YMU4^)WS4X+
M9X-;0&0'3;T^49)D''34*&^S?KH6W$29ZXZ(3IJD$NI0AVG0U07*CK[-$=R]
M]LT-AJUM3@%U<?3M\3FBJEV^G]R#9;OS2UA5O>98N<.-<)LA32OB2&$LNNLM
M+!)JEM+1I]^JS<6&:Q=)+BZF!(3VSW+A. PD=Q5BFVK$=KY=0 D)")"'/ZDB
M0-Z:>RJ::RG:[UNWW<PNP9&N=1N-*4)Y\T;WL=[<&%L$I93/MK3DB]E$F&EI
M3\G8])VT#KE"X1VVDB@I^S1Q'N44\8\MI![PBRPMKQD(U2ZJ]Z)O%MJ9RG))
M-LDR(-OVK6^PXL[:E*BII8.XT6#J/:L?)/4YJ'>R7+'EI>XA+SBT6_,9J[9X
MSL&=MKYDV0ZVE!9C$) WK>:15"#T]I&MCZ,<RSN#/AKT4P-#B.WFACJ,>;LY
MU"M9&Y^E)ARH7;-GB&Y<6%,;? "U1Y$90;4?+JH'SSVK_AJ'U=?"0.K4@\*A
M<;& 8VL/R8"B%L>M<1Y33K)24O+W*W*2M1-?:I'A.P&@T%[1+9NNQYL8-",Z
M*ZOK+3&70@-=V I[> 38D2U>2_Y;E6%->*G5!2$E!^PC6^[;/M;=J>(X6MET
M8'#/GFLGW6&Y-W^:XN /(JMY]:+DN%@F<8C<IKJ46U5MN+;T<J :=1\S'&U2
M:U4*)_#0G?VC[OQ#YCQ-33EDG;6\;:MTLJ!V$!09WS+<<R2S0YZ41YT7(E;0
MTYXVT44ID( !! (3H6O89+<ELWB%.[WKN25L[2YF#^??W*SUZ()UP1Z<^)XC
M4M_S[<\IYTI5XC"3/G*#*NG^F$K2*?8-5\4K6/'D^!U<"$-W[HG^&[;K'(JU
M+PU?&<AX\QN5#^&AB,PTXE!%"4!27![>ZAKZ.LYYGP1ESB3H'N"QE]-;J4IK
M/H%2E=2E /A !3X>GL!\5/VDZN1DFTB_(+B?^5. 6-H+AR3/9()*04M,<:Y&
MPX0#XC5R8@=/VZX!=0FO#XA>H,]-SB6>,18B"A[$LTY'Q9]"B2I!M.=W_P"6
MW ]4^9 D-+ _RJ&GB?'1<BH>6]I2[K(VD_9T^T^S_'462C)JKV1HTFJ;1ZM\
M/=S7@7.K2U%7)DKM:9"6$E!)^5)?<(KT\*6R??TU0=56+KS:S$VM<<NT*XV6
MY,%RUM0&&N?<OS@O7_ACU@S!$YJ*ZABURY1N#@02ILK4EM#:T)&]1W)(H!37
MRX^<[5O)VXT%.!Q-.\8<%N>TSMGL6S,/BR[,%&LF]W W(2'BIBW"-,?@I0K>
M5/ADKCDLH)6V5K">J@*:.H-O=?-8_&A)R-%7;O(\ G"J5OZ:G-DJP^O+#)-U
MN"X=LO[T['IJY'F-I^;< @M,A"P"YN=D4J*IZ]]6.[[08-G< #K9EB./%0=D
MOC%<C( GM]BO13WT))>;5N/EA HDI064 IC*0H^%06CKT/37S!<V!O=PD+JU
M;([(\BMGL+MTS&.BH0!W=Z:IR'R9:;9+7^KWRVVJ&F0(JI-SFL08Z7EN>6$K
M>ENLM(\0[DT]NC39=J#@V)H<92105'H1E%>^7$-5*#L7S8;U9)335_LU]MBI
M"E!IIZ'>[:Y'?H0@*0^U(6UL6$@@[J$'13_*IX2:--16N(5#<;G;NEU.=SX%
M*G!SAD,J@KDQ$//% >G&YPG V\:[$E3;ZJI62:J_*/;J\V$W3;X,D: TL/KX
M=RC[R^WN]H\F DR&1IY99YKA(L=L?:FW)R]8[*E,M+>6N3?+4&V&PDJJ7W)J
M6P4T[;JZLMWV>>YC<=)I0\0J?:V^2\1NP*)6 <H0OU%R'"O5MN$*#+6TMZW2
MV944+\U6]#:H[SJ5E"P0:$]1K/)+&:TN?&*-':"M!CA;<0BN1^"?_B>0N.,6
M]TNDLR VLJ%22UTJK:FJJ]?=76B;3>O-OH<!@%G^_6#&M<]M<%3M_P"X>Y5?
MO?,EBXQQZ>Q+NV/P%F_0Q(0RN"FXB).B$N.K0V\'8KP51!41V/7IK2=B,4D%
M"2L;WB4L?I;B 5$SPY'RIJRVRW7=A\B-,B(MXWA\.O2 IU+;2FRL%"MQJ1T!
MZ5T$]:.A8"(S5Q[%;[(_SH"'4KV*[7Z K1*@\8X7:<@9,22S87)$UA92X6&W
M9(>:7X"H**F70KI4]=!>UM=+,V@PUBJ&.KI'12.#.?P5E3TN1Y$3B^VAY"@T
M\^\8ZS3QMA]]*3MK45 U]*V0(A8#^ ++>[FG'MFKSP'4#;N]E%$"@I[>FKT+
MGBD*RUQ-Q]0O#UL0G<K'\+Y0RF2H*_TDSCBV-0MZ?_S&9(VG_H.N /RR>%/C
M^I>TQKV(,XD?_0^3><<+<*&V[A><<Y4L[?Y2]#S2S-VF^K;%!N3'R3%GRX:]
M%/CWZDO'YE>Q=.;IG["*IPYVJ10D4)'6ON-?X:C3-J^O%>2 T0=<HK4Y$B!*
M0'8=QBOPY"%#<D(=:6TJHZBJTN4UW+"VXM_+< <./<N(I'-E\)(]*IU?5Y]#
M%UX_R:[YG:;&NYX=>Y;TY7D,!U,?YEXN*0=B5 >6'!TV]-?+_673SHNK73BG
MEZ&FFD]JUOIC<S+9",$@M.554@S7CZ?9,ZGR;6RZ8,@K81#4=JF$+\Q#FQ)"
M=FU"NAITII^VWME@6QOX'\0''M1/=0NN8L<Z$Y)K64S9?$W)>-7R-!NL+*L=
MO$7++9<(DY 8=@194>YR&7'6VBDNF/' (W@U/;V:T%DD6\[6X, &J@I\WNS"
M$JFTGI[<E?&]$7J.Q+U;>E_#>3<?EM/72) CV2]VY^<Q(F1[G9H[$6X./,C8
MZVF1*0H@J'BH>IU\]]6[ _9+W4W*0N/A86_VK8?Z>;C%=-F9<4.G3340:5KE
MR2?^H7TUXCZB;%?N/,VQUI5NO+3CK%P@NQ8\J.H(<*E)=4AXA8+@ZT[C5+L^
MZNM[AH=JUU%#JI2BT2\?&828PT=R0K@C!H'I$P23Q'S-PO#Y!QKY]U-@S"P1
MX<.XVG'4O.BU"7*>9N*WI,>WN-^8M(0%*02 .PV[9IK:^:/-:PO-:EQ!J2@&
M>SO)I=43G#'# E.XAYO]/J# 80S/R1<N=:99>L*K=<5R1++2-D47,63Y,)2M
M93MIXO9J^;;64$OF,9&'Y84"(+78[YD EF<XQ$C-KN'>F_<I<<GU/86YQWP#
MP_+X_L#,A3EZS5YV'&NDV %N%Y:%B- DJ*F5*(Z*T40VEO<6Y<6MKI(K155R
M[Z6:C1QKAWH<]/?IAQSA1B%AF,*N]WCVA2Y%PE75U3C[]PDN&5<OB.,,[D)F
M+6$]#T]IUCO5$4=M=5:&T!RR1MMET3;C5B:<U(NKD"T8#BETS.\QV[78\2M<
MBX7)V2MMK_:P&]\CRMP3N.U!I0$ZB[/=->\0_BPS0)U+N&DNCQQ!X_!4*/40
M]DWK$]3^?<P9*&DXY=\DF6NT+4I)EJMD"0JW1GFPIQ3B@&(2:$)IU&C27>QM
MD0:-5:8D. JLQN;,W7?7E6GI3]/2]Z>;#;KC9&Y[\^XP,>FQTK%U"U;U25&4
MT(_G-)"FDH50[:BN@#<=[=N,GBU$XX:@58VD'TD1::!O,8*R[Z2Y$N_Y:8=I
MC*$)F&S;66$I\!2$1DIHD #IY>B/I^R\33A76."&-]@%W5YI3F>%.:M#8'CS
M.-XE8K2R@-B-$9<6D4Z..CS5CH!V*];[;#P,_=63/;1Q')R.B4!*ED=UD$_L
M  U=<$VFWXQ/CWCU \HY2^\TFWXI:\)XAM<@T"%W.2B1EM]80O:"757+)+=&
M4.OQ$ :Z#?R2.'Z!=M'A<[N"!\TD_P!F\E\6<E[O*M;TZ7Q)F;M0A#=ESJ3'
MD8G<)"E>!+%LSB"PRI:J!"+@HU[Z>>*MKR7<XI1_(^].F+""G;50%0JH-#4$
M'\.FH[_'B<TT]Q?FMAE(6I=5$J !!/A%/\H]AUUK.D-PH$V& .U<4C_,W$6*
M<TXG=L(R^"F?;+C"=:"DK;;D07G&EI;DAQ:5G:%@$@4W!-*ZH]RZ:VS=2ZYN
M_,\VE!1U!@KK:]QDV\E\1 =49BM519^J!],7E;TMYU,S_&;))RWCF6ZY):NM
MNCK=9CPW%%?RLAMHR"V\IIS;O50 ]:>S6#]4]%,9,9;=CC0X5>%I&V]3NNVZ
M'.%0VA\)'H[U$9G'#-GSG!X4ZP6VVWN.TP]+O-E>A(5E\.0\VAQZ''R!?5N&
MEQ*D>6&B-@IJ/LFZ[KLH\M@C#!AD"?>G[BSM[MI<-1/J0'].KU#YKZ%N<)$2
M7#GKX0Y!O4>U95ATM3HE8[-E3'(]MG6V:X@L-(=>G.+DE#)W! J1T.I^^W-A
MU):M_F9>9H@[Y*M&.6&.5%=]-1?RZ28Q8:Z9XY55R)E%KO#%GO\ :)S$Z!?[
M6W?;2_$?0ZR;?.CM31;5NM+6A4U##R6ZU!W_ -/LUC[]LVSZDN:7Y\3R]"T:
MTO+B0:7::4'#F@Z5'3.C3(5U0NX0Y:%-.1KFHR@TT04!I(<%$%"3M[>S5DW=
M)MN<T6>G3^T*E6T%W?VM'PZ-0''^U$J/Q=Q<EZ.4X=8PY'<+R*P8VTN;@K>M
M/E>)05V/LT9;7N-U/&VYN-&NHR'P5TSJO?K]G\NO?)%H6\&^*O#&I3G,.=<A
M16XEG0U:XWE!LLV] C(6BFW8H(\*@4BAUI%CNER;<ANG3W<T [O.]DP=A@2A
MA["E/SC+CI;8<F))3\JE+3NY("7%/*225%:J]Z:">I+!M[,7S ZL,C053VW;
MU.UFAVG0/V5#U]7C+LTL_#+.$XZ_<;7;[D78.338:7P%6F07DS"XMG:/]-?<
MDZ&++;Y+>Z;-"/&TUQ(59NS;*X8ZYE+O,#32E:5[E!3Q=!X[@HM3<:UR[I)M
MT!Q&_P \(94MY3;KCSC2XZBIXN=0JOMTYO#+^[KJ:T@X'$#XJCM+BR:VCBZG
M<4_[A>VY/E-_M,>VVR<_'>D(;AVV+!DR)#[@<V-+\]EM24MM@4*2GJ3JMV7I
M^=]U21GJ<$WN5W:M@JQQH0>"MQ?3R]&4_CW'6.0N1VG6;S-4U+M5H3\ -MTJ
MDS&%%:EGPCPJ"2:Z^C.FNF;)D399/,U-((\6'NR64;MU!."^UA+=#@0:MQH>
MWFI@4(2E*0!0!( 'N '04]E-&S;6)N#:T"#"XDD\T 9;DMJPO&<AS"]O>3:L
M:LEQO-P75(/RMMBNRW4-!1 4^\&MC:>ZEJ '4ZD 8T7!PQ3/6,3S.)P!-E14
MK:Y.N4O_ )NN$8$AV1FXRJ!R>FP*ZU-$6N/:=O\ E;V_9J3I&G2I.@^5IXT]
MN:7++\7MF;XOD.'WG>+9DEKEVJ2ZU4/Q%/IW1+C%4**1,M<U#<EE0(*76DG7
MJ<(#@6G(H0X0S>YY=AZ[;E*FV^0<#N+V$\@14J%59!9VFO+OC"#11MN5VMUB
MYQ5TVEJ5M!)0JD=PTGL4,@@T.82QZY27@?;*EN[D!+:T(05MBKKM204';X@E
M%?M'4Z[!J PUI[$S)K'C83Z$4<VP7$N0\5N.'YG8(-^QZYQ5PY5MGQV9#986
MVIM3B?.;<"7DH42DTJ%:B7.W6MRW3(QCN]H/J3D%]+$ZC2YKN.)QHJP/J[^A
MGFF.Y)D?(OI-N$41+L^Y*5A4UQN.VTTMQQTL-K=D--JHAU0H&O9K,^H>F&@.
M^G '[L>7J1SL^_U(9*3X0,2_/UJ$?E+Z?_J3M4R<K*O3]F5YNL)I;+WZ1A]V
M>M0FK!1'DM7"-;'XLQQ#J2I)!\/<'KH$M>G;\LE!\W+BP]J+?Y];0T+2S'D\
M!2:?3YMO/5AXTGX#S;@%]Q!C'I"I.(W#);=,MLASRUO.1H#3EPBQUK35IM 2
MD]104T%W_3EW;2%[Q(!^XX(PV3J""8T!:?XP4\^;&D+*UR6G&G%%2G%%"DH\
MQ1)414 4J=4<EE(34UH#R6B6E]!*W2[1J/:"@6+ *Y0+>YRB54":J-*BHHFO
MOT56I$5NV/B%-,L(Q9IU=A"73#8ZFDHW(7T%>J37M[01HZVN4^7C\O:@/>9-
M3SI/$I<K<($=YM;C@7+FME+; (*V-E&P5-CJV%UKU KIVZB;<.Q(]ZHF7#HL
M1J(1-Y.]-G'G.5IM>/YO9VKK;)-U8:OT1"FVI<FSN.."6PT]L<6RMQI0HK::
M>[5EMNQ1.HXZ2,_E0UO&\2,8]M74I^)&6S?0U]!L9+-V@8IEMO7,C(4&8V52
M VDN(11(#4)(Z=NFB/\ ]6@E P9B?^G5 [^H)VO( =0?MT3U^#?0;Z<?3ZVA
M[ \$;F3?,0\B;DLAF\2HSK0*4?)N38F^.A7YB$GJKKJUL^EK.%@(;'KICX!S
M5'<[S>32$F20,/#6<$\),4-_''@=:;VLQ4O!$9M*:!(V_D% !0T%!TT3VT'T
M[-+1ZA3#DJUT^LXY]Z%P:@$]R 3[?9[QIU>)LO,4Q/(&:XMPO$(?LT!=MY)Y
M84E5648W9[CYN'XE*VDCS\RRF$EU;9H?D+>\2"EP5<C;4U7;&ZG8_*,4IH<7
MYA=K\3=YE:#\V\*K3M2OLT^I2YGN?O/[]))(WF[LWC/*HW.%EC29=ICVZ-CW
M,ED@MK=?NF#1'7'+9FT2(TE2I=[XY>D.N.)2DNOVAY]M-5-M@</;J':F9FX:
MQF,^Y.K@3X5T@PKG;94>?;KC$CSX$Z(ZA^+,A2V42(LJ,^V5-O1Y##B5H6DE
M*DD$=-1TPNY-%?\ CW:1.%!FO#(UN!S7RH5ZC7HUC.B:='K\35@20*CV_P#G
MKE[&2'Q5JO U\>5%Y)?EA*/.(6SO2%M*;+I<62-A K4!*OL.DVU#JM&H\<24
MXU[WN ;2HS30?5]AL#)^*+A*;,:--L,R-<$_[1#4QQIAU3_ELK*DNH(2U0;:
M[M!/6%A:BQ,I#M8',HOZ<EGAN@&C\IU2<.(RQ485O@6^ZVQ"9.[<F.V?B5*B
M?+!JXI76M>]>M=86;9DI.D' \^*UZPOIFTK2M.2!DV"&PZ4P@E+OF U!'Y$J
M\?XC41L9%YY9[\T06NXR&2CCPY(](GV^W6\I04_-!(H:BNX#V5^W1=;R".+5
M7PXJ%>.\^;6VA9D>"\=IOJ42#<Y2QYK=:DGKM2?#U[U 3KP7P=,&5XUR7+[.
ML!+1X>]+CQ]DK=R=ERE.A"PTM,=PJ_\ 4I1!)-*=M:!LUXTLK4U[NQ9UN]@Y
MSRR@)->/H3G< ]35LMY-@R-(2J$0VW() '3VBJ>HZ^_1;!ND+32II2N1]B&7
M]/RS@.;I![QP3K<?S3&<PCH=M-VCRE)6TXMIE] >0K;4)4VAPJ ([]-6T%_!
M(-3#C2F(5%>;+<6O]XVK:9@U'ZD:5*2XA;K:'0>J%)<:518_^E7<=-2VO+CH
MX!4<T8CJ1G5%#DOD.V<98A)R6X1I%SF+>B6C',=@;3=<JRJZK^6L6,VAH@[Y
MUTF$)W4*66DK>71MM9' !)H%(X4&:2OC?$+GB]IN-QRF4Q<^0<UNB\IY NT<
MJ7&=ODAAN/%L=K6NJTX]B5L::MT!';RF2X?$ZHF0!044QC=#:<>*40=C]W\1
MKU=+#W/WG]^DDL_8""""E20I*DJ!"DJ2H%*T*2:$$$$=#I))$K%=U>G:["V3
M5*_X"R*YG])GN+*FN%<BNL@DV2XJ.Y3/&-^N#U84D_#LLIPL.D1EM+::>RN(
MS429IC\315GN_5[DZ\.H?<2IEYISX;2R&W$K3L<3O0X"DD*0M)JD]B.NN&Y8
MJ%-"72>8'T=3Y>:^7I+;;:UN+2VVV%*<<4H)2A"!52E*) 2E(%3[M)CG.=E@
MI$)N01&R%[WDT  J37*@X^A,ZYY^H)Z1O339+A>>5.<\ MKMN"_.L,')[-.R
M5934;6K(F<W+6NHH13OJ1]*Z9A)\ Y]_)%-OTQO=T1JM9H\L7,<![E6O]27_
M '4=FNV8GB3T7<+2<YR"\2_T>TYWELIZU-Q;I-=3$M3MOQYZT7*->$.R5 K^
M, @ =]VN&6;8M9\S($]_M^"*8?Z?QAGFRW!#Z9:!GZ3DI1<)Y=]4%Z]-E@=]
M2V46J^\BYO$1D5Q@V_%;7C!QN%(;;FQ;4&;>A)GH\F46_,4E!^'6G765=;;A
MJA,0. '-65KL,.WR>&2M!RH/55$F'+2S$1X=I=90JNZE"I%:4I]NL2AO3"YV
M&II/-%MA;"5A&JE$&_J#<5PNI="EJ\)!--J5?F/<^P:M;2!EW=>=J#3IRSHK
MV7;FVEN+D2:GU I3GVH$N-V\Q7PAOW'Q'=V%:$T^P:E75T+4:0 X=ZAP6YD?
MJ+L"$#R;BXMI4-MTI*NI=KU\76@'N -.^JB&=TMQ485[5; -;'Y=*@%':R9@
MBR69R*'PTZA"G"^5^*J=W])[_F]^M&VMX9%B^F'-#%Y8,FE\TFE.%.U)K>,^
MFW"Z(<B&K:"/-*7E5=-1U*@*BO[=.W6ZFU=^6=?\25IML9)& QID$8+/RY?<
M9N#,RU7JZ6>45MA*H\J0\RLBGA=8\Q#2JD5ZCH-=6'44KY1'Y9H>.H_8I%UL
M%O/&6%S6^&GRA,/YM_[D?F+BKU28=Z9>*.#$<^WY^7$M*;9:;D]#O-XNTEZ&
MEN$(\*T7!QI :DE2W5*"6T)))UJFTW!G:-=:G#.N'$K+MZZ)LH0ZYEO1'$VK
MC5@X?Q8GD!Q5G7C*!R+R&]C/,O.F/0L1S5%@:3B'%4&YJO=LXL1=X3?ZW<)U
MR4Q&1=<\O*5EAV0&DIM\(?+M>);RU7A:QKB(ZEM<*YH$$;&O)8265PJ*&G,C
M&A/+@EYTEVMCL?N_B-))8>Y^\_OTDEK227&3&C38TF%-C1YL*;'>AS84QEN3
M$F1)+:F9$67&>2MF1&D-+*5H4"E230C223..9[WZCO2_Q)G-Y],?'43U VVT
M6*=,Q#B6]Y#(M.5X2\Q'?=-KQ6\N1;BYE&)))_VEOD?[JWD!M#CC%$M\.;J!
M_%3VI6T-H+QDMW7Z<.&JF8'O(Y\0,E^>%ZPOK!_47YOS_*;!S!G>7<0MVNX3
MF7^(L2;E8MD..>4ZO_:7.9:F['=I"6DH W+"D.!)ZD$ZB6T<GG4XCT+ZHZ/V
M7I86C+PL;+$14/8[4/0>8Y8$**S/N8<NS$^;?[Q?+F9#0>E7?([K/OET62G<
MKX%V>D$*-3_7WU=2S:(: Y!7V^W>R6S--JV4- XU/O*F/^@?Z58_,/J-N7,.
M86>1(P/BF$S<43KA'4AB9D$UJ2_8-C*ZL(*9UNZ4/M[:#-QWOZ:M2<?V:K+Y
M]P;.\^67:17,<5<AY6R2\76;9KTL;5.^?:OTU"=K3<5@L1K>$H2G:D*:K_2.
MVL2ZKW9TKG-J:$<E$!,ASRR_3UHCOR5J;"2-B@@ I[;3M *:?]/;66"=Y>,?
M#7DKFQ.FE,BBO)0\5$E1 4=H'VJ[&G;1)9W9@-<:TY55U<7.NWT#LX(/E%RV
M1UJ?/B6/"2/>.@Z]"174>[O#)4D\^"XM:U'<45OU!3;'S"E$[RNA/?HI76A[
M@ :B6=R0[4XFNKEP4U]:41#N=\E2I 8;=6EIQ0;50GJE70GIV&C6'<0VU+@3
M@.2JZ!TP8[(GFA&P6Z=YRGJJ<9 ZU!['L:]:TU%%_P#4^'&O=13#$R :@.*!
M\N1FE[E,8IQAC\S+>0[\R[!Q?'+>R7I$FZ.J2AF7)*$K^4MD4'<_(6 VTGJH
MZ,.F]HN;^>L+=5,S7!M>)/9ZU0[UOUMM-N9+M^DG - !<_L:,SVG(<T]KZ8W
MT<>,?11?;]ZBN5C;N5?6#R(XY/R'.)K#4NU\>QI1W)QC"&G$J;CF(UM;=E)Z
MN+14$FBAMUE91V4(C::NIB>?=V+$MWWB[WF?S;CPP-/@8,F]I_$[MX9!38$D
MDDDDDU)/4DGN2??J:JI:TDEL=C]W\1I)+#W/WG]^DDM:22S226P2DA224J!!
M!!((([$$=01I)*+3Z@'T@_1_]0NTRYW(N)-X)RVB*XW9^9,$BQK7E#+Q2?+%
M\0PAIJ^Q=U-X=\:DUJ5:0P.K[RM-IWK=-CE,NV2N8'?,S.-_[S<J]HH>U4@O
M6)_VXOKR]+.07.=@L&W\\<27>YQX;7(6*;UW#'[/)D*:?DY+CKJ'Y,$L17:K
M=:3L3M)H *Z8OGR.MW"-M3R'P1]!UGM^Y,T;@9+:[.&/BC=W.S;W.'I5CWT)
M>GNS>E[TTX;@F/.1)DY5LM\_*+E!4P\9-YD1F'Y<>5*8*U/_ "4SS E+A^'4
MT ZZP[JK<7PSACA1]3@20?;[U,B;',=4#];3Q!J/8G%Y1E;4AZ'#DK*' 4@$
MFA\)10CJ""*5KK,-PE-PXXGVE$5E8..'BIAP7B2L&,\\'%*"=W4J)([^\G5,
MVV>79&F"OV6#F8BN'8@=FXJ?;VHJHI>1U/4]"K]U-3W1N9'D:)FX86-J<,5Y
M+XXN0E#9KVK0DTZ]/X:CF%TIXTJNK4Y(HRX+C"5.$J*5#HGQ%-0FG1/Y173S
M+9S2 *J<:T]*"X=KBK6IF8Z$/S3Y4>(VVX_<9*E]$MP(,=#LZ4\HGHEI"C75
M]M^W[AN(^EL(9)9#AX032O,Y#TD*AO=PLMM<)KR1D3 ?O$ \\!F?0"GH\4^D
M3F+D-R-.NMN_XIQ .Q'X][RV'ORJ9%:9 *K-A*'$/)6]W2[<UL-CN6E]M:ET
MY_36>+3<;Y)I&?E,()_B?D.YM3VH&WK^H39&F#9HZ_YCQ0=[69GL+J=RD]X@
MX&XUX0@2&,)LZE7JYH O^9WI;=PR[(%?F4F;="VW\I W]40XJ68K8Z!!(KK6
M[:UMK.$6]JQL<(X 4]?,]IQ69W%Q<7<QN;I[I)W9N<:GN' #L% ECU(3*S22
M6:22V.Q^[^(TDELTJ>I[GV#W_?I)+73WG\!_/226=/>?P'\]))9T]Y_ ?STD
MEG3WG\!_/2271&_Q["NFQ7F4'A\JGC\SKM\K;^;=X:=])),-YK_^% N%P_N$
M6M6<5/S@X75=$9AYVX_^_.$)<LGG;J[OGAW_ #:I]Z_D'D?^?^E\GAYNFOH^
M]ZE*LOK_ #?_ !GG>=_EU]M/#ZU'%GL'A%ZZ-+L.4<_VQWS 8S&7X'QC?&-N
M[\KLNW<CX]>-IZ=7&/, ]A-=8OO/^UY?2W^L#_\ (J6^J6@]16L[#_[_ (%W
MTA;3_'H'>N*I]81=#,QBUR1 N#=T:\=%7"SOV%TIHK9\.-?<D0.G?Q'0DZ+I
M0O\ R9]R K]^" ^JEP$?1R]3!A\Z#;":?=GN!['6Y]Z\6,N307:P[4M16:F5
M<9C83U54[6K6[O('8537WC2GBZ?\CQ3WM*\((_\ ] 4"^EWKRC6"R!J/\>4^
M^W",4N)"?D,FZWY=J;J=Z;)B3>0/#I_Z:[GFN,LJI_U)%=.V,?1H</J9=T<W
MLB@:.S'SG'V*I:_JD_\ :Q[<TX_-),[_ .)H2B8]&],<>3%_Y+O'J)O$0D>8
M;?C>$8W8AX4;O/3A65Y5E2F*^XA7>NM#V/\ VPUM^;S^'U.OX>#X(8WK_<CR
MW5_[?C]-H_\ L^*D[]/W_P 4O('_  #_ ,>"Z[$_-"%US[=L%?GCDA&6ERGY
MMHVUKK7;/Z/Z<?R_ROI*8>7IT_\ +@LNG\_SC]9YGU/'S-6OTZL?@G-JKN5O
M*]]3NW#Q;O;NJ:UKJ0FU\]/>?P'\]))9T]Y_ ?STDEG3WG\!_/226=/>?P'\
0]));%*'J>WN'O'VZ22__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>72
<FILENAME>tm212692d3_sch14-aimg072.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg072.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ :(    & @,!
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MTDIX;?8>MB@->JQ^\J@T&0J*D<$/]?I_3V<\LKW+_I6Z"?- #0-7^->KZ_Y
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M_P!"1?W&=P'GG9;@AE5CI^6>I0V1$>:X205"4I\LGHZNS=WXC!4D%=)-&\;
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M2:PF9J\<E%#42K39/%NM+71RW"30QE8]=-^3(RJQY-KV]Q':L?&$5QVM2O\
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M>:W+E\5MS;F)K\[N#.U]/B\+A<532UF1RF1K'$--1T=+ KR2RRR,!P+ 7)L
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M0I$L\V5E1IZ5)&8^E&O;BX''MLL3UZG[>K!?=>O=>]^Z]U[W[KW78^A_UO\
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MK#8$ 7<_7VIC:X#?""?M'^?JMV)S)_C! :@K@?EPZ5WQ"^.W56R.M<[#T_\
MS!-A=W=*/O[;%3EJP=&_*/K_ ,&XZ?.>3'XZ&GW-U#!'+2U]:?'+(3X447=E
M7GV-MGNMP2E;5GC[?A>,'_C3#CT']]7;9(8Q<LT;A6H>X@FG&@4TIU9COG96
MP*O)8YZ+N#8N*RG@I_LX(L%V95'[W2NDK)0[!EC--YK?T.GVKYWNX[CEEXKB
MTN(/UD.MGC91GA1&9JGUI]O4D_=ZGO=MYP@GV:$[BX@N (HV2)S51J(:X:-
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2NNP!9O4/I_C_ %'^'OW7NO_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>73
<FILENAME>tm212692d3_sch14-aimg073.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg073.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ WBV8W/)^I_)_K[<ZUUU<_P!3_MS[]U[KUS_4_P"W/OW7
MNO7/]3_MS[]U[KUS_4_[<^_=>Z2>[=^;0V)3P5&[MQ4&$-80E!13225&7RDA
ML%AQ&#HDJ<QE9G)L%IX)+D^_=>K3I-TFZ.TMV:?[A]1Y*AQ\UQ#N?MC*#8V/
M9#^FH@VM1PYC>53$0=2^6GI-:_D>_"C"HSTU),L9HW$]/=-UCW-FD\N?[IPN
MVT)!EH.N=@T(\!_M1KGMY5V>JIA_1OMHC_@/?B'!X#JHN86^%B?RZDU71N*I
M$>3<?=W<\[,A\DDV_:' 0&X +10X+"8M8;'D:3<'VE:X9*ZO]7^'I_4A-,CJ
M)B.C]I98228GMSN:J9 REZ3M_+UYB5N!*T4T,L(:_ U*;'VTEX2:4S^73NB.
ME02?R_V>I]1T7NF@T_W:[W[4I2/4$W+!L_>M$&!) E3(;?HJUHOP0)P2/S?G
MVH6>IX8ZH0 *U/\ J_+IJJ=M_(?;MY89>L>TJ%!<Q(N8ZSW),#^("9=T;:E=
M5' ?[96)^H]O@U%>F6D532O^3IC'<6$Q%5#C>Q\'NCJ/)SR"&$[[H(X=M5E0
M2!XL;OK%3Y#:5626%A)4P.?]3[W0\1PZL'4XX'Y]"O'*LL44\,J303QK+!/#
M*DT$\3BZ2P31,T4T3CD,I(/]?>NK=<KG^I_VY]^Z]UZY_J?]N??NO=>N?ZG_
M &Y]^Z]UZY_J?]N??NO==AC9N3]/ZG^H]^Z]UT?J?]<_[W[]U[KKW[KW7O?N
MO=-N8S.(V[BJ_.Y_*4&%PN+@:IR.5RE5%1T%% OUDGJ)F5%U'A5%V=B%4$D#
MW[KW0=XENT.W]$NS(JOJKKJ8^G?VXL0LF_MT4IY\VR=GY./[;;F-JD_S62RZ
M/.RL)(J2UF]^J/SZJS$#'0Q["ZDZ^ZZD;(X3$&MW)72&/([XW16S[CWAF)7U
M"3[G<N4,]<!(;_Y/!X*9+66-0![\^D"I..FXR[?A/19?F_\ S$?C3\%]AY+=
M?=V]<5CJ]*.6HQ6TXJR'^\.2=%;3IHS44[K 66Q8/?D<<^R'<KSP6"QY-/(_
M/SZ/MMVF7</U*4C! )I4Y]*]:1ORT_X4E_,[OW.93#_'>LQ_1_5TDTE/B9<)
M08W-Y?,T2@1B:JJ,[CJR>EEF8,2(IK VM[#=UN=T:A0:5X5/^?H4VO+$ R6-
M:?PCJGO=/R4^3/8V9EW-NON+N"ORCEF9)-][JPM)J-RQ%%BLQ!2V))(&BWL-
M7.X7O$*_#U/0DMN6[44JWG_"O26I/D#WGC:T5-+W/V]CZ^$JY6E[)WJL) /I
M62/^.+&RAOZJ>?=;#<;M)F,@-*>9/2FYY=M?#7PVJ?DJ]'#ZD_G ?S'NCWC_
M -'?R,W774T:A5P^8Q6"W5K4 @*T^XJ#(SFXXY;V)+;=G!!P*'U/IT0W/+:$
M$5:E/X1U;Q\9_P#A61V]L6JH-K_,/J3%YZB=J>FJ]VX7R4FYI C%9\@<'0QX
MO#Q)*I#%5(5;&W'L16^[U^(K7'F>@]<\L@&BZZ5/D.MO?XA?.OXT?/;J^GWE
MTSN?#;PQ=?0QQYW9U8:"KR] L\0\M)E\/)+50&-2&5@S./2;^S>"]BN&T576
M?GT'[W9Y[%/&HYC'R_+/^3H1LMT2VVY6R/1FY$ZZR#EJB;K[,1U.6ZLS;L=3
MQR[>\IK-HS2WL*G#R0!#ZF@E^A5:UX$@]%RAB.!'33MSL0U6=38V^<!5]=]C
MF*66GVWE*B.KQ.YZ>GXGR>P-RQK%1;IQZ_J>$"*OIU/[T"_4V^8X=;!]<'H2
MO?NM]>]^Z]U[W[KW78^A_P!;_B1[]U[KQ^I_US_O?OW7NNO?NO=)7>6\\%L/
M!2Y_/RU!A-33X[&8S'4[5V<W%G*YO%C-N[=QD7[^4S>4G]$,*#CEW*HK,/=>
MX=8-D]0YG>.3Q_8/=]+2RUM%.F0V3U1'.M?M78)!#TN4SG'VV[NP%2QDJY%:
MDH')2D0$>=J,QX+UZGF>C/,0 238 7O_ $]T9M*_/K84,1YGJJ+^9[_,QZE_
MEX=+5NZ<Y54N7[+RAEBV#UXM1$V1K<H4J&@KY8%GAF%&LJBYUW_<''LCO[]X
M\ FM1Z='.W[>9SE:)3YY^7V=?,E^4?RS[L^:'<.ZNSNW\[5YO,YG(32C$U%1
M.,5MV@DT?9T,-+&4B&BDCC)NK&]^?83N=SJW?J/Y#J0]HV]8X6"A1W#S^707
MTDD.,QZK3P-F!$HU342J(Z9A=@H%X38'Z\'VF-[&_$'HY$#+PIUGH:_<&<D&
M1JZREQ4$?)2G:0G2G%BLZL-7MNL#\5QU=9)$X'J/N7?N)Q-/"WW]=65$$C-H
MIZ>A8%E6P\UT5O'?_>?;]M913L0J@$#SKT@W+=9;.-7)8@L1@#TZ#A.Y8LG4
M_P"Y?:-55T"-;R4"RQ5#+_R!40H3_L?:T;<$.-/[>B5N8'?'ZG[!U"SW9M-2
M05,./I8)L#D$;7C,C"LNX*)9 =,43$21^.*_U,A;CW<0%!@CJAW0ODAZ?9T)
M_P 2OFSW9\1-YT>\>CNS,SLS*QY!32KCIUJ,9]G5S'[[%YNCKHZFF!KX&\5T
M1F0WTD'GV_'-+;OX@)X?X>DMS(E[$8*$U(.?EUNM? [_ (5%XK<]/C-G?,'8
M<.W*B 4>-A[#VD))Z:LD($*UF6_BE>L</E(#/XH@!<V'LSBW)F[6)\O3HAFV
MI =0 KG&:=;56UMS]&_+_J/"[FVSE</V)UYNB),A@MPX:M=:S%Y6D>QKL/EJ
M4P9'![@PM:"JSP-')'(I )4D$ZMK@M2A]>B2> QDAL,/]0Z#],MNCJ7/8S9'
M:>3;.;=SM='BNN^W)XH:9<I62@_:;.['\*Q46)WC(HT45>H2DS.DBT53>-C
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MDI:H_O1  <?IXL./]Z]EL=X@<5/GT07%@QD% :?:.A%CK:4*R$*6L-(XO?\
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M!U[3_$1ZZO\ *>OL!]>K4'8&P(Y',<T>T=IM4?6\C+@Z(3(;&_+_ %O[DJT
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MWIX]^Z;Z"_N?9<N_^L=W[:HR8\Q-C#DMMU*:1+1;JP4T6;VS60NW^;>#.8^
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M_'MRN*_+JOE3Y]#C\9XA_H@PN0*VESV?WYN*=N29),UOK<=<LC%@#J:&5/\
M6^@N/=&X];'#H>_>NM]>]^Z]U$J%4D$_5;$<_P!.?]X]O1\*=,W9I:GTJ.M7
M?_A3MUYD,_\ '?JW?-!C36G:^X:K!LXC+B/^\5332:2=+!0W\._I["'-,YMX
M-7_"W/4P>V]LMS:W()S6/%*_A/6ES\7]LTM;0Y"/(4]/'.N:(,C(MX#YJFXN
M5!6WN%+G>R)RIIY?B/IU-&Q[ IGU4/P'\(]1U<=LOH3#Y2OHLQG:6ER&'BH8
MX(T9@&>HD6*2,J #J4*K#Z^R[<][\)T&,K_$>I)VSEGZF%WSVD#X ?+H[.R^
MM-ET=5AM>T8%S- ",9/3P@H(BL@.LJBVNLAYY^OLF?>=><?[UTK;ESP3^+_>
M .B:_*'KK;>'KJS'[%P5+A*VJF2NR=--725D17R()&2.H32"QC'X'M$]YK]/
MV]'>W[20PX\?X?ET/FSZ>@W!T+2X'';?Q<E:8HS%7BF@BE-6K0F8-(D):1!$
MMPI-KGVE>Z\.A^?KT<W>S![=!GB?P_+I9[>Z7H\[MK'I1X_[S(T]/X<U"@.A
METV=8RM['D_@>S.VW#[./KT$;[8Z>N /P]*#'?#KJ^3#5,7]T31Y>L8UU-ED
MEG26AD?UJCVT@LA7FY'MZ;<*KY?MZ)QM&EO/_>>@&[0^,^6R&W,IBL[F)<M@
M(Z67$N2/W$HZV-J1K.LA-Q$/K?V1S;CH[L?MZ43;2[PZ5U5J. ZJU[QZDV'U
M3N7K3%;3QW\.Q50T&.GEDC\]1DJBF-'3N-<IU$%[_0FU_8IV[>-2*I(R%_$?
M3H.[ORPPFMB0W>?X!\OV];Y?\GC:..POPCZ[R=#3PT=5F:O<YJWAIXT>1*;.
MUM/3ZI%LQ*1"W/T]S=R+)XB)(<U#C]AZQL]T8Q8<V36.GM5(CZ9* \.K3XI(
MY9H@60F(A1R&8M_@?J/I[DF2/2*D<1U$-A>K<+.JD8>F#7UZ=O:?I_KWOW7N
MBU[1C%)\C^XJ$*/%DL5UEN:UC;[EMO;@P,K_ $TABF$B^AO<7/X]V_!U4?$>
MGWXR KT/UK&Q!>'!RP2V;5IF@R=?#.A;F[1RQLI_Q'OS?$>MCAT._NO6^O>_
M=>Z@U2%O4#:U@?\ @I_5_L2/;L;$?9TGOJFTH/XAU41_.VV[CLW\%-V35U.E
M0F&W-@<O$''Z&HJ;*2!P1SP3_K>PES4HFL&U9[&ZD+VTO9X][2(,?"<J"/EZ
M=?/CZ6PK8Z;*/(KI2Y+<$\TJ:F4O&U55,FD@@H C?BWO':_MHUN6QG'^#K+V
MR:.%!) "&R/RZO+Z8I:7*T.#IFCDEAIJ>.,(9I0!J(8:K/ZFL?J>;>R?=4A,
MB:AG3T/-@N+GZ>0(W:7%?V='WHL-@L'MYL@:-UJU3B<U,S,O^*ZG]( _I[+E
MB@IA>A$H,F9<GJL#OC.OD-\92*F@.3"A:>&JB_W7&60E#IL'Y8\GGVZL<7 #
MHTMH[5,Z36O1F.G-LU=+UZ"\%9%$E,L@'A4JMRM[$L#>WY^OM#N5$C0KYM_D
MZ.X/HY 5D4D =&6ZKQE!GL?-0-/(KHQ ".U,^K@>MH'5F^GY/MVR93\0KGH-
M;I';"NA2,#_#T.>/Z\HL99JL5$M*$#:3655BP4FY;R<B]N/:^80Z>!K0]!-X
MZN=/"O0 =QY*&FP6;@IHXV$2&*"(^E?&=:G4P&IF"_0GGV'+T)H- ?+IQTE6
M.J$5KU2WEL%-V-WWUUALA&K8/;L&YLF\+1K*L=9&U#/3REW76=#QD@$V]K(+
MCPFB"5&JE>BA7O+UV-RP;P3V>5!^7'@./6[Q_*VBIJ'XE[$QM!*9<?3Y?>_A
MN!;R-N>O:8"Q-E64FPO8>\GO;E=>TQ3_ .B5D%?]MUB)[W47FN:X/]N4A!/^
MTZL9CID!!  _=$A_KJ!-N?\ 8^Y*$CN")#4C Z@JU@$#$PT"NU6^?4_W7HPZ
M][]U[HNF&+-\GM^E9E:*+K'KJ)X 3JBJ6R>_I?(RE0O[M.0 03^FWNWX>M>?
M4SXTS!.L7P9/[^T]]=E;8J([6,38_?>?EIH[?0#["JA*VX"D>]-QZ\.'0_\
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MAMB,[E<# Q>/[.C>F2E 8L-026"9@W-_K[$%COEP" 5CX^A]/MZ$$?+6TO\
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MR^72KCB4H!K=K%A=K:N">. !8?C_  ]VNHDNX_#?"U!Q\NDJ1B,U!/Y]9!&
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M8O)HC =@H4"WLOCD'B4 Q7I-(W2O^*'<^9^.??76O:5%6:(=I[CHVF@#E/\
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4/?NO==@"S>H?3_'^H_P]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>74
<FILENAME>tm212692d3_sch14-aimg074.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg074.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ :(    & @,!
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M2+\VX]N#<(&^&5#_ +8?Y^FFY?F0T<$'YH1UFP?3N2J]K2;ADK)J::EJ:J)
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M&/W\KM^* P;ZVQ<$%XL]M<S:$YO5P4[?51[LIS\NM'UZQ#<F!_NV=X_Q"/\
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M#C*E^.*$]"B.VGLH_'D#! :9P,]7)_!#LW=6[.J<;DJBLJ9Z6=J>,JTCL_A
MM;ZD_I/]?:$Q>&>CRUL1=+K^0/"O'H[/<_4\':N)I9H,E/1POCEH10?;15$=
M4KP)#D/*LI/.I>.#]?9[M\P#"G"AZ*]SM&MHF1_B##RI@\/Y=$T^/7\L7K/I
MW=6:WI1[UAW/M[)Y8[@RNR:O"8LS8[,I/-5F>DG)EJX"E3+(P92A'X]C9)1]
M&YQ\'^3J.CMP?<X9VKI28$XQ\5<]#SU]TO4;+S.\*$5TF8Q.9ERE5C,7D97F
M6C.0DGFIZ>,S&5D-IP !_3W&6ZW12\8CT'G\NI.O7AFV9533_:^5/4]%0_D_
M]R[,^+.=^>%'O3$9$[BH^UMLU4]/30NS4-#78_=E9 @O/ 0E13NK7TC@<>YB
MY3W&D!'$D)YG^'J"Y.1+C<YI94,@19"20@/$DCK:DZO[ Q79NQL%O/"QRQ8O
M-4SSPI4#1*+-I-QK<\-?\^Y5VV8S %>%#_AZB7F?;7V&_DMIO[1=/$4P17-.
M'0GCZ"WTL/\ >O:\\>B4&H!Z[]ZZWT!/84 A[G^/F32PDFK^S-NR'G4U-D-B
M56=*<"UA4;8C//\ 3_'WL<#UH\1UQ^,0*]#=;1L09(<)/!+9M6F:#+9&&9"P
MN"T<L;*?\1[VWQ'KPX=#Q[KUOKWOW7NJP/YP5-6R?!'MZHQ]35T533)@96J:
M*HGIIUA7,TAD'EIWCDTZ ;\_0^PWS1//;;5)-;MIE730_:WSZ'OMO;V]]S7;
MV%\NNQD$FI<BM$)&10C/H<]:0\.V:'L#&]>R9&/7N""#%2XK<+RRQ5'V5*M-
M+)32RHP^[,D"%29-1.KZ^X+M-^WF;<98YYM48D  TKPK\AZ=9 \Y\M[#MFWV
MTNUP>'(X?4=3&M%!'$GSZ,W\/]K0YSL_M_+2QA\CM^HKZ*GJ6+!12Q5.1A$2
MP@^%OVUM<K?GV+=RFE$#%33A_AZBO9Y9/J%!-11O\'1K=M;7P&1W>E7D**GF
M1)6#P3$M"SG4'9H6O&VH_2XX]Q1S!JN&0S9HS4ZR VJ..*SB:(4D>-=1]<='
M@P51C=LTD<F#P<<;P 2TWV>N*,2+9A^U&PC8$@<$'V%S(\1I&:='*P))EQ7I
MOW3!7;FH*RHS<TE5!-33SSQRGQI )XV:6'T:2H4&UA:WM7!-+(:.:C'ETS-%
MX(K'CC_+AU0E\O(QE,M6TM!H^TP\=3%#XS^W&J HJO:XF-HP 7N>/9W:P1HX
MD04?/1%?W%S-"8)&K%48H/\ B^K@OY6F2FJ>G*&G>D^X:FTA6TFP*W%](L"?
M3_3V_(FKCT96%Q/!"0AIVC^0ZN#P&66.EJ!5Q-3,OD$LBQ)(?'=@@6.2Z(0O
MY6Q/MCQ9HC^F:'HIW.:>9R)#48Z[FJ<;%3-403-+]PQCC_8BIR)7)56;PZ?)
M9O\ 57O[4Q;QN>H0F3]-C0B@X>G#IN#;[9XVD=>\+7B>/3!E109,TL;QVJX]
M-3YXG:!A4497[=R8F34$/U4^EOR#[2[E!"[F1E[\9Z=D18]N"I@:O\O5$&ZZ
M.LVM\NODCB8V_P CWGL:GW?EJ:G1(Q75&TMM)2TL[^-597ACKF'IL&N2;GV;
M;'N6X12B**2D9=12@X?LZ6[.(HMONG(.O2"/MTGK;<^(NW9ML_'OK'%U09*F
M3!PY(ARQ/@KPE:BG5R+1SJ/>0W+$T[0H)CWT8G ]<=8D^YLRWO,%Q*K!X@8Q
M7YA/EZ&O1IQ]!_K#V*3T"E^$?9UW[]UOH&>QG_XR-\?8UF$;MO\ W=*T9N#/
M!'T]V,CQBP(.F::-[&WZ;_CWL<#UKID^,\VCK*7",W[^U-^=E[9G0_JA./WW
MGYJ:-@+!1]A5PLH_",/>VX]>7AT8'W7K?7O?NO=%[^4G4M#WIT7V+U=7A_#N
M3!3Q1E%#,U5"K3TD<8/!D>HB4 ?X^R??+8W.W21#SI_(]"3E3<1M6^0WS E5
MU#]H(K]@K7KY_G>&&KNJ>RL'T%1Q2TFY]E9./'2TSKX\AX*.6*FJ1)'_ ,VX
MJ9M7N"VV]K>_D<@T,GIZ'K(W<]S3==LA"E3IC)P2>*_/HZ_PAV?74]-WYNJO
MIIZ&BI<CD8AD:B,QTU3,:ZO01K)8AG9V' _K[$%VNNU/VC_#U&%DWA7JJ?X3
M_@Z66/\ NXJVDR8+Q&OJY!%&18M'&RE9%'^I</<>XPWA*O3T9NI[Y=N5EM57
M%5C3JP7K+;68SM-C3%>17">0Z0P7A?U>GV%Y4-3]G0PB9* U'1?OG5V[5]'[
M(&'VYBY:_+Y:5Z65J9"[H9F2%GL"-*@RD_[#VIM(\^?ETFNG33DC@>JG]Q=1
M9?>FPUSU7D?%6Y^G^\J(Y&42P2/%Y?$P*W4L9B+?X>Q/:Q$D#/GT'I"K-3'5
MT'\M/8S;2ZUI,:E5#4U 91.JD%HQZKE@%X^I_P!M[5O;_;T\DJJ*$CJT+*8^
MMQ%4DE#)32M7A%$4UM+, %8* C?EO:.6V(SGI,[).Q;(/26Q>[*2MSU5M3<R
M4./J(D9J1M7CUS%=46D$+>[$'VE6#2X8UQGJQDT1$(14X_+SZR;GQG\)H6K*
M8Z]*3 RCD)KY2Y_VH>T5_)1SZXZTOZD(B^=>J[=C=(1;_P#FQD:VNCDJL?N/
M;2;5K)T35%%!FJ*@@G#-8 $!#_MO8EY7LS<7"@5S(G\^B3==R7:;"=GI0QL:
M5H30>7KUM [>Q,.W\!A,/3H?#AL=0XB$@!0*>CIHJ56LMA;1"/>1FV0^ JDC
M(!'6(6^7'BN\M>UY-7[:]*T?0?ZP]G725?A'V==^_=;Z 3?<YJ^]^AL1&Y)H
M*'M3==2@/TBI=NX[;5.[C_4M+N=P#_4?Z_NP^$]:\^F/I6H&&[([QV4[!$J\
M]M_L_$1$6UT6],+%C,LT5_U+#N':\^NW"M*/Z^]MY'KPXD=&7]TZWU[W[KW4
M2H8+^I=:@!F'^"\C_"]Q[U)$98M(IQ\^MO*((3,:X]..>M1'^==\*<)0=V?[
M,AMNL?#Y*NQD%;311JJ+6YQ3)452L55KAWG75_@?<5<PV*P7 90.YV/^7J:^
M1=RDW/;9%DX1PJ!]F:?[/0L[,K8,9_+\VAF8L?C8MQ;LI<7)NJHIT =\JZ8V
M:L5SH!+?<SM]>>?:!1XEH3_2Z+IV,6Z!!PT?Y.BF!Z"N;:L-, *A?V94!^DL
M:0J]A<F]_<:;LOZ[?)VZE;EB_(B*DGX$]/GU:9U=+C=M[)IYYW1*TPA@#8-?
M2I'Y_/L-2H*_/H<Q;@:<33\NJ[OEN:'="2I53"JD:KEE1)50E-<JL A U<?C
MVIM$%?S'26ZOV*^? ^G5=.:^.TG8-5CJ2BR6?QDK1-%$U+*XID+K&JC29--K
M_3T^Q781 R 8X'HD6^U34JW#Y=6E?#WHKLSH'%"&IW/+DJ6L16AAJ68RA7#%
M0?V1R!)_7V:/ /ETDFW)D?.JE3Z=6%44V<:>EKZ^O=L@TI\=(3Z556 5@+ V
M<6/M%) OH.EUM?&1 37/3YO1*;<%+3UE%"E-G\,B5]7,@]<T5(%D92>3ZT3V
MAFA 1FQ@'IB2_/CHE3W-3R]>I.0W?25FUM3Z7_R3]P7O:6..Q_/!U7]@O<)/
MU&&?+H0[>-=SX?E0]"]\7-E;>RN]<'NF"F4U]1#45,KZ1Z6Q\T445R"3^GW+
M?(5J)I=6,21_X#U%WN=>M90I$IH)(91\N('5HS64-]+,XT@?3BX;_>?<^+$L
M2?GUC3>OJB'K4=. ^@_UA_O7MWIQ?A'V==^_=;Z+5B*M=P?)[>&2NIHNOMA;
M:V%!)J!C_CNZIZW>.8C6Y],RXV/%JP'/J4?7W>G9\^M>?26W%6KLKMGJSL-C
MX<9EZBMZ?W;, -"4>[YXLELRLJ'8A8X:/>..6FUFP09 \\V][(J.O>?1OO;?
M6^O>_=>Z@54#RMJUZ41;A5^KD_4/<6L/Q;\^Z?4/%)I5013K4L2W,!MG)"L1
MD<>J_P#Y_?%O+_)?K7!TFV((*G<6UI,O4TF.J-:TV3.2HZ6F6&=HD:6]+]OJ
MCM;U'GCV2[ILT6Y@22,RD$G%//RST*^6]_GY966&W5)(Y$"]]< 5R*>9KU4G
M6],[[Z5^%4O7W9VVJC%;EI.PJVJ@%,2X6@3*8UXXP*B4,(Q'$1P/I[!.X68V
M^(QQ$L!0Y^9Z/+'<#NM\L\P5#I(Q\A\^JS=E[II&[%H*261D%/N.LA-.Y "P
MRU*QQFUSZK?CZ>XIWE"LNJGQ.U?EU+NRVT,,6M6)U*O5J.5Q>=#4]2"8=M08
MJ&K6HC+>5R(#(R,I_;TC2![)1;QN>]B#T(XR_P"$5ZIH^0OR=3']EP;:SVV-
MW)C!7M34^06FQQHY8$J$CCF5A5B0PNG()6]O:J*W@CRKDMCIXVCS#]34H_S]
M'.Z$WYLW<>6VYB,'!)D\G7- T..H4A.3\=XO+,15/%3".G#7?UWM] ?9C%=M
M;'6@!IZ]7BV* 2AS(]?RZMP3:4&-I3ELQ2OBZ;&425#U.4EIUA5%B$AN*2>8
MZP$^EK>S%-PFD^)%'^ST3S[1:RR525B Q_P]%,[0^3FS*."JGV/BL]OW)T%3
M%10TFTH:>6L-2C-#4"45]310B&*6.RD&^GZ\^[23$YH.C>RV: 1CO?S].EEU
MKNS=&X7H:[/[;S6TQFZ _P"3;B2GCK 9HD"Q.M'/51!6UV/-[>RYIS+((6 "
M.:$^E>D%[M44+B='<NA+ 8R1FG2QRN(;;.VVI:J8SUN1RDVE&/[4<514RF((
M19M)1Q[*KW8K=[IE21R*#T].E=CN,D %ZRJ)#44/#JT3XI]4U&T-JTN>RDK?
M?UT&NFIE \4--4ZI+W90^IP5/!]SOR9R[#M\!G5W).@Y \EZQ_\ <3F63?+M
M+=T1/!UK5:^; ^?V=&U^U%E!9O26_I_:;5_O'N0BQ<Z6&*UZBZ2%3$(ZF@->
MI@X ']/=NG@*"G3;F,MC\!B,IG<M4I1XO"XZMRN2JY#:.FH,=325=74/_M,-
M/"S'_ >_=;Z(7CI]U8KI7/=HTE),-Y;DW-%W[E,99_NGQ5/NC"[LAVP5U>0N
MG7F!AH E^&8BW)'MWY=5\OGT..]=J4.^=J;BVAD9'@I<_CIZ):R(E9\=6J5J
M,7E:5U]4=7B<G##4Q,.0\0]ZZV<]+;I#?M;OS8U.^X%CIM\[5K:G9G86.0_\
M ]X8 1T^0GC&E/\ (<U"T60I6 TM2U4=B>?=&%#\NO U&>/0O^]=;ZCS![@H
M;'@D'Z,!^/?A&I;6>FB^F2F>L+VT^4.T?T!5;<DG]/T/-S[=I3MH#CIYI.T$
MUZJ\_F?%<7T_39J&AJI)I:R2E<?M: QDI$65AK'J9GO[!/,-NNEL#@O^'H1<
MO7+?4JM33N_P=:?V2W<V!WPN?NT;4.<D>LC!]7HJ04) )N"P//N(=XM58\!@
MMU..V716&,9RJ]7D;/[?BWETI0Y4,AICCQ32DLMR%A1"#SJ^C?3V +^5[<FE
M1@?SZD/:(DN*:@#6O'Y=5C]V8>+-LV9QE*^5AIJEUD,].C+ $D%TC*()"B <
M?7CVDM;^1WH2U*CH3O8QJE0%X?X.C*?&C8^W=Q4V+FGV[B:QXPAJA(<A3311
M*$\TJ/#-3N&B ) O8G^OL2U!@U?/HJ;MEQZ=6.8#8?6K_<4JX+-R8L:%J)$J
MIY*9G 8&*T]:TACO<?3Z>UEM_FZ([IRL@]*GH2/[B[-Q,^G9FV:/ "6GI&:6
MF@#5DI$0+2L:AZB -*3?\?7VME^'Y]&5E(?" /SZ>*B*E6G<U51/331TLE/)
M-E4A#NC)I84WVB,@D-O3>W/LGE8HX;-0>D-XVIP#P)/2(Q>+?M+?.U\%BY'F
MH_XC14\S6)"_;3PPN[<7 X)O[.]GMGO[D,<ZE/&OE]G09WR_CVVS/$*C XZO
M'P5%%AL708J$C_(*&BIG5?[)AIHX_P#6]6@GWD=MMJ+>U5,? O\ (=8L[Q?-
M-=M,:]S,?RKCI]1M0_V_M8P"FO2.*3Q5ZR^Z]/\ 18OD#DQNRNVOT503/KWJ
MXW'V#) 2&QO5NW:V"3)4T[CF&3>N86'$PCZR0O5$?YL^[*//K1].E@-'*^*/
MQ:/'X- \/AL$\'C_ $^'Q^G3]-/'NW7NNC]3_KG_ 'OW[KW00[BR,W46^(NY
M*17.SLU3XW;7=5#"KN*7%TCM!MGLV.&,,SS[0>H-+DRJEGQ,WD-S3+[\144\
M^M<,]''@GAJ88:FFFBJ*>HBCG@G@D26&>&5!)%-#+&622*1&#*RD@@W'MOJW
M7(CU _X>]:P#I\^FRE7U=='Z-_7\7^E^;7_V/NQ-!4>G3C+J '52G\UW<M-C
M^DZ;$K74\U6*FNK:^F60-)!3 4DD;.HY124:WYX]@WF&X72U2*T7_#T(>7;=
MOJE;-.[_  =::6YLA2_>5>5U UE6M4P%[WH2K&@-OI<JQ_Q]QI,5G9QZ$_SZ
MF$5@A@/J!QZ'[J3O*JINN%VB9=+C(2MH+L#I,T9O]; 67V"MUVQY"0H;@/3H
M<['N:1%=149;C7H^W2T]!NG&2)6M%Z4LP8*03I-SR#];>PY'MLD+ZJ-2OR\N
MA]'N23(*%2-/S\^C/;/. P$K)3M&)-8C 2POJ.GZ*!P/9PC?IZ/.O2&Y6B^)
MY8Z-ML[(#PQ,Z@0.%YT@<$"W^]^S.VQ]N.@E=25D'VG_  ]"E59#'!*2B@AU
M&82&>4#Z<KH%^/PWM<_P]&=E)V#\^@SWO7_PC"5,^0'GC60K04:W,E3(2WBB
M4#DF1K <_GV5B/Q;A(A6K/3]IZ+=RN!$AE)%%!/[.CJ?$3I5-NX-.QMP8Z6#
M,9M&FHJ9U4/3TCF3QW0DZ69"I'N:N4>73#$DSAZT89IZ]0)SIS.LTC0(R:#I
MJ17TX='L2,%2R<(>57C@GEK_ .)/N20ZI1#QX=1;(AFJXX#K+&-/^\^V;IJ1
MU^?5[52K4/ITF]];VP'76T\SO+<M2U-B<+2^>584,U96U,KI3T&+QM*G[E9E
M,K72QT]-"EVEGD51]?=E[J4Z5G''HN/7&!ST?]X-_P"^($@[$[(JZ;*YZB61
M9X]JX.CC>+:FP:*=?2U/MG'2G[EE $^1FJ)3?4#[<X8ZT/GQZ$T?0_ZW_$CW
M[KW7C]3_ *Y_WOW[KW6.2**>*6"HABJ*>>*6"HIYXUF@J*>=&BG@GB<%)89H
MG*NI!#*2#[]U[H+MA;EEZ(S..ZZW)//+U!N#("BZQW55.TJ=?Y.L=FAZQW56
M2,3%@YI25V_7RG2JD4,K!D@+:(KD<>O<,>71MIZR.&7QDGTJ'E8#B)6)"%OZ
MZV%A:_M(REIQ0^73R(6'0,]G?(CJ7IV?%T/8.[\9@<QGONC@,-4RG^(9<4D*
MU$QIHXT?2HB<-=](]F$5I),*(1I R>DEW=1VJ@N"2?\ )UI@]Z?+/L7?WR ^
M6.T>PLF\VVZS=NX:[K,%W\"[2KLUE6PN.36[!ZJFQRHKLMD)/''N.><+:6PA
M>21M0 3A\S3H:<DW,.Z7<<42E2=?&GX17RZK6=9:Z(^4E:RA:HB\; WJ**%;
M4L$5A82PJ"&)X-^/<3[5NL=[=7$(5E,;4-:9R1CJ?]RY8N(["UF$L9#)7 ->
M /0>0[IKL3D7JZ1)8!%,4;',0*@LKZ?("#X])^OLUE2)UJ5!Z(56:Q:K-6GI
M\^K&?CIWYMX4XQU17-05K1*)142*/WBA#+8"]PWL-7B1J3I7UZ$VV;R :-J/
MP^8ZLDZ?J:+<V23(25\<E&A)9M=]18G01]?K;V41(SS:1PIT+6OH[FW\)5(<
MGCCRZL6P*8<T-+'#7P*%1!H]6HV"\7MI]FUNI!(^8Z"\R&24A3A2>EC7Y+$X
M6*EEGG@CIS>36\B:F6+2750#]7_''MG<-TCL@0ZLQ%.%//HPL"2X@'Q4)KTH
MNC=O8?N+N/S548K-M;<AI:Z*BDLX:MBBCFB=S;08Q+&;CZV/L[Y8VUMXOXIU
M(6..1"0>)KG_ (OH"\^;R=GLC"@K+,K@'R X'YUSCRZMCBHI8*6.F@^WB6 >
M.!$1UACB7TQH%!OP@'O)"RCCMHQ&XJ!7A\S\^L9[])[IRT34!I\7K3/#Y]38
MX2@ N+D#5:]KVYM?FQ/MJ>-Y)%>,T4'IV)-":6R2.H.8RN+V_B\CG,YD:/$8
M;$T=1D,GD\A41TM#045+&TU15553,RQ0P0Q*69B0 ![W)&\D6BO=7K:J%?4.
M%.BBT-9D>\-SXGLG.T=7CNM-LU/W_46TLG32TE9GLGH>).U]T8ZH5)8&,#LN
M HIEUT\#FKD599$6-2JZ!3SZ]QST,'O?6^NQ]#_K?\2/?NO=>/U/^N?][]^Z
M]UU[]U[INR^(Q6X,5D<%G<=1Y?"Y>CFH,IB\A"M115]%4+IFIZB%^&1AR"+,
MK ,I# $>Z]\N@0R/86[_ (S[9R\^X<;NGM7J#;>'KZ_;>3Q,4^<[!V>*"CDE
MH=J[OI$62LW7ME)(UCHLO&K5=*"$JU=0)O=&6K:Q\76@S(?Z/6A;7?/_ +5^
M='\POM[M#?'\3CV[L*HSNWNN]E9,34]9L_'ROF*#1644[*U+/%0L@MI6Y3Z6
MM[-+&0:2M*&@Z#V\2D*/0%O\'0V=BX^#L5L1G8I?%GL%_#<8S _N9%(Y(Z9Y
M&(!+:E!/X^OL*\Y;>UU:N "<)P(\CT9<A[RMIN$52HIXGD?-3TXXKJM,E!75
M4:@9:CG61(+<L&E/W(L!_91>>?>-&Z1-L-V\CX$TC?%G@:XI]O6:_+E^F_;>
MD:$'PH4^&HXCSKT%_972M3#60[JQL7I$"QUL04V69%TN2!:WJ8^[V>]12'2S
M+Y^1Z1;OLLE"RJQ^'S'0*56RZ^1%R&W()HJR.2T[(IL9E(U'BQ_5[.6,,L>H
M$TIT$XX;B"6A7&H?RZ/9T%D>_-MXVGJ<;BY,A B*QAJ(Y9(W73<DA)4)*CZ>
MRAA&LO:<TZ%^W.ZD,P &>CD4?RG[?@$&";9M)2UMA'YS2U ]0"K?_@3?Z^VX
MY K'[>K0U>62G\7^7I>8_)]N[PK,3E-RY,4E%-D:&F?'P>9(XXYI50$(\CF\
MBBY]AW?) [L!_1_P=&EC%2['^E/5[GP$P%)2KOBLI6#3T4FWJ:1C<L144M3Y
M.;#GT>Y@]NK=BID'D8O\'4-^ZTJ![:-O,24_(CJS/W-O4(])'>^_-I=<X&HW
M+O+-4N%Q,#QP))/KEJJZMG.BEQF*H*=9:[*Y6LD],--3QR32MPJGWL GAU[A
MT5ZLH=S]X9&CSO96)J-L];8VLI\GM+J*N*')9RKI)5GQ^Y^V%A>2G=X)8UFH
M\ K/!3OI>K,LRJD=QCAQZKQX]#"26))-R?\ ??[ #W[K?77OW7NNQ]#_ *W_
M !(]^Z]UX_4_ZY_WOW[KW77OW7NO>_=>Z[!(^GY!!'U!4BS*P/#*P-B#P1[]
MU[JI/Y9?RA_C]WSN_)]U=64&,Z0[_KZ&>ER>ZMO8]*7;F^(FBE2*DWEB:&./
MRLCS,R3Q@E'8G3[=CE:-JCI'>6,-Y'H?#4-"/*O5'O;GPV[J^.<4T/8VSJVF
M:@$?V.Z\5!+D=L9<P-Q54.9I4DI4>2U_'*8Y0>"M_9C(MIN4)C8HLA(PP]#Z
M^?0/AV[<]FO%E4-);@-W)\QYCB.N^LHZ7(_P[*4E-!/6>(#,(R RZIXPK2R
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L^*>_=>Z]8?U'^\_\4]^Z]UZP_J/]Y_XI[]U[KL 6;U#Z?X_U'^'OW7NO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>75
<FILENAME>tm212692d3_sch14-aimg075.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg075.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ :(    & @,!
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MJB9GFK]V=4TY]2(CDRUNWU/@J%U/1B.;]N2X-<'CU7AD<.EWA<UB-QXC'9_
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M1P;*[.Q6VBA:TDW4V9W/@-[4=*&_M1OL.OK,=_2T!7VY7%?EU6AI3Y]#/T'
M,EN#O#>C@E\OV9+M.C8\C^#]=X7'8"!8W^AB_C$E>UAP&8_F_NK=;'KT9'W7
MK?7O?NO=1)78.1X2\>@:F479M5P%5?[5OS_3W=>''/6R#I^756G\VR@B?XI3
M[JIW\-3M#?.T7@$A\;6K=S8:EJ$%B;1>-?6?]3[(M[C\2$'S[O\ !T=[))2?
M3_I?\/6MSG*_N]^PJ?&[!SN"P&%W0]9G<S64+05++CZM'K%^V=J-?)4Z=7IU
M+8D<^XO9-$X^SJ;=NA\:''#4>F3&]![KS&8RE?5[X["W\)LE5B.AKX*O"T&/
M:LE*$T[4&2F6H6?58AD 4+Q[.U?5&H] .ED5F8G9A2I/KT>?XQ]1939F^Z])
MZ',87'C 0)5Q_P 6RC&61*.I$A19)4#W8\?U][Z-+?4E*_/HO&]^LSE/D?F)
MZZGH9,36Q208VLR4,51D(JG]]4_;J(I/2)'7U:R??L?GT;1@2"G1@#UMNZEP
ML&+R.)K,A0T@G\&0H9JJ%$1PO@B%-3A('5P@O_0>V9W\*/7\^E$=@FJM!^WK
M'A>C<=3XW*[EW%LG'U4L],:?S2RR+D/"J2(O[/@NS:#]"WLBN;QO7U\ND,VT
M))*"%''U/KT7#LUHXZ.<QT,]-30)'0I12S34R0P4Z^"G*1*=#7C0?CGV@2\<
MMQ/[.C>#;DCA&!2I\^B$;US.6P4.XJF+*5T%!087(Y2:EH));24]-3&>2+QQ
MR1BH=EXT-PWT/LW2\81%@3P].@;N.TI)=(2 >\^9]>CF_ JBV%5?([XX=H;(
MJ5AR^<W+MK#YV5Z>&EK'>JRF-IFBF2.20D (P-SQ[7;1N,KRKW8SY#K?,&VQ
MP<LNVD8;U)]>MXJGDUHWUN/2=0LQ(N"Q'X#$7']1[DJRG:2M?4=8Q$ .U/7K
M.390?\?^*^S.E3UX"IZY^Z]5Z][]U[HN)IUP'RE61!XZ;L;J45,O/$^<Z\SL
ME(T@'T\G\%W?$I_)6(?TXM^'K7XNG+XRQ?\ &'\+D"/W,]G]^[AF-B"SYK?F
MY*Y&:_)8PRISR/Z&UO?FX]>'#H?/=>M]>]^Z]U&D9UE!52P( ('/%_K_ +"_
MNE?U ORZ<%/#SQKT!?R-ZIQO<_3^^>N\C##/_%\;4U5!%*JM?)T2-5X\@%3Z
MC5Q)8\^TU_$'@^=#_@Z5[9*8[L'.G4M?V]:S6S]C;EQ=?D]CY6EQ]#N#9CMM
M^JJ'C3RH](ST,BEGI]5KQ$>XIO5T3_D.LB^74$D0\P6;HQ6S.LZ[&Q25.8RM
M.M%B(I,C*].L2:VTM*HD98XM0O'Q<^U-JU1]@'0TAV\2 GT'H.E=U;NB'<^X
M\E6M1O)113OC*:<719_&SPBS(PU7U#\_GVKIT775MX7\O*G08?)C";*I,OA$
MK,CCL%G*NJ58)6J5@D%Y80BNUU.H:A_7W[CTGAETMI\JCH!,?\J1U1O&GV9G
M8FS>WO'HGSR,*NEIY6 2F5Y&8(/(U[7_ *>TUT"82/F.CZUE#-Y>?0][G[SV
M548)LI39)*FFK:;4D4 B*0M)'J 8*X TEO\ 'V&;I"/7SZ-XHPV<>75=N^-]
MX?<=?68YJF-ON)&E5O0/VR2T8L&^JJWM$B'4.KS41-/SZ /<&W<91O3Y69H9
MJ"6>.EJS-I>%J65M$RRAKJ8M -P?Q[.(XRRE?4=!FZ4%M>,5/5CGP2Z8QF1[
M^ZMV_M$T+PXVJB[!FJ*5$\<$>*K*/)F-&6,A;":UN/I[.=JLFUK2M<^70>YI
MOHX^7"ST*"05SQXXZVV:0V 0F[@1J[?U(6UQ[DVR@T*2>./\'6)YN$DNGTX'
MB'_#CJ;(0JCGZ'_BOM>N3TN3+=9!]!_K#W0]-GCUW[]U[H"NP83#W-\?<D@L
M\N0[+V]*P!]5/D-B56<*&P(L*C;$9%R!_L3[L.!ZT>(ZX?&)2G0W6T;$%X<+
M/3RV;4%FI\MD8)DU#ZF.6,J?\1[\WQ'KPX=#Q[KUOKWOW7NL,EU;4.#8?[W_
M $/'ML"LX]*=.ID4/#KBP5EU,H8@7Y'^'/\ M_=YE4HU?('JA)1J+@$YZU_?
ME.,'U-\F-^5#B#&8S<.'PF>>F8AQ/E\I4U]165>N:[J9Y64Z0= _ 'N'N8?$
MBG9HS0Z5_GUDM[=/'<;=%XO<P9Q^P=5__*3Y7SX[9K[6VY7)1Y7+Q)1T;TBQ
M&IG:JT1 QK8Z_$)+^T6R7$LK2"4UH!Z=2#-)+"2+<Z0:_LZ*]09GY1;<AV-5
M;*S*4VU<;ASFMT1UJHLF0RCT<-6'DE^SFDC85,).E64<V^GL2H%/$=$=V;B2
MI9AY=5L_*CL#Y._*+?V'P.(@W;2R8?*(*S+T5/-3TT,:547F:*6 *K0A8259
MA>PO[6)#%YCH-SM>(Q*. ,^G1G>G>@]T]?[(J:W?>[*G,Y#*U#)45>=JG*TL
M2,PA]3 Z9(5E.GCU$<^]RVMN8\KY^IZ]87^Y+=!6DJE#Y#_-TJJ+>.Z]I&BV
M[CJRBW1@,MD6I?NJ"05M?'JG$:PB$Q+&H DM<&_'L.WMM ."^OKT+;?<+SS?
MT\ATF<]@]QX[LO$X[*P5E"V3H,E5K1U$?AD$82&2AD9?JMXY;V!L?S[(&CTM
MV\.E$]]<,N6S]@ZP;GW&^(I,A@Z^J60P6J(8Y GI<*TBGZ M9C]#Q[76YDU
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MJPRU1#._UNH5KGV*K"V4RI4#XEZ 6XW1T.*G@W6T)\#_ .9M\I]E?&3>N_\
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M^WK?BT].A6ZHP.]=_P"]-M]>==PY7,Y[=V3I,+B,9BO+]Y+7U<J0EAXM++%
MSEG/T ']3[42QVL$)GE)"**G_-]IZ\DC2.$0 L3U]'+^7]\2J?X>_';:?7F1
MKZK/=@Y#'T64["W%D*AZRMGR\D)ECPD53(\A7'8,U#HB*='E9R/K[ =S.UQ,
M93@$X'H/+H0Q1B) @Z.\/H?];_B1[8Z<Z\?J?]<_[W[]U[K@R)(CQRQQRQ2H
M\4L,J+)%-%*ICEBEC8%9(I8V*LI!#*2#[]U[K2W_ )W?\IO,]39_-_+#XZX&
MLR/5^X*N6O[&V3B8)*B?9&7G8RSY;'T\>MSA:IKMI ]/(_4!J%VP[V(5%E=5
MI^!O^?3_ )/V=!O=]J:1C<VQH3\0_P H_P O6KG-F)B':005( )C9PS$+R H
M]0X'LWOY))9]:$JND<>BVU5H8M#T9JUZ8Z:ODR%1+$X2)5#:/'<*&%]/U)X!
M ]HJ3_QYZ4^(OITJZ2FB6C854BO-H^J<"]OZ-<^_4F_CZ]XB^G0?UT$T54SI
M(J,\B)"Y#>A2]I0?ZZD/X]ZTW'B(=> W^7IQ9$,;@C\/^?JXK^75UMO?O;%X
MC:NS\E#B=V]$;FRW8^UL@$EDE,62JZ?+YB*F6(F1):BGP:J&X6Y!/'N0MKN;
M?P DR:CJ/IU'V[Q4F+1C2=*CK92^4'3'8?=7PBW;DMRTN/R&\MN;<J-X4U;D
M(GDS$TN&QLV7GIH)%F4">I:E"H2+!B+\>P=S1MEO<C7$JK\9X>O0TY,W.]M9
M@KR/HU1XK3 /#JCKXP9C:?9^%I,;D,NHW1%2T..R.%,BM7T%30Q>"85/H*E*
M>0$.!_0^X@;E>?=+OZ&%T1BM:E6(Q]G62!YPV[;]H^JN87D(DIAEKD_/HQ>X
M\+'LA,CBMG".GSTT++)FU4^",.KC5$JVF647^IN+^YFY.Y!EM6!G>%_[/\+#
MAQX^O6.O/7.[WA_Q/Q8E_5QJ7@> QZ=*OX<=_P#=?QN[+H,-NC?>;WGUMO::
MO@S6"R,SR5%"<A*H?)4+Z(H(Z/'&I=F5@SE; <^Y=NMELX;:FF.H8</MZAJU
MWN>6X_Q@R.=)Z0'\]_Y?XO>U;LOXY[ J:67:>U<?@=X[BJ,?(=-5D<M1X_/8
MF&92W,L8GD5[K^J_T]Q#O-L5N!H90-38_/J3-KO#*%T!@.VO[.M;W'U4]8\I
MK2LE,]_%''<,I-^6+7''^'LI",//H4%T)I3KA+2-"Y>+G4U] !)(_ O].![=
M44X]-,">E9BJ=C-CZ22&>?(9:K@H,5C*2&2LR&1K:F41T])1TE,LDTU1,YL
M!_K\>W#(B+J;"CB3TT8V8@ U)ZW;?Y)W\J5?C7MG&_)SOK;]..\-W8U:K9NV
M:V-9_P#1W@J\>:&KFC<%(L_5PL#]-4=]7%E ">Y;B]VWAH3].IQ\_F?\G1W8
MV?TZZWS,?Y?+K8E]E71AUV/H?];_ (D>_=>Z\?J?]<_[W[]U[KKW[KW4#*XK
M%YW&9#"9O'4>7PV7HY\?E,7D($JJ'(4-2ACGI:JGD!26*1#_ *X/(L0#[]U[
MK3,_FX_R%=Q;4K=S_([X586?.[1J#4YK>O3%&IERV!D:3S5F1VH@YJZ$ZF<Q
M?46-['DGMCNE*0W9JO -Z?(_+HGO-NU5EM^/F/\ -UJL'!5^(JJBDR-%58W)
M4=0]-74%=!+25M'4Q-HFIZNFG1)8)HWX*L ?9^&! (-5/1*05-#QZ<A35)!<
M7TCD_P"M_K^[5ZUTU5L<524C(LT2S.S?XJEP?]N/;\$>LD^G2VS90'#&E1U=
ME_(KWU-LKYV;5P$M:C8?L;KO=6%\#D^-\A'M:MIXB5)L2*BL7V9I,(P$)H :
M]$NY6JR$D5K0=;GV*VC/O#;F06I$M1C\3E,MMC-X?Z1UF.AE^PJO0PT%)*<.
M!>XL?:IPMT0A/<WY<>B..5K)]0I2OG\NJ!*WX(;?Z4[>WWO+8/7-9C,CN3<>
MY*VER 6F\$%'E,C5311!8D23]R*< ?CCV8['RXL>XK<OKTZ6%:CCU;=>:9FV
MXP#P_C!X'UZ7.T/CGO+<;9)\O3/!,TXLTB-^@M)].3]!['1:"S4D'R\_ET"'
MEEOFR!GT^?1ALU\<=D=7["S?9N^TBGHME;6R>XIF*"[4^*H3655 "R-ZZY8=
M(_!M["^\;Z"I5"O%?(]'>U[)5P[!N!\QUI?]V;P;?79.^]RQ5$U0F7S]75T<
MDKZ_+@JFIGDPM*AL+KA\<R0D?1;<<>XNN[F66Y4T&G6?\/4E6=K'##Q-=(_P
M=(+$Q>D<#VJ\^GNA,V#L#>?9F\<+L?K_ &MEMX;LSU1'1XO#8:CEK:J2:>18
MHWD$*,*>!7;EWLH_U_;<LJ0H9)" @ZLBL[:4%3UN8_RF_P"1WMKXQU6+^1'R
MF@HM^]]U,<=?M?9M='%D-M=6I*I:(K!,C1U&?1""S&Y5_P!7T"@+WVX/='0E
M1!Z>OV]'%M:"'N;,G6QR26))-R?9;TLZZ]^Z]UV/H?\ 6_XD>_=>Z\?J?]<_
M[W[]U[KKW[KW7O?NO==@D&X_Q'^N"+$$?0@@V(^A'OW6^J;/GW_)8^,WS1CR
M.\=O45-TUW3*DLT6\-M444&%SE61=!N3#T\8BDUN.9(U/)OIOS[66U]/:FB&
ML?H>'Y>G22XLX;@584?UZT[_ )<_RI?F=\.JZO;>G763WCL6!Y/LNP]@TU3G
M<%54H:T<M7#2QR5-#*5(U*P-C[$-ON5M.*$Z)/0_Y#T1SV%Q":@:D]1_FZK$
M\ %14Q2Q%)D/CFBF0QRI>ZLDL4@61"?Z$ ^SJV=4#'U'1>YD7X-0^SJPW^61
MF*;;?S3Z R$C"&2/>N%Q--*+*T29O+8VAG@C:_I2K1]##\CCW223NQPITV2S
M?%6GSZ^AK6U%!MO<?8"X+[E(Q33UDM$-2TBULR5LE1*D>A%O)(+D_FWLYVPJ
MY4S"I!7HJNK<.#2GGT5%LIN/>V5\4PED1)H[(02H6)SIM?BR@>QI<[A'9V!F
MC%&UC@0#D]!ZXVOQ:J::<>1Z,)M3J+'0KDLCD")FJ<>%BIF74L<YA?\ <5-)
MLX<@W_K["EUOLLHHK/FOXAY]*;3:XXR*A?+RZI+_ )V_=4?2WQJ3JW"9&2+<
M?968Q\,J4TWCK$PU'.\.2HI;684=;35P#J19E'LBEF>9JL2?MZ$D"K$**!^7
M6F+3X^;-Y6AQ.$HLEE<U-)XJ+#8>CJ<A5G6P%1!#24D4TNFJ8>H6L?;#10JI
MD?0*#B>EL<LK.(UU9/5V'PK_ )'/RX^3<V*W+OC!MT-U;4-#//GMXT\E/N#(
M4A-W7$8!HS.\CQ_I9@0+_C\DESNT,7;!WR?R_P!GH^AL9'S)VK_/K<6^&/\
M+K^-?P>V]#1]6;5AR>]IZ=8\YV7N*""MW1DY2/W323.CC%4[D\+$==N-5N/8
M?GN9KEM<I)^7D/RZ-(H8X11!_GZ/;[8Z<Z][]U[KWOW7NNQ]#_K?\2/?NO==
ML!<^H?4_U_K_ *WOW7NNK#^H_P!Y_P"*>_=>Z]8?U'^\_P#%/?NO=>L/ZC_>
M?^*>_=>Z]8?U'^\_\4]^Z]U#R8QG\+KOXX<9_!/"_P#$OXW]I_!_M])U_?\
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-ZA]/\?ZC_#W[KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>76
<FILENAME>tm212692d3_sch14-aimg076.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg076.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ E@"6 P$1  (1 0,1 ?_$ :(    & @,!
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M=]T]1/M3/TF5DH3HR>-_?H<YAYAPT&:P&0CI<SB9D;@B>!.?H3[OUKI6W/\
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M#8U<3Y="OL3MG:G\;DP>9BI=F9NF82I_$"*-Y$0DNE/I+Z_I9K@?4>TV^[?
M^WL%4:M2^9Z5[3NZ_6C26KI/D.C@8[O:7$;7R69BP6ZLMA<>GB_B>-QL-32R
M'3(JO#*]3&&3]N]^/8 6P E (''U/KU)%OO#"$Y;X1Y#TZ*)VC\C,+FJ:;'Y
MW/'%Q5=)49#[2:J>FR-/1I'Y[5$$4@6-VB<:0&-_8ZV?EZ*XC4E5SJXD] WF
M#>Y0S49OP^0Z*O1P?';<1KZFHWQ0UN1C%.13SYFL,WGK4,E,JQ_<,C$$68'@
M'V;3\O6]NNO2M0"?B/ET$%WR>1_#U-W&G =%S^2<6T,7A<[%@WEIZ:KVO74L
M<TG^:DFDH1&&5O(]T+GZ_P!/9CLL$6H&F=+=$&_SRE2*_B7JQG_A+O\ RM]Q
M=D]Z9WYM=K[<JL1L[JC*T5+U[3;@AJ:7)YG<%0TU=29G$TGC:DJ,90U6(]<K
M2!@76RFYM*EH%6, #-!_@ZA'=68RFO\ 2_P]?0X"OI+:4$EFLH)T'FZZC:]_
M]A[M.32@]>BE!FOGU(%["]KV%[?2_P";?X>W!PZOUW[WU[HN;P_P'Y20N@\=
M+V+U,\\@_$^<Z]SKTQE_Y:'"[P1?ZZ8A[M^'K7GTX?&:+_C#^$KR+29W/;\W
M#,>;N^:WWN2O5SJYNT,R_P!1_3BWOS<>O#AT/GNO6^O>_=>Z1F^,!1;JV]FM
MNUL0FBS&,JJ/0ZADUR02I$Q!X],C ^RO>+%;K;Y"14FG^''2G:[JYL-UCO(*
M@+^+RR*'^76LCV5AAUCG=W]5[QATT&*R^0J*6<C031"9EA16_;]#)3V'^O[Q
M.YDMVM]Q<9_MG'[#UG]R+OG[RV:*-M-%M8^!)X@^O56?<%5@*;>"Y+9L/BHA
M1R)-_:_<,#@<EI.2Q]L1N6@H>->G+Z6WL[O2Q4=OG3SZ375$]7D1D)8D=LB9
MJD%2"3+'.650H_("W_'L,7\W@2AO5CT(+*&SOX03(HHH.*>?V]"[E.C,?N#
M-D,IB97GAG:IJ(0C^KU+(20".#I/LWVS<_#I4K3/F>BN_P!CLG!_5/EY+T%.
M>V%2Y%L/)CMEQU%?3U<5)#EVI3JH(L;-$M""02I,'XN#]/8LBY@$:X*</4]$
M1Y7LG>OB-Q]%_P W4?;7Q(KZ_*5>=SLW\1W'7561DIIYV:..CI*N5F5+1(B_
MH< 74_3WIN8UE_3)3/\ 2/5;OE>WM[<S0N[."!\*^?'AT>FNZYGP_33; CDC
M<RT;23- B%FD6 Z5\A0/>['V$KGF)([E16/XSYGUZ,++8Y'B.'^$>0ZIII.I
M,C#V/E?[[823,X=AD\?'CB9OO%@+-!$Y"-$1'(@!7U_3W)W+7,T7@*:QT[_,
M^O1%O'+$LA.)/P^0Z<<KUAUG08_<U#MG 1;>GSM*,8_W9G-9&[024VNE\LU3
MIG5F.BQ'/MS=.;(]0C!B[JCB>B%.49$K(1+1<_"/+H,\GT5E\EDMJ[$DQD^X
MH-V5V'VOB5TO)4M69=H:*)0$TDN9I +7/M7L.Z:G&5^%O,]!CF/:]*'#?$OD
M.OHW?%#J?;W2O076/7^WL+28.'$;-VZ*ZEIZ>.GD;(RXFFDK6J=*AY)15.]R
MQ)%S[F_;I=<"\*D#_!UC;O&;Q]-2@)'[#GHQ7LQ9:CHG#4/7/WOISKWOW7N@
M)["@,7<WQ[R2 !I,CV9M^5K&YILCL*LS90D#Z?<;9C/)M<?U/NPX'K1XCKA\
M8@4Z&ZVC8@O!A:BGELVH+-39;(P3)J_)CEC93_B/?F^(]>'#H>?=>M]>]^Z]
MTW52$R%B[,H$/[0 ]-G)U@_7U?G_ %O>_#64:'RA\NGO%\*#4!0U.?\ )U0%
M_-4Z^;;G8>W=XTP6GQF_*67&1PJ#9LGA(!6Y"4MIU:ZA:Q01>W^M[@?W&V6Q
MA*SP1JLK/(2<Y- :\?7K)GV1WVZG6:WN79XT2)5&,+J(I^S'6O\ [M@G:?.Q
MRIX]-2R4ZV_0OF86'];+Q[A"TN9@0DA)&>LA.8+';Y9RZQ]VE1Y_Y^A,Z$PT
M%%7BMKG;[J-(7H*?2FFK:35Y=0(!.A;'C^OMNZ6VF<>,NJAQUI8/I[>/Z*B5
M4:OV8]>K/]I8[#5VW,A5YA*6G9XG#0H!J TM]0]P.#[6VEO9  !/7I%*UT3W
M/7HKO8V[L%M4_P $P>"IZS(3L\U)3@7\[.04D)20."YL3;VNDBMZ=J^72^T1
M2?U,Y'35L:IW)N!VK,]-1X"MA"^'" NCU,"7)8>5'>\2 ?1A>_LL,:%OTQ1N
MC:[2U6T+%*C4/]7'HS.-P)S>WLA+53B".FIY"L<VD"73&_Z& +&]OZ_GW4;/
M:3/XDB*6!K7/'HD.Y-#B LHIZ#\NJE>R*G*;6[9R6;BAA;%))30M12_0+&NA
MY..=,MB;WY]KUCELTTVI" '%/GQX]-K>/<&DA)_V.AYP^U<#NS$09^BQN.05
M2AY($#.1.?JXU:CJU7/UM[([F6[>0-(]2I-#^?V=&D<$;PL*#*_Y.GKIW;^U
ML7\L/C;49;$TTM(_;FQ8HXI3(8TR";AQ\<$V@N%8QR FQN#_ $]R5R,SSRQF
M<U%'/[#U#WN/:F#;9OIAIFJH%/F.MV:&-(PIA 5&TE0O T ?M@#Z *O ]Y-[
M?$BQ54>0_P '6%=Q+<^.$D8D:C7]O4L$ER+_ (_XI[,#0+7I24336F>L_MOJ
MG7O?NO= QV.__&1_CY$)?&[;_P!W3,GJ_?ABZ=[&C>.X!7TS3QO8V_3_ %'O
M8X'K73+\:)O'UG/@V/[^TM_=E[8J(R;F$T&^L]44T7XLOV%9"RBPLK#WMN/7
MEX=& 9E4:F-AQR?\>![KUOKOW[KW4.H=@2J:#=;DD\@ $W%OK8>[J5&2>D%T
MSEO#05J.JA?YK/8G36*Z_P!K[4W!F:')=R>?)97K/8L3E\YGT>FHI-QU=#"
MJ"'$8>'[B4NZ?MKQ<\>X[YULQ>0#36J^(<4\UZEGVUW)]MNFKIT.(@221E6^
M7K7K5VJ<Y-NNIK1/3FGK/N?-+3FVM5\I9B;,PX"^\6MTMVLY=-#\(X_/K,*R
MOAN*>(*$$D8KY?;T+&T\^V JZ&I^V#1Q1I%3LUAY6"A9_'R/\TI!-[>R^VC:
M=S@X(X='UM<1JA1B*J.E#V-\I:':*KM';RR5>YL]3ZS%JM]NLL=R_P#G%&E
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MT_4796.!IJ&K"BIT10Q&3TD<!5_5:Q!]MMM@@.KM)XXKT$8N9YX[CP6\73K
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ME_E1T6ZLK2_&;(]&9?M..J*Y_)9M:9.TJBO%[R5L>\\;B,PLSM?0(Z=%O?0
M;^QA;?3>'_BFCP_Z-/Y^?[>@==?4^*?J]?B_TJ_R\OV=6IL&N-1_LC3];:+>
MG186T6^EN+?3V_TQUQL/ZC_>?^*>_=>Z]8?U'^\_\4]^Z]UZP_J/]Y_XI[]U
>[KUA_4?[S_Q3W[KW78 LWJ'T_P ?ZC_#W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>77
<FILENAME>tm212692d3_sch14-aimg077.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg077.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 3P!0 P$1  (1 0,1 ?_$ :(    & @,!
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M,&CBJ&=DBC,LU*$%V%R;>Q3RYMXEO8T(%"6\_ET#>8]TECL9&#'X1Y#UQU]
M+:F5VYD<;2S;+K</E-K4T HZ.IP]9'7P12QDDQI)$70E8W']J]C[D);)(GTA
M:'[>L>-QOY7G9YB3+K[C3SZ6%.) L:2/Y' LS6 U'^M@!;V\U *CI3( R'Y]
M ?\ (_\ >ZV&#C :IW;OKK/:U''R6EERF_MNF94 (8NE'3ROQ^D*3^/=0V.B
M]8J2%AZCJ)L.<;+[H[7Z^J;Q4>\Q0]S;16RD5 R,-+MK?U)$PL6FH,_C::K=
M.2$R0;^OMJ1/$4?+I_5I/0^U# Q']WP,_IC;2&;4>;*A(U-8'CW:)2GSZ8E
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BV]X[ZKL.&\M0(_8#TKB6%12*GY&O5KGM)T]U[W[KW7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>78
<FILENAME>tm212692d3_sch14-aimg078.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg078.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 4 !0 P$1  (1 0,1 ?_$ :(    & @,!
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M,D9D (-.FFD6+B.A_P#."P4 \\$W "BWU-_Z^_)$8QQKTD-XLCA4!!/5:_\
M-1[TZPZ&^$GR%W+V=)0PT,6Q\I'@L152TZ5.=KY!3F&GQ*275JEP'LEM1TGC
MV@W#;OK8F2J@DU%<T^?0VY=\5;B*6%R J]U#Q&<'[33K3=^.'96!RN%I\#G:
M:2CQ^9H<GD',VE)<?49"JDJL3"864RAWHJI6!"D>X Y]Y>DVF>&61DD'ANV
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M$(X]$E^6?<'=?<?;./VIA=C;GWML.GIH),;F>O<7D]QTWW56FAR9\30V7Q-
MA8ZB ;_T/LE_=D?BEJBFJO >O60'+.[<M;98-];?1(Y@0:>+$T-0 *Y^724W
ME_*T^0/SC^(6^?C-V#@=W;#;=&^Y<WM3L7L&"AH(-C[?ER6'F-32XBJKIMP9
M6OJL9CI(4BC@"(90SL "/9T'MXK=H%J6)KP'4=<T[MMVXWFK;BSQZ -172*C
MY'/\NK"OY:'\@CX1_P N"EQ^YL%MK_2[W7'30K6]J]@4\.1KZ>I6SN<%CY?)
?28V-9"0I50+6(52.$M?)>@C3UZO*]UZWU[W[KW7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>79
<FILENAME>tm212692d3_sch14-aimg079.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg079.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6@!: P$1  (1 0,1 ?_$ :(    & @,!
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MSKSM%LT3;9MC!MV849AD0@_X9/0?AXG-!T.^4N4I-UD7<-P4KMBFH!P92/\
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MTE'1TD,=/2TE+3QK#3TU-3PJD4%/!$@5$4!54   #W%;,S,68DL34D\2>I&
M"@*HHHZD>]=;Z][]U[KWOW7NO>_=>Z][]U[KWOW7NJ-/YA/_  +R'_;J_P"M
M1_S/_P#YF7_F_P"W_P W?^-^Y)Y4^$?\EO\ ZA_[/H!\R<3_ ,DC_F_\?_%]
M:\^8_P"+NG_;MW_.M_Q[_P#Q8/\ ._[N_P";7]/]H]RRG]G_ ,MG\^/4:-\7
M_+)_+AU9M\'O^/@QG_;F_P#6_P#P(_X_/ZG_ (MO_39_T5;V#.9O[)O^5A_Y
M\_/H6;!_:+_R1//_ $WY=;1VU?\ CW</_P 6#_@##_QZO_'N_0_\6?\ Z8?]
M1[A6;^U;XN/XOB_/Y]2O%_9CX>'X>'Y?+I_]M=.=>]^Z]U[W[KW7O?NO=?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>80
<FILENAME>tm212692d3_sch14-aimg080.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg080.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6@!: P$1  (1 0,1 ?_$ :(    & @,!
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M9#>VT(M\;:@J_O$CI]P4E3@Y=-15T&N"DK%,#DFS$0V/,EEN&[2;5 LFM#*
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M]U[W[KW7O?NO=>]^Z]U1/_,-_P"!.2_[=6?JJ_\ F>__ #,[](_SG_-[^O\
MC?W)G*?!?^2WY?V']GT N9?B/_)(X_Z-\?6O9E?^+H?^W='^<7_BP?\ %A_S
MA^G_ #:_U7^T>Y73X/\ EL_GQZC-OC_Y97Y<.K+_ (1?\7_&_P#;G#_/2?\
M%T_X_#\?\6__ *:_Z?X^P9S)_9'_ )6'@.'P?G\NA7L']H/^2'Q/'X_RZVFM
MI?\ 'M83_CW?^+?!_P >E_Q[7T_Y<G_5O_U'^'N%)_[9OCX_B^+\_GU+47]F
<OP\/P\/R^72B]M=.=>]^Z]U[W[KW7O?NO=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>81
<FILENAME>tm212692d3_sch14-aimg081.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg081.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6@!: P$1  (1 0,1 ?_$ :(    & @,!
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MWS\DNV\A#4M(SXK#[KK=I8.,2F[1P8;:9PM#%$/P-)('Y]CZTY9Y?L0!;6<
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M,KVO_LPE?M>@R>(1<0*R@S&(:+[6*.<1N@ID62(Z7[G9]^N))EA^IALW^I9
M)@'K]';K:AF!J:7"25R<@ECI.:KNVS0JKM]/->*8@28B4H;V5YRJD "MNRT%
M!@T U#IR[%V/TS%\!M[;\VOL_KG";:J.GNO*;K2JR6P:&+LFH[8J^^\I3;QW
M-CNU7EGJ\ZFZ-E00I#A_)]YCJ&!A-! JEI$R7.ZKS/;6EU),;PWD6L+(?#$
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MQ.34U/0=&,=#9\;^F,O\B.^NI^E,+#+)/V!O/$XO)S1HT@QVV*>89'=>6G"
ME:?';>I*B1F^@( _/LMWC<8]HVJ?<I.$49(^;'"C\V(Z,-JL'W/<H;"/C)(
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M=*/L'L_>^S-S=.;HJ"[5K4M5LFFQ648R1ZACJBJ!@1]996[7DV]"VRW[1R>
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MQ5110 "G=]ZV^^VB"QM8C'+&8S32*)HA$;!&!R)&&HC2*T#-5J]5XD@ DD
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M64_XN-5_V2+_ )S_ )<7_%G^@_X!?\VOZ_X^Y23X!_R4OS^+\^HY?XO^6?\
MEP_+JQ3X6?\ 'WX[_MT7_P "J/\ YF5_Q\WZ_P#E&_Z;?]1_C["7,?\ N.?^
M2_\ "?@^'\_ET)MB_MA_R1>(^/C^7SZVX.MO^/*P/_'C?\ HO^9;?\>5^D?\
M6'_IB_U/^'N"+O\ W(;^TX_Z)\?^V^?4R6W]@OP</P?#^7RZ7/M-T_U[W[KW
+7O?NO=>]^Z]U_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>82
<FILENAME>tm212692d3_sch14-aimg082.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg082.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 6@!: P$1  (1 0,1 ?_$ :(    & @,!
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M>Z#H[58:H6MR=0.-9D)&K2>O"]Y:N29KWZ9I?I+95&EE 5+=DE3"FDHF T$
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M]U[W[KW6.;_-2_YO_-O_ )[_ #7Z3_G?^;?^J_P][''KW6M]_,;_ .+IE?\
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F_MOGU,MK_8+_ &?#\'P_E\NE[[3=/]>]^Z]U[W[KW7O?NO=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>83
<FILENAME>tm212692d3_sch14-aimg083.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg083.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $0 4 P$1  (1 0,1 ?_$ :(    & @,!
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J>/\ RRP__O18CV8;7_N='^?_ !T](]P_W#?\O\(Z&7V7]+.O>_=>Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>84
<FILENAME>tm212692d3_sch14-aimg084.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg084.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $P H P$1  (1 0,1 ?_$ :(    & @,!
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$\NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>85
<FILENAME>tm212692d3_sch14-aimg085.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg085.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $P 4 P$1  (1 0,1 ?_$ :(    & @,!
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,W5_+RI3\N/[>O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>86
<FILENAME>tm212692d3_sch14-aimg086.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg086.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %  4 P$1  (1 0,1 ?_$ :(    & @,!
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??7_@I_QG3\NIL_W3_NC_ $+]S^%_M-'^'_+7Y]?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>87
<FILENAME>tm212692d3_sch14-aimg087.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg087.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %  4 P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ P?S)OYLOS-_F0?/>;^7/\ >V:CH[K%-^[HZ:VYG<)NRL
MZ^S'>G8>UJ3,_P =J=P=AT$8S&W-H5^5P<^.PU)2- E0_CGJ';R*$UTH5%5=
M;<>JU\YL+^>'_*WV7!\ONP>S>\?CMC\7V[A>J,-@.Q>X*G?$O96YZR#+Y:37
MUED,_NG ;JZ]2CP$IJ*^J6..=9$$#$MJ'NKUC?M'6T7_ -!&NW_^&<?]G@_N
MGMW_ &:S^^/^RV_Z*/+4?W4_V8G^$?Q7^\WA^Y_BG^C?^ZO^_C\7D\_A_P B
M\FK][WNO3/A?J:?+C^76I#\9.X^O?Y3'\R;M'=?RR^,6Z?D+V)\<.S-V8C9N
M'&^4V-5;1WQC-PUGVW:PQ];B\I0;NK\GMV9:S$^>9:>(U0G4R.4=-=/D&1.W
MSZOR_G\_SB/@E\A^G=L?%*CZ0RWR&K]\]0[&^0&R>X<!V'C]IQ_'_L#?.%FR
M.RX6IZ;'Y:JS>Y<;A*H?QO&.T<'@J'I90LWJC]TU&C ZN&>M?;_92>[O^&2?
M]FH_N[7?Z,?]GO\ XA]W]G5_\>M_HG_T;?Z0OM?';^[']_O]Q?W=_#K_ +?X
M]^\NG=0\73\O]GK9&_X4T?\ #0?]\<5_IA_TB_[/Y_=S%^/_ &6S^[7]YO[G
M>.3^[G^GS^]'^_2_@_AU_P ,\O\ N<^W_P U_D_C]^Z9B\3\/P]:HGPG_P"&
MV?\ 3+M[_9[?]F8_T0_QZE^Z_P!%?]T?X/\ :>8ZO](?B_W^G]WM>C[S^!?Y
M7X->GW[I]M=.VE>OJ;_\X,_[(G_S1G_AO[_03_TP?Z&O]!?\!_Y(_AG\,_ZK
..ON_^FKWOI'W:OZ77_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>88
<FILENAME>tm212692d3_sch14-aimg088.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg088.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ %@ 4 P$1  (1 0,1 ?_$ :(    & @,!
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MI+_X3L7_ .WDV[SQJ_[+M^3EK6)Y(WC8&P^GU]^ZU23T_EU5]_LP_P .?]G
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M;\9-F8==HR[EJNE:S.P4^-@W31J=FI2S&;[D2+%(ONMY\ZTIU=;_ 'E^9/\
MPZO_ *:?]%71/^S@?[,1X?\ 9,O]*>Z?NO[A_P"RE_PC[K_35_</_1+_ 'B_
:NW_N5M_%?';]G1YOV??O\_3>-%*XI_EZ_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>89
<FILENAME>tm212692d3_sch14-aimg089.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg089.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40!0 P$1  (1 0,1 ?_$ :(    & @,!
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M[S^87Q*Q,[4^%PO:79^9I)%M6YCLC?-1%+-#J D^VQFZ\5CR9&/J_P G /\
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L@^W_ "=6B0?\6;&_\%;_ *&;W3I=UA]^Z]U[W[KW78^H_P!<?[W[]U[K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>90
<FILENAME>tm212692d3_sch14-aimg090.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg090.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40!0 P$1  (1 0,1 ?_$ :(    & @,!
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&OW7NO__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>91
<FILENAME>tm212692d3_sch14-aimg091.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg091.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40!0 P$1  (1 0,1 ?_$ :(    & @,!
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93JW6#W[KW7O?NO==CZC_ %Q_O?OW7NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>92
<FILENAME>tm212692d3_sch14-aimg092.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg092.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 40!0 P$1  (1 0,1 ?_$ :(    & @,!
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MO_XW=CR8.&HIL?@I=M9/)^*#R(U3F<]D/5*Z%C)H4$#DV_'L$<T3-$G82 7
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%]U[K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>93
<FILENAME>tm212692d3_sch14-aimg093.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg093.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ &  > P$1  (1 0,1 ?_$ 'P   (# 0
M      4&  ,$!P$  P$!                  (# 000  $$ 0(!" L
M      (! P0%!@ 1(5%A$A-3%)0',4%QD2(R0E(C0Q<1  (" 00" P$
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;QU8[B**O&(!LFW'<B35!40I'DF3-@+ ^!/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>94
<FILENAME>tm212692d3_sch14-aimg094.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg094.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ %  4 P$1  (1 0,1 ?_$ '@  0 # 0
M      4#! <& 0 # 0                 " P0!$    P<"!00# 0
M   ! @,1$A,$% 45 !8A,2(C!D%1,E)AD4)B$0 " 0(%!0$            !
M$0 "$B%!44(#87'A(A,R_]H # ,!  (1 Q$ /P#5KU?SW0YIE>H6MAYHTA9+
M+*'%)2?63%BBJRA6""11] U730N^9TD]5;[9#64IV5F+9.2$G,V/$3]R6*E;
M[A:9PX@0XCU J4W XE#BP08.B!8); U$PA$!(G2.[OO.-Q3$]U5^)B,[3S'Z
MIWZPNMWWTOYAO:GXC/H4MS4YJTSP6>Z6A6=05.CX]66^X%2(*AT#K*"=*8$A
M>IQ0@_(--J%P*W(Q5)M(>3$7NWDQ9_R2R7*@G1\=MYUE$YHLNH8ZTR*;"NIL
M? H-X"(<]!3QJDABXPZJW4"L)#0W[*[TQ:T/(1L6P*JD@0(KGW_IWFS6L*QY
M3$7<LXIYKA\PA05F[H?:Q3(T'TJ'NW#]G]!Q-8JWK#Y4\/UTA)]V1DMV9C$M
C+%I8+G/A'INZZWFS1^NU.+]MS4TOHA_X=_/Q9^^6I97/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>95
<FILENAME>tm212692d3_sch14-aimg095.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg095.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'X  0$  P
M      <$ @4& 0 # 0$!               "! 4! P 0  $$  4!!@4%
M      $" P0% !$2$P8A,5&!(D('07$R%!5AD:$6%Q$  @$$ 0,$ P
M     0( $3$2 P0A42)!83)B<1,C_]H # ,!  (1 Q$ /P!;]S?<T\;(JZL)
M=N74ZW'%^9$="OI)3ZEGX##>C1EU-IPW[\>@O!.PY'R"Q>+TZRDON*.?F<4
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JC_.'FFGD_P!3TA+[Z0YN;FXD!:P$[FYN:3U3W=,L3_Z?L^TH>&'UG__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>96
<FILENAME>tm212692d3_sch14-aimg096.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg096.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'P  0 # 0
M      <$!08" 0 # 0$!               " P0%  $0  (" 0,!!@4"!P
M      $" P0% !$&$B%!48$3!S%A<2(50A:AP3)2(U,7$0 " 00!!0$
M       ! @ 1,1(#(4%1(F($L?_:  P# 0 "$0,1 #\ 6_<SW._;C#%XL++F
M9%#R2..I*Z-_22OZG/<-5Z-&7)M$;]^/ O!2_P DY%DIS+<R5JQ*W;MZC[>2
M*0!Y#5XUJ+"0%V-S)N"YWRS"3K)2R,K1J?OK3L98F^15R=O+0OI5KB$FUEL8
MRU?=2C:X-=Y'#7ZKN/"):QQ;;IED=8T/5_K);??PU"?G(<+WEP^@%,NT"L_?
MFR&=R%Z=BTMBQ(Y)\.HA1Y#8:T$%% F>YJ29HN YGDL7JX7BU*/\U?D5_P H
M5#O#"G80>L,JIXG2]RK=CP(S4S66\Y]U+>+L\MD-!HI'AACBOV( %BEM*/\
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3GJ^IM\1U;[:S_//VFAX8>L__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>97
<FILENAME>tm212692d3_sch14-aimg097.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg097.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'T  0$  P
M      <$ 0(% 0 " P$                "!  !!0,0  $# @0#!@4%
M      (! P0%!@ 1(1(B$P<Q05%A<8&1H<%"%C)2<B,5$0 " 0,#!0$
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..NW>>,[GO]IH<-GK/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>98
<FILENAME>tm212692d3_sch14-aimg098.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg098.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'T  0$  P$
M      <$ 0,%!@$  @,!                 @0! P4 $  " 0($ P8$!P
M       ! @,$!0 1$@8A40=!<2)"$Q8Q89%2@:'!,G(S%1$  @(!! (#
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$/K/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>99
<FILENAME>tm212692d3_sch14-aimg099.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg099.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'D   (# 0
M      0'  (% P$! 0$! 0               @0  040  (! @0$ P8'
M      $" P0% !$A!D%1$A,Q4A21T2(RH@=A<<%RPB,6$0 #  (" P$
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M\LS$^5_V_P AA@#KU26ZGN4Z6^N2LHRY,,H25&"DZ*RNBZC\,&&VN4*DL\,
MZ$S^=?J]V$$G0OG7ZO=C&#Z2CMIMM;//7(M6J(*2C5)2SL94ZF9NCH "9\<%
)MY7 DEA\G__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>100
<FILENAME>tm212692d3_sch14-aimg100.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg100.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )@    ' 0$
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4@["WA-FWY=G[ZK6'.@% * 4'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>101
<FILENAME>tm212692d3_sch14-aimg101.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg101.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )<   $$ P$!
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M4M;I+:3.21V1P[[\RV-.KZQ)BFX&CIRZX%+(W)!43/N$<GE?'#-%K-_BA#E
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>102
<FILENAME>tm212692d3_sch14-aimg102.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg102.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ ),   $% 0$! 0
M      4 ! 8'" ,! @D! 0 # 0$                ! @0% Q   0($ P0%
M" 4+!0       0(# !$$!2$2!C%!$P=1<2(4%6&!D:$R0A8(L6(C)!?PP5)R
MHK(S0V.#DX*2<Z,E$0$  P$  P # 0$          1$" R$2!#%!(E$3_]H
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M< BRW-[2NHZ:]VYQ3;C#S:W$ _RE*"5)]$XT9U;)OG3] ;#=F+Q9J*ZT_P#
MKF4/M?JN)"A$O*':OH:>NIE4[X.4R*5I,E(6,4K0=RDG88!M::VH4IVAK2._
M4LLZA@'6S[#J1]:6(W& (P N]J74*8M39(-82:A0VIIT2XG5FF$>> )H0A"$
MH0 E"0 E(P  P $!\KF >C*8#*%99&JW5%T<?DVI%:>,V,,QRCICP[Q46U?-
M%S2X].,4[=*TAM*4@)&4)P CG5[.I.?6/ P^4-J$C.6.,5G-(SJ9#*A;)2HJ
M/:F93BFL^7O'B%?:R82ZE:LH( [0W1ZX1,1,**O]L:0Z^IL$I=) EM C=B7'
M^C52US\O]R>KN6%L+JBHTQ52IGN2T  (TPR7:QYXRB0+OC:V4M75D$O4)*G$
MC:NG5_%1YAVAY1 $>,UP>/G'!RY\^[+*<_1 #K:.\76X5IQ#:DTC/D2T,R_2
MM?J@"A$P1 ?($D@'= 4%S0HJ&V:I=53MY:FN<"@!O49"?JCQ^C7\M?RQ_0[;
M:MVV6Y"5I2XI(FY,@3ZCY(Y^)AU=Q<'-!JVU757";0$/)P("@3AU1;2<9-M1
M:LM=K0INI';1*2=YF)X1286T@5XUC:+DRINF3]HX,JD3[0_T[8MF$7X5A>?N
M5?Q'<67D]@'<3&O#D_1FY:9^6U_B<N$C+ERUM2/04QIADF*6H!C/?$H)24J2
M4J$TD2(.P@P$:S+\%\'F<_>O#I[^%/-/_! %-.B=J;<(DIY;KJNM;BE?G@"4
M H"E.:>F*FKU737-QXI;97]FGR2C%]4^'2^3'BSU[3R;A0(2I9#:9S 44DS'
M2(P<W1U!E8M$VZUUO>&NRM)),U%4Y]<>DPFZ@)UU1MNZAI7G$I#20,X4!M$I
M1-E7!H]HBUS37M!#;A[:L@ GNW0C1&?"N]76MAZO9:]I"')^:-&-,?3G<M$\
MAJ,TNALA3E2:VH4@?5)$C&SG-PYWT9K2Q@,3%W@]@([PS\9<+W<G>\OEX?!G
M $-.2\$I /=24GK2H@_1 $H!0$/U];T.LMOY<Q2<>@1G^C%PZ/Q=:FD;IKBU
M1T1=>/8"9IZ)RCFX\2ZVXB3&VW%:FE5U0E2@XN00F64)!VQHJ'G,(=S U>P]
M5(99IU%8]Y0P]41'.)5C4Q%&.GM4/*I%T=2.V22V-I.&R(WRB'KSFT>N#0J*
MUEO-);Z^&T-\]T.<7+Q[UGRU+H>T*M.EK?1.8/)927O^0I&;UQT<9J'$[]/?
M5CL7>10$?F/CG-A+N/#\L^)G^B >V$Y&JJE.!I:EU('U5JXJ/4N )P"@&E?2
M-UE.Y3NCLJ&!B-9N%N>YSI6-PH6VE55M<&9+<Y ]&Z.9O%2[G+I[0$4UDN#*
MFET]8>[RDID[!%?9ZT ZNMKSZ'$MO)9RX%4B9X;I1;&EHSX1_2UKH[8NHJ'%
M%YQ()XBCL.S"+ZFT72;<H-*45ZO%;=*YE+S%&H(IB<0'$F?T&/7CCRYWV=I7
MN@S&R7DC93EQ-O8)* C.;_U_%/<[_P!TG]3A<*?^6 (N?<[^APX,W)L-J.X/
ML@E/^Y!(\T 5@% <W%2"CF EC,[I8F%I57JBX45?>7JVUO)J*=I(:<6@A0+B
M2<R9C]&<9.^73^/?AQME;2525-ET-K&T&,$1Y="=097J@HN$LN.@(&^>$>\9
M1_T5;?+TTTXY34,BDX*4(F'EO2Z?EY0I&BJEU2>T[6N*/G2F-G*'(^B;E::1
M(1[RSYBGL0DUNE:**@>J99E($FT;U.*[*$^=1 @&?@R_A[P[-]XX>;B_UY\3
M/_DQ@'ESH174:V,W#<P6RZ-J'$',A8ZC ?%JN!JZ8\5/#JV%<*K9_0<&V7U5
M;4GH@'D_1 5GSIYHVO2.FZRG:?2J^U2"BCITD$@JP*E]'9G$1'E$H]R ;M-[
MY8H;9,JUNI=-2H]I9=(3F49[E17KCVA[?/U])?.IM,UMOJBM"2V"<5B.=KGZ
MNGCI&_V@FH&M0NDM!U7#.Q(Q$NN/3.KA,W$^/**U%L73K 6<KA]J<1$JZF?\
M69H'F=0:%[A;;^>[VN[?:M5)]QPCV5 R$NSMC7RA@[+]M5WMMUHTUMMJ6ZNE
M7[+S2@I)EY1'O,,YWF$IC?@(@"0?%+J%)QH+:LR.YRJ&&'2&A^UU0!> 4 -N
M5#4)J$W*W@&L0G*ZR3)+[8QR*.Y0]Q7YH"C>='S%U5@JGM/6*A=9N92./4U*
M2CAS&X;Y>2 S/7W:XW:I=KKE5+J*QXYG7W#,2)]E(B/V+*^7SF"G2NKFZ2M=
MRVFZ28>.Y*Q/A?M*B]6I=-A55%1UM.6Z@!Q"I$+\AV1X;Y6]<=)C\(#J;0-8
MT#46Z3C:<>&=PC+KG,2W<OIC\2K)S2M?<;N&$-\-]:I',#(2VSBN<2T=.L4"
M?,#IY#&BZ$E$T6U>!WC-)/:ENQC;R<K?:Y4?IC7>K-*UHJK+='J,@S*4JS(4
M.C*O,)1ZRHV#R4U[S+U[85O7BWM6VAF$-W=&9+CR?>+:%89C^E*0VQ N"EI6
M*6G;IV$!MEH94(&X" ZP"@% 0_F+RKTIKRW]WN]/EJVQ]VKVP \V>O>/(8#*
MFOOE]UYI-UQ]BG-XM222FKIA-:4_U&]HB*%=I#K3DI%MY!F$J!20H;,#%HD;
M#Y!<QTZITNW;ZQ8\5MB0TM)VK;2) CS")2L6^W>BL]JJ;C7* I:9!6M)P*I;
M$B(F$5_3+%TYUZL^(JR]VET<%P96K>X")MA0&7$CHG$3EJF+A+M053O,/0+M
M U2*%WJ0@=U0"2M04%"4IX3BM,T\XB7/E9\IM-2/M7?7"TU+R2'&K2T9M).T
M<57O=461+2%-34]+3MT],VEEAI(2VT@!*4I&P " Z0"@% * 4 C*6.S? 5AS
M$_ B2_BKP[O,C/ARX_\ U8SZXD0+E]^%/QB/PZ\3\3RJS;.[9-^;B;NB"LI]
MKOO?A[?Q/Q/#LX_@\#+/'V\V$0OFT8I_P!\38\5X???Y/'R<.?\ 8P],2M/L
>N#3_ ,-=T3X%W;N\A+NV79Y98^F(4%8!0"@% ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>103
<FILENAME>tm212692d3_sch14-aimg103.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg103.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )$   (" P$!
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<_E'P*?RUX3PEMGA-%K=^G;[:A(U02@E!*#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>104
<FILENAME>tm212692d3_sch14-aimg104.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg104.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )$    ' 0$
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M5>DN+4O]]8PY4!X0"".1H"D=Y;=Z6Z)O7;ZB9;YD, IX @#C^6N?I&WH<-Q
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,VAH84 ,* &%JP/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>105
<FILENAME>tm212692d3_sch14-aimg105.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg105.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )<   $% 0$! 0
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-/" RP@!80 L)0@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>106
<FILENAME>tm212692d3_sch14-aimg106.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg106.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ (\   $% 0$! 0
M      4 ! 8'" ,! @D!  (# 0                 ! @,$!1   0($ P0&
M!P8$!P$      0(# !$$!2$2!C%!$P=187$B%!6!D:$R0F((DB,S)!87L5)R
M@J)#8X.31#5&$0$!  ,  P # 0           1$" R$2!#%!(E'_V@ , P$
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M*3[J1NQA?L+*^GOF G2VKFZ.M=RVJZ$,.D[$K'X7^)43PAG#8-70T==3EJH
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MI*%YJ[ZV6FJJ$D+:M+9FT@[1Q5?%+HB0PT.RRRPRAAAM+3+8"6VT )2E(V
M0S?< += "P@!80 L( 6$C/W9=Z>R77 %7\P?V&FO]3^ \7\7 EQY_P"U"*H3
MRU_;;]9C]NO,_,.&KB<27ALF_/GQ[(:%6'S \?Y<W^IO_.S#\#AY<V/OYL(B
MGKE$:;]A/-&/-<GCL.#GR<.<O]'#UPT_Z6_8?TYX4>1>&X$O^MEG+KEWO7#1
-$L( 6$ +" %A* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>107
<FILENAME>tm212692d3_sch14-aimg107.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg107.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )0   $% 0$!
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JY7B^NDHN/R+.D/R1Y)/Y5\GY>W_B;=UOQ?>II1/:4C+2F"TH!:6H#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>108
<FILENAME>tm212692d3_sch14-aimg108.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg108.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )0   $$ P$
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M%-%:N*7,2KZ<*GF49PP^&"3J <4T5!/-P)OAZ*E*W.? 5N.4DOBQ'3B K('
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5_:Y<W[WZ_MJN5D4DE<=*@5 J#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>109
<FILENAME>tm212692d3_sch14-aimg109.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg109.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )(   (# 0$! 0
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MJ:J6_O*5T9'4[\IVC>)B)0NP$@) 2 \:VMIJ*F745"\C2-IVDDX  #$DG8(
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M)P0Z-_0K? $H 7>BJI<I[2@D>+)55$;13MRSC]<D(], 3"4I2$I 2D"0 P
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KP_&EP\DN[GX/?]<5@G_)[L?X=X1\GX&67>X<L\OFGW_7$I%("0$@) ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>110
<FILENAME>tm212692d3_sch14-aimg110.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg110.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )0   $$ P$!
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MQAC!U&0F0(&HI2B98EEU.#;Z1M4B^Q0^)&[NJ4B5 J#Q2DI25*(2E(NI1P
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M973HHXNYM^.'2J=E=[%>T"H(SF/,_-/A^9\+-NX63E;]V>@(I)B:^M!P9U)
M6@[@^R+*'XF['\- +ZS\QNC.DHBW]:U%IA:=K"2%/'N0/%Z[4'-GF1_=?JVK
M-/:?TI&Y*$Z"A4QP_G*3LND>$B@I'I=Y;O4\:0\X7'%K45N+]Y14+7-Z37+U
MKOXV7WH\E<)=RK*V=I[ZR^Q7$OH.O?RA+&^#(8#B<3;;55(6X,IR,K%T.*"M
MZ1LJ;663*/S9S6F(+X4.+8FYW4I2957MB#7RO_N Z4Z;UJ<WK$%V\E02=42;
M@ $_Z>4JWUI:J8AA]C9F<.G>F>M>F>I(;<K1]1:E(<%PVE0#@MVHOF%7.61M
M)!]7;0-M6FF' =?2,SMLC"/M.K.5"?6HB@T?)D_(/E>;Q<')Q/\ <][/_'XJ
M!=1:/\WTB1"0\J-(6DF-*;)"VG0#E6DCLH/G?YAZ9U3I?5D[3>IWG)&JQ7"%
M//DK+C9/A6DJOX5"IP(ZV5%5\,VRY%[#T=E,!U#=Y:8T^BX2TM)Q..![:LU_
MXKO&.5^:7+CS=/9=4?RWD@W&Y5KVKG[?5G&8:'1[L1.)%8LV? 0>&..R=U[6
M^NLO7;G$QAMWGXYCDWE=6N@%!C$6V#;]-JMV:XCF)RIC9,QS&$'Z@U)^7Q2L
M938V;.-6]:DS[.?=OQ"IGG XXZHDD9E&U^VN^>&+?F3W0]?UO19;<K29KT)\
M6(6RM2/4K*1>O*5^^7O]VVM02W#ZOCHF1TD),YOP.)3VE(!SGUT'2F@:S%ZL
M3#UJ&%_)FT\6(74E!=>4+9\I^%"=GI/HH))0*@J?SY\DH?F!I'.P ECJ6$@\
MH^< ZD8\)P^G=4Q(X>U32=2T?5']-U..N).C**'F' 001]8]->AK38X'W=I[
MS7GRP1&>%F>6.MAZ&[ICGB<9-T7[*T>O>MXQ+BW5MKG,)XW)6S@HW3V5G][^
M?[U:_P#/_H^UC+5-2;+9"0D+3@!;&LW5IG/C+7V[JS7,(S+B.):=D/[5I4$^
ML5M:NO%:L#?OS*I'6"T\MH[02:IV>JJMLL4%%B%G*+8&JY>UU>0?D-J'6<YC
M6=<94STQ&6%I*Q94I23<)2#\'::#M:+%CQ(S4:,VEJ.RD(::0+)2E(L !0;:
M!4"H*^\T_)3I+S!ADS6^4U=L'EM39 #@.X+^TGOJ<CD7S \B>O\ HIY:Y,)6
MH:8DG)J$1)6BWWTC%)J+<HCB4/Z?U)S3=78D-G*I*@E8.&!-C<5;U_C*-TYA
M=K>I1A#YQ\AMC+F/:<*VHMF&5XSGA"GNI4"=S\5H/PKD(!VC'&_KK.FD?I,M
M&-L^,0>3]2;U.*'F#9) "T#8*NO;,.:<Y1.=T7K^JZNU$T2 ]/D/@#(R@JMW
MG8*X;TQS*^DY7MY4?VDH8D,ZSUVM+JTD+:T=HW0#M'&5O[A54KXATQ$B1H<9
MN-%:2Q'92$---@)2E(V  5"6V@5 J!4"H,7N%PE<;+PK>//;+;TWPH*.\SO_
M #+Q7/U#R?S"^/R__/S?TL+UZKG/")PK#6?^K."WR/SCD\OY/&X>3)NVXUHU
M_;'LXY_//&4:T3_K/BR[_,^7S#C6X-MF.6N:?/*^/'"R_+O_ ,^<FYEY_A9A
MS'.^Y>XMFR;KUXMYGP7_ -*?HWDQ^FN4Y>V/+9<UOO?%[:IG/NM@=J$E0*@5
#!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>111
<FILENAME>tm212692d3_sch14-aimg111.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg111.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ )0   $% 0$! 0
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M;)[1N54$>T?F;!Y8 3S!Y@6'15H-77',Z$_A:-LR*Y>0;HB8&9=5_F-UY?\
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MS^G7B?><AXO?,O=<DAM]Z+*RL;F+XGX<U\3<+PS/CW:>6>,L^>*ROFT(IOZ
M^*L>+_\ <F.%++P9^7@_KB5Y^EV:8^$.ZI^'NZ\*7[B6:7E][TQ#F.0"@% *
# __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>112
<FILENAME>tm212692d3_sch14-aimg112.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg112.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 9 !D P$1  (1 0,1 ?_$ ),   (" P$!
M      4&  <#! @" 0$!  ,! 0                $" P0%$  ! P,!! <#
M"08$!P     ! @,$ !$%$B$Q$P9!46$B%!4'D3)"<8&A4F*"(Q8(L<%R,V.3
MDL(E%_&BLB0T1"81 0 " P " @,!           ! A$A Q($,3)!(A-1_]H
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M[[S?_30%*"4&&2PV^TXRL7#B2E7R&HF,P5G$Y55PY$#+/8J2G8A1,51W:/\
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:3^5?!^&M_P"IHO;[5N][:A8P4$H)02@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>113
<FILENAME>tm212692d3_sch14-aimg113.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg113.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  - !$# 2(  A$! Q$!_\0
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'_GU_7WG_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>114
<FILENAME>tm212692d3_sch14-aimg114.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg114.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'T  0$  P
M      <$ @4& 0 # 0$!               "! 4! P 0  $# @0#!P0#
M      $" P01!0 2$P8A00<Q48&1(D(587&A%#(6%Q$  @$# P0# 0
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ALF5YY.IGSYTC,JB=35U,IXIK6G#$_P#I^GVE#PV?6?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>115
<FILENAME>tm212692d3_sch14-aimg115.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg115.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'D  0$! 0
M      <$!08!  ,! 0                ($!0$#$  !!  #!0<#!0
M   " 0,$!0 1!B$Q01(3<8&1(C)"!U%A(Z%R%187$0 " 00" @,
M   ! @ A,1(#$2)!!%%A8O_:  P# 0 "$0,1 #\ 6?D_Y-/3JI4U/*=PX*&Z
M\2<PQP+T^7B9<$7=AO1HRJ;3AOWXT%X(3[NXL7E>GSGY3I+GFX9%X#N3N3%
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/=J9YXG]\_P!2ATP_,__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>116
<FILENAME>tm212692d3_sch14-aimg116.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg116.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'T  0 " P
M      <#! (%!@$  @,!                 @4  00#$  ! P,"! 0#"0
M       " 0,$$04& !(A(A,',4%187&!D:'!,D)24Q46%Q$  @(!! ,! 0
M         0(  Q$A,1(B05$$8F'_V@ , P$  A$#$0 _ %WN7W-3&U2V6P1>
MO+@[S(^8(X%X*2?F-?)-:Z*.>IVG"^_CH-X*7#*,EN3ZNS+G*?<+C1'#1$^
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..UIPTO[\_U&'3A^9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>117
<FILENAME>tm212692d3_sch14-aimg117.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg117.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'P  0$! 0$
M      <#! 8% 0 " P$                !! (#!0 0  (" 0,"!@ ""P
M      $" P0% !$&(1(Q05&!$P=A4G&1L2(R0F)R(Q87$0 " 0,%  ,
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'H=.'YG__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>118
<FILENAME>tm212692d3_sch14-aimg118.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg118.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ > !X P$1  (1 0,1 ?_$ (P  0 " @,!
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%4"@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>119
<FILENAME>tm212692d3_sch14-aimg119.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg119.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ > !X P$1  (1 0,1 ?_$ (X  0 " @,!
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MSS<=23_CXY#L]SML!T1?Q7T]U5;MGTGR6:H^S/23;:&VTMMI"4( 2E(T  T
M%>4>B<T!"<OXI Y-AUP)/D='GBR +J:< T4/9V([U9KV.'E$-D*E@\X9O"9+
M"9)W'9%HM2&CH?X5I[+0>Z37J1:I91Y]2T\,P:D1% * 4 H!0"@% * S\'@\
MEG,DUCL<UZDAPZG^%">ZUGL!4;M2LLE,NGA'H_B/%H'&L.WCXHW+^N3((LIU
MPC51_<.PKR]FQV\L]"(4K!-563% * @^6</Q')H'VTY&UU%S'E(MZC2CW![C
MQ!JS7L</@A>M4N30G+.#9WC+Y$QKU81-FIS0);5X;OY%>PUZ.O:KZ&&];DKU
M6E8H!0"@% * 4!8N)<%SO)GQ]HWZ,$&SL]T$-@=PG^=7L%5;-RCKU+(UNC??
M%.(8CC,#[6 B[B[&1*78N.J'=1\/ =J\[9L=O+-T:U*X)NJR8H!0"@% ='F6
M7VE,O(2ZTL66VL!22/ @T3!KWD?X5P$]2W\2XK&2%:^F!O8)_P!AU3\#6J/:
MI=>3/?KI].#7N6_$O-L>I1;B)GM#HY%4%$_T*VJK3/LP_!16BD5N3@\W%44R
M<?)9(Z[V5CYVJU6GW*W+78Q?1>O;TU7Z6L;U+)'!E1L'FY2@F-CI+Q/38RL_
M.U1=I=R2EOL67$_B3FV04DN14P&CU<DK (_H3N555>S"\EDZ*9L+CGX6X_ 4
MA_*N*R<A-CZ:AL8!_P!@U5\36:_:I]."^/72Z\FPF66F6DM,H2VT@60V@!*0
,/  5E-!VH!0"@/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>120
<FILENAME>tm212692d3_sch14-aimg120.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg120.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ > !X P$1  (1 0,1 ?_$ )   0 !!0$!
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M]RRF1UV.][2WCA]SP?J(*]+R+"3$7;Q&U'M'4=A%>=DQ.CU-U,BLM#>U63%
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M5Y*XO%P&I>)QOA@PF,OF&VVE*/!"&E:>-P>%+6<-_$$EHOK-5%V_+1L!,ES
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M9-A&J3BU%Q0',L+X.?IX*K+U;Q:/9H[%)4^CA%>B810"@% * 4 H!0"@% *
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FVK/;0OIUTM]3H++++#26F4)::0+(;0 E('8 *RMF@OH!0"@/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>121
<FILENAME>tm212692d3_sch14-aimg121.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg121.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ > !X P$1  (1 0,1 ?_$ (P  0 " @,!
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C_9M/3A?3UZQUY7V.-(T5(U"(HT55&@ '8 *S+W- H%!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>122
<FILENAME>tm212692d3_sch14-aimg122.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg122.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ > !X P$1  (1 0,1 ?_$ )0  0 " @,!
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M:U9;]:RVU+Z9ZO\ "](6E:0M!"DJ%TJ!N"#V&LY><T H!0"@% 0VZ-V8?;<
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04)   '0 5F+SM0"@% ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>123
<FILENAME>tm212692d3_sch14-aimg123.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg123.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 1P!& P$1  (1 0,1 ?_$ )0   (# 0$!
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-37""V>6,&IAX4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>124
<FILENAME>tm212692d3_sch14-aimg124.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg124.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  1 !,# 2(  A$! Q$!_\0
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%Y3TS_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>125
<FILENAME>tm212692d3_sch14-aimg125.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg125.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ E0"6 P$1  (1 0,1 ?_$ )\  0 " @,!
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F_9_EV_V_Y7P].'@<O/I^+7O_ #K%?=^YKIM[)Q5IB @(" @__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>126
<FILENAME>tm212692d3_sch14-aimg126.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg126.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ E@"6 P$1  (1 0,1 ?_$ *   0 " @,!
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MU'F5$W)->L>:=: Y"%E)4$J*1S4 2![S0'% * Y"%JOI256YV!-O?:@.* 4
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MI:7V9DY#>..DR=KNH9>"<&E"9((3=>A25'I\?W?&I5HU>]O\B$_MUKU1F_\
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M\).5!R371D) 58$*24GD4J',5*F164HY?&Z[FO"DGD0:F0&I/F* 7%[7X^5
M+CCQY<Z !23R(/NH#F@% 9D%XHB9) Y.L(2?H?;5_94;;HDMF>>2_P#82?\
MNJ^VNUV.6W,>NG +7%^5Q?W5U!EA=U"^EC;B(A7^F>B;,4(OIZGLM]ZUJRX/
M]MY_-)HO_IKV.N-QF[Y6Z88ST-&0>:BEYE,U:4M(9 X+7IN;)\B*Z[45;-:=
MSBK=NJ>JZ&XST/;TK!8K*O,Q)91D S)7BV5-H6V#9382.*B*JHVLB6NM>O\
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MEJEQAN&"W>1&3IFH3S4T.2_>GQ]E:_6RP^+,WL8YU12];S&* 4 H!0"@% *
M4 H!0"@% * [LLNOO-L,H+CSJ@AM">)*CP %&PD?2&P-I-[:P+<90!G/_FS'
M!^,CY1[$CA7E9LG-R>CBIQ1):J+!0'"T)6A2%@*0H$*2>((/,&@*$[F]O7,#
M,5DL>@JQ$A5R!QZ*S]T_NGPKT<&;DH>YAS8N.JV('6DH% * 4 H!0"@% * 4
M H!0#B38<2>0H"Z>U/;LP$HSV5;_ -ZXF\..H?Z23]\@_>/[*P>QFG1;&S#B
MC5EGUD-(H!0"@/.5%CRH[D>2VEUAU)2XVH7!!\#74X#11V_^U4S$+<R.&0J1
MBS\2V1Q<9_S)K?A]A/1[F++@C5;%>5J,XH!0"@% * 4 H!0"@.[##\AY###:
MG7G#I0V@742?("N-P$I+G[=]J$8\MY7/(2Y-%E,0SQ2UX@J\U?96'-[$Z5V-
MF+#&K+.K(:10"@% * 4 YT! =X]I,/F2N7C2,?D%<5:1^2L_O('(^T5IQ>PZ
MZ/5%&3 GL4_N#9VXL Z49&(I+?W9#=UM*_F'+Z:VTRUML9+XW7<TH(/*K" H
M!0"@% * #B0!Q)X #F: ENV.V.YLZ4N]'T,)7.3(!!(_=1\Q_95&3V*U^TMI
MAM8N?:>P<#MIL*BM]::19R8[8K/L3^$>ZL.3-:VYLIB522546"@% * 4 H!0
M"@% ><GTW07ZK1T+?'U;:+>W5PKJ#*LW-%[*/R'$OS$Q)=_C7"2ZKC[0VAQ/
MU5KQO*9;K&0C(;?V,"I6.W2% _(B1$DIM["I+:OLK0KWZU*76O1FE>QL%N^C
M+1GK<M#<D7_J:35G)]B'%=SP$6.2!ZUH>W2[_DI+['(^TRX^(QCBAU<Y%93?
MB2U+4;>S2R:X[/M_0DJKN2#'8#MD@A62W.XZ/%IB+(1_>+9/[*JM?)TJ35:=
M66-LYOM,V[IPCD9V4 +K?U!T^7^L$\?<*RY?)U-&/Q]"?5G+Q0"@% * 4!__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>127
<FILENAME>tm212692d3_sch14-aimg127.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg127.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ E0"6 P$1  (1 0,1 ?_$ )T  0 " @,!
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M]77V=.FNJ\IZ*I/7?,GJQV&8[@=;,[>P\>EFONYK;ZE>\LOLV[0J1;600$!
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MTB%>Z_*TRCU:J$! 0$$UA+#FX3<4&NC)*L#M.]S;D/Z-57>.L?CPG6>DL3/
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M?IL^O++GL-%K6>2^]58.+"><C /N]X6[U]_^LLF[3YA5BV,H@(" @(" @("
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>128
<FILENAME>tm212692d3_sch14-aimg128.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg128.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ $@ 4 P$1  (1 0,1 ?_$ :(    & @,!
M      <(!@4$"0,* @$ "P$   8# 0$!            !@4$ P<"" $)  H+
M$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R( "#$403(C%0E10A9A)#,7
M4G&!&&*1)4.AL? F-'(*&<'1-2?A4S:"\9*B1%1S148W1V,H5597&K+"TN+R
M9(-TDX1EH[/#T^,I.&;S=2HY.DA)2EA96F=H:6IV=WAY>H6&AXB)BI25EI>8
MF9JDI::GJ*FJM+6VM[BYNL3%QL?(R<K4U=;7V-G:Y.7FY^CIZO3U]O?X^?H1
M  (! P($! ,%! 0$!@8%;0$" Q$$(1(%,08 (A-!40<R811Q"$*!(Y$54J%B
M%C,)L23!T4-R\!?A@C0EDE,88T3QHK(F-1E4-D5D)PIS@Y-&=,+2XO)59756
M-X2%H[/#T^/S*1J4I+3$U.3TE:6UQ=7E]2A'5V8X=H:6IK;&UN;V9W>'EZ>W
MQ]?G]TA8:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:
M  P# 0 "$0,1 #\ W]PP-[$'2=+6(-C8&QM]#8CW[KW58W\QWY[8_P"*>RXM
MB=>R09_Y"[_I?M=HX*GC_B#[4H*US1C=V7H8A(\TYG;QXRC(UUE58V\:-<9\
MH\KOOMQ]3==FTQ&KL<:B,Z ?LRQ\A\R.@OS+S NT0>!;]VY2"BKQTUQJ(_P#
MS/RZ(?\ [(C\X?\ 9.?[_?[,)W/_ +,-_>7_ $P_Z+?[^Y_Q?8?87_NU]Q_$
M/)_?GP_Y5X-?V'W'^3>/5Z_8E_K-RU_6'Z;Z2W_=&CP?$T+QK\5*?!Y5^*F:
M^71#^X-]_<OC_4S_ +SU^+HUGT^'C\7G3A7'23[WW;\K/Y6_R0W_ -IXO*5_
M:_07?><W3FJ*DW5DLG4[?H]SYB3(Y>@PU>S2SMMC.[9K*L_;-3Z(<CC(S$ &
M4B-1M=OL?.VT16+JMONMJJ@E0-144!(_B# 9KE6SPXL;A-NW*FYR7B$S;;<,
MQHQ- QJ0#_"17%,%<=#1_+>^'&\^UM\3_/CY8&KW#OO>%<VXNL=O9ZG*^!9E
M*46^<ACIUTT=/3486+ 46G134RK4?J,1!?S?S!;6-M_5;8J):1C3(R^?J@/G
MGXSYG'"O2WEK9;B[N/ZP[Q5KES5%/EZ,1Y8^ >0SU?=[B_J0.B@?.K_LF[=W
M_,E/^+OL_P#YG_\ \R\_X^G%?Y__ *O/_*E_S=]GO+?_ "5H_P#<GX6_L/[3
MX3P^7K\NB??O^28_]AQ7^V^#XAQ^?IT;#%?\6S'?\ /^ %'_ ,6K_BV?\!X_
I^+=_TP?\<?\ FW;V2/\ &>/$\>/Y_/UZ-E^$<.'EP_+Y=3_=>K=?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>129
<FILENAME>tm212692d3_sch14-aimg129.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg129.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 'P > P$1  (1 0,1 ?_$ :(    & @,!
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*JJ %J<T-1U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>130
<FILENAME>tm212692d3_sch14-aimg130.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg130.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!.0)8 P$1  (1 0,1 ?_$ *H  0 " P$! 0
M       #!0($!@$'" $! 0$! 0$               $" P0%$  !!  "!P4%
M!P0" 0(& P$!  (#!!$%(1*2$U,4!C%!49'1L2)2T@=A<8$R8G(TH4(C%3,6
MP207LD-SLR4U@J*#91$!  (! @0""0,$ @(#      $1 B$#,4%1$F&A\'&!
MD;$B,A,$P='A\4)28G(4@J+"XB/_V@ , P$  A$#$0 _ /U#7KUS7B)B826-
M)):/!!)RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;
MA,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3
M-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9
M"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@
M<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+
M5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;
MA,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3
M-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9
M"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@
M<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+5N$S9"!RU;A,V0@<M6X3-D('+
M5N$S9"!RU;A,V0@CL5ZXKRD1,!#'$$-'@@DK?QHOV-]B"1 0$! 0$! 0$! 0
M$! 0$! 0:&>YS4R7*I\SMA[J]<!SQ& Y^!.&@$CQ4F:6(MXS/LN?D8SL//(&
M#F-<C3J88]GBKN?+Q3#YN#+(\YJ9UE5?,Z@>VO9:71B0!K\ 2-(!/@M98TF.
M5MY95I,S>J[.9,H ?S44#;+CA[FHYQ:,#CVXCP2-;\"=*\6Z@U;F9TJ<U6&P
M_5ENR;FNW G6?ACAH[- 2-9HG2+:W4&?U,CHMMVHYIFOD9"R.NS7D<]^AH#2
M6J7K$=5K29Z-&AUMEUJ[#2L4[N6SV26UA>@,(D<!B6M=BX8X+41;,S2ZO6Q3
MIS6G123"%I<8H6Z\CL.YK>\J-1%I8I-Y&R3 MUP':KA@X8C' CQ5F*9B;9**
M(""J;U%5?GK\FB@L2SPM:;%AD>,$1<TN:U[R1@2!X)CK$R3H7^ILJH9U2R>T
M]T=K,&N=6<0-V2W^TNQT$]R8ZS,1R,M(M-)G-2/.H<G<'\W-"ZPP@#4U&'5.
M)Q[?P2-;\"=*\6^@(" @(" @H+O6>7U[DU2M5N9C+6T6C2A,K8G=NJYV+1K?
M8%(FXODLPL\IS>AFU%EVC)O8'XC'#!S7#0YKFG2' ]H6IBF8EN**(" @(" @
MY^_UI0JW9ZD-.[F$E7 6G4X#*R)Q&.JYV+=.&G *1.E\EF&W!U1DL].C;BL:
M\.8R"&J0#BZ0X^Z1A[I&!QQ6JUIF]+Z+511!HP9Q4FS>SE3 _F:D<<LI(]S5
MEQU<#CV^ZD:Q9.E>+>0$! 0$! 0$! 0$! 0$! 0$!!'9_C2_L=[$"M_&B_8W
MV()$! 0$! 0$! 0$! 0$! 0$!!S?U$ /25P$8@NBQ'_^K5F>./\ RAJ.$_\
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M4W;H]Q'NW:7,U6ZI^\8(,MQ!O&R;MN\:-5K]4:P'@#X(/'5J[PUKXF.:PZS
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M/\&C%2%I&.ILK=>;4:7N#W-C%D-QAWKVZ[8]?XBTXJQ'IZDF5JHH@(" @("
M@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @("
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MUY.DRR:QP/[6E7+/NQR,<.W*'VE>%ZA 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MIL;/=<RN[N=O!W5>9LT$<S?RR-:\?<X8KSR[,T! 0$! 0$! 0$! 0$! 0$!
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M0UWB1C_Y"RJ/4L\1NP?F0-2SQ&[!^9 U+/$;L'YD#4L\1NP?F0-2SQ&[!^9
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MEEH9G!,TUWE]:S*TX2,>XZPUCVEK\5U_)QB[ASV9FM7?+SNP@(" @(" @("
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M$#E:W"9LA Y6MPF;(0.5K<)FR$#E:W"9LA Y6MPF;(0.5K<)FR$#E:W"9LA
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MX@(*_("#E$!'8=<C;<M9\4QX+!940$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
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MJTJ?,ODY6N^=[V1\S5<1?#R7 !L;=74][M.DICK7CK_X\/?W:&45?A\>,?\
MKJO)>L\\=TM'=J-K2YH^^R@0(I'Q@N>&D[H2 EP![!*1]JLQKC$<[\HF?T9F
M:B;Y5YS'[IO^^P4(VT9X&RYI&3')6@U81KAT8Q$;W/+&N,P[2I=SIUKSHX8S
M,\OVM5CZM\Q,'UJ0BJ1B=E@3.:Z835YHXGM#&/&#??.#CV]REQ7=RFOU_9O+
M&KCG$UY6WJ/U2J6LTCRTY=+#.Y]9K]>6( -N#&)S/>QDT#W@W\JWC%^GA;,\
M+\+\Z=PL@@(" @(" @(" @(" @(" @(" @(" @(" @(" @("".S_ !I?V.]B
M!6_C1?L;[$&IGF<0Y1ES[LK'2!I:QD;< 7.><&C%V &GO*DRL0T!U4_D(+)R
MRUO)8W2R08-_QQL +GEY(:1I]W XE:RBI2-63.KJ$EF)D44KZLCHHW7  (V2
M3M#HV.!.MB01W:%>V;KTT2]+2YCU)5HW#7=#+*V)K'6YV :D+97:K"[$@G$C
MN"SCK\/:LZ%3J6K9S 5&PR-CD?)'6M.#=W*^'_D:W ZVC ]HTJQ%P3HMU 0$
M! 0$! 0$! 0$! 0$! 0$!!S/7W1T?5&4,JM<(K4$K9()CW#'"0?BW^N"Z[.Y
MV3;GN8=T-7+.N>D*6;Q]*5I=V*<8B98.J(-=@P,>OC^;_P JY;64QW)&YC$]
MKK7SP,U=>1K=?\FL0,?NQ[5QIU9H(KENM3JRVK,@BKP-+Y9'=@:T8DJQ%I,T
MX'Z0MDLC/\X,;FU\RO.DK/<,"YF)/M<O1^3I4=(<=GG+Z&O,[B @(" @K\XE
MRRA4GSBY#&31B=+OG-!> T$X-=@2,5G*:BXXM8Q<TY.+ZC]-G(H<QS++GQ.>
MR5]ZO%&V<0.;((I0]P#<=9SF]VD%:RJ-.51Y_P PSC<^?E%W[FU)U_TEE^6N
MFDJRUJE3_)8BY<-$ U@ULCFC0 7/&!"N6D^7MX41%Q?77V5=MBSU;TM%F3FR
M5'.L%V[GM-@:X,#7!H,C^W#6(4X7X?S^TE77C%^S3]VC;^H'1%%PEMTY('2L
M8]TAJ8DQ2N#8GN+0?=>[0,4CIZ6L]?7Y<6_E%3)^I)(LYLY8:MK+;4T,$3S@
M08'EC'O:,!CW@=RU$=NO6#+IR_>(EU*R@@(" @(" @(" @(" @(" @(" @("
M @(" @(" @("".S_ !I?V.]B!6_C1?L;[$&EU#2N7<IGKU!$Z5X_XIVZT;QW
ML/ACX]RSE"XRYRGTOU)%D]3+]Y7-3$R6Z3Y96C @:L+9 U[M0$$N'?\ <NF4
MZ]68X-U_368OMN8# S+[%B"Y.&EVNQ\(:-VP:H!:2P:=&'@IC->R9GWD\/7%
M&8]/9Q;GM$/KLBS-D4=XXO)8(7$@QC#WM9IPTX8%3'QZVL]8Z4SR_IN]7O5F
MR/B_UU":>>J6EQE<9];!KP1@-36.D'2K$]>-4DQTYS;HWM+FX!Q8?$8?^<5%
M1[F7CO\ )OH@;F7CO\F^B!N9>._R;Z(&YEX[_)OH@;F7CO\ )OH@;F7CO\F^
MB!N9>._R;Z(&YEX[_)OH@;F7CO\ )OH@QD:Z.-TC[#@Q@+G'!N@ 8GN0473'
M6.2]2;YN6W)-[ ??AD:QKRW'0\##2TKIN;4X\6,-R,N"_P!S+QW^3?1<VS<R
M\=_DWT0-S+QW^3?1 W,O'?Y-]$%=<SS)J4S8+>;10S.. C>^(.Q^T8:/Q6HP
MF>$,SE$.;S;ZJ=-T+3ZL$UG,9HQB[E&,>SQPUB,%UQ_'RG7@QEO1"JK?4KJS
M.'2R=/9#+;I-=J,L/<T:<-.M@W#R*W.QCC]4LQNS/"'MF7ZSYI&ZIRU?+X+0
MU'3!S=>)AT..()/D$B-J-;LG[DK:M](>EAD<>76F.FG;B^2ZW!LID=VD.P[/
M %8G\C+NN&HV<:IH2?17+GUY1)FUR>R&%M1\C\&1D#W<0,<<%O\ [4](9^Q'
M5KU'?6;+8695'7K71"&MAO/<""P:/>)()/WI/VIUX$?<C1%8RCZG=6.&4YXV
M/+,JB>TW)8\/\P!Q]S G'V*QEMX:QK*3&>6DZ0^D4,KAH4X:51[HJU=@9%&
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MPLU)F$!S)"  6/)]W^FA!U: @(->_?KT:KK,Y.HTAH:P%SG.<=5K6M&DEQ.
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M*9J5FQ/E?8ETF2>3\SG$XDZ.P:= [E!L("#6S#,:M&!TT[C[H&$;1K/<2X-
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MMU& URW_ #3:[R-8C'5U&H-C+,N@S:A4AS6-TLF4S>YKC!LNJW_%(<1[V+'
MG[4'1,8Q@U6-#1B3@!@,3I/8@]0$%7GW^_? V')C'%,_6+[<N#A&&C$!K/[B
MXZ/L05F5V3-<@NQL<*F>0:EI@&(BM0M+27:-&L,6G[0$%WE>3Y?EE6.K3A;'
M'$"&GM<<=))=VZ4&X@("#B<XSVXZ[F&6YI6D;EKHY =W'[T<8>UD=ALA=@_$
MNQP Q!5%SEU*+-H*%O-(2;V6N>S5>,!O6^X9-(T@@:P[M*@O&,9&P,8T,8W0
M&M& 'X!!Z@(*WJ&_:HY8ZQ6:"\/8U\A8Z01L<X!TI8W!SM0:< @Y_*LWN2YK
M%>FKEDQ+:=TL:X-EAE)=5LM8<7,&MB"'=F/@J.CRO(\NRR-S:T0UWR.FDE=@
M7E[^TX]V@X:.Y0;Z @CGLUX TSR-B#W"-A>0 7N[&C'O*#C;^:9C?BL0671,
MC-GEMRT%MBG.),*LVDG>->[5.@#M^]47M&G4S4TLXN5RV]#$Z(12# 1OQU9-
M!&G2-'V*"X:UK&AK0&M:,&M&@ #N"#U 05N:7[S8)!D\<-R[#(QL]=[]75:?
M>=B1V.U?RXH*>AFM6QG;;-0/#+[.7S*LYIUZ]B,'=F1N!P)&LT_@@O<KR;+\
MLK,KU(@UK,3KG2\EVEQ+OM0;J @BL6H8-1KWM;)*2V!CG!I>_ G5;CWZ$'*Y
ME9S=\<M;-'5X;K!%<RJ2+6&K,'D" XDZYT88CM!07%3+<MS"S!GTD!YJ2NV-
MK)1^1IQ+AJD=NG#$H+<  8#0!V! 0$! 0$! 0$$=G^-+^QWL0*W\:+]C?8@D
M0$$,M*K-8AL2Q-?-7UMP]VDLUA@2/M03(" @(! ((/8=!0:]"A3H5FU:<+8(
M&8ZL;1HQ)Q)0;" @(""""C4@GFGBC#9K!#II.USB.S$GP\$$Z @("".2O7ED
MCDDC:^2$ET3G $M)&!+2>S0@D  & T#P0$! 0$$%2A4J&4P1ACIWF29VDN<\
M]Y)03H" @(-:[E>77MWSE:.QNG:T>\:':I^S%!LH" @(""."O!7860QMC:YS
MGN:T8 N>=9Q_$G%!(@(" @U;>4Y;<GAGM5HYIJYQA>\8EI.G1Y(-I 0$! 00
M5Z56O)-)#&&R6'[R=^DESL,-)/@.Q!.@("#4S/*<OS2N*]Z$30@ZP:<1@[#
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8 @(" @(" @(" @(" @(" @(" @'L0?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>131
<FILENAME>tm212692d3_sch14-aimg131.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg131.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'P   ,  P
M      ,$!P$"!0$  P$! 0               0($!0 #$  " 0($ @<%"0
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J>(?K[L=.CU)2VYK=6SSUBI5(J"DI0LA9V,BZF+:=  3/CA5;/B,!4__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>132
<FILENAME>tm212692d3_sch14-aimg132.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg132.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ,P R P$1  (1 0,1 ?_$ )4   (# 0$!
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>X,=>08:<S:=F_P#)_8>O\S_/M1/CKU:#L-.&I__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>133
<FILENAME>tm212692d3_sch14-aimg133.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg133.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 6  R P$1  (1 0,1 ?_$ )    ,  P$!
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M-BRB2,Y5O!3(^6;:94TDSTL)DD>)F4GH<'ZPYCVU(Z[(;%*G"1]B1M-CJ?\
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M4 % !0 I;K?<"[?0;_JIIW7\T*O\&+6P_P!F7/\ C(^8TWM[H7UMF5*I"D*
M"@ H * %+=;[@7;Z#?\ 533NOYH5?X,6MA_LRY_QD?,:;V]T+ZVS*E4A2% !
M0!(MPLQS^VY(]%MX4Q 0E)8*6@L+!'$]1JVFN#CE[DMLYIZ"U^(FYOUZ_P"0
MG\E-]-8OVS,2ZY?GUVM[MOGK<=B/@!UOR0G4 @CB!WBM1K@GE&93FUAF-8;[
MF5A:=:M7F,(>(4X"T%:D<N=>SA"6YY&4H[&T_$3<WZ]?\A/Y*QZ:S?MF>\#<
L#=!R:PA"EOE2T@M>0GQ GCV5XZ:\'JMGDN'G3_J4_N.OG_K?!ZJY^A8?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>134
<FILENAME>tm212692d3_sch14-aimg134.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg134.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ,P R P$1  (1 0,1 ?_$ )8  0 " P$!
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'.DHEE __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>135
<FILENAME>tm212692d3_sch14-aimg135.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg135.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 40 R P$1  (1 0,1 ?_$ (P   (" P$!
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MF@MM?<*B.GHX'2R2.#1JC<&.DKDI)5.J+=!G?M1-H;[MA_ET*+^DK_ M>?\
FR)_ZI.&HW+01.GTE:1G@@ "Z +@#$V2^^O\ 0I-DIUQLJ(K/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>136
<FILENAME>tm212692d3_sch14-aimg136.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg136.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ )P R P$1  (1 0,1 ?_$ )$   ,! 0$
M       %!@<$ P$  P$! 0                ($ P$%$  ! @0!! T)"0
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1?2>MEZ/A0G(]'U#?3\_!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>137
<FILENAME>tm212692d3_sch14-aimg137.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg137.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ +  R P$1  (1 0,1 ?_$ )$   ,! 0$
M       &!P4(! $  P$!                  ($ P40   $ @0&# \!
M       ! @,1!!(%!@<A$Q14%1<Q05%AT7*2,Y,U5=5QD:$B,D)2LE-SLZ1E
M)C?A$0 ! P$'! ,!             1$" R$Q46'1$P2A(C(409$S$O_:  P#
M 0 "$0,1 #\ 8FIJU-L;8KD"K-QAYY;QM16M+3:&R-5$DHWB'3:,(.Q \IR9
MQEU06W[?3TCXQ]F&!IL2Q#5!;?M]/2/@]F& ;$L0U06W[?3TCX/9A@&Q+$-4
M%M^WT](^#V88!L2Q,"UUFK6V0;E)M^N5NJ?<4EHV772-)I*,3I0&M.<9V,)4
MA*%KFCK-M9G">JX^B7._&XWD";$>HV]+H9]V']-8\,W]-0>O^?T+1\SH <TN
M      !++^NJZI^>Y[A"SAWJ3<FY";]V"G4GT-N[#^FL>&;^FH)7_/Z'H^9T
M .:7       EE_75=4_/<]PA9P[U)N3<A-^[!3J3Z&U=HXVW>6RMQ1(21S<5
M*.!>@K;,)7_,>EYE[RZ2SAKEIX1SF4M<,NDLX:Y:>$#*#AETEG#7+3P@90<,
MNDLX:Y:>$#*#DOOVF&':LJHFG$.&3[D22HC]0MP5\1+5)^3<A.N[!3J3Z#/;
M"Z:T<O6\Q,5,QELB^M3C9(4E+C=(XFDR4:8PVH#*ER(JC*:5*"O8*,[9BU$B
M2E3=6S;*$85.*0N@1<8L W2I%;E0R6$D^#*IK]I7C,.(%-?M*\9@ ]DC5-=5
M@49&4F9HB.!FRA:R(]\R"K)$O&2*K<,%6W76WGWFT+D52K2C\Y^842226[1B
M:O(,I<B"?(Z49*4[5%4^<+ZOR'8+G?C?X)/87J4["=!]$YN3*]CG49=I?1=
MJ60XK)8X8TX^='C8!7Q\F<GK9NQ,OT/\K]N*^_(F[,P_0_ROVX._(.S,9;":
G.TRQH#3D<8G'8O$8B$<..]6C#9V]P8UG;N_DTI,]CEU'/+0 !__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>138
<FILENAME>tm212692d3_sch14-aimg138.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg138.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 4@ R P$1  (1 0,1 ?_$ )0   (# 0$
M       &!0<( 00!  ,! 0$                #! 4" 1    0# @<,!@L
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K)T[X$#N44YB,CG<H,PR#N4&89!W*#,,AOH[X"^@?PM_V@FKB-IC(%##_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>139
<FILENAME>tm212692d3_sch14-aimg139.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg139.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ +  R P$1  (1 0,1 ?_$ (D   (#  ,
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M-*@KW=>:;J6J9URG!92IY"%*2%)J0H@D RD#/;%G':L9+F3N0V(C*@@ ( "
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>140
<FILENAME>tm212692d3_sch14-aimg140.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg140.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ )P R P$1  (1 0,1 ?_$ )    ,! 0$!
M       %!@<$ @,!  ,! 0$                " P0!!1   0(#! ,*"PD
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I4KC7%XIXL6<IM8-#GNC3^W)+W?\ 9?3-W^NO]%^*)[CT?<-MK7D?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>141
<FILENAME>tm212692d3_sch14-aimg141.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg141.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 5@ R P$1  (1 0,1 ?_$ )D   (!!0$
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M.6K4NVVYQ8<<BSDMJ6D8 D8[1C5LY9K;\$L(XFD='5RSH$H G$G'#$8\W+0
MG->OSMJ_#7Z:NXG<DY/8U--;AJ#XI;([275V(D!SM$CL@SRE*N?FK;U##^IE
M3GE?0,=4YN=HR(/_ %U+G8J*N\+82%+XAU0<=PI''4'G<-N<OZBKRFY/<U%M
M;EPXN^JFI,CC&"N/;CC5EF/\WC3!-#.]9.D20!B3@.FN6= E "#%]N\358F1
M,=2TFX]DZDK/!V)5AAPG9AA71V)U_8AW-6?<]W7J,Z5VJ3A]D0XUC[W6]%+X
MCU&<E:!GI;<8TS)<$,JQ5'2674<J5))W^7?2+XXFQM+S%!6M:4(4M9X4I!*E
M'< -])&B LCHN^KC4J(.-DSUO)/.VC'UJZ4OC5A_0ACUL"?76\28XMD.-)6R
MH\;SB6U%)(W))PZ12>)%/+8SDRQ@P>)YF_5N_P# =MUCN^7\[IK=L?V#+_4T
M=:<LO0[RW?HZ3W>6$I>4-R'D;C]*O7%LRMIYY$,/(4V>;:]1<F&V2W W=(Z4
MAP^TEQ P2Z!\E7+29)U3RM!L6K(X%]X?G_(EP6J,AU#:C@7&DEUAT#G !JK=
M"Q$^)P9DN&<]1,SH%M;;="'?56S&:4CC^<H_'6*JN'4UV3ET#S(.2HV3K<_?
M;XXA$TMGBV@I9;W\(/*I7+4]UN]X0ZJO8LL7\AZ=J#GQ'9I*6%K"4 C$-QFS
MB2KRU2DJH"'FR8^/!+9]R/RW<_\ 1^17.W,NVHONMK@W6 ] G-!Z,^GA6@^D
M<Q%9&33R@:36&(O,.3LSY'NOB5K6XN&A6+$QL8E*3[#J1^ZNC"V-BPR*5<H/
M*":Q:ZQ5,!N^0E!P# OQ<%I5] G9\-)GQ'V8R/)7<WY>MV5([2O#X;[SN&(0
M4):23TJQ5Z*\KBR>IZ?(CV :XWK.>H=P1%CM*[JE7JQV\0RW[SBN4BJ%&%2R
M(<I6,;F1,C0LKV\H!#T]_ RI.&_W4^Z*BMM<WX*ZZU%!/2AA* *+0A:2A:0I
M"A@I)&((Z0:  '4+(V54Y=N=U:M[;,YEI3B'6\4^L/='J^:J:;9;DL]!%M<<
M-X!#2#*=@OC4YZZQ1*5'6@-!1( Q&.X$4[DV2CC JB">HYH5O@P60S#81':'
ML-I"1YJA;;U*TL&Q6&DH E $H '=1/\ Q-X_VZJ;3^:%V_BP*T%_)W3\1'\-
M/YFJ$\;1C7J,J)0!* +'9##6':N);QW<2@,?AHP!C[]!_4-?73\=;AF9![4&
M9$7DN[I0^VI1CJ 2%))/GIE*^:/%K^+ S0I]AJ)=.U<2WBXC#B4![/33^6NJ
M$\;1C4[]!_4-?73\=2893DJF;#4H)2^VI1V !:23YZ,&Y,U8 G-8+<R]F%AT
MW7NJRR 8ZVI2D@ [TJ9;6C;R[:NXTOCH27KKJ GA#7^<1_1G?VJHW>/0C;Y]
ME%6ACA/'?&N'EXF9V'[<6J-WCT&WS[+6[1$V]E?&.G@9F^?A:K=WCT&WS[+_
M  AK_.(_HSO[59N\>@V^?9G@V=A4V.%WY*$]HC%2&9Y5UAU1V6^L<NFGHU1Z
5Z^SHWLC]\[_(X=Q^ONZ_17+.@?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>142
<FILENAME>tm212692d3_sch14-aimg142.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg142.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ '@ > P$1  (1 0,1 ?_$ 'T   ,! 0
M      0%!P # 0 " P$                "!  ! P40  (! @,%!04)
M      $" P0% !$&,4$2$Q0A49$R!['1(M-40E*2(S-3LW05$0 " @(" P$
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$G)__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>143
<FILENAME>tm212692d3_sch14-aimg143.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg143.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ ( #( P$1  (1 0,1 ?_$ 'H   (" P$!
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MQ9"[)ZT!W==M!OJ>;>.I\X(<Z2Y16ORMQ+I@X+O7Q02=1 7W%H'\# P$P)"
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J,R&Q<3KZMTZ+]J:#J@P8D"$Q!AM(S$BMBS'9'Y0;!.T13[$1-!OT'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>144
<FILENAME>tm212692d3_sch14-aimg144.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg144.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ 1@'" P$1  (1 0,1 ?_$ *    (#  ,!
M       '!08( @,$ 0$  P$! 0                ,$!0(!$  ! P(# P<%
M"PL#! ,    ! @,$  41(08Q$@=!88&1(C(347'1%!6A0E*"(S.3=#55%[%B
M<I*RTD-3LR06P:)SPJ,E-O!C-!$  @(!! (" P$! 0        $1 @,Q41($
M(1-!%&%Q,D(B@?_:  P# 0 "$0,1 #\ GI_$36[<^4VB[O)0AYQ*$X(R"5D
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M7]6K2GX),[4_D6=5" !2% J&\D$;R0<,1CF,>3&@#3>C+G9+AIR&[9D!J$A
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MB3.HL4>J!0V.!=^90N=8W5;KCI$J*#[[ ;KB1SY U'VZ:,IZ]O@;U1%(4 %
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M.!U<)=?F>RG3]T=QG,)_LGE'-YM([A/PT#K%0]C#'_2T*L.2?#&;4A0% !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H 3?&F-IE<]#S,M#5_;2D28H2
ML^(T>Z5*2DI2M/.<QT5=U7:/P2YTO_17[B?AI_W>BJR<G-%'4#>HXSFGAX]Q
M1BKP02E*VQWTN%6ZD)/.=M+R\>/_ %H=XYGP:$]I7C[H=_\ S>+\\Q\__([_
, /OV5F\5N6R]C__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>145
<FILENAME>tm212692d3_sch14-aimg145.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg145.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!*P&0 P$1  (1 0,1 ?_$ +\   $% 0$!
M      ,  @0%!@$'" $! 0 # 0$               $"! 4#!A   0,# @($
M!0X("P4( 04! 0(#!  1!1(&(1,Q02('47$R(Q1A@9&QX5)RDK(S4W,5-:'!
M0M*CLV46T6+"0X.3)#1$=!=CE"55-O""TU1DA$5UE:(F5B<W"!$!  (! @0%
M P,$ @(#      $"$0,%(3%Q!$$2,C,542)288$30F)R(Y&Q%#31@B3_V@ ,
M P$  A$#$0 _ /IR2Y($R(VVH(#H<UDB_DI!% ;ER_ID_%]V@7+F?3)^)[M0
M+ES/ID_$]VJ%RY?TR?B>[0+ES/ID_%]V@7+F?3)^)[M N7,^F3\3W:!<N9],
MGXONT"Y<SZ9/Q/=H%RY?TR?B>[0+ES/ID_$]V@7+F?3)^)[M N7+^F3\3W:!
M<N7],GXGNT"Y<OZ9/Q/=H%RY?TR?B^[0+ES/ID_$]V@7+F?3)^)[M N7+^F3
M\7W:!<N7],GXGNT"Y<SZ9/Q/=H%RYGTR?B>[0+ES/ID_%]V@7+E_3)^)[M N
M7,^F3\3W:!<N9],GXGNT"Y<SZ9/Q/=H%RYGTR?B^[0+ES/ID_$]V@7+F?3)^
M+[M N7,^F3\3W:!<N9],GXGNT"Y<OZ9/Q?=H%RY?TR?B>[0+ES/ID_$]V@7+
ME_3)^)[M N7+^F3\7W:!<N9],GXGNT"Y<OZ9/Q/=H%RY?TR?B^[4"Y<OZ9/Q
M?=JA<N9],GXONT"Y<OZ9/Q/=H%RY?TR?B^[0+ES/ID_$]V@7+F?3)^)[M N7
M+^F3\7W:!<N7],GXGNT$<KEIR+3*UI6TXVM1&FQNDI Z_5J!TG[R@^)WY(JB
M;0*@5 J!4"H,OOKO"P6RXD:3E0ZX9CO(AQ8R X^ZYTE*$DI'#QU%56)[YMJY
M#%S<@ZW+Q:8#K;#\?(L^CN<QXD("+J*5:K'H551LCDX22TE<EE*GP"R"XD%8
M/1HX]KUJ!\B=%84AMYYMIQPV0E:TI*CZ@)%Z"B@[[PTO<>7P(ULRL*EI4QY\
M)0P0\ 4:%E7'RNL"L8RI^]=\XG:&WU9S(MO/PT+;:TQ4AQPJ=(2G2"I((N?#
M62*C9_>U@]T9AW$,P<AC)[3 E!G),!CF-$VU-V4N]!KD9.$MI3R)#*V4$A;B
M7$E*;>%0-A168S_>?@L1G,9A$-O9/(94K]';@<ET)"+:BX5.("?*HC4HR,-3
MRH_I#2I"!=;(6DK ]5-[T#$Y;'JU:93"M%N99U!TW\/'A4"3E8"M)3*9(4K0
MFSJ#=0_)''I]2BG+R4)#XCJD-"0?)9+B0L^)-[U4<.4@A8;])9YA5HT%Q&K5
MX+7Z:@>J?$0^AA;S:'E^2TI:0L^))-S3(1G11(]&YS?I%K\G6G7;X-[T&4W_
M -Z>W]CB!]L-25C).<I@QFTN:57 NO4I%AQJ@.4[UMNXW=V,VJ^F2YD<J@+C
M.,H2ID)/$<Q94"+CCT5C7C,Q]%:Y&4@JD*CIDLJD)X%D.(*Q;^*#>JCK>3A.
M+4VB0RIQ )6A+B20!TD@&@I=U;]P>VMONYV6I4J"RXAI?H>AY>IQ6D<-0'CX
MT%S#R4:6REV.XAQ*@"="DJ(*A>QTDV-%8+/=^^S,%N!_"S6IRU174,2\@U'U
M0V77/)2XZ5#CX;"JCT5EU+K27$D*0L72H=!!ZZ!RR0.'2>%!A-O=\.UMP#<'
MH*)3:MM!U602^VE*E)8U:U- *5J'9-KVJ+A.V1WE[<W=@?MV IR) +I8!GZ&
M%E:0#P[2AT*\-7"-,B=&6X&T.MK64ZPA*TE13[X 'H]6H(F4W!C<;AY.8E/I
M&/AMJ=??;\X E/3;3>YHK XW_P#Z"VKD$R1%Q>76_'8$I$0Q 'GV20 MA.OM
MCC51;[([V\+O+*S<7CL=D8DC'H"Y2IK"6DI)-@BZ5K[1\%!>[NWAB]JX)[-9
M0.&*P4I+;".8ZI2U!*4H3PN2345DXW?OM"1A)^54Q.B*QSK3#^.D,!$M3C]@
MTE#6HWU:AUTD<;[]-HG;JL\69X"90Q_V68_]M,D@'1R0JW0H'RJ&#?\ 7W9?
MV"WE>1D"^[+5!1APP/3R\V 5^9U]"0H7[5!L-G[LQ>ZL''S>+4LPY-]*'4Z7
M$*2;*0M-S90JHO*!4"H%0*@5!#>^]H_U3OMHH.2?O*#XG?DB@FT"H%0*@5 J
M#SCOKQL:=A(J9.!F9EII[7Z1C5)3,A*L-+[.I2+GPB]17ET# ;OR6S,^UE8N
M7S6$BRX,C"M9Q#:YI0VI?I(2V%N)  *>%Z2+#<N$>+V::7MJ3-F9-B.=CS([
M*.7CVAY+#>HI,9QO\O2.-('<OM_*Q-SRCO? Y#= ?@0FL3*A$*Y<EL)YW)6I
M25,K*Q<J%KT1#W#M?=CF^,SF58EV5MR-]GO9#!OCF.3 &T(*"KM)<+)[1N>)
M%6!Z%WUXR9F>[%$;$17=3TB$MF.TBSC3?,2?('1RQU=504^4[HMPP-HYG(X[
M.Y#-;IDX],>$Y+<.MEFQ+C+%CV5+O:DJP\/;&?D;1W<AC%/Q1(QK,?[-:CI8
MCN2$E6M:4)/:=/Y2K<?#5E&SG=VN)8WYM,8[;T5F(C&23*=1&0&TS.6CE..V
M'%85>Q/&@S&W=NY])PD!& G1M[0Y[[NX=R.A)2]&+3@5S)&KF.H65)TIZJ"1
MA=@/-=R;K1P?*SLO)!,LAH)DKCB>A0"E>44!L='@ID/WMW<EL[_7B,.IODNX
MQS;S<=&E"'#RE2'8R1P2N^K4H<>FD'BJ]X0]USMP)4-MN,Y"-(QRTY9IA+DE
MU"$M%Q1DJ[;8O>X1T]="3\SL+).[6WGDD8AY6X!FV)&*D)19\("6]3C)Z1<W
MU$5/$6$'#28N?R"=V;8RF>STF6P_A\O$4D*0R$#2&WU+0IH(-]8ZZI*G3M/?
MYW@]'G1I36:5EDR&,^PTA3RHUS9(D*(4EC3P*+^M2"6_[_=LY+<$_:\>)#7*
M9#SWI"FTW#=VCI*CU=H5/$><[:VUWA+W#MW.97&/O3H\GT< I(\W!BK9:U*/
MD\Q21Q]6]7QS!/(.3 W?/W'@LDUM=W"9"/G$.Y-R+'2%I;4^-?.FCSSHT_D\
M4VH-)CM@YI.P=ZOX[%J8W#+RSZFWDH#<IZ#S=2VFG."M+B=5A>W&@[N'"1,C
MW=YR)MC:60Q!>7 +K2TI0T\XA5G"TPA1"5)_+5;C2!K-A[<EX3O5S+<."N#@
M7\=%6E+:=$=<C2=:K#@5^$TD9WO'STO+[M^P)NV,FK:$.2AZ8YCV4%S(26S9
M(<*E( 8!-[WN?!4@>NYB/NF1 B';3\> ; N(EH*K(MP2 D*L15'=N1=Z,N.J
MW%-B2FS;D",@H(/7JN!0?->/V=O^%FI4B%CY#,?.YY<&<H)()AE[F%Q7^S(-
M/##+/'(\/ [KA;=;V\]M%4V"J?-+,UUE$DMK-T-I;CNGE]H %*U6I*.L8_<V
MTMGX'=J6EMYYM,C O0Y!L^6Y1"8VE -U);5JX#HZJ(]SP6(C[&[L6(:HJ\I]
MFQ"N1%80%+DNJ[2@E*K E1/745@^[O+93([HS.X\KA,I%SH@.M8N.XTA&/BQ
M6AYMADA6M3CAMJND=%5&CVE.3LKNR<W+F8+[N1FN&?F&V4H])4[(<X).LHOH
MUVM?HH-!OG<KF/V;]K0\0YF)3R&W(..T:U<Q8"D%Q)]Y>Y\58RKQJ%ALWD]M
MN9H8G,2MR1LM$RN<,QMMM<A#2TDMPTA9!2TA/ *M62+MC.[EQ.%W/NF/MB8Y
MD-QY53^#A/M(4['"6&T)DNH!5ILI/"W@J"EQ.,GXL;?WA$PV;R3N+GRWMQ*G
M-MIR$A^8AL<UI 64EM.BW%561ZOW)X;*8O9:4Y..J')G2Y$X1%>4TA]0*4*'
M41:BO0*(5 J!4"H%00W?O:/]4[[:*#DG[R@^)WY(H!9_<&,P..<R.3>Y$-NP
M4L)4LW5P "4 J/K"ID":W+BGLE'QS,E*YDF.933(!N61;MGP>5UT%;+[R]HQ
M7<@T],5S,9_>T(9><-[V(;T)/-*3Y6B]NNF1=XO+P\I!9GP7.=%D#4TNQ23X
MTJL0?"#5$-W>&":=6TMUPK0HI5I8>4+@V(NE)% T[TP%K\Q[_=W_ ,R@;^^.
MWR;\U[UH[_YE0RXK>6W^'GG@?#Z._P#F4,NC>.W_ *5__=W_ ,RAES]\=O 6
M#KP)_P#3O_F4,N_OCM\?SKW^[O\ YE4RX-X[>!/G7K_Y=_\ ,J&3CO/;]OG7
MO]W?_,JAJ=Y;?/'FO&W_ *=_\RH9=_?#;WTKUNL>CO\ YE4RX-X;?(MS7K?Y
M=_\ ,J&7?WQV_P!)=>\?H[_YE4R7[X[?^E>]3^SO_F4"&\=OW^>>]3^SO_F5
M OWQV_>_-?\ ]WD?F53)?OCM_HYKW^[O_F5#)?OCM^UN:];_ "[_ .90RX-X
M[?Z Z\+?^G?_ #*&7?WQV_\ 2O<?_3R/S*&7!O+;YX\Y^W1;T=_\RJ.G>&WB
M?G'K_P"7?_,H9(;QV_T\Y_\ J)'YE#+AWCM[K=>M_EW_ ,RH9=_?';]K<U__
M '=_\RJ9+]]-OIL.:]X!_9W_ ,R@ZK>6WR+%Q[_=W_S*&3?WRV_JMSGKVXCT
M=_H^)0R[^^&W_I7_ /=W_P RAE53Y>PLCEHN4FLKD38!_LKBX[Z@VKIN$E%K
MCPU!:C>&W@>#CP_]N_\ F53+G[Y8 GYY^W1_=W_S*&0I.Z-K2&RW("WVCQ4A
MR*\M)L;BX4BW BH9%1O#;HL4NO='"T=^UOB4,NKWGM^W%UX?^W?Z_P#N50OW
MQP%[\UZ_^7?_ #*&2.\MO@B[SU^K^SO_ )E AO';P.KF/7_R[_YE0RXYOC;S
M:%+4ZZ$(25+48[]@D"Y)[%46F-R<3(PV)L-P/1)* XPZGH4A0N"* WI48(4L
MO(T(.E:M0L%7M8F_ T#EO,HTZUI3K(";D"Y/0!>@27FE*4E"TJ4@V6 02D^
M^"@ZE:3T&@B.J!RL>WT3OMIJ!2?O*#XG?DBJ*7?NTSN7'1XB2WKCOHD(;?+@
M9647[*^44+Z^HUA,?="^"HQ6PLMBIV+E,3F9+^-Q:\>7)"%:G5K4DA:BBW9
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MU:'"#RP$A(LCJZ_#1*__  T\G[R@^)WY(K(3;"]Z8'-(\%!T) J8"JBNV_\
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MB TF_@H'+\GV*#M!Q72*#M T^6GUZ!U Q/SB_6H'T X_S?KJ]LT!+B@8T1H
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M&WS9;S<=JX',=4E"+GH&I1 XU)D<1D(2G$M)?;+RT\Q#06DJ*/?!(-RGU:*
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M"2R^T\@+:4%H4+I4DW!!\!%!!V_]VCZU[]:J@L'/(5XC0=3Y(\5 -[^;^&*
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M<"KKI7FQO'#JRW>4;;?:NL$!Y-P+> ^"N-O-HMI1CZNSLL8UOV7NT [^[6/
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ML8Y44NZ;J+@/4>UT5I]KND:5/+C+=[G:YU+S:)Q"_C]X^(>C&0ZAQA <#8!
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M,\&FQ7>'.8<??R2?2@#RVDMA*2FQOQZ*ZW;[G>(^YRM?:*S,>25[([R<?R'
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MK5!Y4]NZ1E]QHDRVIK AR&$M820@+BN.W"PWPL1)0%!P*Z+$<*HV^R-I2<%
M2B?(3,D(U".$H"$,M%:G$H X]L%9NJ]04>^-[S5KDXC%QYZ4QW0W+R<*R7-0
M^<88U W<Z#>@C;:P,K< @3&\@48Z Y(:?D!H-R)P6M*KN*-[*[/;/70AL=R;
MEC;9@L.&*Y)=DNB/#A1DW4XYI*M(\'92355YUCY^XIF<=CY$/JR>4+S+,66A
M+K+##B%*;>CD :>7P0XGK-^-$>F;5V\[AL:TQ-E>GS[ /35("-1 L A(\E('
M5>@\]W?O*7GIHQT03L=B(BE&?,0D!+S#A+2'2D\5L(<2KF@$&U!:[+Q>3W#)
MA;HE 0,=Z,EA.(2TE*7EM*4 ^HG\@CBE/X:#TE(   %@.@"@5 J!4"H%0*@A
MN_>T?ZIWVTT')/WE!\3OR103:"FW'N?&82%SYKP:YETL7!.I=N'!()Z:#$;?
MW+F,K/=P&4R++DIYMA]#K#(XM2V%EUH6-ARS8!1-_4H-3LO9V.VE@Q CNK>T
M\793OEJ"!9 /3P0G@*@Q^X>].>WNW'8_ \A^"IB0[)YP6@*=9"B$%S2K2"$\
M"+\:HO\ #[3&7?Q6>S,A3TEAK6F&E :8"BLN-ZD FY;*NR?#QH+;=>X%8Y@P
M(3K0STYIW[(9>X)<=;3<B_D\+]9J#.XB1E<\Y.P,O*#TS'^E0L@ZQ'"5JU);
M4T[JOYL@ZAI3>]4:J% Q&VL#IUJ1"B)+LA]PE;BE=*W7%=*E'K-!YON+O$WI
M'SZUXUEB9MJ7%0[">+?!:7'$M<QI0NI:VU. J;4$T&QP&P6\?N"1GYD]Z?D'
MD-("5 -L)6VT&U.):!4-2OP#A4$/>F^?18<Z%@Y(3FHBDJ6M;1<:2$6=>0?"
MH,W504^/A9'O.PPDY1:\*S'DLE,>.DAU1:(<*^:K0KSJ3PX=FJ-]DLKBMO0&
M52E\E@J1'8%BI2G%<$I  XDVH,!C-Z9_*OF+Z9&=<ES?0W& Q=<(*N4+'&SR
M% 'M*TVH-=M3:$3 +R+Z'UR9$^0IXK<%N6V?);0+FP'6>NHJDS>],E-GB+M*
M9#6J(%F2B5<!YQIT-K90LBR=(OJ4+D>"B.XO"G><3'9G,:HQAS7G! 9&AI0;
M4I"0H\"M.L:PHCC5%]NS=,';V/<<=<2F6\V[]GL$$AQUM!4 0D$Z?#45B=K;
MEWAN*:C$97S,62AQWTOD):<4C2"IK0E2DA/@7JN?!51O=L;;@[6PB84=Q;Z6
M]3CLAXZG%J4;E2C08W-=X^27GX/V&MB5AYD5;C"W$J2VMQ!LM*W "I"Q<:4E
M/:X\:"YPVSF)F0@[CRDIV1,2RTM$6W*82ZE)2E9:!(U)"B!4$O=FY# TXR Z
M$9>6MIEA]U-V&ENK2"5GWV@E21UFBJ';V6G[G:<Q4N<GTEIG(1<BM$:Q<"77
M(C:U$FR#8!>@7O51H\%A,7L_;JFUREK8B-EZ?D9)NM0:18N+/@2A-O4 J*P6
MXN]+=+&?8D86*W*VZZPZIH.H*2XXRD+<2MT!2D*T*24)T]J]5&PP6TW5Y&'N
M')S5299BM(]%0V&F$J3=25Z 3VDZ^%02-Q;NQ4)<K%-Y!N-FN4%,ZTE26U+!
M4WKZ@%!)Z3161Q+N<[RL%D,;F&UX=A+;3'I#";F2K6EWTAI9TZ4]BVGU:J/0
MG9.*VWA4KD.\J%%"&U/+XJ4I1" 5'\I:U'V30>:S>\O=ZLODUQ6(\G!+<8BP
M%:5!YM4AU+"G4ITW=Y:E$J2K3T=-J#=;?V/!Q6X,QGE/KDY'+K0IQ2Q9+:4-
M(04H3<@:B@DGU;4$?=VZD0(4L8V8TWD,<XTN4VZDJTLJ/:)3:]K=:;VH*K'8
MF9OG#LSLZEW&(,E#IQ*!H4E+5]2'%CBOF7!Z*@T^9S.*V_!;4_YM 3HBLH23
MQ X"PZ +<:+EC]N;AW#N%Q@(R<9:''2MYL1K.1TIO9"+D:TK'0YX.JB-?@-M
M0-OMS927W9#TIQ4B3(D*U*"1<A"?>H0GA:J,UE=ZS\C)BS]M2$OXZ ^VG)Q"
MV0MUAUSE+>2HVLAKBKATVH)G[@>F[BC9S)9-U\LJ"FHC"0RPI"5:V0L G4$D
MW]6@VR4A(L*#M J!4"H%0*@5!#>^]H_U3OMIH.2?O*%_2_)% ^=E($".](EO
MI::83K=43Q2D]!(Z>-N%!Y_%RQW[*0G&268\;'RUR(N0;"E/%".#*VP1H(6%
M*UI4;CAPJ#4;<VSBML17]*T%^2\M^5,<2AHK6ZKR>' )!X)3056ZN\&!B\G&
MQ+#C3LY]:TR6W O2A&DA)X).H%W2E6F]KT!]M[,=AICOSY7I(3J=;AZ06F5N
MDJ6EM9[:D J[((H+C-[AQ&'@.29+Z$(;ND 74=2$ZBDA 418<3X!5&8VY+9W
MWB5+R;+*HA:Y3C:0><A\K5<H<M;2$:2E23TT&QBQ(D!!T!#9<(UKX)4XL"UU
M'\I1 H,5D=_(R.YT;?Q1COQI4513)="EH,@J26TE !NV4A?;MIOUT&IQNVL?
MC9LF6S=(DE*U,'YE#B18K;1T(*ORK=-05V]-[P-OXIUYMYEW(N-J7 B+78.J
M0=)[0N$@*X7/7155CL'D-T8J)DI$Q..YK@E*;@ILI7,9#;J%N'2J][C4.KHH
MC:N/Q(4,\UU+34=JZEK5Q"$#BHD^ #B:HP&-WM*W1NE_'8M,)[$0UM/,RUE2
MW%H23S%-I*>RM/5JMZE!IML[1A8)^;(:<,B5D'U2'W2A+8&K\E"$\$B@C;QW
MO#PS11'TR9J%H2^RD*5RD.>2I>@*\'0>J@@X/8;A=CY&?);+/I:\DC&L-A4=
M#KJ5 EM:PEP:]>I7#IH-;-R..Q<4/2W4QXX(2DV/$DV"4I%R3Z@%!AXDJ9O6
M7'=CO)QDG%//%3H;6IX!5T)"4N)"%(<1;5Q]2H-MAL2QBX#45%EJ;!"G=("E
M745$D#U35&7W%OV+&R,2%CW6I"7W'&93J@XIM"T@:1J2E0(X]JW14%Q VMCV
M98GI;2B0ZTEN6VV AAQ2>*5EL<-2;FQH)&XMQ8[$0W.<\@35-.*AQC<K=4A)
M( 2D%5K])M851CL=&G]X&T=;\D8Q<DL+=,9'G4O-Z5+!*M/DV*6U))X<:#=8
MS&Q<;'$>*V4MHZ23J6M1Z5K5^4H]))J*QV[MZ\W)1<)B4Q9S,]+\:4Z\%K8#
MNBS;2M*5!25+-EZ;VZZJ+7';+6QEOM2;,4Z+:D8YH!N,AU2$H4JR?+MI 3J'
M"H)^>W3AMO1VUY*0EM;RM## (+JU'WB/*/K4&/@X@[UF9++-R6X4=:?LQYMM
MDJ6\&CYP/MO!/DFW+/CJCT&&PQC\<S&U69BMA 6L]"4"UR?$*# YW>&(W,1M
MZ"\TMK(+Y#<ET+Y8?97S"6W$A2-24(*D<?*M0:? ;51BY,B:](5D)LK1KDNH
M2A=FTA OIZ5$)XJZ:@#O'>47#17(T527,Z\TXK'0C<ZW4)NE*@D%5B? *HA8
M"/%W7#@[@F!D/M2/2(+\0J"DHTI2MIPD)5VE)(4D]5J@U<[(0H$54J8\EEA
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+CS.;TCIU<--!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>146
<FILENAME>tm212692d3_sch14-aimg146.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg146.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@!3 &0 P$1  (1 0,1 ?_$ +P   $% 0$!
M      ,  @0%!@$'" $!  (# 0                $" P4&!!   0,# 00$
M!0P-"P0" @,! 0(#!  1!1(A,1,&05$B!V%QL3(40G*RTB,S4W.3-!4U@9'!
MT5*"HL)C="46)J%BDD.#L],D5$4VX42T%U4W\/'#A)1D$0$  0,"! ,( 00"
M P$      1$" P0%(3%Q,D$2,U%A@2)R$R,5P;%"@C21%*%20V+_V@ , P$
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M<USA@L2W ;^G.8'R]/R>MP/(AP4A3FD!03VO-!M0>NQD1H\=N-'2$ML("4-
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MDJ^E)UAM/NJ/\.@7[OR3_NL[H_K4?X= U7+\GC@#*SK$7]]1T?V= 3]WG_\
MY2=\JC_#H!L\OR"F_P!*SK&]O=4=?Q= U> E!UL?2L[;^E1[2@*>7I!W96</
M[5'^'0,:Y?D&Y.5G6W>^H_PZ!/8"2D)ME9URH#WU'^'0/_=V057^E9V[9[JC
M_#H&(Y?DEQ7[5G6&P^ZH\?P= G.7Y(23]*SK#]*C_#H'CEV187RLZ_QJ/\.@
M&K R>-H&5G;KCW5'^'0/7R]("#;*SO#[JCVE!QOEZ04 G*SNL>ZH_P .@;]
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M/>D^(^6@XY[^U]GR4!A0#9\T^N-$RY(W(]>FB!: ;?OCGC'L10)[WI?BH"4
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M&TA 2I26W&DKOIN"E#RA8&U L1R+CH,25%==7*9EQ6X3B5H;: 9;24I 2TE
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M5OJ!EI?=]CUR9,I&2R<=4I]3[K;$MQMO6X=MD@V%2.#NZA#=F,OV=OSY[?\
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M4D;S:WW:"/DR/HZ7\2Y[ T <$1]"X_;_ -LU_=IJ($IPCC-?C>05(+<4#&E
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M6K:D'M== DQHP6I7"0%+\\Z1MMUT'/0HA&G@-Z"=6Q(W]= /) #&R["PX+@
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MV@=F^]!Q2T\9':&X_<H':T:3VMPH&M*0IM-R#;;]J@XM38*#KW&@)Q$?A"U
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M:[J2 F<HD$71MOX#6NV:8K+8[W;28B'H(<!W;K[#6^AH'BK;CO[P2!K44ZI
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MP0IQ>A"@L7%CMV6(K-I=1=BK=;2K'K=-;FF+;JT]SN?RK^5<A3I*4AY:2DA
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MBFN,N4EU*K(1I2Z=)"3V'%I'V:"TPO>;,GSX+,C"O0HTUY+2)+CJ2+.ZPTH
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M."VXA9U#6V?5HW:M_106&<RS;./G)COI^D&FE<-M(XC@6$%:0&QVE&PN!TU
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M$@$AU?N3GNETJ0KU-!;<O]V.+C,H?RD9J1DR^9:BR-+#:CN;;2?ZM/X)Z=U
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M*+[#:_34"8B^X[P-M2'4"H%0*@5 J!4%3S!_MOZ^Q^=03&/G\KQ-^0T$J@5
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1=G@\+C:QP?.OKVVM?IH/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>147
<FILENAME>tm212692d3_sch14-aimg147.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg147.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@"2P** P$1  (1 0,1 ?_$ )@   (# 0$! 0
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MG[6<'I6Q2H1#(DH9!4K<!@B:( *) E) 31!11$!1 05"D!0"&!#05% (:5&
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M1-(>+"IY:AF3<@#D <@#F LI@+*811=N45"2U#)<O4(K//()(S7,FFID)]6
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MP$@ $50"MH"&T$(V DGW!2=X%<MRPDE;81')%53)A4-Z 5R>H$-LH23T(%J
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MC<#J8YHENM=A!HB4613-"V,2(:A1*0 UH%1Q"(E! +*V957.UH"V:[9TV,S
MQ7<==P&.]BKN)0QW,379@5K$5=@&^E\& \,7P%"U8R%%'CCJI:'2Q+26Q8@=
MO%A\*T-0CL8\?A1J&);[:(C1:CJ!IAV$5:@BQ!31W"' @( $>X6"2"JY 4S
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M4'E!)#M:!"^4 >4 KM:D!Y0$2M *[.A1'D@'TZ CZ<(/("E=C4!7C@1].NX
M>.J +].@6/IT"S0LJH1JM6Z(S+4-$($6VB$!):Z,=#-*^>]81^+%]HI'%L6H
MR=3E;*R_"*CIN]#,R,%VVDVGO]HA&.[:;::XZ?B;]P*47(<U1M:_A="P4J^G
M7%VTFW[4S0T6L><.:V\'0%-EBQ\/;^E$&FW8?&OB"FN%MM)O^TI2+G'BTNQ=
M]04^D]&_(_9_>&L7UCW#0 @4 4%90CW"GB21?;,HTVY"A<I$5="0H71>A&H/
MR"I3 FH!4 J4+R((<@S):A"398%$V49KLM2Q",MV1M&6]*B%#%-_$PI J4$
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M]@'GL"'? CSP4//!0\\%#SP4//!0\\%(=\"// // // // // // AWP(^H
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M+%<@X7'&?_<[6NTR[XI0)71"GBF46PV"+8@:+:=0C99["*VV-@-UD(U0"M$
MDKD5#!0!(1 4LFB!&T$HDFJ%%$VM1!3+>V9;*<Z\U5ELIAOM5%M.9DM49+'-
MOM:ZDD8Y$17)H!:KO"BJ BI 5 =; !0_^T#RR?SR]K.;H$] #D!*8!4 J 5
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M53?QR]K,-H E ,G0*.0!R *@'V@,MMP ":@0WH!'( J!'( Y> $-U  @
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M6F&YJ$:;;*K7:D$EOQ+UJUD697?E4XMO[2KG]/6[>)T_-Q4YVXRA)?!)4[O
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M H    %G^P#RZ?SR]K,J@"425@$5*W DJBH05  H     *D0O(,CD <@"M0
M   (-@  &B!(  P#(@NM]@5HMNFAJ!JMR*-=J6GV!)72LRR(PLQ^:327MJ5<
MOIZ-Z9Q[V%U*WC7G.%SR6XQK\#0>?%]BC+"4P&#4#3M*HT[" 6Y0Y   "LHJ
MGV 9Y;2]C$*^$R9?^W>_^3$NF*8,S)+1 JKK>Y5:(2T01=;=6!JCL$:;$M K
M3"1$:K<BJTVY$1<I .F%.G4"=@#D!$@%Y ).6H17*6@&>ZZFH6&.X5&2Z%<^
M]+Y@.=>V$C#=,RC-/<@IF%5L!&!     %G^P#RV3?.7M9%202   !4   "K
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M2*Y/BS(B3?Z0$:2"HY># AO78 ^P"S[/N >7S^>7M9E4 "8$IE#("0
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M>OL,BMRU 60$@0]P(K0"RO\ H \RG\\O:PJ  DJD@    8( (85     "@
M  26 %0!0!-6!*V") E[ 2@&0%@$ILHM@V%6P>H%JEJ0A7E/0L)+=T]ZHU#G
M+N0DN)ES3&2 L3T*&BT [>@$-+N 6B[@B4D%6) 2HZ@-30*LLZ;: A=;?QNH
M=(7QD&ET#(M3HT!=%U=34#1;:HZE5IMRJ@-%MZH@T0EL4:K,OF(+X-4*BR$E
M0*NBP+%+X6 .5$J$$QDJ%"2D G(!)2 KDPC/== K+-[@9;LMP,%WYRLL5Z5'
MH1&>YJ1IFN(#/)T*JJ;K4B$ @R$J^\ Y 16H%G^P#S.;?.7M85"V DDJ$02
M  !5@%6  0P! 2!%0(     DL *@  H 9;!$@%6 RV E,!TVP&119%M$%R*J
MR+UJ0A7?==&6$ENP6DDUN:<Y=6W=?'<C"R,P+H2^$0AE(H?F03*0"\P)A.KH
M!<F RV"I;TU >U(I"Z+5?:1TA="@:A?%F18M=P+K35*&H&B%&476Y4V"M=N6
M@%]MH#3;;5: :(2 NA2M.P"Q.FP#\@)JJ>P Y +-T0%=70"MR; 5NB"*+DJ[
MA66ZU1T QWF^->T#'=;JWVE98KRJR(SW=-$1J&>Y_<!FFBJJ:1$*] $;9D*
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M=U(U#/<(,\BJKD1%<F!7*1D1R\ M(;JP%;*+:_Z /-9_/+VL@4"4Z%$IU()
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M 53V(*Y!5$B-E*J @ L_V ><S^>7M9!    " D         (@ @"0
M &6P$@  % #1"+$4-$!T!9$!^PL$H>YIB6BR1&JV5EHBT \2P+$46(!T \6^
M\(T0DC*&J@"J A@$=PL-4-@U"V##2Z)E5L2HM@6!?%T OC+0HO@T%:+?8!JM
MR0%T'J$70:#<+$P+(R0#500<@)Y(C)9-!22: KE)4*,\V$9[CW QW@K-<",M
MSM SW2#++M HF)%4C(IDPL*Y%;5R*I:LR@JP+:O_ " >=S^>7M9!     !4"
M0(J!($, J 5 *D05  "H!4 J 5 *@2  35@2M@)  H :(18BAH@.@'04Z;H6
M$D&F97VFPS+5;;#*Z(%L7H6!8F:%B8#ID#1;"+(R9!9R"#D!*=2!H[A8:(MT
M#4+H4#2U-F56P;*BZ#+ NB!=$HT6P--MJ@%]MH*T0H$6Q:0:A;%H*L30$IZ@
M35 1R9&2R; KDV4))Z:A%,F!GN-I,#)=>H&>X!EN=H&:X09I@43$BJ1D4SV*
MU"F396RR 4B(9!;7_0!YY/YY>UD$      !4  *@    !$         !4"0
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M SS851,2C//<E*ID55<F@V0(5[DF!%24+:O_ ""AY]/YY>UD$ 2@B2
M        4* )6P1( 4    2  -$"2"2JF(18@&B _:$DR L6Q8$HTDK8!B5\
M"JMB ]2I)HNH18@'B]0+8M%$\F <@)6I%A;$*NA0B+8D5="@1:@TM@PJ^#V"
M+EV 70="B^# OM@:;85=#<(N3 LBP+8.H#    LI (W4!),"B3J!GN 9[G:)
M&:8&>Z099]H&>8%$@*)[A5,^TJPJD1HH"2W*( MJO\@'G\_GE[6<Q*V"  (
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MS[0,\P*) 9[A6E$BBN1 D@%JP( M_P!@'PL_GE[6<U*           $," H
M        E-@2$  !* :($@2%3$(=!D\0IT$,@JQ;%A)2C3*V(%J*'384R;#,
MFJPAXMLHLB Z; :H$IL!XME6%D6R*MB"%L2"V+9!H385;%L"V#8%\6!<M@+H
M 7VVRC3!JI1=!U(JZ+ MBPBQ- 3H  3R AL!&T!7)H"B= ,]S=@9[C8%$VB#
M-<; S7'N!GFV!GFV%43J55,BBJ39 L@%[ %JP+:O_(!\).7QR]K.;000
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MVNMKEQD\;LZ8\EG_  '5/P0^3\:'L];7+C*>-V=,>3Z27S/VGX^7[&$$
M
M                                          _^TTR67S/VDEJ$$
M
M                                           _^TTRATJ]MWWD4:>'
MO -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :
M>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/>
M :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\
M/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\
MT\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>
M\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@&GA[P#3P]X!I
MX>\ T\/> :>'O -/#W@&GA[P#3P]X!IX>\ T\/> :>'O -/#W@-IX?)XE1__
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>148
<FILENAME>tm212692d3_sch14-aimg148.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg148.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    /   _^X #D%D
M;V)E &3      ?_; (0 !@0$! 4$!@4%!@D&!08)"P@&!@@+# H*"PH*#! ,
M# P,# P0# X/$ \.#!,3%!03$QP;&QL<'Q\?'Q\?'Q\?'P$'!P<-# T8$! 8
M&A41%1H?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?'Q\?
M'Q\?'Q\?'Q\?_\  $0@ & "6 P$1  (1 0,1 ?_$ (L   ,!  ,!
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ME#*['!BE=;TJHIZVX1F""")U=O7L&=N)/%5'7<ZC16=@?Q+7.-<1!X)MT_\
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3G]U%?K\]FTQI <?\P"TZ'\S_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>149
<FILENAME>tm212692d3_sch14-aimg149.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg149.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  4 !@# 2(  A$! Q$!_\0
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8DDY)HHK+FER\M]#3E7-S6U-.BBBI*/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>150
<FILENAME>tm212692d3_sch14-aimg150.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg150.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" 1, U(# 2(  A$! Q$!_\0
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M+_4_#]Y_;LND17MP7%O/IEPS-;Q9^Z&AF3 [E .PH ^OZ*^4?V6?'OQ \/\
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M,T)DN78YQA %& 3TS5C^*Y\4_%GX<_$33+'4A8WO@36M3?1H92[RR0[<Q #
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M-2M;>U\/SNPD$T)<(RPK*B/Y:ESG[H&33O@3\3+_ %#2M/U?4_&.I:U8VWA
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ME7E1&W7*;P1Z-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 <=<> 89?"7B+0_P"T
MW"^(=2EOFE\D9@+LC;0,_-C9UXZU'\0OAQ8^+;O5;B\OFC.H65A!$OD*ZP2V
M=U)<Q2$'AQYCKN0C!52,_-7:T4 8?@/09-!TV:*X31?/FEW,^D:3]@B*X  *
M>9(21SR6[]!7,^,OA39>(/A3J/@Y]7GM9KK4=0U"UU.*$>99RW=Q<2L%4G##
M9<RQ,,C<C-TSQZ%10!Y[J_PTNY8-:T_2?$[Z=IOBB&./6XA9^9,S+;I;-);2
M;P(7>&-%)99 "H8 ')-GQ)\/&U&76[>RU:&RTW7M)AL)[;[$9)(FB#JDD<GF
M  ;7 *E3G:"".<]S10!QUKX*OK+5M6CL-:M_[!UZZDNM1TN[L6E<-(@658)E
ME3RU?&XAE?#,Q! ( B^$_@#_ (0J&&T$^C75O8VBVEI/#HBVUZR+@ SSB0B5
MMJC)5$!.3CL.VHH \Y^('PM?Q+K6MW4>LVMK%KUK%!<M+I2SW4/E@A5AG+C9
M$3@LFTY)<AE+9&QJ'@6*ZT?7+ ZDZC6M:AU5G\H'RC&UN=@&>0?LXY_VNG%=
M=10!YYJ7PTOYY'L+7Q2;706\2P>(?L(L=TWGI>1WCQ><9,>2\J,VW9N!?[Q
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M));^'3M'%K#=*R%554,C%"#L);<Q.W' /'.V/PSO(/ ?_""/XFW>'+."./2
MMD1?V#0RI+;-]H,A200F-0H,0)"KN)P2?0Z* . OOAQ>:SJ$VK>)/$27FJ2"
MQBADM+ V]O!#;7B76U8FD<[Y'0!F+XPJX48.='Q1X%BUFU\70MJ3P_\ "6:>
MEFY$0;[,%C>/<.?F^_G''2NNHH JV4-['?7DMS>K/!-(K6L(A"&W4(H*EL_/
ME@S9.,;L=LU:HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_'/A>+Q#X8O7O--F=TCF>UE@)93AODE56'(]*\\_X:@^"'_0WW7_ (3^H_\
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MLC!9654/EHI?DNO&W(SSC!KS[_AJ#X(?]#?=?^$_J/\ \8KU^B@#D/A3\4/
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MHX!ZD5L_%3XJ>!?AO-8Q>,M8FT]M15VM1'IUS<[PFW=S#&^W&Y>N,YXKLJ*
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M2G^-']M:/_T%K'_P)3_&@"]15'^VM'_Z"UC_ .!*?XT?VUH__06L?_ E/\:
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M)3_&@"]15'^VM'_Z"UC_ .!*?XT?VUH__06L?_ E/\: +U%4?[:T?_H+6/\
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M97#P^'VFTU0EC(5A+6JCH(SU0#'08H Z"BJ/]M:/_P!!:Q_\"4_QH_MK1_\
MH+6/_@2G^- %ZBHK.ZMKN,R6MQ%.@.TM$X8 ^F1]14M !1110 4444 %%%%
M!7R?\7+7Q!^T)^UGJWP?_P"$DO\ 1? G@RQBFUI-/EV2:E,X5MA.,?\ +3:
MP('EL<$D5]85\R_LQ_\ )]_QO_[<_P"5 RZG[$/P*5 #9:ZQ Y8ZJV3[\"E_
MX8B^!/\ SX:Y_P"#5O\ "OHRB@+L^<_^&(O@3_SX:Y_X-6_PH_X8B^!/_/AK
MG_@U;_"OHRB@+L^<_P#AB+X$_P#/AKG_ (-6_P */^&(O@3_ ,^&N?\ @U;_
M  KZ,HH"[/G/_AB+X$_\^&N?^#5O\*/^&(O@3_SX:Y_X-6_PKZ,HH"[/G/\
MX8B^!/\ SX:Y_P"#5O\ "C_AB+X$_P#/AKG_ (-6_P *^C** NSYS_X8B^!/
M_/AKG_@U;_"C_AB+X$_\^&N?^#5O\*^C** NSYS_ .&(O@3_ ,^&N?\ @U;_
M  H_X8B^!/\ SX:Y_P"#5O\ "OHRB@+L^<_^&(O@3_SX:Y_X-6_PH_X8B^!/
M_/AKG_@U;_"OHRB@+L^<_P#AB+X$_P#/AKG_ (-6_P */^&(O@3_ ,^&N?\
M@U;_  KZ,HH"[/G/_AB+X$_\^&N?^#5O\*/^&(O@3_SX:Y_X-6_PKZ,HH"[/
MG/\ X8B^!/\ SX:Y_P"#5O\ "C_AB+X$_P#/AKG_ (-6_P *^C** NSYS_X8
MB^!/_/AKG_@U;_"C_AB+X$_\^&N?^#5O\*^C** NSYS_ .&(O@3_ ,^&N?\
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M]B[=_P#HLUE?L)?\FC^!_P#L'-_Z-DH#H>MT444""BBB@ HHHH *^9?V8_\
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MZ!+#:1SW-C9Z^;O,5W?6\:236XCV *5#,,[SR%X^88 /;J*\T\;_ !<7P?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(([BEH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M38Y"[B=H) ZUK>"_B?\ %_2_BY\,;#QU=>'[O1_B?IUQ/%9V%D\4NEO';I,
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MBBB@ HHHH **** "BBB@#SG]KS_DUWQ]_P!B[=_^BS65^PE_R:/X'_[!S?\
MHV2M7]KS_DUWQ]_V+MW_ .BS65^PE_R:/X'_ .P<W_HV2@?0];HHHH$%%%%
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MP"P!]JWTQMK*:X6"6<PQLXBA +R8&=J@D D]!R*\*_9W^-GCKX@_'3Q1X/\
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M))@#YVZMP.2>!6W0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV.D:/:Z5IEI%:65C D%M;PKM2&-%"JB@=   !]*LT44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ><_M>?\ )KOC
M[_L7;O\ ]%FLK]A+_DT?P/\ ]@YO_1LE:O[7G_)KOC[_ +%V[_\ 19K*_82_
MY-'\#_\ 8.;_ -&R4#Z'K=%%% @HHHH **** "OF7]F/_D^_XW_]N?\ *OIJ
MOF7]F/\ Y/O^-_\ VY_RH ^FJ*** "BO/?C9#JL%_P"'KG3?$^L::-0URUT^
M>&UDB$9B??N(#(Q#' YSVK'N_%>O>$O%WC39:7NO:;X;TNROKN6]U#RV2$13
M-)Y*A"KS$1DE?W:G"Y89% 'K5%>8>*/C7X?T?QM?:(TFE?9])N[2SOWN-8C@
MNO,N!&P,%L5)F1$FB9VW+U8*&*D5U7Q.\6-X2TZPN%M;60ZA?K9B:^O?LEI;
M%HW<//-L?8I*"-?E.7D1>,YH Z6BO.+[QUXBT7QUKQ\1:=I=KX<T+PO!K-V]
MO?O-<19^TF0JGD@/S 5 W#A0W)8JLFI_$^7PW&TWCGPY)H\<FD7&JVGV6Z^V
M/(D'E[X'78FRX_>IA%+JQW /QR >AT5Y=\0?&.N:%'X5U?Q;:0^';.3Q B2Q
M66IR7;SH]E=D02*L2;G\P1 (OF!GV[22!5C7O$7BS_A87A!;70Y(;G5-+U5V
MTJXU+RX8]CVAC>Y>-7 94+#Y5DVM)M!():@#TFBN!L/B-=ZR^EZ=X=\/)=:Q
M>VEQ=75M>7WV>"Q6"?[/(KS+&Y9C-N50$PP1R2N.<&3XGVZZHWBTPZDMA;^&
MKAI=(W?O/ML=\+9H=N=AE$RM%NSCWQ0!ZY17CWB+XDZGX3\<:S?^,=..GQ:9
MX=M)4L[?5/.LYYKB],$165UC"L7*HS,@VCG)7FKUK\9H+JS,.GZ9IVKZJNLV
M^E&'2-;2ZM2T\3R1RBXV#Y/D96R@*[6(# #< >IT5YE?^-[[2SX@\3WMM"T5
MGJEOH<$,E\8;*TPB--<3S%#L3S9F0OL^[%'P,FMRVU/4;/XA:,EZ(XX_$FFR
MB:W@NC/#!<P;75HG*KE7CDDRVT9\N/@<T =C17G/B3Q%XDT[XSZO8Z-I;ZM'
M#X6M+W[+/J!M[>,BXNP^T[''G. @ V@,(_F9=HSF^+OCSX:TB1I87TU[2UT:
MWUB\-[J\=I<-!,AD1+:%@3/+Y:EBN4'S( Q+8 !ZQ17FWB#XMPZ2WB>ZN=&C
MCTKPWJ$&F?;YM12-;N[G2V:)%RN$C_TI=\C, H&?FYVXE]\4;C7M3\-KH*VE
MU?6?B_\ LZ\MM(UH7%G>+)I-W+&3.JC=$&*,VY,JT+$*2JD@'LE%<-X?^(AN
M?$L>@:OHXTZ]34;C2[QDN_-AANDMH[N-4<JI=)+9VD#$*08RI7/3>\(^(#K_
M (%MO$L%D88[ZW:ZM8I)0/,B.3$Q8CY=Z;&Y^[NQSB@#;HKRF/XV61T769X=
M/TW5[_1KC2H9+;0-;COXI#?WGV6)!-L0+*KABR,HXV\X;(T-:^)NI:+]NT_5
M/"1;7+.\TV!+&QU#SHKB.^E:&"5)GC3 $D<JL&4;?+)R1@T >C45Y]<?$JZL
MKN?0=0\/(GB9=2MK"VT^WOO-M[DW$3RQRB<QJPC"0SER8]P\E\*WR[EA\<-=
M>)=/T+5=+N-/UBU\0)8W-O:WQ> [[&>XCE#[%,T3*C#:RJ0Z\CY1D ] HKSS
MPI\2-5UJ+0KM_"D=G9>)Q-%I4LVI9=KJ.&241RH(ODC=()BLBESA1E02!65X
M)\4>*O%=EX4TW78[2QN=2O;R^N7T^[=_,M;*50%R8X]I,TD"D88-&K9/SD
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M>/O'&M6_PUL_%VN647A;1VU32;D3G5&:X2V>]AWK<H(U6,F-B&57D!RRY/<
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MX7^)0\2:]HMGH^F6JV^L:+::PDFH:A]GFEM[A2W^CQ"-_/,8 \SYD"[TY.:
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M2,E&VL!(O&<@=5!JM^_A<ZJ_AO4DNMC,-*\VW^U'#$!=WF^4&( /,F!G!.:
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MWC<_>5)'52>G((R#F@#+\4> KW5M6\0-'K%O!8>(([-I8VLV>6*:W=3N#>8
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MZ *.@JUX/^(GACQ/>6\.CSWDL=[;R7%C<R64L<-ZD942&)V4!BI=01P3R1D
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M/MY56CD=0P!*DA@#MP>8\=^#_&'BV\M[G5++0FB-C-:MILFK7,EK9RLPVW0
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M5\>67C#PV-/N;J'39M-N;'4+AX(I8WDCD6194CD*LK(1C80P?J"HK/\ AOX
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M[N]/U235;DW,1F,I13:E3$&59FCWA^0,[06(&OX;^)VC7<.M7M_=I]CM=?\
M[*TQ;2TFEN+EOLL,S)Y"AI&E5GFW*%!41G(&UC6ROCWPFUUI-K%JXFGUU=^G
MQ0P22/,H8(QVJI*A68!BV-G.[&#@ 7P;X<GT7X2:5X2>2$S:?H<.G%X\^662
M!8\CC.W(].E<AX8^'7B.?1?#&A>++G2_L/A71I-/2;3I7,FH.]J+7S&5D40A
M8S)\H+[BP.5VX.[H7Q#TN72;34=1EF"ZXTUUI%M9V$UU,]BC(BSLL*N=C;D?
M>0%43(I.>3L^%=9GO-9UG1;\1K>Z3=#!08$MM*"\,@';C=&?5HG/ (% '%Z/
MX/\ 'AU'2KS7(_"]XFC>%KO1!9B:5HM2>9K0F24M%^[1A:X,85]NX\OG 7P[
M\.M>MOLANKNQM[>TN[Z2UTZ&YEN(M.@GM%A6WBE=0SJ) [\JH42;5 50*Z33
M_'6BB.T@N]0%W>7DDP1=,T^YG"HL[1;G"HQC4,NTN^%W*V#BDN/&]M;>*M:L
M[FWF.G:-]EMFFM;6:YFEO94:5H5BB5F.V(P-D _ZWMCD PM<^&$VL^#=%\-W
MM_%%;V?A*\T"]EA!+?Z1;PP[XP1T'EL><=JCT'P%?6VAWPU+PAX9OM2FLTLS
M]HUN[G@OHRZM+O$L+>0"55@JB3D#GC-=4_CSPFLFDQC5A))KHD.G116\KR7'
MENB2 (JE@4:10P(!7YB<!6(E\/\ C/PUK>M/I6F:B9KE5E9,V\B1W"QN$D:&
M1E"3!'958QE@I(!QF@#AY?A]XO;0=%L//TMM1TVZ:6#7GU&X:\TN%KHR_9HR
M4+7,8A"0GS9$#[=S*>E;_P 6/"VM^(=9TBYL187VG6<5PEUI-_>S6T$TKF+R
MIV,2MYAB"2 1L-I\W.Y2H-;&M^-?#6D:^NC7^HF.\(B,@6WEDCMQ*Y2(S2*I
M2'>P(7S&7<1QFH3\0/"0UY='_M4FZ-[]@8K:S&&.YS@0/,%\M)#V5F!;(P#D
M9 .,T/X;^)--TGP?IL"Z%!=>&X[2*37K6>:*Y,,<P::V6 )M>*6,%</)A2Y;
M:2JFNZU#0I[CXG:/XF66(0:=I%_8O&<[V>XFLG4CM@"U?//\2^]8ND_$?3M8
M;4HK..ZT]M+UVWTN235-,N88YS(\2X0LB_.WF[0,G!VLWRD9IV_Q1AU:%6T7
M3KR$P^)X=&N?[2TVX@#(SE2\9D5,M\IXY*\;AR* (;/X<ZW:^"_"VD66LV]C
M>Z!H%UIQO8%)*3RVZQK-&"!G:Z[N<9KGI?A\NB:3XAU7Q2^C:'IVH>'/[+E-
ME>3WEQ]HWDI/YTRJ\DK.XVK@MO"X+%J]+TKQMX8U'6Y=*M-4W7$?G89X)(X9
M3"VV413,HCE,;<.$9MIR#C%8ND_$G2M=^(&AZ)X?N4N+74["ZO'>:TFA>2-/
M*\J6$R!1)$WF/\ZAE.!@^H,=\.=)U;3O@K_Q/8P-=U.TGU#5E1?NW=P&EDC
MZX0OY:_[**.U<E\/_ _BG6/A[X(M]:ETVUMO#GAWR[$PL_G74LMA]F0S(4 A
M"1R/E5+[F(/R[=M=VGC[1Q\1-6\)W$-]:OH^FP7]Q?3V4T=H$D,^<S,@C55%
MN3N+;6R0"2C 7?"GC'P]XCNI+72KV5ITA6X$-Q:36SR0L<++&LJJ9(R> ZY7
MWH YN/P;X@T/4_#NN>'FTNZO-*\/#1+NQO)GMX)D!B99(Y4C=D*M&WR["&#_
M ,)45S7AOPIXL\)_$C3(]'_LW5+I=#U";4&N_,M+>6>[U'[5(8W1)"@61VPA
M!RO4@C->H'Q-H8M9+@Z@GEQ:BNF/\C9%RTJQ"/;C.2S+SC&#NSMYK/L/B#X2
MOKYK2SU*6:3;,T!2QG*7GE9\P6S[-MRRX.5B+G@\4".!A^#=YI5Q8W-LMCKS
M-HJ:;J4-YJ5SIT;.MQ//YT9A5\J6NYQY;#@;,-P<]#JWPYFD\'>/=#TU[.U3
MQ1I?V#3U^;;;*+!;50YQG:",\9X]ZO>&?BAX<U7P9:^(I8M3LX[V\DL[>TDT
MNY-S/*FXD10B/S)1M4L2BD !LGY6QTMGK>E7?AI?$%I>)<::UN;E;B(%PT8&
M20 ,DX!XQG(QC- ' :?HJ:I^TI>ZI8WB3:/I5K'=WD,8RJZR8Y+4-OZ%Q:95
MDZKF,GJ*W?$'A_Q%9_$J3QGX873;R6^TF+3+VQU&Y>V7;#+++#+'*D<A!!N)
M@RE<,"IR-O,7B/XI>&],\+/K<,6JWBQZA;6,MK'I-TMQ"\\B*IDA,7F(,.&!
M90&X"Y+ '1^(/C;3O"7ABRUR[LM3N(;Z^L[2..WTZ>253<3QQ!G14+)CS,[6
M )(V#YB 0#E=8^'GB.YT76O!\-UI@\.^(-7DU"XNWE?[9;)-,)IX$CV;7+/Y
M@60NI0./E;8,ZB^!+W^S8[9KBT++XP;72<'!C-PTH7I]\ @>F1UI=-^)>E)X
MLU[2=8G^S1Z?J%K;VK+8SYCCGM;>16N3M(AW22NH,FP?+CJIK=NO&GAJW\4?
M\(]+J)%\LL<#XMY6ABED :.*28+Y:2,"I5&8,=RX!W#(!Q?B_P"&&HZAKUQK
MMO+9W,Z^(I-2ALIKR:UCG@DL(;5XWFB4O&X:$."%887:1\Q(V=<\"F]^ ?B#
MP+IUI8Z/<:[I%_:[([F6X@AGNDD#.9'4.XWR%BQ4$DDXK=^(VOR^'/"TE]:6
MJ7E_-+%::=:/(8UN+F5Q'$C, 2J[F!9@#M4,V.*H:/X_T.;P#I'B;5IO[-75
M2L'V=U:1X[O#![;"@EI%>.1, <LN!DD"@#E_%_PX\1^-H9SXEU#3;&XMM!FT
MK3Y-/9Y5DDDFMIVN9 50H-]G!^Z4M@;_ -X<@BQ;_#R[F\+:A ^D:3I&J7T]
MAYDT&KW-^LT5M<B8!GFC5EQF7:H! +GGFNE'Q \)'1;?5#JCK!=7S:?%&]G,
MLYNE5V,!@*>8),1MA"H)XP#D9M:)XO\ #NK06$MCJ&_^TKB:VMD>"2.0RQ!S
M)&R.H9&7RWR& /% '*>*O!/BB2;QE8Z!=:6-/\=?-=W%X[B;3)3:1VDCQQA&
M6<&.&,A69,,#R0<"+6_A6]YX+\6:#;WT</\ ;&JV%_ILI+EH_L=O8+$DK##8
M,ED<[3G:_'-=?J'C#0+.SDNGN+J=([U[%UL[">YD$R EEV1(S< ')QCWJKHO
MBI=6\=0Z=ITMK<Z3=:#%JEO<QY+2[Y2H(.<;2H!Z9]Z &?#'PU_84=]=7&AZ
M?IE[?,@F^R:K/?\ FH@.S=+,B-QN?  P,]:Y.3X>>)[B'6Y(!HNB+=36%]9:
M79W<UQ9M?6MX+HW#[HT\KS62-76-#G!8EFKH/!?CZ36OBQXH\&7>F+:#1)E2
MPN1-N^WJ(;>2?Y<#:8S=0#J<B0'UJKX>^*%E>>+?&-GJ-O'8:/X82V:'46D+
M&\\R6X@<",+D$3VSQJ!DN<8'(! ,S5/A_P"+M8UV_P#$U]>Z/::H+[3;_3+6
M%Y)[>)K43*T,KE$9ED69_G"@J6SM.P;NGTO1==O/B!IOBO6[;2[.6STF]L&M
M[.[>Y_UTUK(I$C11Y&+=LC:.2O7K4[>/O"JZ&=5;4)EC%Z+$VYL9Q=_:2H<0
M?9MGG>9L(?9LSM^;&WFJ5Y\2O#Z:]X=TZUBU&]7Q&\J07%MIMQ)'"T>X,LA6
M,[&#JRLK8*8)8*!0!6N/ M]+\ ]3\!-<VINKZQO+993N,(,S2%<\9P XSQV-
M6/%7@V\U36?%U[%<6R_\)#X6@T:VWYW12(U\69N/NG[5'TR?E/'2GI\0_#ME
MI=F^JZM'/=7D<TT4>FV-Q.TL<4A1V2)%9R%X#'&!UZ5<U7Q[X4T^UL+F75&F
MBU*S^W6S6=K-=;K;"G[0WE*VR+#K^\;"\]: .+F^%$J>,-2O9M.TW6=/UYK2
M6]2ZU:YM3:R16\5N^R*-&2962",@,4(.<D@C%CP?\,)-$\8W$MQI^GZEIKZ[
M=:Q;7LVJW*7%L\TSW&P6H4Q,4ED8!]X^7&1D<]U%XFT"3P7#XN&JVZZ'/9)?
M1WSMMC:!U#J_/."K# Z\CO7+^./BCHVF?#O7M=TDWDU]I%L3]CGT>[$T,CHQ
MA::W*+*L3%3\Y"J0" V:!C-!\%:Y:WNBQ7#Z<MGH/BO4-8ADBG=I+B"YCU !
M&0H CJUZ@X9@0C'(.%J*P^&LX\ ^!O#-]=V_E>&M(.G:@T!*^:#I[6K&(D<<
MMD9QQ^5:WC+Q==>%_A?;^(9XXKZXDDM(#)<Q2:;"AGF2(2SAP[V\:^9N?<"5
M /%0:YXYN_".E:0_B[3S<76KZ@+2(Z#9W5Y$%*Y#G;&2#_L]6[9P< CAO!NI
MZO?^,O#;VEYIOB"T\(:!?)))HR2-]H?RX4C\W<H$,S["! "QX<DX  ]&\4:;
MXF\1_"=;'SX]*UV\M;=[I8+B2.-9 R/- )4^=%<!X]Z_,H;<.0*L7/CKPM;^
M(CHDNJ;;I;I+-W%M*;>.X< I ]P%\I)6W)B-F#'<N!\PS1\9?$#2M.TW7H=*
MEDN]4T>QN93BPN)+2.:*!I?*EG5?+5L 90N&Y ZD4 <SX6^&.JV&L27QBT73
M89==LM3%C8RRRK"L,#Q,OF.BF1F)5MQ5>I&.,G:F^'T]Y\#KKP'=:C'#<3I-
MY=W%'YB12&=IHV*'&X!BN5XR 1GG-/\ &7Q"M-)\$W6I6UW9-?::M@^H+*K>
M1:K<2QJV]@0%8([,%+9 VL1@C.M#X[\*MH^HZG+JAM;?265;W[;:RVTD1?'E
M_NY55SO) 0@'>3A<GB@#F/$G@GQ5XL;6-0UZ32+"\F\*WV@:=;V5Q)/$#=;#
M)/*[1HW+0P@(%.T!OF;=QUGCSP_)XA^&&M>%4G2&35='N-/$K E4,D+1[B!S
M@;LUDZQX_LI=-M9] D$DW]N66FWMO?6DUO/;K/*BDM#($D0E&RI88/7D5!XF
M^)FD6^LZ=I6C7<=Q=7.O1:5,TMI,(6.\K,D4V!')*FULJK,5*MN'!P 6]-\.
MZU<>)=:U_5DT^VN=8\/VFF>1:W#S+#)#+>LQ#M&A*D74?\(.5;C@$\7%\'KF
MVNE$]CI>N6FH:+8Z=J=O=ZK=6BQ/!#Y+LBQ(RS(Z8^1PF-OWB&POH%OX^\)3
MWUU:1ZM\]FD[O(UM*L4@@.)O*E*A)C&>&$98J1@XJ"'XD>#Y[>VGM=0N[M+S
MS&MOLNEW4QFC0H'F4)&2809$'FCY,G&[- '5* J@#H!2T44 ><_M>?\ )KOC
M[_L7;O\ ]%FLK]A+_DT?P/\ ]@YO_1LE:O[7G_)KOC[_ +%V[_\ 19K*_82_
MY-'\#_\ 8.;_ -&R4#Z'K=%%% @HHHH **** "OF7]F/_D^_XW_]N?\ *OIJ
MOF7]F/\ Y/O^-_\ VY_RH ^FJ*** .$^)NAZ]?>+-+U+PQIQM]2MVA5M8&H^
M5&MN)@TT$\&#YR&/=M!!PS9!C/S56L? VI6WA"WTZ-;1+A/&UQKLC*YP89-5
MFNNN/O\ DR*"/7(SCFNBUKQQX8TGQ[IG@Z_U:U@U;5K>2>V@DN(U)",BA=I8
M-N<R?* #NV/_ ':M:3XL\+ZIKDVBZ;XCTF\U*WW^=9V][')-'L;:^4!R-K8!
MXX)P: /,='\">.KKQ5IFK:_YDU[9-?+?WDVOS2V]R)8)HXC;6?\ JH5&] ?E
M5P.,O@DV;[X<ZK9?\(3>165Q?+X?\,G1+RRTS7)]-E1L6Y$D4D;QAT!@*LC$
M9!1ARN#UUQ\0-#TSQKJVB>(=6TK2(K$6WV66\O$A-P958D#>0."%'']X>HK:
MU3Q/X;TW7;?1=0U_3+74KO;]GLY[M$FEW$JNU"<G)! XY((% '!V_@O5-'U[
MPT/!V@G0X].AL[:]N?[:>:"2QCW;[62)\M,ZAF6.0@%2<[@,HVYXGTG7].^)
MR^,=#TN#5UN-&_LR>T>Z$$D+),98W1F!!5M[A^_RH0&Q@7?&'C*P\-^,M)TS
M5KJRLK#4+"\N9+RZG$0C:%[950$G!W>>??Y1BKNK>,?"6EZ19ZKJ7BC1[2QU
M%0UE=3W\217*E=VZ-RV'&WYLC(QSTH Y;X:^!-6\.:AX3ENY[.0:1H>J6U]Y
M!(5;B[NK2X"Q CF-?)E4$X. G'/&EXCTC7],^(C>,O#EG;:E]NTR+3M3T^:Y
M\B1D@DED@DA<J5+ W$X9&P"'4[AMPUQ?&%E!XEU^UU6ZL;'3-%L[.Y:_GN%C
MCQ/YN2S,0H \M<'/\5'@7QA9^*->URVTRXL[NQTQX%@N[682+-OCW-DCC(.1
M^'- &3X@T_Q1=^)/#/C>WT&%KS2K>^M+O1Y+U-XBN&B(DCEQL\Q?L\>02!MD
M<;N!NSOA[X!UG3?&EAXDU9+!9&GUJ]N;>"0NMI)>36S1I&Q4;L)"^]L#+,V!
M@UUB>//!,D>H/%XNT.3^R59K[9J,1^S!6VDO\WR@-\N3_%QUXJI'\0] N?@^
M_P 1],:34-+733?B.V>-Y2 FXQG#;%<'Y6RV%(.2 ": .?T?X?ZM8^%?"6FH
M+.-]$:_:[".0I,\,Z@KQSEY03T[FK_@WP3=Z1JG@2:6&S6'POX2N-(E6,_<F
M?[ %\L8^[MM91GCJ..>+?A_QVQU;5-,\6Z9#X=N-*LH;^::348YK46\KRHC-
M+\NQLQ-D, /[I;DB3QYXNUCPO</>S^%FNM!MVC6XOX=003+O95RD! W@%N1O
M#''RJQ(% '*^!_"/C#P/>66HV6E6&LR2^&K/1[F 7H@-M+;37$B.KLIS$PN6
M#8&X>6I"MDXM?#'X;ZCX8L[BUNY;*Y+>#=.T5)8P54S0O>O*%4CY8O\ 28@O
MLO(XK4U_XC/IVL:DR>'IKC0=#NXK/5M7%TB?9Y'$;,4B/,B1B5"[9&/F #%2
M*Z;QMK<7ASPM>:Q+"UPUN@$-NK;6N9F8)%"I/1GD9$'NPH&9NE6FLZ%\*M+T
MR/2X-8U&QTVVM9[5KH1I,514DP[*0> Q&0,\ D9R.*TCP/XETGPL7L](LX5M
M?%<.KZ7X=MK[,5A:"*.)X(Y' 526\Z;8N$!?:IQS6WXB^*,.F_!NS\>V^A75
MY]HEAAFTQ)0)X)6E\J:(G!#/$XD4J.K)@'G-:/Q4\?V'@[P)#XEAMCJRW;QK
M9003!?M(93(S*YR,+"DDGN$P.M CE+_P1XK?P_KO@N"PLCIWB#7Y-4_MAKH!
M[6&:Y6XE5H]NYID;>D9!VX$9++MQ5[1/#?BG2/#OB/P6FD6MS8ZO=:K=6FKK
M>*I O'FG"S1D;MZR2^7E=P*@-D'*UZ97$_#3QEXB\5*=3N?"UEINA,]PL5Z=
M8\V5O*E:/+0^4H4$HQ^^<>] #?@KX4U?P-I)\-2&UN-'CC%Q:W(<_:4F<YFB
MF)'[WYR664G<0=K E=[\WK'@;Q6^@^)/!5M8Z?+IOB379=0&L-<[6M89IEFE
M#Q;=S3(0ZQX.W C)9<$5WNF^.?!>H:1=:K8^+M#N+"QV_:[J+48FBMPWW2[A
ML*&[$GGM5+_A9?@@^)M%T*'Q'ITUUK\,DMB([R(APC!,8+;LLQ*@ ')1QU4T
M 7/!NBWFE^(_%E]<F,Q:WK4=[:[&R1&MA9VYW<<'?;R<<\8/?%<-XR^&NO7W
MPSU2VTF:SA\1C4M7N-/D>1A%+;WL\Q>WE8#(5XI%SP0LB1M@[!7?VOC'PE<W
M6H6UOXGT>2;28WDU"-+^,M:(A(=I!N^15((). ""#TJ&Z\=>"K:U-S<>+=$A
MA#3+YDFH1*I,1590"6YV,Z!L="P!Y- '-:-HGB[P=K$UWH^E6NM6>K65I]LM
MC?"WDMKR&!8"ZEE*O&Z)$#R&4QY ;=A6/X(\0_\ "N[F9I;)_%LFM_\ "0Q!
M9F%M'=+(I6V$A7=Y9A46[/MR59FVC.!V6L:I?2>&8]4\)V=CKCW"I);*=0$,
M$\;8.]9E1P1M.1@$'UKF/AMX[U_Q+X;M]=U3PYI.B6=[<1PVIFU[S&E)E,;#
M'D+\^5^5?XR0,KUH HVOP[UR2S\*Z?/KTM@FBK<:G?WM@(FENM6FSO<)-$Z>
M7F>[;D9RZ8QMS4:_#OQ!8Z3XFTVUU@ZE]IO[?7M$N[\QQRQZBC!WCD$,:(L3
M/#&257)$\P(_O==-X]\#Q7US9R^,=!2XLD9[F)M3A#0JK!6+C=\NUF4'/0L,
M]14UYXQ\)6GA^UUVZ\3Z/#I=\^RUO9+Z-89VYX1R<,?E;H?X3Z&@#C8OA[K]
MWI/AC3KO6FT[[%<W&MZQ=Z>T;R3:I(Q<*BS1.C0AIIV&Y<KY<.!QPL/@OQMH
MMUXAT_0O$<EQ:>)KBWN)-4O3$EUI\I4Q74D<<421DF**#R^ !(7=L\[O0;C5
M=,@T-M9GU&TCTU8/M#7KSJL BQN\PR$[=N.=V<8YK/L_&/A*[T:35[;Q1H\N
MGPS""6Z2_B,4<AP0C/NP&Y'!YY'K0!R>EZ5J'PKTW4;/PYI+:EX:/D'1],BE
M;SK.ZEF6)X02&_<,SB4N<["92?EQCI_'6BWFKWWAV:T,872]:2]GWMC,8AF0
M[>.3F1>/K6AX<US1?$%@U]H.KV.IVR2M$TUG<+,BNOWD)4D!AD9'6L_PSXML
M=5U;5=/E\NSFT_6'TJ%99UW7DBVT=P2@X).QV.T9.$)Z= #SK6/A7XC/PBT/
M3-+EL(_$%A;?8+X/*P@NK1Y@[H6"YW(P61"1U#+P)":ZRUL/%/A+Q#K+Z/H\
M.N:3K5\=0C07JV]Q93.BK(A#C:\99-X8-N!=AM( -='JGBGPUIEO)/J/B'2[
M6.&5H9&FO(T"R+C<AR?O#<N1UY'K45WXR\(VOAZUUZY\4:-#I5\0+2_>_B%O
M<9!/R2%MK<!CP>@)[&@#0M9M0>\5)[&** VRN95N-S"4D[H]NT< 8.[/.>@Q
M7GWQ$\&ZWK>H>,-.@T^WFL/$^F6B)<2W "I)$S*\3IC."A4@C(Z@XXSZ#>:A
M#%HDFJ0+)>PK;F>-;-?-:==NX",#[Q(QCUR*YCPYXPUWQ'\-[?Q)H/A:-KZ:
MZG@?3+[4UA\KRIY(6)E1'!.8\X (YZ\9(!G_ !,\->+[O7-6UCPK=16\UWI5
MA9@K<>3-(L5Y)).B.5(C9H)'5'P=K-GC&:P-.\ ^)K/0=>G@TY_-O/$>EZQ8
MV-WKTU].R6TELTD<EQ.6(<B%]HW%1E5!P,UV_P +_%.K>)O[9CU;0(-*ET?4
M38DV^H?:XIW$:.Y5_+3[I?8>/O*PSP:O^,M3\1:<MN/#_A@:TTA8S[M02U6%
M1C RP)9FR<#&..67B@"A\3M.U;5_"5E+IM@);^QU.QU 63SJF\17$;R1[^5#
M; ^.Q( R <UB:AX*U>[\.^,88X[6&Z\1:];:G;@R?<6.&R4[V X8&V?&,]%Y
M]+%K\2GUK1_#USX0\.7&K77B#21JZVT]REK]EMCL_P!8YW#>6D"JHR"5;D 9
MI^J?$#46\&6GBSP_X2GU727T][Z\9[^*WFME0$O"L9SOF4JP*DJN01OH P?#
M?PWEL/&EV-4TB^U"U?Q)/KEG?Q^)+J.WB,DIG4/9B0(721F4 (590I)R2*W?
MBAHGB"_\3:9J'A?3FM]2MVB UA=1\J-8?.#2P7$.#YT90-M&"0S94QGYZM^*
MO'T&DV/AJ\M=%O[^W\27EI DZ@1QVB3O&BO*6/7,JX0 D\] "1V% 'EFL>$/
M%#WVHFSTZUD^P^+8?$6G-/= 1WZ^6JR0L,$QNN9"I((W+&<]<5M7\#^+=4\6
M-X^_L_3[?4;?6;*^M=%EN\K-#!;7-NWFRJI59B+R1EP& ,40+=2OHD/BSPO+
MXJ;PU%XBTM]93.[3EO$-P,*&(,>=V0I#$8S@@]#3=)\7^$]5UD:1IGB;1[V_
M:'SQ:VU]')*8^/G"JQ) W+SVW+ZB@#B?%G@SQ'XH\<Z1XX2VM]*U'1+&3[%9
M7DXGB>?S>%F" KM:,G#KEHV((S@JUWQ%X-U?5M.\?N;>SAN?%N@1V-NC2[MD
M@MIHRKL%^Z'EZC/&3BM.3X@Z%=>--'T#0M7TK5'OKN>WO!;7B2O:^7#(_(4G
M!W1E3GN".HK:U+Q1X:T_Q!;Z#?\ B#3+75+H*8+*:\1)Y0S%5VH3D[B"!QR0
M<=#0!Y]XH\&^+18>.M"TO3M.OK?QZ@S?W5UM^P.]C%9R":,J3*BK"KH%.6+%
M3L #5)>> O$&G>*/^$CTZ.WU!]/\4IJEO:2W&Q[JW.BQ:<_SD868,KN,\$#!
M*[\CN9/%_A1->BT-_$VD+J<\ABBLC?1^<[C.4";LEOE;C&?E;T-7(-9T>>"Q
MFAU6QDCU.0QV+I<(5NG",Y6(@_.=L;MA<\(QZ T >/R_#/Q3-K'_  D]_81M
M/_PDUYJ3:7I>M36<GV>YM(81MN(S'^^5X1N!(5@S\\BNO\!^!QHWB[2M8M]+
M_L^VMM'O[=X)M2DO)TFNKR.Y<F60EGW,C,26."<#BNHN/%7AB#Q,GAR?Q#I<
M>L28V:>]Y&+ALC(_=YW9(R1QR 2.AK&\7?$'0M,U2VTC3]7TJ\U5]6M+&YL%
MO$,\ EE1&)0'<"H<'!'<9ZB@#C&\+^)T^&FAZ'X?TF2#Q+X3M'TC3M:^W?9E
MM_*$:1R2I@B>WE2.&1X\,,@# 905[OP?8W$WCSQ'XFGC>)+H6^F6JLI4R16I
MF)DP>1F6XG4>JHK#@BK%UXS\.Z7HL&H^(O$.@Z9'<S2Q12-JB&&0H[ A9&"[
MF 4EACY2&!)"YK6M-2TZZG6&UO[6:1[=+E4CF5F:%B0L@ /*'!PW0X- 'EUQ
MX+\5Z?I.DQ:)IZQ:Y9W=Q+'K$&I^7%'%+?/,T,\1'[^-HV^[@X8G!0X>K%QX
M3\9V_@?1X8A+)<WNJSZEXJM=/U1K.XG,ZRMY4-RN&"Q2/$N0R$I",-_"W=_\
M)9X7\ZQA'B/2FDU**.:R1;V,M<QR!F1XP#\RL$<AAP0K$'@U'H_C/P?J]U-;
M:5XJT6^FM[?[5+';:A%(T</_ #T(5CA.1\W3D4 <3\(_A[K>@:IX>OM82UWZ
M7;^(TE"WTMTZ-?ZI!=0@2RC?(1%&P9V^8MZY-1_ OX<S>$UT6PU;2+Z2Y\,V
M+6=KJS^)+FXMYUVB,-':O(5C+H 67: K#"Y&#78'XB_#\0W$Q\<>'1':R+%.
MYU6';$[;L!CNX)\N3_OA_P"Z<7M9\6>%](FLX=5\1Z38R:B-UFMS>QQFX&0,
MIN/S#+*,CC+*.I% 'GWBCX<3W7Q%\1WUYH]]K.E^*)+:5Q;>);K3UMC'"D+I
M+%'(JNF(E=6 9LLP(  )UIO ^J'PUJ=E$+19[[QM::YG>0&ABU"VG;<<??\
M*@( ]0!GO74:AXQ\)6.N)HM[XHT:WU*2X2V6REOXEF,SJK)'L+;MS!T(&,G<
MN.HJ#PKXX\,>(O%&M>'])U:UN-0T&X$%Y!'<1LP.Q&+!58G:ID"$D##JR]J
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M_;O93RO++)"&5+EF"L3'G]V,<YQ7KMKJFF7)Q;:C:3$3& B.=6_> $E.#][
M)QUP#4DU[9Q0SRRW<"1VIQ<,T@ A. V&/\/#*>>Q![T >,6?A?Q'J&L:IJGB
M31?&>HVEQI-C&'N+O3HM0%Y!=F=9(D@=(U$+$.,DY(8 -D!^@T6V\<2:EX/U
MGQ#I-Y/=6S:E8W3H;83P0S2)]GGG5'$>[RXE,@B+ ,WRC' ZRW\9:3+XMGT?
M[3:K!'IUK>17WVI/*G\^6>-44]"<P'H3G=[5OW$T5O"TT\J11H,L[L%51ZDG
MI0!X#X7^''BM/A/_ ,(WJMOXFGUK1O"-_I-IYTNF#3II9+<18C>,+.PE94<>
M:>-N9"&'/IJ^%I(OB9X1U*'38UT_0?#>HV <,N+:6633_+15SGE()AD# "D$
MC<,]1#JNES*K1:E9R*TYMU*SJ091UC&#][VZU+->V<-Y#9S7<$=Q< F&%Y '
MD Z[5/)Q[4 8/PCTF_T/P';:7J-O]GFM[BZV1;U8)$;F5H@"I(QY93 [#CC&
M*Y;0?"7B"W^$/A;1)M/VWVFZ[;75U#YT9\N)+TRLVX-@X3G )/;KQ7HDFI:=
M'>26DE_:I<0Q>=)$TRATC_OE<Y"^_2LGP]XQT7Q#;V=WX=O+;4K.YO)K62>.
MX1?):,29.TG+<QXP.<-N^[S0!Q6A^ ;V&Q\(P7.BQ :;X[U36[X&1#LCE&IM
M#,2&^8EY[8X&2,C( 4XRM1\%^,+#Q9IVOVBZS!;V>I:^)(M&:Q>X6.]NHIHI
MU6Y5HRI$3A@,2#S1VW@^PV.HZ?>2M%9WUM<.B*[+%,KE5894D \ CH>]-M-4
MTRZNGMK74;2::-V1XXYU9E9<;@0#D$9&1VR* ."\1>#K^/X*Z-HNAV5]<R:1
M?V&H-INH3P+/<QPW4=P]NS1D0A\*0H!$>Y5!.W)K'U[PGKWBKQO=>)9/#EQI
M]G/?: HL+R6'S9A97DL\ETX21E&%E15&=Y\HY!&T5ZS)>V<:7#R7<"+:+NN"
MT@ A&W=E_P"Z-O//;FH-9U)+*&'RQ%----$JQ&X2,E'FCC9P6/(7S <#DG"C
ME@* ,3P[IVHZ7XS\8:J]C(UKJ,MM<6JQ.FZY=+9(WP"PPW[M%RV,[1S@5Q.F
MZ+XF@N+?QJWA?41(_C.?5Y=&\RW-Y':R:>UD"?WOE[@=DA4.2$)'+#;77WGQ
M(\-E9!I-];ZD]MK5MI-VD,X'D22NB[SURHW@YZ'!&>#756-W:WMLMS9W,-Q"
MV=LD,@=3@X."..M 'EO@WPMXEG\:Z=KVM>'Q9+%XEU341&]Q#(UO%-;"*%CL
M<C>1D$*3@D\XP3F77@WQGIOB/2=:M$UF"WL]0\1++%HSV,ES&E[?K<03*MR&
MC*E8V#!<2#S!VWBO8X;^QEU"6PBO+=[J%0TMNLJF2-3T++G(!]ZYGX=^.HO%
M<MBD>FO:_;M M=9!:4-L6=G41]!DC9U[YZ4#-3X=:/#H'@72=&MTO8XK.T1$
MBOFB:>(8SL<Q?N\KG;\GR\<9&*P/ %AXC\+?!V\@CT;[3K=O/JES::?]HC N
M'DN[B6%2^[:H8.G)/&><$8KKYM3TZ*\2UEU"UCGDD\I(FF4.S[0VT+G).T@X
M]"#3IKZRAOHK.6\MX[F<$Q0O* \@'4JIY/X4".3T7R/AQX)\-Z#.L^I7U_?Q
M64DD(&^ZNYV>:YN6SCC/GS-[!L#M5?XV-XLO8;+P]H7A_5;O2]2W_P!M7^FW
M5K'/% ,9@B$TT9#RY*F0?<4,1\Q4CM/MUEY*2_;+?RY)?)1_-&&DW%=@/=MP
M(QUR,4V\U+3K.*66[O[6W2W*B9I9E41D]-Q)XSVS0!P\MEJVB>*M+\3Z)X)O
MIK-M _LJ71[:>TCN+#RY \  :982F#(IVR$CY, C.WF;S0/&MMX3T#P+>>%-
M0U'0Y+>2]\33:3=VG^E2RS/(VGKYTT3"(LY\Q\?,@"#[[;?8)K^QBDCCEO;>
M-Y=OEJTJ@ON.%P,\Y/ ]:+&_L;UIEL[RWN#;R>7,(95?RW_NM@\'V- ',?$S
M2]3U_P -Z"NGZ;(DT&NZ7?3VTDD:M;Q17,<DFXABI*JIX4G./ESQ6O8>((+S
MQOJ7AN&UG+Z79V]Q<77'E;IFE"Q#G)<+%N/& '3GFKRZGIK7ZV*ZA:M=/NVP
M"=?,;:<-A<Y.#P?2G?;K+^T/L'VRW^UA-_V?S1YFWUV]<>] 'E=UI7Q!U7XD
M:5?:E;:RT.D^*)K@*)[*/38K#9<10O$%_?O(8Y8]X<\-YN,+M!L>'_!&N6G@
M;X=:7%9_8;K1;N=M3>*6/=:K+I][&7R&P^9YH3A<\D'H"1Z2-5TPR7,8U&TW
MV0S=+YZY@'^V,_+^-(VKZ4+*"\.IV8M[I@MO,;A=DQ/0*V<,3[4 >4^ /#OB
M6'4OAG87G@N33U\$:?+9:AJ#W$!CS]C\D?9]LA=XW958EE!&4R,[PLOQBTGX
M@:_K&J:=:6NLRV*7%E-I$=E/9164B1O%)*UP\G[_ ,T.KX5<+CRR.=[+ZK-?
MV,6H16$M[;I=SJ6BMVE422 =2JYR0/:HXM6TJ2VN+B/4[-X;1BMQ(MPI6$CD
MASG"D>] 'GMQX-U<>&=4@ATM1=WGCZSUE<2Q@O;IJ-K(\N=W!$$3\?>(&W&3
M@U_AIHMZGQJURPE13HGA&>>32F#;@9]1V7,JD?PM#F0 ?\\[E?;'IDVHZ?%8
M)?2W]JEK)MV3M,HC;=TPV<'/:L3X=7NDS>%;V]T?1+;2[>'5-1@>WMXU19)+
M>[F@>4[0!ES"6Z9^;DGK0!POQ%TGXAZ[XQ:W^RZS)8VGB?2+JP2WGLH].%C#
M<VDTTLA;_2'E&RX^7@<* #U:NOACQ1'I^A^%V\(S7+Z3XV;69M9>X@$#6[WL
MT_GIF3S#*4EPRE!C]YC(V;O2O!OBO3->\(Z?KAN+>U-YIMO?S6[W"EK59HUD
M <\8X;J0,UK78L[I9-.NA!,)X6\RVDPWF1GY6RAZJ<X/;F@#QOX8VFM:5J-A
MXNMM O-=L9++4].$-E)")K.0ZI-+N"S2(I24;%)!)!BC)PN2+O@#P_XK\"3:
M5<CPU<:HUWHLEI+;6-Q"$TR474MQ%"S22+F)5N&CW*&QY(X^85U$WCKPAHFF
MWFE>'FL)F\/ZA9:5/IMDR1"U,\L$2A5 P%07"9P,9!7@@XZZUO[&YM'NK>]M
MYH(RP>6.5612OW@2#@8P<^E 'F7P1\%:[H<-C/KFEQP7EM\.]#T0N)D?9=0_
M:S<Q JQX!>#YONGC!.#B/3_ VMV7P_\  .E6NDK#/H?AB?3KZ-)HQY+O8K'Y
M9.[# S(N2"1E02>]>IV-U;7MG'=6=S#<02C,<L+AT<>H8<&LGQ/XP\,>'M)O
M]1U;7+*W@TP9N_WRLT1(R%*CG<>PQDT <KX+\$S:7XH\$W;Z/##!H'@R;2I&
M#H?L\K-9;8P >?EAE^89 P>?FYX31_AUXML-'LK#5[?Q(UGJG@32M"U"UT1]
M,D:*6"*5)K>4W0/R'SB5>-MN?,R1\A/NO]K:4(;68ZE9^7?$"U?SUVW!(R-A
MS\W'I3[[4+"RD@CO;ZVMWN7\N!9I50RM_=4$_,?84 >:ZQX&U8^'_B+#:Z>9
MKO7=8L[C3Y9)H_,NDAL=/C5RQ(VE9()<;L'*D@<@GIO!]IJ6G?$OQ8MQI=R+
M/5[B#4+:_#1F$[;6"W:(C=O#@PEONXP>M7/#OBVUU3PC_;;1+;LTEVD5L\PW
M2&WDD1MI[Y$1;@< ^U6O!7B"R\2>';+4[:2)9+JS@N9;99@[V_FQAPK8Z'![
M@9Q0!YG;^&/%7_"+P>!G\.W*SQ>+_P"UV\0^?";<P#4S>^</WGF^<T?[HKLQ
MN8]8^3W/P=T*Y\.^#IK&\LUM;B;6=3O'4,K%A-?3RHY*DYRCH?4< XQ@7/&7
MBO3]#\"^(/$EN\.HCP]I]Q=SV\$Z[B8HFD,9(SM)VXY'&>E+\0_%%EX4\(ZO
MK,YCGFTO2KG45LO/5)+A(8V=@N<G^'&<'&: /&/A'X=\1>(O@W\+M(LM#N-"
MCT>Q_M"365FB,3)/IUQ$GE!9/,+NUTCL&50-C\YV$[=KX5UC5=!\%Z%J?P_N
MK.T\'Z;<0:I"ES;^7J,;:=+:&SM2)@625I$<-)Y8 C3<5;('K=BVCZ8;30;-
MK&S\JW"VEA$4CV0H-H$<8QA%  X&!C%4_$GB;3M+TN6XAFAO;E9(X(;2&9=\
MLTDGE1IQG;F3(+$87:Q/W30!YW;6'C@^'('O-(UF^M=!\2VESI4%]+:G4YK-
M8PLGF%'$;%&=]I9@[*GS9;EL.UTS7==TGQEX:TWPI-NU;QS]K75A-"(+<13V
M[/)+F3S!+'Y'RA%8$^7@_?*^Q^(_$5CI>GWTZ20W<VF0BXN[2*8&:.$$%WV#
M))"[B!CYB,#K3YYK/3-$EU#2;*UD2XD$Y$+QPK.TC#,A<X4DYSD\G\: /,5\
M,>*?^$;?P0_ARX:9O&)U@>(//A^S^1_:GVT3?ZSS?-$?[K;L^\/^>?-:FC>#
M-7L?!VC6D6EK%>6GC:ZU:8+*FY89;ZYD,N[=R6AF' .<-MQU%=-X7\9VNO\
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M0N#MDBE>)P?;<C8/1A@C((-63K&DBZN;8ZI9>=9QF6YB^T)N@0<EG&<J/<T
M><^%]$U[4]<\'K-X3G\,V_A729[6[D>:!XY2\"1"V@$<C%HLJ)-S!?\ 5QC[
MVX*GPG\,ZPFJ>!-1UGP[-8R>&?!]QHT[7,L3&*Y+6*Y38[95A!+AO0<XW#/>
M^$?$^@^)_#JZ[H>IV]WI[;LSHXPA7J&_ND#GGL0:QHOB3X:O#H\ND7UM?VFI
MZW=:1+<I.JK:R6\%W*[-GJN;-@.@(8,"1U /.+/P)XQTJ^TZYEAU];-_#\ND
M36NB-ILDEN!=S.B,+L,OER12QKE",>4N[C!7I]!^&:+:^,-)F@N;>VUK1K#2
M[2^GE22X\N"T,:NQ4_?1V)SQ\W(KT:34M.CTO^TI+^U2R*A_M+3*(MIZ'?G&
M/QJ=I8EMS.TB"(+O+EAM"XSG/IB@#Q2^\%^/-5T>#7+K2$M=?\6/-IGB>WBN
MXL6%A,(8C*CAL.8XK4%54D[KAR!U-:/B?POK5E=:[J6F^']:_M/^WI+[P_=Z
M/-:?N1_9]K !(DTJJ8G:-T*D<!,_)\C5ZA'K&DO'(Z:I9,L,BQ2,+A"$=L84
M\\$Y&!UYJ:\O;.TEACNKN"![F3RX%ED"F5_[J@]3["@#QJU\%>+9_&6MKXE7
MQ ;7Q)J>G:DYT-].-I%)'!:HRR-.OVA1%+;EP4/*%=HW[@?0/'UGJ7_":>$]
M8LM,N+Z"PO)X[I;=HPT*RP,@D(=ERH;:#C)^;..#7227UE'J$=A)>6ZW4REX
MK=I0)'4=2J]2!ZBL72/&NA:VLI\/7]IJGV7418W8BND7R6R06Y/S#@XQ][!Q
MG% 'G?@_PKXGA\.^"?!=UX;GMIO">L+>7>O-/";>=8_.S+%B4RM)<>80P9!@
M22[OX=V]\0? ^JZ_XD\=75DBVL^M^!8=#TK43(!Y<[/?F08!W*%,MLV<<]LD
M''?6^HZ?<77V6"_M99]A?RDF5GVYQNP#G&>,^M)'JFF/J#6*:C:-=(X1H!.I
MD5BI8 KG(.U6./0$]J /!/B!X7U:7X6WUUJ>F>(GU(P:1I:6>MOIJ6;@ZC;G
MR$-FH)56XW,,!9#CG<!TGC#PIK_C37=4U:7PK<Z?:7<OANV-E?3P>=<I9ZO]
MJN)&$<CIL2)R!\VYL/@$%-WKE_:6E];^1>VL-S%YB2>7-&'7>C!T;!XRK*K
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M#P^:T\1ZK\7-"U"ZT2[M[C3?%MT\L5KH/DV]O9^5=0QW#WK#]^94,1(1L R
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M$M4^9U\Q[@94$J9B<8R1W6AZ!)IO[/\ >:%8R75ZS:;?"U62P:UDQ*96CB6
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MBLCQ%XGT30]8TC2]3NWANM=N6MM/1;>202R*I<@LJD)\H/+$#WS6O0 4444
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MQA'Q@9.TX!K0\.ZK8:[X?L=;TJ?[18:E:QW5I-L9?,BD4.C;6 (RI!P0".]
M%RBBB@ HHHH **** "BBB@ HK,\9^(='\)^%;_Q)X@O/L>EZ9 T]W<>4\GEQ
MCJ=J L?H 35+PWXU\-:]XBN-#TK4))[ZULH+Z6,VDR*(9EW1,'90IR.P)([@
M4 =!1110 451DUK2(_$D/A]]2M5U6>V>[BL?-'G-"K*K2;.NT,RC/3)Q5Z@
MHK#\0^,/#NA^+M!\,:IJ/V?5?$SSII-OY$C?:3"@DE&Y5*IM4@_,1GMDT[Q!
MXM\/Z)XHT/PYJFH>1J?B22:/2H/)D;[0T4?F2#<JE5PG/S$9[9- &U1110 4
M45D>'?$^B:YK&KZ7IEV\UUH5RMMJ"-;R1B*1E#@!F4!_E(Y4D>^: ->BBL/X
MD>,/#O@+P7>>+/%FH_V?H^G^7]IN?(DE\O?(L:_)&K,<NZC@'KGI0!N45R[?
M$/P>/B@/AVNK-)XD\@3M916DSB)"A<&254,<>54D!F!/;.1744 %%%% !111
M0 445B_#OQ;X?\=>#;+Q7X5U#[?I&HAS:W/DR1>8%=D;Y)%5AAD8<@=* -JB
MBN.F^*G@2*^N[-M:<SV.NPZ#<HEA<-Y=]* 8XB1'C!!'S_<'=A0!V-%%% !1
M6?XHUS1_#?A^ZUS7]3M=-TVR3?<7=U*(XXAD 98^I( '4D@#DU!:^)]$N?&M
MWX2ANW;5[&TCO+B V\@5(G)56$A7822#P&)'<4 :]%%% !161J/B?1+'QAIO
MA:ZNW35=6AFFLX!;R,LB1 %R9 I1<;APS GMFM>@ HHHH ***Q?$?BWP_H/B
M+1-"U;4/L^H>(YY(-+A\F1_M$D:&1QN52JX4$Y8@>G- &U116+K?BWP_I'C+
M0_"FHZAY.K^)!<G2K;R9&^T"W17F^=5*KM5E/S$9SQF@#:HHK/\ $6N:/H-M
M!<:UJ=K8QW5U%:6[7$H3SIY&VQQ)G[SL>@'- &A1110!YS^UY_R:[X^_[%V[
M_P#19K*_82_Y-'\#_P#8.;_T;)6K^UY_R:[X^_[%V[_]%FLK]A+_ )-'\#_]
M@YO_ $;)0/H>MT444""BBB@ HHHH *^9?V8_^3[_ (W_ /;G_*OIJOF7]F/_
M )/O^-__ &Y_RH ^FJ*** /"/^"D7_)J.K_]A'3_ /TJCJE^U3HD7B/]JKX'
MZ+/?:A90W8\1+)-I]T]O.%%E$Q59$(9=P!4D$'!."*]^FN[6&ZAM9;F&.>XW
M>3$T@#R[1EMH/)P.3CI5/PGK^B>)]#BUGP[JMKJ>GSLZQ75K*)(W*L58!AP<
M,I!]Q0!\H_#'Q'XE74OAOH]QXEUBZ@L?B;K>C[[B^DDDN+6&-_+CF8G,H7MN
MST'I6?\ LU>+M6L/VD-(T;4?%>I^+KG5+S48)[JTUN\69%7<P;4=*N4(@"D*
MJF/RPO\ M=_M"FK'&)FE$:B1@ SA>2!T!/XG\Z!W/GS]N'7!HWC/X7QWWBC6
M?#^BWFKW<6L7.EW4D+_9_(&XLT?(4 G+=4&6!!&:\BL=:\2:]X9\-:'IOCCQ
M1)X6O?B^^D:)K0U&5+N[TIHF!59C\SH"7"N<X([;0!]?>,?!&B^)?%WAKQ'J
M+70O/"MU-<V BD"H7EB,;>8"#N&T\8(YKHHD2.-8XT5$0!551@*!T % 'QQ\
M>-2_X1GQQXT\-^*_B)XT\/Q^'/#5G_PK:.UU2Y5M5N! V^1V7_CZF^T!$(<\
M*Q' &1E?'KQ;XWM9/#L\/B+Q58ZM=>$;&;XK6NEDM_9-H9(,W"(6Q!=$&0%5
M&=F3P,D_9OBK6-$\/:'-KGB&_M-/T^QP\UW=N$C@R=H)8\#EL?C2^)-=T;P]
MX>GUW7-3M=/TRU0//>7,H2*-20 2QX )('XT!<^5OCQKGB/PCXPE\,^ M:U*
M\TGXR:%I]CX6O%OI9TL+I)(H)7C<L2H:UE$I<')<9//-?2GPOU[PWJ^BW6E>
M&M5FU%/"MXV@WTDZ2B2.ZMT0.C-( 9& 927&02>IYK,N_ACH>I_&2R^)FI:M
MK6HWNFPLNDZ?<7:MI^G,\8C>6&(*"'=1R69NO&,#'4:#HFFZ-)J$FGP-')JE
MZ][>2/*TC33,JKN)8D\(B(!T5450  !0!\9?%;Q)\2O#'Q0UWPCI6J:R]G\.
M-;G\<32FZD87>DN]HZ69.[+*@ENP5;C"8[9%[1=$UGQAXN^!FH^)=9UJWN_'
M6J>)M<F>#4)(YK6VGM5DC@AD!W1(8%1<)C =L8ZU]?\ BC7=&\-Z+)J^OZG:
MZ;81.B/<W4HCC5G8(H+'C)9@![D5H4!<^&]>\4^.;;X2Z%I<WBR_7PS9_$/5
M]'U/4M1URYM"MO"W^B0W%]$CS)&3O!;!R0HX'(W_  S=>+]>TGX-Z+JGC_4[
MBRUKQ+J]NFHZ1J5Y'+=6"P,4C>>:.&24C#H)=O3#*V>1]AS1I+$T<J*Z.,,K
M#((]"*=0%SQK]BN\U1_"?C71=1UC4-4B\-^/=5T?3YM0N6GF2UA9!&C2,2S8
MW'J3U]*^;?$WC:^@F^),NG_$/Q:OQ"TOXG75OX/T.&_G:WN8OMB*T0A'R2+L
M,@96X4*@  ;#?=^JWUGIFEW.I:A<QVMG9PO/<3RMM2*-5+,S$]  "2?:N6^#
MOA#PGX=TO5-8\*73WUIXPUB?Q*UT\RRJ\MVJ,S0L ,1E54CKP>IH \)T>U\:
MZAXN^./BS1-?\1W6M>$[^ZB\-:3%J,C6BS/8\_Z/RLI!*%$8$;E&!DFN0^'/
MBNZ?5M,3P!\0?%?B5;SP%J5UX^74[^>X73+Q;4F%P9/]1-Y^Y-JD851U'-?9
MMYJ.GVMP8+F]MXIA ]QY;R@/Y2$!Y-O7:I9<GH-P]:S8V\/^-O L[:;?0WND
M:_9R1_:[*12LT<B%"RN,@G' //2@+GQS^S]XQU:[UOX5GP5X[\3>(?%NHZ=>
M)XKTC4[Z>:UAA2W)A>2-_DB ;9M<<OG))+'*?LR^*/'6I^++&YN/'AN-1N-'
MU>7Q9I=QK.HW5WO1'$9DMFMA!8/'+M"@2*&7*@DX!^M?@;8>$--^%FBV/@74
MH]4T*SM?L=E?),LQF2)V3!D4 ,58./8@UU:QHKLZHJLY!8@<MVY]: N?%V@Z
M-=1_L^_!'Q;JGB37]:U3Q%\1/#LETVIZE)<1Q!);@((HV.$^4@$CEMH))-;V
M@3^-&_: M?V?9=6UDVNC>+IO%$NI?;)=\FB"-98+5I,[F4SR^4W/\..U?6M<
M/\.OA;H?A'QWKOC-=4UK6=<\0!8Y[W5[I9F@@5BRV\(55"1 GI@G@9)Q0%SS
M_P#;VUGQ+H_@CPQ_9.IMI>C7GB*&WU^\%_-8JD!1BJRW,*/)#$S@!G4?W1T-
M>27&O>+XOV>-%O='\=7NK>,_^$WFA^'Z:7>7=RNHVP9 ]K.]U'#]J@0"3,[
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M&@^,-:TS1K--3E:WM+03Q&5TAR1O6-Y-I_AV+MQ@5C>&?%/Q#M?@I\3K_P
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M?L)?\FC^!_\ L'-_Z-DH'T/6Z***!!1110 4444 %?,O[,?_ "??\;_^W/\
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M">,CY3[<5J:MING:II<FFZG86M[93*%EMKF%9(G ((!1@01D#MVH ^2_CO\
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MT:>'2UVV$<NGQ,MH..(@5P@X'W<=!0!\W>//B)?WOQ2UNS\0_'"Z\!:3X?\
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M_P 3 RVZ-8HY(_A\YCCOY7/O]?:UI>F:QI[6.KZ=::A:LRLT%W LL9(.02K
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M9=CWFX/]H([R;@#NZY%5KCX9_#Z?X@)XXF\&Z-)XBC(9=3:T4S!@  ^<??
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MSPYI]]>PV]KH?B6SUJ>&:S%Q'?) 7W6[*6  <.06.[ _A-6M%^%7PWTGPO\
M\(YIW@G1;?2OMBWIM$M%V-<*<K*<]67 P3TP .E 'DGB;Q%\5+?XK6_PF'Q7
MT_2+K2_"TOB"\\2WFA6P?5&-RZ)$L!;RXXHT4;F!+':3QU'.>$OC/\2OB)J'
MPSTRS\3Z=X+D\:>&K^YO;AM,CN=MQ;3N@D@64X&]8BP5B0%8\$@&OH?XB?#G
MP)X]-J?&7A32]::Q)-L]Y;AVBR02 W7!P,CH<5ROC[X&>$_&'Q(T77M:L]-N
M-#T;0YM)3P_)IJF AW1D=&# 1[-@  7Z$4 >(:/\=OBOXL\.^ -#T^\:QU'7
M)-62]US2=+MKB34/L3[%-O#<.D0# AGYSP=N.E;VC_$;XT^,-:^&GA:V\0Z7
MX8U'Q1HFI3ZO>V]C;ZBBO;2E4FB <H2X5<KNVCS&XRHKW3Q!\+?ASK?A#3_"
MVJ^"M%NM&TK'V"R>S7R[7_KF /ESWQU[YK4T[P?X5T^]TR\L/#VFVL^BVC6>
MFO#;*ALX&QNCCP/E4X' ]* N?,'@WQ=XC^'NC^./%^GWRC0]/^.-]!XH26%&
MW6$PMHFFW8RI1V0_+@'<<\"O;OV6_%GB3QYX'U'QIK=PK:=K&M7;^'8! L9A
MTU)#'#NP,LS%';)[$8I/C5\*I_%/P[U?PAX-O])\+6WBB]DG\0S_ -DBX>[\
MT 2R*-Z@2MM7YSGIV.".Z\':%IWACPGIGAS2(O*L-)LXK2V0G)$<:!5R>YP.
M3W- '@_A[XA^.M?^(?BC6KCXE>'?#&A^&?'!\-IX>U*RBVWD*%!YAG)\U99M
MQ\O'R\'@XXY7QC\;?B99Z+XM^)=GXHTF+3_"GC5O#T?@=M.C:6^A69(B6GW>
M:L[!F<!?E 1N&Z#Z)OOAE\/;SX@1^.+OP;HT_B*)E9-2DLU:8.N-KY(^^N!A
MOO# P>*;>?"[X=7?CY/&UUX*T6;Q CB0:B]FAFW@ !R<<N !ACR,#!H ^>OB
M1\5?C%80^/\ Q+HOBS3X;+P;XXAT:RTJ;1XI%O(I6B39-+D,%7S 05VM][+'
MC#O&WQC^*G@6W^*GAJYUVWU_4?"NK:%:Z?K3Z5##]FCU&,N[/"I5&$> J;CU
M8;B17T?>>!/!MU9ZA:7/AC2Y8-6OEU"_C>V4K=7*E2LSC^)P47D\_**=J7@?
MP=J$FN/?>&=+N6\3)%'K1FM5;^T%B7;$)<CY]@X7/3M0!P?[+_B3X@ZIJ/BO
M0?'4TE\NB7-L-/U&ZAM+>\G26,L\<]O:R.D;(5&#QN5P<>GCGQ"UCQ;H/[1G
MQ[UOPEX\T_PS/HNAZ3JLD%S817+:EY%DQ6(>8?D0EBI*C=NDCP>Q^H?A_P""
M_"?@;16TGPAX>T_1;-Y#*\-G $$CX W,1RQP ,G)P!65XP^$WPS\5ZQ)JWB3
MP-H>J7TTL<LMS=62/)(T:[4W,1E@% &#P0 "* /G?Q9\;_C!K^L2/X6/]A_V
M3X-TO7FL_L-I+#?374*RL+B6YE1H;=2?+W1_,#R3T%0:MJ'B/3/VE_&7Q4U$
MVM]?>&_AQ#K5OI,VGPR^1OCE9;99@<J(Y,L94Y9<CH:^E?&GPQ^'GB[5;'4O
M$_@O1-5N].4):RW=DCF-!R$Y'*@YPIR!GI6S'X=T)/$%UKBZ19C4KVU6TN;K
MR1YDT*DE8V/=1D\=.: N?-GA_P"*OQ-T34O#<>J^.=)\61^-_!6H:ZB6FEQ0
M'09X+7STVE"?,B+$Q_O 264]/NU1;XF?&NU^#7@'7KOQ8MU?_$R^M;>*2RT*
MV#:,GE2,1"LC*DTTV$(\PA058*,$8^A/!_PI^&WA6349/#G@C1-,?5H6@O6M
MK-5,T3?>C/'"'NHP#Z5=USP#X*UCP-#X,U3POI=UH%LB)!ILMLIAA"#"[%_A
M(' (P10!S7[+OB7QCXD\ 7S>-Q#)J6EZU<Z?'=)Y"O>0QE2DLL<$CI%)\Q5H
MPW!4^M?+/CJV\41_!OX\RZCXF.I-'\0+6W2&>T5-TRWEIMFW Y"[-B[!P .*
M^W/"/A[0O"OA^#0_#>D6>E:;; ^3:V<(CC3)R3@=R223U).36'>?"WX=7>KZ
MOJEUX,T>:[UXQG5)9+8-]K,;JZ%P>"0R*V?4 ]: N>#_ !'^+GQ1^&,?Q4TO
M4=>L_$]WX;TK2[[2;V32X[46K7<PA<,D9PR(6W#<2> "3DFO0OV9/$_Q&O\
MQ9XD\-^.;J75+?3H+2YL=1N[>RM+S,JG?'+;VLKJJ\!D8XRI/)[>E:AX0\+7
M]]J=Y?>'M-N9]:M%L]2DFME<WD"YVQR9'S*,G@^M0?#OP)X-\!Z=-8^#?#6F
MZ+!</YDZV< 0RL.A<]6QDXR>.U 'AOQZ\?\ Q2M/B/\ $C3O"OBZWT;3?!/A
M*#7H8SI4-Q)/(%=FB+/T1PAR<$C P5YSC-\:/BGX6OM2N-:U.P\0?;_A5_PF
MEG9QZ8MO%IER9%7R5*L7DA4,22[%CMX(KZ2U'PAX7O[S5+N]T#3[B?7+,6.I
MR20*S7EN 0(I#_$N&;@^IIL7@WPG'J$-^GAS31<P:5_9$4IME++99S]F''^J
M_P!GI0!\SZ3\:/C!X8\ ^)];UN0>((XO!D6NZ=<WMI96LEM<O*D>U8+:5FDM
M<2;Q(P!_=E2<FL?XB>+OB[J/P(^(6B^(_$$UQ:IX6M]5M]4FL[&VNOGD"RV_
MDVTK?N9%8%)2 < @Y-?3_@WX7_#KPG8ZE9^'/!6B:=;ZPA34(H;) MTAR-C@
MCYD^9OE^[R>.:9X;^%/PV\/^'=4T'1?!.BV.G:VACU*WAM%"W:$$;9#U8#<V
M 3@9.,4!<\!U;Q1XF\'>+M4DBU/3]0U;1_@2^JV^L'2H$G:5;N0QJ2 ?W:@+
M\F=I(W8R35_0_BG\5/#GB;1Y?$&N6OB2'Q%\.+KQ/'I::7';"TNH81*L4;H=
MSAL[3N)Y)(QP![GI7PP^'NFZ=]@L?!VD0VYTE]',8ME.ZR>1I&MR3R8R[LQ4
M]2Q-7;KP;X>:2VNK+2[.RU'3M-?3M,OXK6-I;"%EV[(MP("C ^4@J<#((H ^
M=_@W\4_B-=_$[X0:?K'Q(TGQ'9_$33[[4=2L+;2X(9=.,=F\J0[TYVA_ER0&
MW1."2.!ZC^T]XNUO0SX;\.^%_$%]INM^(KN=;6WTS18;^]O$AB+N(A<.D$87
M*EFD/3IWKF/@W^SI>>$_BEHOB_6==\.W#>'1=FT31/"\6EO>2W$?E-+<F-RI
M(3("HJ@%CCOGUWX@>!_"'CFQM[/Q?X<T[6H;67S8$O(!)Y3=RI/(R.#ZC@YH
M ^;_ (?_ !@^+'C72?A)I=KXCL--U/QA?Z]8ZO>C389OELQN214R4$@4$_*=
MI)!(8<%VF_%[XH7_ (=\/>#I?%=E8:U?_$#4O"]YXK;3(CB*T&Y66 _NA+(2
M%'&..F3FOHK0_A_X'T:XTV;2?">D6+Z/-<3:<;>T2/[&\Z[9FB 'R%UX..HJ
M#7/AE\/M8\-WGA_4_!^D7.F7]^^HW-J]JNR2Z8Y:?CD2'G+#DY/K0!Y7^PG)
M?2:A\5O[2U:VU:[C\=W,4U_;0B*.Z9(HE,@0$A<[<D D Y .*Y7X_?&CQWX?
M^(&J7_@_Q-->:1H'B&RTJ^L!H5NEA$TA020RW,LGGR3$L2/)7:HSGINKZ0\&
M>$O#'A&SFM/"^@:?H]O<2"2:*QMUA1V"A 2% &=JJ/H!6+KWPC^&.M^);GQ#
MJ_@/0;W5+S9]HNY[%&DD*D%6)(^\-H^;K@8SB@#Y^^)WQ7^,&G:+\5_&&D^+
M[&VT_P"'/B>*TM-*?1XI/MT+R1(T<LI^95 DR"H#$YRV,8Z'XL?%SX@>%_B-
MXF^&%O?PGQ%KNJZ6/ UR]G&0EK=.5G+IC#B$Q2_,V>H)->XWW@+P7>Z9K&G7
M?A?2YK3Q#<"YU>![52E]*"I#RC'S-E5.3Z"N3D^%>HZK^TA:?%#Q-KUG>6^@
M6DUMX>TVWTWRGM?-&'>68N3(0"X   &[/'.0#TR)66-59R[* "Q RWN<<4ZB
MB@1YS^UY_P FN^/O^Q=N_P#T6:ROV$O^31_ _P#V#F_]&R5J_M>?\FN^/O\
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M3TB'1=-\">#M'O+/1],ADGGNY)+MMTWG&7*A Q8KAB><8QTZ7P-\#_A?X/\
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M4 %%%% 'G/[7G_)KOC[_ +%V[_\ 19K*_82_Y-'\#_\ 8.;_ -&R5J_M>?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YS
M^UY_R:[X^_[%V[_]%FLK]A+_ )-'\#_]@YO_ $;)6K^UY_R:[X^_[%V[_P#1
M9K*_82_Y-'\#_P#8.;_T;)0/H>MT444""BBB@ HHHH *^9?V8_\ D^_XW_\
M;G_*OIJOF7]F/_D^_P"-_P#VY_RH ^FJ*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /.?VO/\
MDUWQ]_V+MW_Z+-97["7_ ":/X'_[!S?^C9*U?VO/^37?'W_8NW?_ *+-97["
M7_)H_@?_ +!S?^C9*!]#UNBBB@04444 %%%% !7S+^S'_P GW_&__MS_ )5]
M-5\R_LQ_\GW_ !O_ .W/^5 'TU1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YS^UY_P FN^/O
M^Q=N_P#T6:ROV$O^31_ _P#V#F_]&R5J_M>?\FN^/O\ L7;O_P!%FLK]A+_D
MT?P/_P!@YO\ T;)0/H>MT444""BBB@ HHHH *^9?V8_^3[_C?_VY_P J^FJ^
M9?V8_P#D^_XW_P#;G_*@#Z:HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \Y_:\_Y-=\??]B[=
M_P#HLUE?L)?\FC^!_P#L'-_Z-DK5_:\_Y-=\??\ 8NW?_HLUE?L)?\FC^!_^
MP<W_ *-DH'T/6Z***!!1110 4444 %?,O[,?_)]_QO\ ^W/^5?35?,O[,?\
MR??\;_\ MS_E0!]-4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ><_M>?\FN^/O^Q=N_\ T6:R
MOV$O^31_ _\ V#F_]&R5J_M>?\FN^/O^Q=N__19K*_82_P"31_ __8.;_P!&
MR4#Z'K=%%% @HHHH **** "OF7]F/_D^_P"-_P#VY_RKZ:KYE_9C_P"3[_C?
M_P!N?\J /IJBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#SG]KS_DUWQ]_V+MW_P"BS65^PE_R
M:/X'_P"P<W_HV2M7]KS_ )-=\??]B[=_^BS65^PE_P FC^!_^P<W_HV2@?0]
M;HHHH$%%%% !1110 5\R_LQ_\GW_ !O_ .W/^5?35?,O[,?_ "??\;_^W/\
ME0!]-4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 ><_M>?\FN^/O\ L7;O_P!%FLK]A+_DT?P/
M_P!@YO\ T;)6K^UY_P FN^/O^Q=N_P#T6:ROV$O^31_ _P#V#F_]&R4#Z'K=
M%%% @HHHH **** "OF7]F/\ Y/O^-_\ VY_RKZ:KYE_9C_Y/O^-__;G_ "H
M^FJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** /.?VO/^37?'W_ &+MW_Z+-97["7_)H_@?_L'-
M_P"C9*U?VO/^37?'W_8NW?\ Z+-97["7_)H_@?\ [!S?^C9*!]#UNBBB@044
M44 %%%% !7S+^S'_ ,GW_&__ +<_Y5]-5\R_LQ_\GW_&_P#[<_Y4 ?35%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% 'G/[7G_)KOC[_L7;O_T6:ROV$O\ DT?P/_V#F_\ 1LE:
MO[7G_)KOC[_L7;O_ -%FLK]A+_DT?P/_ -@YO_1LE ^AZW1110(**** "BBB
M@ KYE_9C_P"3[_C?_P!N?\J^FJ^9?V8_^3[_ (W_ /;G_*@#Z:HHHH ****
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M5CQ3\-/A_P")=+TG3?$'@[1M2L]#C$>F6]U:+)':)A5VHI& N$08Z845U5%
M'*>+_AC\.O%4EC)XD\#Z#JC:9&(;/[5I\;^1&.D:@C[@_N]/:M7Q9X9\/^)_
M#,OAWQ#H]GJ.DS!1)97$0:)@I#+\O3@@$>A K6HH YS1_ '@C2;?28-+\)Z/
M91Z#+)-I:6]FD8LY'7:[Q@#Y68$Y/4YYJC9?";X96?B)M?M? 7A^'5&O5OOM
MD>GQK*+A<D2!@,ALLQX[G/6NQHH Y:/X:_#Y/'1\:)X+T-?$+.9#J8L(_M&\
MC!??C._'&[K[UU-%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% 'G/[7G_)KOC[_L7;O_ -%F
MLK]A+_DT?P/_ -@YO_1LE2?MP:[I>@_LL>,Y-4NX[?[=I<MC;*S?---*-B(H
M[G)SQT )Z U9_8QTN\T?]ECP/8WT31S_ -CQS%&!!42$R*"#T.UQ0/H>G444
M4""BBB@ HHHH *\O_:*^ W@CXQ)9W6O"^T_6=,&+'6--F$5S N[=MR00R[N0
M",@D[2,FO4** /EF3]D3Q<9&,?[2/CI5R=H9Y20/<_:!G\J;_P ,A^,?^CDO
M''YS?_)%?5%% [L^5_\ AD/QC_T<EXX_.;_Y(H_X9#\8_P#1R7CC\YO_ )(K
MZHHH"[/E?_AD/QC_ -')>./SF_\ DBC_ (9#\8_]')>./SF_^2*^J** NSY7
M_P"&0_&/_1R7CC\YO_DBC_AD/QC_ -')>./SF_\ DBOJBB@+L^5_^&0_&/\
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MEXX_.;_Y(H_X9#\8_P#1R7CC\YO_ )(KZHHH"[/E?_AD/QC_ -')>./SF_\
MDBC_ (9#\8_]')>./SF_^2*^J** NSY7_P"&0_&/_1R7CC\YO_DBC_AD/QC_
M -')>./SF_\ DBOJBB@+L^5_^&0_&/\ T<EXX_.;_P"2*/\ AD/QC_T<EXX_
M.;_Y(KZHHH"[/E?_ (9#\8_]')>./SF_^2*/^&0_&/\ T<EXX_.;_P"2*^J*
M* NSY7_X9#\8_P#1R7CC\YO_ )(H_P"&0_&/_1R7CC\YO_DBOJBB@+L^5_\
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M*/\ AD/QC_T<EXX_.;_Y(KZHHH"[/E?_ (9#\8_]')>./SF_^2*/^&0_&/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
:444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>151
<FILENAME>tm212692d3_sch14-aimg151.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm212692d3_sch14-aimg151.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" 1, U(# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 ?._[>7_(T?!?_ +*/I_\ Z&*^B*^=_P!O+_D:/@O_ -E'T_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ\08-<T>P\&ZSXFU);#X=7FK/#I'Q!GF598[R1?M37.T?;C'D QLJE@-N?E
M/;:#\7+OP]XYF\5:SXNN-<T?3O@S9:NX69X[6^O3<%/-6$G:DLCX3. 1NP<8
MQ7TQ9Z+HUF4-II-C;F.%H$,5LB[8RVXH,#A23DCIGFH?^$;\._9_(_L#2_*\
MH1;/L<>W8'WA<8^Z'^;'3//6@+GR/\#OB)X\T+1?%_A7QSK?B]]2\1>#+K7]
M'N]<M+NSEL[^.W<W-K;-.JDJ@,;J8SM7:<<FN_C\=-X@_8BTF#0OB]HVD^,6
M\.::]QJ5]K*&:*4F!9//D)9XF=F\LR,,JT@R0:^@]0TW3K^2-[ZPM;EH0PC:
M:%7*!AM8 D<9'!]15.R\+^&K/S?LGAW2;?SHS%+Y5C&OF(2"5;"\C('!]!0%
MSR?]C7QK#K7P[\1&Z?7VN?#^IO#?C4-=_MQ%98D8BUNUR98R!G:2S L1DY%>
M2_LD_&S6M4_:"N-,UW7-8U:/Q@9)=!LI;V.9/LS33RBYE7SBEJ\4,0C-O& 3
MG)!(S7V!I=A8Z98I9Z;96]G;1_<AMXEC1?HJ@ 55M_#OA^"19(-"TV-XYS<(
MR6<:E93UD! X;WZT ?-/QAU#XG^'_C)J/P<T/6M=DM_BCJ,%_H6M_;Y&ET&W
M4YU&.*1B60*J*45<!1)Q@FN5\0>,G_L;XBZSXO\ C;XF\)>-O">IW=KX=\-0
MZMY,9BA0?9 ;5P3>^=QND;=NW9XZG[,EM+66\ANY;:%[BW5EAF:,%XPV-P5N
MH!P,XZX%5KW1-%O-4AU.\TBPN+VWQY-U+;(\L6#D;7(R.?0T!<^8?$&A^)M6
M^*7P936_&?C[1;GXB65_=>)=,LO$]W;16\\6GI.(X8U<"$"0GY!TZ502\UG_
M (:S\6>'[KQMJO\ 9>@ZAH\%G!?_ !,N-*VH;6(N5M]CBZ+$;F!*[F)R?G)K
MZVGL[2>\@NYK6&2XM=WV>9XP7AW##;6/*Y'!QU%4;SPWX=N]1.H7>@:7/=LP
M8W$MG&TA(Q@[B,Y&!^5 7-2O"/V*=:TCP]^RVVLZ[J=IINGVFM:J\]U=S+''
M&/MLO5FX%>[U\[_"+]E71],\F?XE:Y<>+DL[V>[T[0W=AI-@TLK2%O)/^N<E
MCEG&#G&W@4"+MQ\6_'_Q7N)-,^ VA"UT?>8YO'.OV[1V:@'!-I PW3MZ%AM!
M&".<UU7PC^!?A?PAKA\6:W=WGC#QE-S-XCUMO-G4^D"'*P(,G 7D XW$5Z=;
MPQ6]O'!!$D442A(XT4*J*!@  <  =J?0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%<M\1M%UW5)+>XT*[6">TMIUBWS,JF20QIE@ <XC\['HQ6@#J:*X%O"VO13-
M/916L4\+M(9#=,/M[?;(9HPY"Y"I%#Y8#9(WE1E1EH9O"/C"'5&U.'5K6[\M
M"L-I(TD6YDGBG#O(&9?WCQ.6 C&T3;1N$8R >B45Y\WA+Q9'J<MX=4M+Q+BV
MGL&MI?-0(DQ#/<%U?EC("VQ54A65 XV UKZ7I6MGP#<Z)>R,VHR$V]SJ!EYN
M]Y DN%Q]PE&)"<!"-@^50: .JHKSG2_!_B2WN+-=1ECU"PLY(Y7M6NV8W&^*
M5K@-N&'_ -(='4,0,(HXV@'T"QC6&SCACMTMXXEV1Q( %11PH ' & ..U $U
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YG^U%\%M"^-W@F
MS\/ZUJ=[IK:?>B\MKJT"LP;8R%65A@J0WL<@<XR#X/\ \.^O!_\ T4+7/_ .
M+_&OL2B@+GSCH_[+.M:7\*;GX:Z?\<?%5OX7NR_FZ>EG;XVN<NBR8\Q(V.2R
M*P5MS9!W-GB?^'?7@_\ Z*%KG_@'%_C7V)10.[/)_P!E3X"^'?@7H^K6NBZM
MJ&J7&M2Q/=7%V%7B,.$554<8\Q\G)SGVKUBBB@04444 %%%% !1110 4444
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MBBF97!CVMY@PS)/;':<*?FPW7'8W?B[2X-0NK$1W$D]H;9&5%7YWFD5%126
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M2Z1HH_NX)YSBL>#X;62^*H=8FNDD6*X,RVZI+$L9$[2QB,1RJHQB$-N5@WE
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M@R:A=:[>S3I;+]L4ZG=2+(BI:;E0(&9"WDW \Q%WCS2W))JQ>:#XRM9M4O\
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M-*IV+P!GCDBMC5(O$Z:]J-U#:ZA<+'=6S67E7<20O:@P^;$$+K^]W"8[G'3
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M9H6"QNZ7!*.)2IW*&R% +X9A6G9Z/XQBN#<Q7%U"L-S ;:V>Y5D\MM1F:<R
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $90RE6 96&""."*@TNP
ML=-M!:Z=96]I IR(K>)8T!^B@"K%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<#JWC?5-,NFU&>.RGTN?4[NQM;6.)ENO\
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M1KL:X9RK[#/'D[%)Y(4DA:[VLIO#'AMEN0?#VE$7F?M(-E'^_P L&._CYOF
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MXN$:)=VU&1W(*KO<J#PI8D8)H#0["BBB@04444 %%%% !1110 4444 %%%%
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M*&6X)*<[B*B9/AU<Z+#ISWK&Q@<K:PO<SJNV2":,+%DY:-XS,$VY4[3M^Z,
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M:&^FCD0EIB0K*P*J?M$W QC?QC:N+NB>'=%TAH3IMBMO]G698E1VVH)G5Y
M3C!9%/MC P* -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,WW@V1@'-1V?@:QM;.ZM8-5U-8;Z,BY0M$?-ER3YY)CR)!D="%^5<J<5U-%
M')WOP^TFZ\^.2^U 07C%[R!7C"7+^=),K,=FX%9)6(VD#A000,58D\%Z8;ZW
MNDN;J-K:Y6Y3;Y9/F+#'""&*%E&R)<A2 V6#;E.*Z2B@!L*E(E1I&D95 +MC
M+>YP ,_04ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.13(':<#8>"0 0V>/+=+_9Y&@K)#:^/$BU/4+]Y;6632&>.1FM+R"9I8_/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7FUQX:\9)X>U32K>\:".YU>[NDF^W"'R(99KF56A:- RN&DA+>
M87&%;;R!7I->=ZCI'Q!N-2N(/MC'3I9)[;'GIGR0YGBFYYR5/V9E/./GY'-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%>!^)'^,*>)/&&@
M:(-;:+P_:ZKJFBZC(&,>I274*&TM4=OED,#R7@"-D*8[?/% 'OE%?/.I6/BJ
M_P##?BJ;PS<_$,Z/!'I;Z*-1FU&WU'[6TK+>[1(5G>+RC$<."@;>4P!QTGPK
M_P"$@M/VB?%VEZI_PD;:3;21IHCWO]JRVY@%G:9VS/FT?]YYV2S&4ONH ]BH
MKYH\'Q_%74=<\;QO?^,+.:UCU*[TR6XM[U;=;F#5)7M(PLP"3)+;^4H6W.QH
MMP;Y\&NS\;:7\0[O]FK3[6RUK7+?Q9KVI:;+?7=HLBS:=]IOH3.J)RT<4,3N
MN#T2,EOXC0![)17S%I_B#XX:BOB+5YM \66]YXITNSM-*TI8&C31YO.:VGD5
MFQ'&X2*6<.Q .^+. PI^H:]\7H_"]DMWI7C2UN]"M8+34/)LY[B2Z,.MV ,P
M,(83N]B968Q[L@S 9 - ['TU1570]0M]6TF#4;6.ZCAN$WHMW9RVLP'^U%*J
MNA]F4&K5 @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)B@+;(7R,C[T;Q\;02 :/C#Q=<Z;\.[+Q#;VC17-]"DB6\L(DV,T+2[&S)&
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M$[06P".<\ $<MX.\5^(;FZT'3=0^P7$UQIT,M].$$'FRL9EE2-3(</"T2[U
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M6*07,MHI^0K\R0JI()(.21Z]3X'\26GB;18]4M%\NWNFD-H'?]Y-$C;#(5[
MMGUXVG/.  ;5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %<+H?B75KJVOWU+1H)XYM9N=,TR)(4B28)<3H2\AE<D;806)1.>%#
M9%=U68_ASP\ZW:OH.F,+]P]V#9QG[0P;=F3CYCNYR<\\T <5H_Q+AC\+Z1JM
M_H\C17%A&;VXB:,,DW]G-?LB1@_.OEJ1P?O, ,C)$VI>.--.D#3-6\,:A:0W
M?[E+>6)H!+$IS<2(&",$BBQ(3@$\JH)%=,WA'0FU^UU8V%OYMA (+1%MHE6!
M-C1[5*J&V[7<;"Q49X&:O1:+HT=JEM'I-BD,:NB1+;(%57&' &, ,.OKWH Y
M,?$'3K>R-Z=$FCTJ%&3SHRN__CU:[4+%QE3 JG.>&8+CAF$/B+QK<:=X?U.W
MM- 6WU72;2ZE:)94:&V$4,,A96P-QQ<Q?+@9^<9X!;LFT;1SJ$=^=)L3=11>
M3'.;9/,2/!&P-C(7!(QTY-5_^$7\,G3X[ ^'=)^RPR>;%;_88_+1_P"\J[<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9/,5U!0@3PMA@"5=6&1S0!N45E:#XDT;68=/ETV\,RZK8F^M,PNA:$; 68,
M4.9%&UL-G(Q\K8H:?X]\)7L-]+:ZNKKIUA!J%S^XD4I;S)YD;X*Y;*\X&2.
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *Y/QIX/?Q%J&K"6[6"UU;PY/H[E5W21F0MEP#P0 W0]ZZ
MRB@#E=#TGQ'=>-K;Q%XC32[9M/TN:Q@@T^=YA*TTD+RR,SHA4?Z/&%0;NK98
M\5DZM\.[G4;KQ%#)J,,-C?6TZ:,BQEC92W+++<-(IX<&:-' ST9UX!KT"B@#
MA-8\+>(O$4.MW6LC2[&\O?#\^CV<-I<R3QJ902\LDC1H>HC 4*=H5CD[L"W-
MH.K67Q*U+Q3;6JWD%Q90HD*:K+"^Z)9?E\G'E2;C( "[#'7C%=A10!R_CCPU
M<^+M'T>&\*6,EO.UQ<B.3S&@=K2>(&)L#+)),K!B!]S/M7.P_#WQ!=1WSZCK
M=O:W>O+9-K%WIZ OOAFN)66(2HRLF'@A&]3F-&R,XKTJB@#R^\^%>HSVLUE/
MK\EY!;QZB=/FN6"R&6YDMIQ]HCA1(I8Q-%-F,KM*,BD'!-;?A?PAJFA^.M1\
M1VMQ:$:]=[]4MW+-\BH!$T3XR&5MP*8VL'S\K [NUHH \SUSX<ZM?>/]5UJ.
M:SCAO;R6YBE>[F=E5]+2S,?V?'E(V] _G EMHV8PQK5CT7Q=;:GI6N6UEHKW
MMAITNF2V<FI2B*6)C"ZRK,("RL&B8%-A!# [@5 KMZ* ."\(^$O$'A*^^UZ8
MVF:H]_9Q1:BEQ,]J$F6>>5Y(2L<A*$W,F(S@+L7GYF-.\.>"M1T#6M<U*R_L
MZ]7Q!=W,U_9W3,%E#%S#B3:Q4#=L=-I7#%AA@PD[NB@#@V\':Y<_"7Q%X7FF
MM8)-5BGBTZV6]FGAT^-X501"=E#E0X=A\HV!PBC""L_2/ 6NV&J6^H*EJRI-
M>.+--=NXS")_LIYN@ADN/GMY&/F #]Z!T05Z910!P-OX5\36^G)!"NE^;IOB
M*\UFP=KN3;<B>YN)#%*OE?N_W=RPW OAU5L'&*JZM\/];UA;F_O+FPM+[5=8
M$U_!!(\D2V+6JVDMNLA169FC4/N*CYPHZ*#7I%% ',>!?#%SH?B#6[VXN8I8
M;R?%@B YB@,DL[!\_P 7G7,PXXV+'WS7''X4ZO'X4EM;;4[./4_L5K9QS?/Y
M;PK:16\\;\9*MY8=?]I(R>A%>L44 <%\5_!&I^)]<M;NQDM46.U\D2S7DR?9
MI!,DB3>2@V7&TID)(0N0*+7POXGM-+%O FDF73_$-WK%B[W<FVY$]S<2&*4>
M5^Z_=W#+N7?A@#@CBN]HH \\M/!OB%/$VGZ_<BREN1)?RW<%OJUS;)$9Y;9D
M5&1,S!4ML$.%#$YP <#<\0:7K]MXN;Q%X=ATRZEN=/6RN+?4+AX OER.\<BN
MD<AX,L@9<#.5.1MYZ>B@#S;PG\,)M OM)O8-12YN-(-I&GFLZQ31I;>1,QBY
M1'.YG1E&1@)N"LPJWJO@;4;KXL_\)/&UJL(N+:>.9KN8O#Y<;(ZBVQY3,ZLR
M^83N4,<#-=]10!YMI?@'Q'=^#?"OAO6-5BTNW\-6"PM+I,L=P]Y*MN+=2RW-
MN4";&GRNTG)0YX.;OA'PQXK\+2Q26LVGZTS:?;:?.]]=O!*4MGE6*8NL+[W>
M*12Z850ZDJ<.<=Y10!QW@[PC?^'?%%_JEK=P20ZU?7$^HP2%B0"[O$\38R"
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MJ-CH]O;ZM);W-[';0QW-]'PUY*L:J\C+@;<L#@9/&.G2M2BB@ HHHH ****
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MZ2ARF]3)O.=A&45ESQGAL5=8^(FBZ3JFI6^I6M_;VFDSO!=:BR1M '2R%\P
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MK%OXQC.Y<U+KXF:-!-JROIVI%-)MKR?S$\AA=BU56E$0$N[HZX+A5)(&1D4
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M%G@T<62#Q7H]E+;Q^(MT;_/,)!DW"8_>$,PS)VZ5P]K//X:\=2_#35M/NO\
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MBUA4^WY_TBX9RLJG]V0%12!LZXK[H_MK1_\ H+6/_@2G^-']M:/_ -!:Q_\
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M/1)%+=[&NF0QQ/MEC3S64XF]UKZN_MK1_P#H+6/_ ($I_C1_;6C_ /06L?\
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MKG_@U;_"C_AB+X$_\^&N?^#5O\*^C** NSYS_P"&(O@3_P ^&N?^#5O\*/\
MAB+X$_\ /AKG_@U;_"OHRB@+L^<_^&(O@3_SX:Y_X-6_PH_X8B^!/_/AKG_@
MU;_"OHRB@+L^<_\ AB+X$_\ /AKG_@U;_"C_ (8B^!/_ #X:Y_X-6_PKZ,HH
M"[/G/_AB+X$_\^&N?^#5O\*/^&(O@3_SX:Y_X-6_PKZ,HH"[/G/_ (8B^!/_
M #X:Y_X-6_PH_P"&(O@3_P ^&N?^#5O\*^C** NSYS_X8B^!/_/AKG_@U;_"
MC_AB+X$_\^&N?^#5O\*^C** NSYS_P"&(O@3_P ^&N?^#5O\*/\ AB+X$_\
M/AKG_@U;_"OHRB@+L^<_^&(O@3_SX:Y_X-6_PH_X8B^!/_/AKG_@U;_"OHRB
M@+L^<_\ AB+X$_\ /AKG_@U;_"C_ (8B^!/_ #X:Y_X-6_PKZ,HH"[/G/_AB
M+X$_\^&N?^#5O\*/^&(O@3_SX:Y_X-6_PKZ,HH"[/G/_ (8B^!/_ #X:Y_X-
M6_PH_P"&(O@3_P ^&N?^#5O\*^C** NSYS_X8B^!/_/AKG_@U;_"C_AB+X$_
M\^&N?^#5O\*^C** NSYS_P"&(O@3_P ^&N?^#5O\*/\ AB+X$_\ /AKG_@U;
M_"OHRB@+L^<_^&(O@3_SX:Y_X-6_PH_X8B^!/_/AKG_@U;_"OHRB@+L^<_\
MAB+X$_\ /AKG_@U;_"C_ (8B^!/_ #X:Y_X-6_PKZ,HH"[/G/_AB+X$_\^&N
M?^#5O\*/^&(O@3_SX:Y_X-6_PKZ,HH"[/G/_ (8B^!/_ #X:Y_X-6_PH_P"&
M(O@3_P ^&N?^#5O\*^C** NSYS_X8B^!/_/AKG_@U;_"C_AB+X$_\^&N?^#5
MO\*^C** NSYS_P"&(O@3_P ^&N?^#5O\*/\ AB+X$_\ /AKG_@U;_"OHRB@+
ML^<_^&(O@3_SX:Y_X-6_PH_X8B^!/_/AKG_@U;_"OHRB@+L^<_\ AB+X$_\
M/AKG_@U;_"C_ (8B^!/_ #X:Y_X-6_PKZ,HH"[/G/_AB+X$_\^&N?^#5O\*/
M^&(O@3_SX:Y_X-6_PKZ,HH"[/G/_ (8B^!/_ #X:Y_X-6_PH_P"&(O@3_P ^
M&N?^#5O\*^C** NSYS_X8B^!/_/AKG_@U;_"C_AB+X$_\^&N?^#5O\*^C**
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBOF>;]DO6))GD'[07Q%7<Q.T7SX&>WWZ /IBB
MOF7_ (9(UC_HX3XC?^![_P#Q='_#)&L?]'"?$;_P/?\ ^+H'H?35%?,O_#)&
ML?\ 1PGQ&_\  ]__ (NO)?VT/@CKGPK^#!\51?&/QMKC#48+?[)?WS^5\X;Y
MOOGD;?UH ^]**K:.I72;569G*P("S=3\HY-6:!'G/[7G_)KOC[_L7;O_ -%F
MLK]A+_DT?P/_ -@YO_1LE:O[7G_)KOC[_L7;O_T6:ROV$O\ DT?P/_V#F_\
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ME-PRARH(/7<#T!RNI?M"Z=I&GRV^K>$M8MM<M]2BL&TN22 L?,M/M:RET=E
M\KJ.H<A>GS5Z-XT\#>$_%EU%<^(M$M[Z6&UGM%=RRDP3)LEB;:1N1AC*MD9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %?-G_!5;_DU5O\ L.6G\I*^DZ^;/^"JW_)JK?\ 8<M/Y24
MMSZ,TO\ Y!MO_P!<5_D*GJ#2_P#D&V__ %Q7^0J>@#SG]KS_ )-=\??]B[=_
M^BS65^PE_P FC^!_^P<W_HV2M7]KS_DUWQ]_V+MW_P"BS65^PE_R:/X'_P"P
M<W_HV2@?0];HHHH$%%%% !1110 5\R_LQ_\ )]_QO_[<_P"5?35?,O[,?_)]
M_P ;_P#MS_E0!]-4444 <_XLO=4M/%7A>*TNXH[*^U&:WO83!N>8?9)Y4PY/
MR@-$"0!D\<@ AN@J&XM;>XFMY9X4DDM9#+ S+DQN49"R^AVNP^C&BQM+:RM_
M(M($ACWO)L08&YV+L?J68D^YH FKAOBCJ>OP^,O#ND:++K2Q7L-W-<KI"V)F
M/EM %+&[^41CS6SM^<Y&.AKN:XOXG6UKJ7B#2=,?PEI^O77V6[NXC>79@,*1
MF!66,A&RSM+'P2J_+DG@4 9^B^/=035ET<Z3=ZK+_:=PES-%'*3;P/J=S;0D
M!(F3"+"Q;>Z85,C><BK0\9:_=6?A?4[72-.CTWQ%<DAFOW:86QLYKB-MOE;5
MD(C!*Y8#IDYW!FDZUX#OK[2]1?3;>WO;B0"QC-JSW:33&2>2-U12 0T<CL0S
M*"C,2,9I^FWWPV^PI+86*[/MZS000Z7/YAF='=98H@FXJR-*=Z+M(+\]: *=
MO\39(]%34WT<RV"QB(SO>#[0]P-/^VX,0C V%?EW @YYV;/FKJO!NO76KRW=
MMJ&FK87=H(G:)+CSE,<B;E.[:N&X8$8P"O!(-<K#J/PQ/G:M-H'V>6$W.G,9
M-$F,AB@7R96VJA/E!,(9,8"LJDC.VNCM/$OA2/5IXK*4R7;SQVDIM;*63>X0
MLJ[D0A@J')(.%#*21N&0#F/&7CW6SX>U%-+TR"UFNK.];2;LWN7'D3I \DB&
M$B-@95=0=X.,/M/!Z7Q[JFHZ-X;T^.SDCBNKZ_M-/-U-F1;?S9%0N>!N;G:N
M0 79,C!(I=9TOP=HC76IW6C6ZRZH_E3&WL&GFNF8[RH2-69LE2[!1_"6/0FE
MU+Q'X1U'2_(U&6*XTV^L_M DNK-S9W,/E>;D2,OEO^[!; ).%)QP: ,S6]4U
M#PIK.GVUUK=QJD9TJ^F9M0$:-<3"XLTA7_1X>N9F10D9)+@88XJ"R^(MS=0Q
MO%X<E#36]UY"/+(C75U;R7"/;0YB&7_T<MA]C[&R$)5@*T>I^ UUG_A';K0C
M!:?9+9[9KC2[A7W7-TR$.KQAHAYMO;D.V!G;R-HI;]O!&E^,KS1KGPU:VUII
M&F12FX73Y6)>[GEC6.$)&069FD'R$NQE*@</0!K^*?$]P/@UJGBG2Y8([J#3
M9YHC'ND6*5 P*D2(IRK*05900000"*GTKQ));^ -7\1:IOF72[G5&=8D&XQ6
MUS.JJ!W.R)1[FDT/4O!FJZ='X8TV*&6UN+1R;#[%(JK%YCQN)5*C8?,212KX
M.X,",U<L]5T!+/5+.WMYE6P62XO;0Z?*K,)'D9G6-D!D#NLO*@AB#C- '):M
MX\U;1-0UF;6-.);3;>6<6-E=I*C>59-<%0[1JV6Q@9"X/J.MR\^(US9:GJ5M
M>>&YS%I*,EU<6QF>-)UMTGV[VA6,1D.%#EP=V,H%.ZJ?@W4OA_J%]-I$/AV&
MSBNHH/+673Y%,JW%O@+,2F$++NC 8_,!A<\"M*SUOX;ZO?Q:G%#!<2>(K6-?
MM4FFRB*[@E!2,R.R;-L@4JA<C>!A21Q0 FL>+_$>D:U);ZCHFE^6NGPR(EOJ
M,CLUS+<^1&A=H5 0LR98CY02<'%+_P )UJAU:72(O#(GU*TAOY+J&"^W)FW6
MV9$B8Q@R-(+N'&0NTAP>5 ,NBP_#W5?#L[V>FV\UA8VDD<B36,@(MI5#L KK
MN>-U (P"K;>,XIDE_P##C1[,6216:0+#,C"ULWD6.*58YIG=D4[4(:%WD8@#
M<A8C(H OWWB6Z?X5W_BC3(;.2ZM[&XFCA:63RA)$'!1RT:N"&0AE**P(*G!%
M4;/QM?G5H[:ZT6W6VBOK;3;VYBO69X[J:!)@(XS&-\8$T0+;@1N8[<*2;TVN
M>$-!TRXTJ5/L5K:;8FM6TZ55E\V41 1KL_?;Y9%7Y-V6<9^]SGW3^ ]$\6*T
MVA_9[[2]/BFBO!IDC!(V+Q1HCA3F3YF15'S?/M7.2* -'QQXN3PQ>VYO;+&G
MO!+++>,SA044MY:A48%R <!V3/12QR!AZ7\0M=O_ +/;P>"YA>W,4TR12W$L
M,;I'%$^4>2!2Q+2[/NXW#K@YK0U+Q)X N[Z'4K]XIKBRA\U9)K&4M:JTKP?.
M"G[MO,62/# -D.,=:?X!N_ ;WB:;X8M8;>:S6<1Q+820>4%:-)D7>H *D0JR
MCE<*"!Q0!E7/Q4BF:%]#T"\U6"X5YH'@65FN(8X[=G:-8XG^8-<A K%5W1L"
MR\9ZOQ9K%WICZ?:Z=8PWE[J=T;>!+BY,$0VQ22L6<(Y'RQD !222.P)'.MJ/
MPN2SA$L6GVMKI,[O#)-9/#% 93*[.CLH4QR-%+\P)1V7&22!4_BKQ'X(UC2;
MRTU(0W:60EE*7MK-'$DL,9D9?,,9VNJ9)5<N%W':1F@"#PW\17UB:UFBT)HM
M/FGM;>2>2Z'F)+/"LB@(%PP!8*6W <@KN%'Q@\2>(-%CO+?28+80_P#"+ZKJ
M!N3*1/#-;K%Y>Q2I4\R]&(S[;<--)K_@/33(@2QMK.R9WE<6DB+'+:R0VP\L
M"/:PC9DC)4_*0H /.UWBKQ-X!N-'6^UX>=;1PW1?SM,G9X(D 2X,J>7OC0!U
M#;P!@C/&* *>M_$34--DEL&\,O<:M#</&;.UFFG#(L$<V5>.!CN/FHNTJ!G/
MS8&:N_%[6-7T_P ,Z9-H8U%+B^U2V@,=G';_ &ED<DLJBY_=AL#G=C'/>KOB
MZV\(?:X8M>TM)'NKE)DE:PDD3SRHA0F55*JY!$8!(+!MHSG%4->U_P )Z]X+
MTF_UC1;R^T[5K^".VM[C2Y&=)2QV.\97*@$?>Z>F<T 9V@_$'5!I-H;_ $VW
MNI+6&T&LSI.87AEGN'M]L<.UM[(\;;QN R"$+D8J:Q^),E]K\>D6&C)<RW-U
M EK.MQ*D$T$J7;K,'DA7<-MFY^0.I#+M=JA\-ZI\/M5TFQUNXT.SMKG28XU@
MB33'/D@3F.-8 (_WH67@! VUSQ@FK=S%X:T+PHWC'PMX:TJ:*",W<DK-]C,4
M44<V3ED)5D629 C!=N]@=HS0 _P3XJU/Q!XOM7>VCM=,OM"&H6<:W D:1'E&
MQW&U2C[>J@L!G&3@T[7_ !Q?V6I74%MHMO+;QW<MA!/)>LKO=):-<X:(1DK'
MA67=DG(!V[3NJKHNI:+IWC*1M*\'PV<=Q<I87.H?+%,MQ+ +I8VCQD1_O%!.
M[B23&W&6J*ZU/1(5USQ%JGA"S_X2'39_L!B@=9FO)7MHW54E*KR8I K,5&U5
M?)*+D@'4_#E]0E\ Z/-JMP;B^FL8I+B8N&\QV4$MD*HY)Z!0!TK:JEX;GAN?
M#NGW-M;BWAFM8GCA'2-2@(4?0<5=H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ JCX@T;1]>T_[!KFDV.IVN\/Y%[;)-'N'0[7!&1D\U>HH 10%4*H  &
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'S@9^61>1D<XZ@@ %^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML5_@?X/;4O%E\+K5EF\87]E>WN)X\6[6UQ]I5( 8_D1I=S.#N)+-R.,>E44
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M1UMO[-EL9(%EGA*_Z)-<RQ XB'&;N0'N0J8P029]-^!GA:S\1:'JO]J:Q,-
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MZA:501E0YU%@I([[3CT->E5Y[\8_%GA:[^&.LVUKXET>>:6VVQQ17\3,[$C
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MT?P_H.DW+7&EZ)IMC,R%&DMK1(F*Y!P2H!QD#CV%:5% !1110 4444 %%%%
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MY5Q'' "C%54-=3NN,X5]OT=X<^'HT;1K:TBU)9I+6:PE#_9MF_[+;QPA?O'
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M^[L9KYIIK6V@>:-_M=O)#*7CN/LY"Q,NYMTF%7'))"XSP+4'C3PO--:11ZQ
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BL?QYXA@\+>%;G7+BQN[Y;=HT6VL_+\Z9Y)%C15\QT3
M)9U^\P'O7/\ _"=^*/\ HB_CC_P,T3_Y84 =Q16/X#\0IXH\-1ZNNEWVF,;B
MXMI;.^,1F@D@GD@=6,3R(?GC;!5R",5L4 %%%% !1110 4444 %%<';_ !'U
M2]FNSHWPM\8:K:6M_<V(O;:XTJ.*:2WG>"0HLUZDFWS(W W*I.,XK0\*^-;O
M5/%,>@:KX(\0^';F>RFO+=]3EL9$G2)XD<*;:YF((,\?W@,Y."<4 =91110
M4444 %%%% 'GWB7POKM_XXN+JWA,;37D<EOJXNO^/2T%N(Y+;R\[FW2"1L8V
M_O=^=R 54TOPOXHU+Q-HUUKEH;>QTS[ D\/VX2"Y,%M?J[LJ]5,UQ 0#R0BE
M@""HE\1)K4OQ-ELH==O$5KRREMX'2-DMXC%.LKQC;G.1C+%@&*Y!X%0Z3XJ\
M73>.-.T:YDMH5CBB$GGJL(U(>=/'-(@(W%U$2.$0_+GYOE=2 9T/Q$\/ZIK>
ML:>;262.S2W:*Z\NX:)OFO+*3((YSY<,_(Y&<=ZY'QMX$U^XTC5M+L]-6^LY
M[+4;71X/M@C73GF\LQR<D87_ %@XR4 V@;7;&GXGCO;'XQ7&K([21O::;"K3
MVZ-%;(7OC)M<*' S'&QRQ^]_NXC\,^+=3O-0TJVU/67LX-LA>Y5(98]6N4D5
M3!!,%"&/!^4!1(^[ (:-Z!&+XM\+>)K>34]0GCOIY;C7+7Y;>=%BO[9]8M9$
M1F#>862W5HOG"H SC)4YJ]:^#/$W_"0Z7<3I<PZ=#<-+:6]M/$SZ3_ISS!#N
M8#8T)C0B/=M5&C *D$KX)\2:OXC\6Z.;CS9K2&\6XBG(7<JRV5QF*4QJ$#(Z
M@$ M@L%+$BIO&'C'Q787VMZ?:Q8_L6XA%Q=" 8\BZN(1%*A8%<11&Y#D@@&-
M7;Y<B@8EGX(UZPT+3H1";I/L.GG6[,W6XZA/%(6F&7.TD@]R ZHJ$[<8J>%O
M OB6T\0:;<7T5Q;VL-S)<0+:W,<K6);4;FX9&9V!VR0RPQL4#%@K XP#4EUX
MX\3P76EVZ30W%QL47"Q&.2*[B<SA)X]BEF("1%F!6,$E1N)&-S7=;\2Z3\)]
M'U&XG\S4;QK4:C>+$D:V8EP7<*P*JJDA 7!"@AFS@Y ,33?AUJ%GX7TZQNM/
MCU'[%:Z'++#/.)FEO+>:0W<H,AQO9"@W$C=M S@5V'Q T'4M:U"PDT^X6 VD
M%T4=V.U)V0"%V3^/:XW#/0J#U%<]HWB#QI(T-]<S6ES%#+I\#6]I"&BN_/51
M)*LOH"RL,<#Y@=P((P-'\2^(+C6(M42X^WW$VFVDER/L6!97/V/599(!@8!2
M18EVM\ZA@K$E@: *^JZ%>>'_  ?&VLVS^0ZW .D7-_''FZ-O$L<]NR,Q<ADD
MXR)"TC2!2_!V] \(^)8FT9K^S^V-%-'YZ7CQS6JP-;VT<Q8,V]9@8I-A0$'<
MP;A\BUJ6N^*M/O(M+U/5O(MY'@DN-8BL%_T<2P3MY84AEV^="@#$$X<(3N(:
MDO=775_AU\.]:\2W)ABU-H+C4WC9[="TFFW#XPIW*/-*87.=VT=<4 4O"?@;
M7=,U3PW"]I):V.C:98VL7V(P*+>>&23[2V"PQ'.I3)4%G!(=5(%-T'P%XEL-
M0T!7FN(Q8Z/8Q_;+>6.1[>\0R&Y:0R,"PEW+N90Q?D,!M4T:3XA\76FH:-I<
M4LEK:S3N]F=9)26^MS?NBQ.TW[SS%MA&5'^L)D4OG:P+=0\:>(AX7L+R#7((
M;^_D?[?'<1111Z+.(W9;60,,J"XVEG.6\L[2I=< &]\'_#6J:+K5[>7^E_8$
MFT73;-P;L3&XN8&N3/-P3PQF0[CAG.2P!S7/Z+X;\2WT>I7-I:36URFHZR3>
M37>/MZG4S);PXSN552,@$@! ?ER)&J_=ZWX^DDFF2\BMESJ&V!+$2"/R(U:+
M#'EMSEE)_B3&W:WS'(L_%WB73+77;K35>\OEO=0G716M2S)"+1ITF&!O8&<+
M'D':V_:!O&: +/B3PEXLUG7+G5;C1.;JWU2&S0Z@F_3Y)UL!;3GG *FVE8E"
M60GY=V<UH77A#Q)'',# MY:->337%BMT(_MD3ZE/<%,\ $QR(2"0&P48@,35
MWP+K7B75-?TNWFU2UNM-:&^F>YM_+E>X\LV@B21T&Q3F>?(4 D(G0[A3]0<O
M\;+!=/NRZ9D&H16L\[21M]G;:;A"3$L/";> WF%2,Y>@#9\96-Y<> XK#2=%
MA*L;=7T^5(F,4 92R*I;RBRJ, %MF1W'!X[3O"/BZ'2[BVO+?[5J;:&UGH^J
M->*?[*F"SK\Q^4KD-%^]C4L>A4!!GJ_AG(FF^&8=.OKVX,TNL:E!:_;9VDFF
M"W=RRC<Y+-^[3(_V1Z5S_C2]>[\=:E;^%]2>#6M,TZX9H7U!P;VY:U;R(([=
MFVE%W+*S*H 8* 23+@$5]:\)ZM<M"=(\,OIRFQCATY#>1I_8EVLQ:2Z(1B)-
MZF,Y&6;R2K "1C2ZIX4\6ZG=6^F3Q21V%K<3^=<IJ&TW4<FK6MR H4[EQ;12
M*<X()*CC#',U74M'ATG4+6QO]0?3;Q;2'2IKW5KF!4U!HYO.:29G#*D:>2[@
MG_6!L RX%=O:6TT?Q&T&X34KV^@?PW=1R3&<F"=EELRDI1?W>]@TAW 9(R!P
M*!G-:QX$U4RK)::; UQ%8ZS965RKH'LTGGCDM@')W*@1'0!<[=X  7.#6O">
MK:=97NHFYCBCF?4IM2:>^94NHWU*&:&)W.=JFV6:('H@D([FO3K2>*ZM8KFW
MD$D,R!XW'1E(R"/P-24".*^"]LDO@_4"VGB#3[[5+IK6U>02Q_9RVT*O52AP
MV N4P?E)7!.3X:\!:C96OA+3I;>&'3M)M+!+ZU@EV1M)#;WHD^5<!@9IH&/]
M[&3G%>ET4 >9:5X U2SDLKI2WVJWMM(+.UXS'STNB]Z_)Y)AVQANI3Y!\O%=
M)\1O#,^O:AH]W9I:QW>FR7+0WDL2L]JSVTL:.F1GB1HS@?W?:NIHH \S\/>#
M-4;5=+EETIM+TNVO;::ZTYM0\X321VETCS,02'#RRVWWN6,.]@#7IE%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!YS^UY_P FN^/O^Q=N_P#T6:RO
MV$O^31_ _P#V#F_]&R5J_M>?\FN^/O\ L7;O_P!%FLK]A+_DT?P/_P!@YO\
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M1=+;K-MCB= <EE;<T:EXVVX!PO=Z]HVD:W:I:ZUI5EJ,$<HE2*\MTF17&<.
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M<-JF@Z8L%M!);01"SC"112##QJN,*K #*C@]Z -&W,I@0S(J2%1O5&+*K8Y
M) R/? ^E.IEO#%;V\<$$2111*$CC10JHH&  !P !VI] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ''?'C_DFL_\ V$=._P#2Z"NQK+\:
M:!9>)_#5QHFH27$<%P48R6TOERHR.KJRMV(95/X5S?\ PK;_ *G[QQ_X.?\
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MHHH **** "BBB@ HHHH **** /.?VO/^37?'W_8NW?\ Z+-97["7_)H_@?\
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MW!O5MKPRH5=K29890R@[ER[';UR%).W@$ Y*Z\8WVMV-_;SZG;Z=;S6=ZVG
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MQIU?Q%X@LVT/7?[(N9HY8;>^2*=()(=9M-GE.47(:T,LF " %'S,ZL:^EJ*
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M<A?;C:H^4H?O,,[3M  :'K_A72;G2=(\,2>>FK7KVRP/=S%+,1QEV54<-Y>
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M!P *I^)O!^E:_P"(K?4]45IDM[&:S, =D$J2O$S*Y5AN0^4 4.5;N#BN@HH
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M_I4]3ZO_ ,EN\/?]B[JW_I1IM '54444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 ><_M>?\FN^/O^Q=N_\
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MXQFLCQ1KGB[2]6NO#5IJ<=Y,DVD2KJ$@C@FBBNKN2*2,@1/&Q_<$ [!Q(W=
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MXB6.!Y(EE$3@OOWA'C)VJ0-XYZXL>/K^[TKPQ<:E::A961M1ODDN[1[A67!
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M@5%CLX$A41A@H"@#Y0S,0.. 6)]S5RBB@ HHHH **** "BBB@ HHHH ****
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MTWX=3:S?VYU"[M]5ETQ%@B91<2"]:UC8A%<C)VEMJG!W84\"JZ?$.]=;9_\
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MM=/N+*W@&FQ6RH)I('9B4.2?]'48]S0!V%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G/[7G_)KOC[_L
M7;O_ -%FLK]A+_DT?P/_ -@YO_1LE:O[7G_)KOC[_L7;O_T6:ROV$O\ DT?P
M/_V#F_\ 1LE ^AZW1110(**** "BBB@ KYE_9C_Y/O\ C?\ ]N?\J^FJ^9?V
M8_\ D^_XW_\ ;G_*@#Z:HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \Y_:\_Y-=\??]B[=_\
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M>?\ )KOC[_L7;O\ ]%FLK]A+_DT?P/\ ]@YO_1LE:O[7G_)KOC[_ +%V[_\
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M8Y#'.[2N/B%X@>^U'[!X?ADM8-1.FV\LKL@6<7L-J!(W/#^:SC:/E5!G.\8
M,RQO?%=UIZS:O<:^=.L[Z32)Y-(0R7%RUJKQBZP@+ 23;]P4<&.(-\F^IH;_
M .(:6EK87UKJC:I-(L]Q)#"/)CC_ +&VL/,7Y!_IP/R*<Y(;&WFM;XH-J6C:
M/HW]GW%O9VMA'<3W%I:1R0K,8K.9U1621=B;AG:0W(7TP<CQSX\UJPN+>]MD
MM5MK&^O(_LGG,)[@P:3<7/[P=T9]AQV C;)WX4&=7J5EKT/PWL;&SO\ 4'U1
MY[);F[)5IPKW,7VA^1M&$:3C& !@# Q7+:]-XYL[BSL+&#597M-2<VUTWF2_
M:+?[4G[N0+A#B'<-\ISM^[ODYK=G\:W-WXVG\,:3_9ZS1WI@6ZN'+1@+;0SL
MFU2-TI$PPN1\JLW.W!S[/XAO'JVGV @$RS:@;6[3YBT'F7<\,3>8S ')A)V
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MX#<9V@ XZXM-5T_5M7D=/$T=G?:S%<WKV)N)IC"VG(J&+[V%^T(X98OF&$W
M1UL?#NX\164+7_C:YO\ [9=26=E;VNT&/>UI;F1PL8QGS?.W'[J[&Q@=:-C\
M0+VYO5M8OLJ7EP;6U>:ZCDB@LYVFODD62(N<%3:;!A\.[+AMI4U'X3^).N:O
M'#>OIFE_85>RCG>"Z=S(US>RV@,38P578CY/W@Q''6@#TZBBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MUC#'<2#U4_-\M5?^$Q\.:O-+J4VE0ZJUA<>=HLL=EYLR0_8K:Y>X^;YDQ]H
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M17?><OP/EZD 8&YNITOP[INGWMM=6RR"2U2Z2/<^1BXF2:3/_ XUQZ"LO7_
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9S:QFY$:S;1Y@C)*AN^"><5)110 4444 %%%% !1110 4444 %%%% !1110
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M.'_M[XI_]$YT/_PJV_\ D6C^WOBG_P!$YT/_ ,*MO_D6NXHH$</_ &]\4_\
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M/-,D*=;7@;I%S[9KTZN'_:*_Y);+_P!A;2O_ $XVU S*_P"$M^-O_1&]#_\
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MC_#O2FL-1A$]LUQXF,<AC/W2RBV(4X[9/UKTBN'_ &:?^2!>$?\ L$P_^@T
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M110 4444 %%%% !1110 4444 ><_M>?\FN^/O^Q=N_\ T6:ROV$O^31_ _\
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M7;UQ'[,O_)M_P^_[%/3/_22*NWH **** "BBB@ HHHH **** "BBB@ HHHH
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M)90#C(R.:A'PTT-O#=[XC3XI?'231;/3YM0344\7R-'=PQKN)A4'>VY<E<J
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M*Y/K[^E3:Y\&M+TZ:UMH_BW\:K^\OD>2VM+/QI(TDL:;=[@MM4*N],DL!EU
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M_P##/=K_ -%B^,7_ (6L_P#A1_PSW:_]%B^,7_A:S_X5[%10!X[_ ,,]VO\
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M?_"O8J*!'D6F_L^Z/!KFFZC?_$?XF:TFEZA;W\5EJWBF2ZM9)H9%EC+QLN&
M=5/X5Z[110 4444 %%%% !1110 4444 %%%% !1110 4444 ><_M>?\ )KOC
M[_L7;O\ ]%FLK]A+_DT?P/\ ]@YO_1LE2?MP:[I>@_LL>,Y-4NX[?[=I<MC;
M*S?---*-B(H[G)SQT )Z U9_8QTN\T?]ECP/8WT31S_V/',48$%1(3(H(/0[
M7% ^AZ=1110(**** "BBB@ KR_\ :*^ W@CXQ)9W6O"^T_6=,&+'6--F$5S
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M $<EXX_.;_Y(H_X9#\8_]')>./SF_P#DBOJBB@+L^5_^&0_&/_1R7CC\YO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
*%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
